STUDYID,USUBJID,SUBJID,SITEID,AGE,AGEU,SEX,RACE,RACEN,COUNTRY,COUNTRYC,REGION,REGIONN,SAFFL,ITTFL,HITTFL,TEVLFL,CAEVLFL,ARM,TRTP,TRTPN,TRTA,TRTAN,HENT1ST,HENT1STN,CMSEQ,PARCAT1,PARCAT2,PARCAT3,CMTRT,CMDECOD,CMSTDTC,ASTDT,ASTDTF,CMENDTC,AENDT,AENDTF,CMTREAT,CMONG,CMDOSTXT,CMDOSU,CMROUTE,CMDOSFRQ,CMINDC
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2010-10-14,2010-10-14,,,,,C,Y,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2011-08-18,2011-08-18,,2011-08-26,2011-08-26,,C,,40,mg,ORAL,QD,EDEMA LOWER LIMBS
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2011-08-26,2011-08-26,,,,,C,Y,40,mg,ORAL,BID,PULMONARY EDEMA
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,5000,IU,SUBCUTANEOUS,ONCE,SUSPECTED PULMONARY EMBOLISM
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DOXYLIN (DOXICYCLINE MONOHYDRATE),DOXYCYCLINE MONOHYDRATE,2011-08-09,2011-08-09,,2011-08-16,2011-08-16,,C,,UNK,mg,ORAL,,PNEUMONIA
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,VOLTAREN,DICLOFENAC,2010-07,2010-06-30,D,,,,C,Y,25,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CEPALUX,TAMSULOSIN HYDROCHLORIDE,2011-07,2011-07-01,D,,,,C,Y,0.4,mg,ORAL,QD,NOCTURIA
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PARACET (PARACETAMOL),PARACETAMOL,2010-10,2010-09-30,D,2011-02,2011-02-28,D,C,,500,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,"MOVICOL (SODIUM BICARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE MACROGOL 3350)",MOVICOL                            /01749801/,2010-10-20,2010-10-20,,,,,C,Y,1,BAG,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2010-10-20,2010-10-20,,,,,C,Y,10,gtt,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,AFIPRAN,METOCLOPRAMIDE HYDROCHLORIDE,2010-11-02,2010-11-02,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2010-12-21,2010-12-21,,2010-12-28,2010-12-28,,C,,20,mg,ORAL,QD,EDEMA BOTH LEGS
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2010-12-29,2010-12-29,,2011-02,2011-02-28,D,C,,40,mg,ORAL,QD,EDEMA BOTH LEGS
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DALACIN (CLINDAMYCIN),CLINDAMYCIN,2011-01-07,2011-01-07,,2011-01-16,2011-01-16,,C,,300,mg,ORAL,QID,ERYSIPELAS
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PARACET (PARACETAMOL),PARACETAMOL,2011-02,2011-02-01,D,,,,C,Y,500,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-04-07,2011-04-07,,,,,C,Y,37,ug,TRANSDERMAL,QH,PAIN - ABDOMEN
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CETIRIZINE,CETIRIZINE,2011-05-10,2011-05-10,,,,,C,Y,10,mg,ORAL,QD,RASH/ALLERGY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SOBRIL,OXAZEPAM,2011-07-07,2011-07-07,,,,,C,Y,15,mg,ORAL,TID,ANXIETY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-05-03,2011-05-03,,2011-05-24,2011-05-24,,C,,20000,IU,ORAL,TID,PANCREATIC CANCER/DEFICIENCY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-05-24,2011-05-24,,,,,C,Y,25000,IU,ORAL,TID,PANCREATIC CANCER/DEFICIENCY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2011-07-07,2011-07-07,,2011-09-06,2011-09-06,,C,,15,mg,ORAL,QHS,ANXIETY/DEPRESSION
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SELEXID (PIVMECILLINAMHYDROKLORID),PIVMECILLINAM HYDROCHLORIDE,2011-07-07,2011-07-07,,2011-07-14,2011-07-14,,C,,200,mg,ORAL,TID,UTI
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,KLORAMFENIKOL SALVE,CHLORAMPHENICOL,2011-08-19,2011-08-19,,2011-08,2011-08-31,D,C,,small omount,SALVE,OPHTHALMIC,TID,EYE INFECTION
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2011-09-06,2011-09-06,,,,,C,Y,30,mg,ORAL,QD,ANXIETY/DEPRESSION
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,KETORAX,KETOBEMIDONE HYDROCHLORIDE,2011-09-15,2011-09-15,,2011-09-23,2011-09-23,,C,,4,mg,INTRAVENOUS,PRN,CHOLESTASIS PAIN
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CIPROXIN,CIPROFLOXACIN,2011-09-23,2011-09-23,,2011-09-27,2011-09-27,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-04-12,2011-04-12,,,,,C,Y,20,mg,ORAL,BID,PAIN - ABDOMEN
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-03,2011-02-28,D,,,,C,Y,10,mg,ORAL,PRN,PAIN - ABDOMEN
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LEVAXIN,LEVOTHYROXINE SODIUM,1997,1997-12-31,M,,,,C,Y,50,ug,ORAL,QD,HYPOTHYREODISM
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,SOBRIL,OXAZEPAM,2011,2011-05-03,M,2011-07-07,2011-07-07,,C,,15,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-03,2011-02-28,D,2011-05-03,2011-05-03,,C,,10000,mg,ORAL,TID,PANCREATIC CANCER/DEFICIENCY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,AFIPRAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-05-03,2011-05-03,,,,,C,Y,20,mg,RECTAL,PRN,NAUSEA
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2011-05-10,2011-05-10,,,,,C,Y,4,mg,INTRAVENOUS,Before Gemcitabine treatment,RASH/ALLERGY
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DEKSCHLORPHENIRAMIN,DEXCHLORPHENIRAMINE,2011-05-10,2011-05-10,,,,,C,Y,5,mg,INTRAVENOUS,Before Gemcitabine treatment,RASH/ALLERGY
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FLOX,,2011-08-15,2011-08-15,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2009,2009-12-31,M,,,,C,Y,1.25,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SELO-ZOK,METOPROLOL SUCCINATE,2009,2009-12-31,M,,,,C,Y,25,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ALBYL-E,ALBYL-ENTEROSOLUBILE,2008,2008-12-31,M,,,,C,Y,75,mg,ORAL,QD,ATHEROSCLEROSIS
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2009-05,2009-04-30,D,,,,C,Y,20,mg,ORAL,QD,HEART BURN
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FOSAMAX,ALENDRONATE SODIUM,2010,2010-12-31,M,,,,C,Y,70,mg,ORAL,QS,OSTEOPOROSIS
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011,2011-05-10,M,,,,C,Y,25000,mg,ORAL,TID,PANCREATIC CANCER
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,AFIPRAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-05-10,2011-05-10,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SAG ERYTHROCYTE CONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,2,IU,INTRAVENOUS,ONCE,HEMOGLOBIN GRADE 3
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,5-FU + LEUCOVORIN,,2010-08-26,2010-08-26,,2011-02-03,2011-02-03,,,,,,,,
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2010-07-24,2010-07-24,,2011-11-04,2011-11-04,,C,,10000,IU,ORAL,QID,PANCREATIC DEFICIENCY
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-10-13,2011-10-13,,2011-11-04,2011-11-04,,C,,1,BAG,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TARGINIQ,OXYCODONE HYDROCHLORIDE,2011-10-16,2011-10-16,,2011-11-02,2011-11-02,,C,,5,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-10-10,2011-10-10,,2011-10-16,2011-10-16,,P,,5,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TARGINIQ,OXYCODONE HYDROCHLORIDE,2011-11-02,2011-11-02,,2011-11-04,2011-11-04,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2011-11-04,2011-11-04,,2011-11-07,2011-11-07,,C,,4,mg,INTRAVENOUS,BID,GASTRIC OUTLET OBSTRUCTION
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-10-10,2011-10-10,,2011-11-02,2011-11-02,,C,,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-11-02,2011-11-02,,2011-11-04,2011-11-04,,C,,10,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,KETORAX,KETOBEMIDONE HYDROCHLORIDE,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,P,,5,mg,INTRAVENOUS,ONCE,PROCEDURE NEPHROSTOMY
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-04,2011-10-04,,2011-11-04,2011-11-04,,C,,1000,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-11-04,2011-11-04,,2011-11-07,2011-11-07,,C,,1000,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,AFIPRAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-07,2011-10-07,,2011-11-04,2011-11-04,,C,,10,mg,ORAL,QID,GASTRIC OUTLET OBSTRUCTION
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2011-10-12,2011-10-12,,2011-11-04,2011-11-04,,C,,10,mL,ORAL,PRN,HEARTBURN
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AFIPRAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-04,2011-11-04,,2011-11-07,2011-11-07,,C,,10,mg,INTRAVENOUS,QID,GASTRIC OUTLET OBSTRUCTION
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,IMOVANE,ZOPICLONE,2011-10-07,2011-10-07,,2011-11-04,2011-11-04,,C,,5,mg,ORAL,PRN,INSOMNA
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,APODORM,NITRAZEPAM,2011-10-07,2011-10-07,,2011-11-04,2011-11-04,,C,,5,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CALOGEN - FAT EMULSION,FATS NOS,2011-10-07,2011-10-07,,2011-11-04,2011-11-04,,C,,30,mL,ORAL,TID,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SOMAC,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-10-11,2011-10-11,,2011-10-27,2011-10-27,,P,,20,mg,ORAL,BID,PREVENTION OF ULCER
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SOMAC,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-10-26,2011-10-26,,2011-11-04,2011-11-04,,C,,40,mg,ORAL,BID,PREVENTION OF ULCER
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-13,2011-10-13,,2011-11-04,2011-11-04,,C,,4,mg,ORAL,BID,GASTRIC OUTLET OBSTRUCTION
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-01-08,2012-01-08,,,,,,Y,5000,IU,SUBCUTANEOUS,QD,PROPYLAXIS OF EMBOLISM
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-11,2012-01-11,,,,,,Y,1000,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-01-13,2012-01-13,,2012-02,2012-02-29,D,,,10,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-02-14,2012-02-14,,,,,,Y,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,INSULATARD,INSULIN,2012-01-17,2012-01-17,,,,,,Y,16+8,IU,SUBCUTANEOUS,BID,DIABETES
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TARGINIQ,OXYCODONE HYDROCHLORIDE,2012-02,2012-02-01,D,,,,,Y,10/5,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5FU/PLATINOL,,2011-08-31,2011-08-31,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-01-12,2011-01-12,,,,,C,Y,500,mg,ORAL,PRN,ABDOMINAL PAIN / FEVER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-07-06,2011-07-06,,2011-08-03,2011-08-03,,C,,40,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-07-06,2011-07-06,,2011-07-19,2011-07-19,,C,,25,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-07-20,2011-07-20,,2011-08-02,2011-08-02,,C,,25,mg,ORAL,BID,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-08-03,2011-08-03,,2011-08-09,2011-08-09,,C,,25,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-08-10,2011-08-10,,2011-08-18,2011-08-18,,C,,25,mg,ORAL,BID,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-03-17,2011-03-17,,2011-03-17,2011-03-17,,C,,500,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LITICAN,ALIZAPRIDE,2011-01-20,2011-01-20,,2011-09-15,2011-09-15,,C,,100,mg,INTRAVENOUS,before chemotherapy,PREMEDICATION OF CHEMOTHERAPY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-09-08,2011-09-08,,2011-09-20,2011-09-20,,C,,0.5,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-08-18,2011-08-18,,2011-09-06,2011-09-06,,C,,25,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-09-07,2011-09-07,,2011-09-29,2011-09-29,,C,,100,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DULCOLAX BISACODYL,BISACODYL,2011-01-25,2011-01-25,,2011-01-27,2011-01-27,,C,,2,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PERFUSALGAN,PARACETAMOL,2011-09-08,2011-09-08,,2011-09-21,2011-09-21,,C,,1,g,INTRAVENOUS,PRN,HEADACHE - ABDOMINAL AND BACK PAIN
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-09-10,2011-09-10,,2011-09-10,2011-09-10,,C,,2.5,mg,SUBCUTANEOUS,PRN,BACK PAIN
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011-09-16,2011-09-16,,,,,,Y,1,TABLET,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-08-18,2011-08-18,,2011-09-20,2011-09-20,,C,,40,mg,ORAL,PRN,ASCITES
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ELVORINE,CALCIUM LEVOFOLINATE,2011-08-31,2011-08-31,,,,,C,Y,200,mg/m2,INTRAVENOUS,3w/4,PANCREATIC CANCER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,5FU,FLUOROURACIL,2011-08-31,2011-08-31,,,,,C,Y,2,g/m2,INTRAVENOUS,3w/4,PANCREATIC CANCER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PLATINOL,CISPLATIN,2011-08-31,2011-08-31,,,,,C,Y,25,mg/m2,INTRAVENOUS,3w/4,PANCREATIC CANCER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-09-08,2011-09-08,,,,,C,Y,0.5,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TRADONAL,TRAMADOL HYDROCHLORIDE,2011-09-15,2011-09-15,,,,,C,Y,50,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011-09-16,2011-09-16,,,,,,Y,1,TABLET,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,PERFUSALGAN,PARACETAMOL,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,1000,mg,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2011-09-16,2011-09-16,,2011-09-16,2011-09-16,,,,25,g,INTRAVENOUS,BID,PRE-RENAL INSUFFCIENCY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2011-09-17,2011-09-17,,2011-09-18,2011-09-18,,,,25,g,INTRAVENOUS,QD,PRE-RENAL INSUFFICIENCY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2011-09-19,2011-09-19,,2011-09-20,2011-09-20,,,,25,g,INTRAVENOUS,BID,PRE-RENAL INSUFFICIENCY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2011-09-21,2011-09-21,,2011-09-21,2011-09-21,,,,25,g,INTRAVENOUS,QD,PRE-RENAL INSUFFICIENCY
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-02-17,2011-02-17,,2011-02-23,2011-02-23,,C,,32,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-02-24,2011-02-24,,2011-03-02,2011-03-02,,C,,16,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-03-03,2011-03-03,,2011-03-10,2011-03-10,,C,,8,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-03-30,2011-03-30,,2011-04-28,2011-04-28,,C,,8,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE SODIUM,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-10,2011-02-10,,2011-04-20,2011-04-20,,C,,40,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-04-29,2011-04-29,,,,,C,Y,4,mg,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-02-14,2012-02-14,,2012-03-14,2012-03-14,,,,,,,,
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5FU PLATINOL,,2012-04-03,2012-04-03,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011,2011-05-26,M,2011-06-04,2011-06-04,,C,,16,mg,ORAL,QD,PANCREATIC DISEASE
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-09-07,2011-09-07,,,,,C,Y,100,ug,TRANSDERMAL,Q3D,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011,2011-05-26,M,,,,C,Y,1,TABLET,ORAL,PRN,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,IMODIUM,LOPERAMIDE HYDROCHLORIDE,2011,2011-05-26,M,,,,C,Y,1,TABLET,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011,2011-05-26,M,,,,C,Y,150,mg,ORAL,QID,PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL SODIUM,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-10-13,2011-10-13,,2011-11,2011-11-30,D,C,,40,mg,ORAL,QD,GASTRO-OESOPHAGAL REFLUX
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LYSOMUCIL,ACETYLCYSTEINE,2011-10-26,2011-10-26,,2011-10-27,2011-10-27,,C,,600,mg,ORAL,QD,ACUTE RESPIRATORY AFFECTION
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DUOVENT,DUOVENT,2011-10-26,2011-10-26,,2011-10-27,2011-10-27,,C,,1,monodose,RESPIRATORY (INHALATION),TID,ACUTE RESPIRATORY AFFECTION
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-10-26,2011-10-26,,,,,C,Y,100,mg,SUBCUTANEOUS,every 72 hours prn,PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-10-26,2011-10-26,,2011-10-29,2011-10-29,,C,,2,g,ORAL,QD,ANTIBIOTHERAPY
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,AVELOX,MOXIFLOXACIN HYDROCHLORIDE,2011-10-29,2011-10-29,,2011-11-08,2011-11-08,,C,,400,mg,ORAL,QD,ANTIBIOTHERAPY
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MS DIRECT,MORPHINE SULFATE,2011-06-10,2011-06-10,,,,,C,Y,10,mg,ORAL,PRN,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ROCEPHINE,CEFTRIAXONE SODIUM,2011-10-26,2011-10-26,,2011-10-28,2011-10-28,,C,,2,g,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PERFUSALGAN,PARACETAMOL,2011-10-25,2011-10-25,,2011-10-26,2011-10-26,,C,,1,g,INTRAVENOUS,QID,PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LITICAN,ALIZAPRIDE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,1,AMPULE,INTRAVENOUS,TID,NAUSEA
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,TRADONAL,TRAMADOL HYDROCHLORIDE,2011-10-26,2011-10-26,,2011-10-27,2011-10-27,,C,,50,mg,INTRAVENOUS,QID,PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,0.25,mg,ORAL,QD,ANXIOLYTIC
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,40,mg,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011,2011-05-26,M,,,,C,Y,1,g,ORAL,PRN,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,L-THYROXINE,LEVOTHYROXINE,1998,1998-12-31,M,,,,C,Y,200,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,URSOCHOL,URSODEOXYCHOLIC ACID,2011,2011-05-26,M,,,,C,Y,300,mg,ORAL,QID,PANCREATIC DISEASE
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011,2011-05-26,M,2011-06-07,2011-06-07,,C,,25,ug,TRANSDERMAL,Q3D,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-06,2011-06-01,D,2011-06-21,2011-06-21,,C,,50,ug,TRANSDERMAL,Q3D,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-06-22,2011-06-22,,2011-09-06,2011-09-06,,C,,75,ug,TRANSDERMAL,Q3D,PANCREATIC PAIN
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,LITICAN,ALIZAPRIDE,2011-05-26,2011-05-26,,,,,C,Y,100,mg,INTRAVENOUS,at each chemotherapy,NAUSEA
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-12-15,2011-12-15,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2007-09-26,2007-09-26,,2007-12-19,2007-12-19,,,,,,,,
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,PRIOR RADIOTHERAPY,RADIOTHERAPY,PANCREAS,,2007-07-04,2007-07-04,,2007-08-13,2007-08-13,,,,50.46,Gy,,,
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,5FU,,2007-07-04,2007-07-04,,2007-08-09,2007-08-09,,,,,,,,
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,ANTI-CANCER,PRIOR RADIOTHERAPY,RADIOTHERAPY,L3 VERTEBRA,,2007-12-27,2007-12-27,,2008-01-10,2008-01-10,,,,20,Gy,,,
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2007-05-21,2007-05-21,,,,,C,Y,900,mg,ORAL,TID,PANCREATECTOMY
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2010,2010-12-31,M,,,,C,Y,1,g,ORAL,PRN,MANAGEMENT OF PAIN
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LYSOMUCIL,ACETYLCYSTEINE,2011-06-01,2011-06-01,,2011-06-08,2011-06-08,,P,,600,mg,ORAL,QD,COPD
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PULMICORT,BUDESONIDE,2011-06-10,2011-06-10,,2011-07-14,2011-07-14,,C,,1,PUFF,RESPIRATORY (INHALATION),PRN,COPD
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ATROVENT,IPRATROPIUM BROMIDE,2011-06-10,2011-06-10,,2011-06,2011-06-30,D,C,,1,PUFF,RESPIRATORY (INHALATION),PRN,COPD
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,INSULATARD,INSULIN,2007-05,2007-04-30,D,,,,C,Y,6 + 10,IU,SUBCUTANEOUS,BID,DIABETES
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ACTRAPID,INSULIN HUMAN,2007-05,2007-04-30,D,,,,C,Y,5,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LITICAN,ALIZAPRIDE,2001-06-08,2001-06-08,,,,,C,Y,100,mg,INTRAVENOUS,at each cycle of chemotherapy,PREMEDICATION OF CHEMOTHERAPY
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-08,2011-06-08,,2011-09-21,2011-09-21,,C,,40,mg,INTRAVENOUS,at each cycle of chemotherapy,PREMEDICATION OF CHEMOTHERAPY
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2012-06-07,2012-06-07,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KERLONE,BETAXOLOL HYDROCHLORIDE,1986,1986-12-31,M,,,,C,Y,20,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PERFUSALGAN,PARACETAMOL,2012-06-03,2012-06-03,,2012-07-18,2012-07-18,,C,,4,g,INTRAVENOUS,PRN,PROGRESSION OF PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-06-22,2012-06-22,,2012-06-24,2012-06-24,,C,,1,g,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-06-18,2012-06-18,,2012-07-04,2012-07-04,,C,,4,g,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE SODIUM SESQUIHYDRATE,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-05-30,2012-05-30,,2012-06-01,2012-06-01,,C,,40,mg,ORAL,QD,GASTRIC DISORDER
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2012-05-29,2012-05-29,,2012-06-03,2012-06-03,,C,,25,ug,TRANSDERMAL,every 72hours,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2012-06-03,2012-06-03,,2012-07-18,2012-07-18,,C,,12,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2012-06-27,2012-06-27,,2012-07-10,2012-07-10,,C,,25,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SANDOSTATINE,OCTREOTIDE,2012-06-07,2012-06-07,,2012-06-30,2012-06-30,,C,,0.5,mg,SUBCUTANEOUS,BID,PROGRESSION OF PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-06-05,2012-06-05,,2012-07-09,2012-07-09,,C,,40,mg,INTRAVENOUS,QD,GASTRIC DISORDER
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-07-09,2012-07-09,,2012-07-18,2012-07-18,,,,40,mg,ORAL,QD,GASTRIC DISORDER
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,L-THYROXYNE,LEVOTHYROXINE,1986,1986-12-31,M,,,,C,Y,75,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-06-24,2012-06-24,,2012-07-10,2012-07-10,,C,,5,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-06-08,2012-06-08,,2012-07-06,2012-07-06,,C,,2.5,mg,SUBCUTANEOUS,PRN,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,NEOSTIGMINE BROMIDE,NEOSTIGMINE BROMIDE,2012-06-03,2012-06-03,,2012-07-18,2012-07-18,,C,,0.5,mg,SUBCUTANEOUS,BID,PROGRESSION OF PANCREATIC CANCER
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,EMEND (APREPITANT),APREPITANT,2012-06-22,2012-06-22,,2012-06-23,2012-06-23,,C,,80,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2012-06-22,2012-06-22,,2012-06-23,2012-06-23,,C,,16,mg,ORAL,QD,PROGRESSION OF PANCREATIC CANCER
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ZINACEF,CEFUROXIME,2012-06-25,2012-06-25,,2012-06-27,2012-06-27,,C,,1.5,g,SUBCUTANEOUS,QD,ANTIBACTERIAL
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,TIBERAL,ORNIDAZOLE,2012-06-26,2012-06-26,,2012-06-27,2012-06-27,,C,,1,g,INTRAVENOUS,QD,ANTIBACTERIAL
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,TIBERAL,ORNIDAZOLE,2012-07-04,2012-07-04,,2012-07-05,2012-07-05,,,,1,g,INTRAVENOUS,QD,ANTIBACTERIAL
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TIBERAL,ORNIDAZOLE,2012-07-07,2012-07-07,,2012-07-09,2012-07-09,,,,1,g,ORAL,QD,ANTIBACTERIAL
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ERYTHROMYCINE,ERYTHROMYCIN,2012-07-10,2012-07-10,,2012-07-13,2012-07-13,,,,250,mg,ORAL,QD,ANTIBIOTIC
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,TEMESTA,LORAZEPAM,1971,1971-12-31,M,,,,C,Y,1,mg,ORAL,TID,DIFFICULTIES TO FALL ASLEEP
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ZINNAT (CEFUROXIME AXETIL),CEFUROXIME AXETIL,2012-07-07,2012-07-07,,2012-07-09,2012-07-09,,,,500,mg,ORAL,TID,ANTIBIOTIC
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,URSOCHOL,URSODEOXYCHOLIC ACID,2012-07-06,2012-07-06,,2012-07-18,2012-07-18,,,,300,mg,ORAL,BID,CHOLESTASIS
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,RIOPAN,MAGALDRATE,2012-06-12,2012-06-12,,2012-07-14,2012-07-14,,C,,1,BAG,ORAL,PRN,GASTRIC DISORDERS
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2012-07-14,2012-07-14,,2012-07-18,2012-07-18,,,,5,mg,SUBCUTANEOUS,QD,VOMITING
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-07-18,2012-07-18,,2012-07-18,2012-07-18,,,,250,ug,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-06-12,2012-06-12,,2012-07-13,2012-07-13,,C,,20.5,mg,SUBCUTANEOUS,PRN,PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,"NEOGENYL - IRON, FOLIC ACID, ARGININE",ARGININE,2011-12-20,2011-12-20,,2012-01-20,2012-01-20,,C,,1,TABLET,ORAL,QD,DIETARY SUPPLEMENT
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,"NEOGENYL - IRON, FOLIC ACID, ARGININE",FERRO-FOLSAN                       /00023601/,2011-12-20,2011-12-20,,2012-01-20,2012-01-20,,C,,1,TABLET,ORAL,QD,DIETARY SUPPLEMENT
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-12,2011-11-30,D,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,LITICAN,ALIZAPRIDE,2012-01-03,2012-01-03,,,,,C,Y,100,mg,INTRAVENOUS,PRN,PREMEDICATION OF CHEMOTHERAPY
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,MOTILLIUM,DOMPERIDONE,2012-01,2012-01-03,D,,,,C,Y,10,mg,ORAL,PRN,VOMITING
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,SANDOSTATIN LAR,OCTREOTIDE ACETATE,2012-06-29,2012-06-29,,2012-08-07,2012-08-07,,,,30,mg,ORAL,once a month,PROGRESSION OF PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2012-06-19,2012-06-19,,2012-07-18,2012-07-18,,C,,40,mg,INTRAVENOUS,PRN,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2011-05-02,2011-05-02,,2011-06-15,2011-06-15,,,,,,,,
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SOMATULINE,LANREOTIDE ACETATE,2011-02-25,2011-02-25,,2011-03-11,2011-03-11,,C,,30,mg,INTRAMUSCULAR,Q2S,VOMITING
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-04-14,2011-04-14,,2011-04-16,2011-04-16,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-03-02,2011-03-02,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-03-02,2011-03-02,,2011-04-13,2011-04-13,,C,,60,mg,INTRAVENOUS,before every infusion,PROPHYLAXIS OF ALLERGIC REACTION
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-02,2011-03-02,,2011-04-13,2011-04-13,,C,,1000,mg,ORAL,before every infusion,PROPHYLAXIS OF FEVER
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-02-17,2011-02-17,,2011-03-02,2011-03-02,,C,,50,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ACTISKENAN,MORPHINE SULFATE,2011-02-17,2011-02-17,,,,,C,Y,20,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-01,2010-12-31,D,,,,C,Y,1000,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,IMPORTAL,LACTITOL,2011-01,2010-12-31,D,2011-03-14,2011-03-14,,C,,10,g,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-03-02,2011-03-02,,2011-04-21,2011-04-21,,C,,75,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,FORLAX,MACROGOL 4000,2011-04-18,2011-04-18,,,,,C,Y,10,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-04,2011-04-01,D,,,,C,Y,100,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2011-07-19,2011-07-19,,2011-07-20,2011-07-20,,,,,,,,
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2011-08-10,2011-08-10,,2011-11-21,2011-11-21,,,,,,,,
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ESTREVA,ESTRADIOL,1991,1991-12-31,M,,,,C,Y,1.5,mg,ORAL,QD,PROPHYLAXIS OSTEOPOROSIS
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,BIPERIDYS,DOMPERIDONE,2011-04-08,2011-04-08,,2011-06-01,2011-06-01,,C,,20,mg,ORAL,TID,POST-PRANDIAL ABDOMINAL PAIN
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BINOCRIT,EPOETIN ALFA,2011-04-15,2011-04-15,,2011-05-06,2011-05-06,,C,,20000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-03-31,2011-03-31,,,,,C,Y,60,mg,INTRAVENOUS,before every infusion,PROPHYLAXIS OF ALLERGIC REACTION
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-31,2011-03-31,,,,,C,Y,1000,mg,ORAL,before every infusion,PROPHYLAXIS OF FEVER
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DAFALGAN CODEIN,PANADEINE CO,2011-07-07,2011-07-07,,,,,C,Y,1000,mg,ORAL,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,RIVOTRIL,CLONAZEPAM,2011-04-29,2011-04-29,,2011-05-10,2011-05-10,,C,,0.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,IMOVANE,ZOPICLONE,2011-05-11,2011-05-11,,2011-05-24,2011-05-24,,C,,7.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2011-05-25,2011-05-25,,,,,C,Y,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NUTRIMENTS,OTHER COMBINATIONS OF NUTRIENTS,2011-04-29,2011-04-29,,2011-05-01,2011-05-01,,C,,,,ORAL,PRN,ANOREXIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NUTRIMENTS,OTHER COMBINATIONS OF NUTRIENTS,2011-05-05,2011-05-05,,,,,C,Y,,,ORAL,PRN,ANOREXIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LOXEN,NICARDIPINE HYDROCHLORIDE,2001,2001-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERTENSIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ARANESP,DARBEPOETIN ALFA,2011-05-13,2011-05-13,,,,,C,Y,300,ug,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,UTROGESTAN,PROGESTERONE,1991,1991-12-31,M,,,,C,Y,200,mg,ORAL,QD,PROPHYLAXIS OSTEOPOROSIS
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,FLECAINE,FLECAINIDE ACETATE,2004,2004-12-31,M,,,,C,Y,150,mg,ORAL,QD,VENTRICULAR EXTRASYSTOL
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2010-12,2010-11-30,D,2011-07-06,2011-07-06,,C,,500,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2001,2001-12-31,M,,,,C,Y,40,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2010-12,2010-11-30,D,2011-04-28,2011-04-28,,C,,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,NUTRIMENTS,OTHER COMBINATIONS OF NUTRIENTS,2011-03-23,2011-03-23,,2011-03-29,2011-03-29,,P,,Unkonwn,,ORAL,PRN,ANOREXIA
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,SPASFON LYOC,PHLOROGLUCINOL,2011-03-31,2011-03-31,,2011-06-01,2011-06-01,,C,,80,mg,SUBLINGUAL,PRN,POST-PRANDIAL ABDOMINAL PAIN
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2011-03-31,2011-03-31,,2011-03-31,2011-03-31,,C,,60,mg,INTRAVENOUS,ONCE,POST-PRANDIAL ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,COTAREG,CO-DIOVAN,,2011-03-11,Y,2011-03-25,2011-03-25,,C,,160,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-03-25,2011-03-25,,2011-04-07,2011-04-07,,C,,3,mg,INTRAVENOUS,,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-03,2011-03-11,D,2011-03-25,2011-03-25,,C,,200,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-03,2011-03-11,D,,,,C,Y,UK,mg,ORAL,PRN,GASTRO-OESOPHAGEAL REFLUX
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,QUESTRAN,COLESTYRAMINE,2011-03,2011-03-11,D,,,,C,Y,uk,g,ORAL,QD,CHOLESTEROL
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DUPHALAC,LACTULOSE,2011-03,2011-03-11,D,,,,C,Y,uk,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011-03,2011-03-11,D,,,,C,Y,uk,mg,ORAL,PRN,ANTI-EMETICS
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-04-08,2011-04-08,,,,,C,Y,40,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MOPRAL,OMEPRAZOLE,2011-03,2011-03-11,D,,,,C,Y,40,mg,ORAL,QD,GASTRO-OESOPHAGEAL REFLUX
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-03,2011-03-11,D,,,,C,Y,6,BULB,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-03,2011-03-11,D,,,,C,Y,16,mg,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CRESTOR,ROSUVASTATIN CALCIUM,,2011-03-11,Y,,,,C,Y,10,mg,ORAL,QD,CHOLESTEROL
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CALCIPARINE,HEPARIN CALCIUM,2011-03,2011-03-11,D,,,,C,Y,0.6,mL,SUBCUTANEOUS,QD,ANTICOAGULANT
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-03,2011-03-11,D,,,,C,Y,60,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MOUTHWASH,"STOMATOLOGICALS, MOUTH PREPARATIONS",2011-03,2011-03-11,D,,,,C,Y,3,GLASS,ORAL,QD,MUCOSITIS
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2011-04-07,2011-04-07,,2011-04-14,2011-04-14,,C,,60,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2011-04-14,2011-04-14,,,,,C,Y,40,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SYMBICORT,BUDESONIDE W/FORMOTEROL FUMARATE,,2011-03-11,Y,,,,C,Y,200,ug,RESPIRATORY (INHALATION),QD,ASTHMA
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2011-04-10,2011-04-10,,2011-04-14,2011-04-14,,C,,80,mg,ORAL,QD,EDEMA
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2011-04-14,2011-04-14,,2011-04-19,2011-04-19,,C,,20,mg,ORAL,QD,EDEMA
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-04-10,2011-04-10,,2011-04-24,2011-04-24,,C,,1,g,ORAL,TID,INFECTIOUS SYNDROM
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DIFFU K,POTASSIUM CHLORIDE,2011-04-10,2011-04-10,,2011-04-14,2011-04-14,,C,,1,TABLET,ORAL,TID,HYPONATREMIA
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,,2011-03-11,Y,,,,C,Y,UK,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ALVERINE (= METEOSPASMYL),ALVERINE,,2011-03-11,Y,,,,C,Y,UK,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,LAMALINE (= PARACETAMOL + OPIUM + CAFFEINE),LAMALINE                           /01708901/,2011-02,2011-01-31,D,2011-02,2011-02-28,D,P,,UK,TABLET,ORAL,UNKNOWN,EPISOD OF GOUT
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-02-10,2011-02-10,,2011-04-10,2011-04-10,,C,,0.7,mL,SUBCUTANEOUS,QD,ANTICOAGULANT
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2011-02-22,2011-02-22,,,,,C,Y,100,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-03-25,2011-03-25,,,,,C,Y,UK,mg,INTRAVENOUS,QD,CHOLESTASIS
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-03,2011-03-11,D,,,,C,Y,UK,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,LITHIUM,LITHIUM,1980,1980-12-31,M,2011-07-06,2011-07-06,,C,,6,TABLET,ORAL,QD,MANIC DEPRESSIV SYNDROM
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,IXPRIM,ULTRACET,2011-06-15,2011-06-15,,,,,C,Y,37.5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ROCEPHINE,CEFTRIAXONE SODIUM,2011-07-11,2011-07-11,,2011-07-11,2011-07-11,,C,,2000,mg,INTRAVENOUS,QD,SEPSIS
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CIFLOX,CIPROFLOXACIN,2011-07-12,2011-07-12,,2011-07-19,2011-07-19,,C,,400,mg,INTRAVENOUS,BID,SEPSIS
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TAREG,VALSARTAN,2007,2007-12-31,M,,,,C,Y,80,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,JANUMET,RISTFOR,2011-01,2010-12-31,D,,,,C,Y,50,mg,ORAL,,DIABETES
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2011-06-08,2011-06-08,,2011-06,2011-06-30,D,C,,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06,2011-06-08,D,2011-06-15,2011-06-15,,C,,100,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TRALITHE,LITHIUM CARBONATE,2011-06,2011-06-08,D,2011-06,2011-06-30,D,C,,250,mg,ORAL,QD,MANIC DEPRESSIV SYMDROM
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LARGACTIL,CHLORPROMAZINE,2011-07-05,2011-07-05,,,,,C,Y,UK,mg,ORAL,,HICCUP
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ZYPREXA,OLANZAPINE,2011-07-15,2011-07-15,,,,,C,Y,5,mg,ORAL,QD,MANIAC DEPRESSIV SYNDROM
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-06-08,2011-06-08,,,,,C,Y,8,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2010-10,2010-09-30,D,,,,C,Y,150,ug,patch,TID,PAIN IN THE LEFT HYPOCHONDRIUM
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-06-26,2011-06-26,,2011-07-03,2011-07-03,,C,,25 000,IU,ORAL,TID,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-07-03,2011-07-03,,2011-07-04,2011-07-04,,C,,1,g,ORAL,PRN,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,RELISTOR,METHYLNALTREXONE BROMIDE,2011-06-29,2011-06-29,,2011-06-30,2011-06-30,,C,,12,mg,SUBCUTANEOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DUPHALAC,LACTULOSE,2011-07-03,2011-07-03,,,,,C,Y,2,BAG,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-07-03,2011-07-03,,,,,C,Y,0.25,mg,ORAL,PRN,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-07-03,2011-07-03,,,,,C,Y,20,mg,ORAL,TID,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LAROXYL,AMITRIPTYLINE HYDROCHLORIDE,2011-07-10,2011-07-10,,,,,C,Y,10,gtt,ORAL,QD,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-07-10,2011-07-10,,,,,C,Y,100,mg,ORAL,BID,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FORLAX,MACROGOL 4000,2011-07,2011-07-01,D,,,,C,Y,UK,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2011-06-24,2011-06-24,,,,,C,Y,3,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-06-20,2011-06-20,,,,,C,Y,40,mg,ORAL,BID,ULCER
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,VOGALNE,METOPIMAZINE,2011-06-23,2011-06-23,,,,,C,Y,,mg,ORAL,PRN,VOMITING
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-06-23,2011-06-23,,,,,C,Y,,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MEDROL,METHYLPREDNISOLONE,2011-06-23,2011-06-23,,,,,C,Y,,mg,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-09,2011-09-01,D,,,,C,Y,6,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ACTISKENAN,MORPHINE SULFATE,2011-06,2011-06-23,D,2011-06,2011-06-30,D,C,,40,mg,ORAL,QD,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2011-06-20,2011-06-20,,2011-07,2011-07-31,D,C,,3,TABLET,ORAL,PRN,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2011-06-22,2011-06-22,,,,,C,Y,80,mg,ORAL,TID,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT,TRIMEBUTINE,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,P,,1,BULB,INTRAVENOUS,ONCE,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-06-24,2011-06-24,,2011-07-03,2011-07-03,,C,,50,mg,INTRAVENOUS,PRN,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,MORPHINE PCA,MORPHINE,2011-06-24,2011-06-24,,2011-07-03,2011-07-03,,C,,6,mg,INTRAVENOUS,QH,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-26,2011-06-26,,2011-07-03,2011-07-03,,C,,1,g,ORAL,TID,SUBDIAPHRAGMATIC PAIN (ABDOMINAL PAIN)
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2012-02-13,2012-02-13,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DETENTIEL,BISOPROLOL,2011-07,2011-06-30,D,,,,C,Y,5,mg,ORAL,QD,ARRHYTHMIA
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011,2011-08-30,M,,,,C,Y,UK,mg,ORAL,QD,GASTROESOPHAGEAL REFLUX
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-04,2011-03-31,D,,,,C,Y,1,g,ORAL,Q6H,PANCREATIC PAINS
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BRUFEN,IBUPROFEN,2011-07,2011-06-30,D,,,,C,Y,400,mg,ORAL,TID,PANCREATIC PAINS
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2011-07,2011-06-30,D,,,,C,Y,100,mg,ORAL,QD,PANCREATIC PAINS
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2011-08-09,2011-08-09,,,,,C,Y,1,VIAL,ORAL,PRN,PANCREATIC PAIN
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LORAMYC,MICONAZOLE,2011-09-13,2011-09-13,,,,,C,Y,50,mg,ORAL,QD,MUCOSITIS
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LAROXYL,AMITRIPTYLINE HYDROCHLORIDE,2011-10,2011-10-01,D,,,,C,Y,UK,DROPS,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,HYTACAND,BLOPRESS PLUS,,2012-01-24,Y,2012-02,2012-02-29,D,C,,16,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-03-06,2012-03-06,,2012-03-13,2012-03-13,,C,,Uk,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CIFLOX,CIPROFLOXACIN,2012-03-06,2012-03-06,,2012-03-14,2012-03-14,,C,,500,mg,ORAL,TID,LEUKOCYTOSIS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2012-04-03,2012-04-03,,2012-04-10,2012-04-10,,C,,120,mg,ORAL,PRN,PHLEBITIS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PRAVASTATINE,PRAVASTATIN SODIUM,,2012-01-24,Y,,,,C,Y,20,mg,ORAL,QD,DYSLIPIDEMIA
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,"CAFEINE, PARACETAMOL, OPIUM",CAFFEINE,2011,2011-12-31,M,,,,C,Y,Uk,mg,ORAL,TID,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,"CAFEINE, PARACETAMOL, OPIUM",MORPHINE,2011,2011-12-31,M,,,,C,Y,Uk,mg,ORAL,TID,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,"CAFEINE, PARACETAMOL, OPIUM",PARACETAMOL,2011,2011-12-31,M,,,,C,Y,Uk,mg,ORAL,TID,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,,2012-01-24,Y,,,,C,Y,7.5,mg,ORAL,QD,PHLEBITIS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PERMIXON,SERENOA REPENS EXTRACT,,2012-01-24,Y,,,,C,Y,160,mg,ORAL,QD,BENIGN PROSTATE
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-01,2012-01-24,D,,,,C,Y,10,mg,ORAL,PRN,"NAUSEA, VOMITING"
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-12,2011-11-30,D,,,,C,Y,2,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2012-01,2012-01-24,D,,,,C,Y,40,mg,ORAL,PRN,EPIGASTRICS PAINS
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ACTISKENAN,MORPHINE SULFATE,2012-01,2012-01-24,D,,,,C,Y,10,mg,ORAL,PRN,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,JANUVIA,SITAGLIPTIN PHOSPHATE,2011-11,2011-10-31,D,2012-02,2012-02-29,D,P,,200,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TARDYFERON,FERROUS SULFATE,2012-04-02,2012-04-02,,,,,C,Y,80,mg,ORAL,QD,ANEMIA
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DIFFU K,POTASSIUM CHLORIDE,2012-02-22,2012-02-22,,,,,C,Y,1200,mg,ORAL,QD,HYPOKALIEMA
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TAHOR,ATORVASTATIN CALCIUM,2012,2012-03-01,M,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-03-01,2012-03-01,,2012-05-10,2012-05-10,,C,,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NORMACOL,,2012-05-03,2012-05-03,,2012-05-04,2012-05-04,,C,,1,IU,RECTAL,QD,FECALOMA
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DIAMICRON,GLICLAZIDE,2012-02,2012-01-31,D,,,,C,Y,60,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2012-02,2012-01-31,D,2012-02,2012-02-29,D,P,,Uk,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02,2012-01-31,D,,,,C,Y,3,g,ORAL,PRN,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,BIPRETERAX,BI PREDONIUM,,2012-03-01,Y,,,,C,Y,Uk,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2012-02,2012-01-31,D,,,,C,Y,10,mg,ORAL,QD,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-02,2012-01-31,D,,,,C,Y,20,mg,ORAL,BID,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-02,2012-01-31,D,,,,C,Y,5,mg,ORAL,PRN,EPIGASTRIC PAINS
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,NEORECORMON,EPOETIN BETA,2012-04-02,2012-04-02,,,,,C,Y,30000,IU,INTRAVENOUS,once week,ANEMIA
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-08-03,2011-08-03,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PANCREASE ENZYME,PANCRELIPASE,2010,2010-12-31,M,,,,C,Y,unknown,,ORAL,QD,PANCREATIC CANCER
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,TORSEMIDE,TORASEMIDE,2011-05-16,2011-05-16,,,,,,Y,10,mg,ORAL,QD,ARTERIAL STENOSIS
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2011-01-12,2011-01-12,,2011-02,2011-02-28,D,C,,100,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,OXYCOCET,2011-02-03,2011-02-03,,2011-02-16,2011-02-16,,C,,1.2,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DRONABINOL,DRONABINOL,2011-02-16,2011-02-16,,,,,C,Y,5,mg,ORAL,BID,APETITE
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-03,2011-02-03,,2011-02-03,2011-02-03,,C,,8,mg,ORAL,Prior to Chemotherapy,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-09,2011-02-09,,2011-02-09,2011-02-09,,C,,8,mg,INTRAVENOUS,ONCE,PRE-MEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SODIUM FERRIC GLUCONATE COMPLEX,FERRIC SODIUM GLUCONATE COMPLEX,2011-02-09,2011-02-09,,,,,C,Y,125,mg,INTRAVENOUS,QS,ANEMIA
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE-OXALIPLATIN,,2011-03-02,2011-03-02,,2011-04-27,2011-04-27,,,,,,,,
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CO-1.01,,2011-05-11,2011-05-11,,,,,,,,,,,
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,COSOPT,COSOPT,,,,,,,,Y,2,gtt,OPHTHALMIC,BID,GLAUCOMA
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LUMIGAN,BIMATOPROST,,,,,,,,Y,1,gtt,OPHTHALMIC,QD,GLAUCOMA
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2010,2010-01-01,M,,,,,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ALPRAZOLAM,ALPRAZOLAM,2010-12,2010-12-01,D,2010-12-07,2010-12-07,,C,,0.25,mg,ORAL,PRN,ANXIETY AND INSOMNIA PROPHYLAXIS
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-05-03,2012-05-03,,2012-05-04,2012-05-04,,C,,1,g,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PARAETAMOL,PARACETAMOL,2012-05-22,2012-05-22,,2012-05-22,2012-05-22,,C,,1,g,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-06-01,2012-06-01,,2012-06-02,2012-06-02,,C,,1,g,ORAL,PRN,FEVER
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-06-09,2012-06-09,,2012-06-09,2012-06-09,,C,,1,g,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-06-27,2012-06-27,,2012-06-27,2012-06-27,,C,,1,g,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ALPRAZOLAM,ALPRAZOLAM,2010-12-08,2010-12-08,,2011-02-14,2011-02-14,,C,,0.5,mg,ORAL,PRN,ANXIETY AND INSOMNIA PROPHYLAXIS
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2010-11-09,2010-11-09,,,,,C,Y,50,mg,INTRAVENOUS,QS,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ACETYLCYSTEIN,ACETYLCYSTEINE,2011-06-08,2011-06-08,,2011-06-27,2011-06-27,,C,,200,mg,ORAL,PRN,PRODUCTIVE COUGH
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07-19,2011-07-19,,2011-08-01,2011-08-01,,C,,500,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-09-20,2011-09-20,,2011-10-18,2011-10-18,,C,,50,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2012-03-06,2012-03-06,,2012-04-24,2012-04-24,,C,,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LIDOCANE,LIDOCAINE,2012-02-16,2012-02-16,,2012-02-16,2012-02-16,,C,,20,mg,SUBCUTANEOUS,ONCE,ANESTHESIA FOR IV ACCESS
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2012-04-25,2012-04-25,,,,,C,Y,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN - 5 FLUOROURACIL,,2011-04-11,2011-04-11,,2011-06-06,2011-06-06,,,,,,,,
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SODIUM VALPROATE,VALPROATE SODIUM,2008,2008-12-31,M,,,,C,Y,500,mg,ORAL,BID,EPILEPSY
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,NAPROXENE,NAPROXEN,2011-03-08,2011-03-08,,,,,C,Y,500,mg,ORAL,PRN,FEVER PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-02-08,2011-02-08,,2011-03-22,2011-03-22,,C,,80,mg,INTRAVENOUS,PRN,FEVER PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2011-03-15,2011-03-15,,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2010-12-14,2010-12-14,,2011-03-22,2011-03-22,,C,,50,mg,INTRAVENOUS,At each IP administation,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-03-22,2011-03-22,,,,,C,Y,20,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-11,2011-04-11,,,,,C,Y,8,mg,INTRAVENOUS,At each cisplatin-5FU administation,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-11,2011-04-11,,,,,C,Y,10,mg,INTRAVENOUS,At each cisplatin-5FU administration,ALLERGIC REACTION PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-12,2011-04-12,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PENTOXYFYLLINE,PENTOXIFYLLINE,1999,1999-12-31,M,,,,C,Y,800,mg,ORAL,BID,INFERIOR LIMBS ARTERIOPATHY
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2008,2008-12-31,M,,,,C,Y,300,mg,ORAL,QD,HYPERURICEMIA
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,1999,1999-12-31,M,,,,C,Y,80,mg,ORAL,QD,CARDIOVASCULAR DISEASES PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ZALDIAR,ULTRACET,2010-12-01,2010-12-01,,2010-12-14,2010-12-14,,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAIN (PANCREATIC CANCER RELATED)
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2010-12-31,2010-12-31,,2011-01-05,2011-01-05,,C,,875,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN,AMOXICILLIN,2011-01-20,2011-01-20,,2011-01-24,2011-01-24,,C,,500,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-02-11,2011-02-11,,2011-03-08,2011-03-08,,C,,48,mg,ORAL,PRN,FEVER PROPHYLAXIS
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,LVOCTIRIZINE,LEVOCETIRIZINE,2011-02-08,2011-02-08,,2011-03-22,2011-03-22,,C,,5,mg,ORAL,PRN,FEVER PROPHYLAXIS
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2006,2006-12-31,M,,,,C,Y,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-02,2011-02-01,D,,,,C,Y,20,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2011-02-03,2011-02-03,,,,,C,Y,70,mg,SUBCUTANEOUS,QD,SPLENIC THROMBOSIS (CANCER RELATED)
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-01-27,2011-01-27,,2011-03-31,2011-03-31,,C,,50,mg,INTRAVENOUS,At each IP administration,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEM,ZOLPIDEM,2010,2010-12-31,M,2011-01-26,2011-01-26,,P,,10,mg,ORAL,QD,INSOMNIA PROPHYLAXIS
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,LORMETAZEPAM,LORMETAZEPAM,2011-03-23,2011-03-23,,,,,C,Y,2,mg,ORAL,QD,INSOMNIA PROPHYLAXIS
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METFORMINE,METFORMIN HYDROCHLORIDE,2009,2009-12-31,M,,,,C,Y,425,mg,ORAL,TID,DIABETES MELLITUS TYPE II
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ESOMEPRAZOLE,ESOMEPRAZOLE,2010-11,2010-10-31,D,2011-01-26,2011-01-26,,P,,20,mg,ORAL,QD,ESOPHAGITIS
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2009,2009-12-31,M,,,,C,Y,20,mg,ORAL,QD,DYSLIPIDEMIA
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2010-12,2010-11-30,D,,,,C,Y,10,mg,ORAL,PRN,ABDOMINAL PAIN (CANCER RELATED)
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-01,2011-01-27,D,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN (CANCER RELATED)
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2010-12,2010-11-30,D,2011-02-02,2011-02-02,,C,,80,mg,SUBCUTANEOUS,QD,SPLENIC THROMBOSIS (CANCER RELATED)
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02,2011-02-01,D,2011-03-30,2011-03-30,,C,,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-02,2011-02-01,D,,,,C,Y,10 mg,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-07,2011-06-30,D,,,,C,Y,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TARGINACT,TARGIN,2011-09-13,2011-09-13,,,,,C,Y,1,TABLET,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2011-09-13,2011-09-13,,2011-09-13,2011-09-13,,C,,5,mg,ORAL,ONCE,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MIRTAZIPINE,MIRTAZAPINE,2011-10-04,2011-10-04,,,,,C,Y,15,mg,ORAL,QD,DEPRESSIVE STATE PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LORMETAZEPAM,LORMETAZEPAM,2011-09-13,2011-09-13,,,,,C,Y,2,mg,ORAL,QD,ANXIETY PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,IRBSARTAN,IRBESARTAN,1998,1998-12-31,M,,,,C,Y,300,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,1993,1993-12-31,M,,,,C,Y,100,mg,ORAL,QD,CARDIOVASCULAR DISEASES PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LORMETAZEPAM,LORMETAZEPAM,2011-07,2011-06-30,D,2011-09-12,2011-09-12,,C,,1,mg,ORAL,QD,ANXIETY PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-07,2011-06-30,D,,,,C,Y,40,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-06,2011-05-31,D,,,,C,Y,50,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-06,2011-05-31,D,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,1993,1993-12-31,M,,,,C,Y,5,mg,ORAL,BID,ISCHEMIC CARDIOPATHY PROPHYLAXIS
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-08-30,2011-08-30,,,,,C,Y,1,BAG,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUOROURACIL,,2011-12-19,2011-12-19,,2012-04-11,2012-04-11,,,,,,,,
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN,,2011-12-19,2011-12-19,,2012-04-11,2012-04-11,,,,,,,,
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2011-06,2011-05-31,D,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MOUTH WASH,"STOMATOLOGICALS, MOUTH PREPARATIONS",2011-10-05,2011-10-05,,2011-10-18,2011-10-18,,C,,1,Tbsp,TOPICAL,PRN,STOMATITIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-09-28,2011-09-28,,2011-10-05,2011-10-05,,C,,50,mg,ORAL,PRN,NAUSEA TRATEMENT AND PROPHYLAXIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-09-21,2011-09-21,,2011-11-02,2011-11-02,,C,,50,mg,INTRAVENOUS,QS,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PIPERACILLINE,PIPERACILLIN SODIUM,2011-11-20,2011-11-20,,2011-11-22,2011-11-22,,C,,4,g,INTRAVENOUS,QID,SEPSIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TAZOBACTAM,TAZOBACTAM,2011-11-20,2011-11-20,,2011-11-22,2011-11-22,,C,,500,mg,INTRAVENOUS,QID,SEPSIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CIPROXINE,CIPROFLOXACIN,2011-11-23,2011-11-23,,2011-12-01,2011-12-01,,C,,500,mg,ORAL,TID,SEPSIS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2011-08,2011-07-31,D,,,,C,Y,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,BARNIDIPINE,BARNIDIPINE,2010-08-31,2010-08-31,,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ALDACTAZINE,ALDACTAZINE,2010-08-31,2010-08-31,,,,,C,Y,0.5,TABLET,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,XALATAN,LATANOPROST,2008,2008-12-31,M,,,,C,Y,2,gtt,OPHTHALMIC,QD,INTRAOCULAR HYPERTENSION
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-09,2011-09-21,D,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN AND CEPHALGIA
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2011-09-12,2011-09-12,,2011-10-04,2011-10-04,,C,,60,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-10-04,2011-10-04,,,,,C,Y,14,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-09-28,2011-09-28,,2011-10-05,2011-10-05,,C,,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN - 5 FLUOROURACIL - FOLINIC ACID,,2012-03-26,2012-03-26,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2007,2007-12-31,M,,,,C,Y,20,mg,ORAL,QD,HEARTBURN
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CELOCURINE,SUXAMETHONIUM CHLORIDE,2012-01-23,2012-01-23,,2012-01-23,2012-01-23,,C,,100,mg,INTRAVENOUS,ONCE,ANESTHESIA FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PROPOLIPID,PROPOFOL,2012-01-23,2012-01-23,,2012-01-23,2012-01-23,,C,,200,mg,INTRAVENOUS,ONCE,ANESTHESIA FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SUFENTA,SUFENTANIL CITRATE,2012-01-23,2012-01-23,,2012-01-23,2012-01-23,,C,,5,ug,INTRAVENOUS,ONCE,ANESTHESIA FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ESMERON,ROCURONIUM BROMIDE,2012-01-23,2012-01-23,,2012-01-23,2012-01-23,,C,,10,mg,INTRAVENOUS,ONCE,ANESTHESIA FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-01-21,2012-01-21,,2012-01-21,2012-01-21,,C,,10,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PERFUSALGAN,PARACETAMOL,2012-01-21,2012-01-21,,2012-01-21,2012-01-21,,C,,1,g,INTRAVENOUS,ONCE,FEVER RELATED TO ANGIOCHOLITIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ZINACEF,CEFUROXIME,2012-03-07,2012-03-07,,2012-03-09,2012-03-09,,C,,1.5,g,INTRAVENOUS,BID,FEVER
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FLAGYL,METRONIDAZOLE,2012-03-07,2012-03-07,,2012-03-09,2012-03-09,,C,,500,mg,INTRAVENOUS,BID,FEVER
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,LINISOL,LIDOCAINE HYDROCHLORIDE,2012-01-19,2012-01-19,,2012-01-19,2012-01-19,,C,,20,mg,SUBCUTANEOUS,ONCE,LOCAL ANESTHESIA FOR IV ACCESS PLACEMENT
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-12-29,2011-12-29,,,,,C,Y,50,ug/h,TRANSDERMAL,Q3D,PANCREATIC PAIN
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ZINACEF,CEFUROXIME,2012-01-21,2012-01-21,,2012-01-22,2012-01-22,,C,,1.5,g,INTRAVENOUS,TID,ANGIOCHOLITIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FLAGYL  METRONIDAZOLE,METRONIDAZOLE,2012-01-21,2012-01-21,,2012-01-22,2012-01-22,,C,,500,mg,INTRAVENOUS,TID,ANGIOCHOLITIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-01-23,2012-01-23,,2012-01-30,2012-01-30,,C,,4,g,INTRAVENOUS,QID,ANGIOCHOLITIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2012-01-18,2012-01-18,,,,,C,Y,50,mg,INTRAVENOUS,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2012-01-21,2012-01-21,,2012-01-21,2012-01-21,,C,,50,mg,ORAL,ONCE,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MOUTH WASH,"STOMATOLOGICALS, MOUTH PREPARATIONS",2012-01-18,2012-01-18,,,,,C,Y,15,mL,TOPICAL,PRN,STOMATITIS PROPHYLAXIS
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,LINISOL,LIDOCAINE HYDROCHLORIDE,2012-01-23,2012-01-23,,2012-01-23,2012-01-23,,C,,80,mg,INTRAVENOUS,ONCE,ANESTHESIA FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DILTIAZEM CHLORHYDRATE,DILTIAZEM HYDROCHLORIDE,,2010-08-05,Y,2010-08-03,2010-08-05,,C,,200,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GLUCOSE,GLUCOSE,2010-08-02,2010-08-02,,2010-08-08,2010-08-08,,C,,15,%,INTRAVENOUS,PRN,HYPOGLYCEMIA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2010-08-06,2010-08-06,,2010-08-18,2010-08-18,,C,,1000,mg,INTRAVENOUS,QD,INFECTION PROPHYLAXIS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,BRICARNYL,TERBUTALINE SULFATE,2010-08-08,2010-08-08,,2010-08-26,2010-08-26,,C,,5,mg,RESPIRATORY (INHALATION),PRN,DYSPNEA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LORAMYC,MICONAZOLE,2010-08-08,2010-08-08,,2010-08-17,2010-08-17,,C,,50,mg,TOPICAL,PRN,CANDIDOSIS PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,GLUCOSE,GLUCOSE,2010-08-08,2010-08-08,,2010-08-22,2010-08-22,,C,,30,%,INTRAVENOUS,PRN,HYPOGLYCEMIA PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,IPRATROPIUM,IPRATROPIUM,2010-08-08,2010-08-08,,2010-08-26,2010-08-26,,C,,"0,5",mg,RESPIRATORY (INHALATION),PRN,DYSPNEA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OXYGEN,OXYGEN,2010-08-09,2010-08-09,,2010-09-01,2010-09-01,,C,,1440,mL,RESPIRATORY (INHALATION),QD,DYSPNEA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,RISORDAN (ISOSORBIDE DINITRATE),ISOSORBIDE DINITRATE,2010-08-09,2010-08-09,,2010-08-17,2010-08-17,,C,,2,mg,ORAL,QD,CARDIAC DISORDERS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,OGAST,LANSOPRAZOLE,2010-08-11,2010-08-11,,2010-08-20,2010-08-20,,C,,15,mg,ORAL,QD,ESOPHAGEAL REFLUX PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2010-08-12,2010-08-12,,2010-08-13,2010-08-13,,C,,1000,mg,INTRAVENOUS,QD,PAIN PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,AMLOR,AMLODIPINE BESILATE,2010-08-03,2010-08-03,,2010-08-08,2010-08-08,,C,,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DIFFU K,POTASSIUM CHLORIDE,2010-08-15,2010-08-15,,2010-08-18,2010-08-18,,C,,600,mg,ORAL,BID,HYPOKALIEMIA PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FORLAX (MACROGOL 4000),MACROGOL 4000,2010-08-15,2010-08-15,,2010-08-23,2010-08-23,,C,,20000,mg,ORAL,QD,CONSTIPATION PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2010-08-16,2010-08-16,,2010-08-18,2010-08-18,,C,,1000,mg,INTRAVENOUS,PRN,PAIN PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2010-08-17,2010-08-17,,2010-08-17,2010-08-17,,C,,50,mg,ORAL,PRN,PAIN PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ORBENINE,CLOXACILLIN SODIUM,2010-08-19,2010-08-19,,2010-08-31,2010-08-31,,C,,4000,mg,INTRAVENOUS,PRN,BRONCHIC INFECTION PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,KAYEXALATE,SODIUM POLYSTYRENE SULFONATE,2010-08-19,2010-08-19,,2010-08-19,2010-08-19,,C,,67,mg,INTRAVENOUS,QD,HYPERKALIEMIA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2010-08-20,2010-08-20,,2010-08-20,2010-08-20,,C,,"0,25",mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2010-08-20,2010-08-20,,2010-09-01,2010-09-01,,C,,1000,mg,INTRAVENOUS,PRN,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,"SPASFON (PHLOROGLUCINOL, TRIMETHYLPHLOROGLUCINOL)",SPASFON                            /00765801/,2010-08-22,2010-08-22,,2010-08-23,2010-08-23,,C,,40,mg,INTRAVENOUS,PRN,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,OGAST,LANSOPRAZOLE,2010-08-22,2010-08-22,,2010-08-26,2010-08-26,,C,,15,mg,ORAL,PRN,METASTATIC PANCREATIC CANCER
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,AMLOR,AMLODIPINE BESILATE,2010-08-10,2010-08-10,,2010-08-26,2010-08-26,,C,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,TEMESTA (LORAZEPAM).,LORAZEPAM,2010-08-23,2010-08-23,,2010-08-26,2010-08-26,,C,,"2,5",mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2010-08-23,2010-08-23,,2010-08-23,2010-08-23,,C,,10,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2010-08-24,2010-08-24,,2010-08-24,2010-08-24,,C,,20,mg,INTRAVENOUS,PRN,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,FORLAX (MACROGOL 4000),MACROGOL 4000,2010-08-26,2010-08-26,,2010-08-26,2010-08-26,,C,,20000,mg,ORAL,PRN,CONSTIPATION PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2010-08-27,2010-08-27,,2010-08-31,2010-08-31,,C,,40,mg,INTRAVENOUS,PRN,GASTRO ESOPHAGEAL REFLUX PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2010-08-28,2010-08-28,,2010-09-01,2010-09-01,,C,,20,mg,INTRAVENOUS,QD,HYPOGLYCEMIA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2010-08-03,2010-08-03,,2010-08-03,2010-08-03,,P,,2,mg,ORAL,QD,DIARRHEA PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2010-08-03,2010-08-03,,2010-08-22,2010-08-22,,C,,4000,IU,INTRAVENOUS,QD,LIMB EDEMA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,GLUCOSE,GLUCOSE,2010-08-03,2010-08-03,,2010-08-03,2010-08-03,,P,,30,%,INTRAVENOUS,TID,HYPOGLYCEMIA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2010-08-03,2010-08-03,,2010-08-07,2010-08-07,,C,,1200,kcal,INTRAVENOUS,PRN,DENUTRITION PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DIOSMECTITE,ALUMINIUM MAGNESIUM SILICATE,2010-08-04,2010-08-04,,2010-08-04,2010-08-04,,P,,3000,mg,ORAL,QD,DIARRHEA PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2010-08-04,2010-08-04,,2010-08-26,2010-08-26,,C,,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,,2010-08-05,Y,2010-08-19,2010-08-19,,C,,1,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,DIFFU K,POTASSIUM CHLORIDE,2010-08-04,2010-08-04,,2010-08-09,2010-08-09,,C,,600,mg,ORAL,QD,HYPOKALIEMIA PROPHYLAXIS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2010-08-05,2010-08-05,,2010-08-05,2010-08-05,,C,,50,mg,ORAL,QD,PAIN PROPHYLAXIS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2010-08-05,2010-08-05,,2010-08-07,2010-08-07,,C,,3000,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,LOXEN,NICARDIPINE HYDROCHLORIDE,2010-08-05,2010-08-05,,2010-08-05,2010-08-05,,C,,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2010-08-05,2010-08-05,,2010-08-05,2010-08-05,,C,,10,mg,INTRAVENOUS,QD,ESOPHAGEAL REFLUX PREVENTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2010-08-05,2010-08-05,,2010-08-06,2010-08-06,,C,,1000,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2010-08-29,2010-08-29,,2010-08-31,2010-08-31,,C,,20,mg,INTRAVENOUS,PRN,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,SCOPODERM,HYOSCINE,2010-08-30,2010-08-30,,2010-08-30,2010-08-30,,C,,1,PATCH,TRANSDERMAL,QD,GENITAL AREA EDEMA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL,MIDAZOLAM,2010-08-31,2010-08-31,,2010-08-31,2010-08-31,,C,,1,mg,INTRAVENOUS,ONCE,METASTATIC PANCREATIC CANCER
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2010-08-31,2010-08-31,,2010-09-01,2010-09-01,,C,,100,mg,INTRAVENOUS,ONCE,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,"SPASFON (PHLOROGLUCINOL, TRIMETHYLPHLOROGLUCINOL)",SPASFON                            /00765801/,2010-08-31,2010-08-31,,2010-08-31,2010-08-31,,C,,40,mg,INTRAVENOUS,ONCE,TUMOR PAIN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,LASILIX SPECIAL,FUROSEMIDE,2010-08-09,2010-08-09,,2010-08-18,2010-08-18,,C,,250,mg,INTRAVENOUS,QD,RENAL INSUFFICENSY
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2010-08-05,2010-08-05,,2010-08-09,2010-08-09,,C,,20,mg,INTRAVENOUS,QD,UPPER LIMB EDEMA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2010-08-28,2010-08-28,,2010-09-01,2010-09-01,,C,,20,mg,INTRAVENOUS,QD,UPPER LIMB EDEMA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,PHENOXYMETHYLPENICILLINE,PHENOXYMETHYLPENICILLIN,2009-09,2009-08-31,D,2010-08-06,2010-08-06,,C,,1,MU,ORAL,BID,PROPHYLAXIS OF INFECTION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,PERINDOPRIL,PERINDOPRIL,2010-07-01,2010-07-01,,2010-08-01,2010-08-01,,P,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2010-05,2010-04-30,D,2010-08-26,2010-08-26,,C,,20,mg,ORAL,BID,HYPOGLYCEMIA
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,AMPHOTERICINE,AMPHOTERICIN B,,2010-08-05,Y,2010-08-05,2010-08-05,,C,,1,tsp,ORAL,TID,STOMATITIS
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,,2010-08-05,Y,2010-08-06,2010-08-06,,C,,15,mg,ORAL,PRN,HEARTBURN
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2010-07-01,2010-07-01,,2010-08-03,2010-08-03,,P,,20,mg,ORAL,PRN,HYPERTENSION
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,SODIC TINZAPARINE,TINZAPARIN SODIUM,2007,2007-12-31,M,2012-02-23,2012-02-23,,C,,0.7,mL,SUBCUTANEOUS,QD,PHLEBITIS
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,METOPIMAZINE,METOPIMAZINE,2012-02-16,2012-02-16,,,,,C,Y,15,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETINE ALFA,EPOETIN ALFA,2012-03-22,2012-03-22,,,,,C,Y,40000,IU,TRANSDERMAL,QS,ANEMIA
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,IMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-04,2012-04-01,D,,,,C,Y,1,TABLET,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-05-04,2012-05-04,,2012-05-04,2012-05-04,,C,,1000,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2012-02-24,2012-02-24,,,,,C,Y,0.4,mL,SUBCUTANEOUS,QD,PHLEBITIS
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2012-08-30,2012-08-30,,,,,C,Y,40000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REPAGLINIDE,REPAGLINIDE,2011-10,2011-09-30,D,,,,C,Y,0.5,mg,ORAL,TID,DIABETES
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PANTOPROZOLE,PANTOPRAZOLE,2011,2011-12-31,M,,,,C,Y,20,mg,ORAL,QD,GASTROOESOPHAGEAL REFLUX
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04,2011-03-31,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PHLOROGLUCINOL,PHLOROGLUCINOL,2011-04,2011-03-31,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METEOSPASMYL,METEOSPASMYL                       /02143701/,2011-04,2011-03-31,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CODEIN+PARACETAMOL,LENOLTEC WITH CODEINE NO 1,2011-12-12,2011-12-12,,2012-01,2012-01-31,D,P,,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,HYDROXYZINE,HYDROXYZINE,2012-01-13,2012-01-13,,,,,C,Y,25,mg,ORAL,BID,CHOLESTASIS
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MACROGOL,MACROGOL,2012-02-16,2012-02-16,,,,,C,Y,20,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AZATHIOPRIN,AZATHIOPRINE,2009,2009-12-31,M,,,,C,Y,50,mg,ORAL,QD,MORBUS CROHN
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-02-09,2011-02-09,,2011-02-18,2011-02-18,,C,,2000,mg,ORAL,QD,PROPHYLAXIS OF INFECTION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL,METRONIDAZOLE,2011-02-09,2011-02-09,,2011-02-18,2011-02-18,,C,,500,mg,ORAL,QD,PROPHYLAXIS OF INFECTION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,5000,IU,INTRAVENOUS,ONCE,THROMBUS OF PORT
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-10,2011-03-10,,2011-03-10,2011-03-10,,C,,500,mg,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,TAVANIC,LEVOFLOXACIN,2011-03-11,2011-03-11,,2011-03-15,2011-03-15,,C,,500,mg,ORAL,QD,INCREASED CRP
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,UROKINASE,UROKINASE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,UK,mL,INTRAVENOUS,ONCE,LAVAGE OF PORT SYSTEM
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PACKED RED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02-11,2011-02-11,,2011-02-11,2011-02-11,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PACKED RED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PACKED RED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02-01,2011-02-01,,2011-02-01,2011-02-01,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-01,2011-02-01,,2011-02-01,2011-02-01,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,COMPETACT,MOPADAY,2007,2007-12-31,M,2011-02-10,2011-02-10,,C,,850,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-01,2011-03-01,,2011-03-01,2011-03-01,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-15,2011-03-15,,2011-03-15,2011-03-15,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-22,2011-03-22,,2011-03-22,2011-03-22,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DOLASETRON,DOLASETRON,2011-02-01,2011-02-01,,2011-02-01,2011-02-01,,C,,100,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DOLASETRON,DOLASETRON,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,100,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DOLASETRON,DOLASETRON,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,100,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-03-01,2011-03-01,,2011-03-01,2011-03-01,,C,,3,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-03-15,2011-03-15,,2011-03-15,2011-03-15,,C,,3,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2007,2007-12-31,M,2011-02-09,2011-02-09,,C,,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-03-22,2011-03-22,,2011-03-22,2011-03-22,,C,,3,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,PACKED RED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-03-27,2011-03-27,,2011-03-27,2011-03-27,,C,,UNK,mL,INTRAVENOUS,QD,"ANEMIA, TUMOR BLEEDING"
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE INFUSION,ELECTROLYTE SOLUTIONS,2011-03-27,2011-03-27,,2011-03-27,2011-03-27,,C,,UNK,mL,INTRAVENOUS,QD,"ANEMIA, TUMOR BLEEDING, HYPOTENSION"
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,BLOOD PLASMA,BLOODPLASMA,2011-02-10,2011-02-10,,2011-02-10,2011-02-10,,C,,2,IU,INTRAVENOUS,QD,CHOLESTASIS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,PACKED RED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02-09,2011-02-09,,2011-02-09,2011-02-09,,C,,2,IU,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,KONAKION,PHYTOMENADIONE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,10,mg,INTRAVENOUS,ONCE,PROPHYLAXIS OF VITAMIN K DEFICIENCY
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,KONAKION,PHYTOMENADIONE,2011-02-10,2011-02-10,,2011-02-10,2011-02-10,,C,,10,mg,INTRAVENOUS,ONCE,PROPHYLAXIS OF VITAMIN K DEFICIENCY
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE INFUSION,ELECTROLYTE SOLUTIONS,2011-02-09,2011-02-09,,2011-02-14,2011-02-14,,C,,200,mL/h,INTRAVENOUS,QD,CHOLESTASIS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,ANTRA,OMEPRAZOLE,2011-02-10,2011-02-10,,2011-02-14,2011-02-14,,C,,40,mg,INTRAVENOUS,QD,PROPHYLAXIS OF HEARTBURN
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,KONAKION,PHYTOMENADIONE,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,10,mg,INTRAVENOUS,ONCE,PROPHYLAXIS OF VITAMIN K DEFICIENCY
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2010-12-26,2010-12-26,,,,,C,Y,40,gtt,ORAL,PRN,TUMOR PAIN
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,TAVANIC,LEVOFLOXACIN,2011-02-12,2011-02-12,,2011-02-19,2011-02-19,,C,,250,mg,ORAL,QD,CHOLESTASIS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,VOTUM (OLMESARTANMEDOXOMIL),OLMESARTAN MEDOXOMIL,2011-02-15,2011-02-15,,,,,C,Y,40,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2011-02-14,2011-02-14,,,,,C,Y,5,mg,ORAL,BID,ARTERIAL HSIONYPERTEN
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,COMPETACT,MOPADAY,2011-02-19,2011-02-19,,,,,C,Y,15/850,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,SALOFALK (MESALAZINE),MESALAZINE,2009,2009-12-31,M,,,,C,Y,1000,mg,ORAL,BID,MORBUS CROHN
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,VOTUM (OLMESARTANMEDOXOMIL),OLMESARTAN MEDOXOMIL,2007,2007-12-31,M,2011-02-08,2011-02-08,,C,,20,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,LANTUS (INSULIN GLARGINE),INSULIN GLARGINE,2011-02-09,2011-02-09,,,,,C,Y,20,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-02-11,2011-02-11,,,,,C,Y,13.81,mg,ORAL,BID,PROPHYLAXIS OF OBSTIPATION
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-09,2011-02-09,,,,,C,Y,40,mg,ORAL,QD,GASTROPROTECTION
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLINIC ACID,,2011-09-26,2011-09-26,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-09-26,2011-09-26,,2012-02-17,2012-02-17,,,,,,,,
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-09-26,2011-09-26,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,,2011-01-12,Y,2011-06,2011-06-30,D,C,,40,mg,ORAL,QD,HEARTBURN
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-22,2011-06-22,,2011-06-29,2011-06-29,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM HYDROCHLORIDE,MIDAZOLAM HYDROCHLORIDE,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,3,mg,INTRAVENOUS,ONCE,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,360,mg,INTRAVENOUS,ONCE,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,2000,mg,INTRAVENOUS,ONCE,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,RINGERSOLUTION,RINGER AGUETTANT,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,1000,mL,INTRAVENOUS,ONCE,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-05-19,2011-05-19,,2011-05-25,2011-05-25,,C,,500,mg,ORAL,BID,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,WALLSTENT (BILIARY ENDOPROSTHESIS),ALL OTHER THERAPEUTIC PRODUCTS,2011-05-18,2011-05-18,,,,,C,Y,1,IU,intraductal of bile,ONCE,CHANGE OF STENT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,IMERON 400,IOMEPROL,2011-05-04,2011-05-04,,2011-05-04,2011-05-04,,C,,125,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,VITAMIN B1,THIAMINE HYDROCHLORIDE,2009,2009-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,VITAMIN B1 DEFIENCY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,IMERON 400,IOMEPROL,2011-03-02,2011-03-02,,2011-03-02,2011-03-02,,C,,125,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-07-21,2011-07-21,,2011-07-27,2011-07-27,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-10,2011-08-10,,2011-08-24,2011-08-24,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,IMMERON 300,IOMEPROL,2011-07-14,2011-07-14,,2011-07-14,2011-07-14,,C,,140,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-06,2011-06-01,D,,,,C,Y,40,mg,ORAL,QD,HEARTBURN
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,INFLUENZA VACCINATION NOT FURTHER SPECIFIED,INFLUENZA VACCINE,2011-09,2011-09-01,D,2011-09,2011-09-30,D,C,,1,IU,INTRAMUSCULAR,ONCE,PROPHYLAXIS INFLUENZA
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,GRANISTRON,GRANISETRON,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,1,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NEW CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NEW CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,2,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NEW CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,2,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NEW CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,INDAPAMID,INDAPAMIDE,2005,2005-12-31,M,,,,C,Y,"1,25",mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,IMMERON 400,IOMEPROL,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,130,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PERINDOPRIL,PERINDOPRIL,2005,2005-12-31,M,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2011-03-14,2011-03-14,,2011-03-30,2011-03-30,,C,,2,TABLET,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-12,2011-01-12,,2011-02-23,2011-02-23,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-23,2011-03-23,,2011-03-30,2011-03-30,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-04-13,2011-04-13,,2011-04-13,2011-04-13,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-05-25,2011-05-25,,2011-05-25,2011-05-25,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-02-04,2011-02-04,,2011-05-13,2011-05-13,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-02-04,2011-02-04,,2011-05-13,2011-05-13,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLIN ACID,,2011-02-04,2011-02-04,,2011-05-13,2011-05-13,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN,,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,5.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,6.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLIN ACID,,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,,,,,,,
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTES CONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2011-02-02,2011-02-02,,2011-02-03,2011-02-03,,,,250,mL,INTRAVENOUS,TID,ANEMIA
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-02-01,2011-02-01,,2011-02-28,2011-02-28,,,,0.4,mL,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-01-26,2011-01-26,,2011-01-31,2011-01-31,,,,PRN,IU,SUBCUTANEOUS,PRN,ANTICOAGULATION
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-03-01,2011-03-01,,,,,,Y,0.5,mL,SUBCUTANEOUS,QD,VENOUS THROMBOSIS OF RIGHT UPPER ARM
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-11-09,2011-11-09,,2011-12-07,2011-12-07,,,,,,,,
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLIN ACID,,2011-11-09,2011-11-09,,2011-12-07,2011-12-07,,,,,,,,
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-11-09,2011-11-09,,2011-12-07,2011-12-07,,,,,,,,
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-08-17,2011-08-17,,,,,C,Y,unknown,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-14,2011-09-14,,2011-09-21,2011-09-21,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,IMERON 400,IOMEPROL,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,P,,120,mL,INTRAVENOUS,ONCE,CONTRAST DYE CT SCAN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-12,2011-10-12,,2011-10-26,2011-10-26,,C,,8,mg,INTRAVENOUS,Q2S,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,IMERON 400,IOMEPROL,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,120,mL,INTRAVENOUS,ONCE,CONSTRAST DYE CT SCAN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACINE,CIPROFLOXACIN,2011-10-21,2011-10-21,,2011-10-26,2011-10-26,,C,,500,mg,ORAL,BID,ADVERSE EVENT
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACINE,CIPROFLOXACIN,2011-10-27,2011-10-27,,2011-10-31,2011-10-31,,C,,500,mg,ORAL,QD,ADVERSE EVENT
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,HYDROXYZINE,HYDROXYZINE,2011-10-26,2011-10-26,,,,,C,Y,25,mg,ORAL,PRN,SLEEP DISTURBANCES
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,NOCTAMID,LORMETAZEPAM,2011-10-27,2011-10-27,,,,,C,Y,unknown,mg,ORAL,PRN,SLEEP DISTURBANCES
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-31,2011-10-31,,,,,C,Y,0.7,mL,SUBCUTANEOUS,BID,THROMBOPHLEBITIS OF LEFT THIGH
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,VOMEX,DIMENHYDRINATE,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,100,mg,INTRAVENOUS,QD,PROPHYLAXIS FOR CHEMOTHERAPY
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-08-03,2011-08-03,,,,,C,Y,40,mg,ORAL,QD,STOMACH PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-30,2011-10-30,,2011-10-30,2011-10-30,,C,,"0,7",mL,SUBCUTANEOUS,QD,THROMBOPHLEBITIS OF LEFT THIGH
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,LAXANS,BISACODYL,2011-10,2011-10-01,D,2011-11,2011-11-30,D,C,,Unknown,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,NATRIUMLAURYLSULFOACETAT,SODIUM LAURYL SULFATE,2011-10,2011-10-01,D,2011-11,2011-11-30,D,C,,1,IU,RECTAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DOLORMIN EXTRA,IBUPROFEN,2011-07-27,2011-07-27,,,,,C,Y,400,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,TRAMAL,TRAMADOL HYDROCHLORIDE,2011-08-10,2011-08-10,,2011-08-17,2011-08-17,,C,,20,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2000,2000-12-31,M,,,,C,Y,2.5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,BISOHEXAL,BISOPROLOL FUMARATE,2000,2000-12-31,M,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-17,2011-08-17,,2011-08-31,2011-08-31,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-08-25,2011-08-25,,,,,C,Y,Unknown,gtt,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2011,2011-08-17,M,,,,C,Y,unknown,gtt,ORAL,PRN,OBSTIPATION
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLIN ACID,,2011-10-17,2011-10-17,,2011-11-21,2011-11-21,,,,,,,,
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-10-17,2011-10-17,,2011-11-21,2011-11-21,,,,,,,,
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-10-17,2011-10-17,,2011-11-21,2011-11-21,,,,,,,,
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-08,2011-08-17,D,,,,C,Y,30,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,5-FLUORURACIL,FLUOROURACIL,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,4172,mg,INTRAVENOUS,ONCE,PANCREATIC CANCER
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXALIPLATIN,OXALIPLATIN,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,149,mg,INTRAVENOUS,ONCE,PANCREATIC CANCER
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,1,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,1,g,INTRAVENOUS,BID,PROPHYLAXIS FOR CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,1,g,INTRAVENOUS,BID,PROPHYLAXIS FOR CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-17,2011-08-17,,2011-08-24,2011-08-24,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-21,2011-09-21,,2011-09-28,2011-09-28,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,IMERON,IOMEPROL,2011-08-12,2011-08-12,,2011-08-12,2011-08-12,,P,,81,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT SCAN
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,IMERON,IOMEPROL,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,71,mL,INTRAVENOUS,ONCE,CONTRAST DYE FOR CT SCAN
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2011-08,2011-08-17,D,,,,C,Y,1,TABLET,ORAL,QD,HYPOCALEMIA
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-10,2011-10-01,D,,,,C,Y,10000,IU,ORAL,TID,PANCREATIC CANCER
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,CALCIUMFOLINAT,CALCIUM FOLINATE,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,600,mg,INTRAVENOUS,ONCE,PANCREATIC CANCER
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEM OX,,2011-06-27,2011-06-27,,2011-08-25,2011-08-25,,,,,,,,
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2011-09-15,2011-09-15,,2012-01-05,2012-01-05,,,,,,,,
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAAR ERLOTINIB,,2012-01-12,2012-01-12,,,2012-01-12,Y,,,,,,,
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ACTONEL,RISEDRONATE SODIUM,2010-08,2010-07-31,D,,,,C,Y,35,mg,ORAL,QS,OSTEOPOROSIS
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL,METRONIDAZOLE,2011-06-03,2011-06-03,,2011-06-09,2011-06-09,,C,,500,mg,INTRAVENOUS,TID,INFECTION WITH UNKONWN FOCUS
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CERTOPARIN,CERTOPARIN SODIUM,2011-01-06,2011-01-06,,,,,C,Y,0.3,mL,SUBCUTANEOUS,once daily if in Hospital,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEKRISTOL,COLECALCIFEROL,2000,2000-12-31,M,,,,C,Y,35,mg,ORAL,QS,OSTEOPOROSIS
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2000,2000-12-31,M,,,,C,Y,40,mg,ORAL,BID,GASTRITIS
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2006,2006-12-31,M,,,,C,Y,300,mg,ORAL,PRN,NTERMITTEND BACK PAIN
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,1998,1998-12-31,M,,,,C,Y,500,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2000,2000-12-31,M,,,,C,Y,500,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SULBACTAM / AMPICILLIN ( UNACID I.V.),UNACID                             /00917901/,2011-05-19,2011-05-19,,2011-05-25,2011-05-25,,C,,3000,mg,INTRAVENOUS,TID,PNEUMONIA
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2011-05-27,2011-05-27,,2011-05-31,2011-05-31,,C,,500,mg,ORAL,QD,SUSPICION OF PORT INFECTION NOT CONFIRMED
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXON,CEFTRIAXONE SODIUM,2011-06-03,2011-06-03,,2011-06-09,2011-06-09,,C,,2000,mg,INTRAVENOUS,QD,INFECTION WITH UNKONWN FOCUS
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-07,2011-07-26,D,,,,C,Y,25,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SULBACTAM/ AMPICILLIN  (UNACID IV.),UNACID                             /00917901/,2011-10-07,2011-10-07,,2011-10-13,2011-10-13,,C,,3,g,INTRAVENOUS,TID,PENUMONIA
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TINZAPARIN,TINZAPARIN,2011-10-05,2011-10-05,,,,,C,Y,0.7,mL,SUBCUTANEOUS,QD,LUNG EMBOLISM
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2011-11-07,2011-11-07,,2011-11-14,2011-11-14,,C,,1000,mg,INTRAVENOUS,from 7th to 8th twice a day there after once daily,PORT INFECTION WITH ENTERCOCCUS FAECIUM
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PPERACILLIN TAZOBACTAM,PIP/TAZO,2011-11-04,2011-11-04,,2011-11-10,2011-11-10,,C,,4500,mg,INTRAVENOUS,TID,PORT INFECTION
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2011-10-05,2011-10-05,,2011-11-05,2011-11-05,,C,,500,mg,INTRAVENOUS,QD,PORT INFECTION
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,AMPHO-MORONAL,AMPHOTERICIN B,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,2,mL,ORAL,6 TIMES PER DAY,WHITE COATING OF THE TONGUE
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-07-25,2011-07-25,,,,,C,Y,40,gtt,ORAL,on-demand,PAIN DUE TO PANCREATIC CARCINOMA
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-03,2011-02-28,D,,,,C,Y,1,g,ORAL,QID,PAIN
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,BIMATOPROST,BIMATOPROST,2001,2001-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,QD,GLAUCOMA
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2011-07,2011-07-26,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-07,2011-07-26,D,,,,C,Y,40,mg,ORAL,QD,PROPHYLAXIS OF GASTRIC ULCERA
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,BISOPROLO,BISOPROLOL,2011-07,2011-07-26,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2011-07,2011-07-26,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TRAMADOLOR,TRAMADOL HYDROCHLORIDE,2011-07,2011-07-26,D,,,,C,Y,100,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,INOHEP,TINZAPARIN SODIUM,2011-10-04,2011-10-04,,,,,C,Y,0.7,mL,SUBCUTANEOUS,QD,LUNG EMBOLISM
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE + ERLOTINIB,,2012-01-09,2012-01-09,,2012-05-15,2012-05-15,,,,,,,,
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL HCT AWD,BISELECT                           /01166101/,2002,2002-12-31,M,,,,C,Y,10/25,mg,ORAL,QD,HYPERTONIE
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PENICILLIN V,PHENOXYMETHYLPENICILLIN,2011-11-27,2011-11-27,,2011-12-02,2011-12-02,,C,,1.5,Mega,ORAL,QID,ERYSIPELAS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TINZAPARIN,TINZAPARIN,2011-11-25,2011-11-25,,2011-12-09,2011-12-09,,C,,14 000,IU,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-12-09,2011-12-09,,,,,C,Y,80,mg,SUBCUTANEOUS,QD,THROMBOSIS-PROPHYLAXIS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-12-19,2011-12-19,,2011-12-20,2011-12-20,,C,,500,mg,ORAL,BID,INFECTION - HIGH TEMPERATURE
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-12-19,2011-12-19,,2012-01-02,2012-01-02,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-11-06,2011-11-06,,2011-11-11,2011-11-11,,C,,400,mg,INTRAVENOUS,BID,CHOLANGIOSEPSIS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-11-11,2011-11-11,,2011-11-17,2011-11-17,,C,,500,mg,ORAL,BID,CHOLANGIOSEPSIS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL BETA,RAMIPRIL,2002,2002-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTONIE
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ZYPREXA,OLANZAPINE,2003,2003-12-31,M,,,,C,Y,10,mg,ORAL,1/2-0-1,MANIC EPISODES
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,PANGROL,PANCREATIN,2011,2011-10-26,M,,,,C,Y,40000,IU,ORAL,TID,EXOCRINE PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,LACTULOSE 1 A PHARMA,LACTULOSE,2011,2011-10-26,M,,,,C,Y,6.67,gramm,ORAL,QD,OBSTIPATION
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011,2011-10-26,M,,,,C,Y,40,mg,ORAL,QD,GASTRITIS-PROPHYLAXIS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,FENISTIL,DIMETINDENE MALEATE,2011,2011-10-26,M,,,,C,Y,1,mg,RECTAL,QD,PRURITUS
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FENTANYL RATIO,FENTANYL,2011,2011-10-26,M,,,,C,Y,25,ug,TRANSDERMAL,every third day,PAIN
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011,2011-10-26,M,,,,C,Y,100,mL,ORAL,TID,PAIN
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-06-21,2012-06-21,,2012-06-29,2012-06-29,,,,,,,,
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2001,2001-12-31,M,,,,C,Y,40,mg,ORAL,QD,SEC. PROPHYLAXIS OF CORONARY HEART DISEASE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SERTRALIN,SERTRALINE,2001,2001-12-31,M,,,,C,Y,50,mg,ORAL,QD,MILD DEPRESSION
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TERAZOSIN,TERAZOSIN,2001,2001-12-31,M,,,,C,Y,2,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,NOVORAPID,INSULIN ASPART,2002,2002-12-31,M,,,,C,Y,24-20-22,IU,SUBCUTANEOUS,TID,DIABETES
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PROTAPHANE,"INSULIN HUMAN INJECTION, ISOPHANE",2002,2002-12-31,M,,,,C,Y,16,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,MONO EMBOLEX,CERTOPARIN SODIUM,2011-10-10,2011-10-10,,,,,C,Y,0.3,mL,SUBCUTANEOUS,once dayly if in hospital,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-03-29,2012-03-29,,2012-03-30,2012-03-30,,C,,40,mg,INTRAVENOUS,TID,HYPERTENSIVE PULMONARY EDEMA WITH
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,TORASEMID,TORASEMIDE,2012-03-12,2012-03-12,,,,,C,Y,20,mg,ORAL,PRN,"DYSPNOEA, CARDIAL DECOMPENSASTION"
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-03-07,2012-03-07,,2012-03-12,2012-03-12,,C,,40,mg,INTRAVENOUS,TID,CARDIAL DECOMPENSATION
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,40,mg,INTRAVENOUS,QD,HYPERKALIMIE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,NACL,SODIUM CHLORIDE,2012-06-07,2012-06-07,,2012-07-09,2012-07-09,,C,,2000,mL,INTRAVENOUS,QD,HYPERKALIMIE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2001,2001-12-31,M,,,,C,Y,20,mg,ORAL,QD,PROPHYLAXIS OF GASTRIC ULCERA
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,TORASEMID,TORASEMIDE,2001,2001-12-31,M,,,,C,Y,10,mg,ORAL,QD,SEC. PROPHYLAXIS OF CORONARY HEART DISEASE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ASS,ACETYLSALICYLIC ACID,2001,2001-12-31,M,,,,C,Y,100,mg,ORAL,QD,SEC. PROPHYLAXIS OF CORONARY HEART DISEASE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2001,2001-12-31,M,,,,C,Y,10,mg,ORAL,QD,SEC. PROPHYLAXIS OF CORONARY HEART DISEASE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2001,2001-12-31,M,,,,C,Y,300,mg,ORAL,QD,HYPERUICEMIA
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,BLOPRESS PLUS,BLOPRESS PLUS,2001,2001-12-31,M,,,,C,Y,"4/6,25",mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DIGITOXIN,DIGITOXIN,2001,2001-12-31,M,,,,C,Y,"0,07",mg,ORAL,once per day except saturday and sunday,CORONARY HEART DISEASE
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DEKRISTOL,COLECALCIFEROL,2001,2001-12-31,M,,,,C,Y,20.000,IU,ORAL,QS,VITAMIN D DEFICIANCY
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE AND TARCEVA,,2011-06-23,2011-06-23,,2011-08-29,2011-08-29,,,,,,,,
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLIN,AMITRIPTYLINE HYDROCHLORIDE,2010-12-10,2010-12-10,,2011-02-06,2011-02-06,,C,,10,mg,ORAL,QD,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TILIDINPHOSPHATE,VALORON N                          /00628301/,2011-01-03,2011-01-03,,2011-01-10,2011-01-10,,C,,50,mg,ORAL,BID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEM,ZOLPIDEM,2011-01-03,2011-01-03,,2011-01-09,2011-01-09,,C,,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2011-01-10,2011-01-10,,,,,C,Y,"0,4",mg,ORAL,QD,NOCTURIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-01-10,2011-01-10,,2011-01-31,2011-01-31,,C,,40,gtt,ORAL,QID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-01-10,2011-01-10,,2011-01-31,2011-01-31,,C,,10,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-01-10,2011-01-10,,,,,C,Y,0.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-01-10,2011-01-10,,2011-02-21,2011-02-21,,C,,10,mg,ORAL,BID,EPIGASTALGIA AND ABDOMINAL CRAMPS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,BALDRIAN,VALERIANA OFFICINALIS,2010-12-11,2010-12-11,,2010-12-12,2010-12-12,,P,,unknown,,ORAL,QD,NOT DOCUMENTED
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MACROGOL,MACROGOL,2011-01-31,2011-01-31,,2011-04-17,2011-04-17,,C,,"13,81",g,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-01-31,2011-01-31,,2011-02-22,2011-02-22,,C,,20,gtt,ORAL,PRN,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2010-12-06,2010-12-06,,2011-01-31,2011-01-31,,C,,40,mg,ORAL,QD,ULCER PROPHYLAXIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-01-31,2011-01-31,,2011-02-07,2011-02-07,,C,,10,mL,ORAL,TID,OBSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-02-07,2011-02-07,,2011-02-14,2011-02-14,,C,,20,mL,ORAL,TID,OBSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-02-22,2011-02-22,,2011-05-02,2011-05-02,,C,,10,mg,ORAL,TID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-03-28,2011-03-28,,2011-04-06,2011-04-06,,C,,500,mg,ORAL,BID,CHOLANGITIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-03-29,2011-03-29,,2011-04,2011-04-30,D,C,,40,mg,ORAL,QD,PROPHYLACTIC
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,NADROPARIN-CALCIUM,NADROPARIN CALCIUM,2011-03-29,2011-03-29,,2011-03-31,2011-03-31,,C,,"0,3",mL,SUBCUTANEOUS,QD,PROPHYLACTIC FOR THROMBOSIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DIMENTINDENMALEAT,DIMETINDENE MALEATE,2011-04-04,2011-04-04,,2011-04-10,2011-04-10,,C,,4,mg,ORAL,BID,PRURITIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DIMETINDENMALEAT,DIMETINDENE MALEATE,2011-04-11,2011-04-11,,2011-06-16,2011-06-16,,C,,4,mg,ORAL,QD,PRURITIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,MACROGOL,MACROGOL,2011-04-18,2011-04-18,,,,,C,Y,"13,81",g,INTRAVENOUS,PRN,CONSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DALTEPARIN-SODIUM,DALTEPARIN SODIUM,2010-12-06,2010-12-06,,2010-12-12,2010-12-12,,P,,25.000,IU,SUBCUTANEOUS,QD,PROPHYLAXIS FOR THROMBOSIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2011-04-26,2011-04-26,,2011-06-29,2011-06-29,,C,,20,gtt,ORAL,TID,INCREASED OF PERISTALSIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-05-03,2011-05-03,,2011-05-16,2011-05-16,,C,,10,mg,ORAL,BID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-05-17,2011-05-17,,2011-06-23,2011-06-23,,C,,10,mg,ORAL,TID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-06-23,2011-06-23,,,,,C,Y,25,ug/h,TRANSDERMAL,Q3D,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2011-06-30,2011-06-30,,,,,,Y,15,gtt,ORAL,TID,PROPHYLACTIC
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,OMEGA3,FISH OIL,2011-04-18,2011-04-18,,2011-06-22,2011-06-22,,C,,unknown,,ORAL,UNKNOWN,CARDIAL PROPHYLAXIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2011-03-30,2011-03-30,,2011-03-30,2011-03-30,,C,,7.5,mg,INTRAVENOUS,QD,ANALGESIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SEVREDOL,MORPHINE SULFATE,2011-03-30,2011-03-30,,2011-03-30,2011-03-30,,C,,10,mg,ORAL,QD,ANALGESIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2011-04-18,2011-04-18,,2011-06-22,2011-06-22,,C,,unknown,,ORAL,QD,ADDITIONAL NUTRITION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-04-18,2011-04-18,,2011-06-22,2011-06-22,,C,,unknown,,ORAL,QD,ADDITIONAL NUTRITION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2010-12-08,2010-12-08,,2010-12-12,2010-12-12,,P,,1000,mg,ORAL,QID,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,OLIMEL,OLIMEL,2011-03-29,2011-03-29,,2011-05,2011-05-31,D,C,,1500,mL,INTRAVENOUS,QD,PARENTERAL NUTRITION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,TRACUTIL,TRACUTIL                           /02335301/,2011-03-29,2011-03-29,,2011-04,2011-04-30,D,C,,1,VIAL,INTRAVENOUS,QD,PARENTERAL NUTRITION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,CERNEVIT,CERNEVIT                           /06027301/,2011-03-29,2011-03-29,,2011-04,2011-04-30,D,C,,1,VIAL,INTRAVENOUS,QD,PERENTERAL NUTITION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2010-12-15,2010-12-15,,2011-01-09,2011-01-09,,C,,40,gtt,ORAL,PRN,EPIGASTRALGIA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,MACROGOL,MACROGOL,2010-12-15,2010-12-15,,2011-01-31,2011-01-31,,C,,"13,81",g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYL ACID,ACETYLSALICYLIC ACID,2010-12-15,2010-12-15,,2011-01-10,2011-01-10,,C,,500,mg,ORAL,PRN,PROPHYLAXIS FOR MYOCARDITIS
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-12-27,2010-12-27,,2011-05-31,2011-05-31,,C,,8,mg,INTRAVENOUS,associate with chemotherapy,PROPHYLAXIS FOR NAUSEA
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,ALIZAPRID,ALIZAPRIDE,2010-12-27,2010-12-27,,2011-05-31,2011-05-31,,C,,100,mg,INTRAVENOUS,associate with chemotherapy,PROPHYLAXIS FOR NAUSEA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5FU & OXALIPLATIN,,2011-08-01,2011-08-01,,2011-08-09,2011-08-09,,,,,,,,
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MANNA FEIGE,MANNA,2011-02-03,2011-02-03,,,,,C,Y,20,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MACROGOL,MACROGOL,2011-06-14,2011-06-14,,,,,C,Y,13.81,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2011-06-14,2011-06-14,,,,,C,Y,unknown,0.5 tablets,ORAL,QD,APPETIZING
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTE CONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2011-07-28,2011-07-28,,2011-07-28,2011-07-28,,C,,2,BAG,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9%,SODIUM CHLORIDE,2011-07-25,2011-07-25,,2011-07-29,2011-07-29,,C,,1000,mL,INTRAVENOUS,QD,EXSICCOSIS
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 20%,ALBUMIN HUMAN,2011-07-27,2011-07-27,,2011-07-27,2011-07-27,,C,,100,mL,INTRAVENOUS,QD,HYPOALBUMINEMIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OLIMEL,OLIMEL,2011-07-25,2011-07-25,,2011-07-29,2011-07-29,,C,,1500,mL,INTRAVENOUS,QD,CACHEXIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TRANTIL,CARBAMAZEPINE,2011-07-25,2011-07-25,,2011-07-29,2011-07-29,,C,,unknown,1 vial,INTRAVENOUS,QD,CACHEXIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CERNEVIT,CERNEVIT                           /06027301/,2011-07-25,2011-07-25,,2011-07-29,2011-07-29,,C,,unknown,1 vial,INTRAVENOUS,QD,CACHEXIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-07-25,2011-07-25,,,,,C,Y,40,mg,ORAL,QD,REFLUX PROPHYLAXIS
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTON,SPIRONOLACTONE,2011-06-14,2011-06-14,,,,,C,Y,50,mg,ORAL,QD,ASCITES
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2004,2004-12-31,M,,,,C,Y,100,mg,ORAL,QD,ARTERIOSCLEROSIS PROPHYLAXIS AFTER AORTA ANEURYSM OPERATION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-07-25,2011-07-25,,2011-07-31,2011-07-31,,C,,20,mg,ORAL,BID,ASCITES
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,COSOPT AT (DORZOLAMIDE/TIMOLOL),COSOPT,2011-07-25,2011-07-25,,,,,C,Y,unknown,gtt,OPHTHALMIC,BID,PROPHYLAXIS
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,OPTIDERM LOTION,OPTIDERM                           /01148801/,2011-07-26,2011-07-26,,,,,C,Y,unknown,,TRANSDERMAL,UNKNOWN,SKIN RASH
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,30,DROPS,ORAL,ONCE,PAIN
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,LAXANS,BISACODYL,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,unknown,SUPPOSITORY,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2004,2004-12-31,M,2011-03-31,2011-03-31,,C,,20,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,NEBIVOLOL,NEBIVOLOL,2004,2004-12-31,M,2011-03-03,2011-03-03,,C,,1.25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2004,2004-12-31,M,2011-03-10,2011-03-10,,C,,"2,5",mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,METAMIZOL-SODIUM 1H2O,METAMIZOLE SODIUM,2011-02,2011-02-24,D,,,,C,Y,30,gtt,ORAL,PRN,EPIGASTRALGIA AND BACK PAIN
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-24,2011-02-24,,2011-07-21,2011-07-21,,C,,8,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ALIZAPRID,ALIZAPRIDE,2011-02-24,2011-02-24,,2011-07-21,2011-07-21,,C,,100,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,KREON (LIPASE AND AMYLASE),AMYLASE,2011-05-04,2011-05-04,,,,,C,Y,25000,IU,ORAL,with every meal,CONSTIPATION PROPHYLAXIS
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,KREON (LIPASE AND AMYLASE),LIPASE,2011-05-04,2011-05-04,,,,,C,Y,25000,IU,ORAL,with every meal,CONSTIPATION PROPHYLAXIS
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MST (MORPHIN),MORPHINE,2011-02-11,2011-02-11,,2011,2011-12-31,M,C,,60,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MST (MORPHIN),MORPHINE,2011-02-11,2011-02-11,,2011,2011-12-31,M,C,,80,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BIFITERAL,LACTULOSE,2011-02-03,2011-02-03,,2011,2011-12-31,M,C,,10,mg,ORAL,TID,OBSTIPATION
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SAROTEN,AMITRIPTYLINE HYDROCHLORIDE,2011-02-11,2011-02-11,,2011-03-09,2011-03-09,,C,,25,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SAROTEN,AMITRIPTYLINE HYDROCHLORIDE,2011-03-10,2011-03-10,,2011-04-13,2011-04-13,,C,,50,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SAROTEN,AMITRIPTYLINE HYDROCHLORIDE,2011-04-14,2011-04-14,,2011-06-15,2011-06-15,,C,,25,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SAROTEN,AMITRIPTYLINE HYDROCHLORIDE,2011-06-23,2011-06-23,,2011-07-27,2011-07-27,,C,,50,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-02-11,2011-02-11,,2011-06-23,2011-06-23,,C,,600,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2008,2008-12-31,M,2011-07-27,2011-07-27,,C,,40,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SPIRO COMP.,OSYROL-LASIX,2011-06-30,2011-06-30,,2011-07-27,2011-07-27,,C,,50/20,mg,ORAL,BID,HYPERURIKEMIA
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-18,2011-06-18,,2011-06-19,2011-06-19,,C,,40,mg,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-24,2011-02-24,,,,,C,Y,8,mg,INTRAVENOUS,QS,PROPHYLACTIC FOR NAUSEA
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ALIZAPRID- HCL,ALIZAPRIDE HYDROCHLORIDE,2011-02-24,2011-02-24,,,,,C,Y,100,mg,INTRAVENOUS,QS,PROPHYLACTIV FOR NAUSEA
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,1980,1980-12-31,M,2011-07-27,2011-07-27,,C,,5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,1991,1991-12-31,M,2011-07-27,2011-07-27,,C,,300,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2001,2001-12-31,M,2011-07-27,2011-07-27,,C,,40,mg,ORAL,QD,HYPERCHOLESTERINEMIA
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2008-08,2008-07-31,D,2011-07-27,2011-07-27,,C,,60,mg,ORAL,BID,CHRONIC GASTRITIS
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-02-11,2011-02-11,,2011,2011-12-31,M,C,,40,gtt,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-05-01,2011-05-01,,,,,C,Y,25,gtt,ORAL,PRN,ABDPMINAL PAIN; BACK PAIN; DISK PROLAPSE
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TRANDOLAPRIL,TRANDOLAPRIL,2001,2001-12-31,M,,,,C,Y,0.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-02,2011-01-31,D,,,,C,Y,25000,IU,ORAL,PRN,PANCREAS INSUFFICIENCY
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,INSULIN LISPRO,INSULIN LISPRO,2009-06,2009-05-31,D,,,,C,Y,on demand,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2001,2001-12-31,M,,,,C,Y,100,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-06-01,2011-06-01,,,,,C,Y,20,mg,ORAL,QD,ACID REFLUX
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEMTARTRAT,ZOLPIDEM TARTRATE,2011-06-01,2011-06-01,,,,,C,Y,10,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-05-24,2011-05-24,,,,,C,Y,,mg,ORAL,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLINIC ACID/5-FU/OXALIPLATIN,,2012-06-11,2012-06-11,,2012-09-18,2012-09-18,,,,,,,,
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,MITOMYCIN C,,2012-10-04,2012-10-04,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,,2011-07-22,Y,,,,C,Y,20,mg,ORAL,QD,ULCUS PROPHYLAXE
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-09-08,2011-09-08,,2011-10-05,2011-10-05,,C,,30,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-10-05,2011-10-05,,2011-12-22,2011-12-22,,C,,40,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-12-22,2011-12-22,,2012-01-05,2012-01-05,,C,,60,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,AVALOX,MOXIFLOXACIN HYDROCHLORIDE,2012-01-25,2012-01-25,,2012-02-01,2012-02-01,,C,,400,mg,ORAL,QD,BRONCITIS
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MOXIFLOXACIN,MOXIFLOXACIN,2012-01,2012-01-01,D,,,,C,Y,unknown,,unknown,UNKNOWN,BRONCHITIS
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-07-22,2011-07-22,,2012-05-21,2012-05-21,,C,,8,mg,INTRAVENOUS,prior to every chemo dose,CHEMO PROPHYLAXIS
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-07-22,2011-07-22,,2012-05-21,2012-05-21,,C,,100,mg,INTRAVENOUS,prior to every chemo dose,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011,2011-07-22,M,,,,C,Y,40,gtt,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011,2011-07-22,M,2011-07-28,2011-07-28,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-07-28,2011-07-28,,2011-08-03,2011-08-03,,C,,30,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-08-03,2011-08-03,,2011-08-08,2011-08-08,,C,,30,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-08-08,2011-08-08,,2011-09-08,2011-09-08,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-08-08,2011-08-08,,2011-09-08,2011-09-08,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,I1-GOA-1 STUDY,,2012-03-08,2012-03-08,,2012-04-20,2012-04-20,,,,,,,,
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2012-05-08,2012-05-08,,2012-05-22,2012-05-22,,,,,,,,
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-12-19,2011-12-19,,,,,C,Y,500,mg,ORAL,PRN,PAIN ABDOMINAL
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN-NATRIUM,ENOXAPARIN SODIUM,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,0.6,mL,SUBCUTANEOUS,QD,"THROMBOSIS, ARM VEIN RIGHT"
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN-NATRIUM,ENOXAPARIN SODIUM,2012-01-06,2012-01-06,,2012-01-30,2012-01-30,,C,,0.6,mL,SUBCUTANEOUS,BID,"THROMBOSIS, ARM VEIN RIGHT"
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,INSULIN HUMAN,INSULIN HUMAN,2012-01-05,2012-01-05,,,,,C,Y,6,IU,SUBCUTANEOUS,PRN,HYPERGLYCEMIA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,INSULINDETEMIR,INSULIN DETEMIR,2012-01-05,2012-01-05,,2012-01-06,2012-01-06,,C,,8,IU,SUBCUTANEOUS,QD,HYPERGLYCEMIA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,INSULINDETEMIR,INSULIN DETEMIR,2012-01-07,2012-01-07,,,,,C,Y,8,IU,SUBCUTANEOUS,BID,HYPERGLYCEMIA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,600,mg,ORAL,ONCE,HEADACHE
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-24,2012-01-24,,,,,C,Y,500,mg,ORAL,PRN,PAIN PROPHYLAXIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-31,2012-01-31,,2012-01-31,2012-01-31,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2011-12-19,2011-12-19,,,,,C,Y,36,gtt,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-01,2012-02-01,,2012-02-20,2012-02-20,,C,,50000,IU,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-01,2012-02-01,,2012-02-20,2012-02-20,,C,,25000,IU,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-01,2012-02-01,,,,,C,Y,25000,IU,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-21,2012-02-21,,,,,C,Y,50000,IU,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LOPERAMID,LOPERAMIDE HYDROCHLORIDE,2012-02-21,2012-02-21,,,,,C,Y,2,mg,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,LOPERAMID,LOPERAMIDE HYDROCHLORIDE,2012-01-31,2012-01-31,,2012-01-31,2012-01-31,,C,,2,mg,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-14,2012-02-14,,2012-02-14,2012-02-14,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-28,2012-02-28,,2012-02-28,2012-02-28,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN-NATRIUM,ENOXAPARIN SODIUM,2012-02-21,2012-02-21,,,,,C,Y,0.6,mL,SUBCUTANEOUS,BID,"THROMBOSIS, ARM VEIN RIGHT"
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-01-02,2012-01-02,,2012-01-31,2012-01-31,,C,,25000,IU,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,5,mg,INTRAVENOUS,ONCE,GASTROSCOPY
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,100,mg,INTRAVENOUS,ONCE,GASTROSCOPY
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-01-03,2012-01-03,,,,,C,Y,40,mg,ORAL,QD,PROPHYLAXIS ULCUS VENTRICULI
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA AND EMESIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NUTRIFLEX LIPID PERI,AMINO ACIDS NOS W/CARBOHYDRATES NOS/07403401/,2012-01-05,2012-01-05,,2012-01-08,2012-01-08,,C,,2530,mL,INTRAVENOUS,QD,INSUFFICIENT NUTRICION
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2012-01-09,2012-01-09,,2012-01,2012-01-31,D,C,,500,mg,ORAL,QD,THROMBOPHLEBITIS
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,9 VITAMIN RATIOPHARM,"MULTIVITAMINS, PLAIN",2012-01-06,2012-01-06,,2012-01-10,2012-01-10,,C,,NA,,ORAL,QD,INSUFFICIENT NUTRICION
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2012-01-05,2012-01-05,,2012-01-09,2012-01-09,,C,,5,mg,ORAL,PRN,INSOMNIA PROPHYLAXIS
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2010-11,2010-10-31,D,2011-03-24,2011-03-24,,C,,1,TABLET,ORAL,PRN,DIGESTIVE SUPPLEMENT
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-13,2011-01-13,,,,,C,Y,4,mg,INTRAVENOUS,pre chemotherapy,ANTI NAUSEA
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-17,2011-03-17,,,,,C,Y,1,g,ORAL,PRN,ULCER LEFT HEAL
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03-12,2011-03-12,,,,,C,Y,60,mg,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-03-18,2011-03-18,,,,,C,Y,1,TABLET,ORAL,BID,HYPOKALEMIA
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NEUROFEN,IBUPROFEN,2010-12,2010-11-30,D,2011-01-10,2011-01-10,,P,,2,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,WARFARIN,WARFARIN,2011-01-10,2011-01-10,,,,,C,Y,4,mg,ORAL,QD,THROMBOSIS
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-01-10,2011-01-10,,2011-01-12,2011-01-12,,P,,20,mg,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL / CODEINE,LENOLTEC WITH CODEINE NO 1,2011-01-14,2011-01-14,,2011-01-20,2011-01-20,,C,,8,TABLET,ORAL,PRN,PAIN RIGHT FOOT
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-01-18,2011-01-18,,2011-01-19,2011-01-19,,C,,2,TABLET,ORAL,PRN,PAIN RIGHT FOOT
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ENDONE,OXYCODONE HYDROCHLORIDE,2011-01-20,2011-01-20,,,,,C,Y,5,mg,ORAL,PRN,PAIN RIGHT FOOT
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MAXALON,METOCLOPRAMIDE HYDROCHLORIDE,2011-01-25,2011-01-25,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-01-13,2011-01-13,,,,,C,Y,250,mg,INTRAVENOUS,pre chemotherapy,ANTI NAUSEA
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2009-11-03,2009-11-03,,2010-04-06,2010-04-06,,,,,,,,
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2001,2001-01-01,M,,,,,Y,75,mg,ORAL,QD,PERIPERAL NEUROPATHY
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-03-22,2011-03-22,,,,,,Y,5,mg,ORAL,BID,TUMOUR PAIN
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011,2011-01-01,M,,,,,Y,2,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ENDONE,OXYCODONE HYDROCHLORIDE,2011,2011-01-01,M,,,,,Y,5,mg,ORAL,PRN,TUMOUR PAIN
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-24,2011-03-24,,,,,,Y,4,mg,ORAL,BID,ANOREXIA
CO-101-001,CO-101-001-024-004,01024004,024,64.0,YEARS,F,OTHER,99.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CIPRAMIL  CITALOPRAM HYDROCHLORIDE,CITALOPRAM HYDROCHLORIDE,2002,2002-12-31,M,,,,C,Y,40,mg,ORAL,QHS,DEPRESSION
CO-101-001,CO-101-001-024-004,01024004,024,64.0,YEARS,F,OTHER,99.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,AVAPRO,IRBESARTAN,2000-08-19,2000-08-19,,,,,C,Y,150,mg,ORAL,QHS,HYPERTENSION
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,ABRAXANE/GEMCITABINE,,2011-05-17,2011-05-17,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GLYCAZIDE,GLICLAZIDE,1991,1991-12-31,M,,,,C,Y,60,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,1991,1991-12-31,M,,,,C,Y,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2005,2005-12-31,M,,,,C,Y,20,mg,ORAL,QD,GASTRO ESOPHAGEAL REFLUX DISORDER
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OSTEVIT-D,COLECALCIFEROL,2009,2009-12-31,M,,,,C,Y,25,ug,ORAL,TID,VITAMIN SUPPLEMENT
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FERRO-F TAB,IROFOL C                           /00252201/,2009,2009-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,FOLIC ACID SUPPLEMENT
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PANADEINE FORTE,LENOLTEC WITH CODEINE NO 1,2010-12,2010-11-30,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-01-18,2011-01-18,,,,,C,Y,1000,mg,ORAL,PRN,HOT FLUSHES
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METACLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,2011-01-18,2011-01-18,,,,,C,Y,10,mg,INTRAVENOUS,PRN,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PACKED CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02-16,2011-02-16,,2011-02-16,2011-02-16,,C,,2,IU,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,FISH OIL,FISH OIL,,2011-03-01,Y,,,,C,Y,,,ORAL,,VITAMIN
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,PARIET,RABEPRAZOLE SODIUM,,2011-03-01,Y,2011-03-27,2011-03-27,,C,,20,mg,ORAL,QD,GASTRO OESOPHAGEAL REFLUX DISORDER
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,,2011-03-01,Y,2011-03-27,2011-03-27,,C,,1000,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,AVAPRO,IRBESARTAN,2011-02-07,2011-02-07,,2011-03-27,2011-03-27,,C,,75,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03-08,2011-03-08,,2011-03-27,2011-03-27,,C,,,,SUBCUTANEOUS,,DEEP VENOUS THROMBOSIS
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,MAXOLON,METOCLOPRAMIDE HYDROCHLORIDE,2011-03-01,2011-03-01,,2011-03-01,2011-03-01,,C,,10,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PROGOUT,ALLOPURINOL,1985,1985-01-01,M,,,,,Y,300,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,FELODOR,FELODIPINE,1989,1989-01-01,M,,,,,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-03-10,2011-03-10,,2011-04-06,2011-04-06,,,,10,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,WARFARIN,WARFARIN,2011-03-27,2011-03-27,,2011-04-06,2011-04-06,,,,2,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLISM
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03-23,2011-03-23,,,,,,Y,120,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLISM
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-04-07,2011-04-07,,,,,,Y,20,mg,ORAL,BID,TUMOUR PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2010-09,2010-08-31,D,,,,C,Y,20,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,FENOXIMETYLPENCILLIN,PHENOXYMETHYLPENICILLIN,2010-12-19,2010-12-19,,2010-12-22,2010-12-22,,C,,1000,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-02-08,2011-02-08,,2011-02-15,2011-02-15,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,OXIKODON,OXYCODONE HYDROCHLORIDE,2011-02-08,2011-02-08,,2011-02-14,2011-02-14,,C,,15,mg,ORAL,BID,WORSENED UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,AMOXCILLIN,AMOXICILLIN,2011-02-15,2011-02-15,,2011-02-22,2011-02-22,,C,,500,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXIKODON,OXYCODONE HYDROCHLORIDE,2011-02-15,2011-02-15,,,,,C,Y,20,mg,ORAL,BID,WORSENED UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-02-24,2011-02-24,,2011-03-04,2011-03-04,,,,4000,mg,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,BETAMETASONE,BETAMETHASONE,2011-03-08,2011-03-08,,,,,,Y,5,mg,ORAL,QD,TUMOR RELATED FEVER
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,OXIKODON,OXYCODONE HYDROCHLORIDE,2010-12-08,2010-12-08,,2011-02-07,2011-02-07,,C,,10,mg,ORAL,BID,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,OXIKODON,OXYCODONE HYDROCHLORIDE,2010-11-15,2010-11-15,,,,,C,Y,5,mg,ORAL,PRN,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-11,2010-10-31,D,,,,C,Y,500,mg,ORAL,PRN,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,"COMBIZYM (PANCREATIN,ASPERGILLUSORIZAE ENZYME",COMBIZYM                           /01696401/,2010-10-14,2010-10-14,,,,,C,Y,1 tablet,,ORAL,QD,SECRETORY PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,METOKLOPRAMID,METOCLOPRAMIDE,2010-12-08,2010-12-08,,,,,C,Y,10-20,mg,ORAL,PRN,NAUSEA INTERMITTENT
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2010-12-15,2010-12-15,,,,,C,Y,8,mg,ORAL,PRN,CHEMOTHERAPY INDUCED NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CILAXORAL (NATRIUMPIKOSULFAT),SODIUM PICOSULFATE,2010-12-08,2010-12-08,,,,,C,Y,5-10,gtt,ORAL,PRN,PROPHYLAXIS CONSTIPATION
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,TINZAPARINNATRIUM,TINZAPARIN SODIUM,2011-01-18,2011-01-18,,,,,C,Y,10000,IU,SUBCUTANEOUS,QD,TROMBOEMBOLIC EVENT (DVT RIGHT LEG)
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,MILDISON LIPID,HYDROCORTISONE,1996,1996-12-31,M,,,,C,Y,apply a thin layer,1 %,TOPICAL,BID,CONTACT DERMATITIS
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,AMOSYT,DIMENHYDRINATE,2009-08,2009-07-31,D,,,,C,Y,100,mg,ORAL,PRN,MENIERES DISEASE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-09-26,2012-09-26,,2012-09-26,2012-09-26,,C,,4,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,BISPROLOL,BISELECT                           /01166101/,2012-05-01,2012-05-01,,,,,C,Y,5,mg,ORAL,BID,PAROXYSMAL ATRIAL FIBRILLATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2012-10-05,2012-10-05,,,,,C,Y,20,mg,ORAL,QD,PROPHYLAXIS PYLORIC ULCER
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SELOKEN  METOPROLOL TARTRATE,METOPROLOL TARTRATE,2012-10-01,2012-10-01,,2012-10-10,2012-10-10,,C,,25,mg,ORAL,ONCE,ATRIAL FIBRILLATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CEFOTAXIM,CEFOTAXIME SODIUM,2012-10-01,2012-10-01,,2012-10-01,2012-10-01,,C,,1,g,INTRAVENOUS,TID,SUSPECT INFECTION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-10-02,2012-10-02,,2012-10-07,2012-10-07,,C,,4,g,INTRAVENOUS,TID,SUSPECT INFECTION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,BACTRIM,BACTRIM,2012-10-08,2012-10-08,,,,,C,Y,800/160,mg,ORAL,BID,SUSPECT INFECTION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-10-03,2012-10-03,,,,,C,Y,20,mg,INTRAVENOUS,PRN,OEDEMA RELATED TO HEART FAILURE + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-10-04,2012-10-04,,2012-10-05,2012-10-05,,C,,20,mg,ORAL,QD,OEDEMA RELATED TO HEART FAILURE + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,CALMA,CALCIUM CARBONATE,2010-06,2010-05-31,D,,,,C,Y,20,mg,ORAL,PRN,MENIERES DISEASE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-10-06,2012-10-06,,2012-10-23,2012-10-23,,C,,40,mg,ORAL,BID,OEDEMA REALTED TO HEART FAILURE + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,SPIRONOLAKTON,SPIRONOLACTONE,2012-10-03,2012-10-03,,2012-10-23,2012-10-23,,C,,50,mg,ORAL,QD,PLEURAL EFFUSION + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2012-10-07,2012-10-07,,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,KALEORID DEPOT,POTASSIUM CHLORIDE,2012-10-08,2012-10-08,,2012-10-11,2012-10-11,,C,,750,mg,ORAL,QD,PREVENT POTASSIUM DEFICIENCY
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,OXASCAND,OXAZEPAM,2012-10-04,2012-10-04,,,,,C,Y,5,mg,ORAL,PRN,INTERMITTENT ANXIETY
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-10-12,2012-10-12,,,,,C,Y,2,mg,ORAL,QD,WORSENING NAUSEA
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-10-24,2012-10-24,,,,,C,Y,40,mg,ORAL,QD,OEDEMA REALTED TO HEART FAILURE + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,SPIRONOLAKTON,SPIRONOLACTONE,2012-10-24,2012-10-24,,,,,C,Y,25,mg,ORAL,QD,PLEURAL EFFUSION + HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2009-08,2009-07-31,D,,,,C,Y,20,mg,RECTAL,PRN,MENIERES DISEASE + INTERMITTENT VOMITING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-03-02,2012-03-02,,2012-04-09,2012-04-09,,C,,10,mg,ORAL,BID,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-03-02,2012-03-02,,,,,C,Y,5,mg,ORAL,PRN,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-03-02,2012-03-02,,2012-04-04,2012-04-04,,C,,1,SACHET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-26,2012-03-26,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-03-27,2012-03-27,,2012-03-28,2012-03-28,,C,,5,mg,ORAL,QD,NAUSEA + VOMITING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-03-29,2012-03-29,,2012-03-30,2012-03-30,,C,,4.5,mg,ORAL,QD,NAUSEA + VOMITING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-03-30,2012-03-30,,2012-03-30,2012-03-30,,C,,4,g,INTRAVENOUS,TID,FEVER ( DUE TO SUSPECTED INFECTION NOS )
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,AERIUS,DESLORATADINE,1996,1996-12-31,M,,,,C,Y,5,mg,ORAL,QD,RHINITIS ALLERGIC
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-03-31,2012-03-31,,2012-04-01,2012-04-01,,C,,4,mg,ORAL,QD,NAUSEA+VOMTING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,BETPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-02,2012-04-02,,2012-04-03,2012-04-03,,C,,3.5,mg,ORAL,QD,NAUSEA + VOMITING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,3,mg,ORAL,QD,NAUSEA + VOMTING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,CILAXORAL,SODIUM PICOSULFATE,2012-04-04,2012-04-04,,,,,C,Y,15,gtt,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2012-04-02,2012-04-02,,2012-04-03,2012-04-03,,C,,8,mg,ORAL,PRN,NAUSEA + VOMTING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-06,2012-04-06,,2012-04-07,2012-04-07,,C,,2.5,mg,ORAL,QD,NAUSEA + VOMTING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-08,2012-04-08,,2012-04-09,2012-04-09,,C,,2,mg,ORAL,QD,NAUSEA + VOMTING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-10,2012-04-10,,2012-04-12,2012-04-12,,C,,1.5,mg,ORAL,QD,NAUSEA+VOMITING
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-04-10,2012-04-10,,2012-05-13,2012-05-13,,C,,10+15,mg,ORAL,BID,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2012-04-16,2012-04-16,,2012-04-17,2012-04-17,,C,,40,mg,INTRAVENOUS,BID,PYLORIC ULCER
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,PROPYLESS CUTAN EMULSION,PROPYLENE GLYCOL,1996,1996-12-31,M,,,,C,Y,a thin layer,200mg / Gram,TOPICAL,PRN,DRY SKIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,NEXIUM HP ( NEXIUM + AMIMOX + KLACID,NEXIUM HP,2012-04-17,2012-04-17,,2012-04-24,2012-04-24,,C,,20 + 500 + 500,mg,ORAL,BID,PYLORIC ULCER
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2012-04-25,2012-04-25,,2012-09-11,2012-09-11,,C,,20,mg,ORAL,QD,PROPHYLAXIS PYLORIC ULCER
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-04-20,2012-04-20,,,,,C,Y,1,SACHET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-04-25,2012-04-25,,2012-04-25,2012-04-25,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,PULMICORT TURBOHALER,BUDESONIDE,2012-04-27,2012-04-27,,,,,C,Y,400,ug/dose,RESPIRATORY (INHALATION),PRN,DYSPNEA
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,TROMBYL,ACETYLSALICYLIC ACID,2012-05-04,2012-05-04,,,,,C,Y,75,mg,ORAL,QD,THROMBOEMBOLIC EVENT
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2012-04-30,2012-04-30,,2012-05-01,2012-05-01,,C,,5,mg,INTRAVENOUS,TID,ATRIAL FIBRILLATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,TOBRAMYCIN,TOBRAMYCIN,2012-04-30,2012-04-30,,2012-04-30,2012-04-30,,C,,320,mg,INTRAVENOUS,ONCE,"SUSPECT INFECTION (NOT CONFIRMED) WITH UNKNOWN ORIGIN,DUE TO INCREASED CRP AND FEVER"
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,STILNOCT,ZOLPIDEM TARTRATE,2002,2002-12-31,M,,,,C,Y,10,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,52.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-04-30,2012-04-30,,2012-05-03,2012-05-03,,C,,4,g,INTRAVENOUS,TID,"SUSPECT INFECTION (NOT CONFIRMED) WITH UNKNOWN ORIGIN, DUE TO INCREASED CRP AND FEVER"
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,53.0,CONCOMITANT MEDICATIONS,,,CREAM HIRUDOID,HEPARINOID,2012-05-01,2012-05-01,,2012-05-04,2012-05-04,,C,,3-5,cm,TOPICAL,PRN,THROMBOPHLEBITIS RIGHT FOREARM
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,54.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-05-09,2012-05-09,,2012-05-09,2012-05-09,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,55.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-05-23,2012-05-23,,2012-05-23,2012-05-23,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,56.0,CONCOMITANT MEDICATIONS,,,SELEXID - PIVMECILLINAM,PIVMECILLINAM,2012-05-23,2012-05-23,,2012-05-30,2012-05-30,,C,,200,mg,ORAL,TID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,57.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-05-09,2012-05-09,,,,,C,Y,500,mg,ORAL,PRN,INTERMITTENT FEVER
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,58.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-05-14,2012-05-14,,,,,C,Y,15,mg,ORAL,BID,UPPER ABDOMINAL PAIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,59.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-05-30,2012-05-30,,2012-05-30,2012-05-30,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,60.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMACITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,61.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-06-20,2012-06-20,,2012-06-20,2012-06-20,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMICITABIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,62.0,CONCOMITANT MEDICATIONS,,,PROPAVAN,PROPIOMAZINE MALEATE,2002,2002-12-31,M,,,,C,Y,25,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,63.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-06-27,2012-06-27,,2012-06-27,2012-06-27,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMICITABIN
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,64.0,CONCOMITANT MEDICATIONS,,,FURADANTIN,NITROFURANTOIN,2012-06-27,2012-06-27,,2012-07-01,2012-07-01,,C,,50,mg,ORAL,TID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,65.0,CONCOMITANT MEDICATIONS,,,CEFOTAXIM,CEFOTAXIME SODIUM,2012-07-02,2012-07-02,,2012-07-02,2012-07-02,,C,,1000,mg,INTRAVENOUS,TID,PYELONEPHRITIS
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,66.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-07-03,2012-07-03,,2012-07-16,2012-07-16,,C,,500,mg,ORAL,BID,PYELONEPHRITIS
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,67.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-04,2012-07-04,,2012-07-04,2012-07-04,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,68.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-18,2012-07-18,,2012-07-18,2012-07-18,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,69.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-18,2012-07-18,,2012-07-19,2012-07-19,,C,,5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,70.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-20,2012-07-20,,2012-07-21,2012-07-21,,C,,4.5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,71.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-22,2012-07-22,,2012-07-23,2012-07-23,,C,,4,mg,ORAL,QD,WORSENING FATIQUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,72.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-24,2012-07-24,,2012-07-25,2012-07-25,,C,,3.5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,73.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2005-10,2005-09-30,D,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,74.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-26,2012-07-26,,2012-07-27,2012-07-27,,C,,3,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,75.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-28,2012-07-28,,2012-07-29,2012-07-29,,C,,2.5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,76.0,CONCOMITANT MEDICATIONS,,,BETAPTRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-30,2012-07-30,,2012-07-31,2012-07-31,,C,,2,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,77.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-01,2012-08-01,,2012-08-02,2012-08-02,,C,,1.5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,78.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-03,2012-08-03,,2012-08-04,2012-08-04,,C,,1,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,79.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-05,2012-08-05,,2012-08-06,2012-08-06,,C,,0.5,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,80.0,CONCOMITANT MEDICATIONS,,,FENOXIMETYLPENICILLIN,PHENOXYMETHYLPENICILLIN,2012-08-07,2012-08-07,,2012-08-17,2012-08-17,,C,,2,g,ORAL,TID,INFECTION PROPHYLAXIS DUE TO A PUNCTURE WOUND
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,81.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-07-25,2012-07-25,,2012-07-25,2012-07-25,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMICITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,82.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-01,2012-08-01,,2012-08-01,2012-08-01,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,83.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-16,2012-08-16,,2012-08-16,2012-08-16,,C,,8,mg,ORAL,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,84.0,CONCOMITANT MEDICATIONS,,,SPRAY FLUTIDE,FLUTICASONE PROPIONATE,1996,1996-12-31,M,,,,C,Y,50,ug,RESPIRATORY (INHALATION),BID,RHINITIS ALLERGIC
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,85.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-23,2012-08-23,,2012-08-23,2012-08-23,,C,,8,mg,ORAL,QHS,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,86.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-16,2012-08-16,,2012-09-19,2012-09-19,,C,,1,mg,ORAL,QD,WORSENING FATIGUE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,87.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-08-30,2012-08-30,,2012-08-30,2012-08-30,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,88.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2012-09-12,2012-09-12,,2012-10-04,2012-10-04,,C,,20,mg,ORAL,BID,REDUCE ACID IN STOMACH
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,89.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-09-12,2012-09-12,,2012-09-12,2012-09-12,,C,,4,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,90.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2012-09-19,2012-09-19,,2012-09-19,2012-09-19,,C,,4,mg,INTRAVENOUS,ONCE,PREMEDICATION GEMCITABINE
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,91.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2008-11,2008-10-31,D,2012-04-30,2012-04-30,,C,,2.5,mg,ORAL,BID,PAROXYSMAL ATRIAL FIBRILLATION
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,92.0,CONCOMITANT MEDICATIONS,,,TROMBYL,ACETYLSALICYLIC ACID,2011-11-04,2011-11-04,,2012-04-25,2012-04-25,,C,,75,mg,ORAL,QD,THROMBOEMBOLIC EVENT
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-02-08,2012-02-08,,,,,,,,,,,
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINNATRIUM,ENOXAPARIN SODIUM,2011-10-24,2011-10-24,,2011-10-25,2011-10-25,,,,40,mg,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,GLUCOS,GLUCOSE,2012-01-09,2012-01-09,,2012-01-10,2012-01-10,,,,50000,mg,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTE,RED BLOOD CELLS,2012-01-15,2012-01-15,,2012-01-16,2012-01-16,,,,300,mL,INTRAVENOUS,QD,ANEMI
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-10,2012-01-10,,2012-01-17,2012-01-17,,,,1,g,RECTAL,QID,PAIN AND FEVER
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CEFOTAXIM,CEFOTAXIME SODIUM,2012-01-18,2012-01-18,,2012-01-23,2012-01-23,,,,1,g,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2012-01-18,2012-01-18,,2012-01-19,2012-01-19,,,,1500,mg,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2012-01-19,2012-01-19,,2012-01-23,2012-01-23,,,,1000,g,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-01-24,2012-01-24,,2012-01-28,2012-01-28,,,,500,g,ORAL,BID,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,FLAGYL  METRONIDAZOLE,METRONIDAZOLE,2012-01-24,2012-01-24,,2012-01-28,2012-01-28,,,,400,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PIPERACILLIN/TAZOBACTAM,PIP/TAZO,2012-01-28,2012-01-28,,2012-02-01,2012-02-01,,,,4,g,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTE,RED BLOOD CELLS,2012-01-17,2012-01-17,,2012-01-18,2012-01-18,,,,300,mL,INTRAVENOUS,QD,ANEMI
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINNATRIUM,ENOXAPARIN SODIUM,2011-10-25,2011-10-25,,2011-12-22,2011-12-22,,,,80,mg,SUBCUTANEOUS,BID,THROMBOSIS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2012-01-21,2012-01-21,,,,,,Y,20,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2012-01-22,2012-01-22,,2012-02-02,2012-02-02,,,,80,mg,ORAL,QD,EDEMA LIMBS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,SPIRONOLAKTON,SPIRONOLACTONE,2012-01-23,2012-01-23,,2012-02-02,2012-02-02,,,,25,mg,ORAL,QD,EDEMA LIMBS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTE,RED BLOOD CELLS,2012-01-20,2012-01-20,,2012-01-22,2012-01-22,,,,300,mL,INTRAVENOUS,QD,ANEMI
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2012-02-02,2012-02-02,,,,,,Y,40,mg,ORAL,QD,EDEMA LIMBS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,NATRIUMPIKOSULFAT,SODIUM PICOSULFATE,2011-12-28,2011-12-28,,,,,,Y,10-20,gtt,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-12-28,2011-12-28,,,,,,Y,1,SACHET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINNATRIUM,ENOXAPARIN SODIUM,2011-12-22,2011-12-22,,2012-01-03,2012-01-03,,,,80,mg,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINNATRIUM,ENOXAPARIN SODIUM,2012-01-03,2012-01-03,,2012-01-09,2012-01-09,,,,80,mg,SUBCUTANEOUS,BID,THROMBOSIS
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINNATRIUM,ENOXAPARIN SODIUM,2012-01-09,2012-01-09,,,,,,Y,100,mg,SUBCUTANEOUS,BID,PULMONARY EMBOLISM
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,REHYDREX WITH GLUCOS,REHYDREX MED GLUKOS,2012-01-09,2012-01-09,,2012-01-10,2012-01-10,,,,25000,mg,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,REHYDREX WITH GLUCOS,REHYDREX MED GLUKOS,2012-01-12,2012-01-12,,,,,,Y,25000,mg,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GENCITABINE,,2011-10-13,2011-10-13,,2012-01-13,2012-01-13,,,,,,,,
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATINO,,2011-10-13,2011-10-13,,2012-01-13,2012-01-13,,,,,,,,
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-03-05,2011-03-05,,2011-05-04,2011-05-04,,C,,12,gtt,ORAL,QID,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-05-11,2011-05-11,,2011-05-11,2011-05-11,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-11,2011-05-11,,2011-05-11,2011-05-11,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MEPREDNISONE,MEPREDNISONE,2011-03-05,2011-03-05,,,,,C,Y,2,mg,ORAL,QD,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-04,2011-05-04,,2011-05-10,2011-05-10,,C,,12,gtt,ORAL,QID,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-11,2011-05-11,,2011-06-23,2011-06-23,,C,,18,gtt,ORAL,QD,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,8,mg,INTRAVENOUS,ONCE,PROPHILAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE PHOSPHATE ACETATE,DEXAMETHASONE ACETATE,2011-04-16,2011-04-16,,2011-04-16,2011-04-16,,C,,1,AMPULE,INTRAMUSCULAR,ONCE,ARTRALGIA
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE PHOSPHATE ACETATE,DEXAMETHASONE PHOSPHATE,2011-04-16,2011-04-16,,2011-04-16,2011-04-16,,C,,1,AMPULE,INTRAMUSCULAR,ONCE,ARTRALGIA
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ONSANSENTRON,ONDANSETRON,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-08-31,2011-08-31,,2011-08-31,2011-08-31,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-31,2011-08-31,,2011-08-31,2011-08-31,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-04-14,2011-04-14,,2011-04-14,2011-04-14,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-10-10,2011-10-10,,,,,C,Y,12,gtt,ORAL,TID,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-10,2011-10-10,,,,,C,Y,1,g,ORAL,TID,DORSAL PAIN
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRON,ONDANSETRON,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-04-14,2011-04-14,,2011-04-14,2011-04-14,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULIN NPH - INSULIN ISOPHANE PORCINE,INSULIN ISOPHANE PORCINE,2009,2009-12-31,M,,,,C,Y,30,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-03-08,2012-03-08,,2012-03-08,2012-03-08,,C,,0.1,cc3,INTRAVENOUS,QD,DYSPNOEA
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXTROPROPOXYPHENE,DEXTROPROPOXYPHENE,2011-11-26,2011-11-26,,2012-02-01,2012-02-01,,C,,98,mg,ORAL,QD,SUPRACLAVICULAR PAIN
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DYPIRONE,METAMIZOLE SODIUM,2011-11-26,2011-11-26,,2012-02-01,2012-02-01,,C,,400,mg,ORAL,TID,SUPRACLAVICULAR PAIN
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,RANITIDINE,RANITIDINE,2011-11,2011-10-31,D,,,,C,Y,150,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-01-25,2011-01-25,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QS,ANTIEMETICS PROPHYLAXIS
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONA,DEXAMETHASONE,2011-01-25,2011-01-25,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QS,PROPHYLAXIS
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MORPHINE HYDROCHLORIDE,MORPHINE HYDROCHLORIDE,2012-02-01,2012-02-01,,,,,C,Y,20,mg,ORAL,Q4H,SUPRACLAVICULAR PAIN
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2012-02-01,2012-02-01,,,,,C,Y,25,mg,ORAL,BID,ASCITIS
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-02-01,2012-02-01,,,,,C,Y,40,mg,ORAL,QD,ASCITIS
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2011-09-21,2011-09-21,,2011-10-05,2011-10-05,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2011-10-19,2011-10-19,,2011-11-02,2011-11-02,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2011-11-16,2011-11-16,,2011-11-30,2011-11-30,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2011-12-14,2011-12-14,,2011-12-28,2011-12-28,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-12-14,2011-12-14,,2011-12-18,2011-12-18,,C,,400,mg,ORAL,QID,POST OPERATIVE PAIN CICATRIX
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-12-29,2011-12-29,,2011-12-29,2011-12-29,,C,,10,mg,ORAL,QID,HICCUPS
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2012-01-11,2012-01-11,,2012-01-25,2012-01-25,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2012-02-15,2012-02-15,,2012-02-29,2012-02-29,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDASENTRON,ONDANSETRON,2012-03-14,2012-03-14,,2012-03-28,2012-03-28,,C,,8,mg,INTRAVENOUS,QS,VOMITING
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MORPHINE 3MG/ML,MORPHINE,2011-04-11,2011-04-11,,2011-05-05,2011-05-05,,P,,18,mg,ORAL,6 TIMES PER DAY,PROPHYLAXIS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-05-09,2011-05-09,,2011-05-09,2011-05-09,,C,,700,mL,INTRAVENOUS,ONCE,INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-24,2011-08-24,,2011-08-24,2011-08-24,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-26,2011-08-26,,2011-08-26,2011-08-26,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-27,2011-08-27,,2011-08-28,2011-08-28,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-31,2011-08-31,,2011-08-31,2011-08-31,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-05-16,2011-05-16,,2011-05-16,2011-05-16,,C,,700,mL,INTRAVENOUS,ONCE,INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,2,mg,ORAL,QD,ANTICUAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-03,2011-09-03,,2011-09-04,2011-09-04,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-10,2011-09-10,,2011-09-11,2011-09-11,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-09,2011-05-09,,2011-05-09,2011-05-09,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-13,2011-09-13,,2011-09-13,2011-09-13,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-16,2011-09-16,,2011-09-16,2011-09-16,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-17,2011-09-17,,2011-09-17,2011-09-17,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-09-22,2011-09-22,,2011-10-11,2011-10-11,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-13,2011-10-13,,2011-10-14,2011-10-14,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-15,2011-10-15,,2011-10-15,2011-10-15,,C,,1,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-16,2011-10-16,,2011-10-16,2011-10-16,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-16,2011-05-16,,2011-05-16,2011-05-16,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,MORPHINE 3 MG/ML,MORPHINE,2011-07-18,2011-07-18,,2011-07-22,2011-07-22,,C,,4,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,MORPHINE 6 MG/ML,MORPHINE,2011-07-23,2011-07-23,,2011-08-01,2011-08-01,,C,,5,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,MORPHINE 6 MG/ML,MORPHINE,2011-08-02,2011-08-02,,2011-08-29,2011-08-29,,C,,6,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,MORPHINE 6 MG/ML,MORPHINE,2011-08-30,2011-08-30,,2011-10-11,2011-10-11,,C,,8,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,METHADONE 3 MG/ML,METHADONE,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,6,mL,ORAL,ONCE,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,PICOSULFATE,SODIUM PICOSULFATE,2011-10-11,2011-10-11,,,,,C,Y,20,gtt,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-09,2011-05-09,,2011-05-09,2011-05-09,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICACIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-16,2011-05-16,,2011-05-16,2011-05-16,,C,,8,mL,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-05-11,2011-05-11,,2011-05-11,2011-05-11,,C,,10,mg,ORAL,BID,DYSPHAGIA
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,68.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,69.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,70.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,71.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,72.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,73.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,74.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,75.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,76.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,77.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,700,mL,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,78.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-30,2011-05-30,,2011-05-30,2011-05-30,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,79.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,4,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,80.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,8,mg,INTRAVENOUS,QD,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,81.0,CONCOMITANT MEDICATIONS,,,METHADONE 3 MG/ML,METHADONE,2011-10-18,2011-10-18,,,,,C,Y,6,mL,ORAL,QID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,82.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-17,2011-10-17,,2011-10-22,2011-10-22,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,83.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-23,2011-10-23,,2011-10-23,2011-10-23,,C,,1,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,84.0,CONCOMITANT MEDICATIONS,,,PHYTOMENADIONE,PHYTOMENADIONE,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,10,mg,ORAL,ONCE,REVERSAL OF ANTICOAGULATION BY INR> 10
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,85.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-30,2011-05-30,,2011-05-30,2011-05-30,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,86.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-05-30,2011-05-30,,2011-05-30,2011-05-30,,C,,700,mg,INTRAVENOUS,ONCE,INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,87.0,CONCOMITANT MEDICATIONS,,,MORPHINE 3 MG/ML,MORPHINE,2011-06-01,2011-06-01,,2011-07-05,2011-07-05,,C,,2,mL,ORAL,QID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,88.0,CONCOMITANT MEDICATIONS,,,K VIITAMIN,VITAMIN K NOS,2011-11-21,2011-11-21,,2011-11-21,2011-11-21,,C,,10,mg,ORAL,ONCE,ANTICOAGULATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,89.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-25,2011-10-25,,2011-10-28,2011-10-28,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,90.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-10-29,2011-10-29,,2011-10-29,2011-10-29,,C,,1,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,91.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,92.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-11-04,2011-11-04,,2011-11-06,2011-11-06,,C,,1,mg,ORAL,per 48 hours,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,93.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,94.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,700,mL,INTRAVENOUS,ONCE,PROPHYLAXIS PER INFUSION TREATMENT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,95.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,4,mg,INTRAVENOUS,ONCE,PROPHYLAXIS PER INFUTION TREATMENT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,96.0,CONCOMITANT MEDICATIONS,,,ONDANSENTRONE,ONDANSETRON,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS PER INFUTION TREATMENT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,97.0,CONCOMITANT MEDICATIONS,,,MORPHINE 6 MG/ML,MORPHINE,2011-05-12,2011-05-12,,2011-05-31,2011-05-31,,C,,4,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,98.0,CONCOMITANT MEDICATIONS,,,HYDROXYZINE,HYDROXYZINE,2011-11-21,2011-11-21,,,,,C,Y,50,mg,ORAL,BID,PRURITUS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,99.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-11-14,2011-11-14,,2011-11-20,2011-11-20,,C,,3,mg,INTRAVENOUS,semanal,ANTICOUGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,100.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-12-21,2011-12-21,,,,,,Y,5,mg,INTRAVENOUS,CONTINUOUS,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,101.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-12-21,2011-12-21,,,,,,Y,50,mg,INTRAVENOUS,CONTINUOUS,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,102.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-12,2011-12-01,D,,,,C,Y,UNK,,INTRAVENOUS,UNKNOWN,PER TREATMENT ATB
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,103.0,CONCOMITANT MEDICATIONS,,,PREGABALIN,PREGABALIN,2011-05-16,2011-05-16,,2011-05-31,2011-05-31,,C,,75,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,104.0,CONCOMITANT MEDICATIONS,,,METADONA 3MG/ML,METHADONE HYDROCHLORIDE,2011-10-12,2011-10-12,,2011-10-17,2011-10-17,,C,,3,mL,ORAL,TID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,105.0,CONCOMITANT MEDICATIONS,,,K VITAMIN,VITAMIN K NOS,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,10,mg,ORAL,ONCE,ANTICOAGULATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,106.0,CONCOMITANT MEDICATIONS,,,MORPHYNE 3 MG/ML,MORPHINE,2011-07-06,2011-07-06,,2011-07-17,2011-07-17,,C,,4,mL,ORAL,QID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,107.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,108.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,8,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,109.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,700,mL,INTRAVENOUS,ONCE,INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,110.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-06-13,2011-06-13,,2011-06-13,2011-06-13,,C,,700,mL,INTRAVENOUS,ONCE,INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,111.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-13,2011-06-13,,2011-06-13,2011-06-13,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,112.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-13,2011-06-13,,2011-06-13,2011-06-13,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUSION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,113.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,700,mL,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,114.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-03-18,2011-03-18,,2011-07-17,2011-07-17,,C,,75,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,115.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,4,mg,INTRAVENOUS,ONCE,PHOPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,116.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,117.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,700,mL,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,118.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,119.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,120.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,700,mL,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,121.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,4,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,122.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,8,mg,INTRAVENOUS,ONCE,PHROPHYLAXIS PER INFUTION OF STUDY MEDICATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,123.0,CONCOMITANT MEDICATIONS,,,PREGABALIN,PREGABALIN,2011-06-01,2011-06-01,,2011-07-15,2011-07-15,,C,,75,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,124.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-12,2011-07-12,,2011-07-14,2011-07-14,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,125.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2011-03-18,2011-03-18,,,,,C,Y,30,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,126.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-15,2011-07-15,,2011-07-16,2011-07-16,,C,,3,mg,ORAL,QD,ANTICOUGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,127.0,CONCOMITANT MEDICATIONS,,,DELTISONE B,MEPREDNISONE,2011-06-01,2011-06-01,,2011-07-10,2011-07-10,,C,,10,mg,ORAL,QD,ILIAC VEIN THROMBOSIS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,128.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-17,2011-07-17,,2011-07-17,2011-07-17,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,129.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,130.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-19,2011-07-19,,2011-07-20,2011-07-20,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,131.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,132.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-22,2011-07-22,,2011-07-24,2011-07-24,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,133.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,134.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,135.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-27,2011-07-27,,2011-07-27,2011-07-27,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,136.0,CONCOMITANT MEDICATIONS,,,PREGABALIN,PREGABALIN,2011-03-18,2011-03-18,,2011-05-15,2011-05-15,,C,,75,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,137.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-28,2011-07-28,,2011-07-28,2011-07-28,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,138.0,CONCOMITANT MEDICATIONS,,,PREGABALIN,PREGABALIN,2011-07-16,2011-07-16,,,,,C,Y,75,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,139.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-07-16,2011-07-16,,,,,C,Y,"0,5",mg,ORAL,BID,SOOTHING
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,140.0,CONCOMITANT MEDICATIONS,,,BISACODYL,BISACODYL,2011-07-25,2011-07-25,,,,,C,Y,10,mL,ORAL,QD,CONSTIPATION PREVENTION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,141.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-07-26,2011-07-26,,,,,C,Y,20,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,142.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,143.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-07-30,2011-07-30,,2011-07-31,2011-07-31,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,144.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,145.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,2,mg,ORAL,QD,ANTICOAGULATION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,146.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,147.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-05-02,2011-05-02,,2011-07-17,2011-07-17,,C,,70,mg,SUBCUTANEOUS,BID,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,148.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-04,2011-08-04,,2011-08-04,2011-08-04,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,149.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-05,2011-08-05,,2011-08-06,2011-08-06,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,150.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-06,2011-08-06,,2011-08-07,2011-08-07,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,151.0,CONCOMITANT MEDICATIONS,,,OLANZAPINE,OLANZAPINE,2011-08-02,2011-08-02,,,,,C,Y,"2,5",mg,ORAL,QD,INSOMNIA PREVENTION
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,152.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,3,mg,ORAL,QD,ATICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,153.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,154.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,155.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-11,2011-08-11,,2011-08-11,2011-08-11,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,156.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-12,2011-08-12,,2011-08-12,2011-08-12,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,157.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-13,2011-08-13,,2011-08-14,2011-08-14,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,158.0,CONCOMITANT MEDICATIONS,,,DELTISONA B,MEPREDNISONE,2011-05-02,2011-05-02,,2011-05-31,2011-05-31,,C,,20,mg,ORAL,QD,ILIAC VEIN THROMBOSIS
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,159.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,160.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,161.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,162.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,163.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-19,2011-08-19,,2011-08-19,2011-08-19,,C,,3,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,164.0,CONCOMITANT MEDICATIONS,,,ACENOCUMAROL,ACENOCOUMAROL,2011-08-20,2011-08-20,,2011-08-20,2011-08-20,,C,,2,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,165.0,CONCOMITANT MEDICATIONS,,,MORPHINE 3 MG/ML,MORPHINE,2011-05-06,2011-05-06,,2011-05-11,2011-05-11,,C,,8,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN + CAPECITABINE,,2011-12-14,2011-12-14,,2012-01-06,2012-01-06,,,,,,,,
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2011-07-01,2011-07-01,,,,,C,Y,30,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,IBUPROFENO,IBUPROFEN,2011-07-01,2011-07-01,,,,,C,Y,400,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXTROPROPOXYPHENE,DEXTROPROPOXYPHENE,2011-07-01,2011-07-01,,,,,C,Y,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-09-15,2011-09-15,,2011-09-30,2011-09-30,,C,,0.5,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACINE,CIPROFLOXACIN,2011-09-22,2011-09-22,,2011-09-28,2011-09-28,,C,,500,mg,ORAL,BID,TREATMENT OF CYSTITIS
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-11-24,2011-11-24,,,,,C,Y,150,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,LEVOTIROXINE,LEVOTHYROXINE,2005,2005-12-31,M,,,,C,Y,100,ug,ORAL,QD,HYPOTIROIDSM
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-11-17,2011-11-17,,,,,C,Y,20,mg,ORAL,QHS,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,SIMETHICONE,SIMETICONE,2011-10-20,2011-10-20,,2011-12-07,2011-12-07,,C,,400,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-10-02,2011-10-02,,2011-11-16,2011-11-16,,C,,1200,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-10-01,2011-10-01,,,,,C,Y,0.5,mg,ORAL,TID,DEPRESSION
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-11-17,2011-11-17,,2011-11-23,2011-11-23,,C,,100,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-08-25,2011-08-25,,,,,C,Y,400,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,DEXTROPROPOXYPHENE,DEXTROPROPOXYPHENE,2011-08-28,2011-08-28,,2011-10-01,2011-10-01,,C,,98,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,4,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,SALINE SOLUTION,SODIUM CHLORIDE,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,700,mL,INTRAVENOUS,QD,PREMEDICATION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,INSULINA,INSULIN,2005,2005-12-31,M,2011-09-01,2011-09-01,,C,,6,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-21,2011-09-21,,2011-09-21,2011-09-21,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-21,2011-09-21,,2011-09-21,2011-09-21,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2004,2004-12-31,M,2012-04-03,2012-04-03,,C,,5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-09-21,2011-09-21,,2011-09-21,2011-09-21,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-28,2011-09-28,,2011-09-28,2011-09-28,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-28,2011-09-28,,2011-09-28,2011-09-28,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-09-28,2011-09-28,,2011-09-28,2011-09-28,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2004,2004-12-31,M,2012-01-12,2012-01-12,,C,,100,mg,ORAL,QD,ANTIPLATELET
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2011-09-21,2011-09-21,,2011-09-28,2011-09-28,,C,,5,mL,maw,QID,MUCOSITIS
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-10-02,2011-10-02,,2011-10-04,2011-10-04,,C,,30,mg,ORAL,QD,ACUTE DIARRHEA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,AMOXICILINE,AMOXICILLIN,2011-11-23,2011-11-23,,2011-11-30,2011-11-30,,C,,1,g,ORAL,BID,BRONCHITIS
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,CLAVULANIC ACID,CLAVULANIC ACID,2011-11-23,2011-11-23,,2011-11-30,2011-11-30,,C,,125,mg,ORAL,BID,BRONCHITIS
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,BUDESONIDE,BUDESONIDE,1980,1980-12-31,M,,,,C,Y,2,PUFF,RESPIRATORY (INHALATION),QD,BRONCHIAL ASTHMA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-11-30,2011-11-30,,2011-12-02,2011-12-02,,C,,150,ug,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,700,mL,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,4,mg,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,8,mg,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,700,mL,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,4,mg,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,8,mg,INTRAVENOUS,ONCE,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,700,mL,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,8,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-05-03,2011-05-03,,2011-10-21,2011-10-21,,C,,600,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-12-21,2011-12-21,,2012-01-04,2012-01-04,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-12-21,2011-12-21,,2012-01-04,2012-01-04,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-21,2011-12-21,,2012-01-04,2012-01-04,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-01-19,2012-01-19,,2012-02-01,2012-02-01,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-01-19,2012-01-19,,2012-02-01,2012-02-01,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-19,2012-01-19,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,52.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-02-15,2012-02-15,,2012-03-01,2012-03-01,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,53.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-02-15,2012-02-15,,2012-03-01,2012-03-01,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,54.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-15,2012-02-15,,2012-03-01,2012-03-01,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,55.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2012-04-04,2012-04-04,,,,,C,Y,20,mg,ORAL,BID,HYPERTENTION
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,56.0,CONCOMITANT MEDICATIONS,,,INSULINA,INSULIN,2011-09-02,2011-09-02,,2011-09-08,2011-09-08,,C,,8,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,57.0,CONCOMITANT MEDICATIONS,,,BUDESONIDE,BUDESONIDE,2012-04-04,2012-04-04,,,,,C,Y,200,ug,RESPIRATORY (INHALATION),BID,ASTHMA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,58.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-04-09,2012-04-09,,2012-04-12,2012-04-12,,C,,20,mg,ORAL,QD,LOWER LIMB EDEMA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,59.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-03-15,2012-03-15,,2012-03-29,2012-03-29,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,60.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-03-15,2012-03-15,,2012-03-29,2012-03-29,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,61.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2012-03-15,2012-03-15,,2012-03-29,2012-03-29,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,62.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-04-12,2012-04-12,,2012-04-26,2012-04-26,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,63.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-04-12,2012-04-12,,2012-04-26,2012-04-26,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,64.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2012-04-12,2012-04-12,,2012-04-26,2012-04-26,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,65.0,CONCOMITANT MEDICATIONS,,,AMOXICILIN + CLAVULANIC ACID,AUGMENTIN                          /00756801/,2012-05-03,2012-05-03,,2012-05-09,2012-05-09,,C,,875/125,mg,ORAL,BID,ANTIBIOTIC TREATMENT PER BRONCHITIS
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,66.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2012-05-09,2012-05-09,,,,,C,Y,2,g,INTRAVENOUS,BID,PNEUMONIA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,67.0,CONCOMITANT MEDICATIONS,,,INSULINA,INSULIN,2011-09-09,2011-09-09,,,,,C,Y,10,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,68.0,CONCOMITANT MEDICATIONS,,,CLARITHROMYCIN,CLARITHROMYCIN,2012-05-09,2012-05-09,,,,,C,Y,500,mg,ORAL,BID,PNEUMONIA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,69.0,CONCOMITANT MEDICATIONS,,,HYDROCORTISONE,HYDROCORTISONE,2012-05-09,2012-05-09,,,,,C,Y,500,mg,INTRAVENOUS,ONCE,PNEUMONIA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,70.0,CONCOMITANT MEDICATIONS,,,SALBUTAMOL,SALBUTAMOL,2012-05-09,2012-05-09,,,,,C,Y,"2,5",mg,RESPIRATORY (INHALATION),QID,PNEUMONIA
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,71.0,CONCOMITANT MEDICATIONS,,,INSULINA,INSULIN,2011-09-09,2011-09-09,,,,,C,Y,6,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,72.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-09-01,2011-09-01,,2011-09-01,2011-09-01,,C,,4,mg,INTRAVENOUS,QD,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CEPHALOTHIN,CEFALOTIN,2012-03-27,2012-03-27,,2012-03-30,2012-03-30,,C,,500,mg,INTRAVENOUS,QID,URINARY INFECTION
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-04-01,2012-04-01,,2012-04-08,2012-04-08,,C,,500,mg,ORAL,BID,URINARY INFECTION
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-02-13,2012-02-13,,2012-03-21,2012-03-21,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-02-13,2012-02-13,,2012-03-21,2012-03-21,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2012-02-13,2012-02-13,,2012-03-21,2012-03-21,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,700,mL,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,4,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONE,ONDANSETRON,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,8,mg,INTRAVENOUS,QS,PRE-INFUTION FOR CHEMOTHERAPY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-07,2012-05-07,,2012-05-16,2012-05-16,,C,,3,cc,ORAL,Q4H,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2012-05-07,2012-05-07,,2012-05-16,2012-05-16,,C,,75,mg,INTRAVENOUS,BID,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,YASMIN,DROSPIRENONE W/ETHINYLESTRADIOL,2001,2001-12-31,M,2012-05-21,2012-05-21,,C,,3,mg,ORAL,QD,ANTICONCEPTIVES
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,RANITIDINE,RANITIDINE,2012-05-07,2012-05-07,,2012-05-16,2012-05-16,,C,,100,mg,INTRAVENOUS,TID,PREVENTION OF EROSIVE GASTROPATHY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,RELIVERAN,METOCLOPRAMIDE,2012-05-07,2012-05-07,,2012-05-16,2012-05-16,,C,,10,mg,INTRAVENOUS,QID,PREVENTION OF EROSIVE GASTROPATHY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-17,2012-05-17,,2012-05-20,2012-05-20,,,,4,cc,ORAL,QID,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2012-05-21,2012-05-21,,2012-05-26,2012-05-26,,,,30,mg,SUBCUTANEOUS,BID,ANTICOAGULATION
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-21,2012-05-21,,2012-05-26,2012-05-26,,,,2,mL,ORAL,6 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SUPRAGESIC - DEXTROPROPOXYPHENE / IBUPROFEN,SUPRAGESIC                         /03407301/,2012-01-23,2012-01-23,,2012-05-07,2012-05-07,,C,,400,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2012-01-23,2012-01-23,,2012-05-07,2012-05-07,,C,,40,mg,ORAL,QD,PREVENTION OF EROSIVE GASTROPATHY
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2012-01-27,2012-01-27,,2012-05-26,2012-05-26,,C,,"12,5",mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2004,2004-12-31,M,2012-05-26,2012-05-26,,C,,2,mg,ORAL,QD,IMSOMNIA
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2012-02-13,2012-02-13,,2012-03-26,2012-03-26,,C,,"1,5",mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2012-03-27,2012-03-27,,2012-05-20,2012-05-20,,C,,60,mg,SUBCUTANEOUS,BID,ANTICOAGULATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-04-21,2011-04-21,,,,,C,Y,10,mg,ORAL,TID,NAUSEAS
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-06-19,2011-06-19,,2011-06-21,2011-06-21,,C,,10,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,10,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SODUIM CHLORIDE,SODIUM CHLORIDE,2011-06-19,2011-06-19,,2011-07-03,2011-07-03,,C,,0.9,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-06-19,2011-06-19,,2011-06-19,2011-06-19,,C,,50,gtt,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN,ENOXAPARIN,2011-06-20,2011-06-20,,2011-07-01,2011-07-01,,C,,1,AMPULE,SUBCUTANEOUS,BID,DEEP VENOUS THROMBOSIS IN THE RIGHT LEG
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2011-06-22,2011-06-22,,2011-07-03,2011-07-03,,C,,5,mL,ORAL,TID,ORAL CANDIDIASIS
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2011-06-22,2011-06-22,,2011-07-03,2011-07-03,,C,,5,mL,ORAL,QD,AGITATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CEPHEPIME,CEFEPIME,2011-06-22,2011-06-22,,2011-07-03,2011-07-03,,C,,2,g,INTRAVENOUS,TID,LEUKOCYTOSIS/ INFECTIN WITHOUT A DEFINED FOCUS
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,GLYCERIN ENEMA,GLYCEROL,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,1,U,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-06-24,2011-06-24,,2011-06-24,2011-06-24,,C,,1,TABLET,ORAL,TID,HYDRATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-31,2011-05-31,,2011-06-19,2011-06-19,,C,,4,mg,ORAL,BID,INAPPETENCE
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,WARFARIN SODIUM,WARFARIN SODIUM,2011-06-28,2011-06-28,,2011-06-30,2011-06-30,,C,,5,mg,INTRAVENOUS,QD,DEEP VENOUS THROMBOSIS IN THE RIGHT LEG
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,BROMAZEPAN,BROMAZEPAM,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,3,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BEROTEC,FENOTEROL HYDROBROMIDE,2011-06-20,2011-06-20,,2011-07-03,2011-07-03,,C,,6,gtt,RESPIRATORY (INHALATION),PRN,NEBULIZATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ATROVENT,IPRATROPIUM BROMIDE,2011-06-20,2011-06-20,,2011-07-03,2011-07-03,,C,,35,gtt,RESPIRATORY (INHALATION),PRN,NEBULIZATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2011-06-14,2011-06-14,,2011-07-19,2011-07-19,,C,,25,mg,ORAL,QHS,DEPRESSION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-16,2011-06-16,,2011-06-19,2011-06-19,,C,,25000,IU,SUBCUTANEOUS,TID,DEEP VENOUS THROMBOSIS IN THE RIGHT LEG
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-06-19,2011-06-19,,2011-07-03,2011-07-03,,C,,4,mg,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-19,2011-06-19,,2011-06-19,2011-06-19,,C,,5000,IU,SUBCUTANEOUS,TID,DEEP VENOUS THROMBOSIS IN THE RIGHT LEG
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,GLUCOSE SERUM,GLUCOSE,2011-06-19,2011-06-19,,2011-07-03,2011-07-03,,C,,5,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DIPYRONE,METAMIZOLE SODIUM,2011-06-19,2011-06-19,,2011-07-03,2011-07-03,,C,,1,AMPULE,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE,SODIUM CHLORIDE,2011-06-19,2011-06-19,,2011-06-19,2011-06-19,,C,,20,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/PARACETAMOL,PANADEINE CO,2011-06,2011-05-31,D,2011-07-26,2011-07-26,,C,,30,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DYPIRONE,METAMIZOLE SODIUM,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,1,AMPULE,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,3,mg,SUBCUTANEOUS,PRN,PAIN
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,5000,IU,SUBCUTANEOUS,BID,THROMBOSIS PROPHILAXIE
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,GLUCOSE,GLUCOSE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,5,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE,SODIUM CHLORIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,20,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,10,%,INTRAVENOUS,CONTINUOUS,HYDRATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-07-27,2011-07-27,,2011-07-28,2011-07-28,,C,,5,gtt,ORAL,QHS,IMNSONIA
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LACTULONA,LACTULOSE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,10,mL,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,K VITAMIN,VITAMIN K NOS,2011-07-28,2011-07-28,,2011-07-29,2011-07-29,,C,,1,AMPULE,INTRAVENOUS,BID,COAGULATION IMPROVE
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,1,AMPULE,INTRAVENOUS,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-07-11,2011-07-11,,2011-07-27,2011-07-27,,C,,10,mg,ORAL,QID,NAUSEAS
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,RANITIDIN,RANITIDINE HYDROCHLORIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,50,mg,INTRAVENOUS,BID,GASTRIC PROPHYLAXIE
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,GLUCOSE SERUM,GLUCOSE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,5,%,INTRAVENOUS,ONCE,HYDRATION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CEPHEPIME,CEFEPIME,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,2,g,INTRAVENOUS,BID,DYSPNEIA/ RESPIRATORY INFECTION
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,OXYGEN,OXYGEN,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,5,L,RESPIRATORY (INHALATION),CONTINUOUS,DYSPNEIA
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,BEROTEC,FENOTEROL HYDROBROMIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,5,gtt,RESPIRATORY (INHALATION),QID,DYSPNEIA
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,ATROVENT,IPRATROPIUM BROMIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,15,gtt,RESPIRATORY (INHALATION),QID,DYSPNEIA
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,1,AMPULE,INTRAVENOUS,QID,NAUSEAS
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-27,2011-07-27,,2011-07-29,2011-07-29,,C,,8,mg,INTRAVENOUS,TID,NAUSEAS
CO-101-001,CO-101-001-036-003,01036003,036,77.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CAPTOPRIL,CAPTOPRIL,2006,2006-12-31,M,2011-11,2011-11-30,D,C,,25,mg,ORAL,TID,HYPERTENSION
CO-101-001,CO-101-001-036-003,01036003,036,77.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL/CODEINE PHOSPHATE,PANADEINE CO,2011-10-22,2011-10-22,,,,,C,Y,30,mg,ORAL,QID,CERVICAL PAIN
CO-101-001,CO-101-001-036-003,01036003,036,77.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-11-04,2011-11-04,,2011-11-06,2011-11-06,,C,,2,mg,ORAL,QID,DIAHRREIA
CO-101-001,CO-101-001-036-003,01036003,036,77.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CAPTOPRIL,CAPTOPRIL,2011-11-10,2011-11-10,,,,,C,Y,25,mg,ORAL,TID,HYPERTENSION
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABIN,,2011-11-25,2011-11-25,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-09-09,2011-09-09,,,,,C,Y,20,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2001,2001-12-31,M,2011-09-01,2011-09-01,,P,,850,mg,ORAL,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HIOSCIN,HYOSCINE,2011-09-09,2011-09-09,,,,,C,Y,40,gtt,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DIPYRONE,METAMIZOLE SODIUM,2011-09-09,2011-09-09,,,,,C,Y,40,gtt,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DIAZEPAN,DIAZEPAM,2011-09-09,2011-09-09,,2011-09-22,2011-09-22,,C,,5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DIAZEPAN,DIAZEPAM,2011-09-23,2011-09-23,,,,,C,Y,10,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MINERAL OIL,PARAFFIN,2011-09-23,2011-09-23,,,,,C,Y,10,mL,ORAL,BID,CONSTIPATION PROPHYLAXIS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NEOMICIN+BACITRACIN,BARAMYCIN                          /00324701/,2011-09-23,2011-09-23,,2011-09-30,2011-09-30,,C,,UNK,,TOPICAL,TID,ARM HIPEREMIA
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-10-31,2011-10-31,,,,,C,Y,2,mg,ORAL,QD,ASTHENIA/ANOREXIA
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2011-11-07,2011-11-07,,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-11-07,2011-11-07,,,,,C,Y,30,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2011-09-02,2011-09-02,,,,,C,Y,850,mg,ORAL,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,GLIBENCLAMIDE,GLIBENCLAMIDE,2011-09-09,2011-09-09,,,,,C,Y,5,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2001,2001-12-31,M,2011-10-21,2011-10-21,,C,,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,AMITRIPTILIN,AMITRIPTYLINE HYDROCHLORIDE,2011-09,2011-09-02,D,,,,C,Y,25,mg,ORAL,QD,DEPRESSION PROPHYLAXIS
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/ PARACETAMOL,PANADEINE CO,2011-05,2011-04-30,D,2011-10-31,2011-10-31,,C,,30,mg,ORAL,6 TIMES PER DAY,ABDOMINAL PAIN/THORACIC BACK PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-10-31,2011-10-31,,2011-11-06,2011-11-06,,C,,15,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-31,2011-10-31,,,,,C,Y,500,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,METHOCLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-10,2011-10-10,,2011-10-12,2011-10-12,,C,,10,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-08-11,2011-08-11,,2011-09-08,2011-09-08,,C,,5,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,BISACODIL,BISACODYL,2011-09-09,2011-09-09,,,,,C,Y,10,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",2011-09-09,2011-09-09,,2011-09-10,2011-09-10,,C,,1,TABLET,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,L-ARGININE+ VITAMIN C,ARGININE,2011-09-09,2011-09-09,,2011-09-10,2011-09-10,,C,,1,TABLET,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,L-ARGININE+ VITAMIN C,ASCORBIC ACID,2011-09-09,2011-09-09,,2011-09-10,2011-09-10,,C,,1,TABLET,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-09-09,2011-09-09,,,,,C,Y,10,mg,ORAL,Q4H,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,HERBAL LAXATIVE,SENNA ALEXANDRINA,2011-08-11,2011-08-11,,2011-09-09,2011-09-09,,C,,1,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,EXOMEPRAZOL,ESOMEPRAZOLE,2011-09-12,2011-09-12,,2011-09-13,2011-09-13,,C,,40,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,,2011-09-02,Y,,,,C,Y,850,mg,ORAL,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,HIOSCINE,HYOSCINE,2011-08-11,2011-08-11,,,,,C,Y,40,gtt,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-08-19,2011-08-19,,2011-09-09,2011-09-09,,C,,100,mg,ORAL,QD,ASCITIS
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MINERAL OIL,PARAFFIN,2011-08-11,2011-08-11,,,,,C,Y,10,mL,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LANZOPRAZOL,LANSOPRAZOLE,2011-08-11,2011-08-11,,,,,C,Y,30,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-09-09,2011-09-09,,2011-09-10,2011-09-10,,C,,2,mg,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DIAZEPAN,DIAZEPAM,2011-08-11,2011-08-11,,,,,C,Y,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-11,2011-08-11,,2011-09-08,2011-09-08,,C,,4,mg,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FLUOROURACIL,,2012-03-20,2012-03-20,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN,,2012-03-20,2012-03-20,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2012-03-20,2012-03-20,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,OTHER,LEUCOVORIN,,2012-03-20,2012-03-20,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN,ENOXAPARIN,2011-09-16,2011-09-16,,,,,C,Y,80,IU,SUBCUTANEOUS,BID,PULMONARY EMBOLISM
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-09-25,2011-09-25,,,,,C,Y,20,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-12-17,2011-12-17,,2011-12-19,2011-12-19,,C,,300,ug,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-20,2011-12-20,,2011-12-21,2011-12-21,,C,,8,mg,ORAL,TID,NAUSEA AND VOMITING
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-12-22,2011-12-22,,2011-12-23,2011-12-23,,C,,2,mg,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FILGRASTIN,FILGRASTIM,2012-01-14,2012-01-14,,2012-01-16,2012-01-16,,C,,300,ug,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-02-04,2012-02-04,,2012-02-06,2012-02-06,,C,,300,ug,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MINERAL OIL,PARAFFIN,2011-07,2011-06-30,D,,,,C,Y,5,mL,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DIMETICONE,DIMETICONE,2011-07,2011-06-30,D,,,,C,Y,1,TABLET,ORAL,QID,CONSTIPATION
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ROSUVASTATINE,ROSUVASTATIN CALCIUM,2009,2009-12-31,M,,,,C,Y,10,mg,ORAL,QD,DISLIPIDEMIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,LOSARTAN+HYDROCHLORTIAZIDE,HYDROCHLOROTHIAZIDE W/LOSARTAN,2010,2010-12-31,M,2011-10-24,2011-10-24,,C,,50/25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LOSARTAN+HYDROCHLORTIAZIDE,HYDROCHLOROTHIAZIDE W/LOSARTAN,2011-10-25,2011-10-25,,,,,C,Y,25/12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ALOPURINOL,ALLOPURINOL,2010,2010-12-31,M,2011-10-24,2011-10-24,,C,,100,mg,ORAL,TID,HYPERURICEMIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ALOPURINOL,ALLOPURINOL,2011-10-25,2011-10-25,,,,,C,Y,150,mg,ORAL,QD,HYPERURICEMIA
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2009,2009-12-31,M,,,,C,Y,850,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,BUSCOFEN,IBUPROFEN,2007-07,2007-06-30,D,,,,C,Y,1,TABLET,ORAL,QID,ADOMINAL PAIN
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,METADON,METHADONE,2011-07,2011-06-30,D,2011-10-06,2011-10-06,,C,,5,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"5-FU, FOLINIC ACID AND OXALIPLATIN",,2011-10-04,2011-10-04,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,TRIAL DRUG (FAK INHIBITOR),,2012-02-13,2012-02-13,,2012-02-17,2012-02-17,,,,,,,,
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2010-12-21,2010-12-21,,2010-12-23,2010-12-23,,C,,50,mg,ORAL,QD,SHOULDER PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,VITAMIN K,VITAMIN K NOS,2011-03-02,2011-03-02,,2011-03-02,2011-03-02,,C,,10,mg,INTRAVENOUS,ONCE,HYPERBILIRUBINAEMIA
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CO-CODAMOL,PANADEINE CO,2011-02-23,2011-02-23,,2011-04-21,2011-04-21,,C,,2,TABLET,ORAL,PRN,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-05-04,2011-05-04,,2011-05-08,2011-05-08,,C,,500,mg,ORAL,QD,PYREXIA
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-05-04,2011-05-04,,,,,C,Y,1,g,ORAL,PRN,"PYREXIA, RIGHT UPPER QUADRANT PAIN"
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-07-20,2011-07-20,,,,,C,Y,5,mg,ORAL,PRN,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-12-26,2010-12-26,,2010-12-29,2010-12-29,,C,,1,g,ORAL,PRN,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,COCODAMOL 30/500,PANADEINE CO,2010-12-29,2010-12-29,,2011-04-21,2011-04-21,,C,,2,TABLET,ORAL,PRN,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-01-15,2011-01-15,,2011-01-26,2011-01-26,,C,,500,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2011-01-18,2011-01-18,,2011-01-20,2011-01-20,,C,,1.2,g,INTRAVENOUS,TID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,GLANDOSANE SPRAY,GLANDOSANE,2011-02-16,2011-02-16,,,,,C,Y,1,SPRAY,ORAL,PRN,DRY MOUTH
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-02-22,2011-02-22,,2011-02-23,2011-02-23,,C,,50,mg,ORAL,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-04-11,2011-04-11,,2011-04-18,2011-04-18,,C,,500,mg,ORAL,BID,PYREXIA
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-04-16,2011-04-16,,2011-04-16,2011-04-16,,C,,50,mg,ORAL,QD,VOMITING
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05,2011-04-30,D,2011-06-23,2011-06-23,,P,,100,mg,ORAL,QID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-06,2011-06-29,D,,,,C,Y,1,SACHET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-07-06,2011-07-06,,,,,C,Y,30,mg,ORAL,BID,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-07-13,2011-07-13,,2011-07-20,2011-07-20,,C,,500,mg,ORAL,BID,UTI/URTI
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-20,2011-07-20,,2011-08-03,2011-08-03,,C,,2,mg,ORAL,QD,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-24,2011-08-24,,,,,C,Y,8,mg,ORAL,QD,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SEVREDOL,MORPHINE SULFATE,2011-06,2011-06-29,D,,,,C,Y,10,mg,ORAL,QD,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-05,2011-04-30,D,2011-06-23,2011-06-23,,P,,400,mg,ORAL,QID,PLANTAR FASCIITIS
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-23,2011-06-23,,2011-07-19,2011-07-19,,C,,4,mg,ORAL,QD,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-08-03,2011-08-03,,,,,C,Y,1,g,ORAL,QID,PYREXIA
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ERYTHROMYCIN,ERYTHROMYCIN,2011-08-08,2011-08-08,,2011-08-10,2011-08-10,,C,,500,mg,ORAL,QID,COUGH
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CLARITHROMYCIN,CLARITHROMYCIN,2011-08-10,2011-08-10,,,,,C,Y,500,mg,ORAL,BID,COUGH
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ACICLOVIR CREAM,ACICLOVIR,2011-08-10,2011-08-10,,,,,C,Y,1,APPLICATION,TOPICAL,QID,HERPETIC LESION
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-06-22,2011-06-22,,2011-06-29,2011-06-29,,C,,1,g,ORAL,QID,RIGHT UPPER QUADRANT PAIN
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-07,2011-06-30,D,,,,C,Y,10,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,SEVREDOL,MORPHINE SULFATE,2011-07,2011-06-30,D,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,VENAFLAXINE,VENLAFAXINE,1995,1995-12-31,M,,,,C,Y,75,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DALTEPARIN,DALTEPARIN,2011-08,2011-07-31,D,,,,C,Y,12500,IU,SUBCUTANEOUS,QD,PULMONARY EMBOLI
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-08,2011-07-31,D,,,,C,Y,50,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-03,2011-02-28,D,,,,C,Y,20,mg,ORAL,PRN,PROPHYLAXIS OF GASTRIC SYMPTOMS
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,LEVOMEPROMAZINE,LEVOMEPROMAZINE,2011-09-01,2011-09-01,,,,,C,Y,6,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2011-09-02,2011-09-02,,2011-09-07,2011-09-07,,P,,unknown,,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011,2011-12-31,M,2012-01-10,2012-01-10,,C,,20,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,VITAMIN C,ASCORBIC ACID,2000,2000-12-31,M,2012-01-11,2012-01-11,,C,,60,mg,ORAL,QD,DIETARY SUPPLEMENT
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,COD LIVER OIL,COD-LIVER OIL,2000,2000-12-31,M,2012-01-11,2012-01-11,,C,,550,mg,ORAL,QD,DIETARY SUPPLEMENT
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2012-01-11,2012-01-11,,2012-02-14,2012-02-14,,C,,30,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN,AMOXICILLIN,2012-01-11,2012-01-11,,2012-01-15,2012-01-15,,C,,500,mg,ORAL,TID,COUGH
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CO-DANTHRAMER,DORBANEX                           /00161701/,2012-01-11,2012-01-11,,2012-01-17,2012-01-17,,C,,2,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,PIRITON,CHLORPHENAMINE MALEATE,2012-01-18,2012-01-18,,,,,C,Y,1,TABLET,ORAL,PRN,MACULAR RASH
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,GENTAMYCIN,GENTAMICIN,2012-01-27,2012-01-27,,2012,2012-12-31,M,C,,,,INTRAVENOUS,,PYREXIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-01-27,2012-01-27,,2012,2012-12-31,M,C,,,,INTRAVENOUS,,PYREXIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-08,2012-02-08,,,,,C,Y,6,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,AMOXYCILLIN,AMOXICILLIN,2012-02-15,2012-02-15,,2012-02-20,2012-02-20,,C,,500,mg,ORAL,TID,LOWER RESPIRATORY TRACT INFECTION
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SEVREDOL,MORPHINE SULFATE,2011,2011-12-31,M,,,,C,Y,10,mg,ORAL,PRN,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2012-02-16,2012-02-16,,,,,C,Y,80,mg,ORAL,BID,DIABETES MELLITIS TYPE II
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2012-02-15,2012-02-15,,,,,C,Y,40,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-01-03,2012-01-03,,,,,C,Y,1,SACHET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2010,2010-12-31,M,,,,C,Y,30,mg,ORAL,QD,DYSPEPSIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10,2011-09-30,D,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,QUININE,QUININE,2000,2000-12-31,M,,,,C,Y,200,mg,ORAL,QHS,LEG CRAMPS
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2006,2006-12-31,M,,,,C,Y,75,mg,ORAL,QD,PREVIOUS TIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DIPYRIDAMOLE,DIPYRIDAMOLE,2006,2006-12-31,M,,,,C,Y,200,mg,ORAL,QD,PREVIOUS TIA
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,AMITRYPTILINE,AMITRIPTYLINE,2000,2000-12-31,M,,,,C,Y,25,mg,ORAL,QD,LEG CRAMPS
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,,,,,,,
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-03-02,2011-03-02,,2011-04-18,2011-04-18,,C,,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-04-26,2011-04-26,,2011-04-30,2011-04-30,,C,,20,mg,SUBCUTANEOUS,QD,PAIN
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-04-26,2011-04-26,,2011-04-27,2011-04-27,,C,,150,mg,SUBCUTANEOUS,QD,NAUSEA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-04-28,2011-04-28,,2011-04-30,2011-04-30,,C,,30,mg,SUBCUTANEOUS,QD,VOMITING
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,FORIJUICE,OTHER COMBINATIONS OF NUTRIENTS,2011-04-29,2011-04-29,,2011-05-04,2011-05-04,,C,,1,CARTON,ORAL,BID,DIETRY SUPPLEMENT
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2011-05-01,2011-05-01,,2011-05-04,2011-05-04,,C,,10,mL,ORAL,QID,GASTRIC REFLUX
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,THIAMINE,THIAMINE,2011-05-01,2011-05-01,,2011-05-01,2011-05-01,,C,,100,mg,ORAL,ONCE,DIETRY SUPPLEMENT
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2011-05-05,2011-05-05,,2011-05-07,2011-05-07,,C,,625,mg,ORAL,TID,ASPIRATION PNEUMONIA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2011-05-04,2011-05-04,,2011-05-07,2011-05-07,,C,,400,mg,ORAL,TID,ASPIRATION PNEUMONIA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2011-04-29,2011-04-29,,2011-05-03,2011-05-03,,C,,3.75,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04-26,2011-04-26,,2011-05-04,2011-05-04,,C,,1,g,INTRAVENOUS,QID,PAIN
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-03-25,2011-03-25,,,,,C,Y,1,SACHET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-04-21,2011-04-21,,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-04-19,2011-04-19,,2011-04-20,2011-04-20,,C,,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-04-21,2011-04-21,,,,,C,Y,unknown,,ORAL,PRN,DIARRHOEA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-04-21,2011-04-21,,2011-04-26,2011-04-26,,C,,2,TABLET,ORAL,QD,LOW POTASSIUM
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DIARALYTE,ORALPAEDON                         /01427901/,2011-04-21,2011-04-21,,,,,C,Y,unknown,,ORAL,UNKNOWN,DEHYDRATION
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,EFEXOR,VENLAFAXINE HYDROCHLORIDE,2007,2007-12-31,M,,,,C,Y,150,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2009,2009-12-31,M,2011-05-03,2011-05-03,,C,,20,mg,ORAL,QD,GASTRIC REFLUX
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,"CREON 40,000",PANCREATIN,2011-04-12,2011-04-12,,2011-04-16,2011-04-16,,C,,1-2,TABLET,ORAL,PRN,PANCREATIC DEFICIENCY
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,METROCLOPRAMIDE,METOCLOPRAMIDE,2011-04-21,2011-04-21,,2011-04-26,2011-04-26,,C,,10,mg,ORAL,TID,VOMITING
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DALTEPARIN,DALTEPARIN,2011-04-26,2011-04-26,,2011-05-03,2011-05-03,,C,,5000,IU,SUBCUTANEOUS,QD,THROMBOPROPHYLAXIS
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2011-05-01,2011-05-01,,2011-05-04,2011-05-04,,C,,1.2,g,INTRAVENOUS,TID,ASPIRATION PNEUMONIA
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2011-05-01,2011-05-01,,2011-05-04,2011-05-04,,C,,500,mg,INTRAVENOUS,TID,ASPIRATION PNEUMONIA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-04,2011-03-31,D,,,,C,Y,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-01,2011-06-01,,,,,C,Y,4,mg,ORAL,QD,LETHARGY/ANOREXIA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LOPERIMIDE,LOPERAMIDE,2011-06-07,2011-06-07,,,,,C,Y,,,ORAL,PRN,DIARRHOEA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-06-21,2011-06-21,,2011-08-01,2011-08-01,,C,,15000,IU,SUBCUTANEOUS,QD,DVT
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-06-28,2011-06-28,,2011-06-30,2011-06-30,,C,,1,SACHET,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-28,2011-06-28,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,1,SACHET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-08-02,2011-08-02,,,,,C,Y,10000,IU,SUBCUTANEOUS,BID,DVT / PULMONARY EMBOLISM
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PHOSPHATE ENEMA,ENEMAS,2011-06-29,2011-06-29,,2011-06-30,2011-06-30,,C,,1,ENEMA,RECTAL,QD,CONSTIPATION
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04,2011-03-31,D,2011-05-24,2011-05-24,,C,,4,mg,ORAL,QD,PAIN/WEIGHT LOSS/FATIGUE
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-25,2011-05-25,,2011-05-31,2011-05-31,,C,,2,mg,ORAL,QD,PAIN/ WEIGHT LOSS/FATIGUE
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04,2011-03-31,D,,,,C,Y,1,g,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2011-04,2011-03-31,D,,,,C,Y,3.75,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-05-10,2011-05-10,,,,,C,Y,40000,IU,ORAL,TID,STEATORRHOEA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BENDROFLUMETHIAZIDE,BENDROFLUMETHIAZIDE,2011-05-23,2011-05-23,,,,,C,Y,2.5,mg,ORAL,QD,PEDAL OEDEMA
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ZOMORPH,MORPHINE SULFATE,2011-05,2011-05-17,D,,,,C,Y,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-05,2011-05-17,D,,,,C,Y,,,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-05,2011-05-17,D,2011-06-13,2011-06-13,,C,,200,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN,AMOXICILLIN,2011-05-23,2011-05-23,,2011-05-28,2011-05-28,,C,,,,ORAL,TID,INFECTION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2006,2006-12-31,M,2011-05-24,2011-05-24,,C,,80,mg,ORAL,QD,DIABETES TYPE 2
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FERROUS FUMARATE,FERROUS FUMARATE,2011-07-12,2011-07-12,,,,,C,Y,1,TABLET,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NYSTATIN ORAL SUSPENSION,NYSTATIN,2011-07-21,2011-07-21,,2011-07-26,2011-07-26,,C,,100000,U/mL,ORAL,after food,ORAL THRUSH
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-07-06,2011-07-06,,,,,C,Y,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-26,2011-07-26,,2011,2011-12-31,M,C,,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,FRESUBIN,CARBOHYDRATES NOS W/FATTY ACIDS NOS/MINERALS,,2011-05-17,Y,,,,C,Y,1,PREPARATION,ORAL,PRN,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-26,2011-07-26,,2011-08-02,2011-08-02,,C,,4,mg,ORAL,QD,ORAL THRUSH
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-03,2011-08-03,,,,,C,Y,2,mg,ORAL,QD,ORAL THRUSH
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-08-23,2011-08-23,,,,,C,Y,1,SACHET,ORAL,QID,CONSTIPATION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NOVOMIX 30/70,NOVOMIX,2011,2011-05-17,M,2011-07-12,2011-07-12,,C,,8,IU,SUBCUTANEOUS,BID,DIABETES TYPE 2
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,FLUCONAZOLE,FLUCONAZOLE,2011-08-30,2011-08-30,,2011-09-05,2011-09-05,,C,,100,mg,ORAL,QD,ORAL THRUSH
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2011-08-30,2011-08-30,,2011-09-27,2011-09-27,,C,,500,mg,SUBCUTANEOUS,BID,HYPERGLYCAEMIA
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BLOOD TRANSFUSION - NO ADDITIONAL INFORMATION,"BLOOD TRANSFUSION, AUXILIARY PRODUCTS",2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,1,IU,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PRAVASTATIN,PRAVASTATIN,2007,2007-12-31,M,,,,C,Y,2,TABLET,ORAL,QHS,HYPERCHOLESTERAEMIA
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LERCANIDIPINE,LERCANIDIPINE,2007,2007-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NOVORAPID,INSULIN ASPART,2011-04-30,2011-04-30,,2011-07-12,2011-07-12,,C,,"10, 6",IU,SUBCUTANEOUS,TID,DIABETES
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2011-09-14,2011-09-14,,,,,C,Y,160,mg,ORAL,QD,APPETITE
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-06-14,2011-06-14,,,,,C,Y,400,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DIHYDROCODEINE,DIHYDROCODEINE,2011-04,2011-03-31,D,2011-07-05,2011-07-05,,C,,120,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-05-21,2011-05-21,,2011-05-23,2011-05-23,,C,,,,SUBCUTANEOUS,,ANTI-COAGULANT
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-05-22,2011-05-22,,2011-05-23,2011-05-23,,C,,,,INTRAVENOUS,,HYDRATION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CINNARIZINE,CINNARIZINE,2011-02,2011-01-31,D,,,,C,Y,15,mg,ORAL,TID,MENIERE'S DISEASE
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,LERCANIDIPINE,LERCANIDIPINE,2007,2007-12-31,M,2011-05-31,2011-05-31,,C,,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-04,2011-03-31,D,,,,C,Y,40000 - 80000,IU,ORAL,TID,MALABSORPTION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,OROMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-04,2011-03-31,D,2011-05,2011-05-31,D,C,,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,,2011-05-17,Y,,,,C,Y,2,SACHET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN,AMOXICILLIN,2011-05-21,2011-05-21,,2011-05-23,2011-05-23,,C,,,,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,2001,2001-12-31,M,,,,C,Y,150,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2011,2011-10-18,M,,,,C,Y,,,ORAL,,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-04,2011-03-31,D,,,,C,Y,20,mg,ORAL,BID,HIATUS HERNIA
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-04,2011-03-31,D,,,,C,Y,10,mg,ORAL,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-08,2011-07-31,D,,,,C,Y,9,mL,ORAL,QID,BACK AND ABDOMINAL PAIN
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-08,2011-07-31,D,,,,C,Y,40,mg,ORAL,BID,BACK AND ABDOMINAL PAIN
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-08,2011-07-31,D,,,,C,Y,1,g,ORAL,QID,BACK AND ABDOMINAL PAIN
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011,2011-10-18,M,,2011-12-31,Y,C,,uk,,UNKNOWN,UNKNOWN,CONSTIPATION
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011,2011-10-18,M,2011,2011-12-31,M,C,,,,ORAL,,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011,2011-10-18,M,,,,C,Y,,,ORAL,,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,NEBIVOLOL,NEBIVOLOL,2002,2002-12-31,M,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-02-13,2012-02-13,,2012-02-15,2012-02-15,,C,,625,mg,INTRAVENOUS,,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BLOOD TRANSFUSION - NO ADDITIONAL INFORMATION,"BLOOD TRANSFUSION, AUXILIARY PRODUCTS",2012-05-16,2012-05-16,,2012-05-16,2012-05-16,,C,,2,IU,INTRAVENOUS,ONCE,THROMBOCYTOPENIA
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-01-03,2012-01-03,,2012-01-05,2012-01-05,,P,,,,INTRAVENOUS,PRN,HYDRATION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,GENTAMICIN,GENTAMICIN,2012-04-24,2012-04-24,,2012-04-24,2012-04-24,,C,,120,mg,INTRAVENOUS,,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MEROPENEM,MEROPENEM,2012-04-19,2012-04-19,,2012-04-25,2012-04-25,,C,,1,g,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-04-26,2012-04-26,,2012-05,2012-05-31,D,C,,625,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DALTEPARIN,DALTEPARIN,2012-04-19,2012-04-19,,2012-04-25,2012-04-25,,C,,5000,IU,INTRAVENOUS,QD,CLOT PREVENTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-04-20,2012-04-20,,2012-04-23,2012-04-23,,C,,1,g,ORAL,PRN,PYREXIA
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-04-19,2012-04-19,,2012-04-22,2012-04-22,,C,,1,L,INTRAVENOUS,TID,HYDRATION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2012-04-17,2012-04-17,,,,,C,Y,10,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12,2011-11-30,D,,,,C,Y,20,mg,ORAL,QD,ACIDITY
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-06-14,2012-06-14,,,,,C,Y,40,mg,ORAL,QD,OEDEMA
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2012-06-14,2012-06-14,,,,,C,Y,200,mg,ORAL,QD,HYPERURICAEMIA
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,URSODEOXYCHOLIC ACID,URSODEOXYCHOLIC ACID,2011-12,2011-11-30,D,,,,C,Y,250,mg,ORAL,TID,BILIARY TRACT OBSTRUCTIONS
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-01-06,2012-01-06,,2012-01-13,2012-01-13,,C,,,,,,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-02-09,2012-02-09,,2012-02-13,2012-02-13,,C,,1.2,mg,INTRAVENOUS,PRN,INFECTION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02-09,2012-02-09,,2012-02-13,2012-02-13,,C,,1,g,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-02-09,2012-02-09,,2012-02-10,2012-02-10,,C,,,,INTRAVENOUS,,HYDRATION
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,GAVISCON ADVANCE,GAVISCON ADVANCE,2012-02-10,2012-02-10,,2012-02-10,2012-02-10,,C,,10,mL,ORAL,,ACIDITY
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2012-02-11,2012-02-11,,2012-02-17,2012-02-17,,C,,1,g,INTRAVENOUS,,INFECTION
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,,2012-01-17,Y,,,,C,Y,1,g,ORAL,QID,BACK PAIN
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-07,2012-02-07,,,,,C,Y,4,mg,INTRAVENOUS,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2012-02-07,2012-02-07,,,,,C,Y,40000,IU,ORAL,PRN,MALABSORPTION
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,NOVOMIX 30,NOVOMIX,2011-10,2011-09-30,D,,,,C,Y,16,U,INTRAMUSCULAR,BID,DIABETES
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-09,2011-08-31,D,,,,C,Y,15000,U,ORAL,QD,DEEP VEIN THROMBOSIS  IN LEFT LEG
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2012-01-03,2012-01-03,,2012-01-10,2012-01-10,,P,,7.5,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,MIRTAZAPINE,MIRTAZAPINE,2012-01-11,2012-01-11,,,,,C,Y,15,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,FERROUS GLUCONATE,FERROUS GLUCONATE,2012-01-11,2012-01-11,,2012-02,2012-02-29,D,C,,300,mg,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,FERROUS SULPHATE,FERROUS SULFATE,2012-02-02,2012-02-02,,,,,C,Y,,,ORAL,,ANAEMIA
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-07,2012-02-07,,,,,C,Y,8,mg,INTRAVENOUS,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-01-17,2012-01-17,,2012-02-06,2012-02-06,,C,,"12,500",IU,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OXYCODONE LIQUID,OXYCODONE,2012-03-29,2012-03-29,,,,,C,Y,5-10,mL,ORAL,Every 3 hours,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,,2012-01-24,Y,,,,C,Y,10,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,BUSCOPAN,HYOSCINE BUTYLBROMIDE,2011-11-30,2011-11-30,,,,,C,Y,10,mg,ORAL,PRN,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,1997-01-01,1997-01-01,,,,,C,Y,1,g,ORAL,QID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,STEMETIL,PROCHLORPERAZINE,2011-12-01,2011-12-01,,,,,C,Y,5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2008-02-01,2008-02-01,,2012-03-29,2012-03-29,,C,,10,mg,ORAL,4 - 5 at night,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,2011-08-01,2011-08-01,,,,,C,Y,25,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-02-07,2012-02-07,,,,,C,Y,7500,mL,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2012-03-20,2012-03-20,,,,,C,Y,40000,1-3 tablets with a snack or meal,ORAL,PRN,DIARRHOEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-31,2012-01-31,,2012-03-06,2012-03-06,,C,,8,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2012-03-03,2012-03-03,,2012-03-03,2012-03-03,,C,,2,mg,ORAL,ONCE,DIARRHOEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-11-30,2011-11-30,,,,,C,Y,20,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,BIOTENE ORAL BALANCE GEL,BIOTENE                            /06680101/,2012-03-29,2012-03-29,,,,,C,Y,1,APPLICATION,ORAL,PRN,CLINICAL DETERIORATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,GLYCOPYRRONIUM BROMIDE,GLYCOPYRRONIUM BROMIDE,2012-03-29,2012-03-29,,,,,C,Y,200,ug,SUBCUTANEOUS,PRN,CLINICAL DETERIORATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LEVOMEPROMAZINE,LEVOMEPROMAZINE,2012-03-29,2012-03-29,,,,,C,Y,5,mg,SUBCUTANEOUS,PRN,CLINICAL DETERIORATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-03-29,2012-03-29,,,,,C,Y,2.5-5,mg,SUBCUTANEOUS,PRN,CLINICAL DETERIORATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,BUSCOPAN,HYOSCINE BUTYLBROMIDE,2012-03-29,2012-03-29,,,,,C,Y,20,mg,ORAL,QID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,OXYCODONE M/R,OXYCODONE,2012-03-29,2012-03-29,,,,,C,Y,20,mg,ORAL,BID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ALVERINE,ALVERINE,2012-03-29,2012-03-29,,,,,C,Y,60,mg,ORAL,TID,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2012-03-29,2012-03-29,,,,,C,Y,40,mg,ORAL,Nocte,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-31,2012-01-31,,2012-03-06,2012-03-06,,C,,8,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-03-29,2012-03-29,,,,,C,Y,20,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-03-29,2012-03-29,,,,,C,Y,2.5,mg,SUBCUTANEOUS,Every 2-4 hours,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-31,2012-01-31,,2012-02-02,2012-02-02,,C,,4,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-07,2012-02-07,,2012-03-06,2012-03-06,,C,,2,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-06,2012-03-06,,2012-03-20,2012-03-20,,C,,1,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-20,2012-03-20,,,,,C,Y,0.5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-31,2012-01-31,,,,,C,Y,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2012-03-29,2012-03-29,,,,,C,Y,100,mg,ORAL,QD,ANGINA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-02-03,2012-02-03,,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-02-07,2012-02-07,,,,,C,Y,1,SACHET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2012-01-05,2012-01-05,,,,,C,Y,15,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,ALVERINE,ALVERINE,2011-11-30,2011-11-30,,2012-03-29,2012-03-29,,C,,60,mg,ORAL,PRN,DISEASE RELATED PAIN
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-11-01,2011-11-01,,,,,C,Y,20,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,1995-02-01,1995-02-01,,2012-03-29,2012-03-29,,C,,100,mg,ORAL,QD,ANGINA
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,MELATONINA,MELATONIN,2009,2009-12-31,M,,,,C,Y,1.5,g,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-03,2011-06-03,,2011-06-03,2011-06-03,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-10,2011-06-10,,2011-06-10,2011-06-10,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-17,2011-06-17,,2011-06-17,2011-06-17,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-04,2011-07-04,,2011-07-04,2011-07-04,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-11,2011-07-11,,2011-07-11,2011-07-11,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-05,2011-08-05,,2011-08-05,2011-08-05,,C,,10,mg,INTRAVENOUS,QD,ANTIEMEITC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-12,2011-08-12,,2011-08-12,2011-08-12,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-04-01,2011-04-01,,,,,C,Y,40,mg,ORAL,QD,GASTRIC PROPHYLAXIS
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-16,2011-09-16,,2011-09-16,2011-09-16,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-30,2011-09-30,,2011-09-30,2011-09-30,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-10-03,2011-10-03,,,,,C,Y,4,mg,ORAL,QD,PAIN KILLER
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,17.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-10-03,2011-10-03,,,,,C,Y,75,mg,ORAL,BID,PAIN KILLER
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,18.0,CONCOMITANT MEDICATIONS,,,DEXTROPROPOXIFEN,DEXTROPROPOXYPHENE,2011-09-13,2011-09-13,,2011-10-04,2011-10-04,,C,,98,mg,ORAL,TID,PAIN KILLER
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,19.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-09-13,2011-09-13,,2011-10-04,2011-10-04,,C,,400,mg,ORAL,TID,PAIN KILLER
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,20.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-21,2011-10-21,,2011-10-21,2011-10-21,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,21.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-04-01,2011-04-01,,,,,C,Y,50,mg,ORAL,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,22.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-05-05,2011-05-05,,2011-05-05,2011-05-05,,C,,50,mg,INTRAVENOUS,QD,VOMITS PROPHYLAXIS
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-05,2011-05-05,,2011-05-05,2011-05-05,,C,,8,mg,INTRAVENOUS,QD,VOMITS PROPHYLAXIS
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,24.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-05-12,2011-05-12,,2011-05-12,2011-05-12,,C,,10,mg,INTRAVENOUS,QD,VOMITS PRPHYLAXIS
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,25.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,10,mg,INTRAVENOUS,QD,VOMITS PROPHYLAXIS
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,26.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,5,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,27.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,10,mg,INTRAVENOUS,QD,ANTIEMETICS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2010-12-01,2010-12-01,,2011-01-07,2011-01-07,,C,,16,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NAPROSYN,NAPROXEN,2010-12-20,2010-12-20,,2011-01-01,2011-01-01,,C,,1000,mg,ORAL,QD,SHOULDER/BACK PAIN
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CLINDAMYCIN,CLINDAMYCIN,2010-12-20,2010-12-20,,2011-01-01,2011-01-01,,C,,300,mg,ORAL,BID,REDNESS TO PORT SITE
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,P,,2,mg,INTRAVENOUS,ONCE,IV SEDATION FOR BIOPSY
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,P,,50,ug,INTRAVENOUS,ONCE,IV SEDATION FOR LIVER BIOPSY
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CLOTRIMAZOLE,CLOTRIMAZOLE,2010-12-04,2010-12-04,,2011-01-01,2011-01-01,,C,,1,APPLICATION,VAGINAL,PRN,YEAST INFECTION
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DIAMICRON,GLICLAZIDE,2007-02,2007-01-31,D,2011-04-02,2011-04-02,,C,,120,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2010-10,2010-09-30,D,,,,C,Y,5,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-09,2010-08-31,D,,,,C,Y,2,TABLET,ORAL,PRN,MUSCULOSKELETAL PAIN
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ENDONE,OXYCODONE HYDROCHLORIDE,2010-12-20,2010-12-20,,2011-03-07,2011-03-07,,C,,2,TABLET,ORAL,PRN,PAIN SHOULDER
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CENTRUM MULTIVITAMIN,MINERALS NOS W/VITAMINS NOS,2010-11-25,2010-11-25,,,,,C,Y,1,TABLET,ORAL,QD,FATIGUE
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DICLOXACILLIN,DICLOXACILLIN,2011-02-09,2011-02-09,,2011-03-09,2011-03-09,,C,,500,mg,ORAL,QID,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NAVOBAN,TROPISETRON HYDROCHLORIDE,2010-11-12,2010-11-12,,,,,C,Y,5,mg,ORAL,QS,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-11-12,2010-11-12,,2011-11-04,2011-11-04,,C,,8,mg,ORAL,QS,PREMED FOR CHEMO
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TEMAZEPAM,TEMAZEPAM,2010-11-12,2010-11-12,,,,,C,Y,2,TABLET,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2010-11-12,2010-11-12,,,,,C,Y,1,TABLET,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-01-21,2011-01-21,,2011-02-03,2011-02-03,,C,,40,mg,ORAL,QD,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-03-04,2011-03-04,,2011-03-28,2011-03-28,,C,,25,mg,ORAL,BID,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ALBUTEROL,SALBUTAMOL,2011-03-08,2011-03-08,,2011-03-28,2011-03-28,,C,,100,ug,RESPIRATORY (INHALATION),PRN,BRONCHOSPASMS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ELOCON OINTMENT,MOMETASONE FUROATE,2011-03-08,2011-03-08,,2011-05-01,2011-05-01,,C,,1,APPLICATION,TOPICAL,PRN,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SORBOLENE CREAM,SORBOLENE,2011-03-11,2011-03-11,,2011-05-01,2011-05-01,,C,,1,APPLICATION,TOPICAL,PRN,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,FLUCLOXACILLIN,FLUCLOXACILLIN,2010-11-28,2010-11-28,,2010-12-04,2010-12-04,,C,,2.0,g,INTRAVENOUS,Q 4 to 6 hours,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PIPERACILLIN,PIPERACILLIN,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,4,g,INTRAVENOUS,ONCE,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,TAZOBACTAM,TAZOBACTAM,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,.5,g,INTRAVENOUS,ONCE,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,CEPHALEXIN,CEFALEXIN,2011-03-08,2011-03-08,,2011-05-07,2011-05-07,,C,,1000,mg,ORAL,BID,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ENDONE,OXYCODONE HYDROCHLORIDE,2011-03-08,2011-03-08,,,,,C,Y,5,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,FLUOXETINE,FLUOXETINE,2011-03-11,2011-03-11,,2011-11-21,2011-11-21,,C,,10,mg,ORAL,BID,ANXIETY
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,CEPHAZOLIN,CEFAZOLIN SODIUM,2011-02-08,2011-02-08,,2011-02-13,2011-02-13,,C,,1,g,INTRAVENOUS,TID,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-02-08,2011-02-08,,2011-09-13,2011-09-13,,C,,18,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DIAMICRON,GLICLAZIDE,2011-02-08,2011-02-08,,2011-04-03,2011-04-03,,C,,120,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DIAFORMIN,METFORMIN HYDROCHLORIDE,2011-02-08,2011-02-08,,,,,C,Y,1,g,ORAL,TID,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-02-09,2011-02-09,,2011-02-13,2011-02-13,,C,,40,mg,INTRAVENOUS,QD,DVT PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2010-11-28,2010-11-28,,2010-12-04,2010-12-04,,C,,Unk,,INTRAVENOUS,UNKNOWN,DVT PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-02-04,2011-02-04,,,,,C,Y,40,mg,ORAL,BID,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,40,mg,INTRAVENOUS,QD,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-03-08,2011-03-08,,2011-03-10,2011-03-10,,C,,2,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,CEPHAZOLIN,CEFAZOLIN SODIUM,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,1,g,INTRAVENOUS,TID,CELLULITIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,40,mg,SUBCUTANEOUS,QD,DVT PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-04-01,2011-04-01,,2011-04-01,2011-04-01,,C,,40,mg,INTRAVENOUS,ONCE,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ALUMINUM HYDROXIDE,ALUMINIUM HYDROXIDE,2011-02-11,2011-02-11,,2011-02-11,2011-02-11,,C,,20,mL,ORAL,ONCE,GORD PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-04-02,2011-04-02,,2011-04-12,2011-04-12,,C,,40,mg,SUBCUTANEOUS,QD,DVT PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-04-03,2011-04-03,,2011-04-12,2011-04-12,,C,,2,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2010-11-25,2010-11-25,,2010-11-28,2010-11-28,,C,,20,mg,ORAL,QD,EDEMA BILATERAL LEGS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-04-11,2011-04-11,,2011-04-11,2011-04-11,,C,,2,TABLET,ORAL,ONCE,SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-04-07,2011-04-07,,2011-04-11,2011-04-11,,C,,60,mg,ORAL,QD,PLEURAL EFFUSION
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-04-07,2011-04-07,,,,,C,Y,40,mg,ORAL,QD,PEPTIC ULCER
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,DIAMICRON MR,GLICLAZIDE,2011-04-03,2011-04-03,,,,,C,Y,90,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,MICARDIS PLUS,PRITORPLUS,2011-05-15,2011-05-15,,,,,C,Y,40,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,KEFLEX,CEFALEXIN,2011-05-24,2011-05-24,,2011-06-07,2011-06-07,,C,,500,mg,ORAL,QID,COUGH
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2011-05-20,2011-05-20,,2011-11-04,2011-11-04,,C,,0.5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,MAGMIN,MAGNESIUM ASPARTATE,2011-04-03,2011-04-03,,,,,C,Y,2,TABLET,ORAL,QD,MAGNESIUM SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-04-04,2011-04-04,,2011-08-16,2011-08-16,,C,,2,TABLET,ORAL,QD,POTASSIUM SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,CALTRATE,CALCIUM CARBONATE,2011-04-18,2011-04-18,,,,,C,Y,600,mg,ORAL,QD,CALCIUM SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,DIAFORMIN,METFORMIN HYDROCHLORIDE,2007-02,2007-01-31,D,2011-02-08,2011-02-08,,C,,1,g,ORAL,BID,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,OSTELIN,ERGOCALCIFEROL,2011-04-18,2011-04-18,,,,,C,Y,1000,IU,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-04-18,2011-04-18,,2011-04-20,2011-04-20,,C,,2.5,mg,INTRAVENOUS,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,MOVOCOL,MOVICOL                            /01749801/,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,2,TABLET,ORAL,ONCE,BOWEL MOTILITY PROPHYLAXIS
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,NOVORAPID,INSULIN ASPART,2011-04-09,2011-04-09,,,,,C,Y,6,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-04-18,2011-04-18,,2011-04-22,2011-04-22,,C,,4.5,g,INTRAVENOUS,TID,PLEURAL EFFUSION
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2010-10-24,2010-10-24,,2010-11-30,2010-11-30,,C,,12,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,MICARDIS PLUS,PRITORPLUS,1997-01,1996-12-31,D,2011-04-29,2011-04-29,,C,,80/12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,FLUCLOXACILLIN,FLUCLOXACILLIN,2010-12-04,2010-12-04,,2010-12-20,2010-12-20,,C,,500,mg,ORAL,QID,CELLULITIS
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,AMARYL,GLIMEPIRIDE,2010-07,2010-06-30,D,,,,C,Y,4,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN SR,OXYCODONE HYDROCHLORIDE,2011-01-31,2011-01-31,,2011-03-07,2011-03-07,,C,,40,mg,ORAL,BID,MUSCULOSKELETAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-01-31,2011-01-31,,2011-03-07,2011-03-07,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MAXOLON,METOCLOPRAMIDE HYDROCHLORIDE,2011-01-31,2011-01-31,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-03-07,2011-03-07,,,,,C,Y,80,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-02-25,2011-02-25,,2011-03-28,2011-03-28,,C,,20,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-03-07,2011-03-07,,,,,C,Y,40,mg,ORAL,QD,GORD
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HALOPERDOL,HALOPERIDOL,2011-03-07,2011-03-07,,,,,C,Y,0.5,mg,ORAL,BID,NAUSEA/VOMITING
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-02-14,2011-02-14,,2011-03-06,2011-03-06,,C,,60,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-03-28,2011-03-28,,2011-04-26,2011-04-26,,C,,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-04-27,2011-04-27,,,,,C,Y,40,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DIAFORMIN XR,METFORMIN HYDROCHLORIDE,2010-07,2010-06-30,D,,,,C,Y,1000,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-03-07,2011-03-07,,,,,C,Y,40,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-04-27,2011-04-27,,,,,C,Y,1,mg,SUBLINGUAL,PRN,ANXIETY
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010,2010-12-31,M,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-02-25,2011-02-25,,,,,C,Y,10,mg,INTRAVENOUS,QS,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ZANTAC,RANITIDINE HYDROCHLORIDE,2011-01-17,2011-01-17,,,,,C,Y,30,mg,ORAL,QD,GORD
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-01-17,2011-01-17,,2011-01-31,2011-01-31,,C,,15,mg,ORAL,BID,ABDOMNIAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,GLUCAGEN HYPOKIT,GLUCAGON HYDROCHLORIDE,2010-07,2010-06-30,D,,,,C,Y,1,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2010-07,2010-06-30,D,,,,C,Y,12,IU,SUBCUTANEOUS,QHS,DIABETES
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE HYDROCHLORIDE,METOCLOPRAMIDE HYDROCHLORIDE,2010-12,2010-11-30,D,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,OXYCODONE HYDROCHLORIDE USP,OXYCODONE HYDROCHLORIDE,2010-12,2010-11-30,D,,,,C,Y,10,mg,ORAL,BID,MUSCULOSKELETAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN SR,OXYCODONE HYDROCHLORIDE,2010-12,2010-11-30,D,2011-01-30,2011-01-30,,P,,20,mg,ORAL,BID,MUSCULOSKELETAL PAIN
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,TEMAZEPAM,TEMAZEPAM,2010-12,2010-11-30,D,,,,C,Y,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,NAVOBAN,TROPISETRON HYDROCHLORIDE,2011-01-31,2011-01-31,,2011-03-07,2011-03-07,,C,,5,mg,ORAL,QD,NAUSEA PROPHYALAXIS
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-06-01,2011-06-01,,2011-11-02,2011-11-02,,,,,,,,
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,OXYCODONE SR,OXYCODONE,2011-04-03,2011-04-03,,,,,C,Y,50,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-04-24,2011-04-24,,2011-04-26,2011-04-26,,C,,80,mg,ORAL,BID,DIURETIC
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MIRTAZAPINE,MIRTAZAPINE,2011-04-24,2011-04-24,,,,,C,Y,45,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-04-24,2011-04-24,,,,,C,Y,20,g,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,KEFLEX,CEFALEXIN,2011-04-24,2011-04-24,,2011-05-04,2011-05-04,,C,,2,mg,INTRAVENOUS,TID,INFECTION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2011-04-24,2011-04-24,,,,,C,Y,1,mL,TOPICAL,PRN,ANTIFUNGAL
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2011-04-26,2011-04-26,,2011-04-30,2011-04-30,,C,,0.5,mg,SUBCUTANEOUS,BID,DEPRESSION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PETHIDINE,PETHIDINE,2011-04-24,2011-04-24,,2011-05-04,2011-05-04,,C,,100,mg,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN DUO,SPEKTRAMOX,2011-05-09,2011-05-09,,2011-05-09,2011-05-09,,C,,1,TABLET,ORAL,QD,INFECTION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-05-09,2011-05-09,,2011-05-09,2011-05-09,,C,,500,mg,ORAL,QD,INFECTION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-05,2011-04-05,,2011-11,2011-11-30,D,C,,4,mg,ORAL,PRN,CHEMO PREMED
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-03-11,2011-03-11,,,,,C,Y,40,mg,ORAL,BID,REFLUX
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,FENTENYL PATCH,FENTANYL,2011-05-02,2011-05-02,,2011-05-10,2011-05-10,,C,,1,PATCH,TOPICAL,QOD,PAIN
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-04-29,2011-04-29,,,,,C,Y,1,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2011-04-29,2011-04-29,,2011-05-11,2011-05-11,,C,,80,mg,ORAL,BID,FLUID RETENTION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,HEP SALINE,HEPARIN SODIUM,2011-04-29,2011-04-29,,2011-05-10,2011-05-10,,C,,50,IU,INTRAVENOUS,TID,HYDRATION
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MEROPENEM,MEROPENEM,2011-04-29,2011-04-29,,2011-05-08,2011-05-08,,C,,1,mg,INTRAVENOUS,TID,SEPSIS
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,CASPOFUNGIN,CASPOFUNGIN,2011-04-29,2011-04-29,,2011-05-03,2011-05-03,,C,,50,mg,INTRAVENOUS,QD,SEPSIS
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-02,2011-05-02,,2011-05-02,2011-05-02,,C,,8,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-04-29,2011-04-29,,2011-05-11,2011-05-11,,C,,20,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,NAVOBAN,TROPISETRON HYDROCHLORIDE,2011-04-05,2011-04-05,,,,,C,Y,5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-03-18,2011-03-18,,,,,C,Y,2,TABLET,ORAL,PRN,PANCREATIC EMZYME
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,SLOW K,POTASSIUM CHLORIDE,2011-04-02,2011-04-02,,,,,C,Y,2,TABLET,ORAL,TID,SUPPLEMENT
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-04-02,2011-04-02,,,,,C,Y,40,g,SUBCUTANEOUS,QD,PREVENTION OF VENOUS THROMBOEMBOLISM
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-02,2011-01-31,D,,,,C,Y,1,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-04-02,2011-04-02,,,,,C,Y,40,mg,SUBCUTANEOUS,QD,PREVENTION OF VENOUS THROMBOEMBOLISM
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,GASTROSTOP,LOPERAMIDE HYDROCHLORIDE,2011-04-24,2011-04-24,,2011-04-24,2011-04-24,,C,,2,TABLET,ORAL,QD,ANTIDIARRHOEAL
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2011-04-24,2011-04-24,,2011-05-03,2011-05-03,,C,,1.5,g,INTRAVENOUS,BID,INFECTION
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2011-12-27,2011-12-27,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-09-01,2011-09-01,,,,,C,Y,20,mg,ORAL,QD,GASTRITIS
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/ PARACETAMOL,PANADEINE CO,2011-10-20,2011-10-20,,2011-11-15,2011-11-15,,C,,15,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,NORFLOXACIN,NORFLOXACIN,2011-10-05,2011-10-05,,2011-10-14,2011-10-14,,C,,400,mg,ORAL,BID,URINARY INFECTION
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,HUMECTOL D,COLOXYL WITH DANTHRON,2001-11-03,2001-11-03,,,,,C,Y,01,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/ PARACETAMOL,PANADEINE CO,2011-11-15,2011-11-15,,,,,C,Y,15,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-09-01,2011-09-01,,,,,C,Y,100,mg,ORAL,QD,ASCITIS
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-09-01,2011-09-01,,,,,C,Y,40,mg,ORAL,BID,ASCITIS
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,BROMOPRIDE,BROMOPRIDE,2011-09-21,2011-09-21,,,,,C,Y,1,TABLET,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,HUMECTOL D,COLOXYL WITH DANTHRON,2011-09-23,2011-09-23,,2011-09-28,2011-09-28,,C,,1,TABLET,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,HUMECTOL D,COLOXYL WITH DANTHRON,2011-09-28,2011-09-28,,2011-10-22,2011-10-22,,C,,1,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/ PARACETAMOL,PANADEINE CO,2011-09-06,2011-09-06,,2011-10-14,2011-10-14,,C,,15,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CODEINE PHOSPHATE/ PARACETAMOL,PANADEINE CO,2001-10-14,2001-10-14,,2011-10-20,2011-10-20,,C,,30,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PURAN T4,LEVOTHYROXINE SODIUM,2004,2004-12-31,M,,,,C,Y,100,mg,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2011-07-07,2011-07-07,,2011-07-18,2011-07-18,,C,,60,mg,SUBCUTANEOUS,QD,THROMBOSIS
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DIPIRONE,METAMIZOLE SODIUM,2011-07-14,2011-07-14,,2011-07-15,2011-07-15,,C,,1000,mg,INTRAVENOUS,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DIPIRONE,METAMIZOLE SODIUM,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,500,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-07-16,2011-07-16,,2011-07-18,2011-07-18,,C,,40,mg,INTRAVENOUS,QD,URINARY RETENTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-07-23,2011-07-23,,2011-07-23,2011-07-23,,C,,40,mg,ORAL,QD,URINARY RETENTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,100,mg,INTRAVENOUS,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ABLOK PLUS,TENORETIC,2004,2004-12-31,M,,,,C,Y,50/12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LISADOR,LISADOR,2011-01,2010-12-31,D,2011-07-06,2011-07-06,,C,,35,gtt,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-07-07,2011-07-07,,2011-07-13,2011-07-13,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,AMPICILLIN,AMPICILLIN,2011-07-07,2011-07-07,,2011-07-10,2011-07-10,,C,,500,mg,INTRAVENOUS,QID,INFECTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2011-07-07,2011-07-07,,2011-07-13,2011-07-13,,C,,500,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-07-16,2011-07-16,,2011-07-19,2011-07-19,,C,,400,mg,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-07-07,2011-07-07,,2011-07-24,2011-07-24,,C,,40,mg,INTRAVENOUS,QD,GASTRITIS
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2011-07-16,2011-07-16,,2011-07-19,2011-07-19,,C,,500,mg,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABINE,,2012-01-03,2012-01-03,,2012-01-16,2012-01-16,,,,,,,,
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DIPIRONA,METAMIZOLE SODIUM,2011-09,2011-08-31,D,2011-12-09,2011-12-09,,C,,1000,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-11-08,2011-11-08,,2011-11-09,2011-11-09,,C,,2,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-11-12,2011-11-12,,2011-11-12,2011-11-12,,C,,20,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DRAMIN,DIMENHYDRINATE,2011-11-13,2011-11-13,,2011-11-14,2011-11-14,,C,,1,TABLET,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-11-11,2011-11-11,,2011-11-11,2011-11-11,,C,,3,TABLET,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-11-19,2011-11-19,,2011-11-21,2011-11-21,,C,,3,TABLET,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN HIDROCHLRIDE,CIPROFLOXACIN HYDROCHLORIDE,2011-11-21,2011-11-21,,2011-11-29,2011-11-29,,C,,500,mg,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SIMETICONE,SIMETICONE,2011-11-25,2011-11-25,,2011-11-26,2011-11-26,,C,,75,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CONCENTRATION OF ERYTHROCYTES,"RED BLOOD CELLS, CONCENTRATED",2011-10-19,2011-10-19,,2011-10-19,2011-10-19,,P,,600,mL,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DRAMIN,DIMENHYDRINATE,2011-11-28,2011-11-28,,2011-11-30,2011-11-30,,C,,1,TABLET,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ENSURE,NUTRIENTS NOS,2011-10-04,2011-10-04,,,,,C,Y,4,Med,ORAL,TID,ANOREXIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-11-25,2011-11-25,,2011-11-27,2011-11-27,,C,,40,mg,ORAL,QD,ORCHIEPIDIDIMITIS
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,NIMESULIDE,NIMESULIDE,2011-11-30,2011-11-30,,2011-12-07,2011-12-07,,C,,100,mg,ORAL,BID,ORCHIEPIDIDIMITIS
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CODEINE + PARACETAMOL,LENOLTEC WITH CODEINE NO 1,2011-11-25,2011-11-25,,2011-12-09,2011-12-09,,C,,1,TABLET,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN HIDROCHLRIDE,CIPROFLOXACIN HYDROCHLORIDE,2011-11-30,2011-11-30,,,,,C,Y,500,mg,ORAL,BID,ORCHIEPIDIDIMITIS
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,LUFTAL,SIMETICONE,2011-12-06,2011-12-06,,2011-12-07,2011-12-07,,C,,30,gtt,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,SACCHEAROMYCIS BOULARDII,SACCHAROMYCES BOULARDII,2011-12-03,2011-12-03,,2011-12-06,2011-12-06,,C,,100,mg,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DIPIRONA,METAMIZOLE SODIUM,2011-12-10,2011-12-10,,,,,C,Y,500,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,CODEINE + PARACETAMOL,LENOLTEC WITH CODEINE NO 1,2011-12-10,2011-12-10,,,,,C,Y,1,TABLET,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,LUFTAL,SIMETICONE,2011-12-12,2011-12-12,,2011-12-23,2011-12-23,,C,,30,gtt,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12-15,2011-12-15,,,,,C,Y,20,mg,ORAL,QD,EPIGASTRALGIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,CODEINE + PARACETAMOL,LENOLTEC WITH CODEINE NO 1,2011-10-19,2011-10-19,,2011-11-19,2011-11-19,,C,,1,TABLET,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-12-17,2011-12-17,,2011-12-23,2011-12-23,,C,,40,mg,ORAL,QD,ORCHIEPIDIDIMITIS
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-12-24,2011-12-24,,,,,C,Y,40,mg,ORAL,BID,ORCHIEPIDIDIMITIS
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ERYTHROPOIETIN,ERYTHROPOIETIN,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,1,AMPULE,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,ERYTHROPOIETIN,ERYTHROPOIETIN,2011-12-23,2011-12-23,,2011-12-23,2011-12-23,,C,,1,AMPULE,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ERYTHROPOIETIN,ERYTHROPOIETIN,2011-12-26,2011-12-26,,2011-12-26,2011-12-26,,C,,1,AMPULE,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,CODEINE,CODEINE,2011-12-22,2011-12-22,,,,,C,Y,30,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-03,2012-01-03,,,,,C,Y,500,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,SULFERBEL,FERROUS SULFATE,2012-01-03,2012-01-03,,,,,C,Y,40,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,SACCHEAROMYCIS BOULARDII,SACCHAROMYCES BOULARDII,2012-01-09,2012-01-09,,2012-01-10,2012-01-10,,C,,100,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-10-19,2011-10-19,,2011-10-22,2011-10-22,,C,,2,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,SIMETICONE,SIMETICONE,2011-10-23,2011-10-23,,2011-10-23,2011-10-23,,C,,75,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-10-25,2011-10-25,,2011-10-26,2011-10-26,,C,,10,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,SACCHEAROMYCIS BOULARDII,SACCHAROMYCES BOULARDII,2011-10-23,2011-10-23,,2011-10-26,2011-10-26,,C,,100,mg,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-30,2011-10-30,,2011-11-02,2011-11-02,,C,,10,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDE,LOPERAMIDE,2011-11-03,2011-11-03,,2011-11-04,2011-11-04,,C,,2,mg,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-047-001,01047001,047,65.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DIPIRONE,METAMIZOLE SODIUM,2011-07-21,2011-07-21,,,,,C,Y,40,gtt,ORAL,eight times per day,EPIGASTRIC PAIN
CO-101-001,CO-101-001-047-001,01047001,047,65.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,MORFINE,MORPHINE,2011-07-21,2011-07-21,,2011-09-15,2011-09-15,,C,,20,gtt,ORAL,TID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-047-001,01047001,047,65.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MORFINE,MORPHINE,2011-09-16,2011-09-16,,,,,C,Y,30,gtt,ORAL,6 TIMES PER DAY,EPIGASTRIC PAIN
CO-101-001,CO-101-001-047-001,01047001,047,65.0,YEARS,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-08-11,2011-08-11,,,,,C,Y,1,TABLET,ORAL,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-01-01,2011-01-01,,2011-01-30,2011-01-30,,C,,1000,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TRANSIPEG (MACROGOL),MACROGOL,2010-12-31,2010-12-31,,2011-01-24,2011-01-24,,C,,5.9,g,ORAL,QID,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2011-03-12,2011-03-12,,2011-04-07,2011-04-07,,C,,30,g,ORAL,PRN,BONE PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ZOMETA,ZOLEDRONIC ACID,2011-03-15,2011-03-15,,2011-03-16,2011-03-16,,C,,4,mg,ORAL,QD,HYPERCALCEMIA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,METHYLNALTREXONE BROMURE,METHYLNALTREXONE BROMIDE,2011-02,2011-02-01,D,2011-03-31,2011-03-31,,C,,8,mg,SUBCUTANEOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,JOSIR,TAMSULOSIN HYDROCHLORIDE,2011-02-24,2011-02-24,,2011-04-03,2011-04-03,,C,,0.4,mg,ORAL,QD,MICTION PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE SODIQUE,ENOXAPARIN SODIUM,2011-03-19,2011-03-19,,,,,C,Y,4000,IU,SUBCUTANEOUS,QD,THROMBOSIS PREVENTION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,LACTULOSE SOLUTION,LACTULOSE,2011-03-12,2011-03-12,,2011-04-04,2011-04-04,,C,,1,IU,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE CHLORHYDRATE,AMITRIPTYLINE HYDROCHLORIDE,2011-03-22,2011-03-22,,2011-04-03,2011-04-03,,C,,25,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,NEORECORMON,EPOETIN BETA,2011-03-16,2011-03-16,,2011-03-23,2011-03-23,,C,,30000,IU,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PHOSPHATE MONOSODIQUE DIHYDRATE,SODIUM PHOSPHATE,2011-03-27,2011-03-27,,2011-03-27,2011-03-27,,C,,1,IU,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,LAMIVUDINE,LAMIVUDINE,2011-01-07,2011-01-07,,,,,C,Y,100,mg,ORAL,QD,ASYMPTOMATIC PORTERAGE OF ANTIGEN HBS
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-02-23,2011-02-23,,2011-02-23,2011-02-23,,C,,50,ug,TRANSDERMAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,CLORAZEPATE DIPOTASSIQUE,CLORAZEPATE DIPOTASSIUM,2011-04-04,2011-04-04,,2011-04-05,2011-04-05,,,,10,mg,INTRAVENOUS,PRN,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,BROMAZEPAM,BROMAZEPAM,2011-03-28,2011-03-28,,2011-04-04,2011-04-04,,C,,6,g,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,L CARNITINE,LEVOCARNITINE HYDROCHLORIDE,2011-03-30,2011-03-30,,2011-04-04,2011-04-04,,C,,100,mg,INTRAVENOUS,QD,ASTHENIA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,PYGEUM AFRICANUM EXTRAIT,PRUNUS AFRICANA,2011-03-26,2011-03-26,,2011-04-04,2011-04-04,,C,,50,mg,INTRAVENOUS,BID,MICTIONEL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-02-24,2011-02-24,,2011-03-04,2011-03-04,,C,,75,ug,TRANSDERMAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-03-05,2011-03-05,,,,,C,Y,175,ug,TRANSDERMAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,CLONAZEPAM,CLONAZEPAM,2011-02-23,2011-02-23,,,,,C,Y,15,gtt,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-11,2011-03-11,,,,,C,Y,1,g,INTRAVENOUS,PRN,HYPERTHERMIA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ESCITALOPRAM,ESCITALOPRAM,2011-03-23,2011-03-23,,2011-04-03,2011-04-03,,C,,10,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-01-18,2011-01-18,,,,,C,Y,200,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-01-28,2011-01-28,,2011-02-22,2011-02-22,,C,,25,ug,TRANSDERMAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-02,2011-02-01,D,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ALPRAZOLAM,ALPRAZOLAM,2011-02,2011-02-01,D,,,,C,Y,0.25,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,PHLOROGLUCINOL,PHLOROGLUCINOL,2011-02,2011-02-01,D,,,,C,Y,80,mg,ORAL,6 per day,GASTRIC SPASM
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSTRON,ONDANSETRON,2011-01-21,2011-01-21,,2011-03-04,2011-03-04,,C,,8,mg,INTRAVENOUS,QS,PREMEDICATION INFUSION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,IVERMECTINE,IVERMECTIN,2011-01,2011-01-21,D,2011-01,2011-01-31,D,C,,3,mg,ORAL,ONCE,FILARIASIS
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2010-12-30,2010-12-30,,,,,C,Y,7.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-21,2011-01-21,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,IXPRIM,ULTRACET,2010-12-31,2010-12-31,,2011-01-24,2011-01-24,,C,,37.5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,BROMAZEPAM,BROMAZEPAM,2010-12-30,2010-12-30,,2011-01-24,2011-01-24,,C,,6,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,"PHOSPHATE MONOSODIQUE DIHYDRATE  10,92 G/60ML -  PHOSPHATE DISODIQUE DODECAHYDRATE  4,8 G/60ML",OSMOTICALLY ACTING LAXATIVES,2011-01-02,2011-01-02,,,,,C,Y,1,IU,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-01-21,2011-01-21,,,,,C,Y,20,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,"MODANE (CALCIUM PANTOTHENATE, SENNA ALEXANDRINA)",MODANE                             /06372101/,2011-01-20,2011-01-20,,,,,C,Y,1,IU,ORAL,3 times a week,CONSTIPATION
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-01-06,2011-01-06,,2011-01-17,2011-01-17,,P,,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2011-09-08,2011-09-08,,2011-10,2011-10-31,D,,,,,,,
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,TAXOTERE,,2011-11-05,2011-11-05,,2012-01-11,2012-01-11,,,,,,,,
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,KETOPROFENE (KETOPROFEN),KETOPROFEN,2011-01-23,2011-01-23,,2011-01-24,2011-01-24,,C,,100,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MTOCLOPRAMIDE,METOCLOPRAMIDE,2011-02-14,2011-02-14,,,,,C,Y,10,mg,ORAL,QS,NAUSEA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FLUORO URACILE,FLUOROURACIL,2011-09-08,2011-09-08,,,,,C,Y,3790,mg,INTRAVENOUS,uppon 46 hours every 2 weeks,METASTATIC PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ESOMEPRAZOLE,ESOMEPRAZOLE,2011-02-07,2011-02-07,,,,,C,Y,UNK,,ORAL,PRN,GOR
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSTRON,ONDANSETRON,2011-01-24,2011-01-24,,,,,C,Y,8,mg,ORAL,once the evening after infusion,NAUSEA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04-19,2011-04-19,,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-05-03,2011-05-03,,,,,C,Y,10,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,IBUPROFENE,IBUPROFEN,2011-05-27,2011-05-27,,2011-05-27,2011-05-27,,C,,400,mg,ORAL,ONCE,HEADACHE
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,EMEND TRIPACK - APREPITANT,APREPITANT,2011-06-27,2011-06-27,,,,,C,Y,125,mg,ORAL,during the 3 days of infusion (125+80+80 mg),NAUSEA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,OXALIPLATINE,OXALIPLATIN,2011-09-08,2011-09-08,,,,,C,Y,134,mg,INTRAVENOUS,Q2S,METASTATIC PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,METOPIMAZINE,METOPIMAZINE,2011-09-09,2011-09-09,,,,,C,Y,5,mg,RECTAL,PRN,NAUSEA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,IRINOTECAN,IRINOTECAN,2011-09-08,2011-09-08,,,,,C,Y,284,mg,INTRAVENOUS,Q2S,METASTATIC PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,KETOPROFENE (KETOPROFEN),KETOPROFEN,2011-01-25,2011-01-25,,,,,C,Y,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FLUORO URACILE,FLUOROURACIL,2011-09-08,2011-09-08,,,,,C,Y,630,mg,INTRAVENOUS,Q2S,METASTATIC PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-11,2010-10-31,D,,,,C,Y,1,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,SPAGULAX,PLANTAGO OVATA,2011-01-17,2011-01-17,,,,,C,Y,1,IU,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2010-12-30,2010-12-30,,2011-01-22,2011-01-22,,P,,100,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSTRON,ONDANSETRON,2011-01-24,2011-01-24,,2011-08-22,2011-08-22,,C,,8,mg,INTRAVENOUS,every perfusion day,INFUSION PREMEDICATION
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-01-24,2011-01-24,,,,,C,Y,10,mg,ORAL,one the day of perfusion and an other the next day,NAUSEA
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-02-08,2011-02-08,,2011-08-24,2011-08-24,,C,,20,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FU CISPLATINE,,2012-03-06,2012-03-06,,2012-03-19,2012-03-19,,,,,,,,
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROX,LEVOTHYROXINE SODIUM,2011-10-01,2011-10-01,,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROIDIA
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-03,2012-01-03,,,,,C,Y,8,mg,INTRAVENOUS,before each protocol perfusion,PRE-INFUSION MEDICATION
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,METHYLPREDNISOLONE,METHYLPREDNISOLONE,2012-01-03,2012-01-03,,,,,C,Y,20,mg,ORAL,"40 mg per day , during three days after perfusion",NAUSEA
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,NORMACOL-DIHYDROGNOPHOSPHATE ET HYDROGNOPHOSPHATE DE SODIUM,FLEET                              /01605601/,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,1,IU,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2012-01-05,2012-01-05,,2012-02-07,2012-02-07,,C,,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,TOPALGIC LP,TRAMADOL HYDROCHLORIDE,2011-12-22,2011-12-22,,2012-01-01,2012-01-01,,P,,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2012-02-08,2012-02-08,,2012-02-28,2012-02-28,,C,,30,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-02-08,2012-02-08,,2012-02-28,2012-02-28,,C,,10,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ARTISIAL,ARTISIAL,2012-03-03,2012-03-03,,2012-04-02,2012-04-02,,C,,1,PUFF,ORAL,6 TIMES PER DAY,MOUTH XEROSIS
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-03-03,2012-03-03,,,,,C,Y,40,mg,ORAL,QD,EDEMA OF LOWER LIMBS
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,FENTANYL CITRATE,FENTANYL CITRATE,2012-02-28,2012-02-28,,2012-03-03,2012-03-03,,C,,100,ug,TRANSDERMAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,TIMABAK,TIMOLOL MALEATE,2005,2005-12-31,M,,,,C,Y,0.25,%,OPHTHALMIC,QD,GLAUCOMIA
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-03-03,2012-03-03,,2012-03-10,2012-03-10,,C,,25,ug,TRANSDERMAL,every 72h,WORSENING OF ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-03-03,2012-03-03,,2012-03-07,2012-03-07,,C,,50,mg,INTRAVENOUS,PRN,WORSENING OF ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-03-11,2012-03-11,,,,,C,Y,75,ug,TRANSDERMAL,every 72h,WORSENING OF ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,BIPROFENID,KETOPROFEN,2012-01-31,2012-01-31,,2012-02-06,2012-02-06,,C,,100,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MOTILYO,DOMPERIDONE,2012-01-03,2012-01-03,,,,,C,Y,10,mg,ORAL,QD,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2012-01-31,2012-01-31,,,,,C,Y,20,mg,ORAL,PRN,GASTROESOPHAGEAL REFLUX DISEASE
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2012-01-02,2012-01-02,,2012-01-04,2012-01-04,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-01-02,2012-01-02,,2012-02-07,2012-02-07,,C,,5,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,FORLAX,MACROGOL 4000,2012-01-03,2012-01-03,,,,,C,Y,10,g,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,BROMAZEPAM,BROMAZEPAM,2012-01-02,2012-01-02,,,,,C,Y,6,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,MICROLAX-SODIUM LAURYL SULFOACETATE/ SODIUM CITRATE/ SORBITOL,MICROKLIST,2012-01-02,2012-01-02,,2012-01-02,2012-01-02,,P,,1,IU,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,COLOPEG - MACROGOL 3350/ SODIUM SULFATE/ SODIUM CHLORIDE/ POTASSIUM CHLORIDE/ SODIUM BICARBONATE,COLOPEG                            /06341701/,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,1,IU,ORAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-15,2011-10-15,,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,500,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NEORECORMON,EPOETIN BETA,2011-10-20,2011-10-20,,,,,C,Y,30000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ALTEIS,OLMESARTAN MEDOXOMIL,2011-11-15,2011-11-15,,,,,C,Y,20,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-11-15,2011-11-15,,,,,C,Y,0.6,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLISM
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LOXEN,NICARDIPINE HYDROCHLORIDE,2012-04-10,2012-04-10,,,,,,Y,10,mg,INTRAVENOUS,PRN,SUBDURAL HEMATOMA
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FRAXODIL,NADROPARIN CALCIUM,2012-04-10,2012-04-10,,,,,,Y,1,IU,INTRAVENOUS,QD,SUBDURAL HEMATOMA
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2012-04-10,2012-04-10,,,,,,Y,20,mg,INTRAVENOUS,PRN,SUBDURAL HEMATOMA
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-03-03,2011-03-03,,2011-03-07,2011-03-07,,C,,1000,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-03-03,2011-03-03,,,,,C,Y,8,mg,INTRAVENOUS,QS,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011-03-03,2011-03-03,,,,,C,Y,10,mg,ORAL,PRN,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ARANESP,DARBEPOETIN ALFA,2011-04-11,2011-04-11,,2011-04-11,2011-04-11,,C,,300,IU,SUBCUTANEOUS,ONCE,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,AMOXICILLINE,AMOXICILLIN,2011-04-13,2011-04-13,,2011-04-18,2011-04-18,,C,,1000,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-04-15,2011-04-15,,,,,C,Y,40,mg,ORAL,QD,GASTRO OESOPHAGIAL REFLUX
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04-29,2011-04-29,,,,,C,Y,1000,mg,ORAL,PRN,FEVER PROPHYLAXIS
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TARDYFERON,FERROUS SULFATE,2011-10-20,2011-10-20,,,,,C,Y,1,TABLET,ORAL,QD,ANEMIA
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,MOTILIUM,DOMPERIDONE,2011-04-20,2011-04-20,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-04-20,2011-04-20,,2011-06-08,2011-06-08,,C,,8,mg,INTRAVENOUS,QS,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-05-04,2011-05-04,,2011-06-08,2011-06-08,,C,,40,mg,ORAL,QD,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,APREPITANT,APREPITANT,2011-05-04,2011-05-04,,2011-06-08,2011-06-08,,C,,80,mg,ORAL,QD,CHEMOTHERAPY PROPHYLAXIS
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DALTPARINE SODIQUE,DALTEPARIN SODIUM,2011-03-22,2011-03-22,,,,,C,Y,12500,IU,SUBCUTANEOUS,QD,ASYMPTOMATIC PULMONARY EMBOLISM
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ALIZAPRIDE,ALIZAPRIDE,2011-05-10,2011-05-10,,2011-05-20,2011-05-20,,C,,3,AMPULE,INTRAMUSCULAR,BID,NAUSEA
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,BUDENOSIDE,BUDESONIDE,2011-06-06,2011-06-06,,,,,C,Y,1,PUFF,RESPIRATORY (INHALATION),BID,COUGH
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DIOVAN,VALSARTAN,2000,2000-12-31,M,,,,C,Y,160,mg,ORAL,QD,HYPERTONIA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-03-25,2011-03-25,,2011-04-02,2011-04-02,,C,,40,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-03,2011-02-28,D,,,,C,Y,25000,IU,ORAL,PRN,PANCREATIC CANCER
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-03-22,2011-03-22,,,,,C,Y,50,ug/h,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-03-30,2011-03-30,,2011-04-02,2011-04-02,,C,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-04-07,2011-04-07,,2011-04-09,2011-04-09,,C,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-04-08,2011-04-08,,2011-04-08,2011-04-08,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-04-07,2011-04-07,,2011-04-07,2011-04-07,,C,,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-04-21,2011-04-21,,2011-04-21,2011-04-21,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-04-29,2011-04-29,,2011-04-29,2011-04-29,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,VERAPAMIL,VERAPAMIL,2000,2000-12-31,M,,,,C,Y,120,mg,ORAL,QD,HYPERTONIA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-07,2011-05-07,,2011-05-08,2011-05-08,,C,,2,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-13,2011-05-13,,2011-05-13,2011-05-13,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-13,2011-05-13,,2011-05-13,2011-05-13,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-20,2011-05-20,,2011-05-20,2011-05-20,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-20,2011-05-20,,2011-05-20,2011-05-20,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-27,2011-05-27,,2011-05-27,2011-05-27,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-27,2011-05-27,,2011-05-27,2011-05-27,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-03,2011-06-03,,2011-06-03,2011-06-03,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-10,2011-06-10,,2011-06-10,2011-06-10,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-24,2011-06-24,,2011-06-24,2011-06-24,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,BUNAZOSIN HYDROCHORIDE,BUNAZOSIN HYDROCHLORIDE,2000,2000-12-31,M,,,,C,Y,6,mg,ORAL,QD,HYPERTONIA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-08,2011-07-08,,2011-07-08,2011-07-08,,C,,3,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-08-05,2011-08-05,,2011-08-05,2011-08-05,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-05,2011-08-05,,2011-08-05,2011-08-05,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-19,2011-08-19,,2011-08-19,2011-08-19,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-08-19,2011-08-19,,2011-08-19,2011-08-19,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2000,2000-12-31,M,,,,C,Y,0.4,mg,ORAL,QD,PROSTATAHYPERPLASIA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-26,2011-08-26,,2011-08-26,2011-08-26,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-08-26,2011-08-26,,2011-08-26,2011-08-26,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,FINASTERID,FINASTERIDE,2000,2000-12-31,M,,,,C,Y,5,mg,ORAL,QD,PROSTATAHYPERPLASIA
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,NOVALGIN - METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-03,2011-02-28,D,,,,C,Y,1,g,ORAL,QID,PAIN
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-03,2011-02-28,D,,,,C,Y,1,BAG,ORAL,QD,OBSTIPATION
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,SALVYSAT,SALVIA OFFICINALIS LEAF,2011-03,2011-02-28,D,,,,C,Y,20,gtt,ORAL,BID,NIGHT SWEATS
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ASS,ACETYLSALICYLIC ACID,2000,2000-12-31,M,2011-04-02,2011-04-02,,C,,100,mg,ORAL,QD,HYPERTONIA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-04,2011-03-31,D,,,,C,Y,40,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-06-01,2011-06-01,,2011-06-02,2011-06-02,,C,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-06-07,2011-06-07,,2011-06-09,2011-06-09,,C,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-04,2011-03-31,D,,,,C,Y,30,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-05-30,2011-05-30,,2011-05-31,2011-05-31,,P,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-06-01,2011-06-01,,2011-07-13,2011-07-13,,C,,1,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-07-27,2011-07-27,,2011-08-10,2011-08-10,,C,,1,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-07-27,2011-07-27,,2011-08-10,2011-08-10,,C,,4,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-15,2011-06-15,,2011-06-16,2011-06-16,,C,,2,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,1,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,KREVATIL,GRANISETRON HYDROCHLORIDE,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,1,mg,INTRAVENOUS,QD,NAUSE
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-06,2011-05-31,D,,,,C,Y,40,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2011-07-20,2011-07-20,,2011-07-28,2011-07-28,,P,,1,TABLET,ORAL,BID,HYPOKALEMIA
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,P,,2,TABLET,ORAL,BID,HYPOKALEMIA
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,IRENAT,SODIUM PERCHLORATE,2011-07-21,2011-07-21,,2011-07-29,2011-07-29,,P,,20,gtt,ORAL,TID,THYROID TREATMENT
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-07-23,2011-07-23,,2011-07-27,2011-07-27,,P,,250,mg,ORAL,BID,CHOLANGITIS
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PERITRAST,LYSINE AMIDOTRIZOATE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,P,,30,mL,ORAL,QD,CONTRAST DYE
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-07-13,2011-07-13,,2011-07-23,2011-07-23,,P,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TILIDIN,VALORON N                          /00628301/,2011-07-28,2011-07-28,,2011-07-29,2011-07-29,,P,,50,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2011-07-28,2011-07-28,,2011-07-29,2011-07-29,,P,,4,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-07-18,2011-07-18,,2011-07-22,2011-07-22,,P,,2000,mg,INTRAVENOUS,QD,CHOLANGITIS
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2011-07-29,2011-07-29,,2011-08-01,2011-08-01,,P,,20,gtt,ORAL,QD,OBSTIPATION
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-06,2011-05-31,D,,,,C,Y,75,mg,ORAL,QD,PAIN THERAPY
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OXICODON,OXYCODONE HYDROCHLORIDE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,P,,10,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,OXICODON,OXYCODONE HYDROCHLORIDE,2011-07-30,2011-07-30,,,,,C,Y,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,P,,5,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2011-07-30,2011-07-30,,,,,C,Y,5,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,MONOEMBOLEX,CERTOPARIN SODIUM,2011-07-28,2011-07-28,,2011-08-05,2011-08-05,,C,,3000,IU,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2011-06,2011-05-31,D,,,,C,Y,20,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,BLOPRESS,CANDESARTAN CILEXETIL,2011-06,2011-05-31,D,,,,C,Y,32,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,OBSIDAN  PROPANOLOL HYDROCHLORIDE,PROPRANOLOL HYDROCHLORIDE,2011-06,2011-05-31,D,,,,C,Y,25,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,1981,1981-12-31,M,,,,C,Y,500,mg,ORAL,BID,DIABETES MELLITUS TYPE 2
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ALENDRONSURE,ALENDRONATE SODIUM,2011-06,2011-05-31,D,,,,C,Y,70,mg,ORAL,QS,OSTEOPOROSE
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,CLONT,METRONIDAZOLE,2011-07-18,2011-07-18,,2011-07-27,2011-07-27,,P,,500,mg,ORAL,TID,CHOLANGITIS
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,NOVALGIN - METAMIZOL SODIUM,METAMIZOLE SODIUM,2011,2011-08-04,M,,,,C,Y,4 mal 40,gtt,ORAL,QID,PAIN THERAPY
CO-101-001,CO-101-001-052-007,01052007,052,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ATOSIL,PROMETHAZINE,2012-03-12,2012-03-12,,,,,C,Y,25,mg,ORAL,PRN,HICCUP
CO-101-001,CO-101-001-052-007,01052007,052,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-04-18,2012-04-18,,2012-04-30,2012-04-30,,C,,500,mg,ORAL,BID,INFECT
CO-101-001,CO-101-001-052-007,01052007,052,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,AUGMENTAN- AMOXICILLIN TRIHYDRATE/CLAVULANATE POTASSIUM,SPEKTRAMOX,2012-04-30,2012-04-30,,2012-05,2012-05-31,D,C,,875/125,mg,ORAL,BID,INFECT
CO-101-001,CO-101-001-052-007,01052007,052,56.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CLONT,METRONIDAZOLE,2012-04-30,2012-04-30,,2012-05,2012-05-31,D,C,,500,mg,ORAL,TID,INFECT
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PROGRAF,TACROLIMUS,2002,2002-12-31,M,,,,C,Y,"2,5",mg,ORAL,BID,IMMUNOSUPPRESSION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CEFUROXIN,CEFUROXIME SODIUM,2011-05-19,2011-05-19,,2011-05-30,2011-05-30,,C,,250,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,AUGMENTAN-CLAVULANATE POTASSIUM/ AMOXICILLIN TRIHYDRATE,SPEKTRAMOX,2011-06-06,2011-06-06,,2011-06-08,2011-06-08,,C,,875/125,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-05-17,2011-05-17,,2011-05-19,2011-05-19,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-05-03,2011-05-03,,2011-07-01,2011-07-01,,C,,20,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ACETYLCYSTEIN,ACETYLCYSTEINE,2011-05-03,2011-05-03,,2011-05-13,2011-05-13,,C,,1,VIAL,INTRAVENOUS,0n 3/ 12/13 may,EXPECTORANT
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,460,mg,INTRAVENOUS,ONCE,ANESTHESIA
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,BUSCOPAN,HYOSCINE BUTYLBROMIDE,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,40,mg,INTRAVENOUS,ONCE,ANTICONVULSANT
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DOLANTIN,PETHIDINE HYDROCHLORIDE,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,50,mg,INTRAVENOUS,ONCE,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-07-01,2011-07-01,,2011-07-18,2011-07-18,,C,,40,gtt,ORAL,QID,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,VALORON,TILIDINE HYDROCHLORIDE,2011-07-18,2011-07-18,,2011-08,2011-08-31,D,C,,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,URSODEOXYCHOLACID,URSODEOXYCHOLIC ACID,2002,2002-12-31,M,,,,C,Y,500,mg,ORAL,BID,IMMUNOSUPPRESSION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2011-07-20,2011-07-20,,2011-07-28,2011-07-28,,C,,40,mmol,ORAL,QD,HYPOCALMIA
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ERYTHROZYTHENCONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2011-08-04,2011-08-04,,2011-08-04,2011-08-04,,C,,500,mL,INTRAVENOUS,BID,ANMIA
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-04-30,2011-04-30,,2011-05-06,2011-05-06,,P,,1,mL,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-07-18,2011-07-18,,,,,C,Y,40,mg,ORAL,QD,ULCUS PROPHYLAXIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-08,2011-08-01,D,,,,C,Y,40,gtt,ORAL,QID,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2011-07-18,2011-07-18,,,,,C,Y,20,gtt,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2011-08,2011-08-01,D,,,,C,Y,20,mg,ORAL,QD,ANTI-INFLAMMATORY
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-08,2011-08-01,D,,,,C,Y,40,mg,ORAL,QD,DRAINING
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,40.000,IU,ORAL,TID,DISORDER OF PANCREATIC FUNCTION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TILIDIN COMP (TILIDIN+NALOXON),VALORON N                          /00628301/,2011-08-04,2011-08-04,,,,,C,Y,25,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,JONOSTERIL,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-08-01,2011-08-01,,2011-08-02,2011-08-02,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATIONPROPHYLACIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,IMIPENEM/CILASTATIN,CILASTATIN W/IMIPENEM,2011-08,2011-08-01,D,2011-08,2011-08-31,D,C,,not documented,mg,INTRAVENOUS,not documented,ANTIBIOSIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-06-30,2011-06-30,,2011-07-30,2011-07-30,,C,,1,g,INTRAVENOUS,QD,ANTI-INFLAMMATORY
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL,METRONIDAZOLE,2011-06-08,2011-06-08,,2011-06-17,2011-06-17,,C,,400,mg,ORAL,TID,ENTERITIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2011-06-16,2011-06-16,,2011-06-17,2011-06-17,,C,,500,mg,ORAL,BID,ENTERITIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,JONOSTERIL E1/1- SEE ADDITIONAL NOTES,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-06-08,2011-06-08,,2011-06-15,2011-06-15,,C,,2000,mL,INTRAVENOUS,not documented,DEHYDRATIONSPROPHYLAXIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,"MARCUMAR-PHENPROCOUMON,",PHENPROCOUMON,2011-05-02,2011-05-02,,,,,C,Y,1/2,TABLET,ORAL,PRN,ANTICOAGULATION
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-12,2011-05-12,,2011-07-28,2011-07-28,,C,,3,mg,INTRAVENOUS,once before every chemotherapydose,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2011-04-30,2011-04-30,,2011-07-18,2011-07-18,,C,,300,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-04-30,2011-04-30,,2011-07-18,2011-07-18,,C,,40,mg,ORAL,BID,ULCUS PROPHYLAXIS
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-04-30,2011-04-30,,2011-07-01,2011-07-01,,C,,400,mg,ORAL,BID,PAIN PROPHYLAXIS
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX4 (6),,2012-02-14,2012-02-14,,2012-09-03,2012-09-03,,,,,,,,
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2012-09-19,2012-09-19,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN COMP 875/125,SPEKTRAMOX,2012-02-02,2012-02-02,,2012-02-09,2012-02-09,,C,,875/125,mg,ORAL,BID,UNCLEAR INFECT
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PRAVASTATIN,PRAVASTATIN,,2011-12-01,Y,,,,C,Y,30,mg,ORAL,QD,HYPERLIPIDEMIE
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,COSOPT AT,COSOPT,,2011-12-01,Y,,,,C,Y,unknown,gtt,OPHTHALMIC,BID,GLAUCOM BDS.
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,,2011-12-01,Y,,,,C,Y,40,mg,ORAL,QD,REFLUX- OESOPHAGITIS
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,,2011-12-01,Y,,,,C,Y,20,mg,ORAL,QD,HYPERTONIE
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-12-01,2011-12-01,,2012-01-26,2012-01-26,,C,,3,mg,INTRAVENOUS,once before every chemotherapy,PROPHYLAXE VOR CHEMOTHERAPIE
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-12-29,2011-12-29,,2012-01-05,2012-01-05,,C,,250,mg,ORAL,BID,NEUTROPENIE
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2012-01-26,2012-01-26,,2012-02-01,2012-02-01,,C,,1,TABLET,ORAL,QD,HYPOKALMIA
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2010-12-15,2010-12-15,,,,,C,Y,8,mg,ORAL,PRN,ANTIEMESE
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2011-02-10,2011-02-10,,2011-02-10,2011-02-10,,C,,100,mg,INTRAVENOUS,QD,DYSPNEA
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,THEOPHYLLIN,THEOPHYLLINE,2011-02-10,2011-02-10,,2011-02-10,2011-02-10,,C,,240,mg,INTRAVENOUS,QD,DYSPNEA
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2010-11-30,2010-11-30,,2011-02-07,2011-02-07,,C,,1,mL/kg,INTRAVENOUS,PRN,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2010-11-30,2010-11-30,,2011-02-07,2011-02-07,,C,,10,g,ORAL,PRN,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2010-11,2010-10-31,D,,,,C,Y,40,mg,ORAL,QD,PYROSIS
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2010-11,2010-10-31,D,,,,C,Y,25000,IU,ORAL,TID,PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SPIRIVA,TIOTROPIUM BROMIDE,1993,1993-12-31,M,,,,C,Y,18,ug,RESPIRATORY (INHALATION),PRN,COPD
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOTAHEXAL,SOTALOL HYDROCHLORIDE,2005,2005-12-31,M,,,,C,Y,160,mg,ORAL,BID,CARDIAC DYSRHYTHMIA
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SYMBICORT,BUDESONIDE W/FORMOTEROL FUMARATE,1993,1993-12-31,M,,,,C,Y,320,ug,RESPIRATORY (INHALATION),PRN,COPD
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2010-12-15,2010-12-15,,,,,C,Y,5,mg,ORAL,QD,SLEEP DISORDER
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NEORECORMON,EPOETIN BETA,2011-01-26,2011-01-26,,2011-01-26,2011-01-26,,C,,30000,IU,SUBCUTANEOUS,QD,ANEMIA
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NEORECORMON,EPOETIN BETA,2011-02-02,2011-02-02,,2011-02-02,2011-02-02,,C,,30000,IU,SUBCUTANEOUS,QD,ANEMEA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FU,,2011-03-16,2011-03-16,,2011-11-22,2011-11-22,,,,,,,,
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-03-16,2011-03-16,,2011-11-08,2011-11-08,,,,,,,,
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLINIC ACID,,2011-03-16,2011-03-16,,2011-11-22,2011-11-22,,,,,,,,
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN,,2011-03-16,2011-03-16,,2011-11-22,2011-11-22,,,,,,,,
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,RAMILICH,RAMIPRIL,2010-11,2010-10-31,D,2011-02-16,2011-02-16,,C,,"2,5",mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,APIDRA,INSULIN GLULISINE,2010-11-19,2010-11-19,,,,,C,Y,1,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2010-11,2010-10-31,D,,,,C,Y,1,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LOPERAMID,LOPERAMIDE HYDROCHLORIDE,2011-01-05,2011-01-05,,,,,C,Y,2,mg,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PREPACOL,FLEET                              /01721201/,2011-02-16,2011-02-16,,2011-02-16,2011-02-16,,C,,1,IU,RECTAL,QD,GASTRIC STENOSIS
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MONO EMBOLEX,CERTOPARIN SODIUM,2011-02-16,2011-02-16,,2011-02-23,2011-02-23,,C,,0.9,mL,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-02-18,2011-02-18,,2011-02-23,2011-02-23,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-02-16,2011-02-16,,2011-02-16,2011-02-16,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-02-18,2011-02-18,,2011-02-23,2011-02-23,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,40,mg,ORAL,QD,ULCER
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2010-11,2010-10-31,D,2011-02-16,2011-02-16,,C,,40,mg,ORAL,BID,ULCER
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-18,2011-02-18,,,,,C,Y,40,mg,ORAL,BID,ULCER
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,RAMILICH,RAMIPRIL,2011-02-18,2011-02-18,,,,,C,Y,2.5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-02-17,2011-02-17,,2011-02-19,2011-02-19,,C,,1000,mg,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SUFENTA MITE,SUFENTANIL CITRATE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,50,ug,INTRAVENOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,5,mg,INTRAVENOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,15,mg,SUBCUTANEOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,COMPACTAM,SULBACTAM SODIUM,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,1000,mg,INTRAVENOUS,QD,ANTIBIOSIS
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,BAYPEN,MEZLOCILLIN SODIUM,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,4000,mg,INTRAVENOUS,QD,ANTIBIOSIS
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,SUCCINYLCHOLIN,SUXAMETHONIUM CHLORIDE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,106,mg,INTRAVENOUS,QD,MUSCLE RELAXANT
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2010-12,2010-12-15,D,2011-02-16,2011-02-16,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,200,mg,INTRAVENOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ETOMIDATE LIPURO,ETOMIDATE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,20,mg,INTRAVENOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEHYDROBENZPERIDOL,DROPERIDOL,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,1.25,mg,INTRAVENOUS,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,FORTE CORTIN,DEXAMETHASONE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,8,mg,INTRAVENOUS,QD,ANTIINFLAMMATION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE SOLUTION,ELECTROLYTE SOLUTIONS,2011-02-17,2011-02-17,,2011-02-19,2011-02-19,,C,,2,L,INTRAVENOUS,QD,ANTIECXSICOSIS
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAMMALEAT,MIDAZOLAM MALEATE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,7.5,mg,ORAL,QD,ANESTHESIA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,IMERON,IOMEPROL,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,1,mL/kg,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,10,g,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,ZOPICLON,ZOPICLONE,2011-02-18,2011-02-18,,,,,C,Y,7.5,mg,ORAL,QD,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,MORPHIN,MORPHINE,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,10,mg,SUBCUTANEOUS,QD,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ZOPICLON,ZOPICLONE,2010-12,2010-12-15,D,2011-02-16,2011-02-16,,C,,"7,5",mg,ORAL,QD,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE SOLUTION,ELECTROLYTE SOLUTIONS,2011-02-17,2011-02-17,,2011-02-19,2011-02-19,,C,,500,mL,INTRAVENOUS,PRN,FLUID SUBSTITUTION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2010-11,2010-10-31,D,,,,C,Y,20,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,MIRTAZAPIN,MIRTAZAPINE,2010-11,2010-10-31,D,,,,C,Y,15,mg,ORAL,QD,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2010-11,2010-10-31,D,,,,C,Y,20,gtt,ORAL,QD,OBSTIPATION
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2010-11,2010-10-31,D,,,,C,Y,20,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2010-12-15,2010-12-15,,,,,C,Y,8,mg,ORAL,PRN,ANTIEMESIS
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2011-04-19,2011-04-19,,2011-11-07,2011-11-07,,,,,,,,
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2011-12-12,2011-12-12,,2012-09-10,2012-09-10,,,,,,,,
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR+XELODA,,2012-09-26,2012-09-26,,,2012-09-26,Y,,,,,,,
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,BERLTHYROX,LEVOTHYROXINE SODIUM,1996,1996-12-31,M,,,,C,Y,100,mg,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-02-24,2011-02-24,,,,,C,Y,8,mg,ORAL,PRN,ANTIEMESE
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,1,mL/kg,INTRAVENOUS,PRN,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,10,g,ORAL,PRN,PROPHYLAXIS FOR CT
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,TAGAMED,CIMETIDINE,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,unknown,mg,unknown,ONCE,ANTIALLERGIC PROPHYLAXIS FOR CT
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,FENISTIL,DIMETINDENE MALEATE,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,unknown,mg,unknown,ONCE,ANTIALLERGIC PROPHYLAXIS FOR CT
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,SOLUDECORTIN,PREDNISOLONE SODIUM SUCCINATE,2011-04-15,2011-04-15,,2011-04-15,2011-04-15,,C,,unknown,mg,unknown,ONCE,ANTIALLERGIC PROPHYLAXIS CT
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-05-03,2011-05-03,,2011-05-03,2011-05-03,,C,,1,IU,INTRAVENOUS,QD,ANTIEMESES
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ATROPIN,ATROPINE,2011-04-19,2011-04-19,,,,,C,Y,1,VIAL,INTRAVENOUS,PRN,PREMEDICATION NEW CHEMOTHERAPY FOFIRINOX
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2011-04-19,2011-04-19,,,,,C,Y,1,mg,INTRAVENOUS,PRN,COMEDICATION FOR NEW CHEMOTHERAPY FOLFIRINOX
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-04-19,2011-04-19,,,,,C,Y,1,mg,INTRAVENOUS,PRN,COMEDICATION NEW CHEMOTHERAPY FOLFIRINOX
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CAPTOBETA (ACTIVE INGREDIENT CAPTOPRIL),CAPTOPRIL,2010-12,2010-11-30,D,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-05-03,2011-05-03,,2011-05-03,2011-05-03,,C,,1,TABLET,ORAL,QD,COMEDICATION NEW CHEMOTHERAPY FOLFIRINOX
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ASS 100,ACETYLSALICYLIC ACID,2011-01,2010-12-31,D,,,,C,Y,100,mg,ORAL,QD,PLATELET COUNT INCREASED
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-01,2010-12-31,D,,,,C,Y,unknown,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,TRANSTEC,BUPRENORPHINE,2011-02-15,2011-02-15,,,,,C,Y,35,ug,TRANSDERMAL,every 3.5 days,PAIN
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-02-15,2011-02-15,,,,,C,Y,7.5,mL,ORAL,PRN,OBSTIPATION
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,APREPITANT,APREPITANT,2011-03-10,2011-03-10,,2011-03-23,2011-03-23,,C,,125,mg,ORAL,PRN,ANTIEMESIS
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-03-10,2011-03-10,,2011-03-10,2011-03-10,,C,,1,mg,INTRAVENOUS,ONCE,ANTIEMESE
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,APREPITANT,APREPITANT,2011-03-24,2011-03-24,,2011-04-19,2011-04-19,,C,,1,VIAL,INTRAVENOUS,PRN,ANTIEMESE
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-08-23,2011-08-23,,2011-09-13,2011-09-13,,,,,,,,
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,TARCEVA,,2011-08-23,2011-08-23,,2011-09,2011-09-30,D,,,,,,,
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-02-08,2011-02-08,,2011-02-10,2011-02-10,,P,,40,gtt,ORAL,6 times daily,PAIN (BACK)
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2011-04-01,2011-04-01,,,,,C,Y,10,gtt,ORAL,PRN,OBSTIPATION
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DECORTIN,PREDNISONE,2011-05-23,2011-05-23,,2011-05-25,2011-05-25,,C,,50,mg,ORAL,QD,DECREASED PLATELET COUNT CLINICAL SIGNIFICANT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-06-04,2011-06-04,,2011-06-05,2011-06-05,,C,,200,mg,ORAL,PRN,FEVER AND CHILL
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,P,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-02-21,2011-02-21,,2011-06-15,2011-06-15,,C,,10,g,ORAL,PRN,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,FERRO SANOL,FERROUS GLYCINE SULFATE,2011-06-14,2011-06-14,,,,,C,Y,40,mg,ORAL,TID,HYPOFERREMIA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ASS,ACETYLSALICYLIC ACID,2011-06-15,2011-06-15,,,,,C,Y,100,mg,ORAL,PRN,HEADACHE
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07-05,2011-07-05,,,,,C,Y,500,mg,ORAL,PRN,HEADACHE
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,RIOPAN,MAGALDRATE,2012-07-25,2012-07-25,,,,,,Y,10,mL,ORAL,PRN,REFLUX
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-03-07,2011-03-07,,,,,C,Y,8,mg,ORAL,PRN,EMESIS AND NAUSEA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PRIMOVIST,GADOXETATE DISODIUM,2011-07-07,2011-07-07,,2011-07-07,2011-07-07,,C,,8,mL,INTRAVENOUS,QD,CONTRAST MEDIUM MRI
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-02-08,2011-02-08,,2011-02-14,2011-02-14,,P,,40,mg,SUBCUTANEOUS,QD,ANTIKOAGULATION
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-02-11,2011-02-11,,2011-02-11,2011-02-11,,P,,8,mg,ORAL,QD,NAUSEA AND VOMITING
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-04-13,2011-04-13,,2011-04-13,2011-04-13,,C,,10,mg,INTRAVENOUS,QD,ANAESTHETICUM FOR STENT REMOVAL
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2011-04-13,2011-04-13,,2011-04-13,2011-04-13,,C,,15,mg,INTRAVENOUS,QD,ANAESTHETICUM FOR STENT REMOVAL
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-02-11,2011-02-11,,2011-02-11,2011-02-11,,P,,1,g,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2011-02-08,2011-02-08,,2011-02-15,2011-02-15,,P,,unknown,g,ORAL,BID,HYPOKALCEMIA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,AUGMENTAN (AMOXICILLIN + CLAVULANATE),AUGMENTIN                          /00756801/,2011-02-28,2011-02-28,,2011-03-04,2011-03-04,,P,,1,g,ORAL,BID,COMMON COLD
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-02-06,2011-02-06,,2011-02-13,2011-02-13,,P,,20,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-02-14,2011-02-14,,2011-02-15,2011-02-15,,P,,20,gtt,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-06,2011-02-06,,2011-02-15,2011-02-15,,P,,40,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DOXICYCLIN,DOXYCYCLINE HYDROCHLORIDE,2011-09,2011-09-01,D,,,,C,Y,200,mg,ORAL,QD,RASH ACNEIFORM
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-06,2011-06-01,D,,,,C,Y,unknown,mg,ORAL,PRN,GASTRIC PROTECTION
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-02,2011-01-31,D,2011-02-28,2011-02-28,,P,,20,gtt,ORAL,PRN,PAIN BACK
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-08,2011-08-01,D,,,,C,Y,20,gtt,ORAL,PRN,PAIN THORACIC SPINE
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,CLONT (METRONIDAZOLE),METRONIDAZOLE,2011-02-28,2011-02-28,,2011-03-04,2011-03-04,,P,,400,mg,ORAL,BID,COMMON COLD
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-02-28,2011-02-28,,,,,C,Y,200,mg,ORAL,PRN,PAIN (BACK)
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DECORTIN,PREDNISONE,2011-03-23,2011-03-23,,2011-03-25,2011-03-25,,C,,50,mg,ORAL,QD,PLATELET COUNT DECREASED CLINICAL SIGNIFICANT
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02-28,2011-02-28,,2011-03-01,2011-03-01,,P,,40,mg,ORAL,BID,GASTRIC PROTECTION
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,NEULASTA,PEGFILGRASTIM,2011-03-14,2011-03-14,,2011-03-14,2011-03-14,,C,,6,mg,SUBCUTANEOUS,ONCE,NEUTROPENIA AND LEUCOPENIA
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-03-18,2011-03-18,,,,,C,Y,20,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,RADIOTHERAPY,BRACHYTHERAPIE,,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,,,,,,,
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2008-08-21,2008-08-21,,2009-01-21,2009-01-21,,,,,,,,
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-11-18,2011-11-18,,2012-01-27,2012-01-27,,,,,,,,
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE / TARCEVA,,2012-03-30,2012-03-30,,2012-05-11,2012-05-11,,,,,,,,
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,P,,90,mL,INTRAVENOUS,QD,CT SCAN MEDICATION
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,BRONCHIKUM CODEIN,BRONCHICUM CODEIN,2011-08-26,2011-08-26,,,,,C,Y,20,gtt,ORAL,QHS,DRY COUGH
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-09-23,2011-09-23,,2011-09-23,2011-09-23,,C,,1,VIAL,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,"0,5",mg,ORAL,ONCE,PREVENTION OF VOMITTING
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-08-04,2011-08-04,,2011-08-04,2011-08-04,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-08-04,2011-08-04,,2011-08-04,2011-08-04,,C,,10,g,ORAL,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,10,g,ORAL,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,90,mL,INTRAVENOUS,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,10,g,ORAL,QD,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,P,,10,g,ORAL,QD,CT SCAN MEDICATION
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2011-10-31,2011-10-31,,2011-11-02,2011-11-02,,C,,5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,BIFITERAL,LACTULOSE,2011-11-02,2011-11-02,,2011-11-03,2011-11-03,,C,,unknown,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,8,mg,INTRAVENOUS,QD,BRACHYTHERAPY
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,8,mg,INTRAVENOUS,QD,BRACHYTHERAPY
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,KEVATRIL,GRANISETRON HYDROCHLORIDE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,1,VIAL,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,RULID,ROXITHROMYCIN,2011-09,2011-09-01,D,2011-09,2011-09-30,D,C,,1,mg,ORAL,PRN,DRY COUGH
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-06-17,2011-06-17,,,,,C,Y,8,mg,ORAL,PRN,ANTIEMESE
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-06-24,2011-06-24,,2011-07-08,2011-07-08,,C,,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,FENISTIL,DIMETINDENE MALEATE,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,1,VIAL,INTRAVENOUS,QD,ERYTHEMA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,FENISTIL,DIMETINDENE MALEATE,2011-07-01,2011-07-01,,2011-07,2011-07-31,D,C,,8,mg,ORAL,PRN,ERYTHEMA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-07-29,2011-07-29,,,,,C,Y,30,gtt,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,FERROSANOL,FERROUS GLYCINE SULFATE,2011-08-18,2011-08-18,,2011-09,2011-09-30,D,C,,1,TABLET,ORAL,TID,HYPOFEREMIA
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR MONO,,2012-02-06,2012-02-06,,2012-02-13,2012-02-13,,,,,,,,
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-10-01,2011-10-01,,,,,C,Y,10,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,P,,90,mL,INTRAVENOUS,QD,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,P,,10,g,ORAL,QD,PREMDICATION FOR CONTRAST DYE CT
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-10-01,2011-10-01,,,,,C,Y,20,mg,ORAL,BID,PROPHYLAXIS GASTRIC
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-10-01,2011-10-01,,,,,C,Y,40,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-10-19,2011-10-19,,,,,C,Y,"0,5",mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2011-11-18,2011-11-18,,,,,C,Y,unknown,mg,ORAL,PRN,TUMOR PAIN
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,IVEMEND,FOSAPREPITANT MEGLUMINE,2011-12-01,2011-12-01,,2011-12-01,2011-12-01,,C,,150,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FENISTIL,DIMETINDENE MALEATE,2011-12-01,2011-12-01,,,,,C,Y,1,mg,ORAL,BID,EXANTHEMA THORAX
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-24,2011-11-24,,2011-12-01,2011-12-01,,C,,8,mg,ORAL,QS,ANTIEMESE
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-02,2011-12-02,,,,,C,Y,8,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-11-25,2011-11-25,,2011-12-15,2011-12-15,,C,,10,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PANTOZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-12-16,2011-12-16,,,,,C,Y,40,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-11-25,2011-11-25,,2011-12-27,2011-12-27,,C,,40,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REMERGIL,MIRTAZAPINE,2011-11-24,2011-11-24,,2011-12-16,2011-12-16,,C,,15,mg,ORAL,QHS,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REMERGIL,MIRTAZAPINE,2011-12-17,2011-12-17,,,,,C,Y,30,mg,ORAL,QHS,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2011-12-23,2011-12-23,,2012-01,2012-01-31,D,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CLONT,METRONIDAZOLE,2011-12-23,2011-12-23,,2011-12-27,2011-12-27,,C,,500,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MONO EMBOLEX,CERTOPARIN SODIUM,2011-12-28,2011-12-28,,2011-12-29,2011-12-29,,C,,"0,3",mg,SUBCUTANEOUS,QD,PROPHYLAXIS THROMBOSIS
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,HUMANALBUMIN,ALBUMIN HUMAN,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,20,g,INTRAVENOUS,ONCE,ASCITES
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,URSOFALK,URSODEOXYCHOLIC ACID,2011-12-29,2011-12-29,,2012-01,2012-01-31,D,C,,250,mg,ORAL,TID,CHOLESTASIS
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-11-26,2011-11-26,,,,,C,Y,1,g,ORAL,5 TIMES PER DAY,PAIN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CLONT,METRONIDAZOLE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,500,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL,METRONIDAZOLE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,400,mg,ORAL,QD,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL,METRONIDAZOLE,2011-12-29,2011-12-29,,2012-01,2012-01-31,D,C,,400,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,KONAKION,PHYTOMENADIONE,2011-12-19,2011-12-19,,2011-12-19,2011-12-19,,C,,10,mg,INTRAVENOUS,QD,COAGULATION TIME DECREASED
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,30,mg,INTRAVENOUS,QD,METEORISM
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,KALYMIN,PYRIDOSTIGMINE BROMIDE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,6,mg,INTRAVENOUS,QD,METEORISM
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,30,mg,ORAL,BID,INCREASE PAIN ABDOMEN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MST,MORPHINE SULFATE,2011-12-17,2011-12-17,,2012-01,2012-01-31,D,C,,30,mg,ORAL,TID,INCREASED PAIN ABDOMEN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,5,mg,INTRAVENOUS,QD,PREMEDICATION FOR UNSUCCESSFULL STENTING
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,15,mg,INTRAVENOUS,QD,PREMEDICATION FOR UNSUCCESSFULL STENTING
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-10-07,2011-10-07,,,,,C,Y,25000,IU,ORAL,TID,PANCREATIC INFLAMMATION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,BUSCOPAN,HYOSCINE BUTYLBROMIDE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,2,mL,INTRAVENOUS,QD,PREMEDICATION FOR UNSUCCESSFULL STENTING
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,P,,90,mL,INTRAVENOUS,QD,CONTRAST DYE FOR CT IMAGING
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,1,g,ORAL,QD,ABDOMINAL CRAMPS
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,SEVREDOL,MORPHINE SULFATE,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,10,mg,ORAL,QD,INCREASED PAIN ABDOMEN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,BIFITERAL,LACTULOSE,2011-12-19,2011-12-19,,2011-12-19,2011-12-19,,C,,unknown,mL,ORAL,PRN,LAXATION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2011-12-23,2011-12-23,,,,,C,Y,15,gtt,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,40,gtt,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,35,gtt,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2011-12-29,2011-12-29,,,,,C,Y,35,gtt,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,HUMANALBUMIN,ALBUMIN HUMAN,2012-01,2012-01-01,D,,,,C,Y,unknown,g,INTRAVENOUS,PRN,ASCITES
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-09,2011-12-09,,2011-12-09,2011-12-09,,C,,8,mg,ORAL,QD,ANTIEMESE
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,TEMGESIC TAPE,BUPRENORPHINE HYDROCHLORIDE,2012-01,2012-01-01,D,,,,C,Y,35,ug,TRANSDERMAL,PRN,INCREASED PAIN ABDOMEN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,2012-01,2012-01-01,D,,,,C,Y,unknown,g,ORAL,PRN,INCREASED PAIN ABDOMEN
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,UNACID,UNACID                             /00917901/,2012-01,2012-01-01,D,,,,C,Y,unknown,g,ORAL,PRN,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,P,,10,g,ORAL,QD,PREMEDICATION FOR CONTRAST DYE CT
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-12-09,2011-12-09,,2011-12,2011-12-31,D,C,,15,mL,ORAL,PRN,PROTECTION FOR OBSTIPATION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE SOLUTION E153,ELECTROLYTE SOLUTIONS,2011-12-16,2011-12-16,,2011-12-21,2011-12-21,,C,,1500,mL,INTRAVENOUS,TID,PROPHYLAXIS
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-12-16,2011-12-16,,2011-12-22,2011-12-22,,C,,2000,mg,INTRAVENOUS,QD,INFECTION
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,KONAKION,PHYTOMENADIONE,2011-12-20,2011-12-20,,2011-12-21,2011-12-21,,C,,10,mg,INTRAVENOUS,BID,COAGULATION TIME DECREASED
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,MONO EMBOLEX,CERTOPARIN SODIUM,2011-12-16,2011-12-16,,2011-12-21,2011-12-21,,C,,"0,3",mL,SUBCUTANEOUS,QD,THROMBOSIS PROPHYLAXIS
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2009-03-30,2009-03-30,,2009-09-23,2009-09-23,,,,,,,,
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR / TARCEVA,,2012-02-10,2012-02-10,,2012-05-11,2012-05-11,,,,,,,,
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX IV,,2012-06-20,2012-06-20,,2012-07-24,2012-07-24,,,,,,,,
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRINOX,,2012-08-07,2012-08-07,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2009-01,2008-12-31,D,,,,C,Y,25000,IU,ORAL,TID,PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2012-02-03,2012-02-03,,2012-02-03,2012-02-03,,C,,90,mL,INTRAVENOUS,ONCE,CONTRAST MEDIUM CT
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2012-02-03,2012-02-03,,2012-02-03,2012-02-03,,C,,10,g,ORAL,ONCE,PROPHYLAXIS FOR CT CONTRAST MEDIUM
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,EXCIPIAL LIPOCREME OINTMENT,EXCIPIAL                           /01738401/,2012-02,2012-02-01,D,,,,C,Y,unknown,mL,TOPICAL,PRN,SKIN RASH FACE AND THORAX
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOL OINTMENT,METRONIDAZOLE,2012-02,2012-02-01,D,,,,C,Y,unknown,mL,TOPICAL,PRN,SKIN RASH FACE AND THORAX
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TANTUM VERDE,BENZYDAMINE HYDROCHLORIDE,2012-02,2012-02-01,D,,,,C,Y,unknown,mL,ORAL,PRN,BURNING SENSATION ORAL MUCOSA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2011,2011-12-31,M,,,,C,Y,10,mg,ORAL,BID,PAIN UPPER ABDOMEN
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2007,2007-12-31,M,,,,C,Y,"2,5",mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LYRIKA,PREGABALIN,2011-11,2011-10-31,D,,,,C,Y,75,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOL,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-11,2011-10-31,D,,,,C,Y,40,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2007,2007-12-31,M,2012-02-22,2012-02-22,,C,,40,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ELECTROLYTE SOLUTION,ELECTROLYTE SOLUTIONS,2012-02-03,2012-02-03,,2012-02-03,2012-02-03,,C,,500,mL,INTRAVENOUS,ONCE,HYPOTENSION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-02-10,2012-02-10,,2012-02,2012-02-29,D,C,,500,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-02-19,2012-02-19,,2012-02-19,2012-02-19,,C,,400,mg,ORAL,TID,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SULFAMETHOXAZOL,SULFAMETHOXAZOLE SODIUM,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,800,mg,ORAL,QD,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-02-20,2012-02-20,,2012-02-20,2012-02-20,,C,,40,mg,ORAL,QD,EDEMA /PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,VOMEX,DIMENHYDRINATE,2011,2011-12-31,M,,,,C,Y,150,mg,RECTAL,PRN,NAUSEA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN,AMOXICILLIN,2012-02-20,2012-02-20,,2012-02-21,2012-02-21,,C,,875,mg,ORAL,BID,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,IPATROPIUMBROMID,IPRATROPIUM BROMIDE,2012-02-20,2012-02-20,,2012-02-20,2012-02-20,,C,,20,mg,RESPIRATORY (INHALATION),QD,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,KALINOR,SWISS-KAL EFF,2012-02-20,2012-02-20,,,,,C,Y,1,TABLET,ORAL,BID,HYPOKALEMIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MUCOSOLVAN,AMBROXOL HYDROCHLORIDE,2012-02-20,2012-02-20,,,,,C,Y,20,gtt,ORAL,TID,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,P,,90,mL,INTRAVENOUS,QD,CONTRAST DYE CT
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CLAVULAN ACID,CLAVULANIC ACID,2012-02-20,2012-02-20,,2012-02-21,2012-02-21,,C,,125,mg,ORAL,BID,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,TRIMETHOPRIM,TRIMETHOPRIM,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,160,mg,ORAL,QD,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SULFAMETHOXAZOL,SULFAMETHOXAZOLE SODIUM,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,800,mg,ORAL,BID,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,TRIMETHOPRIM,TRIMETHOPRIM,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,160,mg,ORAL,BID,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SULFAMETHOXAZOL,SULFAMETHOXAZOLE SODIUM,2012-02-23,2012-02-23,,2012-02-23,2012-02-23,,C,,800,mg,ORAL,QD,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-13,2012-01-13,,,,,C,Y,8,mg,ORAL,PRN,PREVENTION OF VOMITING
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,TRIMETHOPRIM,TRIMETHOPRIM,2012-02-23,2012-02-23,,2012-02-23,2012-02-23,,C,,160,mg,ORAL,QD,PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,BIFITERAL,LACTULOSE,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,1,Tbsp,ORAL,TID,OBSTIPATION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,BIFITERAL,LACTULOSE,2012-02-23,2012-02-23,,2012-02-23,2012-02-23,,C,,1,Tbsp,ORAL,QD,OBSTIPATION
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,FENOTEROLHYDROBROMID,FENOTEROL HYDROBROMIDE,2012-02-20,2012-02-20,,2012-02-20,2012-02-20,,C,,50,mg,RESPIRATORY (INHALATION),QD,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,IPRATROPIUMBROMID,IPRATROPIUM BROMIDE,2012-02-21,2012-02-21,,,,,C,Y,20,mg,RESPIRATORY (INHALATION),TID,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,FENOTEROLHYDROBROMID,FENOTEROL HYDROBROMIDE,2012-02-21,2012-02-21,,,,,C,Y,50,mg,RESPIRATORY (INHALATION),TID,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ATROVENT,IPRATROPIUM BROMIDE,2012-02-19,2012-02-19,,2012-02-23,2012-02-23,,C,,unknown,mg,RESPIRATORY (INHALATION),PRN,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,MITRAZEPAM,NITRAZEPAM,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,unknown,mg,ORAL,QD,SLEEP DISTURBANCE
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,TELEBRIX,TELEBRIX                           /01047301/,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,unknown,mL,ORAL,QD,CONTRAST DYE FOR X-RAY
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,OXYGEN,OXYGEN,2012-02-19,2012-02-19,,2012-02-22,2012-02-22,,C,,2,L/min,RESPIRATORY (INHALATION),PRN,PNEUMONIA AND OBSTRUCTIVE BRONCHITIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,MCP,METOCLOPRAMIDE,2012-01-13,2012-01-13,,,,,C,Y,unknown,gtt,ORAL,PRN,PREVENTION OF VOMITING
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2012-02-19,2012-02-19,,2012-02-19,2012-02-19,,C,,40,mval,INTRAVENOUS,QD,HYPOKALEMIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2012-02-21,2012-02-21,,,,,C,Y,40,mg,ORAL,BID,EDEMA/PNEUMONIA
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,P,,10,g,ORAL,QD,PREMEDICATION FOR CONTRAST DYE CT
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-01-13,2012-01-13,,2012-01-13,2012-01-13,,C,,8,mg,ORAL,ONCE,PREVENTION OF VOMITING
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2011,2011-12-31,M,,,,C,Y,5,mg,ORAL,BID,PAIN UPPER ABDOMEN
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,ASS 100,ACETYLSALICYLIC ACID,2007,2007-12-31,M,,,,C,Y,100,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,L-THYROXIN-JOD,LEVOTHYROXINE SODIUM,,2012-01-13,Y,,,,C,Y,125/150,mg,ORAL,QD,HYPOTHYREOSIS
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,TORASEMID,TORASEMIDE,2007,2007-12-31,M,,,,C,Y,10,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR,,2012-04-16,2012-04-16,,2012-04-23,2012-04-23,,,,,,,,
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,TARZEVA,,2012-04-16,2012-04-16,,2012-04-23,2012-04-23,,,,,,,,
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,,,,2012-03-27,2012-03-27,,,,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NOVAMINSULFON,METAMIZOLE SODIUM,2011-11,2011-11-01,D,,,,,Y,unknown,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2012-04-06,2012-04-06,,2012-04-12,2012-04-12,,,,1000,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ERYCINUM,ERYTHROMYCIN,2012-04-06,2012-04-06,,2012-04-11,2012-04-11,,,,1,g,INTRAVENOUS,BID,URINARY RETENTION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-04-07,2012-04-07,,2012-04-07,2012-04-07,,,,1,IU,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-04-08,2012-04-08,,,,,,Y,1,IU,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DIGITONIN,DIGITOXIN,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,1,VIAL,INTRAVENOUS,BID,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,10,mg,INTRAVENOUS,BID,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2012-04-10,2012-04-10,,,,,,Y,5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-04-09,2012-04-09,,2012-04-09,2012-04-09,,,,1,gtt,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MUCOFALK,PLANTAGO AFRA SEED HUSK,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,,,10,g,ORAL,QD,CONTRAST DYE CT
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,IMERON 300,IOMEPROL,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,,,90,mL,INTRAVENOUS,QD,CONTRAST DYE FOR CT
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-03-25,2012-03-25,,2012-03-27,2012-03-27,,,,40,mg,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-03-23,2012-03-23,,2012-03-23,2012-03-23,,,,250,mg,ORAL,QD,METASTASIS TO SPINE WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-03-24,2012-03-24,,2012-03-27,2012-03-27,,,,250,mg,ORAL,BID,METASTASIS TO SPINE WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2011-11,2011-11-01,D,2012-03-27,2012-03-27,,,,5,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,GADOVIST,GADOBUTROL,2012-03-22,2012-03-22,,2012-03-22,2012-03-22,,,,7,mL,INTRAVENOUS,QD,CONTRAST DYE MRI
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,160,mg,INTRAVENOUS,QD,ANAESTHETIC FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ULTIVA,REMIFENTANIL HYDROCHLORIDE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,1.58,mg,INTRAVENOUS,QD,ANALGETIC DRUG FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,4,mg,INTRAVENOUS,QD,PROPHYLAXIS FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL BETA COMP,SALUTEC,,,,2012-03-21,2012-03-21,,,,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,AKRINOR,AKRINOR,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,5,mL,INTRAVENOUS,QD,PROPHYLAXIS FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,1,g,INTRAVENOUS,QD,PROPHYLAXIS FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DIPIDOLOR,PIRITRAMIDE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,7,mg,INTRAVENOUS,QD,PROPHYLAXIS FOR RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,3.75,mg,ORAL,QD,PROPHYLAXIS RADIOFREQUENCY ABLATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PROPOFOL,PROPOFOL,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,658.667,mg,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,SUFENTA MITE,SUFENTANIL CITRATE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,25,ug,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ULTIVA,REMIFENTANIL HYDROCHLORIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,1792,ug,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,ESMERON,ROCURONIUM BROMIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,40,mg,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,AKRINOR,AKRINOR,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,4,mL,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,,,,2012-03-27,2012-03-27,,,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,35.667,IU,INTRAVENOUS,QD,DIABETES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,1,g,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,7,mg,INTRAVENOUS,QD,PROPHYLAXIS SURGERY
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-03-30,2012-03-30,,2012-03-30,2012-03-30,,,,40,mg,INTRAVENOUS,QD,MYELON EDEMA
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-03-30,2012-03-30,,2012-03-30,2012-03-30,,,,8,mg,ORAL,BID,ADVERSE EVENT
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-03-31,2012-03-31,,2012-04-01,2012-04-01,,,,8,mg,ORAL,TID,ADVERSE EVENT
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,,,40,mg,INTRAVENOUS,QD,MYELON EDEMA WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,FORTECORTIN,DEXAMETHASONE,2012-04-02,2012-04-02,,,,,,Y,4,mg,ORAL,TID,ADVERSE EVENT
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,40,mg,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-04-05,2012-04-05,,2012-04-26,2012-04-26,,,,40,mg,SUBCUTANEOUS,QD,ANTICOAGULATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2004,2004-01-01,M,2012-03-27,2012-03-27,,,,100,mg,ORAL,QD,GALL STONES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,ACTRAPID,INSULIN HUMAN,2012-03-31,2012-03-31,,2012-04-26,2012-04-26,,,,1,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2012-04-05,2012-04-05,,2012-04-25,2012-04-25,,,,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2012-04-05,2012-04-05,,2012-04-25,2012-04-25,,,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,100,mg,ORAL,QD,GALL STONES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2012-04-05,2012-04-05,,,,,,Y,100,mg,ORAL,QD,GALL STONES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,L-THYROXIN,LEVOTHYROXINE SODIUM,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,25,mg,ORAL,QD,HYPOTHYREOSIS
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,L-THYROXIN,LEVOTHYROXINE SODIUM,,,,2012-03-27,2012-03-27,,,,25,mg,ORAL,QD,HYPOTHYREOSIS
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,L-THYROXIN,LEVOTHYROXINE SODIUM,2012-04-05,2012-04-05,,2012-04-11,2012-04-11,,,,25,mg,ORAL,QD,HYPOTHEREOSIS
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,L-THYROXIN,LEVOTHYROXINE SODIUM,2012-04-12,2012-04-12,,,,,,Y,75,mg,ORAL,QD,HYPOTHYREOSIS
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2012-03-28,2012-03-28,,2012-03-28,2012-03-28,,,,5,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,10,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,5,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,,,5,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,,,10,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,,,5,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,TIMOLOL,TIMOLOL,2007,2007-01-01,M,,,,,Y,unknown,gtt,OPHTHALMIC,BID,GLAUCOMA
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,68.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2012-04-06,2012-04-06,,2012-04-07,2012-04-07,,,,10,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,69.0,CONCOMITANT MEDICATIONS,,,NALOXON,NALOXONE HYDROCHLORIDE,2012-04-06,2012-04-06,,2012-04-07,2012-04-07,,,,5,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,70.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2012-03-29,2012-03-29,,2012-03-30,2012-03-30,,,,5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,71.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-03-31,2012-03-31,,2012-03-31,2012-03-31,,,,7.5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,72.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2012-03-31,2012-03-31,,2012-03-31,2012-03-31,,,,1,gtt,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,73.0,CONCOMITANT MEDICATIONS,,,KALYMIN,PYRIDOSTIGMINE BROMIDE,2012-04-02,2012-04-02,,2012-04-02,2012-04-02,,,,6,mg,INTRAVENOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,74.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-04-02,2012-04-02,,2012-04-02,2012-04-02,,,,40,mg,INTRAVENOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,75.0,CONCOMITANT MEDICATIONS,,,KALYMIN,PYRIDOSTIGMINE BROMIDE,2012-04-08,2012-04-08,,2012-04-08,2012-04-08,,,,6,mg,INTRAVENOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,76.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-04-08,2012-04-08,,2012-04-08,2012-04-08,,,,40,mg,INTRAVENOUS,QD,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,77.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,,,250,mg,ORAL,BID,METASTASIS TO SPINE WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,78.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2004,2004-01-01,M,2012-03-21,2012-03-21,,,,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,79.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-04-05,2012-04-05,,2012-04-10,2012-04-10,,,,250,mg,ORAL,BID,METASTASIS TO SPINE WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,80.0,CONCOMITANT MEDICATIONS,,,CIPROBAY,CIPROFLOXACIN,2012-04-12,2012-04-12,,2012-04-12,2012-04-12,,,,250,mg,ORAL,QD,METASTASIS TO SPINE WITH PARALYSIS APPEARANCE
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,81.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2012-04-02,2012-04-02,,2012-04-04,2012-04-04,,,,5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,82.0,CONCOMITANT MEDICATIONS,,,NITRAZEPAM,NITRAZEPAM,2012-04-05,2012-04-05,,2012-04-08,2012-04-08,,,,5,mg,ORAL,QD,SLEEP DISTURBANCES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,83.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-04-07,2012-04-07,,2012-04-07,2012-04-07,,,,10,gtt,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,84.0,CONCOMITANT MEDICATIONS,,,TRAMAL,TRAMADOL HYDROCHLORIDE,2012-04-06,2012-04-06,,,,,,Y,1,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,85.0,CONCOMITANT MEDICATIONS,,,JALRA,VILDAGLIPTIN,2004,2004-01-01,M,2012-03-21,2012-03-21,,,,50,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,86.0,CONCOMITANT MEDICATIONS,,,OXYCODON,OXYCODONE HYDROCHLORIDE,2011-11,2011-11-01,D,2012-03-27,2012-03-27,,,,10,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITIBINE,,,2010-08-05,Y,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,,2010-08-05,Y,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CATAPRESAN TTS1,CLONIDINE,2009-12,2009-11-30,D,2010-08-23,2010-08-23,,C,,1,PLASTER,TRANSDERMAL,QS,HYPERTENSION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TICLOPIDINA,TICLOPIDINE HYDROCHLORIDE,2010-08-05,2010-08-05,,2010-08-12,2010-08-12,,C,,250,mg,ORAL,QD,ATRIAL FIBRILLATION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ENTEROFLUID (LACTIC FERMENTS),ANTIDIARRHEAL MICROORGANISMS,2011-01-02,2011-01-02,,2011-01-03,2011-01-03,,C,,10,mL,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-01-17,2011-01-17,,2011-01-23,2011-01-23,,C,,1,g,ORAL,TID,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CIPROXACIN,CIPROFLOXACIN,2011-01-17,2011-01-17,,2011-01-22,2011-01-22,,C,,500,mg,ORAL,BID,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-01-25,2011-01-25,,,,,C,Y,1,TABLET,ORAL,PRN,GASTRIC PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,RED BLOOD CELLS TRANSFUSION,RED BLOOD CELLS,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,NA,,INTRAVENOUS,ONCE,LOW LEVEL OF HEMOGLOBIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-01-11,2011-01-11,,2011-01-12,2011-01-12,,C,,600,mg,ORAL,QD,BACK PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2010-08-05,2010-08-05,,,,,C,Y,20,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-08-05,2010-08-05,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CARDIOASPIRINA,ACETYLSALICYLIC ACID,2010-08-13,2010-08-13,,,,,C,Y,100,mg,ORAL,QD,ATRIAL FIBRILLATION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,RED BLOOD CELLS TRANSFUSION,RED BLOOD CELLS,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-02-24,2011-02-24,,,,,C,Y,2,TABLET,ORAL,BID,DYSPEPSIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FROBEN,FLURBIPROFEN,2011-03-17,2011-03-17,,,,,C,Y,0.25,%,ORAL,TID,APHTA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ALOVEX (CONTAINS ALOE AND IALURONIC AICD),OTHER AGENTS FOR LOCAL ORAL TREATMENT,2011-03-22,2011-03-22,,,,,C,Y,na,,ORAL,TID,APHTA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DELORAZEPAM,DELORAZEPAM,2010-09-09,2010-09-09,,,,,C,Y,0.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2010-09-03,2010-09-03,,,,,C,Y,15,gtt,ORAL,QD,RESTLESSNESS
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-10-16,2010-10-16,,2010-10-22,2010-10-22,,C,,1,g,ORAL,TID,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-09-16,2010-09-16,,,,,C,Y,500,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,RED BLOOD CELLS TRANSFUSION,RED BLOOD CELLS,2010-11-24,2010-11-24,,2010-11-24,2010-11-24,,C,,1,U,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,METFORMINA,METFORMIN,2010-08-17,2010-08-17,,2010-08-19,2010-08-19,,C,,500,mg,ORAL,BID,HYPERGLYCEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2010-08-21,2010-08-21,,,,,C,Y,10,gtt,ORAL,QD,RESTLESSNESS
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,APIDRA - GLULISINE INSULINE,INSULIN GLULISINE,2010-08-20,2010-08-20,,2010-08-30,2010-08-30,,C,,as needed,U,SUBCUTANEOUS,TID,HYPERGLYCEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,INSULIN GLARGINE,INSULIN GLARGINE,2010-08-21,2010-08-21,,,,,C,Y,as needed,U,SUBCUTANEOUS,QD,HYPERGLYCEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,APIDRA - GLULISINE INSULINE,INSULIN GLULISINE,2010-08-31,2010-08-31,,,,,C,Y,10,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,APIDRA - GLULISINE INSULINE,INSULIN GLULISINE,2010-08-31,2010-08-31,,,,,C,Y,18,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,INSULIN GLARGINE,INSULIN GLARGINE,2010-08-31,2010-08-31,,,,,C,Y,14,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,TRANSFUSION (CONCENTRATED ERITHROCYTES),"RED BLOOD CELLS, CONCENTRATED",2010-09-10,2010-09-10,,2010-09-10,2010-09-10,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,CORDARONE,AMIODARONE HYDROCHLORIDE,2009-12,2009-11-30,D,,,,C,Y,200,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,CEFIXIME,CEFIXIME,2010-10-18,2010-10-18,,2010-10-20,2010-10-20,,C,,400,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,AMOXICILLIN POTASSIUM CLAVULANATE,AMOXICILLIN W/CLAVULANATE POTASSIUM,2010-10-21,2010-10-21,,2010-10-27,2010-10-27,,C,,1,g,ORAL,TID,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2010-10-21,2010-10-21,,2010-10-27,2010-10-27,,C,,500,mg,ORAL,BID,FEVER
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,FLUCONAZOL,FLUCONAZOLE,2010-10-26,2010-10-26,,2010-10-27,2010-10-27,,C,,150,mg,ORAL,BID,CANDIDA INFECTION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,IBUPROFENE,IBUPROFEN,2010-10-29,2010-10-29,,,,,C,Y,600,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,TAMSULOSINA,TAMSULOSIN HYDROCHLORIDE,2010-12-02,2010-12-02,,,,,C,Y,0.4,mg,ORAL,QD,PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,NORVASC,AMLODIPINE BESILATE,2009-12,2009-11-30,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2009-12,2009-11-30,D,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLO,LANSOPRAZOLE,2009-12,2009-11-30,D,,,,C,Y,30,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,TORADOL,KETOROLAC TROMETHAMINE,2010-06,2010-05-31,D,2010-08-05,2010-08-05,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2010-08-05,2010-08-05,,2010-08-19,2010-08-19,,C,,500,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,TRAMADOLO,TRAMADOL HYDROCHLORIDE,2010-08-05,2010-08-05,,2010-08-07,2010-08-07,,C,,20,gtt,ORAL,PRN,PAIN
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2010-08-05,2010-08-05,,2010-08-19,2010-08-19,,C,,10,mg,ORAL,TID,"NAUSEA, BELCHING"
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,VALERIAN,VALERIANA OFFICINALIS,2010-09-11,2010-09-11,,,,,C,Y,2,TABLET,ORAL,PRN,SLEEPLESSNESS
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2010-10-01,2010-10-01,,2010-10-02,2010-10-02,,C,,300,mg,ORAL,PRN,TEETH PAIN
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,NEOCOLON - SUPPLEMENT FOR CHOLITIS,ALL OTHER THERAPEUTIC PRODUCTS,2010-09-11,2010-09-11,,,,,C,Y,350,mg,ORAL,PRN,COLITIS
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,GLUTATIONE+EPARGRISEOVIT,EPARGRISEOVIT,2010-09-28,2010-09-28,,,,,C,Y,600,mg,INTRAVENOUS,PRN,MULTISYSTEMIC WASTING
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,GLUTATIONE+EPARGRISEOVIT,GLUTATHIONE,2010-09-28,2010-09-28,,,,,C,Y,600,mg,INTRAVENOUS,PRN,MULTISYSTEMIC WASTING
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2010-09-09,2010-09-09,,2010-09-09,2010-09-09,,C,,10,mg,INTRAVENOUS,ONCE,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2010-09-09,2010-09-09,,,,,C,Y,20,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-09-09,2010-09-09,,,,,C,Y,8,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"FOLINIC ACID, 5-FU, IRINOTECAN",,2010-12-07,2010-12-07,,2011-01-18,2011-01-18,,,,,,,,
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2010-09-20,2010-09-20,,,,,C,Y,10,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,"MISCELA 3 OLII (3 OIL MIX, CONTAINING OLIVE OIL, SWEET ALMOND OIL, VASELINE OIL)",OLEA EUROPAEA OIL,2010-10-07,2010-10-07,,,,,C,Y,NA,,ORAL,TID,COSTIPATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,"MISCELA 3 OLII (3 OIL MIX, CONTAINING OLIVE OIL, SWEET ALMOND OIL, VASELINE OIL)",PARAFFIN,2010-10-07,2010-10-07,,,,,C,Y,NA,,ORAL,TID,COSTIPATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,"MISCELA 3 OLII (3 OIL MIX, CONTAINING OLIVE OIL, SWEET ALMOND OIL, VASELINE OIL)",PRUNUS DULCIS OIL,2010-10-07,2010-10-07,,,,,C,Y,NA,,ORAL,TID,COSTIPATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ACTIQ,FENTANYL CITRATE,2010-09-20,2010-09-20,,,,,C,Y,400,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,BLOOD TRANSFUSION - CONCENTRATED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2010-11-24,2010-11-24,,2010-11-24,2010-11-24,,C,,na,,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2010-09-30,2010-09-30,,2010-10-07,2010-10-07,,C,,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PURSENID,SENNOSIDE A+B CALCIUM,2010-10-07,2010-10-07,,,,,C,Y,1,TABLET,ORAL,QD,COSTIPATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE MONOCLORIDRATO MONOIDRATO,METOCLOPRAMIDE HYDROCHLORIDE,2010-10-07,2010-10-07,,,,,C,Y,10,mg,ORAL,TID,COSTIPATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2010-11-04,2010-11-04,,,,,C,Y,40,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,RIOPAN MAGALDRATE,MAGALDRATE,2010-10-17,2010-10-17,,,,,C,Y,80,mg,ORAL,QD,GASTRIC PAIN
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2010-09-30,2010-09-30,,,,,C,Y,20,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-09-30,2010-09-30,,,,,C,Y,8,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2010-10-07,2010-10-07,,2010-11-04,2010-11-04,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"EPIRUBICINA, CISPLATINO, CAPECITABINA",,2011-03-03,2011-03-03,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLO,PARACETAMOL,2010-10-23,2010-10-23,,2011-01-20,2011-01-20,,C,,1000,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BRUFEN,IBUPROFEN,2010-12-16,2010-12-16,,,,,C,Y,600,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,OSSICODONE,OXYCODONE,2010-12-17,2010-12-17,,2010-12-23,2010-12-23,,C,,5,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLO,PARACETAMOL,2011-01-31,2011-01-31,,2011-02-01,2011-02-01,,C,,1000,mg,ORAL,QD,FLU
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,BISOLVON LINCTUS,MUCOLYTICS,2011-01-31,2011-01-31,,2011-02-07,2011-02-07,,C,,3,SPOON,ORAL,TID,COUGH
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLO,PARACETAMOL,2010-11-06,2010-11-06,,2010-11-06,2010-11-06,,C,,1000,mg,ORAL,PRN,PAIN AND FEVER
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2010-10-21,2010-10-21,,,,,C,Y,20,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-10-21,2010-10-21,,,,,C,Y,8,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2011-04-21,2011-04-21,,2011-05-11,2011-05-11,,,,,,,,
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LANSOX,LANSOPRAZOLE,2011-01-30,2011-01-30,,,,,C,Y,30,mg,ORAL,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-02-17,2011-02-17,,,,,C,Y,20,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-02-17,2011-02-17,,,,,C,Y,8,mg,INTRAVENOUS,QS,PRE-MEDICATION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-02-17,2011-02-17,,2011-02-26,2011-02-26,,C,,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OXICONTIN,OXYCODONE HYDROCHLORIDE,2011-03-23,2011-03-23,,2011-03-31,2011-03-31,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-03-31,2011-03-31,,2011-04-07,2011-04-07,,C,,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-02-27,2011-02-27,,2011-03-03,2011-03-03,,C,,30,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-02-27,2011-02-27,,2011-03-16,2011-03-16,,C,,40,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-03-17,2011-03-17,,2011-03-19,2011-03-19,,C,,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-03-20,2011-03-20,,2011-03-23,2011-03-23,,C,,60,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TARGIN,TARGIN,2011-03-23,2011-03-23,,,,,C,Y,40,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-02-02,2011-02-02,,,,,C,Y,6000,IU,SUBCUTANEOUS,BID,EMBOLISM
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,AVALOX,MOXIFLOXACIN HYDROCHLORIDE,2011-03-03,2011-03-03,,2011-03-07,2011-03-07,,C,,400,mg,ORAL,QD,LEUKOCITOSIS
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DELTACORTENE,PREDNISONE,2011-02-17,2011-02-17,,2011-03-09,2011-03-09,,C,,12.5,mg,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DELTACORTENE,PREDNISONE,2011-03-10,2011-03-10,,2011-03-31,2011-03-31,,C,,12.5,mg,ORAL,BID,ASTHENIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DELTACORTENE,PREDNISONE,2011-03-31,2011-03-31,,,,,C,Y,25,mg,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PAROXETINE HYDROCHLORIDE,PAROXETINE HYDROCHLORIDE,2011-04-01,2011-04-01,,,,,C,Y,20,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SUCRALFIN,SUCRALFATE,2011-04-07,2011-04-07,,,,,C,Y,2,g,ORAL,TID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-04-05,2011-04-05,,,,,C,Y,25,mg,ORAL,BID,WATER RITENTION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-02,2011-02-17,D,2011-02,2011-02-28,D,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,PURSENNID,SENNOSIDE A+B CALCIUM,2011-02-17,2011-02-17,,2011-02-26,2011-02-26,,C,,24,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-04-07,2011-04-07,,,,,C,Y,80,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-02-02,2011-02-02,,,,,C,Y,10,gtt,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PAROXETINE HYDROCHLORIDE,PAROXETINE HYDROCHLORIDE,2011-03-25,2011-03-25,,2011-03-31,2011-03-31,,C,,10,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DELTACORTENE,PREDNISONE,2011-03-31,2011-03-31,,,,,C,Y,12.5,mg,ORAL,QD,ASTHENIA
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-02-07,2011-02-07,,2011-02-17,2011-02-17,,C,,5,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-02-07,2011-02-07,,2011-02-20,2011-02-20,,C,,10,mg,ORAL,TID,VOMITING
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,P,,1000,mg,INTRAVENOUS,ONCE,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,BRUFEN,IBUPROFEN,2011-02-17,2011-02-17,,,,,C,Y,400,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-02-19,2011-02-19,,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,TAZOCINA,PIP/TAZO,2011-02-20,2011-02-20,,2011-02-28,2011-02-28,,C,,4.5,g,INTRAVENOUS,TID,FEVER
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUOROURACILE/FOLINIC ACID/IRINOTECAN (FOLFIRI),,2011-07-19,2011-07-19,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2008,2008-12-31,M,,,,C,Y,5,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CODEINE,CODEINE,2011-06-23,2011-06-23,,2011-07-27,2011-07-27,,C,,30,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-06-30,2011-06-30,,,,,C,Y,6000,IU,SUBCUTANEOUS,BID,PULMONARY EMBOLISM
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,2008,2008-12-31,M,,,,C,Y,25,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,LERCANIDIPINE,LERCANIDIPINE,2008,2008-12-31,M,,,,C,Y,10,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04-21,2011-04-21,,2011-06-22,2011-06-22,,C,,500,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CODEINE,CODEINE,2011-04-21,2011-04-21,,,,,C,Y,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN,ENOXAPARIN,2011-06-30,2011-06-30,,,,,C,Y,6000,IU,SUBCUTANEOUS,BID,PULMUNARY EMBOLISM
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-12,2011-05-12,,,,,C,Y,8,mg,INTRAVENOUS,QS,TREATMENT PRE-MEDICATION
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PLASIL (METOCLPRAMIDE),METOCLOPRAMIDE,2011-05-12,2011-05-12,,,,,C,Y,20,mg,INTRAVENOUS,QS,TREATMENT PRE-MEDICATION
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-06-23,2011-06-23,,2011-07-27,2011-07-27,,C,,500,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEM + OXALIPLATIN,,2011-06-29,2011-06-29,,2011-08-25,2011-08-25,,,,,,,,
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LOPRESOR,METOPROLOL TARTRATE,2004,2004-12-31,M,2011-04-27,2011-04-27,,P,,50,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2011-06-23,2011-06-23,,2011-07-03,2011-07-03,,C,,5,mg,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2011-07-04,2011-07-04,,,,,C,Y,7.5,mg,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LOPRESOR,METOPROLOL TARTRATE,2011-04-28,2011-04-28,,2011-06-22,2011-06-22,,C,,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-05-06,2011-05-06,,2011-05-06,2011-05-06,,C,,500,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-05-02,2011-05-02,,2011-05-02,2011-05-02,,C,,500,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-06-08,2011-06-08,,2011-06-09,2011-06-09,,C,,500,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,500,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TORVAST,ATORVASTATIN CALCIUM,2004,2004-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,LANSOX,LANSOPRAZOLE,2011-03-23,2011-03-23,,2011-04-28,2011-04-28,,C,,30,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CONTRAMAL,TRAMADOL HYDROCHLORIDE,2011-04,2011-04-28,D,,,,C,Y,25,gtt,ORAL,BID,CANCER PAIN
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03,2011-02-28,D,2011-05-03,2011-05-03,,C,,10000,IU,SUBCUTANEOUS,BID,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-05-04,2011-05-04,,2011-05-11,2011-05-11,,C,,15000,IU,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2011-05-16,2011-05-16,,2011-06-23,2011-06-23,,C,,7.5,mg,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-04-28,2011-04-28,,,,,C,Y,10,mg,INTRAVENOUS,before each chemotherapy infusion,PREMEDICATION
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,INDERAL,PROPRANOLOL HYDROCHLORIDE,2011-06-23,2011-06-23,,,,,C,Y,20,mg,ORAL,TID,HYPERTENSION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,EUTIROX,LEVOTHYROXINE SODIUM,2005,2005-12-31,M,2011-06-12,2011-06-12,,C,,150,mg,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-05-19,2011-05-19,,2011-06-13,2011-06-13,,C,,10,mg,INTRAVENOUS,before each chemotherapy infusion,PREMEDICATION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,GLYCEROL,GLYCEROL,2011-05-26,2011-05-26,,2011-05-31,2011-05-31,,C,,1,g,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CIPROXIN,CIPROFLOXACIN,2011-05-09,2011-05-09,,2011-05-19,2011-05-19,,C,,500,mg,ORAL,QD,URINARY INFECTION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,APROVEL,IRBESARTAN,2005,2005-12-31,M,,,,C,Y,150,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ZYLORIC,ALLOPURINOL,2011-06-13,2011-06-13,,,,,C,Y,150,mg,ORAL,QD,HYPERURICEMIA
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DILATREND,CARVEDILOL,2011-05-18,2011-05-18,,,,,C,Y,"6,25",mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-05-13,2011-05-13,,,,,C,Y,8000,IU,SUBCUTANEOUS,QD,ANTICOAGULANT
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DUOTRAV,DUOTRAV,2005,2005-12-31,M,,,,C,Y,40,gtt,TOPICAL,QD,GLAUCOMA
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,EUTIROX,LEVOTHYROXINE SODIUM,2011-06-13,2011-06-13,,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-05-26,2011-05-26,,2011-06-13,2011-06-13,,C,,4,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-06-13,2011-06-13,,,,,C,Y,10,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE AND OXALIPLATIN,,2011-09-08,2011-09-08,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ALPRAZIG,ALPRAZOLAM,2011-05,2011-04-30,D,,,,C,Y,0.25,mg,ORAL,BID,ANXIETY/DEPRESSION
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-08-18,2011-08-18,,2011-08-25,2011-08-25,,C,,250,ug,INTRAVENOUS,Before CO 101-001 infusio,PREVENTION OF NAUSEA
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-18,2011-08-18,,,,,C,Y,16,mg,INTRAVENOUS,Before CO 101-001 infusion,PREVENTION OF NAUSEA
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEPALGOS,OXYCOCET,2011-06-25,2011-06-25,,,,,C,Y,5,mg,ORAL,TID,CANCER PAIN
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-07-05,2011-07-05,,2011-08-06,2011-08-06,,C,,4000,IU,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-08-07,2011-08-07,,,,,C,Y,6000,IU,SUBCUTANEOUS,QD,ANTITHROMBOTIC
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PURSENNID,SENNOSIDE A+B CALCIUM,2011-07-16,2011-07-16,,2011-07-19,2011-07-19,,C,,2,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PLASIL,METOCLOPRAMIDE,2011-07-21,2011-07-21,,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TACHIPIRINA,PARACETAMOL,2011-07-15,2011-07-15,,,,,C,Y,1000,mg,ORAL,PRN,FEVER/CANCER PAIN
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2011-08-01,2011-08-01,,,,,C,Y,40000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LANSOX,LANSOPRAZOLE,2011-07-28,2011-07-28,,,,,C,Y,30,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-01-19,2012-01-19,,2012-01-19,2012-01-19,,,,,,,,
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ACETILSALICILIC ACID,ACETYLSALICYLIC ACID,,2011-11-04,Y,,,,C,Y,100,mg,ORAL,QD,CARDIAC PROBLEMS
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LIMPIDEX,LANSOPRAZOLE,2011-12-21,2011-12-21,,,,,C,Y,30,mg,ORAL,QD,EPIGASTRALGY
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2011-12-21,2011-12-21,,,,,C,Y,7.5,mg,SUBCUTANEOUS,QD,PTE
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,,2011-11-04,Y,,,,C,Y,500,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,,2011-11-04,Y,,,,C,Y,25000,IU,ORAL,TID,PANCREATIC PATHOLOGY
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CRESTOR,ROSUVASTATIN CALCIUM,,2011-11-04,Y,,,,C,Y,5,mg,ORAL,QD,CHOLESTEROL
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,,2011-11-04,Y,,,,C,Y,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ACESISTEM,VASERETIC,,2011-11-04,Y,,,,C,Y,2.5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011,2011-11-04,M,2011-12-20,2011-12-20,,C,,500,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CODEIN,CODEINE PHOSPHATE,2011,2011-11-04,M,2011-12-21,2011-12-21,,C,,30,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LEVOPRAID,LEVOSULPIRIDE,2011-12-21,2011-12-21,,,,,C,Y,25,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABINE,,2012-03-14,2012-03-14,,,2012-03-14,Y,,,,,,,
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CARDIOASPIRIN,ACETYLSALICYLIC ACID,2003-01,2002-12-31,D,2011-05-06,2011-05-06,,C,,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2011-04-29,2011-04-29,,2011-05-02,2011-05-02,,C,,1000,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2011-05-05,2011-05-05,,,,,C,Y,1000,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CARDIOASPIRIN,ACETYLSALICYLIC ACID,2011-05-09,2011-05-09,,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,1000,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LIMPIDEX,LANSOPRAZOLE,2003-01,2002-12-31,D,,,,C,Y,15,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TENORMIN,ATENOLOL,2003-01,2002-12-31,D,,,,C,Y,50,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TORVAST,ATORVASTATIN CALCIUM,2003-01,2002-12-31,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2010,2010-12-31,M,,,,C,Y,75,mg,ORAL,QD,PAIN PROPHYLAXIS
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SELEPARINE,NADROPARIN CALCIUM,2011-04-06,2011-04-06,,2011-04-09,2011-04-09,,P,,2850,IU,SUBCUTANEOUS,QD,THROMBOSIS PROPHYLAXIS
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LIMICAN,ALIZAPRIDE HYDROCHLORIDE,2011-04-22,2011-04-22,,,,,C,Y,50,mg,INTRAVENOUS,every chemotherapy,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ECONAZOLE NITRATE,ECONAZOLE NITRATE,2011-04-23,2011-04-23,,2011-05-13,2011-05-13,,C,,unknown,,TOPICAL,PRN,DERMATITIS
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ZIRTEC,CETIRIZINE HYDROCHLORIDE,2011-04-23,2011-04-23,,2011-05-13,2011-05-13,,C,,10,mg,ORAL,QD,DERMATITIS
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEM+OXALIPLATIN,,2011-07-01,2011-07-01,,2011-08-25,2011-08-25,,,,,,,,
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CARDIOASPIRIN,ACETYLSALICYLIC ACID,,2011-05-05,Y,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LIMICAN,ALIZAPRIDE HYDROCHLORIDE,2011-05-05,2011-05-05,,,,,C,Y,50,mg,INTRAVENOUS,before each chemotherapy,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ANTRA,OMEPRAZOLE,2011-05-05,2011-05-05,,,,,C,Y,20,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ELITEN,FOSINOPRIL SODIUM,,2011-05-05,Y,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,MODURETIC,MODURETIC,,2011-05-05,Y,,,,C,Y,1,TABLET,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,AVODART,DUTASTERIDE,1999,1999-12-31,M,,,,C,Y,0.5,mg,ORAL,QD,BENIGN PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,XATRAL,ALFUZOSIN HYDROCHLORIDE,1999,1999-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,BENIGN PROSTATIC HYPERTROPY
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SOLOSA,GLIMEPIRIDE,2009,2009-12-31,M,,,,C,Y,4,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,TORVAST,ATORVASTATIN CALCIUM,2009,2009-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCOLESTEROLEMIA
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,INSULINA,INSULIN,2009,2009-12-31,M,,,,C,Y,20+8,IU,ORAL,QD,DIABETE
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,AULIN,NIMESULIDE,2011-07-01,2011-07-01,,2011-07-14,2011-07-14,,C,,1,TABLET,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-08-05,2011-08-05,,2011-10-21,2011-10-21,,C,,25,ug,ORAL,Q3D,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-05,2011-08-05,,,,,C,Y,20,gtt,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TACHIDOL,PANADEINE CO,2011-08-26,2011-08-26,,2011-09-09,2011-09-09,,C,,3,BAG,ORAL,QD,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TACHIDOL,PANADEINE CO,2011-09-09,2011-09-09,,2011-09-23,2011-09-23,,C,,2,BAG,ORAL,QD,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TACHIDOL,PANADEINE CO,2011-09-23,2011-09-23,,,,,C,Y,1,BAG,ORAL,QD,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,1000,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TACHIDOL,PANADEINE CO,2011-07-01,2011-07-01,,2011-07-14,2011-07-14,,C,,1,BAG,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LIMICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-14,2011-07-14,,,,,C,Y,1,VIAL,INTRAVENOUS,every cycle of chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ZANTAC,RANITIDINE HYDROCHLORIDE,2011-07-14,2011-07-14,,,,,C,Y,1,VIAL,INTRAVENOUS,every cycle of chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,HALCION,TRIAZOLAM,2011-07-14,2011-07-14,,2011-07-22,2011-07-22,,C,,1,TABLET,ORAL,QD,PROPHYLAXIS OF INSOMNIA
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-07-14,2011-07-14,,,,,C,Y,40,mg,ORAL,QD,GASTRIC PROTECTION
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-07-14,2011-07-14,,,,,C,Y,25,mg,ORAL,Q3D,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-07-22,2011-07-22,,,,,C,Y,10,mg,ORAL,PRN,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TACHIDOL,PANADEINE CO,2011-07-29,2011-07-29,,2011-08-26,2011-08-26,,C,,1,BAG,ORAL,QID,PROPHYLAXIS OF PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2001,2001-12-31,M,,,,C,Y,1,INJECTION,SUBCUTANEOUS,TID,DIABETES
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,FENTANIL,FENTANYL,2011-11-02,2011-11-02,,,,,C,Y,200,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SCOPOLAMINE BUTYLBROMIDE,HYOSCINE BUTYLBROMIDE,2011-11-02,2011-11-02,,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NADROPARINE,NADROPARIN,2011-11-29,2011-11-29,,,,,C,Y,11400,IU,SUBCUTANEOUS,QD,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ENOXAPARINE,ENOXAPARIN,2011-09-06,2011-09-06,,2011-10-11,2011-10-11,,C,,8000,IU,SUBCUTANEOUS,BID,PULMUNARY EMBOLISM
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-09-27,2011-09-27,,,,,C,Y,40,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CO-EFFERALGAN,PANADEINE CO,2011-09-27,2011-09-27,,2011-10-11,2011-10-11,,C,,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LEVOCARNITINE,LEVOCARNITINE,2011-09-27,2011-09-27,,,,,C,Y,1,g,ORAL,BID,ASTHENIA
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NADROPARINE,NADROPARIN,2011-10-11,2011-10-11,,2011-11-02,2011-11-02,,C,,11400,IU,SUBCUTANEOUS,QD,PULMUNARY EMBOLISM
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TRAMADOLE,TRAMADOL HYDROCHLORIDE,2011-10-11,2011-10-11,,,,,C,Y,20,gtt,ORAL,TID,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2011-10-11,2011-10-11,,2011-10-18,2011-10-18,,C,,1,TABLET,ORAL,BID,PAIN
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,BUPRENORFINE,BUPRENORPHINE,2011-10-18,2011-10-18,,,,,C,Y,1,BAND,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-060-008,01060008,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-08,2011-07-31,D,,,,C,Y,40,mg,ORAL,QD,PROPHYLAXIS ANTI GASTRITIS
CO-101-001,CO-101-001-060-008,01060008,060,73.0,YEARS,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-08,2011-07-31,D,,,,C,Y,8,TABLET,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-060-009,01060009,060,77.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CITALOPRAM,CITALOPRAM,,2012-02-15,Y,,,,C,Y,1,TABLET,ORAL,QD,DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-060-009,01060009,060,77.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LASITONE,OSYROL-LASIX,2012-03-23,2012-03-23,,,,,C,Y,1,TABLET,ORAL,QD,RIGHT LEG OEDEMA
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,VASORETIC,VASERETIC,2000,2000-12-31,M,2012-05-16,2012-05-16,,C,,1/2,TABLET,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2012,2012-03-06,M,,,,C,Y,30,mg,ORAL,QD,PROPHYLAXIS ANTIGASTRITIS
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2012,2012-03-06,M,2012-03-20,2012-03-20,,C,,1000,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DESAMETASONE,DEXAMETHASONE,2012,2012-03-06,M,2012-03-20,2012-03-20,,C,,15,gtt,ORAL,QD,PAIN
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-04-03,2012-04-03,,,,,C,Y,1,TABLET,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOLE,PARACETAMOL,2012-04-17,2012-04-17,,,,,C,Y,1000,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACINE,LEVOFLOXACIN HEMIHYDRATE,2012-05-03,2012-05-03,,2012-05-09,2012-05-09,,C,,1,TABLET,ORAL,QD,FEVER
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,NADROPARINE,NADROPARIN,2012-05-03,2012-05-03,,,,,C,Y,11400,U,SUBCUTANEOUS,QD,PORTAL VEIN THROMBOSIS
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-05-03,2012-05-03,,,,,C,Y,1,TABLET,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2009-07,2009-06-30,D,2011-05-17,2011-05-17,,C,,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2011-05-10,2011-05-10,,,,,C,Y,40,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-04-20,2011-04-20,,2011-05-04,2011-05-04,,P,,20,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-05-09,2011-05-09,,,,,C,Y,20,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,LEVOPROMAZINE,LEVOMEPROMAZINE,2011-05-04,2011-05-04,,,,,C,Y,6.25,mg,ORAL,QD,PAIN RELIEF
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-04,2011-05-04,,2011-05-24,2011-05-24,,C,,50,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CODEINE,CODEINE,2011-05-04,2011-05-04,,,,,C,Y,30,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-05-04,2011-05-04,,2011-05-08,2011-05-08,,P,,40,mg,SUBCUTANEOUS,QD,PREVENTION OF BLOOD CLOTS
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SYMBICORT,BUDESONIDE W/FORMOTEROL FUMARATE,2011-05-04,2011-05-04,,,,,C,Y,200,ug,RESPIRATORY (INHALATION),BID,ASTHMA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2011-05-13,2011-05-13,,2011-05-14,2011-05-14,,C,,1,g,INTRAVENOUS,ONCE,SEPSIS
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,GENTOMYCIN,GENTAMICIN,2011-05-13,2011-05-13,,2011-05-18,2011-05-18,,C,,300,ug,INTRAVENOUS,QD,SEPSIS
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2008,2008-12-31,M,2011-05-09,2011-05-09,,C,,40,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-05-14,2011-05-14,,2011-05-18,2011-05-18,,C,,2,g,INTRAVENOUS,QD,SEPSIS
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ACTRAPID,INSULIN HUMAN,2011-05-20,2011-05-20,,2011-05-23,2011-05-23,,C,,4,IU,SUBCUTANEOUS,ONCE,DIABETES
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2011-05-18,2011-05-18,,,,,C,Y,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-05-18,2011-05-18,,2011-05-24,2011-05-24,,C,,500,mg,ORAL,BID,SEPSIS
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-19,2011-05-19,,2011-05-22,2011-05-22,,C,,4,mg,ORAL,QD,INCREASE APPETITE
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-05-16,2011-05-16,,,,,C,Y,2.5,mg,SUBCUTANEOUS,PRN,PAIN
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,LEVOPROMAZINE,LEVOMEPROMAZINE,2011-05-13,2011-05-13,,2011-05-15,2011-05-15,,C,,6.25,mg,SUBCUTANEOUS,QD,PAIN RELIEF
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ENSURE,NUTRIENTS NOS,2011-05-14,2011-05-14,,2011-05-24,2011-05-24,,C,,1,drink,ORAL,QID,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-23,2011-05-23,,2011-05-24,2011-05-24,,C,,2,mg,ORAL,QD,INCREASE APPETITE
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ACTRAPID,INSULIN HUMAN,2011-05-24,2011-05-24,,2011-05-25,2011-05-25,,C,,4,IU,INTRAVENOUS,ONCE,DIABETES
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,FORMOTEROL,FORMOTEROL,2010,2010-12-31,M,,,,C,Y,6,ug,RESPIRATORY (INHALATION),BID,ASTHMA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2011-05-04,2011-05-04,,2011-05-05,2011-05-05,,P,,1000,mL,INTRAVENOUS,BID,HYDRATION
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM SULPHATE,MAGNESIUM SULFATE,2011-05-04,2011-05-04,,2011-05-04,2011-05-04,,P,,8,mol,INTRAVENOUS,BID,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,BUDESONIDE,BUDESONIDE,2010,2010-12-31,M,,,,C,Y,200,mg,RESPIRATORY (INHALATION),BID,ASTHMA
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2009,2009-12-31,M,2011-05-09,2011-05-09,,C,,80,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,IRBESARTAN,IRBESARTAN,2009,2009-12-31,M,2011-05-09,2011-05-09,,C,,150,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,FELODIPINE,FELODIPINE,2009,2009-12-31,M,2011-05-13,2011-05-13,,C,,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,FRESUBIN,CARBOHYDRATES NOS W/FATTY ACIDS NOS/MINERALS,2011-03-18,2011-03-18,,,,,C,Y,200,mL,ORAL,PRN,NUTRIONAL SUPPLEMENT
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,SALBUTAMOL,SALBUTAMOL,2011-03-18,2011-03-18,,2011-05-13,2011-05-13,,C,,100,ug,RESPIRATORY (INHALATION),PRN,ASTHMA
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-08-03,2011-08-03,,,,,C,Y,20,mg,ORAL,QID,NAUSEA AND VOMITING
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CEPHALEXIN,CEFALEXIN,2011-09-01,2011-09-01,,2011-09-07,2011-09-07,,C,,500,mg,ORAL,QID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2011-09-05,2011-09-05,,2011-09-13,2011-09-13,,C,,20,mg,ORAL,QD,FEET OEDEMA
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TRIMETHOPRIM,TRIMETHOPRIM,2011-09-08,2011-09-08,,2011-09-11,2011-09-11,,C,,200,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ORALDENE,HEXETIDINE,2011-09-12,2011-09-12,,,,,C,Y,15,mL,ORAL,BID,MUCOSITIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2011-09-19,2011-09-19,,2011-10-11,2011-10-11,,C,,40,mg,ORAL,QD,FEET OEDEMA
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXIN,CIPROFLOXACIN,2011-09-13,2011-09-13,,2011-09-18,2011-09-18,,C,,250,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,SODIUM DOCUSATE,DOCUSATE SODIUM,2011-09-19,2011-09-19,,,,,C,Y,1,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ACICLOVIR CREAM,ACICLOVIR,2011-09-19,2011-09-19,,,,,C,Y,1,APPLICATION,TOPICAL,TID,MUCOSITIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,AQUEOUS CREAM,EMULSIFYING WAX,2011-09-11,2011-09-11,,,,,C,Y,1,APPLICATION,TOPICAL,PRN,RASH
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,VITAMIN K,VITAMIN K NOS,2011-09-25,2011-09-25,,2011-09-27,2011-09-27,,C,,10,mg,INTRAVENOUS,QD,UNSTABLE CLOTTING
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-13,2011-07-13,,,,,C,Y,4,mg,ORAL,QD,INCREASE APPETITE
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,GENTAMICIN,GENTAMICIN,2011-09-28,2011-09-28,,2011-09-28,2011-09-28,,C,,80,g,INTRAVENOUS,ONCE,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-09-25,2011-09-25,,2011-10-07,2011-10-07,,C,,2,TABLET,ORAL,QD,CONSIPATION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-10-03,2011-10-03,,2011-10-07,2011-10-07,,C,,4.5,mg,INTRAVENOUS,TID,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2011-09-26,2011-09-26,,2011-10-05,2011-10-05,,C,,750,mg,INTRAVENOUS,BID,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,SANDO-K,POTASSIUM-SANDOZ,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,2,TABLET,ORAL,BID,HYPOKALAEMIA
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,SPRINOLACTONE,SPIRONOLACTONE,2011-09-28,2011-09-28,,2011-10-12,2011-10-12,,C,,50,mg,ORAL,QD,FLUID RETENTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,GENTAMICIN,GENTAMICIN,2011-10-05,2011-10-05,,2011-10-06,2011-10-06,,C,,330,mg,INTRAVENOUS,ONCE,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,TINZAPRIN,TINZAPARIN,2011-10-09,2011-10-09,,2011-10-13,2011-10-13,,C,,1800,U,SUBCUTANEOUS,QD,PREVENT PE AND CLOTTING
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,ENSURE TWOCAL,NUTRIENTS NOS,2011-09-30,2011-09-30,,2011-10-13,2011-10-13,,C,,200,mL,ORAL,BID,INCREASE APPETITE
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2011-10-01,2011-10-01,,,,,C,Y,1,gtt,TOPICAL,QID,MUCOSITIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,FINASTERIDE,FINASTERIDE,2011-07-13,2011-07-13,,,,,C,Y,5,mg,ORAL,QD,ENLARGED PROSTATE
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-09-30,2011-09-30,,2011-10-03,2011-10-03,,C,,625,mg,ORAL,TID,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-10-04,2011-10-04,,,,,C,Y,"20,000",U,ORAL,TID,AID DIGESTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ACICLOVIR TABLETS,ACICLOVIR,2011-10-04,2011-10-04,,2011-10-09,2011-10-09,,C,,400,mg,ORAL,5 TIMES PER DAY,MUCOSITIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,MEROPENEM,MEROPENEM,2011-10-05,2011-10-05,,2011-10-13,2011-10-13,,C,,1,g,INTRAVENOUS,TID,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,PHOSPHATE ENEMA,ENEMAS,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,1,TABLET,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-10-11,2011-10-11,,2011-10-13,2011-10-13,,C,,500,mg,ORAL,BID,INFECTION - SEPSIS
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2011-07-13,2011-07-13,,,,,C,Y,30,mg,ORAL,QD,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,ZOMORPH,MORPHINE SULFATE,2011-07-13,2011-07-13,,,,,C,Y,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-07-13,2011-07-13,,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-08-15,2011-08-15,,2011-08-25,2011-08-25,,C,,625,mg,ORAL,TID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-08-24,2011-08-24,,2011-08-25,2011-08-25,,C,,10,g,ORAL,QID,CONSTIPATION
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-08-25,2011-08-25,,,,,C,Y,1,SACHET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-10-27,2011-10-27,,,,,C,Y,20,mg,ORAL,BID,DYSPEPSIA
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-12-14,2011-12-14,,,,,C,Y,90,mg,SUBCUTANEOUS,QD,LEFT FEMORAL VEIN THROMBOSIS
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,2 UNITS BLOOD,"BLOOD, WHOLE",2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,2,IU,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2011-12-21,2011-12-21,,2011-12-22,2011-12-22,,C,,20,mg,ORAL,BID,PREVENTION OF FLUID OVERLOAD DURING BLOOD TRANSFUSION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FLUCOXACILLIN,FLUCLOXACILLIN,2012-01-25,2012-01-25,,2012-02-04,2012-02-04,,C,,500,mg,ORAL,QID,CELLULITIS
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,2 UNITS BLOOD,"BLOOD, WHOLE",2012-02-02,2012-02-02,,2012-02-02,2012-02-02,,C,,2,IU,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02-02,2012-02-02,,,,,C,Y,1,g,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-02-15,2012-02-15,,,,,C,Y,30,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2012-02-15,2012-02-15,,,,,C,Y,10,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2012-02-15,2012-02-15,,,,,C,Y,"10,000",IU,ORAL,QID,DIARRHOEA AND MALABSORPTION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FLOCOXACILLIN,FLUCLOXACILLIN,2012-02-15,2012-02-15,,2012-02-22,2012-02-22,,C,,1,g,ORAL,QID,EAR INFECTION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-28,2011-10-28,,,,,C,Y,10,mg,ORAL,TID,NAUSEA AND VOMITING
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,METACLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,10,mg,SUBCUTANEOUS,ONCE,VOMITING
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-10-20,2011-10-20,,2011-10-28,2011-10-28,,P,,4,mg,INTRAVENOUS,QD,NAUSEA
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-10-20,2011-10-20,,,,,C,Y,5,mg,ORAL,PRN,PAIN RELIEF
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-20,2011-10-20,,2011-10-28,2011-10-28,,P,,1,g,INTRAVENOUS,QID,PAIN RELIEF
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-10-20,2011-10-20,,2011-10-25,2011-10-25,,P,,40,mg,INTRAVENOUS,QD,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-03-07,2012-03-07,,2012-03-10,2012-03-10,,C,,10,mg,ORAL,TID,ANTIEMETIC
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2012-03-07,2012-03-07,,,,,C,Y,10,mL,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2012-03-07,2012-03-07,,,,,C,Y,15,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,METACLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-09,2012-03-09,,,,,C,Y,10,mg,ORAL,TID,ANTIEMETIC
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,PSEUDOEPHEDRINE HYDROCHLORIDE,PSEUDOEPHEDRINE HYDROCHLORIDE,2012-03-09,2012-03-09,,2012-03-10,2012-03-10,,C,,60,mg,RESPIRATORY (INHALATION),TID,DECONGESTANT
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-11-09,2011-11-09,,2012-02-14,2012-02-14,,C,,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-08,2012-03-08,,2012-03-22,2012-03-22,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-10-28,2011-10-28,,2012-02-01,2012-02-01,,C,,500,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-20,2011-10-20,,2011-11-28,2011-11-28,,C,,100,mg,ORAL,QD,PULMONARY EMBOLUS
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-10-28,2011-10-28,,2011-11-15,2011-11-15,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-11-16,2011-11-16,,2012-02-14,2012-02-14,,C,,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-11-09,2011-11-09,,2011-11-10,2011-11-10,,C,,200,mg,ORAL,QD,HEADACHE
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-11-22,2011-11-22,,2011-11-23,2011-11-23,,C,,16,mmol,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07,2011-06-30,D,,,,C,Y,500,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,SITAGLIPTIN,SITAGLIPTIN,2009,2009-12-31,M,,,,C,Y,100,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,WELLWOMEN VITABIOTICS 70+,"VITAMINS, OTHER COMBINATIONS",2011-12-20,2011-12-20,,,,,C,Y,1,TABLET,ORAL,QD,VITAMIN SUPPLEMENT
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ROBITUSSIN COUGH AND COLD,NOVAHISTINE DMX,2011-12-26,2011-12-26,,,,,C,Y,10,mL,ORAL,QID,COLD
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,HYDROCORTISONE,HYDROCORTISONE,2012-02-02,2012-02-02,,2012-02-16,2012-02-16,,C,,1,APPLICATION,TOPICAL,BID,SKIN IRRITATION
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-02-27,2012-02-27,,2012-03-12,2012-03-12,,C,,500,mg,ORAL,BID,PROPHYLAXIS FOR STENT CHANGE
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-02-20,2012-02-20,,2012-02-27,2012-02-27,,C,,625,mg,ORAL,TID,PROPHYLAXIS AGAINST BILIARY SEPSIS
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-10-21,2011-10-21,,2012-03-12,2012-03-12,,C,,15,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-03-13,2012-03-13,,2012-06-06,2012-06-06,,C,,20,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-03-13,2012-03-13,,,,,C,Y,20,mg,ORAL,BID,EPIGASTRIC DISCOMFORT
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,INDAPADMIDE,INDAPAMIDE,2012-04-22,2012-04-22,,2012-05-04,2012-05-04,,C,,2.5,mg,ORAL,QD,BILATERAL OEDEMA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-07,2011-06-30,D,,,,C,Y,50,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,VISCOTEARS,CARBOMER,2012-05-04,2012-05-04,,,,,C,Y,2,gtt,OPHTHALMIC,QID,DRY EYES
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2012-05-14,2012-05-14,,2012-07-02,2012-07-02,,C,,40,mg,ORAL,QD,ANKLE AND LEG OEDEMA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-06-07,2012-06-07,,2012-07-02,2012-07-02,,C,,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DIFFLAM MOUTH WASH,BENZYDAMINE HYDROCHLORIDE,2012-03-13,2012-03-13,,,,,C,Y,15,mL,TOPICAL,PRN,MUCOSITIS
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,FRUSEMIDE,FUROSEMIDE,2012-07-03,2012-07-03,,,,,C,Y,20,mg,ORAL,QD,ANKLE AND LEG OEDEMA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-07-03,2012-07-03,,2012-09-23,2012-09-23,,C,,40,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-09-24,2012-09-24,,,,,C,Y,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-08-08,2012-08-08,,2012-08-12,2012-08-12,,C,,4,mg,ORAL,QD,STIMULATE APPETITE
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2012-10-17,2012-10-17,,,,,C,Y,2,TABLET,ORAL,BID,STOMACH PAIN
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-11-07,2011-11-07,,,,,C,Y,20,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2009,2009-12-31,M,,,,C,Y,500,mg,ORAL,TID,DIABETES
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,DEXMATHASONE,,2012-07-30,2012-07-30,,2012-08-03,2012-08-03,,C,,4,mg,ORAL,QD,STIMULATE APPETITE
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,1993,1993-12-31,M,2012-06-06,2012-06-06,,C,,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,DOXAZOSIN,DOXAZOSIN,1993,1993-12-31,M,,,,C,Y,4,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2010,2010-12-31,M,2012-03-12,2012-03-12,,C,,20,mg,ORAL,QD,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2007,2007-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCHOLESTEREMIA
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-07,2011-06-30,D,,,,C,Y,25000,IU,ORAL,TID,MALABSORPTION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2011-09,2011-08-31,D,2012-05-01,2012-05-01,,C,,50,ug,TOPICAL,Q3D,BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,NAPROXEN,NAPROXEN,2011-09,2011-08-31,D,2012-05-01,2012-05-01,,C,,500,mg,ORAL,BID,REDUCE INFLAMMATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-09,2011-08-31,D,2011-12-01,2011-12-01,,C,,1,g,ORAL,QID,PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DALTEPARIN,DALTEPARIN,2011-09,2011-08-31,D,,,,C,Y,10000,IU,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,BENZYDAMINE,BENZYDAMINE,2011-09,2011-08-31,D,2012-05-01,2012-05-01,,C,,15,mL,ORAL,TID,ANTI-INFLAMMATORY
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2011-09,2011-08-31,D,2011-12-01,2011-12-01,,C,,10,mL,ORAL,PRN,PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2011-09,2011-08-31,D,2012-01-22,2012-01-22,,C,,2,mg,ORAL,BID,ANXIETY/DEPRESSION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2011-11-29,2011-11-29,,2011-12-05,2011-12-05,,C,,250,mg,ORAL,TID,CHEST INFECTION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-11-28,2011-11-28,,,,,C,Y,20,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-11-30,2011-11-30,,2012-01-22,2012-01-22,,C,,160,mg,ORAL,BID,ABDOMINAL AND BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,IRON TABLETS,IRON,2011-11-20,2011-11-20,,2012-05-01,2012-05-01,,C,,200,mg,ORAL,QD,SUPPLEMENTS
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-09,2011-08-31,D,2011-11-29,2011-11-29,,C,,60,mg,ORAL,BID,ABDOMINAL AND BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,VITAMIN B COMPLEX,VITAMIN B COMPLEX,2011-11-20,2011-11-20,,,,,C,Y,2,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,GLUCOSAMINE,GLUCOSAMINE,2011-11-20,2011-11-20,,2012-05-01,2012-05-01,,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OMEGA 3,FISH OIL,2011-11-20,2011-11-20,,2012-05-01,2012-05-01,,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2011-11-30,2011-11-30,,2012-05-01,2012-05-01,,C,,300,mg,ORAL,BID,BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2012-01-23,2012-01-23,,2012-05-01,2012-05-01,,C,,5,mg,ORAL,QID,ANXIETY AND DEPRESSION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-01-23,2012-01-23,,2012-05-01,2012-05-01,,C,,120,mg,ORAL,BID,ABDOMINAL AND BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,COD LIVER OIL,COD-LIVER OIL,2012-02-07,2012-02-07,,2012-05-01,2012-05-01,,C,,1000,mg,ORAL,BID,SUPPLEMENT
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLOV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-04-13,2012-04-13,,2012-04-15,2012-04-15,,C,,250,mg,ORAL,TID,COLD INFECTION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-04-24,2012-04-24,,2012-05-01,2012-05-01,,C,,250,mg,ORAL,TID,CHEST INFECTION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2012-05-09,2012-05-09,,,,,C,Y,300,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2011-09,2011-08-31,D,2011-11-29,2011-11-29,,C,,200,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2012-05-09,2012-05-09,,,,,C,Y,10,mg,ORAL,QD,ANXIETY AND DEPRESSION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,SODIUM DOCUSATE,DOCUSATE SODIUM,2012-05-09,2012-05-09,,,,,C,Y,200,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2012-05-09,2012-05-09,,,,,C,Y,150,ug,TOPICAL,Q3D,BACK AND ABDOMINAL PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2012-05-09,2012-05-09,,,,,C,Y,10,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-05-09,2012-05-09,,,,,C,Y,4,mg,ORAL,QD,STIMULATE APPETITE
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,GLYCEROL SUPPOSITORY,GLYCEROL,2012-05-22,2012-05-22,,2012-05-23,2012-05-23,,C,,1,TABLET,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,PHOSPHATE ENEMAS,ENEMAS,2012-05-21,2012-05-21,,,,,C,Y,1,TABLET,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,ZOPLICONE,ZOPICLONE,2011-09,2011-08-31,D,2011-11-14,2011-11-14,,P,,7.5,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2011-09,2011-08-31,D,,,,C,Y,30,mg,ORAL,QD,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,FLUOXETINE,FLUOXETINE,2010-05,2010-04-30,D,,,,C,Y,40,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-09,2011-08-31,D,2011-12-01,2011-12-01,,C,,2,SACHET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2010-05,2010-04-30,D,2011-12-01,2011-12-01,,C,,10,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,ENSURE,NUTRIENTS NOS,2011-09,2011-08-31,D,,,,C,Y,1,SERVING,ORAL,BID,NUTRIONAL SUPPLEMENT
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-01-26,2012-01-26,,2012-04-25,2012-04-25,,,,,,,,
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12-06,2011-12-06,,,,,C,Y,10,mg,ORAL,QD,PROPHYLACTIC AGAINST DYSPEPSIA
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-06,2011-12-06,,,,,C,Y,2,mg,ORAL,QD,INCREASE APPETITE
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-09,2011-08-31,D,,,,C,Y,500,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-12-06,2011-12-06,,,,,C,Y,2,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2009,2009-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2009,2009-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCHOLESTEREMIA
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2011-12-06,2011-12-06,,,,,C,Y,50,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-12-06,2011-12-06,,,,,C,Y,10000,IU,ORAL,TID,AIDS ABSORPTION
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-12-06,2011-12-06,,,,,C,Y,5,mg,ORAL,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN,ENOXAPARIN,2011-12-10,2011-12-10,,,,,C,Y,90,mg,SUBCUTANEOUS,QD,PREVIOUS DVT AND MULTIPLE PE
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-12-06,2011-12-06,,,,,C,Y,2.5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABINE AND OXALIPLATIN,,2012-08-13,2012-08-13,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12-21,2011-12-21,,2012-03-25,2012-03-25,,C,,20,mg,ORAL,BID,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-12-21,2011-12-21,,2012-05-21,2012-05-21,,C,,10,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-12-21,2011-12-21,,2012-03-26,2012-03-26,,C,,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,AMITRIPTYLINE,AMITRIPTYLINE,2011-12-21,2011-12-21,,,,,C,Y,10,mg,ORAL,QHS,DEPRESSION
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-12-21,2011-12-21,,,,,C,Y,15,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LANSOPRAZOLE,LANSOPRAZOLE,2012-03-26,2012-03-26,,,,,C,Y,30,mg,ORAL,BID,GASTRIC ACIDITY
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-03-27,2012-03-27,,,,,C,Y,40,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-05-22,2012-05-22,,,,,C,Y,20,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2012-07-02,2012-07-02,,,,,C,Y,50,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,PHASE I/II OPEN-LABEL DOSE-ESCALATION CLINICAL TRIAL OF CPI-613 IN COMBINATION WITH GEMCITABINE IN CANCER PATIENTS,,2012-04-02,2012-04-02,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CO-CODAMOL,PANADEINE CO,2012-01-09,2012-01-09,,2012-02-08,2012-02-08,,C,,2,TABLET,ORAL,QID,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXIN,CIPROFLOXACIN,2012-02-15,2012-02-15,,,,,C,Y,500,mg,ORAL,QD,PROPHYLACTIC AGAINST INFECTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-01-23,2012-01-23,,,,,C,Y,120,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLI
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-02-09,2012-02-09,,2012-02-10,2012-02-10,,C,,1.2,g,INTRAVENOUS,TID,INFUSION-RELATED REACTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-02-16,2012-02-16,,2012-02-17,2012-02-17,,C,,4.5,g,INTRAVENOUS,TID,INFUSION RELATED REACTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-02-15,2012-02-15,,2012-02-17,2012-02-17,,C,,1000,mL,INTRAVENOUS,BID,INFUSION RELATED REACTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-03-09,2012-03-09,,2012-03-10,2012-03-10,,C,,4.5,g,INTRAVENOUS,TID,INFUSION RELATED REACTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-03-08,2012-03-08,,2012-03-10,2012-03-10,,C,,1000,mL,INTRAVENOUS,BID,INFUSION RELATED REACTION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2012-03-07,2012-03-07,,,,,C,Y,50,mg,ORAL,TID,ANTIEMETIC
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-02-15,2012-02-15,,,,,C,Y,120,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLI
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-02-15,2012-02-15,,,,,C,Y,20,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-09,2012-01-09,,2012-02-08,2012-02-08,,C,,1,g,ORAL,PRN,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-02-23,2012-02-23,,2012-02-24,2012-02-24,,C,,75,ug,SUBCUTANEOUS,ONCE,ERCP PROCEDURE
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,GLUCAGON,GLUCAGON,2012-02-23,2012-02-23,,2012-02-24,2012-02-24,,C,,1,mg,SUBCUTANEOUS,ONCE,ERCP PROCEDURE
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-02-23,2012-02-23,,2012-02-24,2012-02-24,,C,,4,mg,SUBCUTANEOUS,ONCE,ERCP PROCEDURE
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,XYLOCAINE,LIDOCAINE,2012-02-23,2012-02-23,,2012-02-24,2012-02-24,,C,,100,ug,SUBCUTANEOUS,ONCE,ERCP PROCEDURE
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2012-01-23,2012-01-23,,2012-01-24,2012-01-24,,P,,50,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,BENDROFLUMETHIAZIDE,BENDROFLUMETHIAZIDE,2009,2009-12-31,M,,,,C,Y,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,SODIUM DOCUSATE,DOCUSATE SODIUM,2012-01-09,2012-01-09,,,,,C,Y,100,mg,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-02-08,2012-02-08,,2012-02-17,2012-02-17,,C,,25,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-02-18,2012-02-18,,,,,C,Y,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-02-08,2012-02-08,,,,,C,Y,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,CO-AMOXICLAV,AMOXICILLIN W/CLAVULANATE POTASSIUM,2012-02-11,2012-02-11,,2012-02-17,2012-02-17,,C,,500,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2009-10-08,2009-10-08,,2010-03-31,2010-03-31,,,,,,,,
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,PRIOR RADIOTHERAPY,RADIOTHERAPY,PANCREAS,,2010-05-17,2010-05-17,,2010-06-15,2010-06-15,,,,50.4,Gy,,,
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,CAPECITABINE,,2010-05-17,2010-05-17,,2010-06-15,2010-06-15,,,,,,,,
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2007-08-30,2007-08-30,,2012-06-23,2012-06-23,,C,,850,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ADCAL D3,LEKOVIT CA,2010-01-08,2010-01-08,,,,,C,Y,1,TABLET,ORAL,BID,VITAMIN D SUPPLEMENTS
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2010-06-07,2010-06-07,,,,,C,Y,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE,SODIUM CHLORIDE,2009,2009-12-31,M,,,,C,Y,600,mg,ORAL,QD,HYPONATREMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SODIUM DUCOSATE,DOCUSATE SODIUM,2012-02-27,2012-02-27,,,,,C,Y,100,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2012-02-01,2012-02-01,,,,,C,Y,15,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02-01,2012-02-01,,,,,C,Y,1,g,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-03-05,2012-03-05,,,,,C,Y,1,SACHET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CO-DYDRAMOL,PARAMOL-118,2012-03-05,2012-03-05,,,,,C,Y,2,TABLET,ORAL,BID,LEFT QUADRANT PAIN
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SUGAR-FREE GAVISCON,GASTRON                            /00902401/,2012-03-12,2012-03-12,,,,,C,Y,1,TABLET,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PIRITON,CHLORPHENAMINE MALEATE,2012-03-26,2012-03-26,,,,,C,Y,4,mg,ORAL,QD,SKIN RASH ON ARMS
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ATORVASTATIN,ATORVASTATIN,2010-01-08,2010-01-08,,2012-06-23,2012-06-23,,C,,20,mg,ORAL,QD,HYPERCHOLESTEREMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,UREA CREAM,UREA,2012-03-26,2012-03-26,,,,,C,Y,1,APPLICATION,TOPICAL,PRN,SKIN RASH ON ARMS
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEMECLOCYCLINE HYDROCHLORIDE,DEMECLOCYCLINE HYDROCHLORIDE,2012-03-21,2012-03-21,,,,,C,Y,150,mg,ORAL,BID,SIADH
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-03-12,2012-03-12,,2012-03-13,2012-03-13,,C,,20,mmol,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-04-02,2012-04-02,,2012-04-03,2012-04-03,,C,,20,mmol,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-04-30,2012-04-30,,2012-05-01,2012-05-01,,C,,20,mmol,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,2 UNITS BLOOD,"BLOOD, WHOLE",2012-06-25,2012-06-25,,2012-06-26,2012-06-26,,C,,2,IU,INTRAVENOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-07-02,2012-07-02,,2012-07-03,2012-07-03,,C,,20,mmol,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-07-16,2012-07-16,,2012-08-03,2012-08-03,,C,,4,mg,ORAL,QD,STIMULATE APPETITE
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,FLUCONAZOLE,FLUCONAZOLE,2012-08-13,2012-08-13,,,,,C,Y,100,mg,ORAL,QD,COLD INFECTION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-07-30,2012-07-30,,2012-07-31,2012-07-31,,C,,1,g,INTRAVENOUS,ONCE,HYPOMAGNESEMIA
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,RAMIPRIL,RAMIPRIL,2007-08-30,2007-08-30,,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2007-08-30,2007-08-30,,2012-06-23,2012-06-23,,C,,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2003,2003-12-31,M,,,,C,Y,12,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2003,2003-12-31,M,,,,C,Y,6,IU,SUBCUTANEOUS,QHS,DIABETES
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2010-01-08,2010-01-08,,,,,C,Y,"20,000",IU,ORAL,TID,MALABSORPTION
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,PIOGLITAZONE,PIOGLITAZONE,2011-07-13,2011-07-13,,2012-06-23,2012-06-23,,C,,30,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,GLICAZIDE,GLICLAZIDE,2010-11-08,2010-11-08,,2012-03,2012-03-31,D,C,,120,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-02-03,2012-02-03,,2012-03-22,2012-03-22,,C,,120,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLI
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-20,2012-02-20,,2012-03-17,2012-03-17,,C,,2,g,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-02-20,2012-02-20,,2012-02-27,2012-02-27,,P,,625,mg,ORAL,TID,INFECTION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2012-03-07,2012-03-07,,2012-03-23,2012-03-23,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ODANSETRON,ONDANSETRON,2012-03-17,2012-03-17,,2012-03-23,2012-03-23,,C,,4,mg,INTRAVENOUS,TID,ANTIEMETIC
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CYCLIZINE,CYCLIZINE,2012-03-17,2012-03-17,,2012-03-23,2012-03-23,,C,,50,mg,INTRAVENOUS,TID,ANTIEMETIC
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,HALOPERIDOL,HALOPERIDOL,2012-03-18,2012-03-18,,2012-03-23,2012-03-23,,C,,1.0,mg,SUBCUTANEOUS,QD,HICCUPS
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-03-18,2012-03-18,,2012-03-20,2012-03-20,,C,,1.2,g,INTRAVENOUS,QID,ANTIBIOTICS
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2012-03-19,2012-03-19,,2012-03-22,2012-03-22,,C,,40,mg,INTRAVENOUS,QD,PROPHYLAXIS AGAINST ABDOMINAL IRRITATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SALINE NEBS,SODIUM CHLORIDE,2012-03-20,2012-03-20,,2012-03-23,2012-03-23,,C,,5,mL,RESPIRATORY (INHALATION),5 TIMES PER DAY,STABILISE DESATURATED OXYGEN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2012-03-20,2012-03-20,,2012-03-23,2012-03-23,,C,,4.5,mg,INTRAVENOUS,TID,ANTIBIOTICS
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SODIUM DOCUSATE,DOCUSATE SODIUM,2012-02-13,2012-02-13,,2012-03-19,2012-03-19,,C,,100,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SALBULTAMOL,SALBUTAMOL,2012-03-19,2012-03-19,,2012-03-23,2012-03-23,,C,,2.5,mL,RESPIRATORY (INHALATION),QID,STABILIZING DESATURATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SALINE,SODIUM CHLORIDE,2012-03-17,2012-03-17,,2012-03-28,2012-03-28,,C,,1,L,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DIAMORPHINE,DIAMORPHINE,2012-03-24,2012-03-24,,2012-03-25,2012-03-25,,C,,2.5,mg,SUBCUTANEOUS,ONCE,PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2012-03-24,2012-03-24,,2012-03-25,2012-03-25,,C,,2.5,mg,SUBCUTANEOUS,PRN,SEDATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,GLYCOPYRONIUM,GLYCOPYRRONIUM BROMIDE,2012-03-24,2012-03-24,,2012-03-25,2012-03-25,,C,,2.5,mg,SUBCUTANEOUS,PRN,REDUCTION OF GASTRIC ACID SECRETION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-03-24,2012-03-24,,2012-03-25,2012-03-25,,C,,2.5,mg,SUBCUTANEOUS,QID,PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2012-02-13,2012-02-13,,2012-03-17,2012-03-17,,C,,1,SACHET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02-13,2012-02-13,,2012-03-23,2012-03-23,,C,,1,g,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-02-13,2012-02-13,,2012-03-20,2012-03-20,,C,,20,mg,ORAL,QD,PROPHYLAXIS AGAINST GASTRIC ULCERATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,CODEINE,CODEINE,2012-02-13,2012-02-13,,2012-03-17,2012-03-17,,C,,30,mg,ORAL,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ORAMORPH,MORPHINE SULFATE PENTAHYDRATE,2012-02-20,2012-02-20,,2012-03-17,2012-03-17,,C,,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CODANTHRAMER,DANTRON W/POLOXALCOL,2012-02-20,2012-02-20,,2012-03-17,2012-03-17,,C,,2,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2012-02-20,2012-02-20,,2012-03-17,2012-03-17,,C,,20,mg,ORAL,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FOLIC ACID,FOLIC ACID,2010-04,2010-03-31,D,,,,C,Y,1,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-06-09,2011-06-09,,2011-07-14,2011-07-14,,C,,2,mg,ORAL,every 3-4 hours,PAIN - ADENOCARCINOMA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PROCHOLORPERAZINE,PROCHLORPERAZINE,2011-06-02,2011-06-02,,,,,C,Y,5,mg,ORAL,"Days 1, 8, 15",NAUSEA (PROPHYLAXIS)
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2011-07-14,2011-07-14,,2011-07-29,2011-07-29,,C,,15,mg,ORAL,BID,PAIN - ADENOCARCINOMA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BOOST SHAKE,BIOTIN W/CARBOHYDRATES NOS/FATS NOS/MINERALS,2011-03,2011-02-28,D,,,,C,Y,one,CAN,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SIMETHICONE,SIMETICONE,2011-06-12,2011-06-12,,,,,C,Y,1-2,TABLET,ORAL,PRN,BLOATING
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DUCOLAX,BISACODYL,2011,2011-06-02,M,,,,C,Y,3,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SENOKOT-S,SENOKOT-S,2011-07-02,2011-07-02,,,,,C,Y,2,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2011-06-16,2011-06-16,,,,,C,Y,17,g,ORAL,QHS,CONSTIPATION
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MILK OF MAGNESIA,MAGNESIUM HYDROXIDE,2011-06-20,2011-06-20,,,,,C,Y,60,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2011-07-29,2011-07-29,,,,,C,Y,30,mg,ORAL,BID,PAIN - ADENOCARCINOMA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LOSARTAN,LOSARTAN,2011-04,2011-03-31,D,,,,C,Y,50,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-06-17,2011-06-17,,2011-06-17,2011-06-17,,C,,20,mg,INTRAVENOUS,ONCE,TRANSFUSION PROPHYLAXIS
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,AMBIEN,ZOLPIDEM TARTRATE,2011-05-19,2011-05-19,,2011-05-25,2011-05-25,,P,,5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AMBIEN CR,ZOLPIDEM TARTRATE,2011-05-26,2011-05-26,,,,,C,Y,12.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MARINOL (DRONABINOL),DRONABINOL,2011-05-26,2011-05-26,,,,,C,Y,2.5,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2011,2011-06-02,M,2011-06-06,2011-06-06,,C,,650,mg,ORAL,PRN,PAIN - ADENOCARCINOMA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-06-06,2011-06-06,,2011-06-09,2011-06-09,,C,,800,mg,ORAL,PRN,PAIN - ADENOCARCINOMA
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ZYRTEC,CETIRIZINE HYDROCHLORIDE,2011-06-20,2011-06-20,,,,,C,Y,10,mg,ORAL,PRN,SEASONAL ALLERGY
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-12-30,2011-12-30,,2012-01-04,2012-01-04,,C,,0.25,mg,ORAL,BID,ANXIETY
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LEXAPRO,ESCITALOPRAM OXALATE,2001,2001-12-31,M,,,,C,Y,20,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SENEKOT,SENNA ALEXANDRINA,2011-12-30,2011-12-30,,2012-01-01,2012-01-01,,C,,8.6,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,P,,875-125,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-09,2011-12-09,,2011-12-09,2011-12-09,,C,,10,mg,INTRAVENOUS,ONCE,PRE-MEDICATION FOR CHEMO
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-12-12,2011-12-12,,2011-12-15,2011-12-15,,C,,2,mg,INTRAVENOUS,PRN,METASTATIC PANCREATIC ADENOCARCINOMA PAIN
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ANCEF,CEFAZOLIN SODIUM,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,2,g,INTRAVENOUS,ONCE,INFECTION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DUCOLAX,BISACODYL,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,10,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,NORVASC,AMLODIPINE BESILATE,2011-11-19,2011-11-19,,2011-12-18,2011-12-18,,C,,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2001,2001-12-31,M,,,,C,Y,10,mg,ORAL,QHS,HYPERLIPIDEMIA
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DIOVAN,VALSARTAN,2011-11-14,2011-11-14,,2011-12-09,2011-12-09,,C,,80,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,PEPCID,FAMOTIDINE,2011-12-12,2011-12-12,,2011-12-16,2011-12-16,,C,,20,mg,INTRAVENOUS,QD,HEARTBURN
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,OLMESARTAN-HYDROCHLORTHIAZIDE,HYDROCHLOROTHIAZIDE W/OLMESARTAN,2001,2001-12-31,M,,,,C,Y,20-12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2011-12-29,2011-12-29,,2012-01-06,2012-01-06,,C,,7.5,mg,SUBCUTANEOUS,QD,PULMONARY EMBOLISM
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-01-05,2012-01-05,,2012-01-10,2012-01-10,,C,,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,NORCO,VICODIN,2011-12-10,2011-12-10,,2012-01-10,2012-01-10,,C,,5-325,mg,ORAL,PRN,METASTATIC PANCREATIC ADENOCARCINOMA PAIN
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-09,2011-12-09,,2012-01-08,2012-01-08,,C,,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2012-01-06,2012-01-06,,2012-01-10,2012-01-10,,C,,150,mg,SUBCUTANEOUS,QD,ANTICOAGULANT
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-12-26,2011-12-26,,2012-01-10,2012-01-10,,C,,100,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,TOPROL,METOPROLOL SUCCINATE,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,25,mg,ORAL,ONCE,HYPERTENSION
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,RESTORIL (TEMAZEPAM),TEMAZEPAM,2011-12-12,2011-12-12,,,,,C,Y,15,mg,ORAL,QHS,METASTATIC PANCREATIC ADENOCARCINOMA RELATED INSOMNIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-09-21,2010-09-21,,,,,C,Y,12,mg,SUBCUTANEOUS,with chemotherapy,PRE-CHEMO MED
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SYNTHROID,LEVOTHYROXINE SODIUM,2005,2005-12-31,M,,,,C,Y,0.1,mg,ORAL,QD,HYPOTHYROID
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DOLASETRON MESYLATE,DOLASETRON MESILATE,2010-11-16,2010-11-16,,,,,C,Y,100,mg,ORAL,PRN,CHEMO PRE MED
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PROVENTIL INHALER,SALBUTAMOL,1962,1962-12-31,M,,,,C,Y,PRN,PUFF,RESPIRATORY (INHALATION),PRN,ASTHMA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,1950,1950-12-31,M,,,,C,Y,25,mg,ORAL,PRN,SEASONAL ALLERGIES
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DIGOXIN,DIGOXIN,2011-08-26,2011-08-26,,,,,C,Y,0.125,mg,ORAL,QD,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ATROVENT HFA,IPRATROPIUM BROMIDE,2011-08-26,2011-08-26,,,,,C,Y,2,PUFF,RESPIRATORY (INHALATION),QID,COPD
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TAMBOCOR,FLECAINIDE ACETATE,2011-08-26,2011-08-26,,,,,C,Y,100,mg,ORAL,BID,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LEVEQUIN,LEVOFLOXACIN,2011-08-27,2011-08-27,,2011-09-02,2011-09-02,,C,,500,mg,ORAL,QD,INFECTION
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2011-08-28,2011-08-28,,2011-09-02,2011-09-02,,C,,40/20,mg,ORAL,QD,COPD
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2011-07-17,2011-07-17,,,,,C,Y,325,mg,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2010-09-13,2010-09-13,,,,,C,Y,5,mg,ORAL,QID,GASTROESOPHAGEAL REFLUX DISEASE
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CARDIZEM CD,DILTIAZEM HYDROCHLORIDE,2011-07-17,2011-07-17,,,,,C,Y,120,mg,ORAL,QD,INCREASED HEART RATE
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FLECAINIDE ACETATE,FLECAINIDE ACETATE,2011-08-30,2011-08-30,,,,,C,Y,100,mg,ORAL,BID,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-08-26,2011-08-26,,,,,C,Y,20,mg,ORAL,QD,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,IPRATROPIUM BROMIDE HFA,IPRATROPIUM BROMIDE,2011-08-30,2011-08-30,,,,,C,Y,4,PUFF,RESPIRATORY (INHALATION),QID,COPD
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LANOXIN,DIGOXIN,2011-08-26,2011-08-26,,,,,C,Y,0.125,mg,ORAL,QD,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-09-27,2011-09-27,,,,,C,Y,20,mEq,ORAL,BID,INCREASE POTASSIUM
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2011-10-04,2011-10-04,,,,,C,Y,PRN,BOTTLE,ORAL,PRN,DECREASE DIARREHA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PROBIOTICS,PROBIOTICS,2011-10-04,2011-10-04,,,,,C,Y,PRN,as directed on OTC bottle,ORAL,PRN,COLON HEALTH
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-01-06,2012-01-06,,,,,C,Y,40,mg,ORAL,QD,SWELLING EDEMA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-01-06,2011-01-06,,,,,C,Y,10,mEq,ORAL,QD,SUPPLEMENT DUE TO LASIX
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OMPEPRAZOLE,OMEPRAZOLE,2010-09-13,2010-09-13,,,,,C,Y,20,mg,ORAL,BID,GASTROESOPHAGEAL REFLUX DISEASE
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2012-01-03,2012-01-03,,,,,C,Y,10,mg,ORAL,QD,ASTHMA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PROCRIT,EPOETIN ALFA,2011-11-29,2011-11-29,,,,,C,Y,"40,000",IU,SUBCUTANEOUS,ONCE,HGB< 10
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,IMDUR,ISOSORBIDE MONONITRATE,2011-10-25,2011-10-25,,,,,C,Y,30,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ADVAIR DISKUS,SERETIDE,2011-11-08,2011-11-08,,,,,C,Y,500-50,ug,RESPIRATORY (INHALATION),PRN,ASTHMA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ALBUTEROL SULFATE,SALBUTAMOL SULFATE,2011-09-29,2011-09-29,,,,,C,Y,1,U,RESPIRATORY (INHALATION),PRN,SOB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,FLECAINIDE ACETATE,FLECAINIDE ACETATE,2011-08-30,2011-08-30,,,,,C,Y,100,mg,ORAL,BID,A-FIB
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,LEVAQUIN,LEVOFLOXACIN,2011-12-07,2011-12-07,,2011-12-09,2011-12-09,,C,,750,mg,INTRAVENOUS,QD,PNUEMONIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ATROVENT,IPRATROPIUM BROMIDE,2012-01-14,2012-01-14,,,,,C,Y,1,PUFF,RESPIRATORY (INHALATION),TID,"ASTHMA, COPD"
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-01-13,2012-01-13,,,,,C,Y,1,mg,ORAL,BID,INFECTION
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2012-01-21,2012-01-21,,,,,C,Y,325,mg,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2012-01-21,2012-01-21,,,,,C,Y,100,mg,INTRAMUSCULAR,QID,R/O PNEUMONIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,AZITHROMYCIN,AZITHROMYCIN,2012-01-21,2012-01-21,,,,,C,Y,500,mg,ORAL,QD,R/O PNEUMONIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2012-01-21,2012-01-21,,2012-01-31,2012-01-31,,C,,1000,mg,INTRAVENOUS,QD,PNEUMONIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2012-01-21,2012-01-21,,2012-01-31,2012-01-31,,C,,40,mg,INTRAVENOUS,Q6H,PNEUNMNIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,MUCOSEP,ALL OTHER THERAPEUTIC PRODUCTS,2011-01-23,2011-01-23,,2012-01-25,2012-01-25,,C,,1,APPLICATION,TOPICAL,PRN,DRY LIPS/ MOUTH ULCERS
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,MAGIC MOUTH WASH,"STOMATOLOGICALS, MOUTH PREPARATIONS",2012-01-06,2012-01-06,,,,,C,Y,1,SWISH,ORAL,TID,THRUSH
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,FORTEO,TERIPARATIDE,2009,2009-12-31,M,,,,C,Y,1,INJECTION,SUBCUTANEOUS,QD,OSTEOPOROSIS
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2000,2000-12-31,M,2011-10-26,2011-10-26,,C,,20,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,SYNTHROID,LEVOTHYROXINE SODIUM,2005,2005-12-31,M,,,,C,Y,0.1,TABLET,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,PALONOSETRON HCI,PALONOSETRON HYDROCHLORIDE,2010-09-21,2010-09-21,,,,,C,Y,0.25,mg,INTRAVENOUS,with chemotherapy,PRE-CHEMO MED
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,EXTRA STRENGHT TYLENOL,PARACETAMOL,2011-02-03,2011-02-03,,2011-02-06,2011-02-06,,C,,2,TABLET,ORAL,QID,PAIN-RIGHT UPPER EXTREMITY
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE HCL W/ PACLITAXEL PROTEIN-BOUND PART,,2011-03-10,2011-03-10,,2011-05-18,2011-05-18,,,,,,,,
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN HCL,,2011-07-13,2011-07-13,,2011-07-27,2011-07-27,,,,,,,,
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE SODIUM,LEVOTHYROXINE SODIUM,2008,2008-12-31,M,,,,C,Y,75,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CARAFATE,SUCRALFATE,2011,2011-01-01,M,,,,C,Y,1,g,ORAL,QD,ULCER PROPHALAXIS
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-11-08,2010-11-08,,,,,C,Y,10,mg,INTRAVENOUS,PRN,CHEMO PRE MED
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PALONOSETRON,PALONOSETRON,2010-11-08,2010-11-08,,,,,C,Y,0.25,mg,INTRAVENOUS,PRN,CHEMO PRE MED
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,NIACIN,NICOTINIC ACID,1990,1990-12-31,M,,,,C,Y,500,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,VYTORIN,INEGY,1990,1990-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2010-10,2010-09-30,D,,,,C,Y,2,TABLET,ORAL,PRN,INTERRMITTENT DIARRHEA
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PREVACID,LANSOPRAZOLE,2010-12-06,2010-12-06,,,,,C,Y,15,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-08,2010-11-08,,,,,C,Y,24,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2010-11-08,2010-11-08,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-02-05,2011-02-05,,,,,C,Y,70,mg,SUBCUTANEOUS,QD,DVT PROHYLAXIS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMINS,"MULTIVITAMINS, PLAIN",1980,1980-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-02-01,2011-02-01,,2011-02-01,2011-02-01,,C,,480,ug,SUBCUTANEOUS,ONCE,LOW NEUTROPHILS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PALONOSETRON/HCL,PALONOSETRON HYDROCHLORIDE,2011-11-23,2011-11-23,,,,,,Y,0.25,mg,INTRAVENOUS,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,VIACTIC CALCIUM,CALCIUM,2010-11-18,2010-11-18,,2010-12-01,2010-12-01,,C,,1,TABLET,ORAL,QD,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LANTUS GLARGINE INJECTION,INSULIN GLARGINE,2000,2000-12-31,M,,,,C,Y,1,IU,SUBCUTANEOUS,QD,TYPE II DIABETES
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-11-23,2010-11-23,,2010-12-16,2010-12-16,,C,,8,mg,INTRAVENOUS,QD,CHEMO PRE MED
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-12-16,2010-12-16,,,,,C,Y,2,mg,INTRAVENOUS,QD,CHEMO PRE MED
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,NAPROSYN,NAPROXEN,2011-01-20,2011-01-20,,,,,C,Y,375,mg,ORAL,BID,PAIN IN LEFT CALF
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MEDROL DOSE PACK,METHYLPREDNISOLONE,2011-03-08,2011-03-08,,2011-03-13,2011-03-13,,C,,4,mg,ORAL,"per RX,Titrating down as directed",PAIN IN LEFT LEG
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-03-17,2011-03-17,,,,,C,Y,20,mg,ORAL,QD,EDEMA
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-02-17,2011-02-17,,,,,C,Y,100,mg,ORAL,BID,EDEMA
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-01-28,2011-01-28,,2011-02-01,2011-02-01,,C,,480,ug,ORAL,QD,NUETROPENIA
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE SODIUM PHOSPHATE,DEXAMETHASONE SODIUM PHOSPHATE,2010-11-23,2010-11-23,,,,,C,Y,2,mg,INTRAVENOUS,for chemo days,CHEMO PRE MEDS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DOLASETRON MESYLATE,DOLASETRON MESILATE,2011-01-20,2011-01-20,,,,,C,Y,46.0,mg,INTRAVENOUS,chemo pre med,CHEMO PRE MEDS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON HCI-NACL,ONDANSETRON HYDROCHLORIDE,2011-02-03,2011-02-03,,,,,C,Y,32,mg,INTRAVENOUS,chemo pre med,CHEMO PRE MEDS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON HCI-NACL,SODIUM CHLORIDE,2011-02-03,2011-02-03,,,,,C,Y,32,mg,INTRAVENOUS,chemo pre med,CHEMO PRE MEDS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,AMARYL,GLIMEPIRIDE,2000,2000-12-31,M,2011-02-10,2011-02-10,,C,,2,mg,ORAL,QD,TYPE II DIABETES
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2004-06,2004-05-31,D,,,,C,Y,81,mg,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,GLIMEPIRIDE,GLIMEPIRIDE,2010-11-18,2010-11-18,,2010-11-18,2010-11-18,,P,,4,mg,ORAL,QD,TYPE 2 DIABETES
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-01-20,2011-01-20,,,,,C,Y,120,mg,SUBCUTANEOUS,QD,PROPHYLAXIS FOR BLOOD CLOTS
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2011-04-27,2011-04-27,,2011-04-28,2011-04-28,,C,,1,mg,INTRAVENOUS,PRN,AGITATION
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-04-26,2011-04-26,,2011-04-29,2011-04-29,,C,,1,mg,INTRAVENOUS,PRN,DISEASE RELATED PAIN
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-04-27,2011-04-27,,2011-04-29,2011-04-29,,C,,300,ug,INTRAVENOUS,QD,PANCYTOPENIA
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,MARCAINE,BUPIVACAINE,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,10,mL,INTRAVENOUS,ONCE,DISEASE RELATED PAIN
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEHYDRATED ALCOHOL,ETHANOL,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,10,mL,INTRAVENOUS,ONCE,DISEASE RELATED PAIN
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DEXTROSE,GLUCOSE,2011-04-26,2011-04-26,,2011-04-28,2011-04-28,,C,,5 %,mL,INTRAVENOUS,PRN,HYDRATION
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,THIAMINE,THIAMINE,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,200,mg,INTRAMUSCULAR,ONCE,FAILURE TO THRIVE
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2004-06,2004-05-31,D,,,,C,Y,81,mg,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,FISH OIL,FISH OIL,2004-06,2004-05-31,D,2011-02-10,2011-02-10,,C,,1000,mg,ORAL,QD,MINERAL SUPPLEMENT HEART HEALTH
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2003-06,2003-05-31,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,TOPROL,METOPROLOL SUCCINATE,2010-12-06,2010-12-06,,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN,,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,,,,,,,
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,,,,,,,
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-10-11,2011-10-11,,2011-10-17,2011-10-17,,,,,,,,
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN,,2011-10-10,2011-10-10,,2012-01-10,2012-01-10,,,,,,,,
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FLUOROURACIL,,2011-10-10,2011-10-10,,2012-01-10,2012-01-10,,,,,,,,
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-07-06,2011-07-06,,,,,C,Y,40,mg,ORAL,QD,GASTRIC BYPASS
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SIMETHICONE,SIMETICONE,2011-08-28,2011-08-28,,,,,C,Y,80,mg,ORAL,PRN,GASTRIC BYPASS
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2010,2010-12-31,M,,,,C,Y,1000,IU,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-07,2011-06-07,,,,,C,Y,10,mg,INTRAVENOUS,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2004,2004-12-31,M,,,,C,Y,81,mg,ORAL,QD,HEART HEALTH
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN SODIUM,ENOXAPARIN SODIUM,2011-05-27,2011-05-27,,,,,C,Y,120,mg,INTRAVENOUS,PRN,HX OF PULMONARY EMBOLI
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2004,2004-12-31,M,,,,C,Y,unk,mg,ORAL,QD,HYPERCHOLESTEREMIA
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,TOPROL XL,METOPROLOL SUCCINATE,2004,2004-12-31,M,,,,C,Y,24 hr,mg,ORAL,QD,HTN
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-06-13,2011-06-13,,,,,C,Y,10,mg,INTRAVENOUS,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,AC480,,2012-02-22,2012-02-22,,2012-04-10,2012-04-10,,,,,,,,
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,DOCETAXEL,,2012-03-20,2012-03-20,,2012-04-20,2012-04-20,,,,,,,,
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ACTOS,PIOGLITAZONE HYDROCHLORIDE,2011-03,2011-02-28,D,,,,C,Y,45,mg,ORAL,QD,DIABETICS II
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DURAGESIC,FENTANYL,2011-08-08,2011-08-08,,,,,C,Y,25,ug,TRANSDERMAL,72 hrs patch,PAIN PANCREATIC
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-08-08,2011-08-08,,,,,C,Y,15,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-03,2011-08-03,,,,,C,Y,10,mg,ORAL,AC (TID) at HS,NAUSEA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,P,,20,mg,INTRAVENOUS,QD,GERD
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2011-08-04,2011-08-04,,2011-08-06,2011-08-06,,P,,10,mg,INTRAVENOUS,QD,GERD
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CEFEPINE,CEFEPIME,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,P,,UNk,mg,INTRAVENOUS,QD,ERCP INDUCED PANCREATITIS
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,P,,8,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHINE,HYDROMORPHONE,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,P,,Unknown,mg,INTRAVENOUS,PRN,ABDONIMAL PAIN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CLINDAMYCIN,CLINDAMYCIN,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,P,,300,mg,INTRAVENOUS,QID,ERCP INDUCED PANCREATITIS
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,EC NAPROSYN,NAPROXEN,2011-08-15,2011-08-15,,2011-08-26,2011-08-26,,C,,Unknown,mg,ORAL,BID,PANCREATIC PAIN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CREON DELAYED RELEASED,PANCREATIN,2011-07-26,2011-07-26,,,,,C,Y,Capsule Delayed relased,mg,ORAL,QD,PANCRATIC ADENOCARCINOMA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,LEVAQUIN,LEVOFLOXACIN,2011-08-06,2011-08-06,,2011-08-16,2011-08-16,,C,,500,mg,ORAL,QD,ERCP INDUCED PANCEATITIS
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CARAFATE,SUCRALFATE,2011-08-03,2011-08-03,,,,,C,Y,1,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,AMBIEN,ZOLPIDEM TARTRATE,2011-09-08,2011-09-08,,,,,C,Y,12.5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CELEXA,CITALOPRAM HYDROBROMIDE,2011-09-08,2011-09-08,,,,,C,Y,10,mg,ORAL,QD,DEPRESSION/ANXEITY
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MILK AND MOLASSES ENEMA,ENEMAS,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,unknown,,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MILK OF MAGNESIA,MAGNESIUM HYDROXIDE,2011-08-19,2011-08-19,,,,,C,Y,60,mL,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,MILLER'S  BRAN,UNSPECIFIED HERBAL,2011-08-19,2011-08-19,,,,,C,Y,1,Tbsp,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-01-02,2012-01-02,,,,,C,Y,20,mg,ORAL,QD,REFLUX
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2012-01-07,2012-01-07,,,,,C,Y,1,mg,ORAL,TID,PANCREATIC SUPPLEMENT
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,NOVOLIN R,INSULIN HUMAN,2011-08-17,2011-08-17,,,,,C,Y,1,IU,SUBCUTANEOUS,QD,DM
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,CRESTOR,ROSUVASTATIN CALCIUM,2011-03,2011-02-28,D,,,,C,Y,20,mg,ORAL,QD,HYPERLIPDEMIA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-08-29,2011-08-29,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ZOLPIMIST,ZOLPIDEM,2011-11-02,2011-11-02,,,,,C,Y,1,SPRAY,RESPIRATORY (INHALATION),PRN,SLEEP AID
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DURAGESIC,FENTANYL,2011-01-30,2011-01-30,,,,,C,Y,50,PATCH,TRANSDERMAL,72 hour patch,PAIN RQ
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-01-30,2011-01-30,,,,,C,Y,200,mg,ORAL,PRN,PRN PAIN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-01-26,2011-01-26,,,,,C,Y,20,mg,ORAL,BID,ACID REFLUX
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2012-01-30,2012-01-30,,2012-01-30,2012-01-30,,C,,1,mg,INTRAMUSCULAR,ONCE,PAIN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,VICODEN,VICODIN,2011-07-26,2011-07-26,,2011-08-03,2011-08-03,,P,,500,mg,ORAL,PRN,PANCREATIC ADENOCARCINOMA PAIN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,JANUMET,RISTFOR,2010-10,2010-09-30,D,,,,C,Y,50-500,mg,ORAL,QD,DIABETES II
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,LOSARTAN POTASSIUM,LOSARTAN POTASSIUM,2011-03,2011-02-28,D,2011-08-19,2011-08-19,,C,,50,mg,ORAL,QD,HTN
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,RANITIDINE,RANITIDINE,2011-03,2011-02-28,D,2012-01-09,2012-01-09,,C,,150,mg,ORAL,BID,GERD
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DIFLUCAN,FLUCONAZOLE,2011-08-08,2011-08-08,,2011-08-22,2011-08-22,,C,,100,mg,ORAL,QD x 14 days,THRUSH
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-08-03,2011-08-03,,,,,C,Y,2,mg,ORAL,PRN,PANCREATIC ADENOCARCINOMA PAIN
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FTORAFUR,,2011-07-08,2011-07-08,,2011-08-01,2011-08-01,,,,,,,,
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FTORAFUR,,2011-08-15,2011-08-15,,2011-08-27,2011-08-27,,,,,,,,
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INDAPAMIDE,INDAPAMIDE,2010,2010-12-31,M,,,,C,Y,2.5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-02,2011-06-02,,2011-06-02,2011-06-02,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2010,2010-12-31,M,,,,C,Y,10,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-03,2011-02-28,D,2011-04-26,2011-04-26,,P,,100,mg,INTRAMUSCULAR,BID,ABDOMEN PAIN DUE TO THE PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-28,2011-04-28,,2011-04-28,2011-04-28,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-05,2011-05-05,,2011-05-05,2011-05-05,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-12,2011-05-12,,2011-05-12,2011-05-12,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-04-27,2011-04-27,,,,,C,Y,100,mg,INTRAMUSCULAR,TID,ABDOMEN PAIN DUE TO THE PANCREATIC ADENOCARCINOMA
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-02,2011-06-02,,2011-06-02,2011-06-02,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-07,2011-07-07,,2011-07-07,2011-07-07,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-18,2011-06-18,,2011-07-08,2011-07-08,,C,,8,mg,ORAL,BID,ABDOMEN PAIN
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CEFIXIME,CEFIXIME,2011-07-12,2011-07-12,,2011-07-18,2011-07-18,,C,,400,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07-12,2011-07-12,,2011-07-15,2011-07-15,,C,,500,mg,ORAL,BID,FEVER
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07-16,2011-07-16,,,,,C,Y,500,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,FERROUS PROTEIN SUCCINILATE,IRON SUCCINYL-PROTEIN COMPLEX,2011-07-25,2011-07-25,,,,,C,Y,15,mL,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DOXYCYCLINE,DOXYCYCLINE,2011-07-26,2011-07-26,,2011-07-31,2011-07-31,,C,,200,mg,ORAL,BID,"ABSCESSES HEPAR,LEUCOCYTOSIS"
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-07-26,2011-07-26,,,,,C,Y,800,mg,ORAL,BID,ABSCESSES HEPAR
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-05-11,2011-05-11,,2011-05-15,2011-05-15,,P,,100,mg,INTRAMUSCULAR,TID,ABDOMEN PAIN
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-16,2011-05-16,,2011-06-03,2011-06-03,,C,,100,mg,INTRAMUSCULAR,QID,ABDOMEN PAIN
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-04,2011-06-04,,2011-06-13,2011-06-13,,C,,100,mg,INTRAMUSCULAR,TID,ABDOMEN PAIN
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-14,2011-06-14,,2011-06-17,2011-06-17,,C,,100,mg,INTRAMUSCULAR,BID,ABDOMEN PAIN
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PHOSPHOGLIV,PHOSPHOGLIV,2011-11-08,2011-11-08,,2011-11-29,2011-11-29,,P,,1,TABLET,ORAL,TID,AE
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-04,2012-01-04,,2012-01-04,2012-01-04,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-11,2012-01-11,,2012-01-11,2012-01-11,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FOSPHOGLIV,PHOSPHOGLIV,2012-01-12,2012-01-12,,2012-02-08,2012-02-08,,C,,1,TABLET,ORAL,TID,"ALANINE AMINOTRANSFERASE INCREASED,ASPARTATE AMINOTRANSFERASE INCREASED"
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-01,2012-02-01,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-08,2012-02-08,,2012-02-08,2012-02-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-02-14,2012-02-14,,2012-02-22,2012-02-22,,C,,250,mg,ORAL,TID,PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2012-02-14,2012-02-14,,,,,C,Y,1,TABLET,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATOON
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-22,2012-03-22,,2012-03-22,2012-03-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-03-07,2012-03-07,,2012-03-22,2012-03-22,,C,,250,mg,ORAL,TID,PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-29,2012-03-29,,2012-03-29,2012-03-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2012-04-05,2012-04-05,,2012-05-29,2012-05-29,,C,,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,LEUCOSTIM,FILGRASTIM,2012-04-13,2012-04-13,,2012-04-14,2012-04-14,,C,,300,ug,SUBCUTANEOUS,QD,NEUTROPHILS COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-19,2012-04-19,,2012-04-19,2012-04-19,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-06,2011-12-06,,2011-12-06,2011-12-06,,C,,8,mg,INTRAMUSCULAR,QD,NEUTROPHIL COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-04-12,2012-04-12,,2012-04-19,2012-04-19,,C,,250,mg,ORAL,TID,PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MAGNII SULPHAT,MAGNESIUM SULFATE,2012-04-26,2012-04-26,,2012-04-26,2012-04-26,,C,,1250,mg,INTRAMUSCULAR,QD,HYPERTENSION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-26,2012-04-26,,2012-04-26,2012-04-26,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-05-03,2012-05-03,,2012-05-11,2012-05-11,,C,,250,mg,ORAL,QID,PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,LOZARTAN,LOSARTAN,2012-05-03,2012-05-03,,2012-05-29,2012-05-29,,C,,50,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-05,2012-05-05,,2012-05-05,2012-05-05,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-17,2012-05-17,,2012-05-17,2012-05-17,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-24,2012-05-24,,2012-05-24,2012-05-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2012-05-30,2012-05-30,,,,,C,Y,5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-06-04,2012-06-04,,2012-06-09,2012-06-09,,C,,800,mg,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2011-12-06,2011-12-06,,2012-01-04,2012-01-04,,C,,250,mg,ORAL,TID,PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2012-06-04,2012-06-04,,,,,C,Y,40,mg,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,SOLUTION RINGERI,RINGER                             /01179901/,2012-06-04,2012-06-04,,2012-06-15,2012-06-15,,C,,500,mL,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,5% SOLUTION OF GLUCOSE,GLUCOSE,2012-06-04,2012-06-04,,2012-06-22,2012-06-22,,C,,500,mL,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-05-31,2012-05-31,,2012-05-31,2012-05-31,,C,,40000,IU,SUBCUTANEOUS,QD,ANAEMIA
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-05-31,2012-05-31,,2012-06-06,2012-06-06,,C,,250,mg,ORAL,TID,CLINICAL SIGNIFICANT PLETELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2012-06-04,2012-06-04,,2012-06-22,2012-06-22,,C,,250,mg,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-06-08,2012-06-08,,2012-06-08,2012-06-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-06-13,2012-06-13,,2012-06-17,2012-06-17,,C,,800,mg,INTRAVENOUS,QD,BLOOD BILIRIBIN INCREASD
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,PHOSPHOGLIV,PHOSPHOGLIV,2012-06-13,2012-06-13,,2012-06-20,2012-06-20,,C,,2500,mg,INTRAVENOUS,BID,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,TIOTRIAZOLINE,THIOTRIAZOLINE,2012-06-09,2012-06-09,,2012-06-13,2012-06-13,,C,,200,mg,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,PLATIPHILLINE,PLATYPHYLLINE,2012-06-04,2012-06-04,,2012-06-12,2012-06-12,,C,,2,mg,SUBCUTANEOUS,TID,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-06-12,2012-06-12,,2012-06-12,2012-06-12,,C,,40000,IU,SUBCUTANEOUS,QD,ANAEMIA
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-06-13,2012-06-13,,2012-06-18,2012-06-18,,C,,500,mg,INTRAVENOUS,BID,CLINICAL SIGNIFICANT PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,MERONEM,MEROPENEM TRIHYDRATE,2012-06-15,2012-06-15,,2012-06-20,2012-06-20,,C,,1000,mg,INTRAVENOUS,BID,INFECTION PROPHILAXIS
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,POTASSIUM-MAGNESIUM ASPARAGINATE,POTASSIUM MAGNESIUM ASPARTATE,2012-06-15,2012-06-15,,2012-06-18,2012-06-18,,C,,250,mL,INTRAVENOUS,QD,HYPOKALEMIA
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,DICYNONE,ETAMSILATE,2012-06-20,2012-06-20,,,,,C,Y,250,mg,ORAL,TID,CLINICAL SIGNIFICANT PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-06-21,2012-06-21,,2012-06-22,2012-06-22,,C,,800,mg,INTRAVENOUS,QD,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,PHOSPHPGLIV,PHOSPHOGLIV,2012-06-21,2012-06-21,,,,,C,Y,1,TABLET,ORAL,TID,BLOOD BILIRUBIN INCREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,PLATELET CONCENTRATE,"PLATELETS, CONCENTRATED",2012-06-15,2012-06-15,,2012-06-15,2012-06-15,,C,,300,mL,INTRAVENOUS,QD,CLINICAL SIGNIFICANT PLATELET COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,ERYTHROCYTES MASS,RED BLOOD CELLS,2012-06-18,2012-06-18,,2012-06-18,2012-06-18,,C,,606,mL,INTRAVENOUS,QD,ANAEMIA
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,8,mg,INTRAMUSCULAR,QD,NEUTROPHIL COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-06-09,2012-06-09,,2012-06-09,2012-06-09,,C,,1000,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,8,mg,INTRAMUSCULAR,QD,NEUTROPHILS COUNT DECREASED
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,LEUKOSTIM,FILGRASTIM,2011-12-22,2011-12-22,,2011-12-22,2011-12-22,,C,,300,ug,SUBCUTANEOUS,QD,NEUTROPHIL COUNT DESEASED
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2010-12-01,2010-12-01,,,,,C,Y,30,mg,ORAL,BID,PAIN TREATMENT
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,EMESET,ONDANSETRON HYDROCHLORIDE,2011-01-25,2011-01-25,,2011-02-08,2011-02-08,,C,,8,mg,INTRAVENOUS,Premedication,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PHENAZEPAM,PHENAZEPAM,2011-02-02,2011-02-02,,,,,C,Y,0.5,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-02-24,2011-02-24,,2011-03-02,2011-03-02,,C,,40,mg,ORAL,QOD,DEHYDROTATION
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-03-02,2011-03-02,,2011-03-11,2011-03-11,,C,,40,mg,ORAL,QS,DEHYDROTATION
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ANALGIN (METAMIZOLE SODIUM),METAMIZOLE SODIUM,2011-02-22,2011-02-22,,2011-03-11,2011-03-11,,C,,2,mL,INTRAMUSCULAR,QD,PROPHYLAXIS
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DIMEDROL,DIPHENHYDRAMINE HYDROCHLORIDE,2011-02-22,2011-02-22,,2011-03-11,2011-03-11,,C,,1,mL,INTRAMUSCULAR,QHS,PROPHYLAXIS
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ASPARCAM,TROPHICARD,2011-02-24,2011-02-24,,2011-03-11,2011-03-11,,C,,1,TABLET,ORAL,TID,DEHYDROTATION
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ESSENCIALE (PHOSPHATIDYLCHOLINE),PHOSPHATIDYL CHOLINE,2011-02-24,2011-02-24,,2011-03-01,2011-03-01,,C,,5,mL,INTRAVENOUS,QD,HEPATOPROTECTOR
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,NO-SHPI (DROTAVERINE),DROTAVERINE,2011-02-21,2011-02-21,,2011-03-02,2011-03-02,,C,,1,mL,INTRAMUSCULAR,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SOL.RINGER,RINGER AGUETTANT,2011-02-28,2011-02-28,,2011-03-03,2011-03-03,,C,,400,mL,INTRAVENOUS,QD,DEHYDRATATION
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,MEZYM FORTE,PANCREATIN,2010-12-01,2010-12-01,,,,,C,Y,1,TABLET,ORAL,TID,SUBSTITUTIVE THERAPY
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-12-27,2010-12-27,,2010-12-27,2010-12-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,EMESET,ONDANSETRON HYDROCHLORIDE,2010-12-27,2010-12-27,,2010-12-27,2010-12-27,,C,,16,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-04,2011-01-04,,2011-01-04,2011-01-04,,C,,8,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,EMESET,ONDANSETRON HYDROCHLORIDE,2011-01-04,2011-01-04,,2011-01-04,2011-01-04,,C,,16,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-11,2011-01-11,,2011-01-11,2011-01-11,,C,,8,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,EMESET,ONDANSETRON HYDROCHLORIDE,2011-01-11,2011-01-11,,2011-01-11,2011-01-11,,C,,16,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-25,2011-01-25,,2011-02-08,2011-02-08,,C,,8,mg,INTRAVENOUS,Premedication,ANTIEMETIC
CO-101-001,CO-101-001-066-005,01066005,066,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,GLIMEPIRIDE,GLIMEPIRIDE,2011-01,2010-12-31,D,,,,C,Y,1,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-066-005,01066005,066,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-23,2011-06-23,,2011-11-24,2011-11-24,,C,,8,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-005,01066005,066,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-23,2011-06-23,,2011-11-24,2011-11-24,,C,,16,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-005,01066005,066,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-12-04,2011-12-04,,,,,C,Y,40,mg,ORAL,TID,PAIN IN THE RIGHT SIDE OF RIBS
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-08,2011-07-31,D,,,,C,Y,30,mg,INTRAMUSCULAR,PRN,PAIN IN THE RIGHT SIDE OF ABDOMEN
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-10-10,2011-10-10,,2011-10-12,2011-10-12,,C,,40,mg,INTRAVENOUS,QD,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PANANGIN,TROPHICARD,2011-11-03,2011-11-03,,2011-11-06,2011-11-06,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS OF HYPOKALEMIA
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,8,mg,INTRAVENOUS,QD,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHYLINE,THEOPHYLLINE,2011-09-03,2011-09-03,,2011-09-04,2011-09-04,,C,,10,mL,INTRAVENOUS,BID,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHYLINE,THEOPHYLLINE,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,10,mL,INTRAVENOUS,BID,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHELINE,THEOPHYLLINE,2011-10-27,2011-10-27,,2011-10-29,2011-10-29,,C,,10,mL,INTRAVENOUS,BID,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHELINE,THEOPHYLLINE,2011-11-23,2011-11-23,,,,,C,Y,10,mL,INTRAVENOUS,BID,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-11-03,2011-11-03,,2011-11-06,2011-11-06,,C,,40,mg,INTRAVENOUS,QD,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-10-27,2011-10-27,,2011-10-29,2011-10-29,,C,,40,mg,INTRAVENOUS,QD,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-11-23,2011-11-23,,,,,C,Y,40,mg,INTRAVENOUS,QD,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-09-01,2011-09-01,,2011-10-27,2011-10-27,,C,,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-01,2011-09-01,,2011-10-27,2011-10-27,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PHENAZEPAM,PHENAZEPAM,2011-08-23,2011-08-23,,2011-08-30,2011-08-30,,P,,1,TABLET,ORAL,QD,COANALGESIA DUE TO PAIN
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PAMIDRONAT,PAMIDRONATE DISODIUM,2011-08-24,2011-08-24,,2011-11-24,2011-11-24,,C,,90,mg,INTRAVENOUS,QM,BONE MTS
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-08-26,2011-08-26,,2011-08-30,2011-08-30,,P,,400,mg,INTRAVENOUS,QD,HEPATOPROTECTOR
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHYLLINE,THEOPHYLLINE,2011-08-30,2011-08-30,,2011-09-01,2011-09-01,,C,,10,mL,INTRAVENOUS,BID,DYSPNOE
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-09-05,2011-09-05,,2011-09-10,2011-09-10,,C,,2,g,INTRAVENOUS,BID,PROFHILAXIS OF BACTERIAL COMPLICATIONS AFTER THORACOCENTESIS
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,SOLUTION EUPHYLINE,THEOPHYLLINE,2011-10-10,2011-10-10,,2011-10-11,2011-10-11,,C,,10,mL,INTRAVENOUS,BID,ANTIEDEMA THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-08,2011-07-31,D,2011-10-24,2011-10-24,,C,,1,TABLET,ORAL,PRN,PAIN IN THE LEFT SIDEOF ABDOMEN
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,RHEOPOLYGLUCINI,DEXTRAN,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,500,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TRAMADOL 5%,TRAMADOL,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,2,mL,INTRAMUSCULAR,TID,POSTOPERATIVE ANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ATROPIN,ATROPINE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,0.5,mL,INTRAVENOUS,ONCE,INTRAOPERATIVE ANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,5,mg,INTRAVENOUS,BID,INTRAOPERETIVE ANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PHENTANIL,FENTANYL,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,0.005,%,INTRAVENOUS,BID,INTRAOPERATIVE ANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,2,g,INTRAVENOUS,QD,PROPHYLAXIS OF BACTERIAL COMPLICATONS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OCTREOTIDE,OCTREOTIDE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,1,mL,SUBCUTANEOUS,ONCE,PROPHILAXIS OF POSTOPERATIVE PANCREATIC COMPLICATIONS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,GLUCAGEN,GLUCAGON,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,1,mg,SUBCUTANEOUS,BID,SUPPORTIVE THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,25,mg,ORAL,QD,PROPHILAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NO-SPA,DROTAVERINE HYDROCHLORIDE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,2,mL,INTRAVENOUS,QID,ANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2011-10-05,2011-10-05,,,,,C,Y,30,mg,INTRAMUSCULAR,BID,PAIN IN THE RIGHT SIDE OF ABDOMEN
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,APROTININ,APROTININ,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,500 000,IU,INTRAVENOUS,QD,PROPHYLAXIS POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REOPOLYGLUCIN,DEXTRAN,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,200,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,250,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PENTOXIPHYLLIN,PENTOXIFYLLINE,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,5,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,"SOLUTION""ACESOLUM""",ACESOL,2011-10-12,2011-10-12,,2011-10-13,2011-10-13,,C,,400,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ACIDI ASCORBINICI5%,ASCORBIC ACID,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,10,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,OMEPRASOL,OMEPRAZOLE,2011-10-25,2011-10-25,,2011-11-15,2011-11-15,,,,20,mg,ORAL,QD,TREATMENT OF GASTRITIIS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,"""MAALOX""(ALGELDRATE+MAGNESIUM HYDROXIDE)",ANTACIDA FNA                       /01021901/,2011-10-25,2011-10-25,,2011-11-15,2011-11-15,,,,800,mg,ORAL,TID,TREATMENT OF GASTRITIS
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-10-25,2011-10-25,,2011-11-11,2011-11-11,,,,100,mg,ORAL,BID,PAIN IN THE RIGHT SIDE OF ABDOMEN
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-11-12,2011-11-12,,,,,,Y,100,mg,ORAL,QID,PAIN IN THE RIGHT SIDE OF ABDOMEN
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ADEMEDIONINE,ADEMETIONINE,2011-10-05,2011-10-05,,2011-10-18,2011-10-18,,C,,400,mg,INTRAVENOUS,QD,HEPATOPROTECTOR
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-12,2011-11-12,,,,,,Y,8,mg,INTRAMUSCULAR,QD,COANALGESIA
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ANALGIN (METAMIZOLE SODIUM),METAMIZOLE SODIUM,2011-10-07,2011-10-07,,2011-10-18,2011-10-18,,C,,1,mL,INTRAMUSCULAR,BID,ANALGESIS THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-10-07,2011-10-07,,2011-10-18,2011-10-18,,C,,2,mL,INTRAMUSCULAR,QD,ANALGESIS THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,"GLUCOSAE10%, INSULINI 8ME",GLUCOSE,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,500,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,"GLUCOSAE10%, INSULINI 8ME",INSULIN,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,500,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ACIDI ASCORBINICI5%,ASCORBIC ACID,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,5,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,"S.NACL0,9%",SODIUM CHLORIDE,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,1000,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LASIXI,FUROSEMIDE,2011-10-10,2011-10-10,,2011-10-18,2011-10-18,,C,,40,mg,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2012-01,2011-12-31,D,,,,C,Y,10,mg,ORAL,PRN,PAIN IN THE EPIGASTRIC AREA AND THE RIGHT SIDE UNDER THE RIB
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TRAMADOLI,TRAMADOL,2012-02-21,2012-02-21,,,,,C,Y,100,mg,INTRAMUSCULAR,PRN,PAIN IN THE EPIGASTRIC AREA AND THE RIGHT SIDE UNDER THE RIB
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2012-01,2011-12-31,D,,,,C,Y,40,mg,ORAL,BID,PAIN IN THE EPIGASTRIC AREA AND THE RIGHT SIDE UNDER THE RIB
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-21,2012-02-21,,2012-04-03,2012-04-03,,C,,8,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-21,2012-02-21,,2012-04-03,2012-04-03,,C,,16,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NOVOCAIN0.5%,PROCAINE HYDROCHLORIDE,2011-02-02,2011-02-02,,2011-02-02,2011-02-02,,P,,20,mL,TOPICAL,ONCE,LOCAL ANESTHESIA
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,BETALOC (METOPROLOL TARTRATE),METOPROLOL TARTRATE,2011-09-14,2011-09-14,,,,,C,Y,50,mg,ORAL,QD,HYPERTENSION  DISEASE
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LOSARTAN,LOSARTAN,2011-09-14,2011-09-14,,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION DISEASE
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ATORVASTATIN,ATORVASTATIN,2011-09-14,2011-09-14,,,,,C,Y,20,mg,ORAL,QD,ISCHEMIC HEART DISEASE:STABLE EXERTIONAL ANGINA
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,WARFARIN,WARFARIN,2011-09-27,2011-09-27,,,,,C,Y,2,mg,ORAL,QD,ISCHEMIC HEART DISEASE:STABLE EXERTIONAL ANGINA
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DIGOXIN,DIGOXIN,2011-09-14,2011-09-14,,,,,C,Y,1/2,TABLET,ORAL,BID,ISCHEMIC HEART DISEASE:CONSTANT ATRIAL FIBRILATION
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2012-02-01,2012-02-01,,,,,C,Y,1,TABLET,ORAL,6 TIMES PER DAY,PROPHYLAXIS
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-28,2012-02-28,,2012-08-01,2012-08-01,,C,,8,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-28,2012-02-28,,2012-08-01,2012-08-01,,C,,16,mg,INTRAVENOUS,premedication,PREMEDICAYION
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2012-01,2011-12-31,D,,,,C,Y,100,mg,ORAL,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ACIDI ASCORBINICI,ASCORBIC ACID,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,5,mL,INTRAVENOUS,QD,INFUSION THERAPY
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2012-05-22,2012-05-22,,,,,C,Y,40,mg,ORAL,BID,ANALGETIC THERAPY
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-07,2012-03-07,,2012-07-04,2012-07-04,,C,,8,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-07,2012-03-07,,2012-07-04,2012-07-04,,C,,16,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-06-29,2012-06-29,,2012-06-29,2012-06-29,,C,,8,mg,INTRAVENOUS,ONCE,ANTIEMETIC
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,16,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,4,mg,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,2,mL,INTRAVENOUS,BID,ANALGETIC THERAPY
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,2,mL,INTRAVENOUS,BID,ANALGETIC THERAPY
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,GLUCOSAE 5%,GLUCOSE,2012-07-09,2012-07-09,,2012-07-10,2012-07-10,,C,,1000,mL,INTRAVENOUS,QD,INNFUSION THERAPY
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2012-01,2011-12-31,D,2012-04-02,2012-04-02,,C,,30,mg,ORAL,TID,DIABETES MELITUS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2012-04-20,2012-04-20,,,,,C,Y,75,IU,ORAL,TID,FERMENTATIVE THERAPY
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,NOVOCAIN,PROCAINE HYDROCHLORIDE,2012-02-27,2012-02-27,,2012-02-27,2012-02-27,,P,,20,mL,TOPICAL,ONCE,LOCAL ANESTHESIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,NOVOCAIN,PROCAINE HYDROCHLORIDE,2012-03-13,2012-03-13,,2012-03-13,2012-03-13,,P,,20,mL,TOPICAL,ONCE,LOCAL ANESTHESIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,NISE,NIMESULIDE,2012-07-15,2012-07-15,,,,,C,Y,100,mg,ORAL,QD,ANESTHESIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,"SPASMALGON(METAMIZOLE,FENPIVERINIYA BROMIDE,PINOFENONA HYDROCHLORIDE)",FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2012-09-09,2012-09-09,,,,,C,Y,1 tablet,mg,ORAL,QD,ANASTHESIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,GLYCINE,GLYCINE,2012-10-08,2012-10-08,,,,,C,Y,100,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PHENAZEPAM,PHENAZEPAM,2012-10-08,2012-10-08,,,,,C,Y,1,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2012-01,2011-12-31,D,2012-04-02,2012-04-02,,C,,1,g,ORAL,QD,DIABETES MELITUS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-12,2011-11-30,D,,,,C,Y,40,mg,ORAL,PRN,PAIN IN THE RIGHT SIDE UNDER THE RIBS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,METAMIZOL,METAMIZOLE,2011-12,2011-11-30,D,,,,C,Y,500,mg,ORAL,PRN,PAIN IN THE RIGHT SIDE UNDER THE RIBS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-12,2011-11-30,D,,,,C,Y,10,mg,ORAL,PRN,PAIN IN THE RIGHT SIDE UNDER THE RIBS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-27,2012-03-27,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-27,2012-03-27,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,INSULIN SOLUBLE (HUMAN BIOSYNTHETIC),INSULIN,2012-04-03,2012-04-03,,,,,C,Y,12,IU,SUBCUTANEOUS,QD,DIABETES MELITUS
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,INSULIN H,INSULIN HUMAN,2012-04-03,2012-04-03,,,,,C,Y,18,IU,SUBCUTANEOUS,QD,DIABETES MELITUS
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN AND FTOURACIL,,2011-01-19,2011-01-19,,2011-01-23,2011-01-23,,,,,,,,
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-27,2010-10-27,,2010-12-08,2010-12-08,,C,,16,mg,INTRAVENOUS,with every chemotherapy administration,PREMEDICATION
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-10-27,2010-10-27,,2010-12-08,2010-12-08,,C,,20,mg,INTRAVENOUS,with every chemotherapy administration,PREMEDICATION
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2010-11-24,2010-11-24,,2011-02-28,2011-02-28,,C,,100,mg,ORAL,QD,TROMBOCYTOSIS
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FERROUS SULFATE,FERROUS SULFATE,2010-12-15,2010-12-15,,2011-02-28,2011-02-28,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN,,2011-02-22,2011-02-22,,2011-03-14,2011-03-14,,,,,,,,
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2010-09,2010-08-31,D,,,,C,Y,2,mL,INTRAMUSCULAR,BID,PAIN IN EPIGASTRIC AREA
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-23,2010-11-23,,2011-02-01,2011-02-01,,C,,16,mg,INTRAVENOUS,with every chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-11-23,2010-11-23,,2011-02-01,2011-02-01,,C,,8,mg,INTRAVENOUS,with every chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-01-18,2011-01-18,,,,,C,Y,20,mg,ORAL,QD,HEPATOPROTECTOR
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-02-08,2011-02-08,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,PAIN IN EPIGASTRIC AREA
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PROTEIN ENTERAL NUTRITION,PROTEIN SUPPLEMENTS,2011-03-15,2011-03-15,,,,,,Y,4,Tbsp,ORAL,BID,BODY WEIGHT LOSS
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-29,2010-11-29,,2011-05-03,2011-05-03,,C,,16,mg,INTRAVENOUS,with every chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DICYNON,ETAMSILATE,2011-05-03,2011-05-03,,2011-05-10,2011-05-10,,C,,250,mg,ORAL,TID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-05-17,2011-05-17,,,,,C,Y,1,TABLET,ORAL,PRN,PAIN IN EPIGASTRIC AREA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-17,2011-05-17,,2011-05-17,2011-05-17,,C,,40000,IU,SUBCUTANEOUS,QD,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-11-29,2010-11-29,,2011-05-03,2011-05-03,,C,,8,mg,INTRAVENOUS,with every chamo administration,PREMEDICATION
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,KLEXAN,ENOXAPARIN SODIUM,2011-01-25,2011-01-25,,2011-02-21,2011-02-21,,C,,40,mg,TRANSDERMAL,BID,TROMB OF PORT VEIN
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FERRUS SULFATE,FERROUS SULFATE,2011-03-22,2011-03-22,,2011-04-12,2011-04-12,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DICYNON,ETAMSILATE,2011-04-05,2011-04-05,,2011-04-12,2011-04-12,,C,,1,TABLET,ORAL,BID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,FERRUS SULFATE,FERROUS SULFATE,2011-04-19,2011-04-19,,2011-05-17,2011-05-17,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-01,2011-06-01,,,,,,Y,2,mL,INTRAMUSCULAR,BID,TREATMENT PAIN
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-23,2011-05-23,,2011-05-23,2011-05-23,,C,,40000,ED,SUBCUTANEOUS,QD,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-30,2011-05-30,,2011-05-30,2011-05-30,,C,,40000,ED,SUBCUTANEOUS,QD,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABIN,,2011-09-17,2011-09-17,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2010-10,2010-09-30,D,,,,C,Y,50,mg,ORAL,QHS,TREATMENT PAIN
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,NIMESULIDE,NIMESULIDE,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,100,mg,ORAL,QD,TREATMENT ACUTE RESPIRATORY DESIASE
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-06-28,2011-06-28,,,,,C,Y,500,mg,ORAL,BID,TREATMENT THROMBOCYTOPENIA
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ADEMETIONIN,ADEMETIONINE,2011-07-19,2011-07-19,,,,,C,Y,400,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-14,2010-12-14,,2010-12-14,2010-12-14,,C,,8.0,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-21,2010-12-21,,2010-12-21,2010-12-21,,C,,8.0,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,8.0,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-05,2011-01-05,,2011-01-05,2011-01-05,,C,,8.0,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-11,2011-01-11,,2011-08-02,2011-08-02,,C,,8.0,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-02-07,2011-02-07,,2011-03-03,2011-03-03,,C,,16,mg,INTRAVENOUS,QD,TREATMENT PNEUMONITIS
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,AMONOPHYLLINUM,AMINOPHYLLINE,2011-02-07,2011-02-07,,2011-03-03,2011-03-03,,C,,5,mL,INTRAVENOUS,QD,TREATMENT PNEUMONITIS
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ARBIDOL,ARBIDOL,2011-03-07,2011-03-07,,2011-03-11,2011-03-11,,C,,200,mg,ORAL,QID,TREATMENT ACUTE RESPIRATORE DESIASE
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2010-10,2010-09-30,D,2011-02-17,2011-02-17,,C,,150,mg,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2010-11-15,2010-11-15,,,,,C,Y,400,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ARBIDOL,ARBIDOL,2011-01-02,2011-01-02,,2011-01-09,2011-01-09,,C,,100,mg,ORAL,BID,TREATMENT ACUTE RESPIRATORY DISEASE
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,OXYMETAZOLINE,OXYMETAZOLINE,2011-01-02,2011-01-02,,2011-01-06,2011-01-06,,C,,500,ug,RESPIRATORY (INHALATION),BID,TREATMENT ACUTE RESPIRATORY DISEASE
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-05-27,2011-05-27,,,,,C,Y,150,mg,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TARDYFERON,FERROUS SULFATE,2011-05-31,2011-05-31,,,,,C,Y,256.3,mg,ORAL,BID,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-14,2010-12-14,,2011-05-17,2011-05-17,,C,,8,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2010-09,2010-08-31,D,2011-02-09,2011-02-09,,C,,150,mg,ORAL,QHS,PAIN TREATMENT
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2010-11-27,2010-11-27,,2011-02-09,2011-02-09,,C,,400,mg,ORAL,QD,PROPHYLAXIS LIVER
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-22,2010-12-22,,2010-12-22,2010-12-22,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,8,mg,ORAL,QD,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-01-27,2011-01-27,,2011-02-09,2011-02-09,,C,,2.0,mL,INTRAMUSCULAR,BID,TREATMENT PAIN
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2010-12-24,2010-12-24,,2010-12-27,2010-12-27,,P,,2,mL,INTRAMUSCULAR,TID,PAIN
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2010-12-28,2010-12-28,,2011-01-10,2011-01-10,,C,,2,mL,INTRAMUSCULAR,BID,PAIN UNDER LEFT RIB
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-01-11,2011-01-11,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-01-11,2011-01-11,,,,,C,Y,60,mg,INTRAMUSCULAR,QD,TROMBOCYTOPENIA
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2010-12-21,2010-12-21,,,,,C,Y,800,mg,INTRAVENOUS,QD,HEPATOPROTECTOR
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-01-11,2011-01-11,,,,,C,Y,500,mg,INTRAMUSCULAR,BID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,NOVACOINE,PROCAINE HYDROCHLORIDE,2011-01-12,2011-01-12,,2011-01-12,2011-01-12,,C,,10,mL,TRANSDERMAL,ONCE,LOPAROCENTESIS
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-05,2011-01-05,,2011-01-18,2011-01-18,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-05,2011-01-05,,2011-01-18,2011-01-18,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2011-02-03,2011-02-03,,2011-04-23,2011-04-23,,C,,50,mg,ORAL,BID,TREATMENT HYPERTENSION DISEASE
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-03-01,2011-03-01,,2011-03-09,2011-03-09,,C,,1500,mg,INTRAMUSCULAR,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-03-15,2011-03-15,,2011-03-22,2011-03-22,,C,,1500,mg,INTRAMUSCULAR,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-21,2011-02-21,,2011-03-15,2011-03-15,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-21,2011-02-21,,2011-03-15,2011-03-15,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2011-03-15,2011-03-15,,2011-03-22,2011-03-22,,C,,30,mg,INTRAMUSCULAR,QD,TROMBOCITOPENIA
CO-101-001,CO-101-001-067-010,01067010,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-18,2011-04-18,,2011-05-11,2011-05-11,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-010,01067010,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-04-18,2011-04-18,,2011-05-11,2011-05-11,,C,,8,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-010,01067010,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-04-26,2011-04-26,,2011-05-11,2011-05-11,,C,,400,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"CISPLATIN,5-FU",,2012-06-25,2012-06-25,,2012-07-22,2012-07-22,,,,,,,,
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-25,2011-04-25,,2011-11-22,2011-11-22,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,"DE-NOL(BISMUTHATE,TRIPOTASSIUM DICITRATO)",TRIPOTASSIUM DICITRATOBISMUTHATE,2011-12-05,2011-12-05,,2011-12-20,2011-12-20,,C,,1,TABLET,ORAL,TID,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PALIN,PIPEMIDIC ACID,2011-12-05,2011-12-05,,2011-12-13,2011-12-13,,C,,200,mg,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KANEPHRON,HERBAL EXTRACT NOS,2011-12-13,2011-12-13,,,,,C,Y,2,TABLET,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,1,mL,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,1,mL,INTRAMUSCULAR,QD,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-04-25,2011-04-25,,2011-11-22,2011-11-22,,C,,8,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NIMESULIDE,NIMESULIDE,2011-05-03,2011-05-03,,,,,C,Y,1,TABLET,ORAL,pain,PROPHYLAXIS
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,THROMBO ASS,ACETYLSALICYLIC ACID,2011-07-19,2011-07-19,,2011-08-02,2011-08-02,,C,,50,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2011-11-22,2011-11-22,,2011-11-29,2011-11-29,,C,,1,TABLET,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2011-12-05,2011-12-05,,,,,C,Y,1,TABLET,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,1,mL,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FOLIC ACID,FOLIC ACID,2011-12-05,2011-12-05,,,,,C,Y,1,TABLET,ORAL,TID,TREATMENT AE
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-12-05,2011-12-05,,,,,C,Y,20,mg,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,METOPROLOL SUCCINATE,METOPROLOL SUCCINATE,2011-02-25,2011-02-25,,2011-07-26,2011-07-26,,C,,25,mg,ORAL,QD,CARDIOPROTECTION
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,REVALGIN,BARALGINA,2011-04-14,2011-04-14,,2011-04-14,2011-04-14,,P,,UNK,,INTRAVENOUS,UNKNOWN,TREAMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DIMEDROLUM,DIPHENHYDRAMINE HYDROCHLORIDE,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,,INTRAVENOUS,UNKNOWN,TREATMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,,INTRAVENOUS,UNKNOWN,TREAMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,,ORAL,UNKNOWN,TREATMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METROGYL,METRONIDAZOLE,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,,ORAL,UNKNOWN,TREATMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DIFLUCAN,FLUCONAZOLE,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,TABLET,ORAL,UNKNOWN,TREATMENT PNEUMONIA
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MEZIM-FORTE,PANCREATIN,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,TABLET,ORAL,UNKNOWN,PROPHYLAXIS
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TRIMETAZIDINE,TRIMETAZIDINE,2011-02-25,2011-02-25,,2011-07-26,2011-07-26,,C,,35,mg,ORAL,QD,CACDIOPROTECTION
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-28,2011-04-28,,2011-07-26,2011-07-26,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-04-28,2011-04-28,,2011-07-26,2011-07-26,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE(MULTIVITAMINE+OTHER SUBSTANSES),"MULTIVITAMINS, OTHER COMBINATIONS",2011-05-26,2011-05-26,,2011-07-26,2011-07-26,,C,,500,mg,ORAL,TID,HEPATOPROTECTION
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,THROMBO ASS(ACETYLSALICYLIC ACID),ACETYLSALICYLIC ACID,2011-05-26,2011-05-26,,2011-06-09,2011-06-09,,C,,100,mg,ORAL,QD,PROPHYLAXIS THROMBOSIS
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,THROMBOASS(ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2011-06-09,2011-06-09,,2011-06-16,2011-06-16,,C,,50,mg,ORAL,QD,PROPHYLAXIS THROMBOSIS
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,THROMBOASS(ACETYLSALICYLIC ACID),ACETYLSALICYLIC ACID,2011-06-23,2011-06-23,,2011-07-26,2011-07-26,,C,,50,mg,ORAL,QD,PROHTYLAXIS THROMBOSIS
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ANALGIN(METAMIZOLE SODIUM),METAMIZOLE SODIUM,2011-04-14,2011-04-14,,2011-04-26,2011-04-26,,P,,UNK,,INTRAVENOUS,QD,TREATMENT PNEUMONIA
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2010-08-05,2010-08-05,,,,,C,Y,10,mg,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2010-07-12,2010-07-12,,,,,C,Y,24,ED,SUBCUTANEOUS,BID,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-12,2011-05-12,,2012-02-02,2012-02-02,,C,,16,mg,INTRAVENOUS,wich each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-05-12,2011-05-12,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,wiht each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-16,2012-02-16,,,,,C,Y,8,mg,INTRAVENOUS,wich each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-04,2011-03-31,D,2011-05-30,2011-05-30,,C,,200,mg,ORAL,with each chemo administration,TREATMENT PAIN
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,HUMAN SOLUBLE INSULIN,INSULIN HUMAN,2011-04-19,2011-04-19,,2011-05-30,2011-05-30,,C,,8,ED,SUBCUTANEOUS,TID,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INSULIN BASAL (INSULIN-ISOPHAN[HUMAN SEMISYNTETIC]),INSULIN ISOPHANE HUMAN SEMISYNTHETIC,2011-04-19,2011-04-19,,2011-05-30,2011-05-30,,C,,6,ME,SUBCUTANEOUS,QD,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (MULTIVITAMINE+OTHER SUBSTANSES),"MULTIVITAMINS, OTHER COMBINATIONS",2011-05-03,2011-05-03,,2011-05-30,2011-05-30,,C,,600,mg,ORAL,TID,HEPATOPROTECTION
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-12,2011-05-12,,2011-05-30,2011-05-30,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-05-12,2011-05-12,,,,,C,Y,8,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-05-19,2011-05-19,,2011-05-30,2011-05-30,,C,,1,TABLET,ORAL,TID,TREATMENT THROMBOCYTOPENIA
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,NUTRI DRINK,OTHER COMBINATIONS OF NUTRIENTS,2011-05-19,2011-05-19,,2011-05-26,2011-05-26,,C,,200,mL,ORAL,BID,TREATMENT PROTEIN DECREASE
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-14,2011-06-14,,2011-09-20,2011-09-20,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GEPTOR(ADEMETIONIN),ADEMETIONINE,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,400,mg,ORAL,BID,HEPATOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CANEPHRON,HERBAL EXTRACT NOS,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,2,TABLET,ORAL,TID,NEPHROPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOLUTIO KCL 4%,POTASSIUM CHLORIDE,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,10,mL,INTRAVENOUS,QD,CARDIOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOLUTIO GLUCOSAE 5%,GLUCOSE,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,400,mL,INTRAVENOUS,QD,CARDIOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,INSULINI,INSULIN,2011-09-28,2011-09-28,,2011-09-29,2011-09-29,,C,,4,ED,INTRAVENOUS,QD,CARDIOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KETONAL,KETOPROFEN,2011-09-30,2011-09-30,,,,,C,Y,1,TABLET,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-06-14,2011-06-14,,2011-09-20,2011-09-20,,C,,8,mg,INTRAVENOUS,wiht each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ADEMETIONIN,ADEMETIONINE,2011-08-23,2011-08-23,,2011-09-06,2011-09-06,,C,,400,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE ( PHOSPHOLIPIDES EPL),PHOSPHOLIPIDS,2011-09-06,2011-09-06,,2011-09-20,2011-09-20,,C,,2,TABLET,ORAL,TID,HEPATOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-09-28,2011-09-28,,2011-10-06,2011-10-06,,C,,20,mg,INTRAMUSCULAR,QD,DIURETIC
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ASPARCAM,TROPHICARD,2011-09-29,2011-09-29,,2011-10-06,2011-10-06,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE ( PHOSPHOLIPIDES EPL),PHOSPHOLIPIDS,2011-09-29,2011-09-29,,2011-10-18,2011-10-18,,C,,2,TABLET,ORAL,TID,HEPATOPROTECTION
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-09-29,2011-09-29,,2011-10-06,2011-10-06,,C,,250,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,VEROSPIRON(SPIRONOLACTON),SPIRONOLACTONE,2011-09-29,2011-09-29,,2011-10-18,2011-10-18,,C,,50,mg,ORAL,BID,DIURETIC
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-21,2011-06-21,,2011-10-11,2011-10-11,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-06-21,2011-06-21,,2011-10-11,2011-10-11,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-07-05,2011-07-05,,2011-07-19,2011-07-19,,C,,30,mg,INTRAMUSCULAR,QD,TREATMENT NEUTROPENIA
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CLEXANE(ENOXAPARIN SODIUM),ENOXAPARIN SODIUM,2011-08-16,2011-08-16,,2011-09-06,2011-09-06,,C,,0.8,mg,SUBCUTANEOUS,BID,TREATMENT THROMB PORTAL VIEN
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CLEXANE(ENOXAPARIN SODIUM),ENOXAPARIN SODIUM,2011-09-07,2011-09-07,,,,,C,Y,40,mg,SUBCUTANEOUS,QD,TEATMENT THROMB PORTAL VIEN
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-10-18,2011-10-18,,2011-11-22,2011-11-22,,C,,8,mg,INTRAVENOUS,whit each chemo administrated,PREMEDICATION
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-18,2011-10-18,,2011-11-22,2011-11-22,,C,,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-23,2011-06-23,,2011-11-01,2011-11-01,,C,,1,TABLET,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,4,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-08-31,2011-08-31,,,,,C,Y,2,TABLET,ORAL,TID,TREATMENT AE
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-11-01,2011-11-01,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,TREATMENT PAIN
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,VEROSPIRON,SPIRONOLACTONE,2011-11-01,2011-11-01,,2011-11-08,2011-11-08,,C,,1,TABLET,ORAL,QD,DIURETIC
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METROGYL DENTA,ORAHEX-M,2011-11-01,2011-11-01,,,,,C,Y,10,mg,ORAL,BID,TREATMENT STOMATITIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LIDOCAINE,LIDOCAINE,2011-11-01,2011-11-01,,,,,C,Y,5,mL,ORAL,TID,TREATMENT STOMATITIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,VEROSPIRON,SPIRONOLACTONE,2011-11-08,2011-11-08,,,,,C,Y,2,TABLET,ORAL,QD,DIURETIC
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ACTRAPID HM PENFILL(HUMAN SOLUBLE INSULIN),INSULIN HUMAN,2011-06-23,2011-06-23,,,,,C,Y,10,ED,SUBCUTANEOUS,QD,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-25,2011-10-25,,2011-10-25,2011-10-25,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-08-16,2011-08-16,,2011-08-23,2011-08-23,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ACTRAPID HM PENFILL(HUMAN SOLUBLE INSULIN),INSULIN HUMAN,2011-06-23,2011-06-23,,,,,C,Y,16,ED,SUBCUTANEOUS,QD,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ESSENTILE N,PHOSPHOLIPIDS,2011-06-23,2011-06-23,,,,,C,Y,2,TABLET,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2011-08-09,2011-08-09,,2011-08-16,2011-08-16,,C,,30,mg,INTRAMUSCULAR,QD,TREATMENT THROMBOCYTOPENIA
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-08-09,2011-08-09,,2011-08-16,2011-08-16,,C,,2,TABLET,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-02,2011-08-02,,2011-09-13,2011-09-13,,C,,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SOL.NOVOCAINE 0.5%,PROCAINE HYDROCHLORIDE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,P,,140,mL,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,P,,4,mL,INTRAMUSCULAR,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-020,01067020,067,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-30,2011-08-30,,2012-01-31,2012-01-31,,C,,16,mg,INTRAVENOUS,weath each chemo administrated,PROPHYLAXIS
CO-101-001,CO-101-001-067-020,01067020,067,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-08-30,2011-08-30,,2012-01-31,2012-01-31,,C,,8,mg,INTRAVENOUS,weath each chemo administrated,PROPHYLAXIS
CO-101-001,CO-101-001-067-020,01067020,067,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-09-06,2011-09-06,,2011-09-10,2011-09-10,,C,,30,mg,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-020,01067020,067,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TARDIFERON (FERROUS SULFATE),FERROUS SULFATE,2011-11-15,2011-11-15,,2011-11-21,2011-11-21,,C,,1,TABLET,ORAL,BID,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-06-05,2012-06-05,,2012-06-19,2012-06-19,,,,,,,,
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"CISPLATIN,FTORAFUR",,2012-07-12,2012-07-12,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INSULIN BASAL(HUMAN ISOPHANE INSULIN),INSULIN ISOPHANE BOVINE,2011-06-03,2011-06-03,,,,,C,Y,6,ME,SUBCUTANEOUS,BID,TREATMENT
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,INSULIN RAPID(HUMAN SOLUBLE INSULIN),INSULIN HUMAN,2011-06-03,2011-06-03,,,,,C,Y,6,ME,SUBCUTANEOUS,TID,TREATMENT
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-01,2011-09-01,,2012-01-26,2012-01-26,,C,,16,mg,INTRAVENOUS,weath each chemo administrated,PROPHYLAXIS
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-09-01,2011-09-01,,2011-10-06,2011-10-06,,C,,8,mg,INTRAVENOUS,weath each chemo administrated,PROPHYLAXIS
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-09-15,2011-09-15,,2011-09-18,2011-09-18,,C,,1,TABLET,ORAL,BID,TREATMENT NEUTROPENIA GR.3
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-16,2012-02-16,,,,,C,Y,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABIN,,2012-03-15,2012-03-15,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-22,2011-09-22,,,,,C,Y,16,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-09-22,2011-09-22,,2012-02-09,2012-02-09,,C,,8,mg,INTRAVENOUS,with each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-09-29,2011-09-29,,2011-10-02,2011-10-02,,C,,5,mg,ORAL,QD,TREATMENT AE
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-10-06,2011-10-06,,2011-10-09,2011-10-09,,C,,5,mg,ORAL,QD,TREATMENT AE
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,"SORBIFER DURULES(ASCORBIC ACID,FERROUS SULFATE)",KENDURAL C,2011-11-03,2011-11-03,,2011-11-17,2011-11-17,,C,,1,TABLET,ORAL,BID,TREATMENT ANEMIA
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2011-11-24,2011-11-24,,2011-12-15,2011-12-15,,C,,1,TABLET,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2011-12-01,2011-12-01,,2011-12-01,2011-12-01,,C,,1,mL,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-12-08,2011-12-08,,2011-12-12,2011-12-12,,C,,30,mg,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2012-01-04,2012-01-04,,2012-01-07,2012-01-07,,C,,5,mg,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-05-16,2012-05-16,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SITAGLIPTIN,SITAGLIPTIN,2009,2009-12-31,M,,,,C,Y,100,mg,ORAL,QD,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-09,2012-02-09,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-15,2012-03-15,,2012-03-15,2012-03-15,,C,,16,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-22,2012-03-22,,2012-03-22,2012-03-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,GLIMEPIRIDIN,GLIMEPIRIDE,2009,2009-12-31,M,,,,C,Y,1,mg,ORAL,QD,TREATMENT DIABETES MELLITUS
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CO-DIOVAN,CO-DIOVAN,2006,2006-12-31,M,,,,C,Y,80,mg,ORAL,QD,TREATMENT HIPERTENSIVE DISEASE
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,KORDARON,AMIODARONE HYDROCHLORIDE,2005,2005-12-31,M,,,,C,Y,200,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NIMOTOP,NIMODIPINE,2011-09,2011-08-31,D,,,,C,Y,30,mg,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-15,2011-12-15,,2012-01-12,2012-01-12,,C,,8,mg,INTRAVENOUS,whit chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2012-02-09,2012-02-09,,2012-02-09,2012-02-09,,C,,1000,mg,INTRAMUSCULAR,QD,TREATMENT AE-ANEMIA
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PALIN,PIPEMIDIC ACID,2012-02-22,2012-02-22,,2012-03-07,2012-03-07,,C,,200,mg,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-19,2012-01-19,,2012-01-19,2012-01-19,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-024,01067024,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CLEXANE(ENOXAPARIN SODIUM),ENOXAPARIN SODIUM,2011-11-17,2011-11-17,,2012-01-03,2012-01-03,,C,,40,mg,SUBCUTANEOUS,QD,TREATMENT TROMBOSIS
CO-101-001,CO-101-001-067-024,01067024,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,KETONAL,KETOPROFEN,2011-11,2011-10-31,D,2012-01-03,2012-01-03,,C,,1,TABLET,ORAL,QD,TREATMENT PAIN
CO-101-001,CO-101-001-067-024,01067024,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-26,2011-12-26,,2011-12-26,2011-12-26,,C,,16,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-024,01067024,067,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-12-26,2011-12-26,,2011-12-26,2011-12-26,,C,,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-09-03,2012-09-03,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-16,2012-01-16,,2012-01-16,2012-01-16,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-04-17,2012-04-17,,2012-07-12,2012-07-12,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DAXAMETHAZONE,DEXAMETHASONE,2012-03-21,2012-03-21,,2012-04-05,2012-04-05,,C,,16,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-17,2012-05-17,,2012-06-21,2012-06-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-06-28,2012-06-28,,2012-08-23,2012-08-23,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-08-02,2012-08-02,,2012-08-23,2012-08-23,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-01-16,2012-01-16,,2012-01-16,2012-01-16,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,KLEXAN(ENOXAPARIN NATRII),ENOXAPARIN SODIUM,2012-01-26,2012-01-26,,2012-06-18,2012-06-18,,C,,40,mg,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,20,mg,INTRAVENOUS,QD,TREATMENT AE-NEUTROPENIA
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2012-02-07,2012-02-07,,2012-03-21,2012-03-21,,C,,1000,mg,INTRAMUSCULAR,QD,TREATMENT AE-ANEMIA
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2012-02-07,2012-02-07,,2012-03-21,2012-03-21,,C,,1,TABLET,ORAL,BID,TREATMENT AE-ANEMIA
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-24,2012-01-24,,2012-01-24,2012-01-24,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-01-24,2012-01-24,,2012-01-31,2012-01-31,,C,,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-31,2012-01-31,,2012-05-03,2012-05-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,NUROFEN(IBUPROFEN),IBUPROFEN,2011-11,2011-10-31,D,,,,C,Y,1,TABLET,ORAL,PRN,TREATMENT PAIN
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,NUTRICOMP,VITAMINS NOS,2012-01-10,2012-01-10,,,,,C,Y,1,L,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-30,2012-01-30,,2012-02-07,2012-02-07,,C,,16,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-01-30,2012-01-30,,2012-02-07,2012-02-07,,C,,8,mg,INTRAVENOUS,whit each chemo administration,PREMEDICATION
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2012-02-07,2012-02-07,,,,,C,Y,1,TABLET,ORAL,BID,TREATMENT AE
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,VIT B12,CYANOCOBALAMIN,2012-02-14,2012-02-14,,2012-02-21,2012-02-21,,C,,1000,mg,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DICINON,ETAMSILATE,2012-01-14,2012-01-14,,2012-02-21,2012-02-21,,C,,4,mL,INTRAMUSCULAR,QD,TREATMENT AE
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-14,2012-02-14,,2012-02-14,2012-02-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2012-02-14,2012-02-14,,2012-02-14,2012-02-14,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CARBOPLATIN+FTORURACIL,,2011-03-29,2011-03-29,,2011-04-05,2011-04-05,,,,,,,,
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ACTRAPID (INSULIN),INSULIN HUMAN,2010-11,2010-10-31,D,,,,C,Y,5ED-4ED-5ED,ED,SUBCUTANEOUS,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-10-04,2011-10-04,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2009-11,2009-10-31,D,,,,C,Y,160,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-07,2011-02-07,,2011-02-07,2011-02-07,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-07,2011-02-07,,2011-02-07,2011-02-07,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMATHASONE,DEXAMETHASONE,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-03-07,2011-03-07,,2011-04-10,2011-04-10,,C,,800,mg,ORAL,QD,TOXICAL HEPATITIS
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-14,2011-03-14,,2011-03-14,2011-03-14,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2009-11,2009-10-31,D,,,,C,Y,5,mg,ORAL,BID,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-14,2011-03-14,,2011-03-14,2011-03-14,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-21,2011-03-21,,2011-03-21,2011-03-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-21,2011-03-21,,2011-03-21,2011-03-21,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-28,2011-03-28,,2011-03-28,2011-03-28,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-28,2011-03-28,,2011-03-28,2011-03-28,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-04-11,2011-04-11,,2011-04-17,2011-04-17,,C,,800,mg,ORAL,QD,PROPHYLAXIS OF TOXICAL HEPATITIS
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-11,2011-04-11,,2011-04-11,2011-04-11,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-11,2011-04-11,,2011-04-11,2011-04-11,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-04-18,2011-04-18,,2011-05-09,2011-05-09,,C,,800,mg,ORAL,QD,TOXICAL HEPATITIS
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-18,2011-04-18,,2011-04-18,2011-04-18,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,INDAPAMIDE,INDAPAMIDE,2009-11,2009-10-31,D,,,,C,Y,25,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-18,2011-04-18,,2011-04-18,2011-04-18,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-25,2011-04-25,,2011-04-25,2011-04-25,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-25,2011-04-25,,2011-04-25,2011-04-25,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-05-10,2011-05-10,,2011-07-17,2011-07-17,,C,,800,mg,ORAL,QD,PROPHYLAXIS OF TOXICAL HEPATITIS
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-10,2011-05-10,,2011-05-10,2011-05-10,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-10,2011-05-10,,2011-05-10,2011-05-10,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-16,2011-05-16,,2011-05-16,2011-05-16,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-16,2011-05-16,,2011-05-16,2011-05-16,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-23,2011-05-23,,2011-05-23,2011-05-23,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-23,2011-05-23,,2011-05-23,2011-05-23,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2009-11,2009-10-31,D,,,,C,Y,10,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,12,mg,INTRAVENOUS,QD,PREMDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,SPASMALGON,BARALGINA,2011-07-06,2011-07-06,,,,,C,Y,1,TABLET,ORAL,QD,SPASMOLYTIC+ANALGESIC
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,TRIMETAZIDINE,TRIMETAZIDINE,2009-01,2008-12-31,D,,,,C,Y,35,mg,ORAL,BID,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,12,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PENTALGIN N,PYRALGIN                           /03433001/,2011-01-18,2011-01-18,,2011-02-23,2011-02-23,,C,,1,TABLET,ORAL,PRN,ABDOMEN PAIN
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PENTALGIN N,PYRALGIN                           /03433001/,2011-05-09,2011-05-09,,2011-07-15,2011-07-15,,C,,1,TABLET,ORAL,PRN,ABDOMEN PAIN
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-16,2011-02-16,,2011-08-17,2011-08-17,,C,,16,mg,INTRAVENOUS,Premedication,PROPHYLAXIS
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-16,2011-02-16,,2011-08-17,2011-08-17,,C,,16,mg,INTRAVENOUS,Premedication,PROPHYLAXIS
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE+ASCORBIC ASID),KENDURAL C,2011-03-10,2011-03-10,,,,,C,Y,1,TABLET,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PENTALGIN N,PYRALGIN                           /03433001/,2011-07-16,2011-07-16,,2011-08-06,2011-08-06,,C,,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-08-07,2011-08-07,,,,,C,Y,30,mg,INTRAMUSCULAR,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,URSODEOXYCHOLIC ACID,URSODEOXYCHOLIC ACID,2011-08-11,2011-08-11,,,,,C,Y,250,mg,ORAL,TID,"INCREASE ALT, AST"
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PENTALGIN N,PYRALGIN                           /03433001/,2011-08-26,2011-08-26,,,,,C,Y,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-26,2011-08-26,,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,OTHER,GEFITINIBUM,,2011-06-23,2011-06-23,,2011-08-26,2011-08-26,,,,,,,,
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABINUM,,2011-06-23,2011-06-23,,2011-07-23,2011-07-23,,,,,,,,
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-02-05,2011-02-05,,2011-03-09,2011-03-09,,C,,30,mg,INTRAMUSCULAR,BID,PAIN
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PENTALGIN (CODEINE+CAFFEINE+METAMIZOL SODUM+ NAPROXEN+PHENOBARBITAL),NEMBUDEINE,2011-03-10,2011-03-10,,2011-03-24,2011-03-24,,C,,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PENTALGIN (CODEINE+CAFFEINE+METAMIZOL SODIUM+NAPROXEN+PHENOBARBITAL),NEMBUDEINE,2011-04-18,2011-04-18,,2011-06-05,2011-06-05,,C,,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-05-20,2011-05-20,,2011-06-04,2011-06-04,,C,,30,mg,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-06-05,2011-06-05,,,,,C,Y,30,mg,INTRAMUSCULAR,BID,PAIN
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-02,2011-03-02,,2011-06-08,2011-06-08,,C,,16,mg,INTRAVENOUS,Before every cycle,PREMEDICATION
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-02,2011-03-02,,2011-06-08,2011-06-08,,C,,16,mg,INTRAVENOUS,Before every cycle,PREMEDICATION
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2008,2008-12-31,M,,,,C,Y,25,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2008,2008-12-31,M,,,,C,Y,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ESSENTIAL PHOSPHOLIPIDS,PHOSPHOLIPIDS,2011-04-27,2011-04-27,,2011-05-20,2011-05-20,,C,,2,TABLET,ORAL,TID,"INCREASE AST, ALP"
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,BARALGINUM,BARALGINA,2011-05-16,2011-05-16,,2011-05-23,2011-05-23,,C,,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-05-24,2011-05-24,,2011-06-02,2011-06-02,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-06-03,2011-06-03,,,,,C,Y,100,mg,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,URSODEOXYCHOLIC ACID,URSODEOXYCHOLIC ACID,2011-05-21,2011-05-21,,,,,C,Y,250,mg,ORAL,TID,"INCREASE ALT, AST, ALP"
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-27,2011-04-27,,2011-05-11,2011-05-11,,C,,16,mg,INTRAVENOUS,Before every cycle,PREMEDICATION
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-27,2011-04-27,,2011-05-11,2011-05-11,,C,,16,mg,INTRAVENOUS,Before every cycle,PREMEDICATION
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-06-25,2011-06-25,,,,,C,Y,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM,DIAZEPAM,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,10,mg,INTRAMUSCULAR,ONCE,PREMEDICATION
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SOL. RINGERI,RINGER AGUETTANT,2011-08-13,2011-08-13,,2011-08-14,2011-08-14,,C,,500,mL,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,SOL. RINGERI,RINGER AGUETTANT,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,500,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SOL. RINGERI,RINGER AGUETTANT,2011-08-16,2011-08-16,,2011-08-19,2011-08-19,,C,,500,mL,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SOL. RINGERI,RINGER AGUETTANT,2011-08-20,2011-08-20,,2011-08-25,2011-08-25,,C,,500,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SOL. GLUCOSAE 10%,GLUCOSE,2011-08-13,2011-08-13,,2011-08-14,2011-08-14,,C,,500,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,SOL. GLUCOSAE 10%,GLUCOSE,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,500,mL,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SO;. GLUCOSAE 10%,GLUCOSE,2011-08-16,2011-08-16,,2011-08-25,2011-08-25,,C,,500,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,INSULINI,INSULIN,2011-08-13,2011-08-13,,2011-08-14,2011-08-14,,C,,10,IU,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,INSULINI,INSULIN,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,10,IU,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-13,2011-07-13,,2011-08-10,2011-08-10,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,INSULINI,INSULIN,2011-08-16,2011-08-16,,2011-08-25,2011-08-25,,C,,10,IU,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,NUTRIFLEX LIPID,AMINO ACIDS NOS W/CARBOHYDRATES NOS/07403401/,2011-08-13,2011-08-13,,2011-08-14,2011-08-14,,C,,1250,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,NUTRIFLEX LIPID,AMINO ACIDS NOS W/CARBOHYDRATES NOS/07403401/,2011-08-16,2011-08-16,,2011-08-17,2011-08-17,,C,,1250,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,FORTICARE,OTHER NUTRIENTS,2011-08-13,2011-08-13,,2011-08-25,2011-08-25,,C,,250,mL,ORAL,TID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-03,2011-09-03,,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-13,2011-07-13,,2011-08-10,2011-08-10,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,SOL. RINGERI,RINGER AGUETTANT,2011-08-11,2011-08-11,,2011-08-12,2011-08-12,,C,,500,mL,INTRAVENOUS,QD,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,SOL. GLUCOSAE 10%,GLUCOSE,2011-08-11,2011-08-11,,2011-08-12,2011-08-12,,C,,500,mL,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,INSULINI,INSULIN,2011-08-11,2011-08-11,,2011-08-12,2011-08-12,,C,,10,IU,INTRAVENOUS,BID,STENOSIS OF GASTROENTERO-ANASTOMOSIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-08-10,2011-08-10,,2011-08-25,2011-08-25,,C,,40,mg,INTRAMUSCULAR,BID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,HYDROXIETHYL STARCH 6%,HETASTARCH,2011-08-13,2011-08-13,,2011-08-15,2011-08-15,,C,,500,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,100,mg,INTRAMUSCULAR,ONCE,PREMEDICATION
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,NOVOPEN - INSULIN,INSULIN HUMAN,2011-05-12,2011-05-12,,2011-09-10,2011-09-10,,C,,3,IU,SUBCUTANEOUS,BID,DIABETES MELITUS
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,30,mg,INTRAMUSCULAR,ONCE,PAIN
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LEVEMIRFLEXPEN,INSULIN DETEMIR,2011-05-12,2011-05-12,,2011-09-10,2011-09-10,,C,,4,IU,SUBCUTANEOUS,QD,DIABETUS MELITUS
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,LEVEMIRFLEXPEN,INSULIN DETEMIR,2011-05-12,2011-05-12,,2011-09-10,2011-09-10,,C,,6,IU,SUBCUTANEOUS,QD,DIABETES MELITUS
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE FORTE (PHOSPHOLIPIDES EPL),PHOSPHOLIPIDS,2011-08-04,2011-08-04,,2011-08-28,2011-08-28,,P,,1,TABLET,ORAL,TID,INCREASE AST
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-08-08,2011-08-08,,2011-10-02,2011-10-02,,C,,500,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-30,2011-08-30,,2011-09-27,2011-09-27,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-30,2011-08-30,,2011-09-27,2011-09-27,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2011-09-07,2011-09-07,,2011-10-02,2011-10-02,,C,,380,mg,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PANANGIN,TROPHICARD,2011-09-14,2011-09-14,,2011-10-02,2011-10-02,,C,,1,TABLET,ORAL,TID,DECREASE POTASSIUM
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE FORTE (PHOSPHOLIPIDES EPL),PHOSPHOLIPIDS,2011-09-24,2011-09-24,,2011-10-02,2011-10-02,,C,,1,TABLET,ORAL,TID,INCREASE AST
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2011-02-10,2011-02-10,,2011-02-13,2011-02-13,,C,,0.25,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-04-15,2011-04-15,,2011-04-18,2011-04-18,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-04-22,2011-04-22,,2011-06-10,2011-06-10,,C,,200,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-16,2011-02-16,,2011-04-21,2011-04-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DEXTROSE SOLUTION 5%,GLUCOSE,2011-02-12,2011-02-12,,2011-02-15,2011-02-15,,C,,1000,mL,INTRAVENOUS,QD,WEAKNESS
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,RINGER SOLUTION,RINGER AGUETTANT,2011-02-12,2011-02-12,,2011-02-15,2011-02-15,,C,,500,mL,INTRAVENOUS,QD,ASTHENIA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-02-17,2011-02-17,,2011-02-19,2011-02-19,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-02-25,2011-02-25,,2011-02-28,2011-02-28,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-03-11,2011-03-11,,2011-03-13,2011-03-13,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-03-18,2011-03-18,,2011-03-19,2011-03-19,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-04-08,2011-04-08,,2011-04-12,2011-04-12,,C,,30,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULIN GLARGINE,INSULIN GLARGINE,2010-10-01,2010-10-01,,,,,C,Y,32,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-03-25,2011-03-25,,,,,C,Y,800,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SODIUM ACETATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE,EL-4,2011-03-25,2011-03-25,,,,,C,Y,800,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SODIUM ACETATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE,SODIUM ACETATE,2011-03-25,2011-03-25,,,,,C,Y,800,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KALII CHLORIDUM,POTASSIUM CHLORIDE,2011-03-25,2011-03-25,,,,,C,Y,30,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PLASMA,PLASMA,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,250,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PLASMA,PLASMA,2011-03-27,2011-03-27,,2011-03-27,2011-03-27,,C,,250,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PLASMA,PLASMA,2011-03-29,2011-03-29,,2011-03-29,2011-03-29,,C,,250,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,2006-06,2006-05-31,D,,,,C,Y,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,EPROSARTAN,EPROSARTAN,2006-06,2006-05-31,D,,,,C,Y,600,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOLE,TRAMADOL HYDROCHLORIDE,2011-01-17,2011-01-17,,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-02-19,2011-02-19,,2011-02-20,2011-02-20,,C,,1000,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SODIUM ACETATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE,EL-4,2011-02-16,2011-02-16,,2011-02-20,2011-02-20,,C,,500,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SODIUM ACETATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE,SODIUM ACETATE,2011-02-16,2011-02-16,,2011-02-20,2011-02-20,,C,,500,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-28,2011-02-28,,2011-03-23,2011-03-23,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-02-28,2011-02-28,,2011-03-04,2011-03-04,,C,,1000,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEXTROSE,GLUCOSE,2011-03-25,2011-03-25,,,,,C,Y,800,mg,INTRAVENOUS,QD,ICTERUS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-03-03,2011-03-03,,2011-03-06,2011-03-06,,C,,1,TABLET,ORAL,BID,FEVER
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TROXERUTIN,TROXERUTIN,2011-05-01,2011-05-01,,,,,C,Y,20,mg,TOPICAL,PRN,TROMBOPHLEBITIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DIOSMIN+HESPIRIDIN,CAPIVEN,2011-05-01,2011-05-01,,2011-05-26,2011-05-26,,C,,500,mg,ORAL,BID,TROMBOPHLEBITIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-11,2011-05-11,,2011-09-15,2011-09-15,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 10%,ALBUMIN HUMAN,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,200,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-09-27,2011-09-27,,,,,C,Y,800,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TRIMEPERIDINE,TRIMEPERIDINE,2011-09-27,2011-09-27,,,,,C,Y,2,mL,INTRAMUSCULAR,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MOXIFLOXACIN,MOXIFLOXACIN,2011-03-03,2011-03-03,,2011-03-06,2011-03-06,,C,,1000,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CHLORPYRAMINE,CHLOROPYRAMINE,2011-03-03,2011-03-03,,2011-03-06,2011-03-06,,C,,25,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-16,2011-03-16,,2011-03-16,2011-03-16,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-23,2011-03-23,,2011-03-23,2011-03-23,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-30,2011-03-30,,2011-03-30,2011-03-30,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-13,2011-04-13,,2011-04-13,2011-04-13,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,RABEPRAZOLE,RABEPRAZOLE,2011-02-08,2011-02-08,,,,,C,Y,10,mg,ORAL,BID,GASTRITIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-14,2011-04-14,,2011-04-14,2011-04-14,,C,,16,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-21,2011-04-21,,2011-04-21,2011-04-21,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-28,2011-04-28,,2011-04-28,2011-04-28,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-12,2011-05-12,,2011-05-12,2011-05-12,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-19,2011-05-19,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-26,2011-05-26,,2011-07-21,2011-07-21,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-07-28,2011-07-28,,,,,C,Y,20,mg,ORAL,QD,PAIN IN RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,VENTER,SUCRALFATE,2011-02-08,2011-02-08,,,,,C,Y,0.5,mg,ORAL,TID,CHRONIC DUODENITIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,INDAPAMIDE+PERINDOPRIL,INDAPAMIDE W/PERINDOPRIL,2006,2006-12-31,M,,,,C,Y,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-17,2011-02-17,,2011-02-17,2011-02-17,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDAMSETRON,ONDANSETRON,2011-02-24,2011-02-24,,2011-02-24,2011-02-24,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-17,2011-03-17,,2011-03-17,2011-03-17,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-24,2011-03-24,,2011-03-24,2011-03-24,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-31,2011-03-31,,2011-03-31,2011-03-31,,C,,16,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-070-011,01070011,070,48.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-25,2011-03-25,,2011-05-06,2011-05-06,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-012,01070012,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-21,2011-04-21,,2011-04-21,2011-04-21,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-014,01070014,070,32.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-04-10,2011-04-10,,,,,C,Y,2,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-014,01070014,070,32.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-28,2011-04-28,,2012-01-20,2012-01-20,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-03-11,2011-03-11,,2011-11-15,2011-11-15,,C,,20,mg,ORAL,QD,ABDOMINALPAIN
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-29,2011-04-29,,2011-09-02,2011-09-02,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 20%,ALBUMIN HUMAN,2011-09-17,2011-09-17,,2011-09-21,2011-09-21,,C,,100,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-09-17,2011-09-17,,2011-11-15,2011-11-15,,C,,2,TABLET,ORAL,TID,EDEMA OF LIMB
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-09-17,2011-09-17,,2011-09-26,2011-09-26,,C,,40,mg,ORAL,BIS,EDEMA OF LIMBS
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 20%,ALBUMIN HUMAN,2011-09-24,2011-09-24,,2011-09-28,2011-09-28,,C,,100,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 20%,ALBUMIN HUMAN,2011-10-22,2011-10-22,,2011-11-15,2011-11-15,,C,,100,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,RINGER'S SOLUTION,RINGER AGUETTANT,2011-11,2011-11-01,D,2011-11-15,2011-11-15,,C,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,GLUCOSE 5%,GLUCOSE,2011-11,2011-11-01,D,2011-11-15,2011-11-15,,C,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-017,01070017,070,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN+XELODA,,2011-08-31,2011-08-31,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-070-017,01070017,070,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TRIMEPEREDINE,TRIMEPERIDINE,2011-04-26,2011-04-26,,2011-05-02,2011-05-02,,C,,1.0,mL,INTRAMUSCULAR,QID,ABDOMINAL PAIN
CO-101-001,CO-101-001-070-017,01070017,070,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-05-03,2011-05-03,,,,,C,Y,50,mg,TOPICAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-070-017,01070017,070,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-29,2011-04-29,,2011-08-05,2011-08-05,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-022,01070022,070,52.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-04-20,2011-04-20,,2011-07-02,2011-07-02,,C,,1,TABLET,ORAL,QID,CHRONIC GASTRITIS
CO-101-001,CO-101-001-070-022,01070022,070,52.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-04-20,2011-04-20,,2011-07-02,2011-07-02,,C,,1,TABLET,ORAL,QID,CHRONIC GASTRITIS
CO-101-001,CO-101-001-070-022,01070022,070,52.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-20,2011-06-20,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN,,2011-12-09,2011-12-09,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KETOLORAC,KETOROLAC,2010-11-05,2010-11-05,,,,,C,Y,3,TABLET,ORAL,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-09-10,2011-09-10,,2011-09-19,2011-09-19,,C,,2,mL,INTRAMUSCULAR,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SPIRONOLACTONE,SPIRONOLACTONE,2011-10-01,2011-10-01,,,,,C,Y,1,TABLET,ORAL,TID,EDEMA LIMB
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-10-01,2011-10-01,,,,,C,Y,40,mg,ORAL,BID,EDEMA LIMB
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TRAMADOLE,TRAMADOL HYDROCHLORIDE,2011-10-18,2011-10-18,,2011-11-03,2011-11-03,,C,,50,mg,INTRAMUSCULAR,TID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-10-18,2011-10-18,,2011-11-02,2011-11-02,,C,,75,mg,ORAL,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-11-03,2011-11-03,,,,,C,Y,75,mg,ORAL,TID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,HYOSCINE BUTYLBROMIDE,HYOSCINE BUTYLBROMIDE,2011-11-01,2011-11-01,,,,,C,Y,10,mg,RECTAL,TID,COLITIS
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SUNPRAS,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-11-01,2011-11-01,,,,,C,Y,40,mg,ORAL,BID,COLITIS
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MUCOFALC,PLANTAGO AFRA SEED HUSK,2011-11-01,2011-11-01,,,,,C,Y,1,TABLET,ORAL,QD,COLITIS
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NALBUPHIN,NALBUPHINE,2011-11-03,2011-11-03,,,,,C,Y,1.0,mg,INTRAMUSCULAR,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-07-01,2011-07-01,,,,,C,Y,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CARBAMAZEPINE,CARBAMAZEPINE,2011-11-03,2011-11-03,,,,,C,Y,200,mg,ORAL,BID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-06-01,2011-06-01,,,,,C,Y,1,TABLET,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-06-16,2011-06-16,,2011-06-27,2011-06-27,,C,,2,mL,INTRAMUSCULAR,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-06-16,2011-06-16,,2011-06-27,2011-06-27,,C,,3,mL,INTRAMUSCULAR,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-17,2011-05-17,,2011-11-14,2011-11-14,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,CLEMASTINE,CLEMASTINE,2011-06-18,2011-06-18,,2011-06-20,2011-06-20,,C,,1,TABLET,ORAL,TID,URTICARIA
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,CASTROL OIL,RICINUS COMMUNIS OIL,2011-08-06,2011-08-06,,,,,C,Y,1,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENON+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-09-10,2011-09-10,,2011-09-19,2011-09-19,,C,,3,mL,INTRAMUSCULAR,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE SODIUM,LEVOTHYROXINE SODIUM,2009-03,2009-02-28,D,2012-03-09,2012-03-09,,C,,50,mg,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2009-03,2009-02-28,D,2012-03-09,2012-03-09,,C,,50,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-08-10,2011-08-10,,2012-03-09,2012-03-09,,C,,1,TABLET,ORAL,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2000,2000-12-31,M,2012-03-09,2012-03-09,,C,,25,mg,ORAL,PRN,HYPERTENSION
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2000,2000-12-31,M,2012-03-09,2012-03-09,,C,,25,mg,ORAL,PRN,HYPERTENSION
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-22,2011-08-22,,2011-12-12,2011-12-12,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-07-27,2011-07-27,,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CODEINE+NAPROXEN+METAMIZOLE SODIUM+CAFFEINE+PHENOBARBITAL,CAFFEINE W/PHENOBARBITAL,2011-07-27,2011-07-27,,,,,C,Y,2,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CODEINE+NAPROXEN+METAMIZOLE SODIUM+CAFFEINE+PHENOBARBITAL,CODEINE,2011-07-27,2011-07-27,,,,,C,Y,2,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CODEINE+NAPROXEN+METAMIZOLE SODIUM+CAFFEINE+PHENOBARBITAL,METAMIZOLE SODIUM,2011-07-27,2011-07-27,,,,,C,Y,2,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CODEINE+NAPROXEN+METAMIZOLE SODIUM+CAFFEINE+PHENOBARBITAL,NAPROXEN,2011-07-27,2011-07-27,,,,,C,Y,2,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-08-28,2011-08-28,,,,,C,Y,50,mg,TOPICAL,PRN,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-24,2011-08-24,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,RECINI OLEUM,RICINUS COMMUNIS OIL,2011-11-04,2011-11-04,,,,,C,Y,30,gtt,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-12-17,2011-12-17,,,,,C,Y,50,mg,INTRAMUSCULAR,TID,PAIN
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-12-17,2011-12-17,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,PAIN
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PANCREATIN+BILE COMPONENT+HEMICELLULASE,BILE THERAPY,2011-07-12,2011-07-12,,,,,C,Y,1,TABLET,ORAL,TID,GASTRIC DISCOMFORT
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PANCREATIN+BILE COMPONENT+HEMICELLULASE,HEMICELLULOSE,2011-07-12,2011-07-12,,,,,C,Y,1,TABLET,ORAL,TID,GASTRIC DISCOMFORT
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PANCREATIN+BILE COMPONENT+HEMICELLULASE,PANCREATIN,2011-07-12,2011-07-12,,,,,C,Y,1,TABLET,ORAL,TID,GASTRIC DISCOMFORT
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-09-06,2011-09-06,,,,,C,Y,1,TABLET,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,RABEPRAZOLE,RABEPRAZOLE,2011-09-06,2011-09-06,,,,,C,Y,20,mg,ORAL,QD,CHRONIC GASTRITIS
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-06,2011-09-06,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ACETYLSALYCILIC ACID,ACETYLSALICYLIC ACID,2011-09-12,2011-09-12,,,,,C,Y,100,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,TRIMATAZIDINE,TRIMETAZIDINE,2011-10-01,2011-10-01,,,,,C,Y,50,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DIOSMIN +HESPIRIDIN,CAPIVEN,2011-10-01,2011-10-01,,,,,C,Y,1,TABLET,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-05,2011-10-05,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CHLORPYRAMINE,CHLOROPYRAMINE,2011-09-21,2011-09-21,,2011-09-23,2011-09-23,,C,,2,TABLET,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-09-21,2011-09-21,,2011-09-25,2011-09-25,,C,,15,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-029,01070029,070,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,TRAMADOLE,TRAMADOL HYDROCHLORIDE,2011-10-01,2011-10-01,,,,,C,Y,50,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-070-029,01070029,070,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-10-01,2011-10-01,,,,,C,Y,1,TABLET,ORAL,QD,EPIGASTRIC DISCOMFORT
CO-101-001,CO-101-001-070-029,01070029,070,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,URSODEXYCHOLIC ACID,URSODEOXYCHOLIC ACID,2011-10-01,2011-10-01,,,,,C,Y,1,TABLET,ORAL,QID,PROPHYLAXIS
CO-101-001,CO-101-001-070-029,01070029,070,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-25,2011-11-25,,2012-01-06,2012-01-06,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AMLODOPINE,AMLODIPINE,1991,1991-12-31,M,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ACETIILSALYCILIC ACID,ACETYLSALICYLIC ACID,1991,1991-12-31,M,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,1991,1991-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,1991,1991-12-31,M,,,,C,Y,850,mg,ORAL,TID,DIABETES
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,GLIMEPIRIDE,GLIMEPIRIDE,1991,1991-12-31,M,,,,C,Y,3,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-07,2011-12-07,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AMLODIPIN,AMLODIPINE,2005,2005-12-31,M,,,,C,Y,5,mg,ORAL,QD,ARTHERIAL HYPERTENSION
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-27,2012-01-27,,2012-01-27,2012-01-27,,C,,500,mg,ORAL,QD,PROPHYLAXIS OF FEVER
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE,DIPHENHYDRAMINE,2012-01-27,2012-01-27,,2012-01-27,2012-01-27,,C,,50,mg,ORAL,QD,PROPHYLAXIS OF FEVER
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2005,2005-12-31,M,,,,C,Y,5,mg,ORAL,QD,ARTHERIAL HYPERTENSION
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2005,2005-12-31,M,,,,C,Y,50,mg,ORAL,QD,ARTHERIAL HYPERTENSION
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,GLICLAZIDE,GLICLAZIDE,2011-08-15,2011-08-15,,,,,C,Y,120,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2011-08-15,2011-08-15,,,,,C,Y,1500,mg,ORAL,TID,DIABETES
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,SITAGLIPTIN,SITAGLIPTIN,2011-08-15,2011-08-15,,,,,C,Y,1,TABLET,ORAL,QD,DIABETES
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-08-15,2011-08-15,,,,,C,Y,10000,IU,ORAL,TID,PROPHYLAXIS
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-13,2012-01-13,,,,,C,Y,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-01-14,2011-01-14,,2012-01-15,2012-01-15,,C,,500,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2012-01,2011-12-31,D,,,,C,Y,1,TABLET,ORAL,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2012-02-29,2012-02-29,,,,,C,Y,50,mg,ORAL,BID,WORSENING EPIGASTRIC PAIN
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-21,2012-02-21,,2012-03-20,2012-03-20,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-21,2012-02-21,,2012-03-20,2012-03-20,,C,,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-03-07,2012-03-07,,2012-03-09,2012-03-09,,C,,2,TABLET,ORAL,QD,FEVER
CO-101-001,CO-101-001-071-001,01071001,071,51.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2010-10-20,2010-10-20,,2010-11-10,2010-11-10,,P,,1,mL,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-071-001,01071001,071,51.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2010-11-10,2010-11-10,,2010-11-26,2010-11-26,,C,,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-071-001,01071001,071,51.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TRAMADOLUM,TRAMADOL HYDROCHLORIDE,2010-11-26,2010-11-26,,2011-01-01,2011-01-01,,C,,50,mg,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-071-002,01071002,071,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CAPECITABIN,,2011-10-27,2011-10-27,,2012-03-31,2012-03-31,,,,,,,,
CO-101-001,CO-101-001-071-002,01071002,071,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2010-09,2010-08-31,D,2010-12-05,2010-12-05,,C,,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-071-002,01071002,071,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-05-01,2011-05-01,,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-071-002,01071002,071,59.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-09-15,2011-09-15,,,,,C,Y,1.0,mL,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-071-003,01071003,071,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,UFT,,2011-04-20,2011-04-20,,2011-05-08,2011-05-08,,,,,,,,
CO-101-001,CO-101-001-071-003,01071003,071,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5-FLUOROURACIL,,2011-06-07,2011-06-07,,2011-07-08,2011-07-08,,,,,,,,
CO-101-001,CO-101-001-071-003,01071003,071,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,LEUCOVORIN,,2011-06-07,2011-06-07,,2011-07-08,2011-07-08,,,,,,,,
CO-101-001,CO-101-001-071-003,01071003,071,50.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TRAMADOLUM,TRAMADOL HYDROCHLORIDE,2010-11,2010-10-31,D,2011-01-30,2011-01-30,,C,,50,mg,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,LOZARTAN,LOSARTAN,2010-01,2009-12-31,D,2011-04-07,2011-04-07,,C,,50,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,S.FUROSEMIDI,FUROSEMIDE,2011-02-25,2011-02-25,,2011-03-03,2011-03-03,,C,,20,mg,INTRAVENOUS,QD,"DIZZINES,  HYPOTONIA"
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2010-12,2010-11-30,D,2011-04-07,2011-04-07,,C,,"0,04",g,ORAL,TID,PAIN
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2010-12,2010-11-30,D,2011-04-07,2011-04-07,,C,,30,mg,INTRAMUSCULAR,TID,PAIN
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-18,2011-01-18,,2011-02-22,2011-02-22,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-18,2011-01-18,,2011-02-22,2011-02-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-02-16,2011-02-16,,2011-02-16,2011-02-16,,C,,50,mg,INTRAMUSCULAR,ONCE,GIRDLE PAIN IN THE BACK
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM-25,MAGNESIUM,2011-02-25,2011-02-25,,2011-03-02,2011-03-02,,C,,5,mL,INTRAVENOUS,QD,"DIZZINESS, HYPOTONIA"
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,POTASSIUM-4,POTASSIUM,2011-02-25,2011-02-25,,2011-03-02,2011-03-02,,C,,20,mL,INTRAVENOUS,QD,"DIZZINESS, HYPOTONIA"
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-25,2011-02-25,,2011-03-02,2011-03-02,,C,,12,mg,INTRAVENOUS,QD,"DIZZINESS, HYPOTONIA"
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-01,2011-01-27,D,2011-06-27,2011-06-27,,C,,60,mg,INTRAMUSCULAR,TID,KETOROLACI TROMETAMINUM
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,FAMOTIDINE,FAMOTIDINE,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,40,mg,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-06-25,2011-06-25,,2011-06-26,2011-06-26,,C,,2,mg,INTRAMUSCULAR,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOL.RINGER 500,RINGER AGUETTANT,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MENADIONE SODIUM BISULFITE,MENADIONE SODIUM BISULFITE,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,3,mg,INTRAMUSCULAR,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-06-25,2011-06-25,,2011-06-26,2011-06-26,,C,,4,mg,INTRAMUSCULAR,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-25,2011-06-25,,2011-06-26,2011-06-26,,C,,2,mg,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,"NACL 0,9%",SODIUM CHLORIDE,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,1000,mL,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 10%-400+SOL.KCL 4%-60+SOL.MGSO4 25% -5+AMINOSOL 500+LIPOFUNDIN 500,DEXTROSE W/POTASSIUM CHLORIDE,2011-06-28,2011-06-28,,2011-07-16,2011-07-16,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 10%-400+SOL.KCL 4%-60+SOL.MGSO4 25% -5+AMINOSOL 500+LIPOFUNDIN 500,LIPOFUNDIN,2011-06-28,2011-06-28,,2011-07-16,2011-07-16,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 10%-400+SOL.KCL 4%-60+SOL.MGSO4 25% -5+AMINOSOL 500+LIPOFUNDIN 500,MAGNESIUM SULFATE,2011-06-28,2011-06-28,,2011-07-16,2011-07-16,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 10%-400+SOL.KCL 4%-60+SOL.MGSO4 25% -5+AMINOSOL 500+LIPOFUNDIN 500,PROTEIN HYDROLYSATE,2011-06-28,2011-06-28,,2011-07-16,2011-07-16,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,FAMOTIDINE,FAMOTIDINE,2011-06-28,2011-06-28,,2011-07-10,2011-07-10,,C,,40,mg,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE,METAMIZOLE,2011-01,2011-01-27,D,2011-06-27,2011-06-27,,C,,100,mg,INTRAMUSCULAR,TID,PAIN
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,FAMOTIDINE,FAMOTIDINE,2011-07-11,2011-07-11,,2011-07-16,2011-07-16,,C,,20,mg,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,NO-SPA,DROTAVERINE HYDROCHLORIDE,2011-06-28,2011-06-28,,2011-07-11,2011-07-11,,C,,2,mg,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SOL.RINGER,RINGER AGUETTANT,2011-06-29,2011-06-29,,2011-07-08,2011-07-08,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MENADIONE SODIUM BISULFITE,MENADIONE SODIUM BISULFITE,2011-06-28,2011-06-28,,2011-07-16,2011-07-16,,C,,3,mg,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-06-28,2011-06-28,,2011-07-15,2011-07-15,,C,,4,mg,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE,EL-4,2011-06-30,2011-06-30,,2011-07-16,2011-07-16,,C,,400,mL,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE,SODIUM BICARBONATE,2011-06-30,2011-06-30,,2011-07-16,2011-07-16,,C,,400,mL,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2011-06-23,2011-06-23,,2011-06-26,2011-06-26,,C,,800,mg,INTRAVENOUS,ONCE,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-06-24,2011-06-24,,2011-07-10,2011-07-10,,C,,40,mg,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,VICASOL,HALIBORANGE                        /00262101/,2011-06-24,2011-06-24,,2011-07-17,2011-07-17,,C,,3,mL,INTRAVENOUS,ONCE,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-01-27,2011-01-27,,2011-06-16,2011-06-16,,C,,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-06-24,2011-06-24,,2011-07-15,2011-07-15,,C,,4,mL,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2011-07-05,2011-07-05,,2011-07-17,2011-07-17,,C,,100,mL,INTRAVENOUS,TID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,CEFAZOLIN,CEFAZOLIN,2011-07-05,2011-07-05,,2011-07-17,2011-07-17,,C,,2,mg,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 10%,ALBUMIN HUMAN,2011-07-13,2011-07-13,,2011-07-17,2011-07-17,,C,,100,mL,INTRAVENOUS,ONCE,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-27,2011-01-27,,2011-06-16,2011-06-16,,C,,16,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,"NACL 0,9% 500 + KCL 4% 20+MGSO4 25% 10",EL-4,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,"NACL 0,9% 500 + KCL 4% 20+MGSO4 25% 10",MAGNESIUM SULFATE,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAL 5% 1000 + SOL.KCL 4% 20 + SOL.NO-SPA 4,DEXTROSE W/POTASSIUM CHLORIDE,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAL 5% 1000 + SOL.KCL 4% 20 + SOL.NO-SPA 4,DROTAVERINE HYDROCHLORIDE,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,SOL.RINGER 400,RINGER AGUETTANT,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,"SOL.NACL 0,9% 1000 + HEPTRAL 800 MG",ADEMETIONINE,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,"SOL.NACL 0,9% 1000 + HEPTRAL 800 MG",SODIUM CHLORIDE,2011-06-23,2011-06-23,,2011-06-24,2011-06-24,,C,,1,IU,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,"SOL.GLUCOSAE 10%-400, SOL.KCL 4%-60, SOL.MGSO4 25%-5",MAGNESOL                           /01918801/,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,"SOL.GLUCOSAE 10%-400, SOL.KCL 4%-60, SOL.MGSO4 25%-5",POTASSIUM CHLORIDE,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,1,IU,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-17,2011-03-17,,,,,C,Y,16,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-17,2011-03-17,,,,,C,Y,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-02,2011-01-31,D,,,,C,Y,200,mg,ORAL,PRN,PAIN IN THE EPIGASTRIUM
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CODEINE + CAFFEINE + PARACETAMOL+ PROPYPHENAZONE + PHENOBARBITAL,PARDALE,2011-02,2011-01-31,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN IN THE EPIGASTRIUM
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CODEINE + CAFFEINE + PARACETAMOL+ PROPYPHENAZONE + PHENOBARBITAL,PHENOBARBITAL,2011-02,2011-01-31,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN IN THE EPIGASTRIUM
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CODEINE + CAFFEINE + PARACETAMOL+ PROPYPHENAZONE + PHENOBARBITAL,PROPYPHENAZONE,2011-02,2011-01-31,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN IN THE EPIGASTRIUM
CO-101-001,CO-101-001-073-005,01073005,073,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-31,2011-03-31,,2011-09-01,2011-09-01,,C,,16,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-073-005,01073005,073,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-31,2011-03-31,,2011-09-01,2011-09-01,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-073-005,01073005,073,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-06-02,2011-06-02,,,,,C,Y,400,mg,ORAL,PRN,PAIN IN THE EPIGASTRIUM
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID,ACETYLSALICYLIC ACID,2011-05-23,2011-05-23,,2011-06-13,2011-06-13,,C,,100,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ISOSORBIDE MONONITRATE,ISOSORBIDE MONONITRATE,2011-05-23,2011-05-23,,2011-06-13,2011-06-13,,C,,20,mg,ORAL,BID,ANGINA FUNCTIONAL CLASS II
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TRIMETAZIDINE,TRIMETAZIDINE,2011-05-23,2011-05-23,,2011-06-13,2011-06-13,,C,,20,mg,ORAL,BID,CORONARY ARTERY DISEASE
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-01,2010-12-31,D,2011-06-13,2011-06-13,,C,,10,mg,ORAL,QOD,PAIN
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,16,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-073-011,01073011,073,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,TEGAFUR,,2012-04-02,2012-04-02,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-073-011,01073011,073,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-26,2012-01-26,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-073-011,01073011,073,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,S.DEXAMETHASONI,DEXAMETHASONE,2012-01-26,2012-01-26,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-073-011,01073011,073,61.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-11,2011-10-31,D,,,,C,Y,4,TABLET,ORAL,QD,BACKPAIN
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2011-12,2011-11-30,D,2012-02-26,2012-02-26,,C,,1,TABLET,ORAL,TID,PAIN IN THE EPIGASTIUM
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PAPAVERINE,PAPAVERINE,2012-03-20,2012-03-20,,2012-03-25,2012-03-25,,C,,4,mL,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRONI,ONDANSETRON,2012-02-24,2012-02-24,,2012-03-01,2012-03-01,,C,,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONI,DEXAMETHASONE,2012-02-24,2012-02-24,,2012-03-01,2012-03-01,,C,,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CEFAZOLIN,CEFAZOLIN,2012-02-22,2012-02-22,,2012-02-26,2012-02-26,,C,,1,g,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,METROGIL,METRONIDAZOLE,2012-02-22,2012-02-22,,2012-02-26,2012-02-26,,C,,100,mL,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SOL.TRAMADOLI,TRAMADOL,2012-02-26,2012-02-26,,,,,C,Y,2.0,mL,INTRAMUSCULAR,BID,PAIN IN THE EPIGASTIUM GRADE 2
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,KCL 4%,POTASSIUM CHLORIDE,2012-03-20,2012-03-20,,2012-03-25,2012-03-25,,C,,20,mL,INTRAVENOUS,BID,AE
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MGSO4,MAGNESIUM SULFATE,2012-03-20,2012-03-20,,2012-03-25,2012-03-25,,C,,10,mL,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,NO-SPA,DROTAVERINE HYDROCHLORIDE,2012-03-20,2012-03-20,,2012-03-25,2012-03-25,,C,,4,mL,INTRAVENOUS,QD,AE
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PREDUCTAL (TRIMETAZIDINE),TRIMETAZIDINE,2011-02-09,2011-02-09,,2011-02-20,2011-02-20,,P,,1,TABLET,ORAL,BID,ANTIANGINAL
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-10,2011-03-10,,2011-03-10,2011-03-10,,C,,8,mg,INTRAVENOUS,ONCE,ANTIEMETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-24,2011-03-24,,2011-03-24,2011-03-24,,C,,8,mg,INTRAVENOUS,ONCE,ANTIEMETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-31,2011-03-31,,2011-03-31,2011-03-31,,C,,8,mg,INTRAVENOUS,ONCE,ANTIEMETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2011-03-17,2011-03-17,,2011-04-21,2011-04-21,,C,,1,TABLET,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-07,2011-04-07,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,premedication,ANTIEMETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2010-11,2010-10-31,D,2011-02-07,2011-02-07,,P,,1,TABLET,ORAL,PRN,ANALGETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,BARALGIN (METAMIZOLE SODIUM),METAMIZOLE SODIUM,2010-11,2010-10-31,D,,,,C,Y,1,TABLET,ORAL,PRN,ANALGETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-04,2011-05-04,,2011-05-12,2011-05-12,,C,,4,mg,INTRAMUSCULAR,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2011-05-05,2011-05-05,,,,,C,Y,1,TABLET,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-19,2011-05-19,,2011-06-03,2011-06-03,,C,,2,mL,INTRAMUSCULAR,BID,ANALGETI
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MAGNEROT (MAGNESIUM OROTATE),MAGNESIUM OROTATE,2011-02-09,2011-02-09,,2011-04-11,2011-04-11,,C,,2,TABLET,ORAL,TID,MAGNESIUM DRUG
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PROMEDOL,TRIMEPERIDINE,2011-06-03,2011-06-03,,,,,C,Y,1,mL,INTRAMUSCULAR,TID,ANILGETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SYDNOPHARM (MOLSIDOMINE),MOLSIDOMINE,2011-02-09,2011-02-09,,2011-03-28,2011-03-28,,C,,4,mg,ORAL,BID,ANTIANGINAL
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PANANGIN,TROPHICARD,2011-02-09,2011-02-09,,2011-02-14,2011-02-14,,P,,10,mL,INTRAVENOUS,QD,METABOLIC THERAPY
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,RIBOXIN (INOSINE),INOSINE,2011-02-09,2011-02-09,,2011-02-14,2011-02-14,,P,,10,mL,INTRAVENOUS,QD,METABOLIC THERAPY
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,COCARBOXILAZA,COCARBOXYLASE,2011-02-09,2011-02-09,,2011-02-14,2011-02-14,,P,,50,mg,INTRAVENOUS,QD,METABOLIC THERAPY
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SOLUTION NACL 0.9%,SODIUM CHLORIDE,2011-02-09,2011-02-09,,2011-02-14,2011-02-14,,P,,200,mL,INTRAVENOUS,QD,METABOLIC THERAPY
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,8,mg,INTRAVENOUS,ONCE,ANTIEMETIC
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,GRASALVA (FILGRASTIM),FILGRASTIM,2011-03-09,2011-03-09,,2011-03-09,2011-03-09,,C,,48 million,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-075-003,01075003,075,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2011-08-27,2011-08-27,,,,,C,Y,1,TABLET,ORAL,BID,ANAEMIA
CO-101-001,CO-101-001-075-003,01075003,075,42.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SETRONON,ONDANSETRON HYDROCHLORIDE,2011-08-25,2011-08-25,,2011-09-29,2011-09-29,,C,,8,mg,INTRAVENOUS,premedication,PREMEDICATION
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OMEZ,OMEPRAZOLE,2011-08-25,2011-08-25,,2011-10-29,2011-10-29,,C,,20,mg,ORAL,BID,STOMACH ULCER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CAFFEINE,CAFFEINE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,2,mL,INTRAMUSCULAR,PRN,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PREDNIZOLON,PREDNISOLONE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,150,mg,INTRAVENOUS,ONCE,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REFORTAN,HETASTARCH,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,250,mL,INTRAVENOUS,QD,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ACESOL,ACESOL,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,500,mL,INTRAVENOUS,QD,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DOPAMINE,DOPAMINE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,5,mL,INTRAVENOUS,PRN,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,GRASALVA,FILGRASTIM,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,30 mln,IU,SUBCUTANEOUS,ONCE,LEUCOPENIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,8,mg,INTRAMUSCULAR,QD,"TROMBOCYTOPENIA, LEUCOPENIA"
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,OMEZ,OMEPRAZOLE,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,1,TABLET,ORAL,BID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,BARALGIN,METAMIZOLE SODIUM,2012-03-01,2012-03-01,,2012-03-04,2012-03-04,,C,,2,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DIMEDROL,DIPHENHYDRAMINE HYDROCHLORIDE,2012-03-01,2012-03-01,,2012-03-04,2012-03-04,,C,,2,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-09-02,2011-09-02,,2012-02-28,2012-02-28,,C,,10 000,IU,ORAL,TID,ENZYMATIC DEFICIENCY
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PAPAVERIN,PAPAVERINE HYDROCHLORIDE,2012-03-01,2012-03-01,,2012-03-04,2012-03-04,,C,,2,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXON,CEFTRIAXONE SODIUM,2012-03-01,2012-03-01,,2012-03-05,2012-03-05,,C,,1,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-03-06,2012-03-06,,2012-03-11,2012-03-11,,C,,1.2,g,INTRAVENOUS,TID,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,"NACL 0,9%",SODIUM CHLORIDE,2012-03-05,2012-03-05,,2012-03-11,2012-03-11,,C,,400,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,VITAMINE C,ASCORBIC ACID,2012-03-05,2012-03-05,,2012-03-11,2012-03-11,,C,,5,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PERFOLGAN,PARACETAMOL,2012-03-05,2012-03-05,,2012-03-11,2012-03-11,,C,,1,IU,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ACESOL,ACESOL,2012-03-11,2012-03-11,,2012-03-28,2012-03-28,,C,,400,mL,INTRAVENOUS,QD,PANCREATITIS
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,INFEZOL,INFESOL,2012-03-11,2012-03-11,,2012-03-28,2012-03-28,,C,,500,mL,INTRAVENOUS,QD,PANCREATITIS
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,GORDOX,APROTININ,2012-03-11,2012-03-11,,2012-03-28,2012-03-28,,C,,100000,IU,INTRAVENOUS,QD,PANCREATITIS
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TRAMAL,TRAMADOL HYDROCHLORIDE,2012-03-11,2012-03-11,,2012-03-28,2012-03-28,,C,,50,mg,INTRAMUSCULAR,BID,PANCREATITIS
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2011-09-06,2011-09-06,,2011-10-29,2011-10-29,,C,,2,mL,INTRAMUSCULAR,BID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,C,,2,mL,INTRAMUSCULAR,QD,ANAEMIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ADRENALIN,EPINEPHRINE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,1,mL,INTRAVENOUS,ONCE,REANIMATION
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ATROPIN,ATROPINE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,1,mL,INTRAVENOUS,ONCE,REANIMATION
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,CACL 10%,CALCIUM CHLORIDE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,10,mL,INTRAVENOUS,ONCE,REANIMATION
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SORBIFER,FERROUS SULFATE,2012-02-23,2012-02-23,,2012-02-27,2012-02-27,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2011-10-13,2011-10-13,,2011-10-17,2011-10-17,,C,,5,mL,INTRAVENOUS,QD,LIVER IMPAIRMENT
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,GLUCOSE 5%,GLUCOSE,2011-10-13,2011-10-13,,2011-10-17,2011-10-17,,C,,400,mL,INTRAVENOUS,QD,LIVER IMPAIRMENT
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SETRONON,ONDANSETRON HYDROCHLORIDE,2011-09-22,2011-09-22,,2012-03-29,2012-03-29,,C,,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,PREDNIZOLONE,PREDNISOLONE,2012-02-23,2012-02-23,,2012-02-27,2012-02-27,,C,,25,mg,ORAL,BID,TROMBPCYTOPENIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,OMEZ,OMEPRAZOLE,2012-02-23,2012-02-23,,2012-02-27,2012-02-27,,C,,20,mg,ORAL,BID,TROMBPCYTOPENIA
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,CORDIAMIN,NIKETHAMIDE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,2,mL,INTRAMUSCULAR,PRN,ACUTE CARDIOVASCULAR FAILURE
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ACESOL,ACESOL,2012-02-16,2012-02-16,,2012-03-06,2012-03-06,,C,,400,mL,INTRAVENOUS,QD,HEPATOTOXITY
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-02-16,2012-02-16,,2012-03-06,2012-03-06,,C,,800,mg,INTRAVENOUS,QD,HEPATOTOXITY
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2012-02-16,2012-02-16,,2012-03-06,2012-03-06,,C,,250,mL,INTRAVENOUS,QD,HEPATOTOXITY
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-03-07,2012-03-07,,2012-04-18,2012-04-18,,C,,800,mg,ORAL,BID,HEPATOTOXITY
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SETRONON,ONDANSETRON HYDROCHLORIDE,2012-02-02,2012-02-02,,2012-03-15,2012-03-15,,C,,8,mg,INTRAVENOUS,PRN,PREMEDICATION
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-07,2012-03-07,,2012-03-18,2012-03-18,,C,,8,mg,INTRAMUSCULAR,QD,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,OMEZ,OMEPRAZOLE,2012-03-07,2012-03-07,,2012-03-18,2012-03-18,,C,,20,mg,ORAL,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MANNINIL,GLIBENCLAMIDE,2005,2005-12-31,M,,,,C,Y,1,TABLET,ORAL,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-10,2012-03-10,,2012-03-12,2012-03-12,,C,,1,TABLET,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-22,2012-03-22,,2012-03-22,2012-03-22,,C,,4,mg,INTRAMUSCULAR,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-09,2012-03-09,,,,,C,Y,4,mg,INTRAMUSCULAR,BID,PREMEDICATION
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-06-07,2012-06-07,,2012-06-13,2012-06-13,,C,,4,mg,INTRAMUSCULAR,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2012-07-12,2012-07-12,,2012-07-19,2012-07-19,,C,,20,mg,ORAL,QD,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,1,mL,INTRAMUSCULAR,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,GRASALVA,FILGRASTIM,2012-06-23,2012-06-23,,2012-06-23,2012-06-23,,C,,30,ue,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-09,2012-03-09,,,,,C,Y,4,mg,INTRAMUSCULAR,BID,PREMEDICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULIN PROTOPHAN,"INSULIN HUMAN INJECTION, ISOPHANE",2011-04-18,2011-04-18,,2011-06-02,2011-06-02,,P,,6,IU,TRANSDERMAL,QD,DIABETES MILUTUS
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-30,2011-06-30,,2011-07-03,2011-07-03,,C,,5000,IU,SUBCUTANEOUS,QID,ANTICOAGULATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-07-04,2011-07-04,,2011-07-18,2011-07-18,,C,,2500,IU,SUBCUTANEOUS,QID,ANTICOAGULATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,AMOXICLAV,SPEKTRAMOX,2011-07-01,2011-07-01,,2011-07-06,2011-07-06,,C,,1000,mg,ORAL,BID,DVT
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2011-07-04,2011-07-04,,2011-07-18,2011-07-18,,C,,1000,mg,ORAL,BID,DVT
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TROMBO ASS,ACETYLSALICYLIC ACID,2011-07-04,2011-07-04,,2011-07-18,2011-07-18,,C,,100,mg,ORAL,QD,DVT
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,INVANZ,ERTAPENEM SODIUM,2011-07-06,2011-07-06,,2011-07-10,2011-07-10,,C,,1000,mg,INTRAVENOUS,QD,PNEUMONIA
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,S.GLUCOSAE 5%,GLUCOSE,2011-07-08,2011-07-08,,2011-07-18,2011-07-18,,C,,1000,mL,INTRAVENOUS,QD,DESINTOXICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOL.KCL 8%,POTASSIUM CHLORIDE,2011-07-08,2011-07-08,,2011-07-18,2011-07-18,,C,,40,mL,INTRAVENOUS,QD,DESINTOXICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SOL.MGSO4 25%,MAGNESIUM SULFATE,2011-07-08,2011-07-08,,2011-07-18,2011-07-18,,C,,5,mL,INTRAVENOUS,QD,DESINTOXICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,INSULIN PROTOPHAN,"INSULIN HUMAN INJECTION, ISOPHANE",2011-04-18,2011-04-18,,2011-06-02,2011-06-02,,P,,4,IU,TRANSDERMAL,QD,DIABETES MILUTUS
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MEZIM-FOTE,PANCREATIN,2011-05-25,2011-05-25,,,,,C,Y,1,TABLET,ORAL,TID,NA
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,INSULIN PROTOPHAN,"INSULIN HUMAN INJECTION, ISOPHANE",2011-06-02,2011-06-02,,2011-06-20,2011-06-20,,P,,16,IU,TRANSDERMAL,QD,DIABETES MILUTUS
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,INSULIN PROTOPHAN,"INSULIN HUMAN INJECTION, ISOPHANE",2011-06-20,2011-06-20,,2011-06-30,2011-06-30,,C,,18,IU,TRANSDERMAL,QD,DIABETES MILUTUS
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,INSULIN PROTOPHAN,"INSULIN HUMAN INJECTION, ISOPHANE",2011-06-30,2011-06-30,,,,,C,Y,20,IU,TRANSDERMAL,QD,DIABETES MILUTUS
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,S.GLUCOSAE 5%,GLUCOSE,2011-06-23,2011-06-23,,2011-06-29,2011-06-29,,C,,400,mL,INTRAVENOUS,Premedication,PREMEDICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-06-23,2011-06-23,,2011-06-29,2011-06-29,,C,,2,mL,INTRAVENOUS,Premedication,PREMEDICATION
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETAZON,DEXAMETHASONE,2011-06-23,2011-06-23,,2011-06-29,2011-06-29,,C,,12,mg,INTRAVENOUS,Premedication,PREMEDICATION
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETONAL,KETOPROFEN,2011-12,2011-11-30,D,,,,C,Y,1,TABLET,RECTAL,BID,TO CORRECT PAIN
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GRANOCIT 34,LENOGRASTIM,2012-03-12,2012-03-12,,2012-03-13,2012-03-13,,C,,1.0,mL,TRANSDERMAL,QD,TREATMENT AGRANULOCYTOSIS
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CIPRINOL,CIPROFLOXACIN,2012-03-12,2012-03-12,,2012-03-16,2012-03-16,,C,,500,mg,ORAL,BID,ANTIBACTERIAL
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 5%,GLUCOSE,2012-02-29,2012-02-29,,,,,C,Y,400,mL,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CERUCALI,METOCLOPRAMIDE HYDROCHLORIDE,2012-02-29,2012-02-29,,,,,C,Y,2.0,mL,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETAZON,DEXAMETHASONE,2012-02-29,2012-02-29,,,,,C,Y,12,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,MEZIM,PANCREATIN,2010-11-15,2010-11-15,,,,,C,Y,3500,IU,ORAL,TID,PANCREATIC CANCER
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TENOXICAM,TENOXICAM,2010-12-22,2010-12-22,,2010-12-31,2010-12-31,,C,,20,mg,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2010-12-22,2010-12-22,,2010-12-26,2010-12-26,,C,,100,mL,INTRAVENOUS,BID,ANTIBACTERIAL THERAPY
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,"METRONIDAZOLE,CHLORHEXIDINE",CHLORHEXIDINE,2010-12-22,2010-12-22,,2010-12-26,2010-12-26,,C,,100,mL,INTRAVENOUS,TID,ANTIBACTERIAL THERAPY
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,"METRONIDAZOLE,CHLORHEXIDINE",METRONIDAZOLE,2010-12-22,2010-12-22,,2010-12-26,2010-12-26,,C,,100,mL,INTRAVENOUS,TID,ANTIBACTERIAL THERAPY
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2010,2010-12-23,M,,,,C,Y,1,TABLET,ORAL,QD,PAIN
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ESPUMISAN,SIMETICONE,2011-01-17,2011-01-17,,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-01-12,2011-01-12,,,,,C,Y,100,mg,RECTAL,PRN,PAIN
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-01-31,2011-01-31,,2011-02-09,2011-02-09,,P,,4,mL,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-01-31,2011-01-31,,2011-02-09,2011-02-09,,P,,5,mg,INTRAVENOUS,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-02-10,2011-02-10,,2011-02-15,2011-02-15,,P,,2,mL,INTRAVENOUS,QD,PROPHYLAXIS  OF NAUSEA
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICY,ELECTROLYTES NOS W/GLUCOSE,2011-03-02,2011-03-02,,2011-03-28,2011-03-28,,C,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS  OF DEHYDRATION
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CYTOFLAVINUM,CYTOFLAVIN,2011-03-02,2011-03-02,,2011-03-28,2011-03-28,,C,,20,mL,INTRAVENOUS,QD,?YTOPROTECTION
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-03-02,2011-03-02,,2011-03-09,2011-03-09,,C,,4,mL,INTRAVENOUS,QD,PROPHYLAXIS  OF NAUSEA
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM MONOHYDRATE,METAMIZOLE SODIUM MONOHYDRATE,2011-03-02,2011-03-02,,2011-03-09,2011-03-09,,C,,4,mg,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,RANITIDINE,RANITIDINE,2011-03-02,2011-03-02,,2011-03-09,2011-03-09,,C,,100,mg,INTRAVENOUS,QD,PROPHYLAXIS  OF ULCER
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-03-02,2011-03-02,,2011-03-09,2011-03-09,,C,,16,mg,INTRAVENOUS,QD,DESENSITAZITION
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-03-02,2011-03-02,,2011-03-09,2011-03-09,,C,,8,UA,INTRAVENOUS,QD,PROPHYLAXIS  OF HYPERGLYCEMIA
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2011-01-12,2011-01-12,,,,,C,Y,30,mg,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-03-07,2011-03-07,,2011-03-09,2011-03-09,,C,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS  OF DEHYDRATION
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-03-07,2011-03-07,,2011-03-09,2011-03-09,,C,,5,mL,INTRAVENOUS,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,THIOCTIC ACID,THIOCTIC ACID,2011-03-07,2011-03-07,,2011-03-09,2011-03-09,,C,,600,mg,INTRAVENOUS,QD,PROPHYLAXIS  OF POLYNEUROPATHY
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,VITAMIN B12 (CYANOCOBALAMINE),CYANOCOBALAMIN,2011-03-07,2011-03-07,,2011-03-09,2011-03-09,,C,,2,mL,INTRAMUSCULAR,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PYRIDOXINE,PYRIDOXINE,2011-03-07,2011-03-07,,2011-03-09,2011-03-09,,C,,2,mL,INTRAMUSCULAR,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-01-12,2011-01-12,,,,,C,Y,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-01-31,2011-01-31,,2011-02-15,2011-02-15,,P,,400,mL,INTRAVENOUS,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PANANGIN,TROPHICARD,2011-01-31,2011-01-31,,2011-02-15,2011-02-15,,P,,10,mL,INTRAVENOUS,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICI,ELECTROLYTES NOS W/GLUCOSE,2011-01-31,2011-01-31,,2011-02-15,2011-02-15,,P,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS  OF DEHYDRATION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,CANEPHRON H,HERBAL EXTRACT NOS,2011-04,2011-03-31,D,,,,C,Y,2,TABLET,ORAL,TID,PYELONEPHRITIS
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-05-12,2011-05-12,,2011-06-02,2011-06-02,,C,,2,mL,INTRAVENOUS,QD,PROPHYLAXIS OF VOMITING
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLUM,OMEPRAZOLE,2011-05-12,2011-05-12,,2011-06-02,2011-06-02,,C,,20,mg,ORAL,BID,PROPHYLAXIS OF GASTRIC ULCER
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-28,2011-05-28,,2011-06-02,2011-06-02,,C,,16,mg,INTRAVENOUS,QD,DESENSITAZITION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-05-28,2011-05-28,,2011-06-02,2011-06-02,,C,,8,UA,INTRAVENOUS,QD,PROPHYLAXIS  OF HYPERGLYCEMIA
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,EGILOC,METOPROLOL TARTRATE,2010-06,2010-05-31,D,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ENAP - ENALAPRIL MALEATE,ENALAPRIL MALEATE,2010-06,2010-05-31,D,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,BRAL  PAPAVERINE HYDROCHLORIDE,PAPAVERINE HYDROCHLORIDE,2005,2005-12-31,M,,,,C,Y,1,TABLET,ORAL,PRN,CHRONIC CHOLECYSTITIS
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-04-21,2011-04-21,,2011-04-26,2011-04-26,,P,,20,mg,INTRAVENOUS,QID,HYPERCREATINEMIA
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PROMEDOLUM,TRIMEPERIDINE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,0.02,mg,INTRAMUSCULAR,ONCE,PAIN
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SOL. POLYIONICI,ELECTROLYTES NOS W/GLUCOSE,2011-05-12,2011-05-12,,2011-06-02,2011-06-02,,C,,400,mL,INTRAVENOUS,QD,PROPHYLAXIS OF DEHYDRATION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,CITOFLAVINUM,CYTOFLAVIN,2011-05-12,2011-05-12,,2011-06-02,2011-06-02,,C,,10,mL,INTRAVENOUS,QD,CYTOPROTECTION
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-05-12,2011-05-12,,2011-06-02,2011-06-02,,C,,20,mg,INTRAVENOUS,QD,PROPHYLAXIS OF VOMITING
CO-101-001,CO-101-001-078-005,01078005,078,56.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,SPAZMALGON,BARALGINA,2011-03,2011-02-28,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-078-005,01078005,078,56.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NUROFEN,IBUPROFEN,2011-03,2011-02-28,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-078-005,01078005,078,56.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PENTALGIN,NEMBUDEINE,2011-07,2011-07-01,D,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-078-005,01078005,078,56.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PROMEDOL,TRIMEPERIDINE,2011-03-21,2011-03-21,,,,,C,Y,1,mL,INTRAMUSCULAR,PRN,PAIN
CO-101-001,CO-101-001-078-007,01078007,078,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OMEZ,OMEPRAZOLE,2011-04-25,2011-04-25,,,,,C,Y,20,mg,ORAL,BID,PROPHYLAXIS OF ULCER
CO-101-001,CO-101-001-078-007,01078007,078,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM/ FENPIVERINIUM,FENPIVERINIUM,2011-03,2011-02-28,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-078-007,01078007,078,50.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM/ FENPIVERINIUM,METAMIZOLE SODIUM,2011-03,2011-02-28,D,,,,C,Y,1,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABIN+CISPLATIN,,2012-01-24,2012-01-24,,,2012-01-24,Y,,,,,,,
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KETONAL,KETOPROFEN,2010,2010-12-31,M,,,,C,Y,1,TABLET,ORAL,BID,PAIN
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,2,mL,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,8,mg,INTRAVENOUS,QD,DESENSITAZITION
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICY,ELECTROLYTES NOS W/GLUCOSE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,400,mL,INTRAVENOUS,QD,BEST ELECTROLYTIC BALANCE
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,2,mL,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,8,mg,INTRAVENOUS,QD,DESENSITAZITION
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICY,ELECTROLYTES NOS W/GLUCOSE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,400,mL,INTRAVENOUS,QD,BEST ELECTROLYTIC BALANCE
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,20,mg,INTRAVENOUS,QD,ANTIULCER
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,2,mL,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,BARALGIN,METAMIZOLE SODIUM,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,5,mL,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PHYSIOLOGICAL SOLUTION,SODIUM CHLORIDE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,400,mL,INTRAVENOUS,QD,BEST ELECTROLYTIC BALANCE
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2010,2010-12-31,M,,,,C,Y,10000,IU,ORAL,PRN,CANCER OF PANCREAS
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,2,mL,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,NALBUPHINE,NALBUPHINE,2011-11-18,2011-11-18,,2011-11-27,2011-11-27,,C,,2,mL,INTRAVENOUS,QD,PAIN
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,L-TYROSINE,TYROSINE,2005,2005-12-31,M,,,,C,Y,100,IU,ORAL,QD,PROPHYLAXIS OF HYPOTHYROSIS
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICY,ELECTROLYTES NOS W/GLUCOSE,2011-07-04,2011-07-04,,2011-07-11,2011-07-11,,P,,400,mL,INTRAVENOUS,QD,BEST ELECTROLYTIC BALANCE
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CYTOFLAVINUM,CYTOFLAVIN,2011-07-04,2011-07-04,,2011-07-11,2011-07-11,,P,,10,mL,INTRAVENOUS,QD,BEST CEREBROVASCULAR BLOOD CIRCULATION
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-07-04,2011-07-04,,2011-07-11,2011-07-11,,P,,20,mg,INTRAVENOUS,QD,ANTIULCER
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-04,2011-07-04,,2011-07-11,2011-07-11,,P,,2,mL,INTRAVENOUS,QD,ANTIEMETIC
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-04,2011-07-04,,2011-07-11,2011-07-11,,P,,8,mg,INTRAVENOUS,QD,DESENSITAZITION
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,SOL. POLYONICY,ELECTROLYTES NOS W/GLUCOSE,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,400,mL,INTRAVENOUS,QD,BEST ELECTROLYTIC BALANCE
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DUROGEZIK MATRIX,FENTANYL,2011-10,2011-09-30,D,,,,C,Y,50,ug,TRANSDERMAL,PRN,PAIN
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-11-30,2011-11-30,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN,EPOETIN ALFA,2012-07-25,2012-07-25,,2012-07-25,2012-07-25,,C,,10000,IU,SUBCUTANEOUS,ONCE,ANAEMIA
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HEMOTRANFUSION,"BLOOD TRANSFUSION, AUXILIARY PRODUCTS",2012-08-24,2012-08-24,,2012-08-24,2012-08-24,,C,,1,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOL. POLIONYCI,ELECTROLYTES NOS W/GLUCOSE,2011-11-14,2011-11-14,,,,,C,Y,400,mL,INTRAVENOUS,BID,PROPHYLAXIS OF ELECTROLYTIC DISORDERS
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-11-14,2011-11-14,,,,,C,Y,20,mg,INTRAVENOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-14,2011-11-14,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CYTOFLAVINUM,CYTOFLAVIN,2011-11-14,2011-11-14,,,,,C,Y,10,mL,INTRAVENOUS,QD,BEST SUPPORTIVE CARE
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,AMOXICLAV,SPEKTRAMOX,2012-01-25,2012-01-25,,,,,C,Y,625,mg,ORAL,BID,FOCAL PNEUMONIA
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LINEX,LACTOBACILLUS ACIDOPHILUS,2012-01-25,2012-01-25,,,,,C,Y,1,TABLET,ORAL,QD,PROPHYLAXIS OF DYSBACTERIOSIS
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,AMBROXOLI  HYDROCHLORIDE,AMBROXOL HYDROCHLORIDE,2012-01-25,2012-01-25,,,,,C,Y,4,mL,ORAL,TID,DIFFLUENCE OF BEGMA
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-30,2011-11-30,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PRE-MEDICATION
CO-101-001,CO-101-001-079-001,01079001,079,77.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2010,2010-10-14,M,,,,C,Y,40,mg,ORAL,TID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-001,01079001,079,77.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-10-14,2010-10-14,,2011-01-20,2011-01-20,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-001,01079001,079,77.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-14,2010-10-14,,2011-01-20,2011-01-20,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-002,01079002,079,70.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2010,2010-10-21,M,,,,C,Y,10,mg,ORAL,TID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-079-002,01079002,079,70.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-21,2010-10-21,,2011-01-20,2011-01-20,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-002,01079002,079,70.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-10-21,2010-10-21,,2011-01-20,2011-01-20,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-002,01079002,079,70.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PREDNISOLONE,PREDNISOLONE,2011-01-04,2011-01-04,,2011-01-20,2011-01-20,,C,,30,mg,ORAL,QD,"TROMBOCITOPENIA, LEUKOPENIA, ANAEMIA"
CO-101-001,CO-101-001-079-006,01079006,079,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,"'DOLAREN (PARACETAMOL FORTE RAFFO - PARACETAMOL, DICLOFENAC SODIUM)",PARACETAMOL FORTE RAFFO,2010,2010-10-27,M,2010-12-06,2010-12-06,,C,,1,TABLET,ORAL,QD,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-006,01079006,079,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-10-27,2010-10-27,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-006,01079006,079,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-27,2010-10-27,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-006,01079006,079,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-05-28,2011-05-28,,2011-05-28,2011-05-28,,C,,50,mg,INTRAVENOUS,BID,PAIN IN EPIGASTIUM
CO-101-001,CO-101-001-079-009,01079009,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-28,2010-10-28,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-009,01079009,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-10-28,2010-10-28,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-009,01079009,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM AND ASCORBIC),KENDURAL C,2011-06-16,2011-06-16,,,,,C,Y,1,TABLET,ORAL,TID,ANAEMIA
CO-101-001,CO-101-001-079-010,01079010,079,68.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2010,2010-11-09,M,,,,C,Y,10,mg,ORAL,BID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-010,01079010,079,68.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2010-11-09,2010-11-09,,2010-11-23,2010-11-23,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-010,01079010,079,68.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-09,2010-11-09,,2010-11-23,2010-11-23,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,NEFOPAM,NEFOPAM,2010-11,2010-10-31,D,2011-02-02,2011-02-02,,C,,40,mg,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2010-11,2010-10-31,D,,,,C,Y,50,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-27,2011-01-27,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-01-27,2011-01-27,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-07-14,2011-07-14,,,,,C,Y,40,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE+ASCORBIC ACID),KENDURAL C,2011-07-28,2011-07-28,,,,,C,Y,1,TABLET,ORAL,TID,ANAEMIA
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,RADIOTHERAPY,HEAD OF PANCREAS 37.5 GR,,2011-11-14,2011-11-14,,2011-12-06,2011-12-06,,,,,,,,
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-22,2011-02-22,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-02-22,2011-02-22,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-09-12,2011-09-12,,2011-09-22,2011-09-22,,C,,1000,mg,INTRAMUSCULAR,BID,ACUTE CHOLANGITIS
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NIMESIL,NIMESULIDE,2011-09-12,2011-09-12,,2011-09-22,2011-09-22,,C,,100,mg,ORAL,BID,ACUTE CHOLANGITIS
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-12,2011-09-12,,2011-09-22,2011-09-22,,C,,40,mg,ORAL,TID,ACUTE CHOLANGITIS
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,"ALLOCHOL (BILE 0,08 G, ACTIVATED CHARCOAL 0,025 G, GARLIC 0,04 G, URTICA 0,005 G)",ALLOCHOL,2011-09-12,2011-09-12,,2011-09-22,2011-09-22,,C,,1,TABLET,ORAL,TID,ACUTE CHOLANGITIS
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-02,2011-01-31,D,,,,C,Y,50,mg,INTRAMUSCULAR,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,"PANZYNORM (LIPASE 10000 IU, AMYLASE 7200 IU, PROTEASE 400 IU)",PANZYNORM,2011-01-12,2011-01-12,,,,,C,Y,1,TABLET,ORAL,QID,LOSS OF APPETITE
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,"KREON 25000 (PANCREATIN 300 MG, AMYLASE 8000 IU, LIPASE 25000 IU, PROTEASE 1000 IU)",PANCREATIN,2011-01-12,2011-01-12,,,,,C,Y,1,TABLET,ORAL,QD,LOSS OF APPETITE
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-14,2011-04-14,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-04-14,2011-04-14,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,INSULINN,INSULIN,1991,1991-12-31,M,,,,C,Y,8/16/6,IU,TRANSDERMAL,TID,TYPE 2 DIABETES MELLITUS
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-05-19,2011-05-19,,2012-05-31,2012-05-31,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-19,2011-05-19,,2012-05-31,2012-05-31,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-05-26,2011-05-26,,2011-05-27,2011-05-27,,C,,30000000,IU,TRANSDERMAL,QD,ANAEMIA
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM AND ASCORBIC),KENDURAL C,2011-06-30,2011-06-30,,,,,C,Y,1,TABLET,ORAL,TID,ANAEMIA
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-04-20,2011-04-20,,,,,C,Y,40,TABLET,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-018,01079018,079,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2010-11-01,2010-11-01,,2010-12-13,2010-12-13,,,,,,,,
CO-101-001,CO-101-001-079-018,01079018,079,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-28,2011-07-28,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-018,01079018,079,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-28,2011-07-28,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-06-20,2011-06-20,,2012-06-22,2012-06-22,,C,,40,mg,ORAL,BID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-08-04,2011-08-04,,2012-06-22,2012-06-22,,C,,25000,IU,ORAL,PRN,ABDOMINAL DISTENTION
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DUSPATOLIN,MEBEVERINE HYDROCHLORIDE,2011-06-20,2011-06-20,,2012-06-22,2012-06-22,,C,,200,mg,ORAL,BID,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-06-20,2011-06-20,,2012-06-22,2012-06-22,,C,,1,TABLET,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LOSARTANE,LOSARTAN,2006,2006-12-31,M,2012-06-22,2012-06-22,,C,,50,mg,ORAL,QD,"ESSENTIAL HYPERTENSION, IHD, STROKE/CVA"
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CARDIOMAGNYL,MAGNYL                             /02350501/,2006,2006-12-31,M,2012-06-22,2012-06-22,,C,,1,TABLET,ORAL,QD,"ESSENTIAL HYPERTENSION, IHD, STROKE/CVA"
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,VINPOCETINE,VINPOCETINE,2006,2006-12-31,M,2012-06-22,2012-06-22,,C,,1,TABLET,ORAL,BID,"ESSENTIAL HYPERTENSION, IHD, STROKE/CVA"
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-26,2011-07-26,,2012-06-07,2012-06-07,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-26,2011-07-26,,2012-06-07,2012-06-07,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM AND ASCORBIC),KENDURAL C,2011-11-03,2011-11-03,,2012-06-22,2012-06-22,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-079-020,01079020,079,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-10-11,2011-10-11,,2011-10-18,2011-10-18,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-020,01079020,079,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-11,2011-10-11,,2012-10-18,2012-10-18,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-020,01079020,079,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FARMASULINE H 30/70 (INSULIN HUMAN),INSULIN HUMAN,2011-09-22,2011-09-22,,,,,C,Y,14,IU,SUBCUTANEOUS,"8 units at 8:00, 6 units at 19:00",TYPE 2 DIABETES MELLITUS
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ERISPAL,FENSPIRIDE HYDROCHLORIDE,2010-12,2010-11-30,D,,,,C,Y,80,mg,ORAL,BID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AEROFYLLIN (DOXOFYLLIN),DOXOFYLLINE,2010-12,2010-11-30,D,,,,C,Y,400,mg,ORAL,BID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PREDUCTAL MR,TRIMETAZIDINE HYDROCHLORIDE,2010-12,2010-11-30,D,,,,C,Y,35,mg,ORAL,BID,ISCHEMIC HEART DISEASE
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-02,2011-11-02,,2012-01-11,2012-01-11,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-02,2011-11-02,,2012-01-11,2012-01-11,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-08,2011-07-31,D,2011-12-15,2011-12-15,,C,,10,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,"REOSORBILACT (SORBITOL - 60 G, SODIUM LACTATE - 19 G, SODIUM CHLORIDE - 6 G, ?ALCIUM CHLORIDE - 0.1 G, POTASSIUM CHLORIDE - 0.3 G, MAGNESIUM CHLORIDE - 0.2 G)",,2012-02-07,2012-02-07,,2012-02-16,2012-02-16,,C,,400,mL,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,REFORTAN,HETASTARCH,2012-02-07,2012-02-07,,2012-02-16,2012-02-16,,C,,500,mL,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,L-LYSIRE AESCINAT,LYSINE,2012-02-16,2012-02-16,,2012-02-21,2012-02-21,,C,,10,mL,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,REAMBERIN,MEGLUMINE SODIUM SUCCINATE,2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,250,mL,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,"SORBILACT (SORBITOL - 60 G, SODIUM LACTATE - 19 G, SODIUM CHLORIDE - 6 G, ?ALCIUM CHLORIDE - 0.1 G, POTASSIUM CHLORIDE - 0.3 G, MAGNESIUM CHLORIDE - 0.2 G)",,2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,200,mL,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ACTOVEGIN,"BLOOD, CALF, DEPROT., LMW PORTION",2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,10,mL,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CERAXON,CITICOLINE SODIUM,2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,500,mg,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,400,mg,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PIRACETAM,PIRACETAM,2012-02-16,2012-02-16,,2012-02-20,2012-02-20,,C,,10,mL,INTRAVENOUS,BID,AE #11 (ISCHEMIC STROKE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,NITROGLYCERINE,GLYCERYL TRINITRATE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,10,mg,ORAL,QD,AE #12 (ACUTE MYOCARDIAL INFARCTION)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DUSPATALIN,MEBEVERINE HYDROCHLORIDE,2011-08,2011-07-31,D,2012-02-21,2012-02-21,,C,,135,mg,ORAL,PRN,ABDOMINAL DISTENTION
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ISOSORBIDE DINITRATE,ISOSORBIDE DINITRATE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,20,mg,INTRAVENOUS,QD,AE #12 (ACUTE MYOCARDIAL INFARCTION)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QD,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,APROTININ,APROTININ,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,200000,IU,INTRAVENOUS,BID,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,4,mL,INTRAVENOUS,BID,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,GELATINE,GELATIN,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,500,mL,INTRAVENOUS,BID,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,TRANEXAM,TRANEXAMIC ACID,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,5,mL,INTRAVENOUS,BID,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,PHENYLEPRINE,PHENYLEPHRINE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,25,mg,INTRAVENOUS,6 TIMES PER DAY,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,40,mg,INTRAVENOUS,BID,AE #13 (MULTI-ORGAN FAILURE)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-01,2011-11-01,,2012-02-07,2012-02-07,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-01,2011-11-01,,2012-02-07,2012-02-07,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2012-01-24,2012-01-24,,2012-02-21,2012-02-21,,C,,10,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2012-02-07,2012-02-07,,2012-02-16,2012-02-16,,C,,800,mL,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-07,2012-02-07,,2012-02-16,2012-02-16,,C,,12,mg,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,EUPHYLLINUM,AMINOPHYLLINE,2012-02-07,2012-02-07,,2012-02-16,2012-02-16,,C,,10,mL,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,"NEOHAEMODESUM (100 ML: POVIDONE LOW MOLECULAR WEIGHT (M.M.8000  2000) - 6 G, NACL -0.55 G, KCL-0,042 G, CACL2-0.05 G, MGCL2-0.0005 G, NAHCO3-0.023 G)",SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-08,2012-02-08,,2012-02-16,2012-02-16,,C,,200,mL,INTRAVENOUS,QD,AE #7 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-07,2011-06-30,D,,,,C,Y,40,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PAPAVERINE,PAPAVERINE,2012-02-13,2012-02-13,,,,,C,Y,2,mL,INTRAMUSCULAR,TID,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-02-13,2012-02-13,,,,,C,Y,2,g,INTRAMUSCULAR,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,"NEOHAEMODESUM (100 ML: POVIDONE LOW MOLECULAR WEIGHT (M.M.8000  2000) - 6 G, NACL -0.55 G, KCL-0,042 G, CACL2-0.05 G, MGCL2-0.0005 G, NAHCO3-0.023 G)",SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-13,2012-02-13,,,,,C,Y,200,mL,INTRAVENOUS,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-02-29,2012-02-29,,,,,C,Y,400,mg,ORAL,BID,"ALP INCREASE, AST INCREASE, ALT INCREASE"
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DUSPATALIN,MEBEVERINE HYDROCHLORIDE,2012-03-13,2012-03-13,,,,,C,Y,135,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,"REOSORBILACT (SORBITOL - 60 G, SODIUM LACTATE - 19 G, SODIUM CHLORIDE - 6 G, ?ALCIUM CHLORIDE - 0.1 G, POTASSIUM CHLORIDE - 0.3 G, MAGNESIUM CHLORIDE - 0.2 G)",,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,200,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,200,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,400,mg,INTRAVENOUS,BID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,HEPASOL,HEPASOL,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,500,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,12,mg,INTRAMUSCULAR,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-02,2011-11-02,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,8,mg,INTRAMUSCULAR,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,4,mg,INTRAMUSCULAR,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AESCINE,ESCIN,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,2,TABLET,ORAL,BID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,2,mL,INTRAMUSCULAR,TID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,2,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,VEROSPIRON,SPIRONOLACTONE,2012-04-04,2012-04-04,,2012-04-08,2012-04-08,,C,,1,TABLET,ORAL,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT,ELECTROLYTES NOS W/SORBITOL,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,200,mL,INTRAVENOUS,QD,AE# 10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,200,mL,INTRAVENOUS,QD,AE# 10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,REFORTAN,HETASTARCH,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,500,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,AESCINE,ESCIN,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,2,TABLET,ORAL,BID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-02,2011-11-02,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,TRISOLUM (SODIUM HYDROCARBONATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE),EL-4,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,400,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,TRISOLUM (SODIUM HYDROCARBONATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE),SODIUM BICARBONATE,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,400,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,2,mL,INTRAVENOUS,QD,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,2,mL,INTRAVENOUS,BID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-04-18,2012-04-18,,2012-04-21,2012-04-21,,C,,2,mL,INTRAMUSCULAR,BID,AE #10 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,RESORBILACT,ELECTROLYTES NOS W/SORBITOL,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,200,mL,INTRAVENOUS,QD,AE #17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,200,mL,INTRAVENOUS,QD,AE #17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,HEPASOL,HEPASOL,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,500,mL,INTRAVENOUS,QD,AE #17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,AESCINE,ESCIN,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,2,TABLET,ORAL,BID,AE #17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,INFESOL,INFESOL,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,500,mL,INTRAVENOUS,QD,AE# 17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-05-03,2012-05-03,,2012-05-14,2012-05-14,,C,,2,mL,INTRAVENOUS,QD,AE# 17 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-11-02,2011-11-02,,,,,C,Y,10000,IU,ORAL,TID,ABDOMINAL DISTENSION
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-02,2011-11-02,,,,,C,Y,10,mg,ORAL,TID,ABDOMINAL DISTENSION
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,"NACL 0,9%",SODIUM CHLORIDE,2012-02-13,2012-02-13,,2012-02-17,2012-02-17,,C,,400,mL,INTRAVENOUS,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-13,2012-02-13,,,,,C,Y,12,mg,INTRAVENOUS,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,REFORTAN,HETASTARCH,2012-02-13,2012-02-13,,,,,C,Y,500,mL,INTRAVENOUS,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,EUPHYLLINUM,AMINOPHYLLINE,2012-02-13,2012-02-13,,,,,C,Y,10,mL,INTRAVENOUS,QD,AE #5 (HYPERBILIRUBINEMIA)
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,"CISPLATIN, FLUOROURACIL, LEUCOVORIN",,2011-01-27,2011-01-27,,2011-01-31,2011-01-31,,,,,,,,
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,PRIOR RADIOTHERAPY,RADIOTHERAPY,PANCREAS,,2010-12-08,2010-12-08,,2010-12-29,2010-12-29,,,,40,Gy,,,
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2010-11,2010-10-31,D,,,,C,Y,40,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2012-04-26,2012-04-26,,2012-04-30,2012-04-30,,C,,2000,IU,TRANSDERMAL,QOD,ANEMIA (AE #21)
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,?POBIOCRINUM,,2012-06-07,2012-06-07,,,,,C,Y,10000,IU,TRANSDERMAL,QD,AE # 36 (ANEMIA)
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-11-17,2011-11-17,,,,,C,Y,25,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,NEFOPAM,NEFOPAM,2011-11-17,2011-11-17,,,,,C,Y,20,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-17,2011-11-17,,2012-06-14,2012-06-14,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-17,2011-11-17,,2012-06-14,2012-06-14,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2012-04-12,2012-04-12,,2012-04-12,2012-04-12,,C,,30000,IU,TRANSDERMAL,QD,LEUKOPENIA
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DENEBOL (ROFECOXIBE),ROFECOXIB,2012-04-30,2012-04-30,,,,,C,Y,25,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DUSPATALIN,MEBEVERINE HYDROCHLORIDE,2012-02-16,2012-02-16,,2012-04-30,2012-04-30,,C,,135,mg,ORAL,PRN,PAIN IN EPIGASTIUM
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2012-04-26,2012-04-26,,2012-04-26,2012-04-26,,C,,30000,IU,TRANSDERMAL,QD,NEUTROPENIA
CO-101-001,CO-101-001-079-025,01079025,079,47.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DUSPATALIN,MEBEVERINE HYDROCHLORIDE,2011-07,2011-06-30,D,,,,C,Y,135,mg,ORAL,PRN,ABDOMINAL DISTENTION
CO-101-001,CO-101-001-079-025,01079025,079,47.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-07,2011-06-30,D,,,,C,Y,25,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-025,01079025,079,47.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-29,2011-11-29,,2011-12-20,2011-12-20,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-025,01079025,079,47.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-29,2011-11-29,,2012-12-20,2012-12-20,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-026,01079026,079,61.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-026,01079026,079,61.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-027,01079027,079,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-08,2011-07-31,D,,,,C,Y,40,mg,ORAL,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-027,01079027,079,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-26,2011-12-26,,,,,C,Y,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-027,01079027,079,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-26,2011-12-26,,,,,C,Y,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-029,01079029,079,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-10,2011-09-30,D,2012-06-22,2012-06-22,,C,,25,mg,ORAL,PRN,PAIN IN EPIGASRIUM
CO-101-001,CO-101-001-079-029,01079029,079,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-12,2012-01-12,,2012-06-14,2012-06-14,,C,,20,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-029,01079029,079,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-12,2012-01-12,,2012-06-14,2012-06-14,,C,,8,mg,INTRAVENOUS,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2011-01,2010-12-31,D,,,,C,Y,20,mg,INTRAMUSCULAR,PRN,PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AMINOPLASMAL,AMINO ACIDS NOS W/MINERALS NOS,2012-02-27,2012-02-27,,,,,C,Y,500,mL,INTRAVENOUS,QD,GENERAL WEAKNESS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-27,2012-02-27,,,,,C,Y,4,mg,INTRAVENOUS,TID,GENERAL WEAKNESS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ACTOVEGIN,"BLOOD, CALF, DEPROT., LMW PORTION",2012-02-28,2012-02-28,,2012-03-03,2012-03-03,,C,,10,mL,INTRAVENOUS,BID,DEEP VENOUS THROMBOSIS OF RIGHT CRUS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PHLEBODIA,DIOSMIN,2012-02-28,2012-02-28,,2012-03-10,2012-03-10,,C,,600,mg,ORAL,BID,DEEP VENOUS THROMBOSIS OF RIGHT CRUS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2012-03-04,2012-03-04,,2012-03-10,2012-03-10,,C,,500,mg,ORAL,BID,DEEP VENOUS THROMBOSIS OF RIGHT CRUS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LIOTON 1000,HEPARIN SODIUM,2012-02-28,2012-02-28,,2012-03-10,2012-03-10,,C,,,,TOPICAL,TID,DEEP VENOUS THROMBOSIS OF RIGHT CRUS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2011-01,2010-12-31,D,,,,C,Y,25000,IU,ORAL,before meals,DIGESTANT
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-01-29,2012-01-29,,,,,C,Y,400,mg,ORAL,BID,GGT INCREASE - CLINICALLY SIGNIFICANT
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2012-02-09,2012-02-09,,,,,C,Y,500,mg,ORAL,TID,HYPERGLYCEMIA
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-26,2012-01-26,,,,,C,Y,20,mg,INTRAMUSCULAR,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-26,2012-01-26,,,,,C,Y,8,mg,INTRAMUSCULAR,before every study drug intake,PREMEDICATION
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,"REOSORBILACT (SORBITOL - 60 G, SODIUM LACTATE - 19 G, SODIUM CHLORIDE - 6 G, ?ALCIUM CHLORIDE - 0.1 G, POTASSIUM CHLORIDE - 0.3 G, MAGNESIUM CHLORIDE - 0.2 G)",,2012-02-27,2012-02-27,,,,,C,Y,200,mL,INTRAVENOUS,QD,GENERAL WEAKNESS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,"NEOHAEMODESUM (100 ML: POVIDONE LOW MOLECULAR WEIGHT (M.M.8000  2000) - 6 G, NACL -0.55 G, KCL-0,042 G, CACL2-0.05 G, MGCL2-0.0005 G, NAHCO3-0.023 G)",SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-27,2012-02-27,,,,,C,Y,200,mL,INTRAVENOUS,QD,GENERAL WEAKNESS
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,INFESOL,INFESOL,2012-02-27,2012-02-27,,,,,C,Y,500,mL,INTRAVENOUS,QD,GENERAL WEAKNESS
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-10-11,2010-10-11,,2010-10-11,2010-10-11,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-10-25,2010-10-25,,2010-10-25,2010-10-25,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-25,2010-10-25,,2010-10-25,2010-10-25,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-10-25,2010-10-25,,2010-10-25,2010-10-25,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,C,,20,mg,ORAL,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-11-01,2010-11-01,,2010-11-01,2010-11-01,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-11-08,2010-11-08,,2010-11-08,2010-11-08,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-11-08,2010-11-08,,2010-11-08,2010-11-08,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-08,2010-11-08,,2010-11-08,2010-11-08,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-10-11,2010-10-11,,2010-10-11,2010-10-11,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-11-08,2010-11-08,,2010-11-08,2010-11-08,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,20,mg,ORAL,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-11-22,2010-11-22,,2010-11-22,2010-11-22,,C,,20,mg,ORAL,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DEXALGIN(DEXKETOPROFEN),DEXKETOPROFEN,2011-04-15,2011-04-15,,2011-04-20,2011-04-20,,C,,2,mL,INTRAMUSCULAR,BID,PAIN IN RIGHT LOWER EXTREMITY
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-04-20,2011-04-20,,2011-04-25,2011-04-25,,C,,1,AMPULE,INTRAMUSCULAR,TID,PAIN SYNDROME
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SEDALGIN  (CODEINE + CAFFEINE + METAMIZOLE SODIUM + PARACETAMOL + PHENOBARBITAL),SEDALGIN-NEO,2011-04-20,2011-04-20,,2011-04-25,2011-04-25,,C,,1,TABLET,ORAL,BID,PAIN SYNDROME
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,2% LIDOCAINE,LIDOCAINE,2011-04-25,2011-04-25,,2011-04-25,2011-04-25,,C,,10,mL,INTRAMUSCULAR,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-11,2010-10-11,,2010-10-11,2010-10-11,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,BETAMETHASONE,BETAMETHASONE,2011-04-25,2011-04-25,,2011-04-25,2011-04-25,,C,,1.5,mL,INTRAMUSCULAR,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,L-LYSINE AESCINAT,LYSINE,2011-04-26,2011-04-26,,2011-04-27,2011-04-27,,C,,10,mL,INTRAVENOUS,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-04-26,2011-04-26,,2011-04-30,2011-04-30,,C,,1,AMPULE,INTRAMUSCULAR,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,NEURORUBIN(THIAMINE+PYRIDOXINE+CYANOCOBALAMIN),BEFACT                             /00527001/,2011-04-26,2011-04-26,,2011-04-26,2011-04-26,,C,,3,mL,INTRAMUSCULAR,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2011-04-26,2011-04-26,,2011-04-30,2011-04-30,,C,,300,mg,ORAL,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,CARBAMAZEPINE,CARBAMAZEPINE,2011-05-01,2011-05-01,,2011-05-08,2011-05-08,,C,,1,TABLET,ORAL,BID,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,REUMOXICAM(MELOXICAM),MELOXICAM,2011-05-01,2011-05-01,,2011-05-08,2011-05-08,,C,,15,mg,ORAL,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM SULFATE,MAGNESIUM SULFATE,2011-04-26,2011-04-26,,2011-04-26,2011-04-26,,C,,5,mL,INTRAMUSCULAR,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-05-02,2011-05-02,,,,,C,Y,1,AMPULE,INTRAMUSCULAR,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PENTOXIFYLLINE,PENTOXIFYLLINE,2011-05-01,2011-05-01,,2011-05-08,2011-05-08,,C,,200,mg,ORAL,TID,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-10-11,2010-10-11,,2010-10-11,2010-10-11,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,NEOSTIGMINE,NEOSTIGMINE,2011-04-25,2011-04-25,,2011-04-25,2011-04-25,,C,,1,mL,SUBCUTANEOUS,ONCE,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,NALBUPHINE,NALBUPHINE,2011-05-08,2011-05-08,,2011-05-09,2011-05-09,,C,,10,mg,INTRAMUSCULAR,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,NATRII OXYBUTYRAS,OXYBATE SODIUM,2011-05-01,2011-05-01,,2011-05-05,2011-05-05,,C,,750,mg,ORAL,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,NALBUPHINE,NALBUPHINE,2011-05-16,2011-05-16,,2011-06-24,2011-06-24,,C,,10,mg,INTRAMUSCULAR,QD,L5-S1 HERNIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-06,2011-06-06,,2011-06-06,2011-06-06,,C,,8,mg,INTRAMUSCULAR,ONCE,NAUSEA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-07-11,2011-07-11,,2011-07-18,2011-07-18,,C,,0.5,mg,ORAL,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-24,2011-10-24,,2011-10-26,2011-10-26,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-12-05,2011-12-05,,2011-12-09,2011-12-09,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-12-19,2011-12-19,,2011-12-23,2011-12-23,,C,,2000,IU,INTRAMUSCULAR,QOD,ANEMIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-12-26,2011-12-26,,2011-12-30,2011-12-30,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-10-18,2010-10-18,,2010-10-18,2010-10-18,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-12-26,2011-12-26,,,,,C,Y,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-12-26,2011-12-26,,2012-01-10,2012-01-10,,C,,1,TABLET,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-01-23,2012-01-23,,2012-02-06,2012-02-06,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-30,2012-01-30,,2012-01-30,2012-01-30,,C,,20,mg,INTRAMUSCULAR,QD,TROMBOCYTOPENIA
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-10-18,2010-10-18,,2010-10-18,2010-10-18,,C,,2,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-10-18,2010-10-18,,2010-10-18,2010-10-18,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-10-18,2010-10-18,,2010-10-18,2010-10-18,,C,,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-10-25,2010-10-25,,2010-10-25,2010-10-25,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE SODIUM,LEVOTHYROXINE SODIUM,1973,1973-12-31,M,,,,C,Y,25,ug,ORAL,QD,HYPOFUNCTION OF THYROID GLAND
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,"HEPADIF (CARNITINE OROTATE , LIVER EX.ANTITOXIC FRACTION,  ADENINE HCL ,   PYRIDOXINE HCL )",HEPADIF                            /00799501/,2010-11-11,2010-11-11,,2010-11-11,2010-11-11,,C,,5,mL,INTRAVENOUS,ONCE,HEPATOPROTECTOR
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2010-12-20,2010-12-20,,2010-12-20,2010-12-20,,C,,2,mL,INTRAMUSCULAR,ONCE,AE - PAIN
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2010-12-20,2010-12-20,,2010-12-20,2010-12-20,,C,,4,mL,INTRAMUSCULAR,QD,AE - PAIN
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2010-10-01,2010-10-01,,,,,C,Y,500,mg,ORAL,QD,"PAIN IN EPIGASTRIA, RIGHT HYPOCHONDRIUM"
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,200,mL,INTRAVENOUS,ONCE,GENERAL FATIGUE
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,5,mL,INTRAVENOUS,ONCE,GENERAL FATIGUE
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,12,mg,INTRAVENOUS,ONCE,GENERAL FATIGUE
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,20,mg,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,4,mL,INTRAVENOUS,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,BARALGIN (METAMIZOLE SODIUM),METAMIZOLE SODIUM,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,5,mL,INTRAVENOUS,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,"HEPADIF (CARNITINE OROTATE , LIVER EX.ANTITOXIC FRACTION,  ADENINE HCL ,   PYRIDOXINE HCL)",HEPADIF                            /00799501/,2011-03-03,2011-03-03,,2011-03-03,2011-03-03,,C,,5,mL,INTRAVENOUS,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-03-03,2011-03-03,,,,,C,Y,25,IU,SUBCUTANEOUS,QID,SECONDARY DIABETES MELLITUS
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-04-14,2011-04-14,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,"PAIN IN ABDOMINAL, LUMBAR AND ILIAC AREAS"
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-04-14,2011-04-14,,,,,C,Y,5,mL,INTRAMUSCULAR,BID,"PAIN IN ABDOMINAL, LUMBAR AND ILIAC AREAS"
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,2,mg,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2010-10-28,2010-10-28,,2011-04-07,2011-04-07,,C,,200,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-02-09,2011-02-09,,2011-02-09,2011-02-09,,C,,1,VIAL,TRANSDERMAL,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE + ASCORBIC ACID),KENDURAL C,2011-07-06,2011-07-06,,2011-08-03,2011-08-03,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INFESOL 100  (AMINOACIDS FOR PARENTERAL NUTRITION ),INFESOL,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,250,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA & PLEURISY
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,INFESOL (AMINOACIDS FOR PARENTERAL NUTRITION ),INFESOL,2011-07-09,2011-07-09,,2011-07-09,2011-07-09,,C,,250,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA & PLEURISY
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,INFESOL (AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-14,2011-07-14,,2011-07-14,2011-07-14,,C,,250,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,INFESOL ( AMINOACODS FOR PARENTERAL NUTRITION ),INFESOL,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,250,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,1,g,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE 1% SOLUTION,DIPHENHYDRAMINE,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,2,mL,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ERYTROPOETIN ALPHA,EPOETIN ALFA,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ERYTROPOETIN ALPHA,EPOETIN ALFA,2011-08-05,2011-08-05,,2011-08-05,2011-08-05,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-08-10,2011-08-10,,2011-08-31,2011-08-31,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-26,2011-01-26,,,,,C,Y,8,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LACTOPROTEIN-C,LACTOPROTEIN,2011-08-25,2011-08-25,,2011-08-27,2011-08-27,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-08-31,2011-08-31,,,,,C,Y,250,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,"HEPADIF (CARNITINE OROTATE , LIVER EX.ANTITOXIC FRACTION,  ADENINE HCL ,   PYRIDOXINE HCL )",HEPADIF                            /00799501/,2011-08-31,2011-08-31,,2011-09-04,2011-09-04,,C,,1,VIAL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-08-31,2011-08-31,,2011-09-04,2011-09-04,,C,,200,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,HEMAX (ERYTHROPOETIN),EPOETIN ALFA,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,10000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDES ),PHOSPHOLIPIDS,2011-09-07,2011-09-07,,,,,C,Y,600,mg,ORAL,TID,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,"HEPADIF (CARNITINE OROTATE , LIVER EX.ANTITOXIC FRACTION,  ADENINE HCL ,   PYRIDOXINE HCL )",HEPADIF                            /00799501/,2011-09-07,2011-09-07,,2011-09-11,2011-09-11,,C,,1,VIAL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-07,2011-09-07,,2011-09-11,2011-09-11,,C,,200,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-04-06,2011-04-06,,2011-08-25,2011-08-25,,C,,12,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-01-26,2011-01-26,,2011-04-06,2011-04-06,,C,,20,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT ( POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-01-26,2011-01-26,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT ( POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2011-01-26,2011-01-26,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT ( POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2011-01-26,2011-01-26,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT ( POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2011-01-26,2011-01-26,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-01-26,2011-01-26,,,,,C,Y,200,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE 1% SOLUTION,DIPHENHYDRAMINE,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,1,AMPULE,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,20,mg,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,ANALGINUM - METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-03-25,2011-03-25,,2011-03-25,2011-03-25,,C,,1000,mg,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,OTHER,THERMOABLATION,,2011-12-22,2011-12-22,,2011-12-22,2011-12-22,,,,,,,,
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-02-09,2011-02-09,,,,,C,Y,20,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,25% NIKETHAMIDE,NIKETHAMIDE,2011-06-08,2011-06-08,,2011-06-12,2011-06-12,,C,,2,mL,INTRAMUSCULAR,QD,HYPOTENSION
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-06-15,2011-06-15,,2011-07-20,2011-07-20,,C,,100,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-07-22,2011-07-22,,2011-07-22,2011-07-22,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE + ASCORBIC,KENDURAL C,2011-08-03,2011-08-03,,2011-09-14,2011-09-14,,C,,0.38,mg,ORAL,TID,ANEMIA II GR
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-09-14,2011-09-14,,2011-09-16,2011-09-16,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-09-28,2011-09-28,,2011-10-12,2011-10-12,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-12,2011-10-12,,2011-10-14,2011-10-14,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-10-26,2011-10-26,,2011-11-16,2011-11-16,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL,SORBITOL LACTATED RINGER'S,2011-02-09,2011-02-09,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-09,2011-02-09,,,,,C,Y,8,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-02-09,2011-02-09,,,,,C,Y,200,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE + ASCORBIC ACID),KENDURAL C,2011-03-09,2011-03-09,,2011-03-16,2011-03-16,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE + ASCORBIC ACID),KENDURAL C,2011-04-20,2011-04-20,,2011-06-01,2011-06-01,,C,,1,TABLET,ORAL,TID,ANEMIA II GR
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-06-01,2011-06-01,,2011-06-08,2011-06-08,,C,,100,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,0.24 G ACETYLSALICYLIC ACID  + 0.03 G CAFFEINE + 0.18 G PARACETAMOL,THOMAPYRIN N,2011-06-05,2011-06-05,,2011-06-12,2011-06-12,,C,,1,TABLET,ORAL,QD,HYPOTENSION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDES),PHOSPHOLIPIDS,2011-02-01,2011-02-01,,,,,C,Y,1,TABLET,ORAL,TID,CR PANCREAS
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-05-30,2011-05-30,,2011-06-29,2011-06-29,,C,,2,mL,INTRAMUSCULAR,QD,ANEMIA TREATMENT & PREVENTION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-07-11,2011-07-11,,2011-07-18,2011-07-18,,C,,250,mg,ORAL,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-07-25,2011-07-25,,2011-08-29,2011-08-29,,C,,2,mL,INTRAMUSCULAR,QD,ANEMIA TREATMENT & PREVENTION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-08-29,2011-08-29,,,,,C,Y,250,mg,ORAL,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-08-29,2011-08-29,,,,,C,Y,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,400,mL,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,10,mL,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,20,mg,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PANCREATIN),PANCREATIN,2011-02-01,2011-02-01,,,,,C,Y,10000,IU,ORAL,QD,CR PANCREAS
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,10,mg,INTRAMUSCULAR,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,40,mg,INTRAMUSCULAR,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,5% PYRIDOXINE,PYRIDOXINE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,1,mL,INTRAMUSCULAR,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,400,mL,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,400,mL,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,400,mL,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-02,2011-09-02,,2011-09-04,2011-09-04,,C,,8,mg,INTRAVENOUS,QD,NAUSEA II GRADE & VOMITING II GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,10,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,20,mg,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,8,mg,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,10,mg,INTRAMUSCULAR,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-02-28,2011-02-28,,2011-08-29,2011-08-29,,C,,8,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,40,mg,INTRAMUSCULAR,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,5% PYRIDOXINE,PYRIDOXINE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,1,mL,INTRAMUSCULAR,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING I GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,8,mg,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,10,mg,INTRAMUSCULAR,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,20,mg,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,40,mg,INTRAMUSCULAR,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GRADE & VOMITING III GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,800,mL,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-02-28,2011-02-28,,2011-08-29,2011-08-29,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-02-28,2011-02-28,,2011-08-29,2011-08-29,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-02-28,2011-02-28,,2011-08-29,2011-08-29,,C,,400,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,10,mL,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,20,mg,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,40,mg,INTRAMUSCULAR,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,8,mg,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,10% MILDRONATE,MELDONIUM,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,5,mL,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDES),PHOSPHOLIPIDS,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,5,mL,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,HARTMAN'S SOLUTION,RINGER-LACTATE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,400,mL,INTRAVENOUS,ONCE,VOMITING IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,400,mL,INTRAVENOUS,ONCE,VOMITING  IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,400,mL,INTRAVENOUS,ONCE,VOMITING  IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,400,mL,INTRAVENOUS,ONCE,VOMITING  IV GRADE
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,HARTMAN'S  SOLUTION,RINGER-LACTATE,2011-09-13,2011-09-13,,,,,C,Y,400,mL,INTRAVENOUS,QD,VOMITING
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-02-02,2011-02-02,,2011-08-29,2011-08-29,,C,,200,mL,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-02-28,2011-02-28,,2011-08-29,2011-08-29,,C,,20,mg,INTRAVENOUS,as chemotherapy administered,PREMEDICATION
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-03-21,2011-03-21,,2011-03-28,2011-03-28,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-03-21,2011-03-21,,2011-03-28,2011-03-28,,C,,250,mg,ORAL,BID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-04-18,2011-04-18,,2011-05-30,2011-05-30,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-03-15,2011-03-15,,2011-07-27,2011-07-27,,C,,1,AMPULE,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-21,2011-05-21,,2011-05-21,2011-05-21,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-28,2011-05-28,,2011-05-28,2011-05-28,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2010-06-02,2010-06-02,,2011-06-02,2011-06-02,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-04,2011-06-04,,2011-06-04,2011-06-04,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE + ASCORBIC ACID),KENDURAL C,2011-06-15,2011-06-15,,2011-07-06,2011-07-06,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-22,2011-06-22,,2011-06-22,2011-06-22,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-24,2011-06-24,,2011-06-24,2011-06-24,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-07-06,2011-07-06,,2011-07-19,2011-07-19,,C,,100,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-04-28,2011-04-28,,,,,C,Y,12,mg,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-07-27,2011-07-27,,2011-08-03,2011-08-03,,C,,100,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,NALBUPHINE,NALBUPHINE,2011-07-27,2011-07-27,,,,,C,Y,40,mg,INTRAMUSCULAR,QD,PAIN SYNDROME LUMBAR AREA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,PARECOXIB,PARECOXIB,2011-08-03,2011-08-03,,2011-08-05,2011-08-05,,C,,20,mL,INTRAMUSCULAR,QD,PAIN SYNDROME IN LUMBAR AREA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE+ASCORBIC ACID),KENDURAL C,2011-08-10,2011-08-10,,2011-09-07,2011-09-07,,C,,0.38,mg,ORAL,TID,ANEMIA PROPHYLAXIS
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,NIMESULIDE,NIMESULIDE,2011-08-05,2011-08-05,,,,,C,Y,100,mg,ORAL,BID,PAIN SYNDROME IN LUMBAR AREA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-08-05,2011-08-05,,2011-08-05,2011-08-05,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-09-07,2011-09-07,,2011-09-09,2011-09-09,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-09-27,2011-09-27,,2011-10-10,2011-10-10,,C,,20,mg,INTRAMUSCULAR,BID,WORSENING OF PAIN SYNDROME IN LUMBAR AREA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-09-28,2011-09-28,,2011-10-02,2011-10-02,,C,,500,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2011-04-28,2011-04-28,,,,,C,Y,1,AMPULE,INTRAMUSCULAR,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-06,2011-10-06,,2011-10-08,2011-10-08,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-05,2011-10-05,,2011-10-07,2011-10-07,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-10-10,2011-10-10,,,,,C,Y,1,AMPULE,INTRAMUSCULAR,QD,PAIN SYNDROME IN LUMBAR AREA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,NIMESULIDE,NIMESULIDE,2011-10-06,2011-10-06,,2011-10-13,2011-10-13,,C,,2,g,ORAL,QD,FEVER
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-19,2011-10-19,,2011-10-21,2011-10-21,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,1,mL,INTRAMUSCULAR,TID,PAIN SYNDROME III GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-10-25,2011-10-25,,2011-10-31,2011-10-31,,C,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME II GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,40,mg,INTRAMUSCULAR,ONCE,PAIN SYNDROME II GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,1,mL,INTRAMUSCULAR,ONCE,PAIN SYNDROME II GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,10,mg,INTRAMUSCULAR,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-04-28,2011-04-28,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-04-28,2011-04-28,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,20,mg,INTRAVENOUS,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,2% INOSINE,INOSINE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,10,mL,INTRAVENOUS,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,1,VIAL,INTRAVENOUS,ONCE,HEPATIC FAILURE PREVENTION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-26,2011-10-26,,2011-10-30,2011-10-30,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-10-26,2011-10-26,,2011-11-02,2011-11-02,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA I GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-10-31,2011-10-31,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,PAIN SYNDROME IN LUMBAR AREA & RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,ERYTHROPOIETIN,ERYTHROPOIETIN,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,10000,IU,SUBCUTANEOUS,ONCE,ANEMIA II GR
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,INFESOL 100 (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),INFESOL,2011-11-03,2011-11-03,,2011-11-05,2011-11-05,,C,,250,mL,INTRAVENOUS,QOD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-28,2011-04-28,,,,,C,Y,8,mg,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-04-28,2011-04-28,,,,,C,Y,200,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,LIPRAZID (LIZINOPRIL DIHYDRATE + HYDROCHLOROTHIAZIDE),CARACE PLUS                        /01613901/,2011-03-15,2011-03-15,,,,,C,Y,1,TABLET,ORAL,BID,ESSENTIAL HYPERTENSION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,TRIMETAZIDINE,TRIMETAZIDINE,2011-03-15,2011-03-15,,,,,C,Y,1,TABLET,ORAL,BID,ESSENTIAL HYPERTENSION
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-05-12,2011-05-12,,2011-05-14,2011-05-14,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,UNKNOWN,,2012-08-10,2012-08-10,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE+ASCORBIC ACID),KENDURAL C,2011-06-09,2011-06-09,,2011-07-07,2011-07-07,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-02,2011-06-02,,2011-06-02,2011-06-02,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-02,2011-06-02,,2011-06-02,2011-06-02,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-02,2011-06-02,,2011-06-02,2011-06-02,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,400.0,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,400.0,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-30,2011-06-30,,2012-07-25,2012-07-25,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-30,2011-06-30,,2012-07-25,2012-07-25,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-30,2011-06-30,,2012-07-25,2012-07-25,,C,,200.0,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-07-07,2011-07-07,,2011-07-21,2011-07-21,,C,,2,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,TROXEVASIN(TROXERUTIN) GEL,TROXERUTIN,2011-07-21,2011-07-21,,2011-08-11,2011-08-11,,C,,nd,,TOPICAL,BID,VARICOSITY DESEASE OF LOWER EXTREMITIES GRII
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,20,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRIC(III)-HYDROXIDE POLYISOMALTOSATE),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-07-28,2011-07-28,,2011-08-11,2011-08-11,,C,,100,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-05-19,2011-05-19,,2012-07-25,2012-07-25,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-05-19,2011-05-19,,2012-07-25,2012-07-25,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-06-16,2011-06-16,,2012-07-25,2012-07-25,,C,,10,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,2,mL,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE,DIPHENHYDRAMINE,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,1,mL,INTRAMUSCULAR,ONCE,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERROUS SULFATE+ASCORBIC ACID),KENDURAL C,2011-08-11,2011-08-11,,2011-09-15,2011-09-15,,C,,0.38,mg,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-09-15,2011-09-15,,2011-09-17,2011-09-17,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRISTIM),FILGRASTIM,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,5,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRISTIM),FILGRASTIM,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,0.5,mL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-11-10,2011-11-10,,2011-11-16,2011-11-16,,C,,1,TABLET,ORAL,TID,ANEMIA PREVENTION & TREATMENT
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-16,2011-11-16,,,,,C,Y,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-23,2011-11-23,,2011-11-29,2011-11-29,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,0.5,mL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-30,2011-11-30,,2011-12-04,2011-12-04,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-01-04,2012-01-04,,2012-01-04,2012-01-04,,C,,0.5,mL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-18,2012-01-18,,2012-01-24,2012-01-24,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-02-01,2012-02-01,,2012-02-02,2012-02-02,,C,,0.5,mL,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-02-15,2012-02-15,,2012-02-19,2012-02-19,,C,,20,mg,INTRAMUSCULAR,QOD,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,200.0,mL,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,RIBONUCLEINIC ACID,RIBONUCLEIC ACID,2012-02-15,2012-02-15,,2012-02-22,2012-02-22,,C,,1,TABLET,ORAL,TID,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,1,VIAL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-03-14,2012-03-14,,,,,C,Y,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-03-14,2012-03-14,,2012-03-21,2012-03-21,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-04-04,2012-04-04,,2012-04-10,2012-04-10,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-05-23,2012-05-23,,,,,C,Y,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-05-23,2012-05-23,,2012-05-27,2012-05-27,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-05-30,2012-05-30,,2012-06-03,2012-06-03,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-06-06,2012-06-06,,2012-06-06,2012-06-06,,C,,1,VIAL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-06-06,2012-06-06,,,,,C,Y,2,mL,INTRAMUSCULAR,QOD,ANEMIA
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-06-27,2012-06-27,,2012-07-03,2012-07-03,,C,,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA GR2
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-07-04,2012-07-04,,,,,C,Y,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA GR2
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,SPASMALGONUM (METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE),FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2012-07-11,2012-07-11,,2012-07-11,2012-07-11,,C,,2,mL,INTRAMUSCULAR,ONCE,HYPERTENSION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2012-07-27,2012-07-27,,2012-07-31,2012-07-31,,C,,2000,IU,SUBCUTANEOUS,QOD,"ANEMIA, GRADE 2"
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2012-08-01,2012-08-01,,2012-08-05,2012-08-05,,C,,2000,IU,SUBCUTANEOUS,QOD,"ANEMIA, GRADE 2"
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-05-19,2011-05-19,,2011-05-19,2011-05-19,,C,,200.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-26,2011-05-26,,2011-05-26,2011-05-26,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETANOV(KETOROLAK),KETOROLAC,2011-05-26,2011-05-26,,2011-06-09,2011-06-09,,C,,0.01,g,ORAL,QD,PAIN IN RIGHT SUBCOSTAL  AND EPIGASTRIC AREA
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ASPARKAM(POTASSIUM AND MAGNESIUM ASPARTATE),POTASSIUM MAGNESIUM ASPARTATE,2011-06-16,2011-06-16,,2011-06-18,2011-06-18,,C,,10.0,mL,INTRAVENOUS,QD,HYPOTENSION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MILDRONATE,MELDONIUM,2011-06-16,2011-06-16,,2011-06-18,2011-06-18,,C,,10.0,mL,INTRAVENOUS,QD,HYPOTENSION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID   10%,ASCORBIC ACID,2011-06-16,2011-06-16,,2011-06-18,2011-06-18,,C,,6,mL,INTRAMUSCULAR,QD,APPETITE DECREASE
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CORDIAMIN,NIKETHAMIDE,2011-06-16,2011-06-16,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,HYPOTENSION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-05-26,2011-05-26,,,,,C,Y,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-26,2011-05-26,,,,,C,Y,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-05-26,2011-05-26,,,,,C,Y,200,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN(COMB DRUG),MEGLUMINE SODIUM SUCCINATE,2011-05-26,2011-05-26,,,,,C,Y,400,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,SORBIFER(FERROUS SULFATE AND ASCORBIC ACID),KENDURAL C,2011-06-09,2011-06-09,,,,,C,Y,0.38,mg,ORAL,TID,ANEMIA IIGR
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,NACLOFEN(DICLOFENAC),DICLOFENAC,2011-06-09,2011-06-09,,2011-06-16,2011-06-16,,C,,75,mg,INTRAMUSCULAR,QD,"PAIN IN RIGHT SUBCOSTAL AREA,EPIGASTRIUM AREA,LOWER PART OF ABDOMEN"
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC (50 MG) + PARACETAMOL (500 MG),PARACETAMOL FORTE RAFFO,2011-06-09,2011-06-09,,2011-06-16,2011-06-16,,C,,1,TABLET,ORAL,QD,"PAIN IN RIGHT SUBCOSTAL AREA,EPIGASTRIUMAREA,LOWER PART OF ABDOMEN"
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-06-16,2011-06-16,,,,,C,Y,50,mg,INTRAMUSCULAR,PRN,AGGRAVATION OF PAIN SYNDROME
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ALMAGEL A,MALUGEL B,2011-06-16,2011-06-16,,,,,C,Y,5,mL,ORAL,TID,AGGRAVATION OF PAIN SYNDROME
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ARGININUM,ARGININE,2011-06-16,2011-06-16,,,,,C,Y,100.0,mL,INTRAVENOUS,QD,HYPOTENSION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ARMADIN,METHYLETHYLPIRIDINOL SUCCINATE,2011-06-16,2011-06-16,,,,,C,Y,2.0,mL,INTRAMUSCULAR,BID,HYPOTENSION
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-16,2011-06-16,,2011-06-18,2011-06-18,,C,,400.0,mL,INTRAVENOUS,QD,HYPOTENSION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-03,2011-02-28,D,,,,C,Y,0.01,g,ORAL,BID,PAIN IN RIGHT AND LEFT SUBCOSTAL AREA
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,REAMBERIN(MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-06-02,2011-06-02,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,REAMBERIN(MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-06-02,2011-06-02,,,,,C,Y,400,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MILDRONATE,MELDONIUM,2011-06-30,2011-06-30,,,,,C,Y,250,mg,ORAL,TID,SUPRAVENTRICULAR EXTRASYSTOLE
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FERROUS SULFATE+ASCORBIC ACID,KENDURAL C,2011-06-30,2011-06-30,,2011-07-07,2011-07-07,,C,,1,TABLET,ORAL,TID,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,FERROUS SULFATE+ASCORBIC ACID,KENDURAL C,2011-07-07,2011-07-07,,,,,C,Y,1,TABLET,ORAL,TID,ANEMIA GRII
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ERYTHROPOIETIN,ERYTHROPOIETIN,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,10000,IU,TRANSDERMAL,QD,ANEMIA GRIII
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-07-14,2011-07-14,,,,,C,Y,10.000,IU,TRANSDERMAL,QD,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,INFESOL 100 (AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,INFESOL 100(AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-17,2011-07-17,,2011-07-17,2011-07-17,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA GRII
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,INFESOL 100(AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-19,2011-07-19,,2011-07-19,2011-07-19,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA GRII
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,INFESOL 100(AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,6000,U,TRANSDERMAL,QD,ANEMIA II GR
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,INFESOL 100 (AMINOACIDS FOR PARENTERAL NUTRITION),INFESOL,2011-07-23,2011-07-23,,2011-07-23,2011-07-23,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,6000,IU,TRANSDERMAL,QD,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-07-23,2011-07-23,,2011-07-23,2011-07-23,,C,,6000,IU,TRANSDERMAL,QD,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,LACTOPTROTEIN,LACTOPROTEIN,2011-07-28,2011-07-28,,2011-07-28,2011-07-28,,C,,100,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,LACTOPRETEIN,LACTOPROTEIN,2011-06-29,2011-06-29,,2011-07-29,2011-07-29,,C,,100,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,LACTOPROTEIN,LACTOPROTEIN,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,100,mL,INTRAVENOUS,ONCE,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,HEPTRAL (ADEMETIONINUM),ADEMETIONINE,2011-07-28,2011-07-28,,2011-07-28,2011-07-28,,C,,400,mg,INTRAVENOUS,ONCE,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,HEPTRAL (ADEMETIONINUM),ADEMETIONINE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,400,mg,INTRAVENOUS,ONCE,HYPOPREOTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,HEPTRAL (ADEMETIONINUM),ADEMETIONINE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,400,mg,INTRAVENOUS,ONCE,HYPOPROTEINEMIA GR II
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,GEMAX (ERYTHROPOETIN),EPOETIN ALFA,2011-07-30,2011-07-30,,2011-07-30,2011-07-30,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,6000,U,TRANSDERMAL,QD,ANEMIA IIGR
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,GEMAX (ERYTHROPOETIN),EPOETIN ALFA,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,10 000,IU,SUBCUTANEOUS,ONCE,ANEMIA GR III
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,GEMAX (ERYTHROPOETIN),EPOETIN ALFA,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,10000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,INFESOL 100 (AMINOACIDS FOR PARENTERAL ),INFESOL,2011-08-25,2011-08-25,,2011-08-27,2011-08-27,,C,,250,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-08-27,2011-08-27,,,,,C,Y,0.01,g,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-09-01,2011-09-01,,,,,C,Y,40,mg,INTRAMUSCULAR,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,PANCREATIN 10000,PANCREATIN,2011-09-01,2011-09-01,,,,,C,Y,1,TABLET,ORAL,every meal,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,6000,IU,TRANSDERMAL,QD,ANEMIA II GR
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-06-18,2011-06-18,,2011-06-18,2011-06-18,,C,,6000,IU,TRANSDERMAL,QD,ANEMIA II GR
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-06-02,2011-06-02,,,,,C,Y,5,AMPULE,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,CLEMASTINUM,CLEMASTINE FUMARATE,2011-06-02,2011-06-02,,,,,C,Y,2,mL,INTRAMUSCULAR,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-02,2011-06-02,,,,,C,Y,8,mg,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-06-02,2011-06-02,,,,,C,Y,200,mL,INTRAVENOUS,as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,FESTAL (HEMICELLULASE + BILE COMPONENTS + PANCREATIN),PANCREAS EXTRACT,2011-05,2011-04-30,D,,,,C,Y,2,TABLET,ORAL,taken during every ingestion,EXTRACELLULAR DIGESTION FAILURE
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-18,2011-08-18,,2011-08-22,2011-08-22,,C,,2,mL,INTRAMUSCULAR,BID,NAUSEA
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-18,2011-08-18,,2011-08-22,2011-08-22,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-18,2011-08-18,,2011-08-21,2011-08-21,,C,,2,mL,INTRAMUSCULAR,BID,VOMITING
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-18,2011-08-18,,2011-08-21,2011-08-21,,C,,8,mg,ORAL,BID,VOMITING
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-08-27,2011-08-27,,2011-08-27,2011-08-27,,C,,1,VIAL,INTRAMUSCULAR,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-08-27,2011-08-27,,2011-08-27,2011-08-27,,C,,1,VIAL,INTRAMUSCULAR,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-27,2011-08-27,,2011-08-27,2011-08-27,,C,,1,VIAL,INTRAMUSCULAR,ONCE,NAUSEA
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,1,VIAL,INTRAMUSCULAR,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,1,VIAL,INTRAMUSCULAR,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-30,2011-08-30,,,,,C,Y,8,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-19,2011-07-19,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-07-19,2011-07-19,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SOLUTION NACL 0.9%,SODIUM CHLORIDE,2011-07-19,2011-07-19,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-07-19,2011-07-19,,,,,C,Y,5,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-07-19,2011-07-19,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-07-19,2011-07-19,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-16,2011-08-16,,,,,C,Y,2,mL,INTRAMUSCULAR,applied as chemotherapy administered,NAUSEA PREVENTION
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-08-12,2011-08-12,,2011-08-14,2011-08-14,,C,,2,mL,INTRAMUSCULAR,BID,NAUSEA
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-12,2011-08-12,,2011-08-14,2011-08-14,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-08-04,2011-08-04,,,,,C,Y,60,mg,INTRAMUSCULAR,PRN,PAIN SYNDROME IN ABDOMEN
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-21,2011-11-21,,2011-11-23,2011-11-23,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-28,2011-11-28,,2011-12-02,2011-12-02,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-12-05,2011-12-05,,2011-12-09,2011-12-09,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-12-12,2011-12-12,,2011-12-19,2011-12-19,,C,,320,mg,ORAL,TID,ANEMIA I GR
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,NALBUPHINE,NALBUPHINE,2011-12-19,2011-12-19,,,,,C,Y,10,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,APOETIN ALFA,EPOETIN ALFA,2011-12-19,2011-12-19,,,,,C,Y,2000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,"NATRIUM CHLORIDE 0,9%",SODIUM CHLORIDE,2011-09-12,2011-09-12,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-12,2011-09-12,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-12,2011-09-12,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,REAMBERIN [MEGLUMINE SODIUM SUCCINATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE],EL-4,2011-09-12,2011-09-12,,,,,C,Y,400,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,REAMBERIN [MEGLUMINE SODIUM SUCCINATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE],MAGNESIUM CHLORIDE,2011-09-12,2011-09-12,,,,,C,Y,400,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,REAMBERIN [MEGLUMINE SODIUM SUCCINATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE],MEGLUMINE,2011-09-12,2011-09-12,,,,,C,Y,400,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,REAMBERIN [MEGLUMINE SODIUM SUCCINATE+SODIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE],SUCCINATE SODIUM,2011-09-12,2011-09-12,,,,,C,Y,400,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-10-15,2011-10-15,,2011-10-22,2011-10-22,,C,,40,mg,INTRAMUSCULAR,QD,PAIN SYNDROME IN ABDOMEN
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-10-24,2011-10-24,,2011-11-21,2011-11-21,,C,,320,mg,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,INFESOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),INFESOL,2011-11-01,2011-11-01,,2011-11-03,2011-11-03,,C,,250,mL,INTRAVENOUS,QOD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-10-04,2011-10-04,,2011-12-19,2011-12-19,,C,,60,mg,ORAL,QID,PAIN IN RIGHT AND LEFT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-06,2011-05-31,D,,,,C,Y,150,mg,ORAL,QD,PAIN SYNDROME
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-11-01,2011-11-01,,,,,C,Y,320,mg,ORAL,TID,PREVENTION & TREATMENT OF ANEMIA
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INFESOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),INFESOL,2012-02-07,2012-02-07,,2012-02-09,2012-02-09,,C,,250,mL,INTRAVENOUS,QD,PROTEINEMIA
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,EPREX  EPOETIN ALFA,EPOETIN ALFA,2012-02-28,2012-02-28,,,,,C,Y,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PRIFINIUM BROMIDE,PRIFINIUM BROMIDE,2011-06,2011-05-31,D,,,,C,Y,30,mg,ORAL,QD,PAIN SYNDROME
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,GLIMEPIRIDE,GLIMEPIRIDE,2011-06,2011-05-31,D,,,,C,Y,2,mg,ORAL,QD,HYPERGLYCEMIA
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-12,2011-09-12,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-12,2011-09-12,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-12,2011-09-12,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-09-12,2011-09-12,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,HEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-09-12,2011-09-12,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,HEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-25,2011-10-25,,2011-10-27,2011-10-27,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,TRAUMEEL,TRAUMEEL                           /06048201/,2011-10-25,2011-10-25,,,,,C,Y,n/a,,TOPICAL,PRN,OSTEOARTROSIS & FROZEN SHOULDER
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MILDRONATE,MELDONIUM,2011-09-15,2011-09-15,,2011-12-28,2011-12-28,,C,,250,mg,ORAL,TID,VENTRICULAR PREMATURE BEATS
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA & INCREASED ALT  LEVEL
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA & INCREASED ALT  LEVEL
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA & INCREASED ALT  LEVEL
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA & INCREASED ALT  LEVEL
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,5,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA & INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-15,2011-09-15,,2012-03-28,2012-03-28,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-15,2011-09-15,,2012-03-28,2012-03-28,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),MEGLUMINE,2011-09-15,2011-09-15,,2012-03-28,2012-03-28,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (MEGLUMINE SODIUM SUCCINATE),SUCCINATE SODIUM,2011-09-15,2011-09-15,,2012-03-28,2012-03-28,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FERRUM-LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-02-01,2012-02-01,,2012-03-01,2012-03-01,,C,,2,mL,INTRAMUSCULAR,QD,PROPHYLAXIS OF ANEMIA
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,INFESOL 100,INFESOL,2012-02-23,2012-02-23,,2012-02-27,2012-02-27,,C,,250,mL,INTRAVENOUS,QOD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,EPREX  EPOETIN ALFA,EPOETIN ALFA,2012-03-21,2012-03-21,,2012-03-27,2012-03-27,,C,,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,EPREX  EPOETIN ALFA,EPOETIN ALFA,2012-03-28,2012-03-28,,2012-04-01,2012-04-01,,C,,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-03-28,2012-03-28,,,,,C,Y,1,VIAL,INTRAVENOUS,QD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-15,2011-09-15,,,,,C,Y,400,mg,INTRAVENOUS,every time chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-15,2011-09-15,,,,,C,Y,400,mg,INTRAVENOUS,every time chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-15,2011-09-15,,,,,C,Y,400,mg,INTRAVENOUS,every time chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-09-22,2011-09-22,,,,,C,Y,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,HEPADIF (CARNITINE OROTAT+DL-CARNITINE HYDROCHOLYDE),HEPADIF                            /00799501/,2011-09-27,2011-09-27,,2011-09-28,2011-09-28,,C,,1,VIAL,INTRAVENOUS,QD,"HYBERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,HEPADIF (CARNITINE OROTAT+DL-CARNITINE HYDROCHOLYDE),HEPADIF                            /00799501/,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,1,VIAL,INTRAVENOUS,ONCE,"HYBERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,"NATRIUM CHLORIDE 0,9% SOLUTION",SODIUM CHLORIDE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,200,mL,INTRAVENOUS,ONCE,SOVLENT FOR HEPADIF
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE + POTASSIUM CHLORIDE + MAGNUIM CHLORIDE),EL-4,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,400.0,mL,INTRAVENOUS,ONCE,"HYPERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE + POTASSIUM CHLORIDE + MAGNUIM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,400.0,mL,INTRAVENOUS,ONCE,"HYPERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE + POTASSIUM CHLORIDE + MAGNUIM CHLORIDE),SUCCINATE SODIUM,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,400.0,mL,INTRAVENOUS,ONCE,"HYPERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,20,mg,INTRAVENOUS,ONCE,"HYBERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-09-30,2011-09-30,,2011-09-30,2011-09-30,,C,,500,mL,INTRAVENOUS,ONCE,"HYPERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-01,2011-10-01,,2011-10-01,2011-10-01,,C,,500,mL,INTRAVENOUS,ONCE,"HYPERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-15,2011-09-15,,,,,C,Y,8,mg,INTRAVENOUS,every time chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-02,2011-10-02,,2011-10-02,2011-10-02,,C,,500,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,500,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,500,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-14,2011-10-14,,2011-10-14,2011-10-14,,C,,500,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-15,2011-10-15,,2011-10-15,2011-10-15,,C,,500,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-10-01,2011-10-01,,2011-10-01,2011-10-01,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-15,2011-10-15,,2011-10-15,2011-10-15,,C,,500,mL,INTRAVENOUS,ONCE,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-20,2011-10-20,,2011-10-22,2011-10-22,,C,,500,mL,INTRAVENOUS,QD,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,HEPAZYL (DIETARY SUPPLEMENTS),"VITAMINS, OTHER COMBINATIONS",2011-10-20,2011-10-20,,2011-11-24,2011-11-24,,C,,1,VIAL,ORAL,QD,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-28,2011-10-28,,2011-10-30,2011-10-30,,C,,500,mL,INTRAVENOUS,QD,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-15,2011-09-15,,,,,C,Y,12,mg,INTRAVENOUS,chemotherapy premedication,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,5,mL,INTRAVENOUS,ONCE,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9 % SOLUTION,SODIUM CHLORIDE,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,200,mL,INTRAVENOUS,ONCE,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID 10%,ASCORBIC ACID,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,10,mL,INTRAVENOUS,ONCE,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-10-27,2011-10-27,,2011-10-27,2011-10-27,,C,,1,VIAL,INTRAVENOUS,ONCE,HIPERBILIRUBEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-10-27,2011-10-27,,2011-11-03,2011-11-03,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA I GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-11-03,2011-11-03,,2011-11-17,2011-11-17,,C,,320,mg,ORAL,TID,ANEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-17,2011-11-17,,2011-11-21,2011-11-21,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,FERRUM-LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-11-24,2011-11-24,,2011-12-14,2011-12-14,,C,,2,mL,INTRAMUSCULAR,QD,ANEMIA II GR
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,400.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,400.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,400.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,1,VIAL,INTRAVENOUS,ONCE,HYPERNILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-15,2011-09-15,,,,,C,Y,200,mL,INTRAVENOUS,chemotherapy premedication,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,40,mg,INTRAMUSCULAR,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-11-25,2011-11-25,,2011-11-27,2011-11-27,,C,,500,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,HEPTRAL (ADEMETIONINE),ADEMETIONINE,2011-11-27,2011-11-27,,,,,C,Y,400,mg,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-11-28,2011-11-28,,,,,C,Y,400.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-11-28,2011-11-28,,,,,C,Y,20,mg,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-11-24,2011-11-24,,2011-12-08,2011-12-08,,C,,1,TABLET,ORAL,TID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ,SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-12-09,2011-12-09,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-12-09,2011-12-09,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2011-12-09,2011-12-09,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2011-12-09,2011-12-09,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2011-12-09,2011-12-09,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-11-19,2011-11-19,,2011-11-21,2011-11-21,,C,,500,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,HEPADIF (CARNITINE OROTAT+DL-CARNITINE HYDROCHOLYDE),HEPADIF                            /00799501/,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,1,VIAL,INTRAVENOUS,ONCE,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,HEPADIF (CARNITINE OROTAT+DL-CARNITINE HYDROCHOLYDE),HEPADIF                            /00799501/,2011-09-16,2011-09-16,,2011-11-23,2011-11-23,,C,,2,TABLET,ORAL,TID,"HYBERBILIRUBEMIA, AST AND ALT LEVEL"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,C,,200,mL,INTRAVENOUS,ONCE,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,HEPADIF (CARNITINE OROTAT+DL-CARNITINE HYDROCHOLYDE),HEPADIF                            /00799501/,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,1,VIAL,INTRAVENOUS,ONCE,"HYBERBILIRUBEMIA, ALT AND AST LEVEL INCREASE"
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,200,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PHARMASULIN (INSULINUM HUMANUM ),INSULIN HUMAN,2011-08-25,2011-08-25,,,,,C,Y,100,IU/mL,SUBCUTANEOUS,QD,SECONDARY DIABETES MELLITUS
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-10-06,2011-10-06,,,,,C,Y,600,mg,ORAL,TID,HYPERBILIRUBINEMIA ANS PREVENTION OG RELAL COMPLICATIONS
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-10,2011-10-10,,,,,C,Y,8,mg,ORAL,TID,NAUSEA I GRADE &  VOMITING  I GRAD
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,KETOLORAC,KETOROLAC,2011-08-25,2011-08-25,,,,,C,Y,20,mg,INTRAMUSCULAR,PRN,PAIN SYNDROME
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-19,2011-09-19,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-09-19,2011-09-19,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-19,2011-09-19,,,,,C,Y,12,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-19,2011-09-19,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-19,2011-09-19,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-19,2011-09-19,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-09-26,2011-09-26,,2011-09-28,2011-09-28,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2011-10-03,2011-10-03,,2011-10-05,2011-10-05,,C,,400,mg,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-10-03,2011-10-03,,2011-10-05,2011-10-05,,C,,5,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOLORAC,KETOROLAC,2011-08,2011-07-31,D,,,,C,Y,20,mg,INTRAMUSCULAR,PRN,PAIN SYNDROME
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SODIUM CLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,200,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,5% ASCORBIC ACID,ASCORBIC ACID,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,5,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,400,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,GLUCOSE SOLUTION,GLUCOSE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,200,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,5% ASCORBIC ACID,ASCORBIC ACID,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,5,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,200,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-10,2011-11-10,,2011-11-12,2011-11-12,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-17,2011-11-17,,2011-11-21,2011-11-21,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-11-24,2011-11-24,,2012-02-23,2012-02-23,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-08,2011-07-31,D,2011-12-22,2011-12-22,,C,,2,TABLET,ORAL,TID,SUPPORTIVE THERAPY FOR PANCREAS CANCER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-12-22,2011-12-22,,2011-12-22,2011-12-22,,C,,2,mL,INTRAMUSCULAR,ONCE,PAIN SYNDROME IN RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2011-12-22,2011-12-22,,2011-12-22,2011-12-22,,C,,5,mL,INTRAMUSCULAR,ONCE,PAIN SYNDROME IN RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-12-22,2011-12-22,,,,,C,Y,10000,IU,ORAL,TID,SUPPORTIVE THERAPY FOR PANCREAS CANCER & PAIN SYNDROME IN RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-19,2012-01-19,,2012-01-23,2012-01-23,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-26,2012-01-26,,,,,C,Y,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-02-23,2012-02-23,,,,,C,Y,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9%  SOLUTION,SODIUM CHLORIDE,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-09-29,2011-09-29,,2012-03-01,2012-03-01,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,0.5,g,ORAL,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,50% METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,2,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,GLUCOSE SOLUTION,GLUCOSE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,200,mL,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM,METAMIZOLE SODIUM,2011-09-16,2011-09-16,,2011-11-03,2011-11-03,,C,,0.5,g,ORAL,QD,PAIN SYNDROME
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-12-15,2011-12-15,,2012-01-05,2012-01-05,,C,,1,VIAL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CITRARGININE,CITRARGININE,2011-12-15,2011-12-15,,2011-12-22,2011-12-22,,C,,1,VIAL,ORAL,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-12-15,2011-12-15,,2011-12-19,2011-12-19,,C,,500,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2011-12-22,2011-12-22,,2011-12-29,2011-12-29,,C,,1,AMPULE,ORAL,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-01-05,2012-01-05,,2012-01-26,2012-01-26,,C,,1,AMPULE,ORAL,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2012-01-13,2012-01-13,,2012-01-14,2012-01-14,,C,,500,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,1,VIAL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-01-16,2012-01-16,,2012-01-18,2012-01-18,,C,,5,mL,INTRAVENOUS,QD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-01-05,2012-01-05,,2012-01-19,2012-01-19,,C,,2,TABLET,ORAL,TID,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,400,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,400,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,400,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,400,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,HARTMAN'S SOLUTION,RINGER-LACTATE,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,400,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,12,mg,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-01-21,2012-01-21,,2012-01-25,2012-01-25,,C,,1,AMPULE,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-30,2012-01-30,,2012-02-02,2012-02-02,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-30,2012-01-30,,2012-02-02,2012-02-02,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-30,2012-01-30,,2012-02-02,2012-02-02,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-30,2012-01-30,,2012-02-02,2012-02-02,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-30,2012-01-30,,2012-02-02,2012-02-02,,C,,12,mg,INTRAVENOUS,QD,"INCLEASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-30,2012-01-30,,2012-02-01,2012-02-01,,C,,1,VIAL,INTRAVENOUS,QD,"INCREASED ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT AND HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT AND HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT AND HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT AND HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHEARPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,1,VIAL,INTRAVENOUS,QD,"INCREASED ALT, AST & HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,200.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,HARTMAN'S SOLUTION,RINGER-LACTATE,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,400.0,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-02-03,2012-02-03,,2012-02-06,2012-02-06,,C,,5,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-02-03,2012-02-03,,2012-02-05,2012-02-05,,C,,12,mL,INTRAVENOUS,QD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,ANTRAL (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-02-09,2012-02-09,,,,,C,Y,0.2,g,ORAL,TID,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,HEPAZIL (DIETARY SUPPLEMENTS),"VITAMINS, OTHER COMBINATIONS",2012-02-09,2012-02-09,,,,,C,Y,1,AMPULE,ORAL,QD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-02-09,2012-02-09,,2012-02-13,2012-02-13,,C,,12,mg,INTRAMUSCULAR,QOD,"INCREASED AST, ALT, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,1,VIAL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,HARTMAN'S SOLUTION,RINGER-LACTATE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,800,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-11-21,2012-11-21,,2012-12-15,2012-12-15,,,,1,TABLET,ORAL,TID,INCREASED AST & ALT
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-06,2011-10-06,,2012-02-02,2012-02-02,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-11-03,2011-11-03,,,,,C,Y,100,mg,ORAL,BID,PAIN SYNDROME
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-11-18,2011-11-18,,2011-11-20,2011-11-20,,C,,400,mg,INTRAVENOUS,TID,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,C,,400,mL,INTRAVENOUS,ONCE,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,C,,400,mL,INTRAVENOUS,ONCE,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,C,,400,mL,INTRAVENOUS,ONCE,INCREASED ALT & AST
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,C,,1,VIAL,INTRAVENOUS,ONCE,INCREASED AST & ALT
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-10-05,2011-10-05,,,,,C,Y,1,TABLET,ORAL,TID,HEPATIC FAILURE PREVENTION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PYRIDOXINE,PYRIDOXINE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,1,mL,INTRAMUSCULAR,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SPASMALGON (METAMIZOLE SODIUM + PITOFENONE + FENPIVERINIUM BROMIDE),FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,2,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NEOHEMODES (POVIDONE+SODIUM CHLORIDE+POTASSIUM CHLORIDE+CALCIUM CHLORIDE+MAGNESIUM CHLORIDE+SODIUM HYDROCARBONATE),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,200,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-10-27,2011-10-27,,2011-11-03,2011-11-03,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-10-28,2011-10-28,,,,,C,Y,500,mL,INTRAVENOUS,QOD,INCREASED ALT & AST LEVEL
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-10-28,2011-10-28,,,,,C,Y,200,mL,INTRAVENOUS,QOD,INCREASED ALT & AST LEVEL
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-10-28,2011-10-28,,,,,C,Y,20,mg,INTRAVENOUS,QOD,INCREASED ALT & AST LEVEL
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-11-03,2011-11-03,,,,,C,Y,320,mg,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,HEPAZYL (DIETARY SUPPLEMENT),"VITAMINS, OTHER COMBINATIONS",2011-11-03,2011-11-03,,2011-11-24,2011-11-24,,C,,1,VIAL,ORAL,QD,INCREASED ALT & AST LEVEL
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-11-24,2011-11-24,,2011-11-26,2011-11-26,,C,,400,mg,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-10-13,2011-10-13,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-11-24,2011-11-24,,2011-12-01,2011-12-01,,C,,5,mL,INTRAVENOUS,QD,INCREASED ALT &  AST
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-11-24,2011-11-24,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT &  AST
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-11-24,2011-11-24,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT &  AST
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-11-24,2011-11-24,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT &  AST
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-01,2011-12-01,,2011-12-01,2011-12-01,,C,,8,mg,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-01,2011-12-01,,2011-12-01,2011-12-01,,C,,20,mg,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-12-01,2011-12-01,,,,,C,Y,1,VIAL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-12-02,2011-12-02,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-12-02,2011-12-02,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-12-02,2011-12-02,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,10%  ASCORBIC ACID,ASCORBIC ACID,2011-12-02,2011-12-02,,,,,C,Y,6,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-02,2011-12-02,,,,,C,Y,20,mg,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-12-02,2011-12-02,,,,,C,Y,200,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,GLUCOSE SOLUTION 5%,GLUCOSE,2011-12-09,2011-12-09,,,,,C,Y,600,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-13,2011-10-13,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-12-09,2011-12-09,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2011-12-09,2011-12-09,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2011-12-09,2011-12-09,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2011-12-09,2011-12-09,,,,,C,Y,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-09,2011-12-09,,,,,C,Y,20,mg,INTRAVENOUS,QOD,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-10-13,2011-10-13,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-13,2011-10-13,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-13,2011-10-13,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-13,2011-10-13,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,5% GLUCOSE SOLUTION,GLUCOSE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,200,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,400,mL,INTRAVENOUS,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,6,mL,INTRAVENOUS,ONCE,NAUSEA & VIOMITING
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,2,mL,INTRAMUSCULAR,ONCE,NAUSEA & VOMITING
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2011-10,2011-09-30,D,,,,C,Y,5,mL,INTRAMUSCULAR,PRN,PAIN SYNDROME
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2011-11-27,2011-11-27,,,,,C,Y,400,mg,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-11-27,2011-11-27,,2011-11-30,2011-11-30,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2011-11-27,2011-11-27,,2011-11-30,2011-11-30,,C,,6,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-11-26,2011-11-26,,2011-11-30,2011-11-30,,C,,20,mg,INTRAVENOUS,QOD,INCREASED ALT &  AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-12-01,2011-12-01,,,,,C,Y,1,TABLET,ORAL,TID,PREVENTION & TREATMENT ANEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-12-03,2011-12-03,,2011-12-07,2011-12-07,,C,,500,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,200,mL,INTRAVENOUS,QOD,NCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,1,VIAL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,200,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-11-17,2011-11-17,,2012-02-16,2012-02-16,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,6,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-02,2011-12-02,,2011-12-06,2011-12-06,,C,,20,mg,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-12-08,2011-12-08,,,,,C,Y,1,TABLET,ORAL,TID,INCREASED AST & PREVENTION OF HEPATIC COMPLICATIONS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CITRARGININE (ARGININE CITRATE 0.1 G ;BETAIN HYDROCHLORIDE 0.05 G ; BETAIN 0.05 G),CITRARGININE,2011-12-08,2011-12-08,,2011-12-15,2011-12-15,,C,,1,VIAL,ORAL,QD,INCREASED AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-12-12,2011-12-12,,,,,C,Y,1,VIAL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE+CALCIUM CHLORIDE+MAGNESIUM CHLORIDE+SODIUM HYDROCARBONATE+SODIUM CHLORIDE+POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-12-12,2011-12-12,,,,,C,Y,200.0,mL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-12-22,2011-12-22,,2012-01-05,2012-01-05,,C,,1,TABLET,ORAL,TID,INCREASED AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-01-05,2012-01-05,,,,,C,Y,2,TABLET,ORAL,TID,INCREASED AST & ALT
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-01-19,2012-01-19,,2012-01-20,2012-01-20,,C,,5,mL,INTRAMUSCULAR,BID,WORSENING CENTRAL PAIN SYNDROME
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-17,2011-11-17,,2012-02-16,2012-02-16,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2012-02-16,2012-02-16,,,,,C,Y,1,TABLET,ORAL,BID,PHLEBITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,SERRATIOPEPTIDASE,SERRAPEPTASE,2012-02-16,2012-02-16,,,,,C,Y,1,TABLET,ORAL,BID,PHLEBITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,L-LYSINE-AESCINAT,LYSINE,2012-02-16,2012-02-16,,2012-02-24,2012-02-24,,C,,10,mL,INTRAVENOUS,QD,PHLEBITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-02-16,2012-02-16,,2012-02-24,2012-02-24,,C,,100,mL,INTRAVENOUS,QD,PHLEBITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REFORTAN,HETASTARCH,2012-02-16,2012-02-16,,2012-02-24,2012-02-24,,C,,250,mL,INTRAVENOUS,QD,PHLEBITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NADROPARINUM CALCICUM,NADROPARIN CALCIUM,2012-02-16,2012-02-16,,2012-02-24,2012-02-24,,C,,0.3,IU,SUBCUTANEOUS,BID,PHLEVITIS
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,INFESOL 100,INFESOL,2012-02-17,2012-02-17,,2012-02-19,2012-02-19,,C,,250,mg,INTRAVENOUS,QOD,PROTEINEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-02-23,2012-02-23,,2012-02-27,2012-02-27,,C,,4000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,INFESOL 100,INFESOL,2012-02-23,2012-02-23,,2012-02-25,2012-02-25,,C,,250,mL,INTRAVENOUS,QOD,HYPOALBUMINEMIA & HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2012-02-23,2012-02-23,,2012-02-25,2012-02-25,,C,,200,mL,INTRAVENOUS,QOD,HYPOPROTEINEMIA & HYPOALBUMINEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-11-17,2011-11-17,,2012-02-16,2012-02-16,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-11-17,2011-11-17,,2012-02-16,2012-02-16,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-11-17,2011-11-17,,2012-02-16,2012-02-16,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,1,VIAL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,100,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,200,mL,VAGINAL,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,5,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2012-02-23,2012-02-23,,2012-02-28,2012-02-28,,C,,6,mL,INTRAVENOUS,QOD,INCREASED AST & ALT LEVEL
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-11-24,2011-11-24,,2011-11-30,2011-11-30,,C,,2000,IU,SUBCUTANEOUS,QD,ANEMIA
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,ARGININUM,ARGININE,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,100,mL,INTRAVENOUS,ONCE,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,5,mL,INTRAVENOUS,ONCE,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,HEPASOL (AMINOACIDS FOR PARENTERAL NUTRITION + OTHER MEDICINES [MULTIMINERAL]),HEPASOL,2011-11-25,2011-11-25,,2011-11-26,2011-11-26,,C,,500,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-11-25,2011-11-25,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-11-25,2011-11-25,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-11-25,2011-11-25,,2011-11-26,2011-11-26,,C,,400,mL,INTRAVENOUS,QD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-10-28,2011-10-28,,,,,C,Y,30,mg,INTRAMUSCULAR,PRN,AIN SYNDROME IN EPIGASTRIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CORDIAMIN,NIKETHAMIDE,2011-12-06,2011-12-06,,2011-12-06,2011-12-06,,C,,2,mL,INTRAMUSCULAR,ONCE,ARTERIAL HYPOTENSION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-12-20,2011-12-20,,2012-01-03,2012-01-03,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2011-12-27,2011-12-27,,,,,C,Y,200.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-12-27,2011-12-27,,,,,C,Y,400.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2011-12-27,2011-12-27,,,,,C,Y,400.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2011-12-27,2011-12-27,,,,,C,Y,400.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2011-12-27,2011-12-27,,,,,C,Y,400.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-27,2011-12-27,,,,,C,Y,20.0,mg,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-27,2011-12-27,,,,,C,Y,8,mg,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,HARTAMN'S SOLUTION,RINGER-LACTATE,2011-12-27,2011-12-27,,,,,C,Y,400.0,mL,INTRAVENOUS,QD,FATIGUE AND DYSOREXIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-12-27,2011-12-27,,,,,C,Y,30,mg,INTRAMUSCULAR,TID,PAIN SYNDROME IN EPIGASTRIUM
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-12-26,2011-12-26,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,PAIN SYNDROME IN EPIGASTRIUM
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-01-03,2012-01-03,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2011-10-28,2011-10-28,,2011-12-27,2011-12-27,,C,,1,TABLET,ORAL,BID,PAIN SYNDROME IN EPIGASTRIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-11-22,2011-11-22,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-22,2011-11-22,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-11-22,2011-11-22,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-11-22,2011-11-22,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-11-22,2011-11-22,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-11-22,2011-11-22,,,,,C,Y,200,mL,ORAL,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2011-12-06,2011-12-06,,2011-12-13,2011-12-13,,C,,1,TABLET,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-12-06,2011-12-06,,2011-12-13,2011-12-13,,C,,2,mL,INTRAMUSCULAR,BID,ANEMIA
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,6000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2011-11-22,2011-11-22,,2012-01-12,2012-01-12,,C,,1,TABLET,ORAL,TID,LIVER COMPLICATIONS PROHYLAXIS
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,200.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-02-17,2012-02-17,,2012-02-21,2012-02-21,,C,,5.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-03-15,2012-03-15,,2012-03-22,2012-03-22,,C,,250,mg,ORAL,TID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CALSHAKE [HIGH-CALORIC FEEDING],OTHER COMBINATIONS OF NUTRIENTS,2012-03-15,2012-03-15,,2012-03-22,2012-03-22,,C,,1,SACHET,ORAL,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-03-30,2012-03-30,,,,,C,Y,200,mL,INTRAVENOUS,QOD,ALT AND AST LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-03-30,2012-03-30,,,,,C,Y,400,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-03-30,2012-03-30,,,,,C,Y,400,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-03-30,2012-03-30,,,,,C,Y,400,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-03-30,2012-03-30,,,,,C,Y,400,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-03-30,2012-03-30,,,,,C,Y,5.0,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-03-30,2012-03-30,,,,,C,Y,20,mg,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,20,mg,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-12-01,2011-12-01,,2011-12-05,2011-12-05,,C,,400,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-12-01,2011-12-01,,2011-12-05,2011-12-05,,C,,400,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-12-01,2011-12-01,,2011-12-05,2011-12-05,,C,,400,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ESSENTIAL PHOSPHOLIPIDES,PHOSPHOLIPIDS,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,5.0,mL,INTRAVENOUS,QOD,AST AND ALT LEVEL INCREASED
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,C,,30,MU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,EPREX (EPOETIN ALFA),EPOETIN ALFA,2012-06-07,2012-06-07,,2012-06-11,2012-06-11,,C,,2 000,IU,SUBCUTANEOUS,QD,ANEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,1,VIAL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,20,mg,INTRAMUSCULAR,ONCE,TROMBOCYTOPENIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-06-07,2012-06-07,,,,,C,Y,250,mg,ORAL,TID,TROMBOCYTOPENIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 10%,ALBUMIN HUMAN,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,200,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,2,mL,INTRAVENOUS,QD,LOWER EXTREMITIES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,PANANGINE,NOVO-PETRIN,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,10,mL,INTRAVENOUS,QD,LOWER EXTREMITIES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-01,2011-12-01,,2011-12-05,2011-12-05,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,L-LYSINE AESCINAT,LYSINE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,10,mL,INTRAVENOUS,QD,LOWER EXTREMITIES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,100,mL,INTRAVENOUS,QD,LOWER EXTREMITIES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,LOWER EXTREMITIES EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,LOWER EXTREMITIES EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,LOWER EXTREMITIES EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-06-07,2012-06-07,,2012-06-09,2012-06-09,,C,,400,mL,INTRAVENOUS,QD,LOWER EXTREMITIES EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ALBUMIN 10%,ALBUMIN HUMAN,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,200,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,L-LYSINE AESCINAT,LYSINE,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,10,mL,INTRAVENOUS,QD,LOWER EXTREMITIES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,100,mL,INTRAVENOUS,QD,LOWER EXTREMITES AND LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-06-15,2012-06-15,,2012-06-17,2012-06-17,,C,,400,mL,INTRAVENOUS,QD,LEFT FOREARM EDEMA
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-01,2011-12-01,,2011-12-04,2011-12-04,,C,,8,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-01-12,2012-01-12,,,,,C,Y,800,mg,ORAL,TID,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,AST & ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,AST & ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,AST & ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,AST & ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,400.0,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,12,mg,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-01-10,2012-01-10,,2012-02-14,2012-02-14,,C,,5,mL,INTRAVENOUS,QOD,ALT LEVEL INCREASE
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,20,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-01-07,2012-01-07,,2012-01-07,2012-01-07,,C,,200.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-01-08,2012-01-08,,2012-01-08,2012-01-08,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-01-08,2012-01-08,,2012-01-08,2012-01-08,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-01-08,2012-01-08,,2012-01-08,2012-01-08,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,HARTMAN SOLUTION,RINGER-LACTATE,2012-01-08,2012-01-08,,2012-01-08,2012-01-08,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID 10%,ASCORBIC ACID,2012-01-08,2012-01-08,,2012-01-08,2012-01-08,,C,,2,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MANNIT,MANNITOL,2012-01-09,2012-01-09,,2012-01-09,2012-01-09,,C,,100,mL,INTRAVENOUS,QD,TOXIC SYBDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-09,2012-01-09,,2012-01-09,2012-01-09,,C,,8,mg,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,8,mg,INTRAVENOUS,QD,CHEMOTERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,400.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,400.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,400.0,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,6,mL,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-12-19,2011-12-19,,,,,C,Y,1,TABLET,ORAL,TID,FERMENTATIVE DECOMPENSATION OF PANCREAS
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,2,mL,INTRAMUSCULAR,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,20,mg,INTRAMUSCULAR,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,8,mg,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT [POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL],CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-07,2012-01-07,,2012-01-07,2012-01-07,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT [POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL],EL-4,2012-01-07,2012-01-07,,2012-01-07,2012-01-07,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT [POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL],SODIUM LACTATE,2012-01-07,2012-01-07,,2012-01-07,2012-01-07,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT [POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL],SORBITOL,2012-01-07,2012-01-07,,2012-01-07,2012-01-07,,C,,400.0,mL,INTRAVENOUS,QD,TOXIC SYNDROME
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PANCREATIN),PANCREATIN,2011-12-21,2011-12-21,,,,,C,Y,1,TABLET,ORAL,TID,FERMENTATIVE PANCREAS FAILURE
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,200,mL,INTRAVENOUS,QOD,INCREASED ALT & AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,400,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,6,mL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,20,mg,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-13,2012-01-13,,2012-01-17,2012-01-17,,C,,1,VIAL,INTRAVENOUS,QOD,INCREASED AST & ALT
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,400.0,mL,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,20,mg,INTRAVENOUS,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-20,2012-01-20,,2012-01-24,2012-01-24,,C,,1,VIAL,INTRAMUSCULAR,QOD,INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,200.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,200.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,200.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,200.0,mL,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-29,2011-12-29,,,,,C,Y,12,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,400,mg,INTRAVENOUS,ONCE,HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-25,2012-01-25,,2012-01-25,2012-01-25,,C,,6 000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,400,mg,INTRAVENOUS,QD,INCREASED AST & HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-01-26,2012-01-26,,2012-01-30,2012-01-30,,C,,400,mL,INTRAVENOUS,QD,INCREASED AST & HYPERBILIRUBEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-01-31,2012-01-31,,,,,C,Y,1,VIAL,ORAL,QD,HYPERBILIRUINEMIA & INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-01-31,2012-01-31,,,,,C,Y,2,TABLET,ORAL,TID,HYPERBILIRUINEMIA & INCREASED AST
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-29,2011-12-29,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2011-12-29,2011-12-29,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2011-12-29,2011-12-29,,,,,C,Y,400,mL,applied as chemotherapy administered,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2011-12-29,2011-12-29,,,,,C,Y,400,mL,applied as chemotherapy administered,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2011-12-29,2011-12-29,,,,,C,Y,400,mL,applied as chemotherapy administered,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2011-12-21,2011-12-21,,2012-01-12,2012-01-12,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-05,2012-01-05,,2012-01-07,2012-01-07,,C,,6000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-01-12,2012-01-12,,2012-01-16,2012-01-16,,C,,4000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-01-12,2012-01-12,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,PHTHORAFURUM,,2012-03-21,2012-03-21,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-23,2012-01-23,,,,,C,Y,12,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-23,2012-01-23,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-01-23,2012-01-23,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAY PREMEDICATION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-01-23,2012-01-23,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAY PREMEDICATION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-01-23,2012-01-23,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAY PREMEDICATION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2012-02-06,2012-02-06,,,,,C,Y,320,mg,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-03-05,2012-03-05,,2012-03-19,2012-03-19,,C,,1,VIAL,ORAL,QD,"PREVENTION OF HEPATIC COMPLICATIONS , INCREASED AST & ALT"
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LISOTIASID (LISINOPRIL/HYDROCHLOROTHIAZIDE),ZESTORETIC,2011-09,2011-08-31,D,,,,C,Y,20,mg,ORAL,QD,ESSENTIAL HYPERTENSION
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-03-19,2012-03-19,,,,,C,Y,1,TABLET,ORAL,TID,HEPATIC COMPLICATIONS PREVENTION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,UNKNOWN,,2012-06-22,2012-06-22,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2012-02-01,2012-02-01,,,,,C,Y,40,mg,ORAL,TID,PAIN SYNDROME IN ABDOMEN
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-02-29,2012-02-29,,,,,C,Y,12,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-02-29,2012-02-29,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-02-29,2012-02-29,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-02-29,2012-02-29,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-03-21,2012-03-21,,2012-04-02,2012-04-02,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-03-21,2012-03-21,,2012-03-22,2012-03-22,,C,,30000000,IU,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-03-21,2012-03-21,,2012-04-04,2012-04-04,,C,,250,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-04-18,2012-04-18,,,,,C,Y,1,TABLET,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-04-19,2012-04-19,,2012-04-23,2012-04-23,,C,,12,mg,INTRAMUSCULAR,QOD,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2012-04-25,2012-04-25,,2012-04-25,2012-04-25,,C,,80,mg,INTRAMUSCULAR,ONCE,WORSENING OF PAIN SYNDROME
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KETALONG,KETOPROFEN,2012-04-25,2012-04-25,,2012-04-25,2012-04-25,,C,,2,mL,INTRAMUSCULAR,ONCE,WORSENING OF PAIN SYNDROME
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-06-06,2012-06-06,,,,,C,Y,0.25,mg,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2012-02-01,2012-02-01,,,,,C,Y,50,mg,ORAL,BID,PAIN SYNDROME IN ABDOMEN
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-06-08,2012-06-08,,2012-06-10,2012-06-10,,C,,12,mg,INTRAMUSCULAR,QOD,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-06-06,2012-06-06,,2012-06-06,2012-06-06,,C,,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-06-13,2012-06-13,,2012-06-13,2012-06-13,,C,,1,VIAL,SUBCUTANEOUS,ONCE,PT'S SAFETY
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ACTRAPID,INSULIN HUMAN,2012-02-21,2012-02-21,,,,,C,Y,"7,6,5,4",IU,ORAL,QID,DIABETES MELLITUS
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-03-07,2012-03-07,,2012-03-08,2012-03-08,,C,,30000000,IU,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,12,mg,INTRAVENOUS,ONCE,NEUTROPENIA &  THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,5% ASCORBIC ACID,ASCORBIC ACID,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,5,VIAL,INTRAVENOUS,ONCE,NEUTROPENIA &  THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-03-14,2012-03-14,,2012-03-14,2012-03-14,,C,,30000000,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-02-29,2012-02-29,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-29,2012-02-29,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2012-02-29,2012-02-29,,,,,C,Y,1,TABLET,ORAL,TID,PANCREAS FAILURE
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-12,2012-03-12,,2012-05-07,2012-05-07,,C,,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-03-12,2012-03-12,,2012-05-07,2012-05-07,,C,,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-03-12,2012-03-12,,2012-05-07,2012-05-07,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-03-12,2012-03-12,,2012-05-07,2012-05-07,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-03-12,2012-03-12,,2012-05-07,2012-05-07,,C,,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-03-26,2012-03-26,,2012-04-02,2012-04-02,,C,,250,mg,ORAL,TID,THROMBOCITOPENIA
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-04-23,2012-04-23,,2012-05-03,2012-05-03,,C,,1,VIAL,ORAL,QD,INCREASED AST LEVEL
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,CLOPIDOGREL,CLOPIDOGREL,2012-05-18,2012-05-18,,,,,C,Y,75,mg,ORAL,QD,THROMBOSIS
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CARDIOMAGNYL,MAGNYL                             /02350501/,2012-05-18,2012-05-18,,,,,C,Y,75,mg,ORAL,QD,THROMBOSIS
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NICERGOLINE,NICERGOLINE,2012-05-18,2012-05-18,,,,,C,Y,30,mg,ORAL,QD,THROMBOSIS
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MEZYM FORTE (PANCREATIN),PANCREATIN,2012-03,2012-02-29,D,,,,C,Y,1,TABLET,ORAL,TID,SUPPORTIVE CARE FOR PANCREAS
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,400,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,200,mL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-04-13,2012-04-13,,2012-04-15,2012-04-15,,C,,20,mg,INTRAMUSCULAR,QOD,NEUTROPENIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-04-18,2012-04-18,,2012-04-22,2012-04-22,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATE,ETAMSILATE,2012-04-18,2012-04-18,,,,,C,Y,1,TABLET,ORAL,TID,THROMBOCYTOPENIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM ),FILGRASTIM,2012-04-13,2012-04-13,,2012-04-13,2012-04-13,,C,,0.5,mL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NUCLEINATE SODIUM,CYTOKINES AND IMMUNOMODULATORS,2012-04-11,2012-04-11,,2012-04-18,2012-04-18,,C,,1,TABLET,ORAL,TID,PREVENTION & TREATMENT OF NEUTROPENIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-05-08,2012-05-08,,2012-05-13,2012-05-13,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HEAZYL,"VITAMINS, OTHER COMBINATIONS",2012-05-30,2012-05-30,,,,,C,Y,1,VIAL,ORAL,QD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST, ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST, ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST, ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST, ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXKETOPROFEN,DEXKETOPROFEN,2012-03,2012-02-29,D,,,,C,Y,2,mL,INTRAMUSCULAR,TID,PAIN SYNDROME IN LEFT & RIGHT HYPOCHONDRIUM
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,1,VIAL,INTRAVENOUS,QOD,"INCREASED ALT, AST & ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,5% GLUCOSE SOLUTION,GLUCOSE,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,200,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST & ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS ),PHOSPHOLIPIDS,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,5,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST & ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-06-08,2012-06-08,,2012-06-12,2012-06-12,,C,,200,mL,INTRAVENOUS,QOD,"INCREASED ALT, AST & ALP"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,400,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,1,VIAL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,5% GLUCOSE SOLUTION,GLUCOSE,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,200,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,5,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-06-15,2012-06-15,,2012-06-19,2012-06-19,,C,,200,mL,INTRAVENOUS,QOD,"INCREASED ALP, AST, ALT & HYPERBILIRUBINEMIA"
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-06-20,2012-06-20,,2012-07-02,2012-07-02,,C,,2,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-04-04,2012-04-04,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-06-20,2012-06-20,,2012-06-26,2012-06-26,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-06-22,2012-06-22,,2012-07-02,2012-07-02,,C,,2,CAPSULE,ORAL,TID,ALT AND AST LEVEL INCREASE
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-04,2012-04-04,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-04-04,2012-04-04,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-04-04,2012-04-04,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-04-04,2012-04-04,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-04-04,2012-04-04,,,,,C,Y,2,TABLET,ORAL,TID,PREVENTION OF LIVER FERMENTS
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-04-11,2012-04-11,,2012-04-18,2012-04-18,,C,,1,VIAL,ORAL,QD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,SORBIFER (FERRUM SULFATE 320 MG + ACCORBIC ACID 60 MG),KENDURAL C,2012-04-11,2012-04-11,,2012-04-18,2012-04-18,,C,,1,TABLET,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-04-12,2012-04-12,,2012-04-16,2012-04-16,,C,,1,VIAL,INTRAVENOUS,QOD,INCREASED ALT LEVEL
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN (FILGRASTIM),FILGRASTIM,2012-04-12,2012-04-12,,2012-04-12,2012-04-12,,C,,0.5,mL,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,GLUCOSE 5% SOLUTION,GLUCOSE,2012-07-05,2012-07-05,,2012-07-05,2012-07-05,,C,,200,mL,INTRAVENOUS,ONCE,ANEMIA GR 3
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID 5%,ASCORBIC ACID,2012-07-05,2012-07-05,,2012-07-05,2012-07-05,,C,,6,mL,INTRAMUSCULAR,ONCE,ANEMIA GR 3
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-07-05,2012-07-05,,2012-07-05,2012-07-05,,C,,20,mg,INTRAVENOUS,ONCE,ANEMIA GR 3
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FERRUM-LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-07-05,2012-07-05,,2012-07-05,2012-07-05,,C,,2,mL,INTRAMUSCULAR,ONCE,ANEMIA GR3
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,1,VIAL,INTRAVENOUS,QOD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,400,mL,INTRAVENOUS,QOD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),EL-4,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,400,mL,INTRAVENOUS,QOD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SODIUM LACTATE,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,400,mL,INTRAVENOUS,QOD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL),SORBITOL,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,400,mL,INTRAVENOUS,QOD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID 6%,ASCORBIC ACID,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,5,mL,INTRAMUSCULAR,QD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DROTAVERINE,DROTAVERINE,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,2,mL,INTRAMUSCULAR,QD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,NEOGEMODEZ (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,400,mL,INTRAVENOUS,QD,"AST & ALT LEVEK INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-07-20,2012-07-20,,2012-07-24,2012-07-24,,C,,12,mg,INTRAVENOUS,QD,"AST & ALT LEVEL INCREASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MEZYM FORTE (PANCREATIN),PANCREATIN,2012-01,2011-12-31,D,,,,C,Y,1,TABLET,ORAL,TID,PANCREAS SUPPORTIVE CARE
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-07-27,2012-07-27,,,,,C,Y,400,mg,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-07-27,2012-07-27,,,,,C,Y,16,mg,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-07-27,2012-07-27,,,,,C,Y,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-07-27,2012-07-27,,,,,C,Y,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-07-27,2012-07-27,,,,,C,Y,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-07-27,2012-07-27,,,,,C,Y,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,HEPAZYL,"VITAMINS, OTHER COMBINATIONS",2012-08-03,2012-08-03,,2012-08-23,2012-08-23,,C,,1,AMPULE,ORAL,QD,"ALT LEVEL INCREASE, GRADE 2"
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-08-02,2012-08-02,,2012-08-08,2012-08-08,,C,,2000,IU,SUBCUTANEOUS,QOD,ANEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-08-09,2012-08-09,,,,,C,Y,2,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,1,VIAL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,400,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,NEOHAEMODESUM (POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM HYDROCARBONATE + SODIUM CHLORIDE + POVIDONE 8000),SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,200,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-01,2011-12-31,D,,,,C,Y,1,TABLET,ORAL,TID,PREVENTION OF HEPATIC COMPLICATIONS
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-08-23,2012-08-23,,2012-08-29,2012-08-29,,C,,12,mg,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-08-30,2012-08-30,,2012-09-05,2012-09-05,,C,,1,VIAL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-08-30,2012-08-30,,2012-09-05,2012-09-05,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-08-30,2012-08-30,,2012-09-05,2012-09-05,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-08-30,2012-08-30,,2012-09-05,2012-09-05,,C,,400,mL,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-09-01,2012-09-01,,2012-09-05,2012-09-05,,C,,12,mg,INTRAVENOUS,QOD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,10% ALBUMIN,ALBUMIN HUMAN,2012-09-01,2012-09-01,,2012-09-05,2012-09-05,,C,,200,mL,INTRAVENOUS,QOD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,CALSHAKE,OTHER COMBINATIONS OF NUTRIENTS,2012-08-30,2012-08-30,,2012-09-06,2012-09-06,,C,,1,SACHET,ORAL,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,RBC MASS,RED BLOOD CELLS,2012-09-06,2012-09-06,,2012-09-07,2012-09-07,,C,,750,mL,INTRAVENOUS,ONCE,ANMEIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,FROZEN PLASMA,PLASMA,2012-09-06,2012-09-06,,2012-09-07,2012-09-07,,C,,520,mL,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,ADEMETIONINE,ADEMETIONINE,2012-09-06,2012-09-06,,2012-09-07,2012-09-07,,C,,400,mg,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,10% ASCORBIC ACID,ASCORBIC ACID,2012-09-06,2012-09-06,,2012-09-07,2012-09-07,,C,,6,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,CARSYL (SILYMARIN),SILYBUM MARIANUM,2012-01,2011-12-31,D,,,,C,Y,2,TABLET,ORAL,TID,PREVENTION OF HEPATIC COMPLICATIONS
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-09-06,2012-09-06,,2012-09-07,2012-09-07,,C,,200,mL,INTRAVENOUS,QD,HYPERBILIRUBINEMIA
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-04-05,2012-04-05,,,,,C,Y,20,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-05,2012-04-05,,,,,C,Y,8,mg,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE 0.9% SOLUTION,SODIUM CHLORIDE,2012-04-05,2012-04-05,,,,,C,Y,200,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),EL-4,2012-04-05,2012-04-05,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),MAGNESIUM CHLORIDE,2012-04-05,2012-04-05,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,REAMBERIN (NATRIUM SUCCINATE+NATRIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNIUM CHLORIDE),SUCCINATE SODIUM,2012-04-05,2012-04-05,,,,,C,Y,400,mL,INTRAVENOUS,applied as chemotherapy administered,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-06-27,2012-06-27,,2012-06-30,2012-06-30,,C,,2 000,IU,SUBCUTANEOUS,QOD,ANEMIA GR 2
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CONTRAMAL,TRAMADOL HYDROCHLORIDE,2010-10-18,2010-10-18,,2010-10-28,2010-10-28,,P,,50,mg,ORAL,QID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-11-19,2010-11-19,,2010-11-25,2010-11-25,,C,,1,mL,EPIDURAL,QID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FUROSEMID,FUROSEMIDE,2010-12-24,2010-12-24,,2010-12-24,2010-12-24,,C,,40,mg,INTRAVENOUS,QD,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOL. MANNITI 15%,MANNITOL,2010-12-24,2010-12-24,,2010-12-24,2010-12-24,,C,,200,mL,INTRAVENOUS,QD,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-12-24,2010-12-24,,2010-12-26,2010-12-26,,C,,8,mg,INTRAVENOUS,TID,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SOL. NATRII HYDROCARBONATI 4%,SODIUM BICARBONATE,2010-12-24,2010-12-24,,2010-12-24,2010-12-24,,C,,200,mL,INTRAVENOUS,QD,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SOL. MORPHYNI 1%,MORPHINE,2010-12-25,2010-12-25,,2010-12-25,2010-12-25,,C,,1.0,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,BUPIVACAIN M 0.5%,BUPIVACAINE HYDROCHLORIDE,2010-11-19,2010-11-19,,2010-11-25,2010-11-25,,C,,40,mg,EPIDURAL,QID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NO-SPA,DROTAVERINE HYDROCHLORIDE,2010-12-02,2010-12-02,,2010-12-05,2010-12-05,,C,,40,mg,INTRAVENOUS,BID,UROLYTHIASIS (AE#2)
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-11-25,2010-11-25,,2010-11-26,2010-11-26,,C,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-11-26,2010-11-26,,2010-12-09,2010-12-09,,C,,1,mL,INTRAMUSCULAR,QID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SOL.SIBASONI 0.5%,DIAZEPAM,2010-11-26,2010-11-26,,2010-12-24,2010-12-24,,C,,2,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2010-11-27,2010-11-27,,2010-12-30,2010-12-30,,C,,3,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,BUPIVACAIN M 0.5%,BUPIVACAINE HYDROCHLORIDE,2010-12-04,2010-12-04,,2010-12-24,2010-12-24,,C,,50,mg,EPIDURAL,6 TIMES PER DAY,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,RENALGAN,BARALGINA,2010-12-27,2010-12-27,,2010-12-31,2010-12-31,,C,,5,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-10-22,2010-10-22,,2010-10-25,2010-10-25,,P,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SOL. TRAMADOLI 5%,TRAMADOL,2010-12-27,2010-12-27,,2010-12-27,2010-12-27,,C,,2,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,1,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,INFESOL,INFESOL,2010-12-14,2010-12-14,,2010-12-20,2010-12-20,,C,,500,mL,INTRAVENOUS,QD,HYPOALBUMINEMIA
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SOL.ALBUMINI 10%,ALBUMIN HUMAN,2010-12-21,2010-12-21,,2010-12-24,2010-12-24,,C,,200,mL,INTRAVENOUS,QD,HYPOALBUMINEMIA
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SOL.ATROPINI 0.1%,ATROPINE,2010-12-24,2010-12-24,,2010-12-24,2010-12-24,,C,,1,mL,INTRAVENOUS,QD,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,SOL.CORDIAMINI 25%,NIKETHAMIDE,2010-12-24,2010-12-24,,2010-12-24,2010-12-24,,C,,2,mL,INTRAVENOUS,QD,TOXIC REACTION OF LOCAL ANESTHETIC
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,SOL.PROMEDOLI 2%,TRIMEPERIDINE,2010-10-26,2010-10-26,,2010-10-28,2010-10-28,,P,,1,mL,INTRAMUSCULAR,QID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,SOL.MORPHINI 1%,MORPHINE,2010-10-28,2010-10-28,,2010-11-16,2010-11-16,,C,,1,mL,INTRAMUSCULAR,TID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM 0.5%,DIAZEPAM,2010-11-16,2010-11-16,,2010-11-16,2010-11-16,,C,,2,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,SOL. MORPHINI 1%,MORPHINE,2010-11-17,2010-11-17,,2010-11-17,2010-11-17,,C,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,SOL. MORPHINI 1%,MORPHINE,2010-11-18,2010-11-18,,2010-11-18,2010-11-18,,C,,1,mL,INTRAMUSCULAR,ONCE,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SOL. MORPHINI 1%,MORPHINE,2010-11-19,2010-11-19,,2010-11-25,2010-11-25,,C,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DIAZEPAM 0.5%,DIAZEPAM,2010-11-19,2010-11-19,,2010-11-25,2010-11-25,,C,,2,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,PREDNISOLON,PREDNISOLONE,2010-12-30,2010-12-30,,2011-01-09,2011-01-09,,C,,30,mg,INTRAVENOUS,TID,LOW LEVEL OF PLATELETS
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-13,2010-12-13,,2010-12-13,2010-12-13,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-12-20,2010-12-20,,2010-12-20,2010-12-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-20,2010-12-20,,2010-12-20,2010-12-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-12-27,2010-12-27,,2010-12-27,2010-12-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2010-12-20,2010-12-20,,2010-12-20,2010-12-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DICLOBERL,DICLOFENAC SODIUM,2010-11-23,2010-11-23,,,,,C,Y,3,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2010-11-23,2010-11-23,,,,,C,Y,1,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-10,2011-01-10,,2011-01-10,2011-01-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-10,2011-01-10,,2011-01-10,2011-01-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,LENOGRASTIM,LENOGRASTIM,2010-12-24,2010-12-24,,2010-12-27,2010-12-27,,C,,33.6 mln,IU,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-17,2011-01-17,,2011-01-17,2011-01-17,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-14,2011-02-14,,2011-02-14,2011-02-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-21,2011-02-21,,2011-02-21,2011-02-21,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-28,2011-02-28,,2011-02-28,2011-02-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-14,2011-03-14,,2011-03-14,2011-03-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-01-24,2011-01-24,,2011-01-24,2011-01-24,,C,,300,mg,INTRAVENOUS,QD,LEUKOPENIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-14,2011-03-14,,2011-03-14,2011-03-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-21,2011-03-21,,2011-03-21,2011-03-21,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-21,2011-03-21,,2011-03-21,2011-03-21,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-28,2011-03-28,,2011-03-28,2011-03-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-28,2011-03-28,,2011-03-28,2011-03-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-03-28,2011-03-28,,2011-03-28,2011-03-28,,C,,300,mg,INTRAVENOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-04-04,2011-04-04,,2011-04-04,2011-04-04,,C,,300,mg,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,EPOBIOCRIN,EPOETIN ALFA,2011-02-02,2011-02-02,,2011-02-04,2011-02-04,,C,,10 000,IU,SUBCUTANEOUS,QD,ANEMIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,GEPACEF,CEFOPERAZONE SODIUM,2011-02-04,2011-02-04,,2011-02-06,2011-02-06,,C,,2000,mg,INTRAVENOUS,BID,PNEUMONIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,SULFOCAMFOCAIN,SULFOCAMPHOCAIN,2011-02-04,2011-02-04,,,,,C,Y,2,mL,INTRAMUSCULAR,BID,PNEUMONIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,MUCOLVAN,AMBROXOL HYDROCHLORIDE,2011-02-04,2011-02-04,,,,,C,Y,2,mL,INTRAVENOUS,BID,PNEUMONIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,DIFLUZOL,FLUCONAZOLE,2011-02-04,2011-02-04,,2011-02-04,2011-02-04,,C,,150,mg,ORAL,QD,PNEUMONIA
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2010-12-13,2010-12-13,,2010-12-13,2010-12-13,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-16,2011-03-16,,2011-03-16,2011-03-16,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-23,2011-03-23,,2011-03-23,2011-03-23,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-23,2011-03-23,,2011-03-23,2011-03-23,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-04-27,2011-04-27,,,,,C,Y,0.25,mg,ORAL,TID,REPLACEMENT THERAPY
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-05-11,2011-05-11,,2011-05-11,2011-05-11,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-11,2011-05-11,,2011-05-11,2011-05-11,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-18,2011-05-18,,2011-05-18,2011-05-18,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-01,2011-06-01,,2011-06-15,2011-06-15,,C,,2500,IU,SUBCUTANEOUS,QID,THROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-08,2011-06-08,,2011-06-08,2011-06-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-15,2011-06-15,,2011-06-15,2011-06-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-06-22,2011-06-22,,2011-06-23,2011-06-23,,C,,48 000 000,IU,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-06,2011-07-06,,2011-07-06,2011-07-06,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-07-27,2011-07-27,,,,,C,Y,2500,IU,SUBCUTANEOUS,QID,TROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMRTHASON,DEXAMETHASONE,2011-07-27,2011-07-27,,2011-07-27,2011-07-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-27,2011-07-27,,2011-07-27,2011-07-27,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,HEXAMETHONIUM BENZOSULFONATE,HEXAMETHONIUM,2011-08-04,2011-08-04,,2011-08-10,2011-08-10,,C,,0.25,g,INTRAMUSCULAR,BID,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-31,2011-08-31,,2011-08-31,2011-08-31,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-31,2011-08-31,,2011-08-31,2011-08-31,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,INDAPAMID,INDAPAMIDE,2010-10-25,2010-10-25,,2011-04-06,2011-04-06,,C,,1.5,mg,ORAL,QD,HYPERTONIC DISEASE
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,EGILOK,METOPROLOL TARTRATE,2010-10-25,2010-10-25,,2011-04-06,2011-04-06,,C,,25,mg,ORAL,BID,HYPERTONIC DISEASE
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,BETALOK,METOPROLOL SUCCINATE,2011-08-31,2011-08-31,,,,,C,Y,25,mg,ORAL,BID,HYPERTONIC DISEASE
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-03-01,2011-03-01,,2011-03-01,2011-03-01,,C,,300,mg,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,CARDOSAL,OLMESARTAN MEDOXOMIL,2011-08-31,2011-08-31,,,,,C,Y,20,mg,ORAL,QD,HYPERTONIC DISEASE
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-29,2011-06-29,,2011-07-13,2011-07-13,,C,,2500,IU,SUBCUTANEOUS,QID,TROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-07-27,2011-07-27,,2011-08-10,2011-08-10,,C,,2500,IU,SUBCUTANEOUS,QID,TROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-09-14,2011-09-14,,,,,C,Y,2500,IU,SUBCUTANEOUS,QID,TROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-08-31,2011-08-31,,2011-09-07,2011-09-07,,C,,2500,IU,SUBCUTANEOUS,QID,TROMBOCYTOSIS
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2011-03-17,2011-03-17,,2011-03-17,2011-03-17,,C,,300,mg,SUBCUTANEOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-09,2011-03-09,,2011-03-09,2011-03-09,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-09,2011-03-09,,2011-03-09,2011-03-09,,C,,8,mg,INTRAVENOUS,QD,PREMADICATION
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-03-16,2011-03-16,,2011-03-16,2011-03-16,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-03-03,2011-03-03,,2011-03-21,2011-03-21,,C,,600,mg,INTRAVENOUS,QD,CHOLEMIA
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-24,2011-03-24,,2011-03-24,2011-03-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONI,DEXAMETHASONE,2011-03-03,2011-03-03,,2011-04-05,2011-04-05,,C,,8,mg,INTRAMUSCULAR,BID,CHOLEMIA
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOL.NACL 0.9%,SODIUM CHLORIDE,2011-03-03,2011-03-03,,2011-04-05,2011-04-05,,C,,400,mL,INTRAVENOUS,QD,CHOLEMIA
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOL.GLUCOSAE 5%,GLUCOSE,2011-03-03,2011-03-03,,2011-04-05,2011-04-05,,C,,400,mL,INTRAVENOUS,QD,CHOLEMIA
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,INFESOLI,INFESOL,2011-03-03,2011-03-03,,2011-04-05,2011-04-05,,C,,500,mL,INTRAVENOUS,QD,HYPOPROTEINEMIA
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SOL.MORPHYNI 1%,MORPHINE,2011-02-25,2011-02-25,,2011-04-05,2011-04-05,,C,,1,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONI,DEXAMETHASONE,2011-03-17,2011-03-17,,2011-03-17,2011-03-17,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-03-17,2011-03-17,,2011-03-17,2011-03-17,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONI,DEXAMETHASONE,2011-03-24,2011-03-24,,2011-03-24,2011-03-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FARMASULIN,HUMAN MIXTARD,2011-08-29,2011-08-29,,,,,C,Y,10,IU,SUBCUTANEOUS,TID,HYPERGLICEMIA
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,8,IU,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-01,2011-08-01,,2011-08-01,2011-08-01,,C,,8,mg,INTRAVENOUS,BID,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-10,2011-10-10,,2011-10-10,2011-10-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-10,2011-10-10,,2011-10-10,2011-10-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-24,2011-10-24,,2011-10-24,2011-10-24,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-07-11,2011-07-11,,,,,C,Y,3,mL,INTRAMUSCULAR,QD,PAIN SYNDROME
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-07-11,2011-07-11,,,,,C,Y,0.25,mg,ORAL,TID,SUPPORTIVE THERAPY
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,FARMASULIN,HUMAN MIXTARD,2011-08-15,2011-08-15,,2011-08-29,2011-08-29,,C,,10,IU,SUBCUTANEOUS,TID,HYPERGLICEMIA
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,8,mg,SUBCUTANEOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DIABETON,GLICLAZIDE,2011-06,2011-05-31,D,,,,C,Y,60,mg,ORAL,QD,DIABETIS
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-12-19,2011-12-19,,2011-12-19,2011-12-19,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-19,2011-12-19,,2011-12-19,2011-12-19,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-12-26,2011-12-26,,2011-12-26,2011-12-26,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-26,2011-12-26,,2011-12-26,2011-12-26,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-06,2011-05-31,D,,,,C,Y,20,IU,SUBCUTANEOUS,QD,DIABET
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,INSULIN,INSULIN,2011-06,2011-05-31,D,,,,C,Y,10,IU,SUBCUTANEOUS,QD,DIABET
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-11-08,2011-11-08,,,,,C,Y,0.25,mg,ORAL,QID,REPLACEMENT THERAPY
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-11-08,2011-11-08,,,,,C,Y,3.0,mL,INTRAMUSCULAR,BID,PAIN SYNDROME
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,8,mg,INTRAMUSCULAR,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,8,mg,INTRAMUSCULAR,QD,PREMEDICATION
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,PANCREATIN,PANCREATIN,2011-12-10,2011-12-10,,,,,C,Y,0.25,mg,ORAL,QID,REPLACEMENT THERAPY
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-02-08,2012-02-08,,2012-02-08,2012-02-08,,C,,48,IU,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,48,IU,SUBCUTANEOUS,ONCE,"NEUTROPENIA, LEUCOPENIA"
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-02-16,2012-02-16,,2012-02-16,2012-02-16,,C,,48,IU,SUBCUTANEOUS,ONCE,"NEUTROPENIA, LECOPENIA"
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-03-14,2012-03-14,,2012-03-14,2012-03-14,,C,,48,IU,SUBCUTANEOUS,ONCE,"NEUTROPENIA, LEUCOPENIA"
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-01-04,2012-01-04,,2012-01-04,2012-01-04,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-03-14,2012-03-14,,2012-03-14,2012-03-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-14,2012-03-14,,2012-03-14,2012-03-14,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEXAMRTHASON,DEXAMETHASONE,2012-04-11,2012-04-11,,2012-04-11,2012-04-11,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-04-18,2012-04-18,,2012-04-18,2012-04-18,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-04-18,2012-04-18,,2012-04-18,2012-04-18,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-03,2012-05-03,,2012-05-03,2012-05-03,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-05-03,2012-05-03,,2012-05-03,2012-05-03,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-04,2012-01-04,,2012-01-04,2012-01-04,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-10,2012-05-10,,2012-05-10,2012-05-10,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-05-10,2012-05-10,,2012-05-10,2012-05-10,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-17,2012-05-17,,2012-05-17,2012-05-17,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-05-17,2012-05-17,,2012-05-17,2012-05-17,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-31,2012-05-31,,2012-05-31,2012-05-31,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-05-31,2012-05-31,,2012-05-31,2012-05-31,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-06-07,2012-06-07,,2012-06-07,2012-06-07,,C,,48,IU,SUBCUTANEOUS,ONCE,"NEUTROPENIA, LEUKOPENIA"
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-06-14,2012-06-14,,2012-06-14,2012-06-14,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-01-11,2012-01-11,,2012-01-11,2012-01-11,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-06-14,2012-06-14,,2012-06-14,2012-06-14,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-07-02,2012-07-02,,2012-07-02,2012-07-02,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-07-02,2012-07-02,,2012-07-02,2012-07-02,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-07-09,2012-07-09,,2012-07-09,2012-07-09,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-07-09,2012-07-09,,2012-07-09,2012-07-09,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,FILGRASTIM,FILGRASTIM,2012-06-21,2012-06-21,,2012-06-21,2012-06-21,,C,,48,IU,SUBCUTANEOUS,ONCE,"NEUTROPENIA, LEUKOPENIA"
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-07-16,2012-07-16,,2012-07-16,2012-07-16,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-07-16,2012-07-16,,2012-07-16,2012-07-16,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-07-30,2012-07-30,,2012-07-30,2012-07-30,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-07-30,2012-07-30,,2012-07-30,2012-07-30,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-11,2012-01-11,,2012-01-11,2012-01-11,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-08-06,2012-08-06,,2012-08-06,2012-08-06,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-08-06,2012-08-06,,2012-08-06,2012-08-06,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,DEXAMETASON,DEXAMETHASONE,2012-08-13,2012-08-13,,2012-08-13,2012-08-13,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-08-13,2012-08-13,,2012-08-13,2012-08-13,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-08-27,2012-08-27,,2012-08-27,2012-08-27,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-08-27,2012-08-27,,2012-08-27,2012-08-27,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-09-03,2012-09-03,,2012-09-03,2012-09-03,,C,,8,mL,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-09-03,2012-09-03,,2012-09-03,2012-09-03,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-09-10,2012-09-10,,2012-09-10,2012-09-10,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-09-10,2012-09-10,,2012-09-10,2012-09-10,,C,,8,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-01-18,2012-01-18,,2012-01-18,2012-01-18,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-18,2012-01-18,,2012-01-18,2012-01-18,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASON,DEXAMETHASONE,2012-02-01,2012-02-01,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-01,2012-02-01,,2012-02-01,2012-02-01,,C,,8,mg,INTRAVENOUS,QD,PREMEDICATION
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2010-09-06,2010-09-06,,,,,C,Y,50,mg,INTRAMUSCULAR,TID,BACK PAIN
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2010-11-23,2010-11-23,,2010-11-30,2010-11-30,,C,,"37,5 mln",IU,INTRAVENOUS,QD,NEUTROPENIA
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN,EPOETIN ALFA,2010-11-23,2010-11-23,,2010-11-30,2010-11-30,,C,,2000,IU,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,"CAFFETIN (CAFFEINE, AMINOPHENAZONE, PHENACETIN, CODEINE)",CAFFETIN                           /00541501/,2011-01-11,2011-01-11,,,,,C,Y,520,mg,ORAL,TID,BACK PAIN
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ANALGINUM,METAMIZOLE SODIUM,2011-01-11,2011-01-11,,,,,C,Y,1,mg,INTRAMUSCULAR,QD,BACK PAIN
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DIMEDROLUM,DIPHENHYDRAMINE HYDROCHLORIDE,2011-01-11,2011-01-11,,,,,C,Y,0.01,mg,INTRAMUSCULAR,QD,BACK PAIN
CO-101-001,CO-101-001-082-002,01082002,082,65.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MORPHINUM,MORPHINE,2010-11-15,2010-11-15,,,,,C,Y,00.1,mg,INTRAMUSCULAR,QD,BACK PAIN
CO-101-001,CO-101-001-082-004,01082004,082,69.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,EPOETIN,EPOETIN ALFA,2011-03-29,2011-03-29,,2011-03-30,2011-03-30,,C,,2000,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,PHTHORAFURUM,,2011-06-19,2011-06-19,,2011-06-26,2011-06-26,,,,,,,,
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CARDIOMAGNIL,MAGNYL                             /02350501/,2011-03-09,2011-03-09,,,,,C,Y,75,mg,ORAL,QD,VENTRICULAR EXTRASYSTOLE
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-03-20,2011-03-20,,2011-04-27,2011-04-27,,C,,2,mL,INTRAMUSCULAR,QD,BONE PAIN
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ESSENTIALS  PHOSPHOLIPIDS,PHOSPHOLIPIDS,2011-03-30,2011-03-30,,2011-04-05,2011-04-05,,C,,2,TABLET,ORAL,TID,HIGH LEVEL OF AST
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,HEPABENE,HEPABENE,2011-03-30,2011-03-30,,2011-04-05,2011-04-05,,C,,1,TABLET,ORAL,TID,HIGH LEVEL OF ALT
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CITRARGININE,CITRARGININE,2011-03-30,2011-03-30,,2011-04-05,2011-04-05,,C,,1,AMPULE,ORAL,TID,HIGH LEVEL OF ALT
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FRAGMINE,DALTEPARIN SODIUM,2011-04-06,2011-04-06,,2011-04-16,2011-04-16,,C,,5000,IU,SUBCUTANEOUS,BID,TROMBOSIS OF BOTH LEG'S VEINS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-03-30,2011-03-30,,2011-04-28,2011-04-28,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ESSENTIALS  PHOSPHOLIPIDS,PHOSPHOLIPIDS,2011-04-06,2011-04-06,,2011-04-06,2011-04-06,,C,,2,TABLET,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,HEPABENE,HEPABENE,2011-04-06,2011-04-06,,2011-04-06,2011-04-06,,C,,1,TABLET,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CITRARGININE,CITRARGININE,2011-04-06,2011-04-06,,2011-04-06,2011-04-06,,C,,1,AMPULE,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE  PHOSPHOLIPIDS,PHOSPHOLIPIDS,2011-04-07,2011-04-07,,2011-04-20,2011-04-20,,C,,2,TABLET,ORAL,TID,PROPHYLAXIS OF HEPATOTOXICITY
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-03-09,2011-03-09,,2011-03-09,2011-03-09,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,HEPABENE,HEPABENE,2011-04-07,2011-04-07,,2011-04-20,2011-04-20,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS OF HEPATOTOXICITY
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,CITRARGININE,CITRARGININE,2011-04-07,2011-04-07,,2011-04-20,2011-04-20,,C,,1,AMPULE,ORAL,TID,PROPHYLAXIS OF HEPATOTOXICITY
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-05-01,2011-05-01,,,,,C,Y,75,mg,INTRAMUSCULAR,QD,CHEST PAIN
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-04-17,2011-04-17,,,,,C,Y,0.2,mg,SUBCUTANEOUS,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,OFLOXACINUM,OFLOXACIN,2011-05-05,2011-05-05,,2011-05-10,2011-05-10,,,,200,mg,ORAL,BID,CYSTITIS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PREDUCTAL,TRIMETAZIDINE,2011-04-14,2011-04-14,,,,,C,Y,1,TABLET,ORAL,BID,CARDIOMYOPATHY TOXIC
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-03-16,2011-03-16,,2011-03-16,2011-03-16,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-03-23,2011-03-23,,2011-03-23,2011-03-23,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-03-30,2011-03-30,,2011-03-30,2011-03-30,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-04-06,2011-04-06,,2011-04-06,2011-04-06,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,KETOROLACUM,KETOROLAC,2011-02-09,2011-02-09,,2011-03-16,2011-03-16,,C,,10,mg,ORAL,QD,ABDOMEN PAIN FROM CANCER PANCREAS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,NORMOVEN,CAPIVEN,2010-09-01,2010-09-01,,2011-04-18,2011-04-18,,C,,1,TABLET,ORAL,BID,VARIX DILATATION
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,CAPTOPRIL,CAPTOPRIL,2009-01-01,2009-01-01,,2011-03-30,2011-03-30,,C,,25,mg,ORAL,QD,HYPERTENSION DISEASE
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,AMARYL,GLIMEPIRIDE,2007-01-01,2007-01-01,,,,,C,Y,2,mg,ORAL,QD,DIABETUS MELLITUS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,FRAXIPARINE,NADROPARIN CALCIUM,2011-03-12,2011-03-12,,,,,C,Y,0.6,mL,TRANSDERMAL,QD,TROMBOPHLEBITIS OF LEFT LEG'S VEINS
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-03-17,2011-03-17,,2011-03-19,2011-03-19,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-03-19,2011-03-19,,,,,C,Y,0.8,mL,SUBCUTANEOUS,QD,TROMBOSIS OF RIGHT LEG'S VEINS
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-03-10,2011-03-10,,2011-05-04,2011-05-04,,C,,1,AMPULE,INTRAMUSCULAR,QID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,HEPA-MERZ,ORNITHINE ASPARTATE,2011-05-04,2011-05-04,,2011-05-16,2011-05-16,,C,,1,PUFF,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,GLUTARGIN,ARGININE GLUTAMATE,2011-05-12,2011-05-12,,2011-05-31,2011-05-31,,C,,1,TABLET,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-05-19,2011-05-19,,2011-05-31,2011-05-31,,C,,1,BOTTLE,INTRAVENOUS,QD,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BERLITHION,THIOCTIC ACID,2011-05-12,2011-05-12,,2011-05-31,2011-05-31,,C,,300,mg,INTRAVENOUS,QD,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-04-27,2011-04-27,,2011-04-27,2011-04-27,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2011-03-10,2011-03-10,,2011-05-04,2011-05-04,,C,,10,mg,INTRAMUSCULAR,BID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,METAMISOLUM NATRICUM,METAMIZOLE SODIUM,2011-03-10,2011-03-10,,2011-05-04,2011-05-04,,C,,500,mg,INTRAMUSCULAR,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINUM,DIPHENHYDRAMINE,2011-03-10,2011-03-10,,2011-05-04,2011-05-04,,C,,1,mg,INTRAMUSCULAR,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TRAMADOLUM,TRAMADOL HYDROCHLORIDE,2011-04-05,2011-04-05,,2011-05-04,2011-05-04,,C,,50,mg,ORAL,TID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-04-13,2011-04-13,,2011-04-13,2011-04-13,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-04-20,2011-04-20,,2011-04-20,2011-04-20,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HEPABENE,HEPABENE,2011-04-28,2011-04-28,,2011-05-31,2011-05-31,,C,,1,TABLET,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE-PHOSPHOLIPIDS,PHOSPHOLIPIDS,2011-04-28,2011-04-28,,2011-05-31,2011-05-31,,C,,2,TABLET,ORAL,TID,HIGH LEVEL OF BILIRUBIN
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-07-08,2011-07-08,,2011-08-01,2011-08-01,,P,,0.4,mL,SUBCUTANEOUS,QD,TELA OF BOTH LUNGS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,50,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,50,mg,RECTAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DICLOFENAC,DICLOFENAC,2011-10-20,2011-10-20,,2011-10-21,2011-10-21,,C,,50,mg,RECTAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-25,2011-10-25,,2011-10-28,2011-10-28,,C,,0.2,mg,SUBCUTANEOUS,QD,TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ASPIGREL,NEFAZAN COMPUESTO,2011-10-29,2011-10-29,,,,,C,Y,100,mg,ORAL,QD,TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-10-26,2011-10-26,,2011-10-28,2011-10-28,,C,,50,mg,RECTAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-10-30,2011-10-30,,2011-10-30,2011-10-30,,C,,50,mg,RECTAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,WARFARINUM,WARFARIN,2011-08-05,2011-08-05,,2011-09-11,2011-09-11,,C,,1,TABLET,ORAL,QD,PROPHYLAXIS OF TROMBOEMBOLY
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-08,2011-11-08,,2011-11-08,2011-11-08,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-15,2011-11-15,,2011-11-15,2011-11-15,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,50,mg,RECTAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-11-08,2011-11-08,,2011-11-08,2011-11-08,,C,,100,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-11-15,2011-11-15,,2011-11-15,2011-11-15,,C,,100,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-08-10,2011-08-10,,2011-08-18,2011-08-18,,C,,0.4,mL,SUBCUTANEOUS,QD,TROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-07-29,2011-07-29,,,,,C,Y,50,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2011-08-10,2011-08-10,,2011-09-11,2011-09-11,,C,,1,TABLET,ORAL,BID,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-09-12,2011-09-12,,2011-10-04,2011-10-04,,C,,0.4,mL,SUBCUTANEOUS,BID,TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2011-09-12,2011-09-12,,,,,C,Y,2,TABLET,ORAL,TID,TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-05,2011-10-05,,,,,C,Y,0.4,mL,SUBCUTANEOUS,QD,TROMBOSIS
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DICLOFENACUM,DICLOFENAC,2011-09-30,2011-09-30,,,,,C,Y,50,mg,ORAL,BIS,ABDOMEN PAIN
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-08-16,2011-08-16,,2011-09-18,2011-09-18,,P,,50,mg,INTRAMUSCULAR,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2011-10-18,2011-10-18,,,,,C,Y,1,TABLET,ORAL,BID,DEEP VENOUS THROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,KSARELTO,RIVAROXABAN,2011-10-29,2011-10-29,,,,,C,Y,10,mg,ORAL,QD,DEEP VENOUS THROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,FERROUS SULFATE/ SERINE,FERROUS SULFATE,2011-11-01,2011-11-01,,2011-11-07,2011-11-07,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FERROUS SULFATE/ SERINE,SERINE,2011-11-01,2011-11-01,,2011-11-07,2011-11-07,,C,,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-11-12,2011-11-12,,2011-11-24,2011-11-24,,C,,2.0,mg,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SUPRADYN,MINERALS NOS W/VITAMINS NOS,2011-11-12,2011-11-12,,2011-11-24,2011-11-24,,C,,1,TABLET,ORAL,QD,ANEMIA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,NEOFILIN,THEOPHYLLINE,2011-11-12,2011-11-12,,2011-11-24,2011-11-24,,C,,300,mg,ORAL,QD,DYSPNEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,OMNOPON,OPIUM ALKALOIDS TOTAL,2011-09-19,2011-09-19,,,,,C,Y,1.0,mL,INTRAMUSCULAR,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-10-25,2011-10-25,,2011-10-25,2011-10-25,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ASPARCAM,TROPHICARD,2011-10-06,2011-10-06,,2011-10-10,2011-10-10,,C,,5,mL,INTRAVENOUS,QD,EDEMA OF BOTH FOOT
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,CORGLYCONUM,CONVALLATOXIN,2011-10-06,2011-10-06,,2011-10-10,2011-10-10,,C,,6,mg,INTRAVENOUS,QD,EDEMA OF BOTH FOOT
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,THIOTRIASOLINUM,THIOTRIAZOLINE,2011-10-06,2011-10-06,,2011-10-10,2011-10-10,,C,,100,mg,INTRAVENOUS,QD,EDEMA OF BOTH FOOT
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDUM,FUROSEMIDE,2011-10-06,2011-10-06,,2011-10-08,2011-10-08,,C,,40,mg,ORAL,QD,EDEMA OF BOTH FOOT
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,TRIFAS,TORASEMIDE,2011-10-17,2011-10-17,,2011-10-23,2011-10-23,,C,,10,mg,ORAL,QD,DEEP VENOUS THROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,UNGUENTUM HEPARINI,HEPARIN,2011-10-17,2011-10-17,,,,,C,Y,0.5,g,TOPICAL,TID,DEEP VENOUS THROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-10-18,2011-10-18,,2011-10-28,2011-10-28,,C,,0.8,mg,SUBCUTANEOUS,BID,DEEP VENOUS THROMBOSIS OF RIGHT LEG
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-01-31,2012-01-31,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2011-07-01,2011-07-01,,2011-12-13,2011-12-13,,C,,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDUM,LOPERAMIDE,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,C,,6,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDUM,LOPERAMIDE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,6,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LOPERAMIDUM,LOPERAMIDE,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,4,mg,ORAL,6 TIMES PER DAY,DIARRHEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2011-12-13,2011-12-13,,2011-12-14,2011-12-14,,C,,20,mg,INTRAVENOUS,QD,PROPHYLAXIS OF GASTRIC EROSION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,400,mL,INTRAVENOUS,QD,INFUSION OF CORGLUCONUM
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,6,IU,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ASPARKAM,TROPHICARD,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,10,mL,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CORGLYCONUM,CONVALLATOXIN,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,0.6,mg,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,200,mg,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,200,mg,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,VIS-NOL,TRIPOTASSIUM DICITRATOBISMUTHATE,2011-10-10,2011-10-10,,2011-11-10,2011-11-10,,P,,120,mg,ORAL,BID,GASTRIC ULCER
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINUM,DIPHENHYDRAMINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,10,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ATROPINI SULFAS,ATROPINE SULFATE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,1,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SUPRASTINI,CHLOROPYRAMINE HYDROCHLORIDE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,20,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,400,mL,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,6,IU,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ASPARKAM,TROPHICARD,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,10,mL,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,CORGLYCONUM,CONVALLATOXIN,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,0.6,mg,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ASCORBIS ACID,ASCORBIC ACID,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,200,mg,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,200,mg,INTRAVENOUS,BID,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PHENAZEPAM,PHENAZEPAM,2011-12-14,2011-12-14,,2011-12-15,2011-12-15,,C,,0.5,mg,ORAL,QD,PREPARATION FOR NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CONCOR,BISOPROLOL FUMARATE,2009,2009-12-31,M,,,,C,Y,5,mg,ORAL,QD,ISCHEMIC HEART DISEASE
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PROMEDOL,TRIMEPERIDINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,20,mg,INTRAVENOUS,QID,POSTOPERATIVE ANESTHESIA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PROMEDOL,TRIMEPERIDINE,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,20,mg,INTRAVENOUS,TID,POSTOPERATIVE ANESTHESIA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PROMEDOL,TRIMEPERIDINE,2011-12-17,2011-12-17,,2011-12-17,2011-12-17,,C,,20,mg,INTRAVENOUS,BID,POSTOPERATIVE ANESTHESIA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SIBAZONUM,DIAZEPAM,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,10,mg,INTRAVENOUS,QD,PREOPERATIVE PREPARATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,NATRII OXYBUTYRAS,OXYBATE SODIUM,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,2000,mg,INTRAVENOUS,QD,ANESTHESIA DURING OPERATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,FENTALYNUM,FENTANYL,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,0.05,mg,INTRAVENOUS,7 times per day,ANESTHESIA DURING OPERATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,KETAMINUM,KETAMINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,100,mg,INTRAVENOUS,QD,ANESTHESIA DURING OPERATION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,THIOPENTAL SODIUM,THIOPENTAL SODIUM,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,700,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,BLOOD PLASMA,BLOODPLASMA,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,250,mL,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,40,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,AMYLASE,2011-11-13,2011-11-13,,2011-11-22,2011-11-22,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,LIPASE,2011-11-13,2011-11-13,,2011-11-22,2011-11-22,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,TRYPSIN,2011-11-13,2011-11-13,,2011-11-22,2011-11-22,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,ARCURON (PIPECURONIUM BROMIDE),PIPECURONIUM BROMIDE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,1,mg,INTRAVENOUS,QID,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,DIPROFOL,PROPOFOL,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,400,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,RCURON (PIPECURONIUM BROMIDE),PIPECURONIUM BROMIDE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,4,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,DITHYLIN,SUXAMETHONIUM CHLORIDE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,100,mg,INTRAVENOUS,QD,NARCOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,PENTOXYPHYLLINUM,PENTOXIFYLLINE,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,100,mg,INTRAVENOUS,QD,PROPHYLAXIS OF ANASTOMOTIC FAILURE
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-12-16,2011-12-16,,2011-12-16,2011-12-16,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF POSTOPERATIVE TROMBOSIS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mL,INTRAVENOUS,BID,INFUSION OF CORGLYCONUM
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,6,IU,INTRAVENOUS,BID,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,ASPARKAM,TROPHICARD,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,20,mL,INTRAVENOUS,BID,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,CORGLYCONUM,CONVALLATOXIN,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,0.3,mg,INTRAVENOUS,BID,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-22,2011-11-22,,2011-11-22,2011-11-22,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONUM,CEFTRIAXONE,2011-12-15,2011-12-15,,2011-12-16,2011-12-16,,C,,1000,mg,INTRAVENOUS,BID,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2011-12-15,2011-12-15,,2011-12-16,2011-12-16,,C,,20,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,ASCORBIC ACID,ASCORBIC ACID,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,50,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2011-12-15,2011-12-15,,2011-12-16,2011-12-16,,C,,200,mL,INTRAVENOUS,QD,INFUSION OF GEERDIN
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,THIOTRIAZOLINUM,THIOTRIAZOLINE,2011-12-15,2011-12-15,,2011-12-16,2011-12-16,,C,,50,mg,INTRAMUSCULAR,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,CALCII CHLORIDI,CALCIUM CHLORIDE DIHYDRATE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,1000,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,THIAMINE,THIAMINE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,50,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL,CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mL,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL,EL-4,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mL,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL,SODIUM LACTATE,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mL,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE + CALCIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM LACTATE + SODIUM CHLORIDE + SORBITOL,SORBITOL,2011-12-15,2011-12-15,,2011-12-15,2011-12-15,,C,,200,mL,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONUM,CEFTRIAXONE,2011-12-16,2011-12-16,,2011-12-18,2011-12-18,,C,,1000,mg,INTRAVENOUS,TID,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,ISLA-MINT (CETRARIA ISLANDICA),CETRARIA ISLANDICA,2011-09-01,2011-09-01,,2011-12-13,2011-12-13,,C,,100,mg,ORAL,QD,CHRONIC COUGH
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONUM,CEFTRIAXONE,2011-12-19,2011-12-19,,2011-12-19,2011-12-19,,C,,1000,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2011-12-16,2011-12-16,,2011-12-19,2011-12-19,,C,,20,mg,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2011-12-16,2011-12-16,,2011-12-19,2011-12-19,,C,,200,mL,INTRAVENOUS,QD,INFUSION OF GEERDIN
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,GORDOX,APROTININ,2011-12-16,2011-12-16,,2011-12-17,2011-12-17,,C,,10,mL,INTRAVENOUS,QD,PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,OMIKS,TAMSULOSIN HYDROCHLORIDE,2011-12-30,2011-12-30,,2012-01-04,2012-01-04,,C,,0.4,mg,ORAL,QD,PROSTATE ADENOMA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,68.0,CONCOMITANT MEDICATIONS,,,PROSTAN  FINASTERIDE,FINASTERIDE,2011-12-30,2011-12-30,,2012-01-04,2012-01-04,,C,,5,mg,ORAL,QD,PROSTATE ADENOMA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,69.0,CONCOMITANT MEDICATIONS,,,DROTAVERIN,DROTAVERINE HYDROCHLORIDE,2012-01-07,2012-01-07,,,,,C,Y,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,70.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,AMYLASE,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,71.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,LIPASE,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,72.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,TRYPSIN,2012-01-07,2012-01-07,,2012-01-08,2012-01-08,,C,,2,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREAS FUNCTION
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,73.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-11-23,2011-11-23,,2011-11-25,2011-11-25,,C,,5,mg,ORAL,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,74.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,75.0,CONCOMITANT MEDICATIONS,,,CERUCAL,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,2,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2011-11-22,2011-11-22,,2011-11-27,2011-11-27,,P,,1,AMPULE,INTRAMUSCULAR,TID,BACK PAIN
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,VIKASOLUM,MENADIONE SODIUM BISULFITE,2011-11-30,2011-11-30,,2011-12-06,2011-12-06,,P,,1,mg,INTRAMUSCULAR,TID,PROPHYLAXIS OF HEMORRHAGE
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ETAMSYLATIIM,ETAMSILATE,2011-11-30,2011-11-30,,2011-12-06,2011-12-06,,P,,2.0,mL,INTRAMUSCULAR,TID,PROPHYLAXIS OF HEMORRHAGE
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CALCIUM CHLORIDE DIHYDRATE,CALCIUM CHLORIDE DIHYDRATE,2011-11-30,2011-11-30,,2011-12-02,2011-12-02,,P,,1000,mg,INTRAVENOUS,TID,PROPHYLAXIS ALLERGY ON FRESH FROZEN PLASMA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TRIMEPERIDINE,TRIMEPERIDINE,2011-11-30,2011-11-30,,2011-12-01,2011-12-01,,P,,20,mg,INTRAMUSCULAR,QD,BACK PAIN
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,FRESH FROZEN PLASMA,PLASMA,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,P,,290,mL,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACINUM,CIPROFLOXACIN,2011-12-14,2011-12-14,,2011-12-15,2011-12-15,,C,,750,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,FERRUMLEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011-12-14,2011-12-14,,2011-12-19,2011-12-19,,C,,2.0,mL,INTRAMUSCULAR,QD,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,325,mg,ORAL,BID,HYPERTERMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TRAMADOLUM,TRAMADOL HYDROCHLORIDE,2011-11-28,2011-11-28,,,,,C,Y,100,mg,INTRAMUSCULAR,QD,BACK PAIN
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-27,2011-12-27,,2011-12-27,2011-12-27,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-12-27,2011-12-27,,2011-12-28,2011-12-28,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-12-27,2011-12-27,,2011-12-27,2011-12-27,,C,,325,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2011-12-21,2011-12-21,,,,,C,Y,1,TABLET,ORAL,BID,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,8,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-01-10,2012-01-10,,2012-01-11,2012-01-11,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-01-11,2012-01-11,,,,,C,Y,4,mg,INTRAMUSCULAR,BID,SUBCOMPENSATED STOMACH STENOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMID,METOCLOPRAMIDE,2012-01-11,2012-01-11,,,,,C,Y,40,mg,INTRAMUSCULAR,BID,SUBCOMPENSATED STOMACH STENOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2012-01-11,2012-01-11,,,,,C,Y,40,mg,INTRAMUSCULAR,QD,SUBCOMPENSATED STOMACH STENOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-01-17,2012-01-17,,2012-01-18,2012-01-18,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,P,,180,mL,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-01-24,2012-01-24,,2012-01-25,2012-01-25,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONUM,CEFTRIAXONE,2012-02-03,2012-02-03,,2012-02-08,2012-02-08,,C,,1,g,INTRAMUSCULAR,BID,HYPERTERMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,P,,180,mL,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,P,,513,mL,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,P,,4,mg,INTRAVENOUS,QD,PROPHYLAXIS ALLERGY ON PACKED RED BLOOD CELLS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-02,2011-12-02,,2011-12-02,2011-12-02,,P,,4,mg,INTRAVENOUS,QD,PROPHYLAXIS ALLERGY ON PACKED RED BLOOD CELLS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,P,,4,mg,INTRAVENOUS,QD,PROPHYLAXIS ALLERGY ON PACKED RED BLOOD CELLS
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,QUAMATEL,FAMOTIDINE,2011-11-30,2011-11-30,,2011-12-03,2011-12-03,,P,,20,mg,INTRAVENOUS,BID,PROPHYLAXIS OF HEMORRHAGE
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ANTRALUM,LIVER THERAPY,2011-11-02,2011-11-02,,2011-11-27,2011-11-27,,P,,200,mg,ORAL,BID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-06,2011-12-06,,2011-12-06,2011-12-06,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ANTRAL,LIVER THERAPY,2011-11-30,2011-11-30,,,,,C,Y,200,mg,ORAL,TID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-12-10,2011-12-10,,2011-12-10,2011-12-10,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,12,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2011-12-13,2011-12-13,,,,,C,Y,1,TABLET,ORAL,BID,TROMBOSIS OF DEEP VEINS
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2011-12-29,2011-12-29,,2012-01-04,2012-01-04,,C,,0.2,mL,INTRAMUSCULAR,BID,"TROMBOSIS, TELA"
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,KSARELTO,RIVAROXABAN,2012-01-05,2012-01-05,,,,,C,Y,10,mg,ORAL,QD,"TROMBOSIS, TELA"
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-01-19,2012-01-19,,2012-01-20,2012-01-20,,C,,325,mg,ORAL,BID,HYPERTERMIA
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CAPTOPRES,CAPOZIDE,2012-01-19,2012-01-19,,,,,C,Y,1,TABLET,ORAL,QD,AGGRAVATION OF HYPERTENSION
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-01-19,2012-01-19,,,,,C,Y,1,AMPULE,INTRAMUSCULAR,BID,BACK PAIN
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,BERLIPRILUM,ENALAPRIL MALEATE,2006-08-19,2006-08-19,,,,,C,Y,5,mg,ORAL,BID,HYPERTENSION DISEASE
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,CARDIOMAGNIL,MAGNYL                             /02350501/,2006-08-19,2006-08-19,,,,,C,Y,1,TABLET,ORAL,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2011-11-27,2011-11-27,,2011-11-27,2011-11-27,,P,,10,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DROTAVERINUM,DROTAVERINE HYDROCHLORIDE,2011-11-22,2011-11-22,,2011-11-26,2011-11-26,,P,,80,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,OINTMENT PREDNISOLONUM,PREDNISOLONE,2011-11-02,2011-11-02,,2011-11-25,2011-11-25,,P,,250,mg,TRANSDERMAL,BID,RASH ON LEGS AND HANDS
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2011-11-30,2011-11-30,,2011-12-02,2011-12-02,,C,,5,mg,ORAL,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-06-12,2012-06-12,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,PANZINORM,PANZYNORM,2011-10-14,2011-10-14,,2012-01-14,2012-01-14,,C,,20000,IU,ORAL,QD,PROPHYLAXIS OF PANCREATIC FAILURE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-21,2011-12-21,,2011-12-22,2011-12-22,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,CAPTOPRES,CAPOZIDE,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,1,TABLET,ORAL,QD,HIGH LEVEL OF AT
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2011-12-26,2011-12-26,,2012-02-01,2012-02-01,,C,,1,TABLET,ORAL,BID,PROPHYLAXIS OF HEPATOTOXICITY
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,AFLUBIN,HOMEOPATHIC PREPARATION,2012-01-01,2012-01-01,,2012-01-03,2012-01-03,,C,,10,gtt,ORAL,BID,INFLUENZA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,FARINGOSEPT,AMBAZONE,2012-01-02,2012-01-02,,2012-01-05,2012-01-05,,C,,1,TABLET,ORAL,QID,INFLUENZA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,IMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-01-10,2012-01-10,,2012-01-12,2012-01-12,,C,,2,mg,ORAL,QID,DIARRHEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-01-15,2012-01-15,,,,,C,Y,1,TABLET,ORAL,BID,PROPHYLAXIS OF PANCREATIC FAILURE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,BIFIDUMBACTERINUM,BIFIDOBACTERIUM BIFIDUM,2012-01-14,2012-01-14,,,,,C,Y,1,PUFF,ORAL,QD,PROPHYLAXIS OF DIARRHEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-02-11,2012-02-11,,2012-02-11,2012-02-11,,C,,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,BIFIFORM,IDOFORM,2011-11-28,2011-11-28,,2012-01-14,2012-01-14,,C,,2,TABLET,ORAL,BID,SECRETORY DIARRHEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-10,2012-02-10,,2012-02-14,2012-02-14,,C,,1,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREATIC FAILURE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,HEPTRAL,ADEMETIONINE,2012-02-15,2012-02-15,,,,,C,Y,1,TABLET,ORAL,BID,PROPHYLAXIS OF HEPATOTOXICITY
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,KREON,PANCREATIN,2012-02-15,2012-02-15,,,,,C,Y,1,TABLET,ORAL,TID,PROPHYLAXIS OF PANCREATIC FAILURE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-02-18,2012-02-18,,2012-02-18,2012-02-18,,C,,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,OMEGA 3,FISH OIL,2012-03-05,2012-03-05,,2012-03-12,2012-03-12,,C,,1,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREATIC FAILURE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,TRAMADOLUM,TRAMADOL HYDROCHLORIDE,2012-03-08,2012-03-08,,2012-03-13,2012-03-13,,C,,50,mg,ORAL,BID,ABDOMEN PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-03-29,2012-03-29,,2012-04-03,2012-04-03,,C,,100,mg,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-04-04,2012-04-04,,,,,C,Y,100,mg,ORAL,TID,PROPHYLAXIS OF ANEMIA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2012-03-30,2012-03-30,,2012-03-31,2012-03-31,,C,,10,mg,ORAL,QD,LEFT BACK PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-03-30,2012-03-30,,2012-03-31,2012-03-31,,C,,1,TABLET,ORAL,QD,LEFT BACK PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,ENTEROSGELUM (ACIDUM METHYLSILICONICUM),INTESTINAL ADSORBENTS,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,P,,30,mL,ORAL,QS,SECRETORY DIARRHEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2012-05-08,2012-05-08,,2012-05-08,2012-05-08,,C,,10,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,XARELTO,RIVAROXABAN,2011-12-01,2011-12-01,,,,,C,Y,10,mg,ORAL,QD,PROPHYLAXIS OF TROMBOSIS
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,PAPAVERINE,PAPAVERINE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,P,,20,mg,INTRAMUSCULAR,QD,AGGRAVATION OF HYPERTENSION DISEASE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,DIBAZOL,BENDAZOL HYDROCHLORIDE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,P,,10,mg,INTRAMUSCULAR,QD,AGGRAVATION OF HYPERTENSION DISEASE
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ONDASETRON,ONDANSETRON,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,8,mg,INTRAVENOUS,QD,PROPHYLAXIS OF NAUSEA
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2011-12-21,2011-12-21,,2011-12-21,2011-12-21,,C,,1,AMPULE,INTRAMUSCULAR,QD,HEADACHE
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ANAPRILINUM,PROPRANOLOL HYDROCHLORIDE,2011-12-25,2011-12-25,,2012-02-07,2012-02-07,,C,,40,mg,ORAL,QD,ESOPHAGEAL VARICOSE VEINS DILATATION
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-02-02,2012-02-02,,2012-02-02,2012-02-02,,C,,4,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-02-03,2012-02-03,,2012-02-04,2012-02-04,,C,,4,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,BIFI-FORM,IDOFORM,2012-02-02,2012-02-02,,2012-02-05,2012-02-05,,C,,1,TABLET,ORAL,QD,PROPHYLAXIS OF PANCREATIC INSUFFICIENCY
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,REHYDRON,REHYDRON,2012-02-02,2012-02-02,,2012-02-04,2012-02-04,,C,,1,PUFF,ORAL,QD,PROPHYLAXIS OF DEHYDRATION
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE +,POTASSIUM CHLORIDE,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,200,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE +,POTASSIUM CHLORIDE,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,200,mL,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT - POTASSIUM CHLORIDE +,POTASSIUM CHLORIDE,2012-02-10,2012-02-10,,2012-02-13,2012-02-13,,C,,200,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,XYLOSE,XYLOSE,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,200,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,XYLOSE,XYLOSE,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,200,mL,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,XYLOSE,XYLOSE,2012-02-10,2012-02-10,,2012-02-13,2012-02-13,,C,,200,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,AMYLASE,2011-12-30,2011-12-30,,2012-01-22,2012-01-22,,P,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,LIPASE,2011-12-30,2011-12-30,,2012-01-22,2012-01-22,,P,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,TRYPSIN,2011-12-30,2011-12-30,,2012-01-22,2012-01-22,,P,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BERLITHION,THIOCTIC ACID,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,600,mg,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,BERLITHION,THIOCTIC ACID,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,600,mg,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,200,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,200,mL,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,GLUCOSUM,GLUCOSE,2012-02-10,2012-02-10,,2012-02-13,2012-02-13,,C,,400,mL,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,6,IU,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,6,IU,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,INSULINUM,INSULIN ISOPHANE PORCINE,2012-02-10,2012-02-10,,2012-02-13,2012-02-13,,C,,6,IU,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2012-02-06,2012-02-06,,2012-02-07,2012-02-07,,C,,2,mg,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,2,mg,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PANZYNORM,PANZYNORM,2012-01-14,2012-01-14,,2012-01-22,2012-01-22,,P,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2012-02-10,2012-02-10,,2012-02-13,2012-02-13,,C,,2,mg,INTRAVENOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,GEERDIN,RABEPRAZOLE SODIUM,2012-02-07,2012-02-07,,2012-02-09,2012-02-09,,C,,20,mg,INTRAVENOUS,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,BARALGETAS,BARALGINA,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,1,AMPULE,INTRAMUSCULAR,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-02-06,2012-02-06,,2012-02-06,2012-02-06,,C,,0.2,mL,SUBCUTANEOUS,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ATROPINI SULFAS,ATROPINE SULFATE,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,1,mg,INTRAMUSCULAR,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ANALGINUM,METAMIZOLE SODIUM,2012-02-07,2012-02-07,,2012-02-10,2012-02-10,,C,,500,mg,INTRAMUSCULAR,QD,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINUM NATRII,DIPHENHYDRAMINE,2012-02-07,2012-02-07,,2012-02-10,2012-02-10,,C,,1,mg,INTRAMUSCULAR,BID,PROGRESSIVE OF PANCREATIC CANCER
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,BIFI-RORM,IDOFORM,2012-01-18,2012-01-18,,2012-01-22,2012-01-22,,P,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,PANZYNORM,PANZYNORM,2012-01-23,2012-01-23,,2012-01-27,2012-01-27,,C,,3,TABLET,ORAL,TID,PROPHYLAXIS OF DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,BIFI-FORM,IDOFORM,2012-01-23,2012-01-23,,2012-01-27,2012-01-27,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS OF DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,AMYLASE,2012-01-27,2012-01-27,,2012-02-02,2012-02-02,,C,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,LIPASE,2012-01-27,2012-01-27,,2012-02-02,2012-02-02,,C,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,TRYPSIN/ LIPASE/ AMYLASE,TRYPSIN,2012-01-27,2012-01-27,,2012-02-02,2012-02-02,,C,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,BIFI-FORM,IDOFORM,2012-01-27,2012-01-27,,2012-02-01,2012-02-01,,C,,1,TABLET,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOLUM,ALLOPURINOL,2012-01-27,2012-01-27,,,,,C,Y,1,TABLET,ORAL,TID,PROPHYLAXIS OF UROLITHIASIS
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2012-05-16,2012-05-16,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DICLOBERL,DICLOFENAC SODIUM,2011-12-14,2011-12-14,,2012-03-05,2012-03-05,,C,,100,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ESSENTIALE (PHOSPHOLIPIDS),PHOSPHOLIPIDS,2012-04-17,2012-04-17,,,,,C,Y,2,TABLET,ORAL,TID,HIGH LEVEL OF ALT (CLINICAL SIGNIFICANT)
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HEPABENE,HEPABENE,2012-04-17,2012-04-17,,,,,C,Y,1,TABLET,ORAL,TID,HIGH LEVEL OF ALT (CLINICAL SIGNIFICANT)
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2012-03-13,2012-03-13,,2012-03-14,2012-03-14,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2012-03-28,2012-03-28,,2012-03-30,2012-03-30,,C,,5,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DICLOBERL,DICLOFENAC SODIUM,2012-04-01,2012-04-01,,2012-04-01,2012-04-01,,C,,100,mg,ORAL,QD,PAIN IN THE SPINE
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2012-04-10,2012-04-10,,2012-04-13,2012-04-13,,C,,5,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DICLOBERL,DICLOFENAC SODIUM,2012-04-08,2012-04-08,,2012-04-08,2012-04-08,,C,,100,mg,ORAL,QD,PAIN IN THE SPINE
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TROPISETRON,TROPISETRON,2012-04-04,2012-04-04,,2012-04-06,2012-04-06,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DICLOBERL,DICLOFENAC SODIUM,2012-04-22,2012-04-22,,2012-04-22,2012-04-22,,C,,100,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,"DOLAREN  PARACETAMOL, DICLOFENAC SODIUM",PARACETAMOL FORTE RAFFO,2011-12-27,2011-12-27,,2012-02-28,2012-02-28,,C,,1,TABLET,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,XARELTO,RIVAROXABAN,2012-03-20,2012-03-20,,,,,C,Y,15,mg,ORAL,BID,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-04-02,2012-04-02,,2012-04-04,2012-04-04,,C,,0.4,mL,SUBCUTANEOUS,QD,MEDIAL SURAL VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-04-09,2012-04-09,,2012-04-09,2012-04-09,,C,,325,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2012-04-09,2012-04-09,,2012-04-09,2012-04-09,,C,,10,mg,ORAL,QD,ANESTESIA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-04-02,2012-04-02,,2012-04-04,2012-04-04,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDI,METOCLOPRAMIDE,2012-04-13,2012-04-13,,,,,C,Y,40,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-04-09,2012-04-09,,2012-04-11,2012-04-11,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,KETORAL,KETOCONAZOLE,2012-04-23,2012-04-23,,,,,C,Y,10,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-04-17,2012-04-17,,2012-04-19,2012-04-19,,C,,325,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-04-24,2012-04-24,,2012-04-26,2012-04-26,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,KETOROL,KETOROLAC TROMETHAMINE,2011-12-27,2011-12-27,,2012-02-20,2012-02-20,,P,,10,mg,ORAL,QD,ABDOMEN PAIN
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2012-04-18,2012-04-18,,,,,C,Y,1,TABLET,ORAL,BID,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-04-24,2012-04-24,,2012-05-05,2012-05-05,,C,,325,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,ASAPHEN,ACETYLSALICYLIC ACID,2012-04-25,2012-04-25,,,,,C,Y,1,TABLET,ORAL,QD,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACINUM,CIPROFLOXACIN,2012-05-03,2012-05-03,,2012-05-07,2012-05-07,,C,,750,mg,ORAL,BID,HYPERTERMIA
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-05-08,2012-05-08,,2012-05-09,2012-05-09,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS OF THROMBOSIS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,ENALAPRILUM,ENALAPRIL,2011-11-01,2011-11-01,,,,,C,Y,1,TABLET,ORAL,QD,HYPERTENSION DISEASE
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,CLEXANE,ENOXAPARIN SODIUM,2012-02-21,2012-02-21,,2012-03-02,2012-03-02,,C,,0.4,mL,SUBCUTANEOUS,BID,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DETRALEX,CAPIVEN,2012-02-21,2012-02-21,,2012-04-17,2012-04-17,,C,,1,TABLET,ORAL,BID,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,LIOTON,HEPARIN SODIUM,2012-02-21,2012-02-21,,2012-04-17,2012-04-17,,C,,5,g,TOPICAL,BID,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,INDOVASIN,INDOVASIN,2012-02-21,2012-02-21,,2012-04-17,2012-04-17,,C,,5,g,TOPICAL,BID,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ASAPHEN,ACETYLSALICYLIC ACID,2012-02-21,2012-02-21,,2012-04-17,2012-04-17,,C,,1,TABLET,ORAL,QD,DEEP VENOUS THROMBOSIS OF BOTH LEGS
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2012-02-28,2012-02-28,,2012-02-28,2012-02-28,,C,,325,mg,ORAL,QD,HYPERTERMIA
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-01-25,2011-01-25,,2011-04-10,2011-04-10,,C,,5,mL,INTRAMUSCULAR,QD,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-02-29,2012-02-29,,2012-03-06,2012-03-06,,C,,2000,IU,SUBCUTANEOUS,TIS,ANEMIA
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,EPOETIN ALFA,EPOETIN ALFA,2012-03-28,2012-03-28,,,,,C,Y,2000,IU,SUBCUTANEOUS,TIS,ANEMIA
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-04-07,2011-04-07,,,,,C,Y,8.0,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-04-07,2011-04-07,,,,,C,Y,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ACETYLSALICYLIC ACID + MAGNESIUM HYDROXIDE,MAGNYL                             /02350501/,2011-05-06,2011-05-06,,,,,C,Y,75,mg,ORAL,QD,THROMBOCYTOSIS
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN SODIUM,ENOXAPARIN SODIUM,2011-05-11,2011-05-11,,2011-05-18,2011-05-18,,C,,40,mg,SUBCUTANEOUS,QD,THROMBOCYTOSIS
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN,,2011-07-27,2011-07-27,,2011-07-27,2011-07-27,,,,,,,,
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FLUOROURACIL,,2011-07-25,2011-07-25,,2011-07-27,2011-07-27,,,,,,,,
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,LEUCOVORIN,,2011-07-25,2011-07-25,,2011-07-27,2011-07-27,,,,,,,,
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,BARALGINUM,BARALGINA,2011-04-12,2011-04-12,,,,,C,Y,5.0,mL,INTRAMUSCULAR,PRN,WITH PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2011-04-12,2011-04-12,,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,WITH PAIN IN EPIGASTRIUM
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-05-18,2011-05-18,,2011-07-13,2011-07-13,,C,,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-05-18,2011-05-18,,2011-07-13,2011-07-13,,C,,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-004,01084004,084,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,SOLPADEINE,SOLPADEINE                         /00154101/,2011-05,2011-04-30,D,2011-09-04,2011-09-04,,C,,1,TABLET,ORAL,PRN,"EPIGASTRIC PAIN, LOWER BACK"
CO-101-001,CO-101-001-084-004,01084004,084,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-07-13,2011-07-13,,2011-08-23,2011-08-23,,C,,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-004,01084004,084,57.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-13,2011-07-13,,2011-08-23,2011-08-23,,C,,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DEXKETOPROFEN,DEXKETOPROFEN,2011-06-06,2011-06-06,,,,,C,Y,25,mg,ORAL,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,BARALGINUM,BARALGINA,2011-06-06,2011-06-06,,,,,C,Y,5,mL,INTRAMUSCULAR,QHS,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-10-05,2011-10-05,,,,,C,Y,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-05,2011-10-05,,,,,C,Y,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DEXKETOPROFEN,DEXKETOPROFEN,2012-01-22,2012-01-22,,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PARECOXIB,PARECOXIB,2012-01-22,2012-01-22,,,,,C,Y,40,mg,INTRAMUSCULAR,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-007,01084007,084,75.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATIN+FLUOROURACIL,,2012-10-09,2012-10-09,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-084-007,01084007,084,75.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2011-10,2011-09-30,D,,,,C,Y,10,mg,ORAL,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-007,01084007,084,75.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-21,2011-12-21,,,,,C,Y,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-007,01084007,084,75.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-21,2011-12-21,,,,,C,Y,16,mg,ORAL,QS,PREMEDICATION
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,CARDIOMAGNYL,MAGNYL                             /02350501/,2011-09,2011-08-31,D,,,,C,Y,75,mg,ORAL,QD,FORWARD HEART FAILURE
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,METAMIZOLE SODIUM+PITOFENONE+FENPIVERINIUM BROMIDE,FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011-09,2011-08-31,D,,,,C,Y,5.0,mL,INTRAMUSCULAR,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-21,2011-12-21,,,,,C,Y,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-21,2011-12-21,,,,,C,Y,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FERRI (III) HYDROXYDI POLYMALTOSUM COMPLEXUS,FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2012-01-11,2012-01-11,,2012-01-25,2012-01-25,,C,,100,mg,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ENOXAPARIN SODIUM,ENOXAPARIN SODIUM,2012-01-25,2012-01-25,,2012-02-01,2012-02-01,,C,,40,mg,SUBCUTANEOUS,QD,THROMBOCYTOSIS
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KETOPROFEN,KETOPROFEN,2012-02-05,2012-02-05,,,,,C,Y,2.0,mL,INTRAMUSCULAR,TID,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-010,01084010,084,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2011-11,2011-10-31,D,,,,C,Y,10,mg,ORAL,PRN,EPIGASTRIC PAIN
CO-101-001,CO-101-001-084-010,01084010,084,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2011-12-28,2011-12-28,,,,,C,Y,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-010,01084010,084,55.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,N,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-12-28,2011-12-28,,,,,C,Y,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-011,01084011,084,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-01-25,2012-01-25,,,,,C,Y,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-011,01084011,084,64.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-01-25,2012-01-25,,,,,C,Y,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-084-012,01084012,084,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-07,2012-03-07,,2012-03-14,2012-03-14,,C,,16,mg,INTRAVENOUS,QS,PREMEDICATION
CO-101-001,CO-101-001-084-012,01084012,084,62.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONUM,DEXAMETHASONE,2012-03-07,2012-03-07,,2012-03-14,2012-03-14,,C,,8,mg,INTRAMUSCULAR,QS,PREMEDICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,5% GLUCOSE,GLUCOSE,2011-04-18,2011-04-18,,,,,C,Y,400,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,SOL. AMINIPHYLLINE 2.4%,AMINOPHYLLINE,2011-04-18,2011-04-18,,,,,C,Y,5,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-05-04,2011-05-04,,2011-05-04,2011-05-04,,C,,278,mL,INTRAVENOUS,ONCE,TREATMENT OF ANEMIA
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-05-05,2011-05-05,,2011-05-05,2011-05-05,,C,,273,mL,INTRAVENOUS,ONCE,TREATMENT OF ANEMIA
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,KURANTIL,DIPYRIDAMOLE,2011-04-18,2011-04-18,,,,,C,Y,2,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SPASMALGON (METHAMIZOL NATRIYA+FENPIVIRIN BROMIDI+PITOFENON GIDROCHLORID),FENPIVERINIUM BR W/METAMIZOLE SOD/PITOFENONE,2011,2011-04-18,M,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,ANALGESIA
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,FERRUM LEK (FERRI HYDROXYDI POLYMALTOSUM COMPLEXUS),FERRIC HYDROXIDE POLYMALTOSE COMPLEX,2011,2011-04-18,M,,,,C,Y,100,mg,INTRAMUSCULAR,PRN,PROFILAXIC ANEMIA
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,EPREX (E-POETIN ALFA),EPOETIN ALFA,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,2000,IU,INTRAVENOUS,ONCE,HAEMOSTIMYLATOR
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,SOLUTIO RINGER,RINGER                             /01179901/,2011-04-18,2011-04-18,,,,,C,Y,400,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,0.9% NACL,SODIUM CHLORIDE,2011-04-18,2011-04-18,,,,,C,Y,400,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (SORBITOLI+SODIUM LACTATE+CALCIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE),CALCIUM CHLORIDE W/MAGNESIUM CHLORIDE,2011-04-18,2011-04-18,,,,,C,Y,200,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (SORBITOLI+SODIUM LACTATE+CALCIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE),POTASSIUM CHLORIDE,2011-04-18,2011-04-18,,,,,C,Y,200,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (SORBITOLI+SODIUM LACTATE+CALCIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE),SODIUM LACTATE,2011-04-18,2011-04-18,,,,,C,Y,200,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,REOSORBILACT (SORBITOLI+SODIUM LACTATE+CALCIUM CHLORIDE+POTASSIUM CHLORIDE+MAGNESIUM CHLORIDE),SORBITOL,2011-04-18,2011-04-18,,,,,C,Y,200,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OSETRON,ONDANSETRON HYDROCHLORIDE,2011-04-18,2011-04-18,,,,,C,Y,8,mg,INTRAVENOUS,before eath infusion,PROPHILAXIS VOMITING
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,VIT C,ASCORBIC ACID,2011-04-18,2011-04-18,,,,,C,Y,5,mL,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,HEPADIF,HEPADIF                            /00799501/,2011-04-18,2011-04-18,,,,,C,Y,439.25,mg,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,KORGLICON (CONVALLARIAE GLYCOSIDE),CONVALLARIA MAJALIS EXTRACT,2011-04-18,2011-04-18,,,,,C,Y,1,mg,INTRAVENOUS,before eath infusion,DEINTOXICATION
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,KETANOV,KETOROLAC TROMETHAMINE,2011,2011-04-18,M,,,,C,Y,2.0,mL,INTRAMUSCULAR,PRN,ANALGESIA
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ONDASETRONI,ONDANSETRON,2011-05-11,2011-05-11,,,,,C,Y,8,mg,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GLIBENCLAMIDUM,GLIBENCLAMIDE,1996,1996-12-31,M,,,,C,Y,3.5,mg,ORAL,QD,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KETOROLAC,KETOROLAC,2011-05-18,2011-05-18,,,,,C,Y,10,mg,ORAL,PRN,PEIN
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHAZONE,DEXAMETHASONE,2011-05-11,2011-05-11,,,,,C,Y,8,mg,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,EUPHIYLLINUM (2.4%),AMINOPHYLLINE,2011-05-11,2011-05-11,,,,,C,Y,5,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CONVALLARIAE GLYCOZIDE,CONVALLARIA MAJALIS EXTRACT,2011-05-11,2011-05-11,,,,,C,Y,1,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MILDRONATE,MELDONIUM,2011-05-11,2011-05-11,,,,,C,Y,5,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PANANGIN,TROPHICARD,2011-05-11,2011-05-11,,,,,C,Y,10,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,RIBOXINUM,INOSINE,2011-05-11,2011-05-11,,,,,C,Y,5,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,"HEPADIF - CARNITINE OROTATE, CARNITINE HYDROCHLORIDE, ANTITOXIC FRACTION OF THE EXTRACT OF THE LIVER, ADENOSINE, PYRIDOXINE HYDROCHLORIDE, TSIANKOBALAMIN",HEPADIF                            /00799501/,2011-05-11,2011-05-11,,2012-07-18,2012-07-18,,C,,1,VIAL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DIPYRIDAMOLE,DIPYRIDAMOLE,2011-05-11,2011-05-11,,,,,C,Y,2,mL,INTRAVENOUS,before each chemotherapy,PREMEDICATION
CO-101-001,CO-101-001-086-003,01086003,086,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXALGIN,DEXKETOPROFEN TROMETAMOL,2010-10,2010-09-30,D,,,,C,Y,50,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-086-003,01086003,086,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,OSETRON,ONDANSETRON HYDROCHLORIDE,2010-12-02,2010-12-02,,2011-01-06,2011-01-06,,C,,8,mg,INTRAVENOUS,QS,"NAUSEA, VOMMITING"
CO-101-001,CO-101-001-086-003,01086003,086,63.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINUM HYDROCHLORICUM,MORPHINE HYDROCHLORIDE,2011-01-19,2011-01-19,,,,,C,Y,10,mg,SUBCUTANEOUS,QD,SEVERE PAIN AS RESULT DISEASE PROGRESSION
CO-101-001,CO-101-001-086-004,01086004,086,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KETANOV (KETOROLAC),KETOROLAC,2011-03-16,2011-03-16,,,,,C,Y,30,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-086-004,01086004,086,50.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEXALGIN (DEXKETOPROPHEN),DEXKETOPROFEN,2011-03-16,2011-03-16,,,,,C,Y,25,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-086-005,01086005,086,58.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,AMARYL,GLIMEPIRIDE,2010-12,2010-11-30,D,,,,C,Y,2,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETASONE,DEXAMETHASONE,2011-05-30,2011-05-30,,2011-05-31,2011-05-31,,C,,8,mg,INTRAVENOUS,BID,CORRECTION OF VITAL FUNCTION
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,HYDROXYETHYLAMYLON 6 %,HETASTARCH,2011-05-30,2011-05-30,,2011-05-31,2011-05-31,,C,,500,mL,INTRAVENOUS,QD,CORRECTION OF VITAL FUNCTION
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ISOTINIC SOLUTION OF CHLORICUM SODIUM,SODIUM CHLORIDE,2011-05-30,2011-05-30,,2011-05-31,2011-05-31,,C,,800,mL,INTRAVENOUS,QD,CORRECTION OF VITAL FUNCTION
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-05-17,2011-05-17,,2011-05-31,2011-05-31,,C,,10,mg,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2011-05-17,2011-05-17,,2011-05-31,2011-05-31,,C,,30,mg,INTRAMUSCULAR,QD,PAIN
CO-101-001,CO-101-001-086-007,01086007,086,74.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2011-03,2011-02-28,D,,,,C,Y,10,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-086-008,01086008,086,49.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,KETOROLAK,KETOROLAC TROMETHAMINE,2011-05,2011-04-30,D,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-086-008,01086008,086,49.0,YEARS,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,EPREX 2000,EPOETIN ALFA,2011-08-23,2011-08-23,,,,,C,Y,2000,IU,SUBCUTANEOUS,3 time on week,ANEMIA
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"FOLFIRINOX : FLUORO-URACILE, OXALIPLATINE AND IRINOTECAN",,2011-08-04,2011-08-04,,2011-09-15,2011-09-15,,,,,,,,
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE-CISPLATINE,,2011-10-06,2011-10-06,,2011-11-29,2011-11-29,,,,,,,,
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,OTHER,TARCEVA -ERLOTINIB,,2011-12-27,2011-12-27,,2012-01-22,2012-01-22,,,,,,,,
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROX,LEVOTHYROXINE SODIUM,1986,1986-12-31,M,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-07,2011-07-07,,2011-07-07,2011-07-07,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-07,2011-07-07,,2011-07-07,2011-07-07,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-21,2011-07-21,,2011-07-21,2011-07-21,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KARDEGIC,ACETYLSALICYLATE LYSINE,2011-07-14,2011-07-14,,2011-07-21,2011-07-21,,C,,160,mg,ORAL,QD,THROMBOCYTOSIS
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,OROCAL D3,LEKOVIT CA,1986,1986-12-31,M,,,,C,Y,2,TABLET,ORAL,QD,PROPHYLAXIS OSTEOPOROSIS
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ORACILLINE,PHENOXYMETHYLPENICILLIN,2011-01,2010-12-31,D,,,,C,Y,2,M.UI,ORAL,BID,PROHYLAXIS POST-PANCREACTECTOMY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-04-18,2011-04-18,,2011-06-28,2011-06-28,,C,,1,g,ORAL,PRN,LEFT PELVIC PAINS
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,BICARBONATE DE SODIUM,SODIUM BICARBONATE,2011-06-09,2011-06-09,,,,,C,Y,1,IU,TOPICAL,PRN,PROPHYLAXIS STOMATITIS
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-09,2011-06-09,,2011-06-09,2011-06-09,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-16,2011-06-16,,2011-06-16,2011-06-16,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUOROURACILE + OXALIPLATINE,,2011-10-07,2011-10-07,,2011-11-08,2011-11-08,,,,,,,,
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,EFFERALGAN CODEINE,PANADEINE CO,2011-05,2011-05-31,D,2011-05-10,2011-05-31,,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-06-04,2011-06-04,,2011-06-15,2011-06-15,,C,,1,TABLET,ORAL,TID,NAUSEA VOMITING PROPHYLAXIS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-06-16,2011-06-16,,2011-07-11,2011-07-11,,C,,1,TABLET,ORAL,TID,INTERMITTENT NAUSEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2011-06-21,2011-06-21,,2011-09-05,2011-09-05,,C,,1,TABLET,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-06-21,2011-06-21,,,,,C,Y,a quarter,TABLET,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-06-22,2011-06-22,,2011-07-11,2011-07-11,,C,,1,PACKET,ORAL,PRN,INTERMITTENT DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ARESTAL,LOPERAMIDE,2011-06-28,2011-06-28,,2011-07-11,2011-07-11,,C,,1,TABLET,ORAL,PRN,INTERMITTENT DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-08-04,2011-08-04,,2011-08-04,2011-08-04,,C,,8,mg,ORAL,BID,VOMITING
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ARESTAL,LOPERAMIDE,2011-08-01,2011-08-01,,2011-08-16,2011-08-16,,C,,1,TABLET,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-08-10,2011-08-10,,2011-08-16,2011-08-16,,C,,1,PACKET,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,QUESTRAN,COLESTYRAMINE,2011-08-16,2011-08-16,,2011-09-15,2011-09-15,,C,,1,PACKET,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2011-05-10,2011-05-10,,2011-05-31,2011-05-31,,C,,10,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-08-16,2011-08-16,,2011-09-26,2011-09-26,,C,,2,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MOPRAL,OMEPRAZOLE,2011-08-16,2011-08-16,,2011-09-26,2011-09-26,,C,,20,mg,ORAL,QD,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-05-31,2011-05-31,,2011-05-31,2011-05-31,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-05-31,2011-05-31,,2011-05-31,2011-05-31,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEM,ZOLPIDEM,2011-05-10,2011-05-10,,2011-06-21,2011-06-21,,C,,1,TABLET,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-05,2011-07-05,,2011-07-05,2011-07-05,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-05,2011-07-05,,2011-07-05,2011-07-05,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-05-10,2011-05-10,,2011-05-31,2011-05-31,,C,,1,PACKET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2011-09-20,2011-09-20,,,,,C,Y,1,BAG,INTRAVENOUS,PRN,ANOREXIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,VANCOMYCINE,VANCOMYCIN HYDROCHLORIDE,2011-09-06,2011-09-06,,2011-09-12,2011-09-12,,C,,50,mg,INTRAVENOUS,PRN,VESPERAL FEVER
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,VANCOMYCINE,VANCOMYCIN HYDROCHLORIDE,2011-09-13,2011-09-13,,2011-09-23,2011-09-23,,C,,50,mg,INTRAVENOUS,QD,VESPERAL FEVER
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2011-06-01,2011-06-01,,2011-06-30,2011-06-30,,C,,10,mg,ORAL,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2011-09-06,2011-09-06,,2011-09-19,2011-09-19,,C,,1,TABLET,ORAL,UNKNOWN,VESPERAL FEVER
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,OFLOCET,OFLOXACIN,2011-09-06,2011-09-06,,2011-09-19,2011-09-19,,C,,1,TABLET,ORAL,UNKNOWN,VESPERAL FEVER
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-09-01,2011-09-01,,2011-09-15,2011-09-15,,C,,1,g,ORAL,PRN,VESPERAL FEVER
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,TIORFAN,ACETORPHAN,2011-09-16,2011-09-16,,2011-09-23,2011-09-23,,C,,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,MOXYDAR,MOXYDAR,2011-09-16,2011-09-16,,2011-09-25,2011-09-25,,C,,1,TABLET,ORAL,PRN,EPIGASTRALGIAS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2011-09-16,2011-09-16,,2011-09-25,2011-09-25,,C,,2,TABLET,ORAL,TID,EPIGASTRALGIAS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,52.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT,TRIMEBUTINE,2011-09-16,2011-09-16,,2011-09-25,2011-09-25,,C,,200,mg,ORAL,TID,EPIGASTRALGIAS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,53.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2011-09-20,2011-09-20,,2011-09-28,2011-09-28,,C,,10,mg,ORAL,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,54.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2011-09-29,2011-09-29,,,,,C,Y,20,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,55.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-09-29,2011-09-29,,2011-10-07,2011-10-07,,C,,UNK,mL,SUBCUTANEOUS,QD,PORTAL THROMBOSIS SUSPICION
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,56.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-06-01,2011-06-01,,,,,C,Y,5,mg,ORAL,PRN,ABDOMINAL PAINS+ EPIGASTRALGIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,57.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,10,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,58.0,CONCOMITANT MEDICATIONS,,,SODIUM BICARBONATE,SODIUM BICARBONATE,2011-06-01,2011-06-01,,,,,C,Y,1,IU,TOPICAL,PRN,PROPHYLAXIS OF STOMATITIS
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,59.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2011-06-03,2011-06-03,,2011-09-13,2011-09-13,,C,,1,BAG,INTRAVENOUS,PRN,ANOREXIA
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,60.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-06-03,2011-06-03,,2011-06-03,2011-06-03,,C,,1,TABLET,ORAL,TID,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-05,2011-04-30,D,2011-06-29,2011-06-29,,C,,10,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT- TRIMEBUTINE,TRIMEBUTINE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,2,VIAL,INTRAVENOUS,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,2,VIAL,INTRAVENOUS,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,8,mg,ORAL,QD,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL- METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,40,mg,INTRAVENOUS,ONCE,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PLITICAN-ALIZAPRIDE,ALIZAPRIDE,2011-06-23,2011-06-23,,2011-06-23,2011-06-23,,C,,2,VIAL,INTRAVENOUS,ONCE,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,10,mg,ORAL,PRN,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN-METOCLOPRAMIDE,METOCLOPRAMIDE,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,10,mg,ORAL,PRN,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,VOGALENE-METOPIMAZINE,METOPIMAZINE,2011-06-11,2011-06-11,,2011-06-11,2011-06-11,,C,,10,mg,INTRAMUSCULAR,ONCE,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SOLUPRED-PREDNISOLONE,PREDNISOLONE,2011-05-30,2011-05-30,,2011-06-02,2011-06-02,,P,,30,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SOLUPRED-PREDNISOLONE,PREDNISOLONE,2011-06-03,2011-06-03,,2011-06-06,2011-06-06,,P,,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-05,2011-04-30,D,2011-06-30,2011-06-30,,C,,10,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL,MIDAZOLAM,2011-06-10,2011-06-10,,2011-07-03,2011-07-03,,C,,10,mg,INTRAVENOUS,QHS,INSOMNIA
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-06-10,2011-06-10,,2011-06-27,2011-06-27,,C,,50,mg,ORAL,PRN,ANXIO-DEPRESSIVE SYNDROM AND FOR ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,SOLUPRED-PREDNISOLONE,PREDNISOLONE,2011-06-21,2011-06-21,,2011-06,2011-06-30,D,C,,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SOLUPRED-PREDNISOLONE,PREDNISOLONE,2011-06-11,2011-06-11,,2011-06-20,2011-06-20,,C,,40,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-07-02,2011-07-02,,2011-07-03,2011-07-03,,C,,20,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,HALDOL 2MG/ML,HALOPERIDOL,2011-06-27,2011-06-27,,2011-06-27,2011-06-27,,C,,9,gtt,ORAL,TID,VOMITING INTERMITTENT
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,HALDOL 2MG/ML,HALOPERIDOL,2011-06-28,2011-06-28,,2011-07-04,2011-07-04,,C,,9,gtt,ORAL,TID,PROPHYLAXIS NAUSEA-VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-26,2011-06-26,,2011-07-04,2011-07-04,,C,,1,g,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2011-06-26,2011-06-26,,2011-07-02,2011-07-02,,C,,1,mg,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TAZOCILLINE- PIPERACILLINE+TAZOBACTAM,PIP/TAZO,2011-06-26,2011-06-26,,2011-07-03,2011-07-03,,C,,4,g,INTRAVENOUS,TID,COLITIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-05,2011-04-30,D,2011-06-26,2011-06-26,,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,SANDOSTATINE-OCTREOTIDE ACETATE,OCTREOTIDE ACETATE,2011-06-28,2011-06-28,,2011-07-04,2011-07-04,,C,,600,ug,INTRAVENOUS,over 24 hours,COLITIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT INJECTABLE,TRIMEBUTINE,2011-06-29,2011-06-29,,2011-07-04,2011-07-04,,C,,2,VIAL,INTRAVENOUS,TID,COLITIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,INEXIUM INJECTABLE,ESOMEPRAZOLE MAGNESIUM,2011-06-26,2011-06-26,,2011-07-04,2011-07-04,,C,,40,ug,INTRAVENOUS,QD,PROPHYLAXIS EPIGASTRALGIAS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-06-26,2011-06-26,,2011-07-01,2011-07-01,,C,,0.2,mL,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-07-01,2011-07-01,,2011-07-02,2011-07-02,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,0.5,mL,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN INJECTABLE,METOCLOPRAMIDE HYDROCHLORIDE,2011-06-27,2011-06-27,,2011-07-03,2011-07-03,,C,,1,VIAL,INTRAVENOUS,TID,PROPHYLAXIS VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-06-28,2011-06-28,,2011-07-02,2011-07-02,,C,,50,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,50,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,75,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,SEROPLEX,ESCITALOPRAM OXALATE,2011-05-15,2011-05-15,,2011-06-26,2011-06-26,,C,,20,mg,ORAL,QD,MOOD ALTERATION : ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,MORPHINE-MORPHINE CHLORHYDRATE,MORPHINE HYDROCHLORIDE,2011-06-27,2011-06-27,,2011-06-28,2011-06-28,,C,,5,mg,SUBCUTANEOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,MORPHINE-MORPHINE CHLORHYDRATE,MORPHINE HYDROCHLORIDE,2011-07-02,2011-07-02,,2011-07-02,2011-07-02,,C,,15,mg,SUBCUTANEOUS,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,MORPHINE-MORPHINE CHLORHYDRATE,MORPHINE HYDROCHLORIDE,2011-07-03,2011-07-03,,2011-07-04,2011-07-04,,C,,30,mg,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,MORPHINE-MORPHINE CHLORHYDRATE,MORPHINE HYDROCHLORIDE,2011-07-03,2011-07-03,,2011-07-04,2011-07-04,,C,,5,mg,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,MORPHINE-MORPHINE CHLORHYDRATE,MORPHINE HYDROCHLORIDE,2011-07-04,2011-07-04,,2011-07-05,2011-07-05,,C,,50,mg,INTRAVENOUS,over 24 hours,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL,MIDAZOLAM,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,5,mg,INTRAVENOUS,from 06:00 AM to 08:00PM,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL,MIDAZOLAM,2011-07-04,2011-07-04,,2011-07-05,2011-07-05,,C,,20,mg,INTRAVENOUS,over 24 hours,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,SPASFON INJECTABLE,PHLOROGLUCINOL,2011-06-27,2011-06-27,,2011-07-04,2011-07-04,,C,,2,VIAL,INTRAVENOUS,TID,COLITIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,8,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL-METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,60,mg,INTRAVENOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-05,2011-04-30,D,2011-06,2011-06-30,D,C,,20,mg,ORAL,QD,PROPHYLAXIS POST-SURGERY
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL-METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,80,mg,INTRAVENOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL-METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-07-01,2011-07-01,,2011-07-02,2011-07-02,,C,,80,mg,INTRAVENOUS,TID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL-METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-07-03,2011-07-03,,2011-07-04,2011-07-04,,C,,80,mg,INTRAVENOUS,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,HYDROXYZINE,HYDROXYZINE,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,25,mg,ORAL,ONCE,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,LORAMYC- MICONAZOLE,MICONAZOLE,2011-06-30,2011-06-30,,2011-07-03,2011-07-03,,C,,1,TABLET,ORAL,QD,OROPHARYNGEAL CANDIDIASIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,SODIUM BICARBONATE,SODIUM BICARBONATE,2011-06-30,2011-06-30,,2011-07-03,2011-07-03,,C,,1,IU,TOPICAL,TID,OROPHARYNGEAL CANDIDIASIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,1,PUFF,oral transmucous,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,VANCOMYCINE,VANCOMYCIN HYDROCHLORIDE,2011-07-03,2011-07-03,,2011-07-05,2011-07-05,,C,,1500,mg,INTRAVENOUS,over 24 hours,SEPSIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,TIENAM,PRIMAXIN,2011-07-03,2011-07-03,,2011-07-05,2011-07-05,,C,,500,mg,INTRAVENOUS,TID,SEPSIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,GENTALLINE-GENTAMICINE,GENTAMICIN SULFATE,2011-07-03,2011-07-03,,2011-07-04,2011-07-04,,C,,150,mg,INTRAVENOUS,QD,SEPSIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-05,2011-04-30,D,2011-06-25,2011-06-25,,C,,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS POST-SURGERY
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-07-04,2011-07-04,,2011-07-04,2011-07-04,,C,,0.6,mL,SUBCUTANEOUS,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,1,g,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-27,2011-06-27,,2011-06-27,2011-06-27,,C,,1,g,INTRAVENOUS,ONCE,FEVER
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,8,mg,ORAL,QD,VOMITING
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-07-01,2011-07-01,,2011-07-02,2011-07-02,,C,,10,mg,SUBLINGUAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL-METHYLPREDNISOLONE,METHYLPREDNISOLONE,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,C,,80,mg,INTRAVENOUS,QD,CHEMOTHERAPY PREMEDICATION
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-06-20,2011-06-20,,2011-06-20,2011-06-20,,C,,2,VIAL,INTRAVENOUS,QD,CHEMETHERAPY PREMEDICATION
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2011-05-08,2011-05-08,,2011-07-04,2011-07-04,,C,,1.2,L,INTRAVENOUS,over 24 hours,SUPPORTIVE NUTRITION
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,JAMYLENE,DOCUSATE SODIUM,2011-05-26,2011-05-26,,2011-06-26,2011-06-26,,C,,50,mg,ORAL,TID,PROPHYLAXIS CONSTIPATION
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,DOMPERIDONE,DOMPERIDONE,2011-05-26,2011-05-26,,2011-06-10,2011-06-10,,C,,10,mg,ORAL,TID,DYSPEPSIA
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,SOLUPRED - PREDNISOLONE,PREDNISOLONE,2011-05-26,2011-05-26,,2011-05-29,2011-05-29,,P,,40,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATINE + 5 FLUORO-URACILE,,2011-12-26,2011-12-26,,2012-01-24,2012-01-24,,,,,,,,
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-04,2011-03-31,D,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAINS + EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-07-11,2011-07-11,,2011-07-13,2011-07-13,,C,,50,ug,TRANSDERMAL,Q3D,ABDOMINAL PAINS + EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-07-13,2011-07-13,,2011-07-15,2011-07-15,,C,,62,ug,TRANSDERMAL,72 hr,ABDOMINAL PAINS + EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-07-15,2011-07-15,,,,,C,Y,75,ug,TRANSDERMAL,72 hr,ABDOMINAL PAINS + EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,INEXIUM - ESOMEPRAZOLE,ESOMEPRAZOLE,2011-07-11,2011-07-11,,2011-08-09,2011-08-09,,C,,40,mg,ORAL,QD,EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-06-27,2011-06-27,,2011-06-30,2011-06-30,,P,,25,ug,TRANSDERMAL,Q3D,ABDOMINAL PAINS +EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,INIPOMP - PANTOPRAZOLE,PANTOPRAZOLE,2011-08-21,2011-08-21,,,,,C,Y,20,mg,ORAL,PRN,EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,6,mg,ORAL,ONCE,PROPHYLAXIS ANXIETY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,6,mg,ORAL,ONCE,PROPHYLAXIS ANXIETY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,2,VIAL,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,2,VIAL,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,TRANXENE,CLORAZEPATE DIPOTASSIUM,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,10,mg,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,2,VIAL,INTRAVENOUS,ONCE,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-07-11,2011-07-11,,2011-07-11,2011-07-11,,C,,1,g,INTRAVENOUS,ONCE,EPIGASTRIC PAINS + ABDOMINAL PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DUROGESIC,FENTANYL,2011-06-30,2011-06-30,,2011-07-11,2011-07-11,,C,,37,ug,TRANSDERMAL,Q3D,ABDOMINAL PAINS + EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-10,2011-10-10,,2011-10-10,2011-10-10,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-10,2011-10-10,,2011-10-10,2011-10-10,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-11,2011-07-11,,2011-07-11,2011-07-11,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-09,2011-11-09,,2011-11-09,2011-11-09,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-11,2011-07-11,,2011-07-11,2011-07-11,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,LASILIX,FUROSEMIDE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,20,mg,ORAL,ONCE,EDEMA ( LOWER LIMBS)
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2011-09-21,2011-09-21,,,,,C,Y,30000,IU,SUBCUTANEOUS,QS,ANEMIA CLINICALLY SIGNIFICANT
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,ARNICA,ARNICA MONTANA,2011-10-14,2011-10-14,,2011-10-14,2011-10-14,,C,,3,dose,ORAL,ONCE,LOWER GENIAN HEMATOMA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,HEMOCLAR CREAM,PENTOSAN POLYSULFATE,2011-10-14,2011-10-14,,2011-10-31,2011-10-31,,C,,variable,IU,TOPICAL,PRN,LOWER GENIAN HEMATOMA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-11-02,2011-11-02,,2011-11-02,2011-11-02,,C,,0.25,TABLET,ORAL,ONCE,PROPHYLAXIS INSOMNIA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,SPASFON LYOC,PHLOROGLUCINOL,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,C,,80,mg,ORAL,ONCE,ABDOMINAL SPASMS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,SPASFON LYOC,PHLOROGLUCINOL,2011-11-15,2011-11-15,,2011-11-19,2011-11-19,,C,,160,mg,ORAL,BID,PROPHYLAXIS ABDOMINAL SPASMS
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,PYOSTACINE,PRISTINAMYCIN,2011-11-22,2011-11-22,,2011-11-28,2011-11-28,,C,,1,g,ORAL,BID,LOWER LIMB'S INFLAMMATION
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,PYOSTACINE,PRISTINAMYCIN,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,C,,2,g,ORAL,ONCE,LOWER LIMB'S INFLAMMATION
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,PYOSTACINE,PRISTINAMYCIN,2011-11-30,2011-11-30,,2011-12-18,2011-12-18,,C,,1,g,ORAL,BID,LOWER LIMB'S INFLAMMATION
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-12-05,2011-12-05,,,,,C,Y,0.5,TABLET,ORAL,QD,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,FERINJECT- CARBOXYMALTOSE FERRIQUE,FERRIC CARBOXYMALTOSE,2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,700,mg,INTRAVENOUS,ONCE,IRON DEFICIENCY ANEMIA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,VENOFER- HYDROXYDE FERRIQUE,FERROUS HYDROXIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,2,VIAL,INTRAVENOUS,ONCE,IRON DEFICIENCY ANEMIA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,VENOFER- HYDROXYDE FERRIQUE,SACCHARATED IRON OXIDE,2011-09-05,2011-09-05,,2011-09-05,2011-09-05,,C,,2,VIAL,INTRAVENOUS,ONCE,IRON DEFICIENCY ANEMIA
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-18,2011-07-18,,2011-07-18,2011-07-18,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATINE + 5 FLUORO-URACILE,,2011-11-02,2011-11-02,,2012-02-22,2012-02-22,,,,,,,,
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,IRINOTECAN + 5 FLUORO-URACILE,,2012-03-21,2012-03-21,,,2012-03-21,Y,,,,,,,
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,COTAREG LP,CO-DIOVAN,2003,2003-12-31,M,,,,C,Y,160,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-19,2011-07-19,,2011-07-19,2011-07-19,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-19,2011-07-19,,2011-07-19,2011-07-19,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-25,2011-07-25,,2011-07-25,2011-07-25,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LERCAN,LERCANIDIPINE HYDROCHLORIDE,2011-05,2011-04-30,D,,,,C,Y,20,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-07-14,2011-07-14,,2011-07-16,2011-07-16,,C,,50,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DAFALGAN -PARACETAMOL,PARACETAMOL,2011-07-17,2011-07-17,,,,,C,Y,1000,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DAFALGAN-CODEINE,PANADEINE CO,2011-07-20,2011-07-20,,2011-09,2011-09-30,D,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,GYNO-PEVARYL LP,ECONAZOLE NITRATE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,150,mg,VAGINAL,ONCE,VAGINAL MYCOSIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PEVARYL (ECONAZOLE),ECONAZOLE,2011-07-20,2011-07-20,,2011-07-25,2011-07-25,,C,,1,APPLICATION,TOPICAL,PRN,VAGINAL MYCOSIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DERMAZOL (ECONAZOLE),ECONAZOLE NITRATE,2011-07-26,2011-07-26,,2011-07-31,2011-07-31,,C,,1,APPLICATION,TOPICAL,PRN,VAGINAL MYCOSIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-04,2011-03-31,D,2011-07-14,2011-07-14,,C,,1000,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,LYSOPAINE,FRUBIENZYM,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,2,TABLET,ORAL,QD,DYSPHAGIA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,MAXILASE,ALPHA-AMYLASE SWINE PANCREAS,2011-08-08,2011-08-08,,2011-08-09,2011-08-09,,C,,2,TABLET,ORAL,QD,DYSPHAGIA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-24,2011-08-24,,2011-08-24,2011-08-24,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,2,TABLET,ORAL,QD,EPIGASTRALGIAS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-14,2011-09-14,,2011-09-14,2011-09-14,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DAFALGAN-CODEINE,PANADEINE CO,2011-04,2011-03-31,D,2011-07-14,2011-07-14,,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-21,2011-09-21,,2011-09-21,2011-09-21,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-09-24,2011-09-24,,2011-10-05,2011-10-05,,C,,1,PACKET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-13,2011-09-13,,2011-09-13,2011-09-13,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-13,2011-09-13,,2011-09-13,2011-09-13,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,2,VIAL,INTRAVENOUS,ONCE,PREEMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-11,2011-10-11,,2011-10-11,2011-10-11,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,TANAKAN,GINKGO BILOBA EXTRACT,2003,2003-12-31,M,,,,C,Y,40,mg,ORAL,TID,PROHYLAXIS COGNITIVE TROUBLES
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,MAXILASE,ALPHA-AMYLASE SWINE PANCREAS,2011-10-10,2011-10-10,,2011-10-15,2011-10-15,,C,,1,TABLET,ORAL,PRN,RHINOPHARYNGITIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,LYSOPAINE,FRUBIENZYM,2011-10-10,2011-10-10,,2011-10-15,2011-10-15,,C,,1,TABLET,ORAL,PRN,RHINOPHARYNGITIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-12,2011-10-12,,2011-10-12,2011-10-12,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,SURBRONC,AMBROXOL HYDROCHLORIDE,2011-10-13,2011-10-13,,2011-10-20,2011-10-20,,C,,30,mg,ORAL,TID,RHINOPHARYNGITIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-10-17,2011-10-17,,2011-10-26,2011-10-26,,C,,2,PACKET,ORAL,BID,DIARRHEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-19,2011-10-19,,2011-10-19,2011-10-19,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS NAUSEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,ARESTAL,LOPERAMIDE,2011-10-19,2011-10-19,,2011-10-26,2011-10-26,,C,,3,TABLET,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,VENOFER-FERRIC HYDROXYL,FERROUS HYDROXIDE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,2,VIAL,INTRAVENOUS,ONCE,PROPHYLAXIS FERRUGINOUS DEFICIENCY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,VENOFER-FERRIC HYDROXYL,SACCHARATED IRON OXIDE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,2,VIAL,INTRAVENOUS,ONCE,PROPHYLAXIS FERRUGINOUS DEFICIENCY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,KARDEGIC,ACETYLSALICYLATE LYSINE,2011-07,2011-07-13,D,,,,C,Y,75,mg,ORAL,QD,PROPHYLAXIS ISCHEMIA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,FERINJECT-FERRIC CARBOXYMALTOSE,FERRIC CARBOXYMALTOSE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,700,mg,INTRAVENOUS,ONCE,PROPHYLAXIS FERUGINOUS DEFICIENCY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,EFFERALGAN-CODEINE,PANADEINE CO,2011-10-30,2011-10-30,,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,PROTIFAR,CARBOHYDRATES NOS W/LIPIDS NOS/MINE/07460201/,2011-10-20,2011-10-20,,,,,C,Y,1,MEASURE,ORAL,PRN,PROTEIN SUPPLEMENTATION FOR ANOREXIA
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,MONURIL,FOSFOMYCIN TROMETAMOL,2011-10-20,2011-10-20,,2011-10-20,2011-10-20,,C,,3,g,ORAL,ONCE,ACUTE CYSTITIS
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUOROURACILE + OXALIPLATINE,,2011-12-01,2011-12-01,,2012-08-16,2012-08-16,,,,,,,,
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUOROURACILE + IRINOTECAN,,2012-09-20,2012-09-20,,,2012-09-20,Y,,,,,,,
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BISOPROLOL,BISOPROLOL,1995,1995-12-31,M,,,,C,Y,5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT,TRIMEBUTINE,2011-08-12,2011-08-12,,2011-09-01,2011-09-01,,C,,1,TABLET,ORAL,TID,ABDOMINAL DISTENSION
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,RENNIE - CALCIUM AND MAGNESIUM CARBONATES,MAGNESIA KOMP N,2011-08-21,2011-08-21,,2011-08-21,2011-08-21,,C,,1,TABLET,ORAL,ONCE,NAUSEA
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,1,TABLET,ORAL,ONCE,NAUSEA-VOMITING
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-23,2011-08-23,,2011-09-01,2011-09-01,,C,,1,TABLET,ORAL,TID,PROPHYLAXIS EPIGASTRALGIA
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-09-01,2011-09-01,,,,,C,Y,0.5,mL,SUBCUTANEOUS,QD,PULMONARY EMBOLISM
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LAROXYL,AMITRIPTYLINE HYDROCHLORIDE,2011-09-26,2011-09-26,,2011-10-12,2011-10-12,,C,,12,gtt,ORAL,QHS,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP- OXYCODONE,OXYCODONE,2011-09-26,2011-09-26,,2011-09-28,2011-09-28,,C,,20,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,OXYNORM - OXYCODONE,OXYCODONE HYDROCHLORIDE,2011-09-26,2011-09-26,,2011-09-28,2011-09-28,,C,,5,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SKENAN LP - MORPHINE SULFATE,MORPHINE SULFATE,2011-09-30,2011-09-30,,2011-10-03,2011-10-03,,C,,20,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SKENAN LP- SULFATE MORPHINE,MORPHINE SULFATE,2011-10-04,2011-10-04,,2011-10-06,2011-10-06,,C,,30,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ICAZ LP,ISRADIPINE,2000,2000-12-31,M,,,,C,Y,2.5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ACTISKENAN- SULFATE MORPHINE,MORPHINE SULFATE,2011-09-30,2011-09-30,,2011-10-03,2011-10-03,,C,,5,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ACTISKENAN - SULFATE MORPHINE,MORPHINE SULFATE,2011-10-04,2011-10-04,,2011-10-05,2011-10-05,,C,,10,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,IXPRIM -TRAMADOL + PARACETAMOL,ULTRACET,2011-10-05,2011-10-05,,2011-10-06,2011-10-06,,C,,1,TABLET,ORAL,QD,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,FORLAX,MACROGOL 4000,2011-10-03,2011-10-03,,2011-11-10,2011-11-10,,C,,2,BAG,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-10-07,2011-10-07,,2011-10-13,2011-10-13,,C,,100,mg,ORAL,TID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE -PARACETAMOL,PARACETAMOL,2011-10-07,2011-10-07,,2011-10-13,2011-10-13,,C,,1000,mg,ORAL,TID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-07,2011-10-07,,2011-10-26,2011-10-26,,C,,1,IU,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,LAROXYL,AMITRIPTYLINE HYDROCHLORIDE,2011-10-13,2011-10-13,,,,,C,Y,15,gtt,ORAL,QHS,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE- PARACETAMOL,PARACETAMOL,2011-10-13,2011-10-13,,,,,C,Y,1000,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CONTRAMAL LP - TRAMADOL,TRAMADOL,2011-10-13,2011-10-13,,2011-11-17,2011-11-17,,C,,200,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,GINKOR FORT- TROXERUTINE+HEPTAMINOL,GINKOR PROCTO,2001,2001-12-31,M,,,,C,Y,3,TABLET,ORAL,QD,PROPHYLAXIS VENOUS INSUFFICIENCY
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,LYRICA - PREGABALINE,PREGABALIN,2011-10-13,2011-10-13,,2011-10-20,2011-10-20,,C,,50,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,LYRICA - PREGABALINE,PREGABALIN,2011-10-21,2011-10-21,,,,,C,Y,75,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,OXYNORM- OXYCODONE,OXYCODONE,2011-10-13,2011-10-13,,,,,C,Y,5,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,SOLUPRED - PREDNISOLONE,PREDNISOLONE,2011-10-14,2011-10-14,,2011-10-18,2011-10-18,,C,,40,mg,ORAL,QD,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP - OXYCODONE,OXYCODONE,2011-11-17,2011-11-17,,,,,C,Y,10,mg,ORAL,BID,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LANSOYL - LIQUID PARAFFIN,"PARAFFIN, LIQUID",2011-11-10,2011-11-10,,,,,C,Y,1,SPOON,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,SPASFON LYOC,PHLOROGLUCINOL,2011-11-03,2011-11-03,,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-27,2011-10-27,,,,,C,Y,2,IU,ORAL,PRN,NAUSEA AND PROPHYLAXIS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,EFFERALGAN CODEINE -PARACETAMOL + CODEIN,PANADEINE CO,2011-11-07,2011-11-07,,2011-11-08,2011-11-08,,C,,1,g,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,VOGALENE,METOPIMAZINE,2011-11-06,2011-11-06,,2011-11-16,2011-11-16,,C,,7.5,mg,ORAL,PRN,NAUSEA- VOMITING
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-06-23,2011-06-23,,,,,C,Y,1000,mg,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,HALDOL - HALOPERIDOL,HALOPERIDOL,2011-11-17,2011-11-17,,2011-11-22,2011-11-22,,C,,2,gtt,ORAL,PRN,NAUSEA-VOMITING
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,SOLUPRED - PREDNISOLONE,PREDNISOLONE,2011-11-03,2011-11-03,,2011-11-07,2011-11-07,,C,,40,mg,ORAL,QD,PROPHYLAXIS (ANTI-INFLAMMATORY)
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,SOLUPRED - PREDNISOLONE,PREDNISOLONE,2011-11-18,2011-11-18,,2011-11-25,2011-11-25,,C,,20,mg,ORAL,QD,PROPHYLAXIS (ANTI-INFLAMMATORY)
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-11-17,2011-11-17,,C,,2,VIAL,INTRAVENOUS,at each chemotherapy,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-07-13,2011-07-13,,2011-11-17,2011-11-17,,C,,80,mg,INTRAVENOUS,at each chemotherapy,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,IXPRIM,ULTRACET,2011-06-23,2011-06-23,,,,,C,Y,1,TABLET,ORAL,PRN,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,LAROXYL,AMITRIPTYLINE HYDROCHLORIDE,2011-06-23,2011-06-23,,2011-09-26,2011-09-26,,C,,10,gtt,ORAL,QHS,ABDOMINAL PAINS + DORSAL PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,NO STEROIDAL ANTI-INFLAMMATORY CREAM (EXACT TRADE NAME NOT RECORDED),"ANTIINFLAMMATORY PREPARATIONS, NON-STEROIDS F",2011-07-25,2011-07-25,,2011-07-28,2011-07-28,,C,,1,IU,TOPICAL,PRN,LEFT CALF PAINS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-07-29,2011-07-29,,2011-08-25,2011-08-25,,C,,0.5,mL,SUBCUTANEOUS,QD,LEFT CALF SUPERFICIAL VENOUS THROMBOSIS
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,RENNIE - CALCIUM AND MAGNESIUM CARBONATES,MAGNESIA KOMP N,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,1,TABLET,ORAL,ONCE,EPIGASTRALGIAS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ALPHAGAN,BRIMONIDINE TARTRATE,2000-03,2000-02-29,D,,,,C,Y,1,gtt,OPHTHALMIC,BID,GLAUCOMA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-09-15,2011-09-15,,2011-10-06,2011-10-06,,C,,1,g,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2011-09-15,2011-09-15,,2011-09-21,2011-09-21,,C,,7.5,mg,INTRAVENOUS,Q24H,PROPHYLAXIS AGITATION+ CONFUSION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2011-10-26,2011-10-26,,,,,C,Y,7.5,mg,INTRAVENOUS,Q24H,AGITATION AND CONFUSION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CYMBALTA,DULOXETINE HYDROCHLORIDE,2011-10-06,2011-10-06,,2011-10-13,2011-10-13,,C,,30,mg,ORAL,QD,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-10-05,2011-10-05,,2011-10-13,2011-10-13,,C,,1.25,TABLET,ORAL,QID,ANXIO-DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DEROXAT,PAROXETINE HYDROCHLORIDE,2011-08-25,2011-08-25,,2011-09-09,2011-09-09,,P,,20,mg,ORAL,QD,DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-08-25,2011-08-25,,2011-09-06,2011-09-06,,P,,"0,75",TABLET,ORAL,BID,DEPRESSIVE SYNDROME + INSOMNIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FORLAX- MACROGOL,MACROGOL,2011-09-06,2011-09-06,,2011-09-07,2011-09-07,,P,,2,BAG,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,FORLAX- MACROGOL,MACROGOL,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,P,,2,BAG,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,100,mg,ORAL,BID,ABDOMINAL + LUMBAR PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,P,,100,mg,ORAL,QD,ABDOMINAL + LUMBAR PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LORAMYC,MICONAZOLE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,1,TABLET,ORAL,QD,PROPHYLAXIS STOMATITIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-08-25,2011-08-25,,2011-09-06,2011-09-06,,P,,40,mg,ORAL,QD,PROPHYLAXIS ESOPHAGITIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-09-08,2011-09-08,,2011-09-14,2011-09-14,,P,,1,VIAL,INTRAVENOUS,QD,PROPHYLAXIS ESOPHAGITIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,XALATAN,LATANOPROST,2000-03,2000-02-29,D,,,,C,Y,1,gtt,OPHTHALMIC,QD,GLAUCOMA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEROXAT,PAROXETINE HYDROCHLORIDE,2011-09-11,2011-09-11,,2011-09-14,2011-09-14,,P,,20,mg,ORAL,QD,DEPRESSIVE SYNDROME
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,P,,0.5,TABLET,ORAL,BID,DEPRRESSIVE SYNDROME + INSOMNIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,P,,0.5,TABLET,ORAL,QD,DEPRESSIVE SYNDROME + INSOMNIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,1,TABLET,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT,TRIMEBUTINE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,1,TABLET,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,40,mg,ORAL,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-09-07,2011-09-07,,2011-09-07,2011-09-07,,P,,30,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,20,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,1,g,INTRAVENOUS,TID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-16,2011-09-16,,2011-09-16,2011-09-16,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-09-07,2011-09-07,,2011-09-14,2011-09-14,,P,,1,g,INTRAVENOUS,QID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-09-15,2011-09-15,,2011-09-15,2011-09-15,,P,,1,g,INTRAVENOUS,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT,TRIMEBUTINE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,2,VIAL,INTRAVENOUS,BID,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,40,mg,INTRAVENOUS,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,IMOVANE,ZOPICLONE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,P,,1,TABLET,ORAL,ONCE,INSOMNIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-09-07,2011-09-07,,2011-09-08,2011-09-08,,P,,3,mg,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-07,2011-09-07,,2011-09-15,2011-09-15,,P,,60,mg,INTRAVENOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-07,2011-09-07,,2011-09-08,2011-09-08,,P,,2,VIAL,INTRAVENOUS,BID,NAUSEA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,LARGACTIL,CHLORPROMAZINE,2011-09-07,2011-09-07,,2011-09-08,2011-09-08,,P,,0.25,VIAL,INTRAVENOUS,from 03:30 to 09:00 AM,CONFUSION AND AGITATION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,LARGACTIL,CHLORPROMAZINE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,P,,0.5,VIAL,INTRAVENOUS,from midnight to 04:00 AM,CONFUSION AND AGITATION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-16,2011-09-16,,2011-09-16,2011-09-16,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-09-06,2011-09-06,,2011-10-25,2011-10-25,,C,,0.5,mL,SUBCUTANEOUS,QD,PROPHYLAXIS DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,AMLOR,AMLODIPINE BESILATE,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,P,,5,mg,ORAL,ONCE,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,AMLOR,AMLODIPINE BESILATE,2011-09-12,2011-09-12,,2011-10-06,2011-10-06,,C,,5,mg,ORAL,QD,PROPHYLAXIS HYPERTENSION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-09-11,2011-09-11,,2011-09-11,2011-09-11,,P,,1,BAG,ORAL,ONCE,DIARRHEA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ATARAX - HYDROXYZINE,HYDROXYZINE,2011-09-09,2011-09-09,,2011-09-09,2011-09-09,,P,,25,mg,ORAL,ONCE,INSOMNIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2011-09-09,2011-09-09,,2011-09-15,2011-09-15,,P,,7.5,mg,INTRAVENOUS,over 24h,"CONFUSION , AGITATION AND PROPHYLAXIS"
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,ACUPAN,NEFOPAM HYDROCHLORIDE,2011-09-09,2011-09-09,,2011-09-13,2011-09-13,,P,,1,VIAL,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2011-09-10,2011-09-10,,2011-10-06,2011-10-06,,C,,1,VIAL,INTRAVENOUS,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL- MIDAZOLAM,MIDAZOLAM,2011-09-09,2011-09-09,,2011-09-14,2011-09-14,,P,,10,mg,INTRAVENOUS,QHS,AGITATION AND FOR PROPHYLAXIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-09-09,2011-09-09,,2011-09-14,2011-09-14,,P,,5,mg,INTRAVENOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,NOVORAPID - INSULINE ASPART,INSULIN ASPART,2011-09-04,2011-09-04,,2011-09-15,2011-09-15,,P,,variable,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,CERNEVIT,CERNEVIT                           /06027301/,2011-08-31,2011-08-31,,,,,C,Y,1,VIAL,INTRAVENOUS,Q24H,UNDERNUTRITION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,NONAN,ELECTROLYTES NOS,2011-08-31,2011-08-31,,,,,C,Y,1,VIAL,INTRAVENOUS,Q24H,UNDERNUTRITION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2011-09-08,2011-09-08,,2011-09-23,2011-09-23,,C,,variable,mL,INTRAVENOUS,Q24H,UNDERNUTRITION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,LASILIX - FUROSEMIDE,FUROSEMIDE,2011-09-14,2011-09-14,,2011-09-15,2011-09-15,,P,,20,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE,SODIUM CHLORIDE,2011-09-13,2011-09-13,,2011-09-15,2011-09-15,,P,,2,g,INTRAVENOUS,Q24H,HYPONATREMIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-09-13,2011-09-13,,2011-09-15,2011-09-15,,P,,2,g,INTRAVENOUS,Q24H,HYPOKALIEMIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2011-10-03,2011-10-03,,2011-10,2011-10-31,D,C,,1500,mL,INTRAVENOUS,Q24H,UNDERNUTRITION-ANOREXIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,SODIUM BICARBONATE,SODIUM BICARBONATE,2011-09-05,2011-09-05,,2011-09-15,2011-09-15,,P,,1,dose,TOPICAL,QID,PROPHYLAXIS STOMATITIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,3,mg,INTRAVENOUS,QHS,PROPHYLAXIS AGITATION + INTERMITTENT AGITATION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,LANTUS - INSULINE GLARGINE,INSULIN GLARGINE,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,16,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-09-15,2011-09-15,,,,,C,Y,40,mg,INTRAVENOUS,QD,PROPHYLAXIS ESOPHAGITIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-09-16,2011-09-16,,,,,C,Y,40,mg,INTRAVENOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,EUROBIOL - 25000 U LIPASE,LIPASE,2011-09-15,2011-09-15,,,,,C,Y,2,TABLET,ORAL,TID,PROPHYLAXIS DYSPEPSIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,BACTRIM FORTE,BACTRIM,2011-10-03,2011-10-03,,2011-10,2011-10-31,D,C,,1,TABLET,ORAL,BID,URINARY INFECTION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,SODIUM CHLORIDE,SODIUM CHLORIDE,2011-09-16,2011-09-16,,2011-10-26,2011-10-26,,C,,4,g,INTRAVENOUS,Q24H,HYPONATREMIA
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,MIDAZOLAM,MIDAZOLAM,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,5,mg,INTRAVENOUS,ONCE,AGITATION INTERMITTENT
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,68.0,CONCOMITANT MEDICATIONS,,,HYPNOVEL - MIDAZOLAM,MIDAZOLAM,2011-10-26,2011-10-26,,,,,C,Y,15,mg,INTRAVENOUS,QHS,AGITATION INTERMITTENT
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,69.0,CONCOMITANT MEDICATIONS,,,LANTUS - INSULINE GLARGINE,INSULIN GLARGINE,2011-10-26,2011-10-26,,,,,C,Y,12,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,70.0,CONCOMITANT MEDICATIONS,,,ACTRAPID - HUMAN INSULINE,INSULIN HUMAN,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,variable,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,71.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,72.0,CONCOMITANT MEDICATIONS,,,NOVORAPID INSULINE,INSULIN ASPART,2011-10-26,2011-10-26,,,,,C,Y,4,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,73.0,CONCOMITANT MEDICATIONS,,,TRACITRANS,OTHER MINERAL PRODUCTS,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,1,VIAL,INTRAVENOUS,Q24H,UNDERNUTRITION
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,74.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP,OXYCODONE HYDROCHLORIDE,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,5,mg,ORAL,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,75.0,CONCOMITANT MEDICATIONS,,,ORAMORPH - SULFATE OF MORPHINE,MORPHINE SULFATE,2011-09-15,2011-09-15,,2011-10-25,2011-10-25,,C,,4,gtt,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,76.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-10-26,2011-10-26,,,,,C,Y,0.4,mL,SUBCUTANEOUS,QD,PROPHYLAXIS DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,77.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-15,2011-09-15,,2011-10-06,2011-10-06,,C,,10,mg,INTRAVENOUS,PRN,PROPHYLAXIS EMESIS
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,78.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-10-06,2011-10-06,,2011-10-06,2011-10-06,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,79.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATINE + 5 FLUORO-URACILE,,2012-01-05,2012-01-05,,2012-07-05,2012-07-05,,,,,,,,
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FLUORO-URACILE + IRINOTECAN,,2012-09-13,2012-09-13,,,2012-09-13,Y,,,,,,,
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROX,LEVOTHYROXINE SODIUM,2003,2003-12-31,M,2011-12-30,2011-12-30,,C,,125,ug,ORAL,QD,HYPOTHYROIDISM POST-THYROIDECTOMY
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOLUPRED,PREDNISOLONE,2012-01-04,2012-01-04,,2012-01-04,2012-01-04,,C,,60,mg,ORAL,QD,"PRURITUS (ABDOMEN, BACK)"
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,SOLUPRED,PREDNISOLONE,2012-01-05,2012-01-05,,2012-01-05,2012-01-05,,C,,40,mg,ORAL,QD,"PRURITUS (ABDOMEN, BACK)"
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,SOLUPRED,PREDNISOLONE,2012-01-06,2012-01-06,,2012-01-06,2012-01-06,,C,,20,mg,ORAL,QD,"PRURITUS (ABDOMEN, BACK)"
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXERYL (WHITE SOFT PARAFFIN + PARAFFIN LIQUID + GLYCEROL),DEXERYL                            /01579901/,2012-01-05,2012-01-05,,,,,C,Y,1,IU,TOPICAL,PRN,"PRURITUS (ABDOMEN, BACK)"
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-11-10,2011-11-10,,2011-12-22,2011-12-22,,C,,2,VIAL,INTRAVENOUS,before each study drug infusion,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-10,2011-11-10,,2011-12-22,2011-12-22,,C,,80,mg,INTRAVENOUS,before each chemotherapy(study drug infusion),PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROX,LEVOTHYROXINE SODIUM,2011-12-30,2011-12-30,,,,,C,Y,150,ug,ORAL,QD,HYPOTHYROIDISM POST-THYROIDECTOMY
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PERINDOPRIL,PERINDOPRIL,2011-12-30,2011-12-30,,,,,C,Y,2,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TAHOR,ATORVASTATIN CALCIUM,2007,2007-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PRETERAX - PERINDOPRIL + INDAPAMIDE,BI PREDONIUM,2006,2006-12-31,M,2011-12-30,2011-12-30,,C,,1,TABLET,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CODOLIPRANE (PARACETAMOL DAFALGAN+ CODEINE),PANADEINE CO,2011-07,2011-06-30,D,2011-12,2011-12-31,D,C,,1,TABLET,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL (DAFALGAN),PARACETAMOL,2011-11-24,2011-11-24,,,,,C,Y,1000,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,1000,mg,ORAL,BID,PROPHYLAXIS PAINS AFTER SETTING OF CENTRAL VENOUS ACCESS SITE
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SODIUM BICARBONATE,SODIUM BICARBONATE,2011-11-11,2011-11-11,,2011-11-17,2011-11-17,,C,,1,IU,TOPICAL,PRN,DRY MOUTH
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-12-12,2011-12-12,,,,,C,Y,0.8,mL,SUBCUTANEOUS,QD,THROMBOSIS OF RIGHT SUBCLAVIAN VEIN
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ZYRTEC,CETIRIZINE HYDROCHLORIDE,2011-12-29,2011-12-29,,2012-01-05,2012-01-05,,C,,1,TABLET,ORAL,QD,"PRURITUS (ABDOMEN, BACK)"
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,GEMCITABINE,,2010-12-15,2010-12-15,,2011-05-17,2011-05-17,,,,,,,,
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,OXALIPLATINE + 5 FLUORO-URACILE,,2012-06-08,2012-06-08,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DIAMICRON,GLICLAZIDE,2011-08,2011-07-31,D,,,,C,Y,60,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,500,mg,ORAL,ONCE,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-02-19,2012-02-19,,2012-02-20,2012-02-20,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-02-27,2012-02-27,,2012-02-28,2012-02-28,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2012-03-08,2012-03-08,,2012-03-08,2012-03-08,,C,,1,IU,ORAL,ONCE,GASTROESOPHAGEAL REFLUX
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),BIOFLAVONOIDS,2012-03-08,2012-03-08,,2012-03-11,2012-03-11,,C,,2,TABLET,ORAL,TID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),DIOSMIN,2012-03-08,2012-03-08,,2012-03-11,2012-03-11,,C,,2,TABLET,ORAL,TID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),BIOFLAVONOIDS,2012-03-12,2012-03-12,,2012-03-17,2012-03-17,,C,,2,TABLET,ORAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),DIOSMIN,2012-03-12,2012-03-12,,2012-03-17,2012-03-17,,C,,2,TABLET,ORAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),BIOFLAVONOIDS,2012-03-18,2012-03-18,,2012-03-23,2012-03-23,,C,,1,TABLET,ORAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),DIOSMIN,2012-03-18,2012-03-18,,2012-03-23,2012-03-23,,C,,1,TABLET,ORAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),BIOFLAVONOIDS,2012-03-24,2012-03-24,,2012-04-24,2012-04-24,,C,,1,TABLET,ORAL,PRN,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,DAFLON (DIOSMIN + FLAVONOIDS),DIOSMIN,2012-03-24,2012-03-24,,2012-04-24,2012-04-24,,C,,1,TABLET,ORAL,PRN,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CIRKAN- PREDNACINOLONE,CIRKAN A LA PREDNACINOLONE,2012-03-08,2012-03-08,,2012-03-22,2012-03-22,,C,,1,TABLET,RECTAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,CIRKAN- PREDNACINOLONE,CIRKAN A LA PREDNACINOLONE,2012-03-27,2012-03-27,,2012-04-24,2012-04-24,,C,,1,TABLET,RECTAL,QD,HEMORRRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,STAGID,METFORMIN EMBONATE,2011-08,2011-07-31,D,,,,C,Y,700,mg,ORAL,TID,DIABETES
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,COLOFOAM (HYDROCORTISONE ACETATE),HYDROCORTISONE ACETATE,2012-03-08,2012-03-08,,2012-03-22,2012-03-22,,C,,1,IU,RECTAL,BID,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,COLOFOAM (HYDROCORTISONE ACETATE),HYDROCORTISONE ACETATE,2012-03-23,2012-03-23,,2012-04-24,2012-04-24,,C,,1,IU,RECTAL,QD,HEMORRHOIDS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ULCAR (SUCRALFATE),SUCRALFATE,2012-03,2012-03-01,D,2012-05-15,2012-05-15,,C,,1,IU,ORAL,PRN,GASTROESOPHAGEAL REFLUX
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2012-05-27,2012-05-27,,2012-05-28,2012-05-28,,C,,1.5,g,ORAL,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2012-04,2012-04-01,D,2012-04,2012-04-30,D,C,,1,g,ORAL,PRN,SHIVER
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,PLITICAN,ALIZAPRIDE HYDROCHLORIDE,2011-12-22,2011-12-22,,2012-05-30,2012-05-30,,C,,2,VIAL,INTRAVENOUS,ONCE,PREMEDICATION CHEMOTHERAPY
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-12-22,2011-12-22,,2012-05-30,2012-05-30,,C,,80,mg,INTRAVENOUS,ONCE,PREMEDICATION
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,SPASFON,PHLOROGLUCINOL,2012-06-08,2012-06-08,,,,,C,Y,1,TABLET,ORAL,PRN,POST-PRANDIAL EPIGASTRIC PAINS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-01-08,2012-01-08,,2012-01-09,2012-01-09,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-01-15,2012-01-15,,2012-01-16,2012-01-16,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-01-29,2012-01-29,,2012-01-30,2012-01-30,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE,PARACETAMOL,2012-02-01,2012-02-01,,2012-02-01,2012-02-01,,C,,1,g,ORAL,ONCE,SHIVERS
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,GAVISCON,GASTRON                            /00902401/,2012-02-01,2012-02-01,,2012-02-01,2012-02-01,,C,,1,IU,ORAL,ONCE,GASTROESOPHAGEAL REFLUX
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,GRANOCYTE 34 (LENOGRASTIM),LENOGRASTIM,2012-02-05,2012-02-05,,2012-02-06,2012-02-06,,C,,33.6,MUI,SUBCUTANEOUS,QD,PROPHYLAXIS NEUTROPENIA
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,SODIUM BICARBONATE,SODIUM BICARBONATE,2012-02-24,2012-02-24,,,,,C,Y,1,IU,TOPICAL,PRN,PROPHYLAXIS STOMATITIS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2012-07-03,2012-07-03,,2012-08-21,2012-08-21,,,,,,,,
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CRESTOR,ROSUVASTATIN CALCIUM,2001,2001-12-31,M,2012-01-12,2012-01-12,,P,,1,TABLET,ORAL,QD,DYSLIPEMIA
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INEXIUM - ESOMEPRAZOLE,ESOMEPRAZOLE,2012-01-12,2012-01-12,,2012-01-16,2012-01-16,,P,,40,mg,INTRAVENOUS,QD,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2012-01-12,2012-01-12,,2012-01-14,2012-01-14,,P,,80,mg,INTRAVENOUS,QD,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP- OXYCODONE,OXYCODONE,2012-01-13,2012-01-13,,2012-01-13,2012-01-13,,P,,15,mg,ORAL,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP-OXYCODONE,OXYCODONE,2012-01-14,2012-01-14,,2012-01-15,2012-01-15,,P,,15,mg,ORAL,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP- OXYCODONE,OXYCODONE,2012-01-16,2012-01-16,,2012-01-16,2012-01-16,,P,,15,mg,ORAL,QD,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OXYNORM -  OXYCODONE,OXYCODONE,2012-01-14,2012-01-14,,2012-01-24,2012-01-24,,C,,5,mg,ORAL,PRN,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LYRICA - PREGABALINE,PREGABALIN,2012-01-16,2012-01-16,,2012-01-16,2012-01-16,,P,,75,mg,ORAL,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SANDOSTATINE - OCTREOTIDE ACETATE,OCTREOTIDE ACETATE,2012-01-12,2012-01-12,,2012-01-14,2012-01-14,,P,,600,ug,INTRAVENOUS,24 hours,INTESTINAL OCCLUSION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PARENTERAL NUTRITION,SOLUTIONS FOR PARENTERAL NUTRITION,2012-01-14,2012-01-14,,2012-01-20,2012-01-20,,C,,1,bag infusion,INTRAVENOUS,24 hours,PROPHYLAXIS UNDERNUTRITION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,60,mg,INTRAVENOUS,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,KARDEGIC,ACETYLSALICYLATE LYSINE,2011,2011-12-31,M,2012-01-12,2012-01-12,,P,,75,mg,ORAL,QD,ATHEROMATOUS STENOSIS CAELIAC TRUNK
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,SOLUPRED- PREDNISOLONE,PREDNISOLONE,2012-01-18,2012-01-18,,2012-01-20,2012-01-20,,C,,40,mg,ORAL,QD,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN LP-OXYCODONE,OXYCODONE,2012-01-17,2012-01-17,,2012-01-24,2012-01-24,,C,,20,mg,ORAL,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LYRICA- PREGABALINE,PREGABALIN,2012-01-17,2012-01-17,,,,,C,Y,75,mg,ORAL,PRN,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SPASFON- PHLOROGLUCINOL,PHLOROGLUCINOL,2012-01-18,2012-01-18,,2012-01-20,2012-01-20,,C,,2,TABLET,ORAL,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DEBRIDAT- TRIMEBUTINE,TRIMEBUTINE,2012-01-18,2012-01-18,,2012-01-20,2012-01-20,,C,,2,BAG,ORAL,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,PERFALGAN-INJECTABLE PARACETAMOL,PARACETAMOL,2012-01-18,2012-01-18,,2012-01-18,2012-01-18,,C,,1,g,INTRAVENOUS,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DOLIPRANE -PARACETAMOL,PARACETAMOL,2012-01-18,2012-01-18,,2012-01-19,2012-01-19,,C,,1000,mg,ORAL,QD,"ACUTE ABDOMINAL PAINS, FEVER"
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,TAVANIC,LEVOFLOXACIN,2012-01-19,2012-01-19,,2012-01-20,2012-01-20,,C,,500,mg,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ROCEPHINE,CEFTRIAXONE SODIUM,2012-01-19,2012-01-19,,2012-01-20,2012-01-20,,C,,2,g,INTRAVENOUS,QD,FEVER
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,TRANSIPEG,TRANSIPEG                          /01618701/,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,1,BAG,ORAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011,2011-12-31,M,2012-01-12,2012-01-12,,P,,1,g,ORAL,PRN,ABDOMINAL PAINS GRADE 1
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MICROLAX- SORBITOL + SODIUM CITRATE,MICROKLIST,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,1,IU,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,FORLAX,MACROGOL 4000,2012-01-20,2012-01-20,,2012-01-20,2012-01-20,,C,,2,BAG,ORAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,TRANSIPEG,TRANSIPEG                          /01618701/,2012-01-20,2012-01-20,,2012-01-20,2012-01-20,,C,,2,BAG,ORAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,INEXIUM - ESOMEPRAZOLE,ESOMEPRAZOLE,2012-01-17,2012-01-17,,2012-01-19,2012-01-19,,C,,40,mg,ORAL,QD,PROHYLAXIS EPIGASTRALGIAS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,PERFALGAN - PARACETAMOL,PARACETAMOL,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,P,,1,g,INTRAVENOUS,QID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,PERFALGAN-PARACETAMOL,PARACETAMOL,2012-01-13,2012-01-13,,2012-01-13,2012-01-13,,P,,1,g,INTRAVENOUS,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SPASFON - PHLOROGLUCINOL,PHLOROGLUCINOL,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,P,,80,mg,INTRAVENOUS,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,CONTRAMAL - TRAMADOL,TRAMADOL,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,P,,100,mg,INTRAVENOUS,BID,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,P,,1,VIAL,INTRAVENOUS,ONCE,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,P,,8,mg,INTRAVENOUS,PRN,ACUTE ABDOMINAL PAINS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,KARDEGIC,ACETYLSALICYLATE LYSINE,1995-11,1995-10-31,D,2011-01-07,2011-01-07,,P,,160,mg,ORAL,QD,AURICULAR FIBRILATION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ELISOR,PRAVASTATIN SODIUM,2007,2007-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-01-26,2011-01-26,,2011-02-04,2011-02-04,,C,,10,mg,ORAL,TID,EMESIS PROPHYLAXIS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,2011-03-22,2011-03-22,,2011-03-23,2011-03-23,,C,,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,2011-06-09,2011-06-09,,,,,C,Y,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2011-06-25,2011-06-25,,2011-06-28,2011-06-28,,C,,20,mg,ORAL,QD,GASTRITIS PROPHYLAXIS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FUNGIZONE,AMPHOTERICIN B,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,2,little spoons,ORAL,BID,CANDIDIASIS PROPHYLAXIS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HEMIGOXINE,DIGOXIN,2011-06-30,2011-06-30,,,,,C,Y,0.125,mg,ORAL,QD,AURICULAR FIBRILLATION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-06-29,2011-06-29,,,,,C,Y,3,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,1000,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,PLAVIX,CLOPIDOGREL BISULFATE,2011-06-25,2011-06-25,,2011-06-26,2011-06-26,,C,,75,mg,ORAL,QD,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,CAPTEA,CAPOZIDE,1995-11,1995-10-31,D,2011-06-23,2011-06-23,,C,,50/25,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PLAVIX,CLOPIDOGREL BISULFATE,2011-06-28,2011-06-28,,,,,C,Y,75,mg,ORAL,QD,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PREVISCAN  FLUINDIONE,FLUINDIONE,2011-07-03,2011-07-03,,,,,C,Y,10,mg,ORAL,QD,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2011-07-01,2011-07-01,,,,,C,Y,5,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,BENERVA,THIAMINE HYDROCHLORIDE,2011-06-24,2011-06-24,,2011-06-27,2011-06-27,,C,,500,mg,INTRAVENOUS,BID,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-06-23,2011-06-23,,,,,C,Y,4000,IU,INTRAVENOUS,QD,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,10,IU,SUBCUTANEOUS,ONCE,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-06-29,2011-06-29,,2011-06-30,2011-06-30,,C,,15/10,IU,SUBCUTANEOUS,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,10,IU,SUBCUTANEOUS,ONCE,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-07-02,2011-07-02,,2011-07-03,2011-07-03,,C,,15/10,IU,SUBCUTANEOUS,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,NOVOMIX,NOVOMIX,2011-07-04,2011-07-04,,,,,C,Y,15/8,IU,SUBCUTANEOUS,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,MONO-TILDIEM,DILTIAZEM HYDROCHLORIDE,2010-04,2010-03-31,D,,,,C,Y,200,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-24,2011-06-24,,2011-06-24,2011-06-24,,C,,100,mL,INTRAVENOUS,QD,CERVICODYNIA
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-25,2011-06-25,,2011-06-25,2011-06-25,,C,,200,mL,INTRAVENOUS,QD,CERVICODYNIA
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2011-06-26,2011-06-26,,2011-06-26,2011-06-26,,C,,100,mL,INTRAVENOUS,QD,PROPHILAXIX CERVICODYNIA
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PYRIDOXINE,PYRIDOXINE,2011-06-24,2011-06-24,,2011-06-27,2011-06-27,,C,,4,AMPULE,INTRAVENOUS,QD,STROKE
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,UMULINE,INSULIN HUMAN ZINC SUSPENSION,2011-06-23,2011-06-23,,2011-06-25,2011-06-25,,C,,40,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,UMULINE,INSULIN HUMAN ZINC SUSPENSION,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,40,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,AMYCOR,BIFONAZOLE,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,1,APPLICATION,TOPICAL,ONCE,CANDIDIASIS PROPHYLAXIS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,NORMACOL (DIHYDRATE MONOSODIC PHOSPHATE + DODECAHYDRATE DISODIC PHOSPHATE),FLEET                              /01605601/,2011-07-03,2011-07-03,,2011-07-03,2011-07-03,,C,,1,ENEMA,RECTAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,DIGOXINE,DIGOXIN,2001-01,2000-12-31,D,2011-06-29,2011-06-29,,C,,"0,25",mg,ORAL,QD,AURICULAR FIBRILATION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,STAGID,METFORMIN EMBONATE,2007,2007-12-31,M,,,,C,Y,700,mg,ORAL,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,AMAREL,GLIMEPIRIDE,2007,2007-12-31,M,,,,C,Y,3,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,TRAMADOL HYDROCHLORIDE,TRAMADOL HYDROCHLORIDE,2011-01-07,2011-01-07,,2011-03-16,2011-03-16,,C,,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,KARDEGIC,ACETYLSALICYLATE LYSINE,2011-01-09,2011-01-09,,,,,C,Y,160,mg,ORAL,QD,AURICULAR FIBRILLATION
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-01-08,2011-01-08,,2011-01-08,2011-01-08,,P,,0.4,mL,SUBCUTANEOUS,ONCE,ANTITHROMBOTIC PROPHYLAXIS
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,MODIFIED 4 FOLFOX,,2011-08-24,2011-08-24,,2011-10-06,2011-10-06,,,,,,,,
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,CELECTOL,CELIPROLOL HYDROCHLORIDE,1993-06,1993-05-31,D,,,,C,Y,200,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-06-08,2011-06-08,,,,,C,Y,25000,IU,ORAL,TID,PANCREAS FAILURE
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,VENOFER,SACCHARATED IRON OXIDE,2011-06-10,2011-06-10,,2011-06-10,2011-06-10,,P,,1,INJECTION,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,TARDIFERON,FERROUS SULFATE,2011-06-22,2011-06-22,,2011-07-20,2011-07-20,,C,,80,mL,ORAL,TID,ANEMIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2011-06-30,2011-06-30,,2011-07-25,2011-07-25,,C,,40000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PACKED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,2,PACK,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-06-22,2011-06-22,,2011-06-23,2011-06-23,,C,,1,g,ORAL,QD,FEVER
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,LOXEN,NICARDIPINE HYDROCHLORIDE,1993-09,1993-08-31,D,,,,C,Y,50,mg,ORAL,BID,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TOPALGIC,TRAMADOL HYDROCHLORIDE,2011-07-09,2011-07-09,,,,,C,Y,100,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-07-09,2011-07-09,,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-07-13,2011-07-13,,2011-07-16,2011-07-16,,C,,1,g,ORAL,PRN,FEVER
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2011-07-24,2011-07-24,,,,,C,Y,5,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SOLUPRED-PREDNISOLONE,PREDNISOLONE,2011-08-04,2011-08-04,,2011-08-06,2011-08-06,,C,,10,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-07-26,2011-07-26,,2011-07-28,2011-07-28,,C,,1,g,ORAL,PRN,FEVER
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2011-08-04,2011-08-04,,,,,C,Y,40000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-05-26,2011-05-26,,,,,C,Y,3,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,STILNOX,ZOLPIDEM TARTRATE,2011-05-26,2011-05-26,,2011-06-22,2011-06-22,,C,,5,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2011-05-26,2011-05-26,,,,,C,Y,8,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,NOVORAPID FLEXPEN,INSULIN ASPART,2011-05-26,2011-05-26,,,,,C,Y,5,IU,SUBCUTANEOUS,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,MODIFIED 4 FOLFOX,,2011-08-25,2011-08-25,,2012-07-13,2012-07-13,,,,,,,,
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI III,,2012-08-02,2012-08-02,,2012-10-02,2012-10-02,,,,,,,,
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LAMALINE (PARACTAMOL/OPIUM/CAFINE),LAMALINE                           /01708901/,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,P,,,mg,ORAL,,EPIGASTRIAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-06,2011-07-06,,2011-07-11,2011-07-11,,C,,5,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ZOFREN,ONDANSETRON,2011-07-13,2011-07-13,,2011-07-15,2011-07-15,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ZOFREN,ONDANSETRON,2011-07-20,2011-07-20,,2011-07-22,2011-07-22,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-07-20,2011-07-20,,2011-07-20,2011-07-20,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CRON,PANCREATIN,2011-07-13,2011-07-13,,,,,C,Y,25000,IU,ORAL,TID,DIARHOEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CODEINE PARACETAMOL,LENOLTEC WITH CODEINE NO 1,2011-07-22,2011-07-22,,2011-07-25,2011-07-25,,C,,1,g,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2011-07-26,2011-07-26,,2011-07-27,2011-07-27,,C,,10,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SKENAN,MORPHINE SULFATE,2011-07-28,2011-07-28,,,,,C,Y,20,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ZOFREN,ONDANSETRON,2011-07-26,2011-07-26,,2011-07-29,2011-07-29,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,KITRIL,GRANISETRON HYDROCHLORIDE,2011-08-03,2011-08-03,,2011-08-03,2011-08-03,,C,,1,AMPULE,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ZOFREN,ONDANSETRON,2011-08-03,2011-08-03,,2011-08-06,2011-08-06,,C,,8,mg,ORAL,BID,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,EPREX,EPOETIN ALFA,2011-07-28,2011-07-28,,,,,C,Y,40000,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,EMEND - APREPITANT,APREPITANT,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,125,mg,ORAL,ONCE,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,EMEND-APREPITANT,APREPITANT,2011-08-11,2011-08-11,,2011-08-12,2011-08-12,,C,,80,mg,ORAL,QD,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,FUNGIZONE,AMPHOTERICIN B,2011-08-25,2011-08-25,,,,,C,Y,2,little spoons,ORAL,TID,CANDIDIASIS PROPHYLAXIS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-08-25,2011-08-25,,,,,C,Y,0.5,mL,INTRAMUSCULAR,QD,THROMBOSIS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,IMODIUM,LOPERAMIDE HYDROCHLORIDE,2011-08-25,2011-08-25,,,,,C,Y,2,mg,ORAL,TID,DIARRHOEA PROPHYLAXIS
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-05,2011-04-30,D,,,,C,Y,1,g,ORAL,PRN,EPIGASTRIAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,LEXOMIL,BROMAZEPAM,2011-05-31,2011-05-31,,,,,C,Y,3,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,VOGALNE,METOPIMAZINE,2011-06-07,2011-06-07,,2011-06-23,2011-06-23,,P,,80,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-01,2011-07-01,,2011-07-01,2011-07-01,,C,,10,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,DAFALGAN,PARACETAMOL,2011-06-29,2011-06-29,,,,,C,Y,1,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-07-08,2011-07-08,,2011-07-08,2011-07-08,,C,,1,PACKET,ORAL,QD,DIARHOEA
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,F,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,SMECTA,DIOSMECTITE,2011-07-13,2011-07-13,,2011-07-13,2011-07-13,,C,,1,PACKET,ORAL,QD,DIARHOEA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,,,,,,,
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,PARIET,RABEPRAZOLE SODIUM,2005,2005-12-31,M,2012-01-27,2012-01-27,,C,,20,mg,ORAL,QD,ESOPHAGEAL REFLUX PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-12-23,2011-12-23,,,,,C,Y,14000,IU,SUBCUTANEOUS,QD,PULMONARY EMBOLISM AND PHLEBIIS PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,CO-DOLIPRANE,PANADEINE CO,2012-01-11,2012-01-11,,2012-01-27,2012-01-27,,C,,800/400,mg,ORAL,TID,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-01-27,2012-01-27,,2012-02-14,2012-02-14,,C,,25,ug,TRANSDERMAL,"By hour, every 72 hours",ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,PARACTAMOL,PARACETAMOL,2012-01-28,2012-01-28,,2012-01-31,2012-01-31,,C,,1,g,ORAL,QD,FEVER
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,INEXIUM,ESOMEPRAZOLE MAGNESIUM,2012-01-28,2012-01-28,,,,,C,Y,20,mg,ORAL,QD,ESOPHAGEAL REFLUX PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-01-30,2012-01-30,,2012-01-30,2012-01-30,,C,,5,mg,SUBCUTANEOUS,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-01-30,2012-01-30,,2012-01-30,2012-01-30,,C,,10,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PERFALGAN,PARACETAMOL,2012-01-29,2012-01-29,,2012-01-29,2012-01-29,,C,,1,g,ORAL,QD,ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-01-31,2012-01-31,,2012-02-28,2012-02-28,,C,,5,mg,ORAL,TID,ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-02-08,2012-02-08,,2012-02-09,2012-02-09,,C,,8,mg,ORAL,BID,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PRITORPLUS,PRITORPLUS,2008-10,2008-09-30,D,,,,C,Y,80/12.5,mg,ORAL,QD,ARTERIAL HYPERTENSION
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-02-01,2012-02-01,,,,,C,Y,10,mg,ORAL,TID,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,4,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-02-22,2012-02-22,,2012-02-24,2012-02-24,,C,,8,mg,ORAL,QD,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SERESTA,OXAZEPAM,2012-02-15,2012-02-15,,,,,C,Y,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-02-15,2012-02-15,,2012-03-21,2012-03-21,,C,,50,ug,TRANSDERMAL,"By hour, every 72 hours",ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ARANESP,DARBEPOETIN ALFA,2012-02-22,2012-02-22,,,,,C,Y,500,mg,SUBCUTANEOUS,once every three weeks,ANEMIA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-02-29,2012-02-29,,2012-04-04,2012-04-04,,C,,10,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,SOLUPRED (PREDNISOLONE ),PREDNISOLONE,2012-02-29,2012-02-29,,2012-03-02,2012-03-02,,C,,40,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-03-01,2012-03-01,,2012-03-04,2012-03-04,,C,,8,mg,ORAL,QD,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-02-29,2012-02-29,,2012-02-29,2012-02-29,,C,,3,mg,INTRAVENOUS,ONCE,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,3,mg,INTRAVENOUS,ONCE,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,ZOPHREN,ONDANSETRON,2012-03-08,2012-03-08,,2012-03-11,2012-03-11,,C,,8,mg,ORAL,QD,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-03-22,2012-03-22,,,,,C,Y,75,ug,TRANSDERMAL,"By hour, every 72 hours",ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,BATHS OF MOUTH OF FUNGIZONE,AMPHOTERICIN B,2012-03-22,2012-03-22,,,,,C,Y,100,mg by ml,ORAL,PRN,MUCITIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,PROFENID,KETOPROFEN,2012-03-22,2012-03-22,,,,,C,Y,200,mg,ORAL,QD,ESOPHAGIAL REFLUX PROPHYLAXIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2012-04-05,2012-04-05,,,,,,Y,15,mg,ORAL,PRN,ABDOMINAL PAINS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,CETIRIZINE,CETIRIZINE,2012-04-04,2012-04-04,,,,,C,Y,10,mg,ORAL,QD,VASCULAR PURPURA
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,AMIODARONE,AMIODARONE,2010-03-16,2010-03-16,,,,,C,Y,200,mg,ORAL,During 5 days per week.,EXTRASYSTOLES
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROX,LEVOTHYROXINE SODIUM,2010-05-15,2010-05-15,,,,,C,Y,75,mg,ORAL,QD,HYPOTHYRODISM
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,AERIUS,DESLORATADINE,2007-07-30,2007-07-30,,,,,C,Y,5,mg,ORAL,QD,ALLERGIC RHINITIS
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,PARACETAMOL,PARACETAMOL,2011-11,2011-10-31,D,,,,C,Y,1,g,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,SPIRIVA,TIOTROPIUM BROMIDE,2006-07-19,2006-07-19,,,,,C,Y,18,ug,RESPIRATORY (INHALATION),QD,CHRONIC OBSTRUCTIVE PULMONAY DISEASE
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,M,,,FRA,FRANCE,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,"SYMBICOR (BUDSONIDE, FORMOTROL)",FORMOTEROL W/BUDESONIDE,2010,2010-12-31,M,,,,C,Y,400/12,ug,RESPIRATORY (INHALATION),BID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELOX,,2011-11-30,2011-11-30,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,"INSULIN HUMAN INJECTION, ISOPHANE","INSULIN HUMAN INJECTION, ISOPHANE",2010-10-06,2010-10-06,,,,,C,Y,various,U,SUBCUTANEOUS,QHS,DIABETES MELLITUS
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2010-12-19,2010-12-19,,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,PROPAVAN,PROPIOMAZINE MALEATE,2008-11-06,2008-11-06,,,,,C,Y,25,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2010-12-15,2010-12-15,,,,,C,Y,4,mg,INTRAVENOUS,in connection with study drug,PROPHYLAXIS
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2010,2010-12-15,M,,,,C,Y,10,gtt,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,"SODIUM BICARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL, MACROGOL 3350 (MOVICOL)",MOVICOL                            /01749801/,2010,2010-12-15,M,,,,C,Y,1,PACKAGE,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TROMBYL,ACETYLSALICYLIC ACID,2011-01-17,2011-01-17,,,,,C,Y,75,mg,ORAL,QD,STROKE
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-03-23,2011-03-23,,2011-04-05,2011-04-05,,C,,37,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-04-06,2011-04-06,,2011-04-19,2011-04-19,,C,,50,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-04-20,2011-04-20,,2011-05-20,2011-05-20,,C,,75,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-05-21,2011-05-21,,2011-05,2011-05-31,D,C,,100,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NOVORAPID,INSULIN ASPART,2010-10-06,2010-10-06,,,,,C,Y,various,U,SUBCUTANEOUS,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-05,2011-05-01,D,2011-05-31,2011-05-31,,C,,150,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-06-01,2011-06-01,,2011-07-16,2011-07-16,,C,,200,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-06-01,2011-06-01,,,,,C,Y,75,mg,ORAL,BID,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOL,OMEPRAZOLE,2011-07-17,2011-07-17,,,,,C,Y,20,mg,ORAL,QD,MELAENA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ERYTROCYTE CONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,2,IU,INTRAVENOUS,BID,ANEMIA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-07-16,2011-07-16,,,,,C,Y,225,ug,TRANSDERMAL,QH,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,KEPPRA,LEVETIRACETAM,2011-07-26,2011-07-26,,,,,C,Y,250,mg,ORAL,BID,NERVOUS SYSTEM DISORDERS
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-08-10,2011-08-10,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-08-11,2011-08-11,,,,,C,Y,4,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2011-09-09,2011-09-09,,,,,C,Y,4,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ENALAPRIL,ENALAPRIL,2005,2005-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-07-16,2011-07-16,,,,,C,Y,20,mg,ORAL,PRN,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,TRAMADOL RETARD,TRAMADOL,2010-11-12,2010-11-12,,2010-12-19,2010-12-19,,C,,200,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PANODIL,PARACETAMOL,2010-10-13,2010-10-13,,,,,C,Y,1,g,ORAL,PRN,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,IBUMETIN,IBUPROFEN,2010-11-12,2010-11-12,,2011-07-16,2011-07-16,,C,,600,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2010-12-15,2010-12-15,,2011-03-22,2011-03-22,,C,,25,ug,TRANSDERMAL,QH,PAIN
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2010-11-15,2010-11-15,,,,,C,Y,1,TABLET,ORAL,TID,PANCREAS CANCER
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2005,2005-12-31,M,2011-07-16,2011-07-16,,C,,80,mg,ORAL,QHS,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-090-002,01090002,090,63.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELOX,,2011-09-01,2011-09-01,,2012-04-10,2012-04-10,,,,,,,,
CO-101-001,CO-101-001-090-002,01090002,090,63.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2011-03-17,2011-03-17,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-090-002,01090002,090,63.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,KVEPENIN,PHENOXYMETHYLPENICILLIN POTASSIUM,2011-05-24,2011-05-24,,2011-05-31,2011-05-31,,C,,1,g,ORAL,TID,UPPER RESPIRATORY INFECTION
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELOX,,2011-08-02,2011-08-02,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ALVEDON,PARACETAMOL,2011-03-22,2011-03-22,,,,,C,Y,665,mg,ORAL,PRN,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-05-04,2011-05-04,,2011-06-08,2011-06-08,,C,,14000,IU,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-06-08,2011-06-08,,,,,C,Y,10000,IU,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LOPERAMID,LOPERAMIDE HYDROCHLORIDE,2011-05-17,2011-05-17,,,,,C,Y,2,mg,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-08-20,2011-08-20,,,,,,Y,1,TABLET,ORAL,TID,DIARRHEA
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-08-20,2011-08-20,,,,,,Y,50,ug,TRANSDERMAL,QH,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DOLCONTIN - MORPHINE SULPHAT,MORPHINE SULFATE,2011-03-22,2011-03-22,,2011-04-08,2011-04-08,,P,,30,mg,ORAL,QD,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TADOLAN RETARD,TRAMADOL HYDROCHLORIDE,2011-03-24,2011-03-24,,2011-04-08,2011-04-08,,P,,100,mg,ORAL,TID,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,TARGINIQ DEPOT,OXYCODONE HYDROCHLORIDE,2011-04-11,2011-04-11,,,,,C,Y,20+10,mg,ORAL,QD,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-04-19,2011-04-19,,2011-08-01,2011-08-01,,C,,25,ug,TRANSDERMAL,QH,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MATRIFEN,FENTANYL,2011-04-21,2011-04-21,,,,,C,Y,12,ug,TRANSDERMAL,QH,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2011-04-11,2011-04-11,,2011-07-19,2011-07-19,,C,,8,mg,INTRAVENOUS,PRN,PROPHYLACTIC
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-04-11,2011-04-11,,,,,C,Y,1,PACKAGE,ORAL,PRN,PROPHYLACTIC
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-04-08,2011-04-08,,,,,C,Y,5,mg,ORAL,PRN,GASTROINTESTINAL PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-05-06,2011-05-06,,,,,C,Y,1,PACKAGE,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,IMDUR,ISOSORBIDE MONONITRATE,2009-06-29,2009-06-29,,,,,C,Y,60,mg,ORAL,QHS,ANGINA PECTORIS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2009-12-17,2009-12-17,,2011-10-19,2011-10-19,,C,,40,mg,ORAL,QD,DIURETIC
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SELOKEN ZOC,METOPROLOL SUCCINATE,2010-02-09,2010-02-09,,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NORVASC,AMLODIPINE BESILATE,2008-10-08,2008-10-08,,,,,C,Y,10,mg,ORAL,QHS,HYPERTENSION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ATACAND PLUS,BLOPRESS PLUS,2008-05-15,2008-05-15,,,,,C,Y,32+25,mg,ORAL,QHS,HYPERTENSION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2008-06-19,2008-06-19,,2012-01-11,2012-01-11,,C,,40,mg,ORAL,QHS,LIPID LOWERING
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,SPEKTRAMOX,SPEKTRAMOX,2011-05-17,2011-05-17,,2011-07-26,2011-07-26,,C,,875+125,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NOVORAPID PENFILL,INSULIN ASPART,2011-03-31,2011-03-31,,2011-10-12,2011-10-12,,C,,8,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,FURIX,FUROSEMIDE,2011-03-23,2011-03-23,,2011-12-06,2011-12-06,,C,,40,mg,INTRAVENOUS,PRN,DIURETIC
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,IPREN,IBUPROFEN,2011-05-18,2011-05-18,,,,,C,Y,400,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,NOVORAPID FLEXPEN,INSULIN ASPART,2009-02-13,2009-02-13,,,,,C,Y,26,IU,SUBCUTANEOUS,TID,DIABETES MELLITUS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PANODIL,PARACETAMOL,2011-04-14,2011-04-14,,,,,C,Y,500,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-05-16,2011-05-16,,2011-05-17,2011-05-17,,P,,4,g,INTRAVENOUS,TID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2011-05-31,2011-05-31,,,,,C,Y,8,mg,INTRAVENOUS,PRN,PROPHYLACTIC
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-07-26,2011-07-26,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,SPEKTRAMOX,SPEKTRAMOX,2011-07-26,2011-07-26,,2011-09-13,2011-09-13,,C,,875,mg,ORAL,QD,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NOSKAPIN,NOSCAPINE HYDROCHLORIDE,2011-08-31,2011-08-31,,,,,C,Y,UN,mL,ORAL,PRN,COUGH
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-09-09,2011-09-09,,2011-09-13,2011-09-13,,C,,4,g,INTRAVENOUS,TID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-09-13,2011-09-13,,2011-10-04,2011-10-04,,C,,500,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,COCILLANA-ETYFIN,OPIUM DERIVATIVES AND EXPECTORANTS,2011-11-15,2011-11-15,,2011-11-29,2011-11-29,,C,,5,mL,ORAL,PRN,COUGH
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-11-21,2011-11-21,,2011-12-01,2011-12-01,,C,,500,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,INSULATARD FLEXPEN,INSULIN,2010-05-03,2010-05-03,,,,,C,Y,60,IU,SUBCUTANEOUS,QHS,DIABETES MELLITUS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,MORFINSULFATHYDRAPENTAT,MORPHINE SULFATE PENTAHYDRATE,2011-12-08,2011-12-08,,2011-12-28,2011-12-28,,C,,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,MORFINSULFATPENTAHYDRAT,MORPHINE SULFATE PENTAHYDRATE,2011-12-28,2011-12-28,,2012-01-04,2012-01-04,,C,,20,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,MORFINSULFATPENTAHYDRAT,MORPHINE SULFATE PENTAHYDRATE,2011-01-04,2011-01-04,,,,,C,Y,30,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-01-09,2012-01-09,,2012-01-19,2012-01-19,,C,,500,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ERYTROCYTE CONCENTRATE,"RED BLOOD CELLS, CONCENTRATED",2012-02-15,2012-02-15,,,,,C,Y,2,IU,INTRAVENOUS,PRN,ANEMIA
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-02-15,2012-02-15,,2012-02-25,2012-02-25,,C,,500,mg,ORAL,BID,BILIARY TRACT INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,FLUCLOXACILLIN,FLUCLOXACILLIN,2012-02-27,2012-02-27,,2012-03-08,2012-03-08,,C,,1,g,ORAL,TID,SKIN INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,DALACINA,CLINDAMYCIN HYDROCHLORIDE,2012-03-27,2012-03-27,,2012-04-06,2012-04-06,,C,,300,mg,ORAL,TID,SKIN INFECTION
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,METFORMIN ACTAVIS,METFORMIN HYDROCHLORIDE,2008-05-29,2008-05-29,,2012-01-11,2012-01-11,,C,,1000,mg,ORAL,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,INNOHEP,TINZAPARIN SODIUM,2011-04-14,2011-04-14,,,,,C,Y,4500,IU,SUBCUTANEOUS,QHS,PROPHYLAXIS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,TROMBYL,ACETYLSALICYLIC ACID,2008-06-19,2008-06-19,,2012-01-11,2012-01-11,,C,,75,mg,ORAL,QD,POPHYLACTIC
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,DUROFERON,FERROUS SULFATE,2011-03-23,2011-03-23,,2011-12-06,2011-12-06,,C,,200,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,BEHEPAN,CYANOCOBALAMIN,2008-10-14,2008-10-14,,2012-01-11,2012-01-11,,C,,1,mg,ORAL,QHS,PROPHYLAXIS
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,FOLACIN,FOLIC ACID,2009-07-02,2009-07-02,,2012-01-11,2012-01-11,,C,,5,mg,ORAL,QHS,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELOX,,2011-08-08,2011-08-08,,2011-10-02,2011-10-02,,,,,,,,
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,PRIMPERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-04-05,2011-04-05,,,,,C,Y,10,mg,ORAL,PRN,PROPHYLACTIC
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-04-26,2011-04-26,,,,,C,Y,5,mg,SUBCUTANEOUS,PRN,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,OXYNORM,OXYCODONE HYDROCHLORIDE,2011-03-18,2011-03-18,,,,,C,Y,5,mg,ORAL,PRN,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,IMOVANE,ZOPICLONE,2009-02-06,2009-02-06,,,,,C,Y,5,mg,ORAL,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,BETAPRED,BETAMETHASONE SODIUM PHOSPHATE,2011-06-01,2011-06-01,,2011-07-14,2011-07-14,,C,,8,mg,INTRAVENOUS,in connection with gemcitabine,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-07-26,2011-07-26,,,,,C,Y,25000,IU,ORAL,TID,FLATULENCE
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-06-08,2011-06-08,,2011-07-13,2011-07-13,,C,,10,mg,ORAL,BID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-07-13,2011-07-13,,2011-08-09,2011-08-09,,C,,20,mg,ORAL,BID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-08-09,2011-08-09,,2011-08-12,2011-08-12,,C,,40,mg,ORAL,BID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-08-12,2011-08-12,,,,,,Y,80,mg,ORAL,BID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,TROMBYL,ACETYLSALICYLIC ACID,2009-02-02,2009-02-02,,,,,C,Y,75,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2009-02-02,2009-02-02,,,,,C,Y,40,mg,ORAL,QHS,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,LEVAXIN,LEVOTHYROXINE SODIUM,2009-02-02,2009-02-02,,,,,C,Y,50,ug,ORAL,QD,HYPOTHYREOS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-04-20,2011-04-20,,2011-06-08,2011-06-08,,C,,5,mg,ORAL,BID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,16.0,CONCOMITANT MEDICATIONS,,,ALVEDON,PARACETAMOL,2011-03-25,2011-03-25,,2011-07-13,2011-07-13,,C,,1330,mg,ORAL,TID,PAIN IN ABDOMEN
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,17.0,CONCOMITANT MEDICATIONS,,,OXIS TURBUHALER,FORMOTEROL FUMARATE,2009-02-02,2009-02-02,,,,,C,Y,4.5,ug,RESPIRATORY (INHALATION),BID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,18.0,CONCOMITANT MEDICATIONS,,,LAXOBERAL,SODIUM PICOSULFATE,2011-04-05,2011-04-05,,,,,C,Y,10,gtt,ORAL,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,19.0,CONCOMITANT MEDICATIONS,,,MOVICOL,MOVICOL                            /01749801/,2011-04-05,2011-04-05,,,,,C,Y,1,PACKAGE,ORAL,PRN,PROPHYLAXIS
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2008-01,2007-12-31,D,,,,C,Y,20,mg,ORAL,QD,HYPERLIDEMIA
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,0.25,mg,INTRAVENOUS,QS,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,DEACDRON,DEXAMETHASONE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-30,2011-08-30,,2011-08-30,2011-08-30,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-20,2011-09-20,,2011-09-20,2011-09-20,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-09-27,2011-09-27,,2011-09-27,2011-09-27,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-11-15,2010-11-15,,2010-11-15,2010-11-15,,C,,10,mg,INTRAVENOUS,QS,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-04,2011-10-04,,2011-10-04,2011-10-04,,C,,10mg,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-10-25,2011-10-25,,2011-10-25,2011-10-25,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-25,2011-10-25,,2011-10-25,2011-10-25,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,FLULAVAL,INFLUENZA VACCINE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,0.5,mL,INTRAMUSCULAR,QD,FLU VACCINATION
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-11-15,2011-11-15,,2011-11-15,2011-11-15,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-11-23,2010-11-23,,2010-11-23,2010-11-23,,C,,0.25,mg,INTRAVENOUS,QS,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-15,2011-11-15,,2011-11-15,2011-11-15,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,LOCOID CREAM,HYDROCORTISONE BUTYRATE,2011-07-15,2011-07-15,,,,,C,Y,Unknown,,TOPICAL,PRN,"PERIORBITAL EDEMA, PRURITIS"
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,LEVAQUIN,LEVOFLOXACIN,2011-10-03,2011-10-03,,2011-10-07,2011-10-07,,C,,750,mg,ORAL,QD,UPPER REPIRATORY INFECTION
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-22,2011-11-22,,2011-11-22,2011-11-22,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-11-22,2011-11-22,,2011-11-22,2011-11-22,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-11-29,2011-11-29,,2011-11-29,2011-11-29,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2011-12-19,2011-12-19,,,,,C,Y,1000mg,mg,INTRAMUSCULAR,QD,ANTIBIOTIC
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,AMPICILLIN,AMPICILLIN,2011-12-19,2011-12-19,,,,,C,Y,500,mg,ORAL,QID,ANTIBIOTIC
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-11-23,2010-11-23,,2010-11-23,2010-11-23,,C,,10,mg,INTRAVENOUS,QS,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,CLARINEX-D 24 HOUR,CLARINEX-D 24-HOUR,2011-12-19,2011-12-19,,,,,C,Y,5-240,mg,ORAL,QD,ANTIHISTAMINE
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-20,2011-12-20,,2011-12-20,2011-12-20,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-28,2011-12-28,,2011-12-28,2011-12-28,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,0.25,mg,INTRAVENOUS,QD,PREMED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-11-30,2010-11-30,,2010-11-30,2010-11-30,,C,,0.25,mg,INTRAVENOUS,QS,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,10,mg,INTRAVENOUS,QD,PREMED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,KEFLEX,CEFALEXIN,2012-01-09,2012-01-09,,2012-01-12,2012-01-12,,C,,750,mg,ORAL,BID,ANTIBIOTIC
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-01-24,2012-01-24,,2012-01-24,2012-01-24,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-24,2012-01-24,,2012-01-24,2012-01-24,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,ZOVIRAX CREAM,ACICLOVIR,2012-01-25,2012-01-25,,,,,C,Y,5%,,TOPICAL,BID,FEVER BLISTER (LIP)
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-07,2012-02-07,,2012-02-07,2012-02-07,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-14,2012-02-14,,2012-02-14,2012-02-14,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-14,2012-02-14,,2012-02-14,2012-02-14,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-11-30,2010-11-30,,2010-11-30,2010-11-30,,C,,10,mg,INTRAVENOUS,QS,PRE- MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,57.0,CONCOMITANT MEDICATIONS,,,ALEVE,NAPROXEN SODIUM,2012-03-03,2012-03-03,,,,,C,Y,,,ORAL,QD,KNEE PAIN/ARTHITIS
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,58.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-06,2012-03-06,,2012-03-06,2012-03-06,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,59.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-06,2012-03-06,,2012-03-06,2012-03-06,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,60.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-13,2012-03-13,,2012-03-13,2012-03-13,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,61.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-13,2012-03-13,,2012-03-13,2012-03-13,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,62.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-20,2012-03-20,,2012-03-20,2012-03-20,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,63.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-20,2012-03-20,,2012-03-20,2012-03-20,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,64.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,65.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,66.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-12-14,2010-12-14,,2010-12-14,2010-12-14,,C,,0.25,mg,INTRAVENOUS,QS,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,67.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-04-10,2012-04-10,,2012-04-10,2012-04-10,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,68.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-04-10,2012-04-10,,2012-04-10,2012-04-10,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,69.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-04-17,2012-04-17,,2012-04-17,2012-04-17,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,70.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-04-17,2012-04-17,,2012-04-17,2012-04-17,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,71.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-05-01,2012-05-01,,2012-05-01,2012-05-01,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,72.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-05-01,2012-05-01,,2012-05-01,2012-05-01,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,73.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-05-08,2012-05-08,,2012-05-08,2012-05-08,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,74.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-05-08,2012-05-08,,2012-05-08,2012-05-08,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,75.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-05-14,2012-05-14,,2012-05-14,2012-05-14,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,76.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-05-14,2012-05-14,,2012-05-14,2012-05-14,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,77.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-12-14,2010-12-14,,2010-12-14,2010-12-14,,C,,10,mg,INTRAVENOUS,QS,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,78.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-05-30,2012-05-30,,2012-05-30,2012-05-30,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,79.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-05-30,2012-05-30,,2012-05-30,2012-05-30,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,80.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-06-05,2012-06-05,,2012-06-05,2012-06-05,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,81.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-06-05,2012-06-05,,2012-06-05,2012-06-05,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,82.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-06-12,2012-06-12,,2012-06-12,2012-06-12,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,83.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-06-12,2012-06-12,,2012-06-12,2012-06-12,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,84.0,CONCOMITANT MEDICATIONS,,,ROCEPHIN,CEFTRIAXONE SODIUM,2012-06-15,2012-06-15,,2012-06-15,2012-06-15,,C,,250,mg,SUBCUTANEOUS,QD,NASAL CONGESTION/SINUSITIS
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,85.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-12-21,2010-12-21,,2010-12-21,2010-12-21,,C,,0.25,mg,INTRAVENOUS,QS,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,86.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-12-21,2010-12-21,,2010-12-21,2010-12-21,,C,,10,mg,INTRAVENOUS,QS,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,87.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2010-01,2009-12-31,D,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,88.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2010-12-15,2010-12-15,,2010-12-15,2010-12-15,,C,,8,mg,ORAL,QD,"NAUSEA, VOMITING"
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,89.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE SODIUM PHOSPHATE,DEXAMETHASONE SODIUM PHOSPHATE,2012-06-15,2012-06-15,,2012-06-15,2012-06-15,,C,,1,mg,SUBCUTANEOUS,QD,NASAL CONGESTION/SINUSITIS
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,90.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-06-26,2012-06-26,,2012-06-26,2012-06-26,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,91.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-06-26,2012-06-26,,2012-06-26,2012-06-26,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,92.0,CONCOMITANT MEDICATIONS,,,SUPARTZ (HYALURONAN),HYALURONATE SODIUM,2012-06-28,2012-06-28,,,,,C,Y,Unk,,SUBCUTANEOUS,,CHRONIC KNEE PAIN
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,93.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-07-03,2012-07-03,,2012-07-03,2012-07-03,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,94.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-07-03,2012-07-03,,2012-07-03,2012-07-03,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,95.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-07-10,2012-07-10,,2012-07-10,2012-07-10,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,96.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-07-10,2012-07-10,,2012-07-10,2012-07-10,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,97.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-07-24,2012-07-24,,2012-07-24,2012-07-24,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,98.0,CONCOMITANT MEDICATIONS,,,IV HYDRATION/NORMAL SALINE,SODIUM CHLORIDE,2010-12-17,2010-12-17,,2010-12-17,2010-12-17,,C,,2,L,INTRAVENOUS,ONCE,"NAUSEA, VOMITING, DEHYDRATION"
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,99.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-07-24,2012-07-24,,2012-07-24,2012-07-24,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,100.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-07-31,2012-07-31,,2012-07-31,2012-07-31,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,101.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-07-31,2012-07-31,,2012-07-31,2012-07-31,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,102.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-08-07,2012-08-07,,2012-08-07,2012-08-07,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,103.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-08-07,2012-08-07,,2012-08-07,2012-08-07,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,104.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-08-21,2012-08-21,,2012-08-21,2012-08-21,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,105.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-08-21,2012-08-21,,2012-08-21,2012-08-21,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,106.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-08-28,2012-08-28,,2012-08-28,2012-08-28,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,107.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-08-28,2012-08-28,,2012-08-28,2012-08-28,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,108.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-09-04,2012-09-04,,2012-09-04,2012-09-04,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,109.0,CONCOMITANT MEDICATIONS,,,PRILOSEC,OMEPRAZOLE,2010-12-21,2010-12-21,,,,,C,Y,20,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,110.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-09-04,2012-09-04,,2012-09-04,2012-09-04,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,111.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-09-18,2012-09-18,,2012-09-18,2012-09-18,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,112.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-09-18,2012-09-18,,2012-09-18,2012-09-18,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,113.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-09-25,2012-09-25,,2012-09-25,2012-09-25,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,114.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-09-25,2012-09-25,,2012-09-25,2012-09-25,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,115.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-10-01,2012-10-01,,2012-10-01,2012-10-01,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,116.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-10-01,2012-10-01,,2012-10-01,2012-10-01,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,117.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-10-17,2012-10-17,,2012-10-17,2012-10-17,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,118.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-10-17,2012-10-17,,2012-10-17,2012-10-17,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,119.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-10-23,2012-10-23,,2012-10-23,2012-10-23,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,120.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,121.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-10-23,2012-10-23,,2012-10-23,2012-10-23,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,122.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-10-30,2012-10-30,,2012-10-30,2012-10-30,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,123.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-10-30,2012-10-30,,2012-10-30,2012-10-30,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,124.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-12-28,2010-12-28,,2010-12-28,2010-12-28,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,125.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-01-13,2011-01-13,,2011-01-13,2011-01-13,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,126.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-01-13,2011-01-13,,2011-01-13,2011-01-13,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,127.0,CONCOMITANT MEDICATIONS,,,ZANTAC,RANITIDINE HYDROCHLORIDE,2011-03-20,2011-03-20,,,,,C,Y,unk,mg,ORAL,BID,ACID REFLUX
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,128.0,CONCOMITANT MEDICATIONS,,,GLYPIZIDE,GLIPIZIDE,2011-04-27,2011-04-27,,,,,C,Y,5,mg,ORAL,BID,HYPERGLYCEMIA
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,129.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-01-18,2011-01-18,,2011-01-18,2011-01-18,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,130.0,CONCOMITANT MEDICATIONS,,,AMBIEN,ZOLPIDEM TARTRATE,1996,1996-12-31,M,,,,C,Y,10,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,131.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-01-18,2011-01-18,,2011-01-18,2011-01-18,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,132.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-01-25,2011-01-25,,2011-01-25,2011-01-25,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,133.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-01-25,2011-01-25,,2011-01-25,2011-01-25,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,134.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,135.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-02-08,2011-02-08,,2011-02-08,2011-02-08,,C,,10,mg,INTRAVENOUS,QD,10
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,136.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-02-15,2011-02-15,,2011-02-15,2011-02-15,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,137.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-02-15,2011-02-15,,2011-02-15,2011-02-15,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,138.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,139.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-02-22,2011-02-22,,2011-02-22,2011-02-22,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,140.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-03-08,2011-03-08,,2011-03-08,2011-03-08,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,141.0,CONCOMITANT MEDICATIONS,,,ZANTAC,RANITIDINE HYDROCHLORIDE,2010-03,2010-02-28,D,2010-12-21,2010-12-21,,C,,20,mg,ORAL,QD,GASTROINTESTINAL REFLUX DISEASE
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,142.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-03-08,2011-03-08,,2011-03-08,2011-03-08,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,143.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-03-15,2011-03-15,,2011-03-15,2011-03-15,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,144.0,CONCOMITANT MEDICATIONS,,,DEACDRON,DEXAMETHASONE,2011-03-15,2011-03-15,,2011-03-15,2011-03-15,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,145.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-03-22,2011-03-22,,2011-03-22,2011-03-22,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,146.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-03-22,2011-03-22,,2011-03-22,2011-03-22,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,147.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-04-05,2011-04-05,,2011-04-05,2011-04-05,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,148.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-04-05,2011-04-05,,2011-04-05,2011-04-05,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,149.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-04-12,2011-04-12,,2011-04-12,2011-04-12,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,150.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-04-12,2011-04-12,,2011-04-12,2011-04-12,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,151.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-04-19,2011-04-19,,2011-04-19,2011-04-19,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,152.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",1996,1996-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,153.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-04-19,2011-04-19,,2011-04-19,2011-04-19,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,154.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-05-03,2011-05-03,,2011-05-03,2011-05-03,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,155.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-05-03,2011-05-03,,2011-05-03,2011-05-03,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,156.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-05-10,2011-05-10,,2011-05-10,2011-05-10,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,157.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-05-10,2011-05-10,,2011-05-10,2011-05-10,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,158.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-05-17,2011-05-17,,2011-05-17,2011-05-17,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,159.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-05-17,2011-05-17,,2011-05-17,2011-05-17,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,160.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,161.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-06-01,2011-06-01,,2011-06-01,2011-06-01,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,162.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,163.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2010-11-16,2010-11-16,,,,,C,Y,2,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,164.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-06-07,2011-06-07,,2011-06-07,2011-06-07,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,165.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,0.25,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,166.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-06-14,2011-06-14,,2011-06-14,2011-06-14,,C,,10,mg,INTRAVENOUS,QD,PRE MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,167.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,168.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,169.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-07-05,2011-07-05,,2011-07-05,2011-07-05,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,170.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-07-05,2011-07-05,,2011-07-05,2011-07-05,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,171.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,172.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,173.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,.025,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,174.0,CONCOMITANT MEDICATIONS,,,MIRALAX (NO FURTHER INFORMATION),MACROGOL,2010-11-16,2010-11-16,,,,,C,Y,10,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,175.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,176.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,177.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-02,2011-08-02,,2011-08-02,2011-08-02,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,178.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,179.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-09,2011-08-09,,2011-08-09,2011-08-09,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,180.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-08-23,2011-08-23,,2011-08-23,2011-08-23,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,181.0,CONCOMITANT MEDICATIONS,,,AZITHROMYCIN,AZITHROMYCIN,2010-12-10,2010-12-10,,2010-12-14,2010-12-14,,C,,250,mg,ORAL,QD,"SORE THROAT, NASAL DRAINAGE, BILAT TYMPANIC EFFUSIONS"
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,182.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2010-12-10,2010-12-10,,2010-12-10,2010-12-10,,C,,10,mg,INTRAMUSCULAR,ONCE,"SORE THROAT, NASAL DRAINAGE, BILAT TYMPANIC EFFUSIONS."
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR/CISPLATIN,,2012-01-26,2012-01-26,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,ABRAXANE,,2012-03-21,2012-03-21,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,TOPROL XL,METOPROLOL SUCCINATE,2002,2002-12-31,M,,,,C,Y,1,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-07,2011-06-30,D,,,,C,Y,unknown,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,10,mg,INTRAVENOUS,ONCE,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,1000,mL,INTRAVENOUS,ONCE,"PROPHYLAXIS, DEHYDRATION"
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,IC FLUID WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-10,2011-08-10,,2011-08-10,2011-08-10,,C,,2000,mL,INTRAVENOUS,ONCE,"PROPHYLAXIS, DEHYDRATION"
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-12,2011-08-12,,2011-08-12,2011-08-12,,C,,2000,mL,INTRAVENOUS,ONCE,"PROPHYLAXIS, DEHYDRATION"
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2011-08-13,2011-08-13,,2011-08-15,2011-08-15,,C,,500,mg,ORAL,QD,"PROPHYLAXIS, UTI"
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-16,2011-08-16,,2011-08-16,2011-08-16,,C,,2000,mL,INTRAVENOUS,QD,PROPHYLAXIS DEHYDRATION
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-17,2011-08-17,,2011-08-17,2011-08-17,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-18,2011-08-18,,2011-08-18,2011-08-18,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-19,2011-08-19,,2011-08-19,2011-08-19,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2002,2002-12-31,M,,,,C,Y,20,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-20,2011-08-20,,2011-08-20,2011-08-20,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-21,2011-08-21,,2011-08-21,2011-08-21,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELEECTTROLYTES,ELECTROLYTE SOLUTIONS,2011-08-25,2011-08-25,,2011-08-25,2011-08-25,,C,,2000,mL,INTRAVENOUS,QD,DHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS WITH ELECTROLYTES,ELECTROLYTE SOLUTIONS,2011-09-08,2011-09-08,,2011-09-08,2011-09-08,,C,,2000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-08,2011-08-08,,2011-08-08,2011-08-08,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-15,2011-08-15,,2011-08-15,2011-08-15,,C,,10,mg,INTRAVENOUS,QD,PREMED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-22,2011-08-22,,2011-08-22,2011-08-22,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-29,2011-08-29,,2011-08-29,2011-08-29,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,CLINDAMYCIN,CLINDAMYCIN,2011-09-15,2011-09-15,,2011-09-24,2011-09-24,,C,,400,mg,ORAL,QD,AE - CELLULITIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,LEVOXYL,LEVOTHYROXINE SODIUM,2011-08-15,2011-08-15,,,,,C,Y,75,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,TYLENOL ES,PARACETAMOL,2011-09-06,2011-09-06,,,,,C,Y,1000,mg,ORAL,PRN,PAIN - EPIGASTRIC
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-12,2011-09-12,,2011-09-12,2011-09-12,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-10,2011-10-10,,2011-10-10,2011-10-10,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-17,2011-10-17,,2011-10-17,2011-10-17,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2011-10-21,2011-10-21,,2011-10-21,2011-10-21,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION PROPHYLAXIS
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-10-10,2011-10-10,,,,,C,Y,40,mg,ORAL,QD,GASTROESOPHAGEAL REFLUX
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-31,2011-10-31,,2011-10-31,2011-10-31,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,CLARINEX,DESLORATADINE,2004,2004-12-31,M,,,,C,Y,5,mg,ORAL,QD,SEASONAL ALLERGIES
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,FLULAVAL,INFLUENZA VACCINE,2011-10-21,2011-10-21,,2011-10-21,2011-10-21,,C,,0.5,mL,INTRAMUSCULAR,QD,FLU VACCINCATION
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-14,2011-11-14,,2011-11-14,2011-11-14,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-28,2011-11-28,,2011-11-28,2011-11-28,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-05,2011-12-05,,2011-12-05,2011-12-05,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-12,2011-12-12,,2011-12-12,2011-12-12,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-27,2011-12-27,,2011-12-27,2011-12-27,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,LORTAB (HYDROCODONE-ACETAMINOPHEN),VICODIN,2011-07,2011-06-30,D,,,,C,Y,7.5,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,TOPROL XL,METOPROLOL SUCCINATE,2011-09-06,2011-09-06,,,,,C,Y,50,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-03,2012-01-03,,2012-01-03,2012-01-03,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-10,2012-01-10,,2012-01-10,2012-01-10,,C,,10,mg,INTRAVENOUS,QD,PREMED
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,"OCUVITE (LUTEIN 5MG, ZEAXANTHIN 1MG, OMEGA-3 20MG)",FISH OIL,2004,2004-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,"OCUVITE (LUTEIN 5MG, ZEAXANTHIN 1MG, OMEGA-3 20MG)",LUTEIN ZEAXANTHIN,2004,2004-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2002,2002-12-31,M,,,,C,Y,81,mg,ORAL,QD,"PROPHYLAXIS, CAD"
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,51.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",2004,2004-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,52.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-07,2011-06-30,D,,,,C,Y,unknown,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,1997,1997-12-31,M,,,,C,Y,81,mg,ORAL,QD,BLOOD THINNER
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,NOVOLOG,INSULIN ASPART,2005,2005-12-31,M,,,,C,Y,10,IU,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12-19,2011-12-19,,,,,C,Y,20,mg,ORAL,QD,REFLUX
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LORTAB (HYDROCODONE-ACETAMINOPHEN),VICODIN,2011,2011-12-31,M,,,,C,Y,7.5,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NORCO,VICODIN,2012-02-03,2012-02-03,,,,,C,Y,7.5-325,mg,ORAL,QD,SINUS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-02-09,2012-02-09,,2012-03-22,2012-03-22,,C,,1,mg,ORAL,QD,"ANXIETY,NAUSEA"
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-02-09,2012-02-09,,,,,C,Y,500,mg,ORAL,BID,NEUTROPENIC FEVER
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PHENERGAN,PROMETHAZINE,2012-02-09,2012-02-09,,,,,C,Y,25,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NOVOLIN N,"INSULIN HUMAN INJECTION, ISOPHANE",2005,2005-12-31,M,,,,C,Y,100,U/mL,SUBCUTANEOUS,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ZANTAC,RANITIDINE HYDROCHLORIDE,2012-01-03,2012-01-03,,,,,C,Y,150,mg,ORAL,QD,REFLUX
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-01-03,2012-01-03,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2005,2005-12-31,M,,,,C,Y,40,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-10,2012-02-10,,2012-02-10,2012-02-10,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-10,2012-02-10,,2012-02-10,2012-02-10,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PHENERGAN SUPPOSITORIES,PROMETHAZINE,2012-02-09,2012-02-09,,2012-02-09,2012-02-09,,P,,25,mg,RECTAL,PRN,"NAUSEA, VOMITING"
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-17,2012-02-17,,2012-02-17,2012-02-17,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-17,2012-02-17,,2012-02-17,2012-02-17,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS/D5 NS,DEXTROSE AND SODIUM CHLORIDE INJECTION,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2012-01-17,2012-01-17,,2012-03-22,2012-03-22,,C,,10,mg,ORAL,QD,GASTRIC MOTILITY
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-02-24,2012-02-24,,2012-02-24,2012-02-24,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-24,2012-02-24,,2012-02-24,2012-02-24,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2012-03-02,2012-03-02,,,,,C,Y,0.25,mg,ORAL,TID,ANXIETY
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2005,2005-12-31,M,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DURAGESIC PATCH,FENTANYL,2012-03-02,2012-03-02,,,,,C,Y,72H/25,ug,TRANSDERMAL,Q3D,GENERAL PAIN
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-03-09,2012-03-09,,,,,C,Y,5,mg,ORAL,1-2 tabs Q 4 hrs prn,GENERAL PAIN
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-09,2012-03-09,,2012-03-09,2012-03-09,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-09,2012-03-09,,2012-03-09,2012-03-09,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-16,2012-03-16,,2012-03-16,2012-03-16,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-16,2012-03-16,,2012-03-16,2012-03-16,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-03-22,2012-03-22,,,,,C,Y,0.5,mg,ORAL,TID,ANXIETY
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-03-22,2012-03-22,,,,,C,Y,40,mg,ORAL,QD,GERD/SATIETY
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,LEXAPRO,ESCITALOPRAM OXALATE,2012-03-22,2012-03-22,,,,,C,Y,10,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2012-03-22,2012-03-22,,,,,C,Y,10,mg,ORAL,QD before meals & at bedtime,GERD/EPIGASTRIC DISCOMFORT
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,PRAVASTATIN,PRAVASTATIN,2005,2005-12-31,M,,,,C,Y,40,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS/D5 NS,DEXTROSE AND SODIUM CHLORIDE INJECTION,2012-03-22,2012-03-22,,2012-03-22,2012-03-22,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2012-03-23,2012-03-23,,2012-03-23,2012-03-23,,C,,0.25,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-03-23,2012-03-23,,2012-03-23,2012-03-23,,C,,10,mg,INTRAVENOUS,QD,PRE-MED
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS/D5 NS,DEXTROSE AND SODIUM CHLORIDE INJECTION,2012-03-30,2012-03-30,,2012-03-30,2012-03-30,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,POTASSIUM REPLACEMENT,POTASSIUM,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,,,INTRAVENOUS,QD,HYPOKALEMIA
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS/NORMAL SALINE,SODIUM CHLORIDE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,,,INTRAVENOUS,QD,RENAL FAILURE/HYPONATREMIA
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,,,INTRAVENOUS,,ANTIBIOTIC PROPHYLAXIS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,FLAGYL,METRONIDAZOLE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,,,INTRAVENOUS,,ANTIBIOTIC PROPHYLAXIS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2012-04-03,2012-04-03,,2012-04-04,2012-04-04,,C,,2,mg,INTRAVENOUS,,ABDOMINAL PAIN
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2005,2005-12-31,M,,,,C,Y,1000,mg,ORAL,BID,DIABETES MELLITUS
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,TERAZOSIN,TERAZOSIN,2005,2005-12-31,M,,,,C,Y,10,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,FINASTERIDE,FINASTERIDE,2010,2010-12-31,M,,,,C,Y,5,mg,ORAL,QD,"HAIR LOSS, BALDNESS"
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2005,2005-12-31,M,,,,C,Y,40,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",1997,1997-12-31,M,,,,C,Y,,,ORAL,QD,DAILY VITAMIN
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-03-26,2012-03-26,,2012-07-24,2012-07-24,,,,,,,,
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,1994,1994-12-31,M,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROID
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-02-20,2012-02-20,,,,,C,Y,500,mg,ORAL,BID,FEVER
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-02-20,2012-02-20,,,,,C,Y,0.5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-02-20,2012-02-20,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MEGACE ES,MEGESTROL ACETATE,2012-02-20,2012-02-20,,,,,C,Y,625/5,625mg/5mL,ORAL,QD,WEIGHT LOSS/LOSS OF APPETITE
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-02-06,2012-02-06,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-03-05,2012-03-05,,2012-03-05,2012-03-05,,C,,20,mg,INTRAVENOUS,QD,EDEMA
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,EMLA CREAM,EMLA                               /00675501/,2012-02-27,2012-02-27,,,,,C,Y,2.5-2.5,%,TOPICAL,Apply as directed,LOCAL ANESTHETIC
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2012-03-05,2012-03-05,,2012-03-09,2012-03-09,,C,,100,mg,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,NORCO,VICODIN,2012-02-27,2012-02-27,,,,,C,Y,5-325,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PANCREASE MT 10,PANCRELIPASE,2012-02-28,2012-02-28,,,,,C,Y,10000,IU,ORAL,2 caps before meals,PANCREATIC ENZYME DEFICIENCY
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,TEGRETOL,CARBAMAZEPINE,2007,2007-12-31,M,,,,C,Y,200,mg,ORAL,PRN,NERVE PAIN IN TOES
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,COUMADIN,WARFARIN SODIUM,2012-03-06,2012-03-06,,,,,C,Y,5,mg,ORAL,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,IV FLUIDS (DEXTROSE %5 NORMAL SALINE),DEXTROSE AND SODIUM CHLORIDE INJECTION,2012-03-06,2012-03-06,,2012-03-06,2012-03-06,,C,,1000,mL,INTRAVENOUS,QD,DEHYDRATION
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2012-03-07,2012-03-07,,2012-03-07,2012-03-07,,C,,2,IU,INTRAVENOUS,QD,ANEMIA
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PREDNISONE DOSE PACK,PREDNISONE,2012-03-08,2012-03-08,,2012-03-12,2012-03-12,,C,,10,mg,ORAL,QD,ITCHING FROM RASH
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-03-12,2012-03-12,,,,,C,Y,20,mg,ORAL,QD,EDEMA
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ATARAX/HYDROXYZINE HCL,HYDROXYZINE HYDROCHLORIDE,2012-03-12,2012-03-12,,,,,C,Y,100,mg,ORAL,Q 6 hours prn,ITCHING
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,GLIPIZIDE,GLIPIZIDE,2011-01,2010-12-31,D,,,,C,Y,10,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,COLCHICINE,COLCHICINE,2010,2010-12-31,M,,,,C,Y,0.6,mg,ORAL,PRN,GOUT
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,FLEXERIL,CYCLOBENZAPRINE HYDROCHLORIDE,,2012-02-20,Y,2011,2012-02-20,M,C,,10,mg,ORAL,QD,MUSCLE SPASMS
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,METFORMIN HCL,METFORMIN HYDROCHLORIDE,2011,2011-12-31,M,,,,C,Y,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,MICARDIS HCT,PRITORPLUS,1992,1992-12-31,M,,,,C,Y,80-12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,PROBENECID,PROBENECID,2010,2010-12-31,M,2011-11,2011-11-30,D,P,,500,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,LORTAB (HYDROCODONE-ACETAMINOPHEN),VICODIN,2012-02-01,2012-02-01,,,,,C,Y,5-325,mg,ORAL,QID,PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR,,2012-08-17,2012-08-17,,2012-08-24,2012-08-24,,,,,,,,
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2007-06-01,2007-06-01,,,,,C,Y,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-02-17,2012-02-17,,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2012-02-17,2012-02-17,,,,,C,Y,1,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,CEPHULAC,LACTULOSE,2012-03-05,2012-03-05,,2012-03-19,2012-03-19,,P,,10,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2012-03-05,2012-03-05,,,,,C,Y,1,TABLET,ORAL,QID,DIABETES
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METHADONE,METHADONE,2012-03-19,2012-03-19,,,,,C,Y,5,mg,ORAL,TID,PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CEPHULAC,LACTULOSE,2012-03-19,2012-03-19,,,,,C,Y,15,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-03-19,2012-03-19,,,,,C,Y,30,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-07-19,2012-07-19,,2012-08-19,2012-08-19,,C,,500,mg,ORAL,BID,DIVERTICULITIS
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2012-07-19,2012-07-19,,2012-08-19,2012-08-19,,C,,50,ug,TRANSDERMAL,QOD,DIVERTICULITIS/CONSTIPATION PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,FLAGYL,METRONIDAZOLE,2012-07-19,2012-07-19,,2012-08-19,2012-08-19,,C,,500,mg,ORAL,TID,DIVERTICULITIS
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,GLIZIPIDE,GLIPIZIDE,2007-06-01,2007-06-01,,,,,C,Y,10,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MARINOL - DRONABINOL,DRONABINOL,2012-06-20,2012-06-20,,2012-08-19,2012-08-19,,C,,2.5,mg,ORAL,BID,NAUSEA/VOMITING
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-07-19,2012-07-19,,2012-08-19,2012-08-19,,C,,100,mg,ORAL,PRN,DIVERTICULITIS/CONSTIPATION PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,PHENERGAN,PROMETHAZINE,2012-07-24,2012-07-24,,2012-08-19,2012-08-19,,C,,25,mg,ORAL,PRN,DIVERTICULITIS/CONSTIPATION PAIN
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-04-17,2012-04-17,,2012-08-19,2012-08-19,,C,,40,mg,ORAL,QD,DYSPEPSIA
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2012-07-21,2012-07-21,,2012-07,2012-07-31,D,C,,1000,mL,INTRAVENOUS,ONCE,HYDRATION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,CEFOXITIN,CEFOXITIN,2012-07-21,2012-07-21,,2012-07-24,2012-07-24,,C,,2,g,ORAL,ONCE,DIVERTICULITIS
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,PRAVACHOL,PRAVASTATIN SODIUM,2012,2012-03-20,M,2012-08-19,2012-08-19,,C,,40,mg,ORAL,QHS,HYPERLIPIDEMIA
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,FENOFIBRATE,FENOFIBRATE,2007-06-01,2007-06-01,,,,,C,Y,160,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2007-06-01,2007-06-01,,,,,C,Y,325,mg,ORAL,QD,CARDIAC - PROPHYLAXIS
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,NITROSTAT,GLYCERYL TRINITRATE,2008-06-01,2008-06-01,,,,,C,Y,0.4,mg,ORAL,PRN,ANGINA
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,BYSTOLIC,NEBIVOLOL HYDROCHLORIDE,2010-03-01,2010-03-01,,,,,C,Y,2.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,NORVASC,AMLODIPINE BESILATE,2010-03-01,2010-03-01,,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,PRAVASTATIN,PRAVASTATIN,2010-03-01,2010-03-01,,,,,C,Y,40,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,HUMULIN 70/30,HUMAN MIXTARD,2011-06-01,2011-06-01,,,,,C,Y,26,IU,SUBCUTANEOUS,BID,DIABETES
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,XELODA,,2011-09-23,2011-09-23,,2011-11-01,2011-11-01,,,,,,,,
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2006-12-14,2006-12-14,,,,,C,Y,10,mg,ORAL,QD,DYSLIPIDEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",2005,2005-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-06-28,2011-06-28,,,,,C,Y,0.5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PROCHLORPERAZINE,PROCHLORPERAZINE,2011-06-22,2011-06-22,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-06-28,2011-06-28,,2011-06-30,2011-06-30,,C,,4,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,DROPERIDOL,DROPERIDOL,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,0.625,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,125,mL,INTRAVENOUS,QH,DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-28,2011-06-28,,2011-06-28,2011-06-28,,C,,4,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,DROPERIDOL,DROPERIDOL,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,0.875,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,2010-03-08,2010-03-08,,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,500,mL,INTRAVENOUS,ONCE,DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DROPERIDOL,DROPERIDOL,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,0.625,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-06-29,2011-06-29,,2011-06-30,2011-06-30,,C,,5000,IU,SUBCUTANEOUS,BID,DVT PROPHYLAXIS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,0.3-0.5,mg,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,INSULIN ASPART,INSULIN ASPART,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,1-5,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,125,mL,INTRAVENOUS,QH,DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,NACL 0.9%,SODIUM CHLORIDE,2011-06-29,2011-06-29,,2011-06-30,2011-06-30,,C,,100,mL,INTRAVENOUS,QH,DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-06-30,2011-06-30,,2011-06-30,2011-06-30,,C,,40,mg,ORAL,QD,GI UPSET PROPHYLAXIS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-29,2011-06-29,,2011-06-29,2011-06-29,,C,,8,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,ERYTHROMYCIN,ERYTHROMYCIN,2011-06-30,2011-06-30,,,,,C,Y,250,mg,ORAL,QID,GASTROPARESIS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,LANTUS INSULIN,INSULIN GLARGINE,2010-01-07,2010-01-07,,,,,C,Y,"9,9",IU,SUBCUTANEOUS,"9 units in am, 9 units in the pm",DIABETES MELLITUS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-30,2011-06-30,,,,,C,Y,4,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,FOSAPREPITANT,FOSAPREPITANT,2011-07-11,2011-07-11,,,,,C,Y,150,mg,INTRAVENOUS,premedication for each chemotherapy infusion,NAUSEA PREVENTION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PALONOSETRON,PALONOSETRON,2011-07-11,2011-07-11,,,,,C,Y,250,ug,INTRAVENOUS,premedication for each chemotherapy,NAUSEA PREVENTION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,FAMOTIDINE,FAMOTIDINE,2011-07-11,2011-07-11,,2011-07-30,2011-07-30,,C,,20,mg,INTRAVENOUS,ONCE,UPSET STOMACH
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-05-03,2011-05-03,,,,,C,Y,40,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-06-22,2011-06-22,,,,,C,Y,2,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NACL,SODIUM CHLORIDE,2011-07-12,2011-07-12,,2011-07-12,2011-07-12,,C,,1000,mL,INTRAVENOUS,ONCE,DEHYDRATION PREVENTION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,NACL,SODIUM CHLORIDE,2011-07-14,2011-07-14,,2011-07-14,2011-07-14,,C,,1000,mL,INTRAVENOUS,ONCE,NAUSEA AND DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM OXIDE,MAGNESIUM OXIDE,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,400,mg,ORAL,QID,HYPOMAGNESEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM SULFATE,MAGNESIUM SULFATE,2011-07-17,2011-07-17,,2011-07-17,2011-07-17,,C,,2,g,INTRAVENOUS,every 4 hours times 4,HYPOMAGNESEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,CIALIS,TADALAFIL,2011-03-22,2011-03-22,,,,,C,Y,20,mg,ORAL,PRN,ERECTILE DYSFUNCTION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,NACL,SODIUM CHLORIDE,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,1000,mL,INTRAVENOUS,ONCE,DEHYDRATION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,4,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,4,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE (WITH 1% LIDOCAINE),LIDOCAINE,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,10,mEq,INTRAVENOUS,every hour times 6,HYPOKALEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE (WITH 1% LIDOCAINE),POTASSIUM CHLORIDE,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,10,mEq,INTRAVENOUS,every hour times 6,HYPOKALEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,DROPERIDOL,DROPERIDOL,2011-07-17,2011-07-17,,2011-07-18,2011-07-18,,C,,0.625,mg,INTRAVENOUS,QID,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,DROPERIDOL,DROPERIDOL,2011-07-15,2011-07-15,,2011-07-16,2011-07-16,,C,,0.625,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2011-07-15,2011-07-15,,2011-07-18,2011-07-18,,C,,5000,IU,SUBCUTANEOUS,BID,DVT PROPHYLAXIS
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-07-17,2011-07-17,,,,,C,Y,10,mg,ORAL,QID,DELAYED GASTRIC EMPTYING
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,NACL WITH POTASSIUM CHLORIDE 20 MEQ,EL-4,2011-07-17,2011-07-17,,2011-07-18,2011-07-18,,C,,75,mL,INTRAVENOUS,QH,DEHYDRATION/HYPOKALEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,NACL WITH POTASSIUM CHLORIDE 20 MEQ,EL-4,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,125,mL,INTRAVENOUS,QH,DEHYDRATION/HYPOKALEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,46.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-06-13,2011-06-13,,,,,C,Y,4-8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,47.0,CONCOMITANT MEDICATIONS,,,NACL WITH POTASSIUM CHLORIDE 20 MEQ,EL-4,2011-07-15,2011-07-15,,2011-07-15,2011-07-15,,C,,100,mL,INTRAVENOUS,QH,DEHYDRATION/HYPOKALEMIA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,48.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-16,2011-07-16,,2011-07-17,2011-07-17,,C,,4,mg,INTRAVENOUS,Q4H,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,49.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,4,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,50.0,CONCOMITANT MEDICATIONS,,,PROCHLORPERAZINE,PROCHLORPERAZINE,2011-07-16,2011-07-16,,2011-07-16,2011-07-16,,C,,10,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,51.0,CONCOMITANT MEDICATIONS,,,DIPROLENE,BETAMETHASONE DIPROPIONATE,2011-07-18,2011-07-18,,2011-07-25,2011-07-25,,C,,small,AMOUNT,TOPICAL,BID,RASH
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,52.0,CONCOMITANT MEDICATIONS,,,DIFLUCAN,FLUCONAZOLE,2011-07-25,2011-07-25,,,,,C,Y,100,mg,ORAL,QD,RASH
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,53.0,CONCOMITANT MEDICATIONS,,,OXYCONDONE,OXYCODONE,2011-06-13,2011-06-13,,,,,C,Y,5-10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,54.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2011-06-18,2011-06-18,,,,,C,Y,0.4,mg,ORAL,QD,ENLARGED BLADDER
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,55.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2006-04-07,2006-04-07,,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION AND VASCULAR PROTECTION
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,56.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2006-09-01,2006-09-01,,2011-07-18,2011-07-18,,C,,81,mg,ORAL,QD,CARDIOVASCULAR EVENT PROTECTION
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,PRIOR RADIOTHERAPY,RADIOTHERAPY,UPPER ABDOMEN,,2010-10-26,2010-10-26,,2010-12-02,2010-12-02,,,,5040,cGY,,,
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,PRIOR ADJUVANT CHEMOTHERAPY,CYTOTOXIC CHEMOTHERAPY,XELODA,,2010-10-18,2010-10-18,,2010-12-02,2010-12-02,,,,,,,,
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,ACIDOPHILUS,LACTOBACILLUS ACIDOPHILUS,2010-10,2010-09-30,D,,,,C,Y,1,TABLET,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SERTRALINE,SERTRALINE,2011-02-22,2011-02-22,,,,,C,Y,50,mg,ORAL,QD,MOOD DISCORDER
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-08,2011-08-08,,,,,C,Y,16,mg,INTRAVENOUS,"Days 1, 8, 15, 29, 36 and 43 of chemo cycle",ANTIEMETIC
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-08-08,2011-08-08,,,,,C,Y,12,mg,INTRAVENOUS,"Days 1,8,15,29,36 and 43 of chemo",ANTIEMETIC
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,VITAMIN C,ASCORBIC ACID,2011-03,2011-02-28,D,,,,C,Y,1000,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-09-19,2011-09-19,,2011-09-20,2011-09-20,,C,,40,mEq,ORAL,ONCE,HYPOKALEMIA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-09-27,2011-09-27,,2011-09-29,2011-09-29,,C,,40,mEq,ORAL,QD,EDEMA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-09-27,2011-09-27,,2011-09-29,2011-09-29,,C,,20,mg,ORAL,QD,20
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ANDROGEL,TESTOSTERONE,2011-11-02,2011-11-02,,,,,C,Y,50,mg,TRANSDERMAL,QD,LOW TESTOSTERONE
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-10-11,2011-10-11,,2012-01-08,2012-01-08,,C,,20,mg,ORAL,PRN,EDEMA OF LOWER EXTREMITIES
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2011-08-08,2011-08-08,,,,,C,Y,81,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-10-11,2011-10-11,,,,,C,Y,20,mEq,ORAL,PRN,EDEMA LOWER EXTREMITIES
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,INFLUENZA VACCINE,INFLUENZA VACCINE,2011-11-07,2011-11-07,,2011-11-07,2011-11-07,,C,,0.5,mL,SUBCUTANEOUS,ONCE,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MAALOX,ALUDROX                            /00082501/,2011-12-17,2011-12-17,,2011-12-17,2011-12-17,,C,,3,Tbsp,ORAL,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,MAALOX,ALUDROX                            /00082501/,2011-12-27,2011-12-27,,2011-12-27,2011-12-27,,C,,2,Tbsp,ORAL,ONCE,STOMACH CRAMPING/DIARREHA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-01-09,2012-01-09,,2012-01-17,2012-01-17,,C,,20,mg,ORAL,QD,EDEMA LOWER EXTREMITES
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-01-18,2012-01-18,,2012-01-23,2012-01-23,,C,,20,mg,ORAL,BID,EDEMA LOWER EXTREMITES
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2012-02-13,2012-02-13,,2012-02-13,2012-02-13,,C,,40,mg,INTRAVENOUS,ONCE,HYPOKALEMIA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2012-02-13,2012-02-13,,2012-02-13,2012-02-13,,C,,20,mEq,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-03-19,2012-03-19,,2012-03-19,2012-03-19,,C,,2,TABLET,ORAL,ONCE,DIARRHEA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2006,2006-12-31,M,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CALCIUM PLUS D,CALCIUM D3                         /01483701/,2010,2010-12-31,M,,,,C,Y,1,TABLET,ORAL,BID,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2011-02-22,2011-02-22,,,,,C,Y,50000,IU,ORAL,QD,VITAMIN D DEFICIENCY
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ESOMEPRAZOLE MAGNESIUM,ESOMEPRAZOLE MAGNESIUM,2011-04-20,2011-04-20,,,,,C,Y,40,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,MULTI-VITAMIN,"MULTIVITAMINS, PLAIN",2010-11-19,2010-11-19,,,,,C,Y,1,TABLET,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-27,2011-07-27,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2011-08-11,2011-08-11,,,,,C,Y,2,TABLET,ORAL,TID,BOWEL URGENCY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2011-08-10,2011-08-10,,2011-11-01,2011-11-01,,C,,50000,IU,ORAL,QS,VITAMIN D DEFICIENCY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,SENEKOT,SENNA ALEXANDRINA,2011-10-03,2011-10-03,,,,,C,Y,2,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-10-07,2011-10-07,,,,,C,Y,"12,500",IU,SUBCUTANEOUS,QD,DEEP VEIN THROMBOSIS
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-10-13,2011-10-13,,,,,C,Y,12,mg,INTRAVENOUS,Before chemo,PRE-MEDICATION BEFORE CHEMO
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-10-13,2011-10-13,,,,,C,Y,16,mg,INTRAVENOUS,Premedication before chemo,PREMEDICATION BEFORE CHEMO
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-10-20,2011-10-20,,,,,C,Y,0.5,mg,INTRAVENOUS,PRN,ANXIETY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,NICODERM,NICOTINE,2011-10-20,2011-10-20,,2011-10-22,2011-10-22,,C,,21,mg,TRANSDERMAL,QD,SMOKING CESSATION
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-10-22,2011-10-22,,,,,C,Y,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2011-11-03,2011-11-03,,,,,C,Y,"500,000",IU,ORAL,TID,THRUSH
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-03,2011-11-03,,,,,C,Y,8,mg,ORAL,TID,NAUSEA/VOMITING
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2011-11-01,2011-11-01,,,,,C,Y,15,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-09-27,2011-09-27,,,,,C,Y,0.5,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2011-11-01,2011-11-01,,,,,C,Y,2000,mg,ORAL,QD,VITAMIN D DEFICIENCY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-11-02,2011-11-02,,,,,C,Y,1,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM CITRATE,MAGNESIUM CITRATE,2011-09-27,2011-09-27,,,,,C,Y,148,mL,ORAL,PRN,GENERAL HEALTH
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHINE ER,MORPHINE,2011-09-27,2011-09-27,,,,,C,Y,15,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,NAPROXEN,NAPROXEN,2011-10-05,2011-10-05,,,,,C,Y,500,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2011-09-13,2011-09-13,,,,,C,Y,17,g,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2011-10-05,2011-10-05,,2011-11-01,2011-11-01,,C,,30,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-10-05,2011-10-05,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,ACETAMINOPHEN,PARACETAMOL,2011-09-27,2011-09-27,,,,,C,Y,325,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,2008,2008-12-31,M,,,,C,Y,88,ug,ORAL,QD,HYPOTHYROID
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2012-01-05,2012-01-05,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-05,2012-01-05,,,,,C,Y,12,mg,INTRAVENOUS,Pre-infusion,PROPHYLAXIS
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-01-05,2012-01-05,,,,,C,Y,16,mg,INTRAVENOUS,Pre-infusion,PROPHYLAXIS
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SENNA PLUS,SENNOSIDE A+B,2012-01-12,2012-01-12,,2012-01-13,2012-01-13,,C,,1,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SENNA PLUS,SENNOSIDE A+B,2012-01-13,2012-01-13,,,,,C,Y,6,TABLET,ORAL,2 after every meal,CONSTIPATION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,AMINO ACID COMPLEX,AMINO ACID COMPLEX,2012-01-13,2012-01-13,,,,,C,Y,1,TABLET,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2012-01-11,2012-01-11,,,,,C,Y,5000,IU,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,GREEN TEA,CAMELLIA SINENSIS,2012-01-09,2012-01-09,,,,,C,Y,250,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PROTEIN TABLETS,PROTEIN SUPPLEMENTS,2012-01-09,2012-01-09,,,,,C,Y,5000,g,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FLAXSEED OIL,LINUM USITATISSIMUM SEED OIL,2012-01-09,2012-01-09,,,,,C,Y,1000,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,ACETAMINOPHEN,PARACETAMOL,2011-12-04,2011-12-04,,,,,C,Y,500,mg,INTRAVENOUS,PRN,PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,VITAMIN C,ASCORBIC ACID,2012-01-09,2012-01-09,,,,,C,Y,500,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,BEANO,ALPHA-D-GALACTOSIDASE,2012-02-01,2012-02-01,,2012-02-07,2012-02-07,,C,,1,TABLET,ORAL,PRN,GAS/BLOATING
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,SIMETHICONE,SIMETICONE,2012-02-01,2012-02-01,,2012-02-07,2012-02-07,,C,,80,mg,ORAL,PRN,GAS/BLOATING
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,GINGER,ZINGIBER OFFICINALE RHIZOME,2012-02-08,2012-02-08,,,,,C,Y,1-2,TABLET,ORAL,PRN,GAS/BLOATING
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,FISH OIL,FISH OIL,2012-02-22,2012-02-22,,,,,C,Y,1,TABLET,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-03-02,2012-03-02,,2012-03-05,2012-03-05,,C,,500,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,MICROBID,BACTRIM,2012-03-06,2012-03-06,,2012-03-12,2012-03-12,,C,,100,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-03-08,2012-03-08,,2012-03-12,2012-03-12,,C,,8,mg,ORAL,Take before antibiotic,VOMITING
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2012-03-22,2012-03-22,,,,,C,Y,50,mEq,TRANSDERMAL,Q3D,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-03-22,2012-03-22,,,,,C,Y,2,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,OXYBUTYNIN,OXYBUTYNIN,1996,1996-12-31,M,,,,C,Y,5,mg,ORAL,QD,OVERACTIVE BLADDER
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-03-22,2012-03-22,,2012-03-24,2012-03-24,,C,,4,mg,ORAL,QD,ABDOMINAL PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2012-03-22,2012-03-22,,,,,C,Y,10,mg,ORAL,Before meals,APPETITE STIMULANT
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEM,ZOLPIDEM,2012-04-02,2012-04-02,,2012-04-02,2012-04-02,,C,,5,mg,ORAL,ONCE,INSOMNIA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM SULFATE,MAGNESIUM SULFATE,2012-04-02,2012-04-02,,2012-04-02,2012-04-02,,C,,2,g,INTRAVENOUS,ONCE,PROPHYLACTIC
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-04-02,2012-04-02,,2012-04-04,2012-04-04,,C,,5000,IU,SUBCUTANEOUS,QD,PROPHYLACTIC
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2012-04-02,2012-04-02,,2012-04-05,2012-04-05,,C,,20,mEq,INTRAVENOUS,PRN,HYPOKALEMIA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,CEFTAZIDIME,CEFTAZIDIME,2012-04-02,2012-04-02,,2012-04-02,2012-04-02,,C,,0.5,mg,INTRAVENOUS,ONCE,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,SIMETHICONE,SIMETICONE,2012-04-02,2012-04-02,,2012-04-04,2012-04-04,,C,,80,mg,ORAL,QID,FLATULENCE
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2012-04-03,2012-04-03,,2012-04-05,2012-04-05,,C,,10,IU,INTRAVENOUS,PRN,PROHYLACTIC
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-04-03,2012-04-03,,2012-04-03,2012-04-03,,C,,1,mg,ORAL,ONCE,ANXIETY
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2009,2009-12-31,M,,,,C,Y,40,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-04-04,2012-04-04,,2012-04-05,2012-04-05,,C,,40,mg,ORAL,QD,BLOATING/GAS
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,ERTAPENEM,ERTAPENEM,2012-04-03,2012-04-03,,2012-04-05,2012-04-05,,C,,1,g,INTRAVENOUS,QD,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-04-03,2012-04-03,,2012-04-05,2012-04-05,,C,,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,KLONOPIN,CLONAZEPAM,2012-04-03,2012-04-03,,2012-04-05,2012-04-05,,C,,0.25,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,ACETAMINOPHEN,PARACETAMOL,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,650,mg,ORAL,ONCE,BACK PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,40.0,CONCOMITANT MEDICATIONS,,,FLUCONAZOLE,FLUCONAZOLE,2012-04-04,2012-04-04,,2012-04-04,2012-04-04,,C,,200,mg,ORAL,ONCE,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,41.0,CONCOMITANT MEDICATIONS,,,MYLICON,SIMETICONE,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,C,,80,mg,ORAL,QD,FLATULENCE
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,42.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-04-05,2012-04-05,,2012-04-05,2012-04-05,,C,,24,mg,ORAL,ONCE,NAUSEA
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,43.0,CONCOMITANT MEDICATIONS,,,ERTAPENEM,ERTAPENEM,2012-04-01,2012-04-01,,2012-04-01,2012-04-01,,C,,1,g,INTRAVENOUS,QD,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,44.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2012-04-01,2012-04-01,,2012-04-01,2012-04-01,,C,,0.5,mg,INTRAVENOUS,ONCE,ANXIETY
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,45.0,CONCOMITANT MEDICATIONS,,,ALPRAZOLAM,ALPRAZOLAM,2011-12-04,2011-12-04,,,,,C,Y,0.5,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,46.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2012-04-01,2012-04-01,,2012-04-01,2012-04-01,,C,,0.5,mg,INTRAVENOUS,ONCE,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,47.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-12-22,2011-12-22,,2012-03-21,2012-03-21,,C,,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,48.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-12-05,2011-12-05,,2012-01-04,2012-01-04,,P,,20,mg,ORAL,QD,EXCESSIVE GAS
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,49.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2011-12-22,2011-12-22,,2012-03-21,2012-03-21,,C,,12,ug,TRANSDERMAL,QD,PAIN
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,50.0,CONCOMITANT MEDICATIONS,,,GAS RELIEF,SIMETICONE,2012-01-04,2012-01-04,,,,,C,Y,1,TABLET,ORAL,TID,EXCESSIVE GAS
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,TERAZOSIN,TERAZOSIN,2002,2002-12-31,M,2012-02-22,2012-02-22,,C,,5,mg,ORAL,BID,ENLARGED PROSTATE
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,NOVOLOG,INSULIN ASPART,2012-01-20,2012-01-20,,,,,C,Y,50,IU,SUBCUTANEOUS,TID,DIABETES
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2002,2002-12-31,M,,,,C,Y,150,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2012-02-08,2012-02-08,,2012-02-08,2012-02-08,,C,,650,mg,ORAL,QD,PANCREATIC CANCER PAIN
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-02-08,2012-02-08,,,,,C,Y,5,mg,ORAL,PRN,PANCREATIC CANCER PAIN
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-02-08,2012-02-08,,,,,C,Y,1/2,CAPFUL,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-08,2012-02-08,,,,,C,Y,12,mg,INTRAVENOUS,Before chemo treatment,PRE-MEDICATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-02-08,2012-02-08,,,,,C,Y,16,mg,INTRAVENOUS,before chemo treatment,PRE-MEDICATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2012-02-13,2012-02-13,,2012-02-23,2012-02-23,,C,,324,mg,ORAL,QD,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-13,2012-02-13,,2012-02-13,2012-02-13,,C,,4,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,METHYPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE SODIUM SUCCINATE,2012-02-13,2012-02-13,,2012-02-13,2012-02-13,,C,,125,mg,INTRAVENOUS,QD,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SAW PALMETTO,SERENOA REPENS,2005,2005-12-31,M,2012-02-13,2012-02-13,,C,,1,TABLET,ORAL,QD,ENLARGED PROSTATE
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE HCL,DIPHENHYDRAMINE HYDROCHLORIDE,2012-02-13,2012-02-13,,2012-02-13,2012-02-13,,C,,25,mg,INTRAVENOUS,QD,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,LOPRESSOR,METOPROLOL TARTRATE,2012-02-13,2012-02-13,,2012-02-23,2012-02-23,,C,,12.5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2012-02-13,2012-02-13,,2012-02-23,2012-02-23,,C,,40,mg,ORAL,BID,GERD
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,PLAVIX,CLOPIDOGREL BISULFATE,2012-02-14,2012-02-14,,2012-02-23,2012-02-23,,C,,75,mg,ORAL,QD,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,COZAAR,LOSARTAN POTASSIUM,2012-02-14,2012-02-14,,2012-02-23,2012-02-23,,C,,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM OXIDE,MAGNESIUM OXIDE,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,400,mg,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2012-02-15,2012-02-15,,2012-02-15,2012-02-15,,C,,20,mEq,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,MYLICON,SIMETICONE,2012-02-15,2012-02-15,,2012-02-19,2012-02-19,,C,,80,mg,ORAL,QD,PANCREATIC CANCER
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,LABETALOL,LABETALOL,2012-02-16,2012-02-16,,2012-02-16,2012-02-16,,C,,5mg/mL,mg,INTRAVENOUS,QD,ATRIAL FLUTTER
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2012-02-16,2012-02-16,,2012-02-16,2012-02-16,,C,,5000,IU,INTRAVENOUS,Q8H,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-01-25,2012-01-25,,2012-02-08,2012-02-08,,C,,3350,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2012-02-17,2012-02-17,,2012-02-17,2012-02-17,,C,,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-02-17,2012-02-17,,2012-02-19,2012-02-19,,C,,500,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-02-17,2012-02-17,,2012-02-19,2012-02-19,,C,,17,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-02-18,2012-02-18,,2012-02-22,2012-02-22,,C,,5000,U,SUBCUTANEOUS,QD,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,SENNA DOCUSATE,DOCUSATE W/SENNA,2012-02-19,2012-02-19,,2012-02-22,2012-02-22,,C,,2,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,CAMPHOR MENTHOL LOTION,CAMPHOR W/MENTHOL,2012-02-21,2012-02-21,,2012-02-22,2012-02-22,,C,,Application,LOTION,TOPICAL,PRN,PAPULAR RASH(UPPER BACK AND FACE)
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,ENULOSE,LACTULOSE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,20,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,31.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2012-02-22,2012-02-22,,2012-02-22,2012-02-22,,C,,15,mg,ORAL,QD,INSOMNIA
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,32.0,CONCOMITANT MEDICATIONS,,,NYSTATIN,NYSTATIN,2012-02-22,2012-02-22,,2012-02-23,2012-02-23,,C,,"500,000",IU,ORAL,QD,MUCOSAL INFECTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,33.0,CONCOMITANT MEDICATIONS,,,PERCOCET,OXYCOCET,2012-01-30,2012-01-30,,2012-02-08,2012-02-08,,C,,1,TABLET,ORAL,PRN,PANCREATIC CANCER PAIN
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,34.0,CONCOMITANT MEDICATIONS,,,HEPARIN,HEPARIN,2012-02-13,2012-02-13,,2012-02-14,2012-02-14,,C,,"25,000",IU,INTRAVENOUS,CONTINUOUS,ACUTE MYOCARDIAL INFARCTION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,35.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2012-01-31,2012-01-31,,,,,C,Y,1-2,TABLET,ORAL,PRN,PANCREATIC CANCER PAIN
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,36.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2012-01-16,2012-01-16,,2012-02-12,2012-02-12,,C,,20,mg,ORAL,BID,GASTRIC REFLUX
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,37.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE HCL,METOCLOPRAMIDE HYDROCHLORIDE,2012-01-17,2012-01-17,,,,,C,Y,10,mg,ORAL,QD,GASTROINTESTIONAL STIMULANT
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,38.0,CONCOMITANT MEDICATIONS,,,LOSARTEN,LOSARTAN,1971,1971-12-31,M,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,39.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2012-01-20,2012-01-20,,,,,C,Y,10,IU,SUBCUTANEOUS,QD,DIABETES
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2012-02-16,2012-02-16,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,1998,1998-12-31,M,,,,C,Y,450,mg,ORAL,QD,GOUT
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,PHYTOADIONE,PHYTOMENADIONE,2011-08-19,2011-08-19,,2011-08-19,2011-08-19,,P,,2,mg,SUBCUTANEOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ANCEF,CEFAZOLIN SODIUM,2011-10-26,2011-10-26,,2011-10-26,2011-10-26,,C,,1,g,INTRAVENOUS,ONCE,INFECTION PROPHYLAXIS DURING PORT PLACEMENT
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,25,mg,INTRAVENOUS,ONCE,PROPHYLAXIS DURING VENOFER INFUSION
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,VENOFER,SACCHARATED IRON OXIDE,2011-09-22,2011-09-22,,2011-09-22,2011-09-22,,C,,200,mg,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FLU SHOT,INFLUENZA VACCINE,2011-09-29,2011-09-29,,2011-09-29,2011-09-29,,C,,unk,mg,SUBCUTANEOUS,ONCE,INFLUENZA PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PROCRIT,EPOETIN ALFA,2011-11-17,2011-11-17,,2011-11-17,2011-11-17,,C,,40000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,TUMS,CALCIUM CARBONATE,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,2,TABLET,ORAL,ONCE,HEARTBURN
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-11-19,2011-11-19,,,,,C,Y,2,TABLET,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,HYDROCODONE-ACETAMINOPHEN,VICODIN,2011-12-29,2011-12-29,,,,,C,Y,325,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,VENOFER,SACCHARATED IRON OXIDE,2012-01-26,2012-01-26,,2012-01-26,2012-01-26,,C,,300,mg,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2008,2008-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON HCI,ONDANSETRON HYDROCHLORIDE,2012-01-05,2012-01-05,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,2012-01-26,2012-01-26,,2012-01-26,2012-01-26,,C,,25,mg,INTRAVENOUS,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ACETAMINOPHEN,PARACETAMOL,2012-01-26,2012-01-26,,2012-01-26,2012-01-26,,C,,1000,mg,ORAL,ONCE,PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LOAZEPAM,LORAZEPAM,2012-02-16,2012-02-16,,,,,C,Y,.5,mg,ORAL,PRN,"NAUSEA, VOMITTING"
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2007,2007-12-31,M,,,,C,Y,81,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,HYZAAR,HYZAAR,2010-02-01,2010-02-01,,,,,C,Y,12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",1985,1985-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,NUTITIONAL SUPPLEMENT
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,NORVASC,AMLODIPINE BESILATE,2003,2003-12-31,M,,,,C,Y,10,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,URSODIOL,URSODEOXYCHOLIC ACID,2011-08-11,2011-08-11,,,,,C,Y,500,mg,ORAL,QD,GALL STONE PROPHYLAXIS
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-08-25,2011-08-25,,,,,C,Y,8,mg,INTRAVENOUS,QS,NAUSEA PROPHYLAXI
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-25,2011-08-25,,,,,C,Y,10,mg,INTRAVENOUS,QS,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2011-08-11,2011-08-11,,2011-08-31,2011-08-31,,C,,25,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-22,2011-08-22,,,,,C,Y,4,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2011-08-22,2011-08-22,,,,,C,Y,20,mL,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-09-01,2011-09-01,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PROCRIT,EPOETIN ALFA,2011-08-29,2011-08-29,,,,,C,Y,40k,IU,SUBCUTANEOUS,QS,ANEMIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,PROCRIT,EPOETIN ALFA,2011-09-19,2011-09-19,,2011-09-19,2011-09-19,,C,,40000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PROCRIT,EPOETIN ALFA,2011-09-26,2011-09-26,,2011-09-26,2011-09-26,,C,,40000,IU,SUBCUTANEOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2011-10-05,2011-10-05,,,,,C,Y,125,ug,TRANSDERMAL,Q3D,BACK PAIN-MUSCULOSKELETAL
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-10-03,2011-10-03,,2011-10-03,2011-10-03,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-10-05,2011-10-05,,2011-10-05,2011-10-05,,C,,.25,mg,INTRAVENOUS,ONCE,BACK PAIN-MUSCULOSKELETAL
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-07-28,2011-07-28,,,,,C,Y,.5,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,OXYCODONE HCI,OXYCODONE HYDROCHLORIDE,2011-08-02,2011-08-02,,,,,C,Y,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,STOOL SOFTENER,DOCUSATE SODIUM,2011-08-02,2011-08-02,,,,,C,Y,100,mg,ORAL,PRN,CONSTIPATION PROPHYLAXIS
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,LEXAPRO,ESCITALOPRAM OXALATE,2011-08-11,2011-08-11,,,,,C,Y,unk,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-15,2011-08-15,,,,,C,Y,10,mg,INTRAVENOUS,pre-chemo,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-08-15,2011-08-15,,2011-10-05,2011-10-05,,C,,16,mg,INTRAVENOUS,chemo pre med,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2011-08-31,2011-08-31,,2011-10-04,2011-10-04,,C,,75,ug,TRANSDERMAL,Q3D,PAIN
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,SEPTRA,BACTRIM,2011-08-21,2011-08-21,,2011-09-01,2011-09-01,,C,,800-160,mg,ORAL,BID,PYURIA
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,10,mg,INTRAVENOUS,ONCE,GOUT EXACERBATION
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2012-02-17,2012-02-17,,,,,C,Y,100,mg,ORAL,QHS,GOUT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,GLIPIZIDE,GLIPIZIDE,2012-01-25,2012-01-25,,,,,C,Y,10,mg,ORAL,QD,TYPE 2 DIABETES
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2012-02-02,2012-02-02,,,,,C,Y,5-500,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2010-08-31,2010-08-31,,,,,C,Y,20,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2012-01-03,2012-01-03,,,,,C,Y,1000,mg,ORAL,BID,TYPE 2 DIABETES
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2008-08-07,2008-08-07,,,,,C,Y,50,mg,ORAL,QD,HYPERTESNION
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MULTI VITAMIN,"MULTIVITAMINS, PLAIN",2006,2006-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2012-04-25,2012-04-25,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2006,2006-12-31,M,,,,C,Y,500,mg,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2006,2006-12-31,M,,,,C,Y,81,mg,ORAL,QD,PROPHYLAXIS
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,ERTAPENAM,ERTAPENEM,2012-02-21,2012-02-21,,2012-02-21,2012-02-21,,C,,1,g,INTRAVENOUS,ONCE,CHOLANGITIS
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,PRESERVISION,OCUVITE LUTEIN,2009-10-20,2009-10-20,,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-02-25,2012-02-25,,,,,C,Y,500,mg,ORAL,BID,CHOLANGITIS
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,PHYTONADIONE,PHYTOMENADIONE,2012-01-17,2012-01-17,,2012-01-19,2012-01-19,,P,,100,ug,ORAL,QD,ASPIRIN REVERSAL PRIOR TO PROCEDURE
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,TRIAMCINOLONE CREAM,TRIAMCINOLONE,2012-01-24,2012-01-24,,2012-02-20,2012-02-20,,C,,1%,APPLICATION,TOPICAL,TID,DRY SKIN
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-08,2012-02-08,,,,,C,Y,4,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,COLCRYS,COLCHICINE,2012-02-20,2012-02-20,,,,,C,Y,0.6,mg,ORAL,TID,GOUT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ARIXTRA,FONDAPARINUX SODIUM,2012-02-25,2012-02-25,,,,,C,Y,2.5,mg,SUBCUTANEOUS,QD,SUPERFICIAL THROMBUS RIGHT LEG
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-02-21,2012-02-21,,,,,C,Y,20,mg,ORAL,QD,BILATERAL LEG EDEMA
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2012-03-07,2012-03-07,,,,,C,Y,10,mg,ORAL,QD,BILATERAL LEG EDEMA
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,AUGMENTIN,SPEKTRAMOX,2012-04-17,2012-04-17,,,,,C,Y,500,mg,ORAL,BID,LIVER ABCESS
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2012-02-28,2012-02-28,,,,,C,Y,25,ug,TRANSDERMAL,Q3D,BACK PAIN
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,CALCIUM WITH VITAMIN D,CALCIUM D3                         /01483701/,2012-02-20,2012-02-20,,,,,C,Y,600-400,mg,ORAL,BID,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,FISH OIL,FISH OIL,2009-10-20,2009-10-20,,,,,C,Y,1000,mg,ORAL,QD,NUTRITIONAL SUPPLEMENT
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,FONDAPARINUX SODIUM,FONDAPARINUX SODIUM,2012-02-28,2012-02-28,,,,,C,Y,2.5,mg,SUBCUTANEOUS,QD,SUPERFICIAL  THROMBOPHLEBITIS
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2009,2009-12-31,M,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ZOLPIDEM TARTRATE,ZOLPIDEM TARTRATE,2011-10-21,2011-10-21,,,,,C,Y,10,mg,ORAL,PRN,SLEEP AID
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2012-01,2011-12-31,D,,,,C,Y,100,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-01,2011-12-31,D,,,,C,Y,17,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2012-02-14,2012-02-14,,,,,C,Y,5/325,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-02-15,2012-02-15,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2012-02-15,2012-02-15,,,,,C,Y,1,mg,ORAL,PRN,SLEEP AID
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,GLIMEPERIDE,GLIMEPIRIDE,2002,2002-12-31,M,,,,C,Y,0.5,mg,ORAL,BID,TYPE 2 DIABETES
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2012-04-05,2012-04-05,,,,,C,Y,0.5,mg,ORAL,PRN,CHEMO INDUCED NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2012-04-09,2012-04-09,,,,,C,Y,30,IU,SUBCUTANEOUS,QD,TYPE 2 DIABETES
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,NOVOLOG,INSULIN ASPART,2012-04-16,2012-04-16,,,,,C,Y,sliding scale,IU,SUBCUTANEOUS,PRN,TYPE 2 DIABETES
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,BACTRIM DS,BACTRIM,2012-05-10,2012-05-10,,2012-05-17,2012-05-17,,C,,800/160,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SCOPALAMINE PATCH,HYOSCINE BUTYLBROMIDE,2012-05-13,2012-05-13,,,,,C,Y,1.5,mg,TRANSDERMAL,Q3D,NAUSEA
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CIPRO,CIPROFLOXACIN,2012-04-23,2012-04-23,,2012-04-30,2012-04-30,,C,,500,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,BETAMETHASONE,BETAMETHASONE,2012-04-06,2012-04-06,,2012-04-16,2012-04-16,,C,,0.05,%,TOPICAL,BID,HERPES ZOSTER
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2012-04-06,2012-04-06,,2012-05-07,2012-05-07,,C,,15,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,TRIAMTERENE/HCTZ,DYAZIDE,2006,2006-12-31,M,2012-04-16,2012-04-16,,C,,37.5-25,mg,ORAL,1/2 tab weekly,HYPERTENSION
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,JANUVIA,SITAGLIPTIN PHOSPHATE,2011,2011-12-31,M,2012-04-09,2012-04-09,,C,,0.5,mg,ORAL,QD,T2 DIABETES
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,LEVOTHYROXINE,LEVOTHYROXINE,1982,1982-12-31,M,,,,C,Y,100,ug,ORAL,QD,HYPOTHYROIDISM
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2012-04-23,2012-04-23,,,,,C,Y,5/325,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2012-04-30,2012-04-30,,,,,C,Y,800,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,SULFAMETHAXAZOLE,SULFAMETHOXAZOLE,2012-03-10,2012-03-10,,2012-03-17,2012-03-17,,P,,800/160,mg,ORAL,BID,URINARY TRACT INFECTION
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-04-04,2012-04-04,,,,,C,Y,17,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-03-24,2012-03-24,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-03-27,2012-03-27,,,,,C,Y,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-04-05,2012-04-05,,,,,C,Y,10,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,STOOL SOFTNER CAPS,DOCUSATE SODIUM,2012-03-27,2012-03-27,,,,,C,Y,1,TABLET,ORAL,QHS,CONSTIPATION PROPHYLAXIS
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2012-05-15,2012-05-15,,,,,C,Y,400-800,mg,ORAL,PRN,FRACTURED RIBS/PAIN
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-05-15,2012-05-15,,,,,C,Y,25,ug,TRANSDERMAL,Q3D,FRACTURED RIBS/PAIN
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-10-26,2011-10-26,,,,,C,Y,8.6,mg,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,FENTAYNL PATCH,FENTANYL,2012-01-10,2012-01-10,,,,,C,Y,50,ug,TRANSDERMAL,QD,PAIN
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ENSURE,NUTRIENTS NOS,2012-01-17,2012-01-17,,,,,C,Y,8,oz,ORAL,QID,WEIGHT LOSS
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,LACTOSE ENZYME,LACTOSE,2012-01-24,2012-01-24,,,,,C,Y,no dose,TABLET,ORAL,PRN,DIGESTIVE SUPPLEMENT
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OVER THE COUNTER CREAMS - NO ADDITONAL INFORMATION,OTHER EMOLLIENTS AND PROTECTIVES,2012-02-28,2012-02-28,,,,,C,Y,UKN,UKN,TOPICAL,PRN,HYPERPIGMENTATION - HANDS
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OMEGA-3 FISH OIL,FISH OIL,2012-02-28,2012-02-28,,,,,C,Y,1000,mg,ORAL,BID,SUPPLEMENT
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,TEMAZEPAM,TEMAZEPAM,2011,2011-12-13,M,,,,C,Y,15,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2011,2011-12-13,M,,,,C,Y,0.4,mg,ORAL,BID,DIFFICULTY UNRINATING
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,FELODIPINE,FELODIPINE,2012-04-15,2012-04-15,,2012-04-18,2012-04-18,,C,,5,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,HYDROCODONE,HYDROCODONE,2011-10-26,2011-10-26,,,,,C,Y,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,FENTANYL PATCH,FENTANYL,2012-01-24,2012-01-24,,2012-04-15,2012-04-15,,C,,25,ug,TRANSDERMAL,transdermal film extended release patch,PAIN
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,CITLOPRAM,CITALOPRAM,2011-10-27,2011-10-27,,,,,C,Y,40,mg,ORAL,QD,ANXIETY
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,METOPROLOL,METOPROLOL,2011-10-27,2011-10-27,,,,,C,Y,100,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,METAMUCIL,PLANTAGO OVATA,2011-10-27,2011-10-27,,,,,C,Y,3.4,g,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-10-27,2011-10-27,,,,,C,Y,20,mg,ORAL,BID,GERD
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2011-10-27,2011-10-27,,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,NICOTINE PATCH,NICOTINE,2011-12-13,2011-12-13,,,,,C,Y,14,mg,TRANSDERMAL,QD,STOP SMOKING
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,MORPHINE EXTENDED RELEASE,MORPHINE,2011-10-27,2011-10-27,,,,,C,Y,30,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,CRESTOR,ROSUVASTATIN CALCIUM,2001,2001-12-31,M,2012-06-20,2012-06-20,,C,,10,mg,ORAL,QD,DYSLIPIDEMIA
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,VALTREX,VALACICLOVIR HYDROCHLORIDE,2011-11-29,2011-11-29,,2011-12-11,2011-12-11,,C,,500,mg,ORAL,BID,COLD SORE
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-12-02,2011-12-02,,2012-01-04,2012-01-04,,C,,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,COLD FX (200 MG OF CVT-E002),UNSPECIFIED HERBAL,2011-12-25,2011-12-25,,2011-12-27,2011-12-27,,C,,2,TABLET,ORAL,BID,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,COMPRESSION STOCKINGS,ALL OTHER NON-THERAPEUTIC PRODUCTS,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,1,pair stockings,worn,ONCE,BILATERAL SWOLLEN ANKLES
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,CHINESE HERBAL LAXATIVE,SENNOSIDE A+B,2012-01-04,2012-01-04,,2012-01-05,2012-01-05,,C,,1,TABLET,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,SENOKOT-S,SENOKOT-S,2012-01-05,2012-01-05,,,,,C,Y,1,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,2012-01-04,2012-01-04,,2012-01-05,2012-01-05,,C,,25,mg,ORAL,ONCE,PRURITIS TO FACE
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,HYDROMORPH CONTIN,HYDROMORPHONE HYDROCHLORIDE,2012-01-05,2012-01-05,,,,,C,Y,6,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2012-01-05,2012-01-05,,,,,C,Y,1,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,KAYEXALATE,SODIUM POLYSTYRENE SULFONATE,2012-01-18,2012-01-18,,2012-01-19,2012-01-19,,C,,30,mg,ORAL,ONCE,HYPERKALEMIA
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,PANTOLOC,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2001,2001-12-31,M,,,,C,Y,40,mg,ORAL,BID,DECREASE GASTRIC SECRETIONS
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-01-04,2012-01-04,,,,,C,Y,1,TABLET,ORAL,q 4-6 hours prn,NAUSEA
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,CIPRALEX,ESCITALOPRAM,2012-03-20,2012-03-20,,2012-04-18,2012-04-18,,C,,10,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,IRON SUPPLEMENT,IRON,2012-02-27,2012-02-27,,2012-02-28,2012-02-28,,C,,1,TABLET,ORAL,PRN,ANEMIA
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,16.0,CONCOMITANT MEDICATIONS,,,DULOXETINE,DULOXETINE,2012-05-02,2012-05-02,,2012-05-02,2012-05-02,,C,,30,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,17.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-05-17,2012-05-17,,,,,C,Y,12500,IU,SUBCUTANEOUS,QD,PULMONARY EMBOLI
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,18.0,CONCOMITANT MEDICATIONS,,,VITAMIN B COMPLEX,VITAMIN B COMPLEX,2012-06-06,2012-06-06,,2012-06-20,2012-06-20,,,,1,mL,SUBCUTANEOUS,twice weekly,HEALTH PROMOTION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,19.0,CONCOMITANT MEDICATIONS,,,PROZAC,FLUOXETINE HYDROCHLORIDE,2012-05-02,2012-05-02,,2012-06-13,2012-06-13,,C,,10,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,20.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-06-20,2012-06-20,,,,,,Y,4,mg,ORAL,QD,PAIN AND NAUSEA
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,21.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2012-06-20,2012-06-20,,,,,,Y,2,mg,ORAL,every three hours,PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,22.0,CONCOMITANT MEDICATIONS,,,AVAPRO,IRBESARTAN,2001,2001-12-31,M,2012-01-19,2012-01-19,,C,,300,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,23.0,CONCOMITANT MEDICATIONS,,,ADALAT,NIFEDIPINE,2001,2001-12-31,M,2012-06-20,2012-06-20,,C,,30,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,24.0,CONCOMITANT MEDICATIONS,,,TYLENOL EXTRA STRENGTH,PARACETAMOL,2011-05,2011-04-30,D,2011-09-14,2011-09-14,,P,,2,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,25.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-09-15,2011-09-15,,2012-01-04,2012-01-04,,C,,1,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,26.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2011-09-08,2011-09-08,,,,,C,Y,1,mg,ORAL,QHS,SLEEP AID
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,27.0,CONCOMITANT MEDICATIONS,,,ZOPICLONE,ZOPICLONE,2011-09-22,2011-09-22,,2011-09-25,2011-09-25,,C,,7.5,mg,ORAL,QHS,SLEEP AID
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,28.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-09-22,2011-09-22,,2012-03-01,2012-03-01,,C,,10,mg,INTRAVENOUS,pre chemotherapy,NAUSEA
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-09-28,2011-09-28,,2011-11-02,2011-11-02,,C,,1,mg,SUBCUTANEOUS,Q4H,PAIN
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-10-14,2011-10-14,,2011-11-20,2011-11-20,,C,,4,mg,ORAL,x2 days post chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-10-07,2011-10-07,,2011-10-07,2011-10-07,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-21,2011-10-21,,2011-11-18,2011-11-18,,C,,8,mg,INTRAVENOUS,pre chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,GRAVOL,DIMENHYDRINATE,2011-11-02,2011-11-02,,2011-11-06,2011-11-06,,C,,50,mg,ORAL,prn q4h,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULPHATE,MORPHINE SULFATE,2011-11-02,2011-11-02,,2011-11-06,2011-11-06,,C,,5,mg,ORAL,prn q4h,PAIN
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-11-07,2011-11-07,,,,,C,Y,1,mg,SUBCUTANEOUS,Q4H,PAIN CONTROL
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,GRAVOL,DIMENHYDRINATE,2011-11-07,2011-11-07,,,,,C,Y,50,mg,RECTAL,q4h prn,NAUSEA AND VOMITING CONTROL
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,CEFUROXIME,CEFUROXIME,2011-11-03,2011-11-03,,2011-11-10,2011-11-10,,C,,500,mg,ORAL,BID,RESPIRATORY INFECTION
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,GRAVOL,DIMENHYDRINATE,2011-09-28,2011-09-28,,2011-11-01,2011-11-01,,C,,50,mg,SUBCUTANEOUS,q4h prn,NAUSEA
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SURFAK,DOCUSATE CALCIUM,2011-08-23,2011-08-23,,,,,C,Y,1,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2011-08-23,2011-08-23,,,,,C,Y,1,TABLET,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,LAX-A-DAY,MACROGOL,2011-08-17,2011-08-17,,,,,C,Y,17,mL,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,BOOST,BIOTIN W/CARBOHYDRATES NOS/FATS NOS/MINERALS,2011-09-02,2011-09-02,,,,,C,Y,1,BOTTLE,ORAL,QD,INCREASE NUTRITION
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-09-28,2011-09-28,,,,,C,Y,1,mg,SUBCUTANEOUS,PRN,PAIN
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,AKABUTU'S MOUTHWASH,"STOMATOLOGICALS, MOUTH PREPARATIONS",2011-09-30,2011-09-30,,2011-10-09,2011-10-09,,C,,30,mL,ORAL,PRN,TENDER THROAT
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-10-14,2011-10-14,,2011-11-20,2011-11-20,,C,,8,mg,ORAL,bid x2 days post chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,OLANZAPINE,OLANZAPINE,2011-10-16,2011-10-16,,,,,C,Y,5,mg,SUBLINGUAL,PRN,ANXIETY
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-10,2011-11-10,,2011-11-10,2011-11-10,,C,,8,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,RESTORALAX,MACROGOL 3350,2011-07-28,2011-07-28,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,HYDROXYZINE,HYDROXYZINE,2011-11-07,2011-11-07,,,,,C,Y,25,mg,ORAL,PRN,RASH (ANTI ITCH)
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,BENADRYL CREAM,DIPHENHYDRAMINE HYDROCHLORIDE,2011-11-12,2011-11-12,,,,,C,Y,1,dab of lotion,TOPICAL,PRN,RASH
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE 0.9%,SODIUM CHLORIDE,2011-11-10,2011-11-10,,2011-11-10,2011-11-10,,C,,1000,mL,INTRAVENOUS,ONCE,DEHYDRATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2011-11-25,2011-11-25,,,,,C,Y,0.8,mg,ORAL,QD,ENLARGED PROSTATE
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PHOSPHATE,SODIUM PHOSPHATE,2011-11-25,2011-11-25,,,,,C,Y,500,mg,ORAL,TID,TO INCREASE PHOSPHATE
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-11-25,2011-11-25,,,,,C,Y,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2011-11-20,2011-11-20,,,,,C,Y,40,mg,SUBCUTANEOUS,QD,BLOOD CLOTS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-11-19,2011-11-19,,,,,C,Y,70,mg,SUBCUTANEOUS,Q4H,PAIN
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-09-11,2011-09-11,,2011-11-19,2011-11-19,,C,,10,mg,ORAL,PRN,BREAKTHROUGH PAIN (ABDOMINAL)
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,POLYETHYLENE GLYCOL,MACROGOL,2011-11-25,2011-11-25,,2011-11-25,2011-11-25,,C,,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2011-11-19,2011-11-19,,2011-11-25,2011-11-25,,C,,40,mmol,INTRAVENOUS,BID,HYPOKALEMIA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,FLOMAX CR (TAMSULOSIN HCL),TAMSULOSIN HYDROCHLORIDE,2011-11-23,2011-11-23,,2011-11-25,2011-11-25,,C,,0.4,mg,ORAL,QD,ENLARGED PROSTATE
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,ZYPREXA ZYDIS,OLANZAPINE,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,5,mg,SUBLINGUAL,q12h prn,ANXIETY
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,GRAVOL,DIMENHYDRINATE,2011-11-22,2011-11-22,,2011-11-23,2011-11-23,,C,,50,mg,INTRAVENOUS,q4h prn,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-22,2011-11-22,,2011-11-22,2011-11-22,,C,,8,mg,INTRAVENOUS,q6h prn,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,RIVOTRIL,CLONAZEPAM,2011-11-21,2011-11-21,,2011-11-21,2011-11-21,,C,,0.5,mg,ORAL,qh prn,ANXIETY
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-11-19,2011-11-19,,2011-11-19,2011-11-19,,C,,8,mg,INTRAVENOUS,ONCE,STOMACH ACID
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,CLOZAPINE,CLOZAPINE,2011-11-19,2011-11-19,,2011-11-19,2011-11-19,,C,,0.5,mg,ORAL,qd prn,INSOMNIA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-11-24,2011-11-24,,,,,C,Y,400,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,SENNOSIDES,SENNOSIDE A+B,2011-09-11,2011-09-11,,,,,C,Y,8.6,mg,ORAL,2 tabs bid,CONSTIPATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-11-24,2011-11-24,,,,,C,Y,50,mg,ORAL,PRN,BREAKTHROUGH PAIN (ABDOMEN)
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-12-08,2011-12-08,,2011-12-08,2011-12-08,,C,,20,mg,INTRAVENOUS,ONCE,FLUID OVERLOAD
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2011-12-10,2011-12-10,,2011-12-17,2011-12-17,,C,,40,mEq,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,CEFTRIAXONE,CEFTRIAXONE,2011-12-28,2011-12-28,,2012-01-13,2012-01-13,,C,,1,g,INTRAVENOUS,QD,SUBACUTE BACTERIAL PERITONITIS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,TAZOCIN,PIP/TAZO,2011-12-18,2011-12-18,,2011-12-28,2011-12-28,,C,,4.5,g,INTRAVENOUS,Q8H,SUBACUTE BACTERIAL PERITONITIS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,RESTORALAX,MACROGOL 3350,2011-12-18,2011-12-18,,,,,C,Y,17,g,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,DEXEDRINE,DEXAMFETAMINE SULFATE,2012-01-03,2012-01-03,,2012-01-10,2012-01-10,,C,,2.5,mg,ORAL,QD,APPETITE STIMULANT
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,IMMOVANE,ZOPICLONE,2011-12-20,2011-12-20,,,,,C,Y,7.5,mg,ORAL,QHS,AID SLEEP
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,SCOPOLAMINE,HYOSCINE BUTYLBROMIDE,2012-01-17,2012-01-17,,,,,,Y,0.4,mg,SUBCUTANEOUS,q1h prn,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2012-01-15,2012-01-15,,,,,,Y,1000,mg,INTRAVENOUS,Q12H,SUBACUTE BACTERIAL PERITONITIS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,BISACODYL,BISACODYL,2011-10-15,2011-10-15,,,,,C,Y,10,mg,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,CILASTATIN,CILASTATIN,2012-01-16,2012-01-16,,,,,,Y,500,mg,INTRAVENOUS,Q6H,SUBACUTE BACTERIAL PERITONITIS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,GLYCOPYRROLATE,GLYCOPYRRONIUM,2012-01-15,2012-01-15,,,,,,Y,0.4,mg,SUBCUTANEOUS,q1h prn,DECREASE RESPIRATORY SECRETIONS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2012-01-13,2012-01-13,,,,,,Y,1,mg,SUBCUTANEOUS,q1h prn,AGITATION
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2012-01-15,2012-01-15,,,,,,Y,20,mg,SUBCUTANEOUS,ONCE,FLUID OVERLOAD
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,IMIPENEM,IMIPENEM,2012-01-15,2012-01-15,,,,,,Y,500,mg,INTRAVENOUS,Q6H,SUBACUTE BACTERIAL PERITONITIS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,DEXTROSE (D50),GLUCOSE,2012-01-12,2012-01-12,,2012-01-12,2012-01-12,,,,1,AMPULE,INTRAVENOUS,ONCE,HYPOGLYCEMIA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,41.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-09-11,2011-09-11,,2011-11-19,2011-11-19,,C,,100,mg,ORAL,bid x3 caps,PAIN (ABDOMINAL)
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,42.0,CONCOMITANT MEDICATIONS,,,METACLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,2011-09-11,2011-09-11,,2011-11-24,2011-11-24,,C,,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,43.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2011-07-28,2011-07-28,,2011-11-24,2011-11-24,,C,,0.4,mg,ORAL,QD,ENLARGED PROSTATE
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,44.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2011-07-28,2011-07-28,,,,,C,Y,40,mg,ORAL,QD,STOMACH ULCERS
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,45.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-27,2011-10-27,,,,,C,Y,10,mg,INTRAVENOUS,pre chemotherapy,NAUSEA
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"5-FU, LEUCOVORIN",,2012-05-15,2012-05-15,,2012-05-16,2012-05-16,,,,,,,,
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-10-11,2011-10-11,,2011-12-02,2011-12-02,,C,,2,mg,ORAL,QHS,PAIN
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-11-10,2011-11-10,,,,,C,Y,10,mg,ORAL,q4h prn,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-12-01,2011-12-01,,2012-04-26,2012-04-26,,C,,18000,IU,SUBCUTANEOUS,QD,DVT RIGHT LEG
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,SENOKOT-S,SENOKOT-S,2011-12-16,2011-12-16,,,,,C,Y,8.5,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ROBITUSSIN DM,TUSSIN DM,2012-03-01,2012-03-01,,2012-03-09,2012-03-09,,C,,10,mL,ORAL,q6-8 hours,COUGH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,BUCKLEY'S COUGH AND PHLEGM,DEXTROMETHORPHAN HYDROBROMIDE,2012-03-09,2012-03-09,,,,,C,Y,10,mL,ORAL,PRN,COUGH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-11-10,2011-11-10,,2012-02-17,2012-02-17,,C,,10,mg,INTRAVENOUS,pre chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-09,2012-03-09,,2012-04-13,2012-04-13,,C,,10,mg,ORAL,pre chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2012-03-29,2012-03-29,,2012-03-29,2012-03-29,,C,,500,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-04-03,2012-04-03,,2012-04-13,2012-04-13,,C,,500,mg,ORAL,BID,LEFT EPIDYMITIS
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2012-04-27,2012-04-27,,,,,C,Y,15000,IU,SUBCUTANEOUS,QD,DVT RIGHT LEG
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,SENOKOT -S,SENOKOT-S,2011-10-11,2011-10-11,,2011-12-15,2011-12-15,,C,,8.5,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2012-04-27,2012-04-27,,,,,C,Y,2,mg,ORAL,q2h prn,SHOULDER PAIN
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,CLOXACILLIN,CLOXACILLIN,2012-04-27,2012-04-27,,2012-04-29,2012-04-29,,C,,2000,mg,INTRAVENOUS,Q6H,CENTRAL LINE INFECTION
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2012-04-28,2012-04-28,,2012-05-04,2012-05-04,,C,,1,g,INTRAVENOUS,Q12H,CENTRAL LINE INFECTION
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2012-05-04,2012-05-04,,2012-05-11,2012-05-11,,C,,500,mg,ORAL,QD,LUNG INFECTION
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,CALCIUM MAGNESIUM,CALCIUM W/MAGNESIUM,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,1,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,PROBIOTICS,PROBIOTICS,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,1,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,BODYWISE AG IMMUNE,OTHER NUTRIENTS,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,2,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,PROTEA SE PLUS ENZYMES,PROTEASE,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,2,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DIGESTIVE ENZYMES,DIGESTIVES ENZYMES,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,1,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,OMEGA FISH OIL,FISH OIL,2011-10-09,2011-10-09,,2011-12-15,2011-12-15,,C,,1,TABLET,ORAL,PRN,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,BOOST,BIOTIN W/CARBOHYDRATES NOS/FATS NOS/MINERALS,2011-10-09,2011-10-09,,2011-11-30,2011-11-30,,C,,1,BOTTLE,ORAL,QD,PROMOTE GOOD NUTRITION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,OXYCODONE SR,OXYCODONE,2011-12-06,2011-12-06,,2012-01-03,2012-01-03,,C,,20,mg,ORAL,BID,PAIN CONTROL
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DULCOLAX,BISACODYL,2011-12-28,2011-12-28,,,,,C,Y,1,SUPPOSITORY,RECTAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-28,2011-12-28,,,,,C,Y,8,mg,ORAL,q8h prn,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,IMOVANE,ZOPICLONE,2011-12-31,2011-12-31,,,,,C,Y,7.5,mg,ORAL,QHS,PROMOTE SLEEP
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,OXYCODONE SR,OXYCODONE,2012-01-03,2012-01-03,,2012-04-20,2012-04-20,,C,,30,mg,ORAL,BID,PAIN CONTROL
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCODONE IR,OXYCODONE,2012-01-03,2012-01-03,,2012-02-20,2012-02-20,,C,,15,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,STEMATIL,PROCHLORPERAZINE,2012-01-03,2012-01-03,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,STEMATIL,PROCHLORPERAZINE,2011-12-30,2011-12-30,,2012-02-29,2012-02-29,,C,,10,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-01-04,2012-01-04,,,,,C,Y,1,mg,SUBLINGUAL,PRN,ANXIETY
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-04,2012-01-04,,2012-01-09,2012-01-09,,C,,4,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2011-12-30,2011-12-30,,,,,C,Y,2,L,INTRAVENOUS,QS,HYDRATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCODONE IR,OXYCODONE,2011-12-13,2011-12-13,,2012-01-03,2012-01-03,,C,,5,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,BENADRYL CREAM,DIPHENHYDRAMINE HYDROCHLORIDE,2012-01-04,2012-01-04,,2012-01-05,2012-01-05,,C,,1,Dab of cream,TOPICAL,PRN,RASH TO NECK
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-10,2012-01-10,,2012-01-17,2012-01-17,,C,,4 mg,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-18,2012-01-18,,2012-01-24,2012-01-24,,C,,2,mg,ORAL,QD,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-25,2012-01-25,,2012-01-31,2012-01-31,,C,,2,mg,ORAL,QOD,NAUSEA
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,BISACODYL,BISACODYL,2012-02-12,2012-02-12,,,,,C,Y,5,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,PAXIL,PAROXETINE HYDROCHLORIDE,2012-02-22,2012-02-22,,,,,C,Y,20,mg,ORAL,QHS,ANXIETY
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,OXYCODONE IR,OXYCODONE,2012-02-20,2012-02-20,,2012-04-20,2012-04-20,,C,,5,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2011-12-30,2011-12-30,,2012-02-29,2012-02-29,,C,,10,mg,INTRAVENOUS,pre chemotherapy,NAUSA/VOMITING
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-07,2012-03-07,,,,,C,Y,10,mg,ORAL,pre chemotherapy,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,OXYCODONE SR,OXYCODONE,2012-04-20,2012-04-20,,,,,C,Y,40,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,SENOKOT S,SENOKOT-S,2011-11-08,2011-11-08,,,,,C,Y,2,TABLET,ORAL,QHS,CONSTIPATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,OXYCODONE IR,OXYCODONE,2012-04-20,2012-04-20,,,,,C,Y,10,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-12-13,2011-12-13,,,,,C,Y,100,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,CENTRUM MULTIVITAMIN,MINERALS NOS W/VITAMINS NOS,2006-01-01,2006-01-01,,,,,C,Y,1,TABLET,ORAL,QD,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,VITAMIN D,VITAMIN D NOS,2011-10-20,2011-10-20,,,,,C,Y,3000,IU,ORAL,QD,PROMOTE GOOD HEALTH
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,SEROQUEL XR,QUETIAPINE FUMARATE,2011-10-20,2011-10-20,,2011-12-30,2011-12-30,,C,,50,mg,ORAL,QHS,PROMOTE SLEEP
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,29.0,CONCOMITANT MEDICATIONS,,,LAX A DAY,MACROGOL,2011-12-28,2011-12-28,,,,,C,Y,17,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,F,ASIAN,2.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,30.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2011-12-29,2011-12-29,,2011-12-29,2011-12-29,,P,,2,L,INTRAVENOUS,ONCE,HYDRATION
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-01-10,2012-01-10,,2012-03-03,2012-03-03,,C,,10,mg,ORAL,Q6H,PAIN
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-02-21,2012-02-21,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-02-15,2012-02-15,,2012-02-29,2012-02-29,,C,,10,mg,INTRAVENOUS,pre chemo,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-03-04,2012-03-04,,2012-03-08,2012-03-08,,C,,10,mg,ORAL,QD,PAIN
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,MAXERAN,METOCLOPRAMIDE HYDROCHLORIDE,2012-03-07,2012-03-07,,2012-09-26,2012-09-26,,C,,10,mg,ORAL,pre chemo,NAUSEA/VOMITING
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,ENSURE,NUTRIENTS NOS,2012-01-10,2012-01-10,,,,,C,Y,1,CAN,ORAL,QD,NUTRITION
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,FINASTERIDE,FINASTERIDE,2012-03-03,2012-03-03,,2012-04-10,2012-04-10,,C,,5,mg,ORAL,QD,BENIGN PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN,TAMSULOSIN,2012-03-03,2012-03-03,,2012-04-10,2012-04-10,,C,,0.4,mg,ORAL,QD,BENIGN PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,PEPTOBISMOL,BISMUTH SUBSALICYLATE,2012-03-12,2012-03-12,,2012-04-04,2012-04-04,,C,,2,oz,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,B COMPLEX,VITAMIN B COMPLEX,2012-03-12,2012-03-12,,,,,C,Y,1,TABLET,ORAL,QD,GOOD HEALTH PROMOTION
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",2012-01-10,2012-01-10,,2012-06-19,2012-06-19,,C,,1,TABLET,ORAL,QD,GOOD HEALTH PROMOTION
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-01-10,2012-01-10,,,,,C,Y,2.5,mg,ORAL,PRN,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,"CCI MOUTHWASH (VISCOUS XYLOCAINE 2%, NYSTATIN SUSP 100,000 UNITS/ML, NORMAL SALINE, HYDROCORTISONE 20 MG TABLETS, GLYCERIN)","STOMATOLOGICALS, MOUTH PREPARATIONS",2012-03-13,2012-03-13,,2012-04-21,2012-04-21,,C,,30,mL,ORAL,qid prn,STOMATITIS
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,AZITHROMYCIN,AZITHROMYCIN,2012-04-10,2012-04-10,,2012-04-10,2012-04-10,,C,,500,mg,ORAL,ONCE,PRODUCTIVE COUGH AND SORE THROAT
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,AZITHROMYCIN,AZITHROMYCIN,2012-04-11,2012-04-11,,2012-04-14,2012-04-14,,C,,250,mg,ORAL,QD,PRODUCTIVE COUGH AND SORE THROAT
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,COTAZYM (PANCREALIPASE),PANCRELIPASE,2012-04-03,2012-04-03,,2012-04-16,2012-04-16,,C,,3,TABLET,ORAL,TID,DIGESTION AIDE
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,COTAZYM (PANCREALIPASE),PANCRELIPASE,2012-04-17,2012-04-17,,,,,C,Y,4,TABLET,ORAL,TID,DIGESTION AIDE
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2012-07-18,2012-07-18,,,,,C,Y,200,mg,ORAL,PRN,HEADACHE
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-02-15,2012-02-15,,2012-02-29,2012-02-29,,C,,10,mg,INTRAVENOUS,pre chemo,NAUSEA
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PANTOLOC,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-10-15,2011-10-15,,,,,C,Y,40,mg,ORAL,QD,DECREASE GASTRIC SECRETIONS
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,FINASTERIDE,FINASTERIDE,2011-11-15,2011-11-15,,2012-02-21,2012-02-21,,C,,5,mg,ORAL,QD,BENIGN PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,TAMSULOSIN CR,TAMSULOSIN,2011-11-15,2011-11-15,,2012-02-21,2012-02-21,,C,,0.4,mg,ORAL,QD,BENIGN PROSTATIC HYPERTROPHY
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,GRAVOL,DIMENHYDRINATE,2011-12-10,2011-12-10,,,,,C,Y,50,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,COTAZYM (PANCREALIPASE),PANCRELIPASE,2012-01-10,2012-01-10,,2012-04-02,2012-04-02,,C,,2,TABLET,ORAL,TID,AIDS DIGESTION
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,M,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,BISACODYL,BISACODYL,2012-01-10,2012-01-10,,,,,C,Y,5,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,"5FU, LEUCOVORIN, OXALIPLATIN",,2012-05-17,2012-05-17,,2012-08-01,2012-08-01,,,,,,,,
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,VALSARTAN,VALSARTAN,2012-02-22,2012-02-22,,2012-04-04,2012-04-04,,C,,160,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-02,2012-05-02,,2012-05-04,2012-05-04,,C,,10,mg,ORAL,q1h prn,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2012-05-02,2012-05-02,,2012-05-07,2012-05-07,,C,,4,mg,PO or IV,BID,NAUSE/VOMITING
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,D5NS WITH 20 MEQ KCL,OSMOTAN,2012-05-02,2012-05-02,,2012-05-05,2012-05-05,,C,,150,mL,INTRAVENOUS,QH,DEHYDRATION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-04,2012-05-04,,2012-05-05,2012-05-05,,C,,5,mg,SC/IV,q1h prn,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-04,2012-05-04,,2012-05-05,2012-05-05,,C,,10,mg,SC/IV,Q4H,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,HALDOL,HALOPERIDOL,2012-05-04,2012-05-04,,2012-05-04,2012-05-04,,C,,1,mg,SUBCUTANEOUS,q4h prn,NAUSEA
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-04,2012-05-04,,2012-05-07,2012-05-07,,C,,20,mg,ORAL,Q4H,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2012-05-04,2012-05-04,,2012-05-04,2012-05-04,,C,,8.6,mg,ORAL,bid prn,CONSTIPATION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2012-05-04,2012-05-04,,2012-05-04,2012-05-04,,C,,100,mg,ORAL,bid prn,CONSTIPATION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,PANTOPRAZOLE,PANTOPRAZOLE,2012-05-02,2012-05-02,,,,,C,Y,40,mg,IV/PO,QD,ACID REFLUX
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2012-02-13,2012-02-13,,2012-04-22,2012-04-22,,C,,10,mg,ORAL,Q4H,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2012-05-07,2012-05-07,,,,,C,Y,30,mg,ORAL,Q8H,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE IR,MORPHINE SULFATE,2012-05-07,2012-05-07,,,,,C,Y,10,mg,ORAL,q1h prn,PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHINE SULFATE,MORPHINE SULFATE,2012-03-09,2012-03-09,,2012-04-22,2012-04-22,,C,,5,mg,ORAL,QD,BREAK THROUGH PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,RESTORALAX,MACROGOL 3350,2012-03-23,2012-03-23,,,,,C,Y,30,mL,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-03-27,2012-03-27,,2012-05-01,2012-05-01,,C,,10,mg,ORAL,pre chemotherapy,NAUSEA
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2012-03-28,2012-03-28,,,,,C,Y,10,mg,ORAL,QID PRN,NAUSEA
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-04-23,2012-04-23,,2012-05-02,2012-05-02,,C,,10,mg,ORAL,q4h prn,BREAKTHROUGH PAIN
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2012-04-23,2012-04-23,,2012-05-02,2012-05-02,,C,,45,mg,ORAL,BID,PAIN CONTROL
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,F,WHITE,5.0,CAN,CANADA,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-02,2012-05-02,,2012-05-02,2012-05-02,,C,,15,mg,SUBCUTANEOUS,ONCE,PAIN CONTROL
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,5 FU,,2011-12-12,2011-12-12,,2012-03-13,2012-03-13,,,,,,,,
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,LEUCOVORIN,,2011-12-12,2011-12-12,,2012-03-13,2012-03-13,,,,,,,,
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2012-04-10,2012-04-10,,,2012-04-10,Y,,,,,,,
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2009,2009-12-31,M,2011-06,2011-06-30,D,C,,10,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,VITAMIN B COMPLEX,VITAMIN B COMPLEX,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,MULTIVITAMIN,"MULTIVITAMINS, PLAIN",2003-09,2003-08-31,D,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,OMEGA 3 FATTY ACIDS,OMEGA-3 FATTY ACIDS,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,GLUCOSEMINE,GLUCOSAMINE,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,ZINC,ZINC,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,mg,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,ALPHAGAN,BRIMONIDINE TARTRATE,1990,1990-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,BID,GLAUCOMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,TIMOLOL,TIMOLOL,1990,1990-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,BID,GLAUCOMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,LUMIGAM,BIMATOPROST,1990,1990-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,QD,GLAUCOMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,ZYMAR,GATIFLOXACIN,1990,1990-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,QD,GLAUCOMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2007,2007-12-31,M,,,,C,Y,20,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,BACITRACIN OPTHALMIC OINTMENT,BACITRACIN,1990,1990-12-31,M,,,,C,Y,1,gtt,OPHTHALMIC,PRN,GLAUCOMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,IMMODIUM,LOPERAMIDE HYDROCHLORIDE,2011-08-01,2011-08-01,,,,,C,Y,1,TABLET,ORAL,PRN,INTERMITTENT DIARRHEA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,NEULASTA,PEGFILGRASTIM,2011-07-03,2011-07-03,,2011-11-03,2011-11-03,,C,,6,mg,SUBCUTANEOUS,ONCE,NEUTRPOENIA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-06-28,2011-06-28,,2011-09-06,2011-09-06,,C,,300,mg,SUBCUTANEOUS,given after treament dates,NEUTRPENIA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-06-21,2011-06-21,,,,,C,Y,1000,ug,INTRAVENOUS,each day of treatment,PRE MEDICATION
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-08-12,2011-08-12,,,,,C,Y,20,mg,ORAL,PRN,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-10-18,2011-10-18,,2011-10-18,2011-10-18,,C,,300,ug,SUBCUTANEOUS,ONCE,NEUTROPENIA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,PACKED RED BLOOD CELLS,"RED BLOOD CELLS, CONCENTRATED",2011-10-19,2011-10-19,,2011-10-19,2011-10-19,,C,,2,IU,INTRAVENOUS,ONCE,ANEMIA
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,LORATADINE,LORATADINE,2011-11-22,2011-11-22,,2011-11-29,2011-11-29,,C,,10,mg,ORAL,QD,SUFFY NOSE/ POST NASAL DROP
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,SALINE NASAL WASH,SODIUM CHLORIDE,2011-11-22,2011-11-22,,2011-11-29,2011-11-29,,C,,1,gtt,RESPIRATORY (INHALATION),PRN,STUFFY NOSE / POST NASAL DROP
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,PIROXICAM,PIROXICAM,2006,2006-12-31,M,,,,C,Y,20,mg,ORAL,QD,SPINAL STENOSIS
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-07-05,2011-07-05,,,,,C,Y,325,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2011-07-05,2011-07-05,,,,,C,Y,8.6,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,ZITHROMAX,AZITHROMYCIN,2011-10-28,2011-10-28,,2011-11-01,2011-11-01,,C,,500,mg,ORAL,QD,COUGH
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-09-02,2011-09-02,,2011-09-02,2011-09-02,,C,,480,ug,SUBCUTANEOUS,ONCE,NEUTROPENIA PREVENTIVE
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-09-06,2011-09-06,,2011-09-06,2011-09-06,,C,,480,ug,SUBCUTANEOUS,ONCE,NEUTROPENIA PREVENTIVE
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,32.0,CONCOMITANT MEDICATIONS,,,NEUPOGEN,FILGRASTIM,2011-09-23,2011-09-23,,2011-09-23,2011-09-23,,C,,480,ug,SUBCUTANEOUS,ONCE,NEUTROPENIA PREVENTIVE
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,33.0,CONCOMITANT MEDICATIONS,,,NEULASTA,PEGFILGRASTIM,2011-09-28,2011-09-28,,2011-09-28,2011-09-28,,C,,6,mg,SUBCUTANEOUS,ONCE,NEUTROPENIA PREVENTIVE
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,34.0,CONCOMITANT MEDICATIONS,,,OXYGEN,OXYGEN,2011-08-30,2011-08-30,,,,,C,Y,1-2,L,RESPIRATORY (INHALATION),PRN,SHORTNESS OF BREATH
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,35.0,CONCOMITANT MEDICATIONS,,,RANITIDINE,RANITIDINE,2005,2005-12-31,M,,,,C,Y,150,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,36.0,CONCOMITANT MEDICATIONS,,,GABAPENTIN,GABAPENTIN,2011-04,2011-03-31,D,,,,C,Y,300,mg,ORAL,TID,SPINAL STENOSIS
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,37.0,CONCOMITANT MEDICATIONS,,,ASPIRIN,ACETYLSALICYLIC ACID,2008,2008-12-31,M,,,,C,Y,65,mg,ORAL,QD,PREVENTIVE
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,38.0,CONCOMITANT MEDICATIONS,,,CALCIUM WITH VITAMIN D,CALCIUM D3                         /01483701/,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,39.0,CONCOMITANT MEDICATIONS,,,VITAMIN D3,COLECALCIFEROL,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,40.0,CONCOMITANT MEDICATIONS,,,VITAMIN C,ASCORBIC ACID,2006,2006-12-31,M,2011-06,2011-06-30,D,C,,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AMITIZIA,LUBIPROSTONE,2010,2010-12-31,M,,,,C,Y,24,ug,ORAL,QD,INTERMITTENT CONSTIPATION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,TYLENOL ARTHRITIS,PARACETAMOL,2008,2008-12-31,M,,,,C,Y,650,mg,ORAL,QD,PSORIATIC ARTHRITIS
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ZAROXOLYN,METOLAZONE,2007,2007-12-31,M,2011-10,2011-10-31,D,C,,5,mg,ORAL,QD,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2006-02-10,2006-02-10,,2011-10,2011-10-31,D,C,,25,mg,ORAL,QD,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ALLOPURINOL,ALLOPURINOL,2006-06,2006-05-31,D,,,,C,Y,400,mg,ORAL,QD,"GOUT, INTERMITTENT"
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,CELEXA,CITALOPRAM HYDROBROMIDE,2010-12,2010-11-30,D,,,,C,Y,20,mg,ORAL,QD,DEPRESSION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,KLOR CON,POTASSIUM CHLORIDE,2011-10,2011-10-01,D,,,,C,Y,20,mEq,ORAL,QD,POTASSIUM REPLACEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2011-10,2011-10-01,D,2012-02-09,2012-02-09,,C,,100,mg,ORAL,QD,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-10,2011-10-01,D,2011-11,2011-11-30,D,C,,40,mg,ORAL,QD,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-11,2011-11-01,D,,,,C,Y,80,mg,ORAL,QD,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2012-01-14,2012-01-14,,,,,C,Y,2,TABLET,ORAL,BID,INTERMITTENT CONSTIPATION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,BIFERA,BIFERA,2011-05,2011-04-30,D,,,,C,Y,28,mg,ORAL,QD,MACROCYTIC ANEMIA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-12,2011-12-01,D,2011-12-29,2011-12-29,,C,,100,mg,ORAL,QHS,INTERNMITTENT CONSTIPATION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-12-29,2011-12-29,,,,,C,Y,30,mL,ORAL,BID,INTERMITTENT CONSTIPATION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,MINERAL OIL,PARAFFIN,2012-01-04,2012-01-04,,,,,C,Y,15,mg,ORAL,PRN,INTERNMITTENT CONSTIPATION
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2011-08-11,2011-08-11,,,,,C,Y,40,mg,ORAL,PRN,CT CONTRAST ALLERGY
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,TAGAMET,CIMETIDINE,2011-08-11,2011-08-11,,,,,C,Y,unknown,mg,ORAL,PRN,CT CONTRAST ALLERGY
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,2011-08-11,2011-08-11,,,,,C,Y,50,mg,ORAL,PRN,CT CONTRAST ALLERGY
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,ALDACTONE,SPIRONOLACTONE,2012-02-09,2012-02-09,,,,,C,Y,100,mg,ORAL,BID,LOWER EXTREMITY EDEMA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,ZITHROMAX,AZITHROMYCIN,2012-01-30,2012-01-30,,2012-02-03,2012-02-03,,C,,500,mg,ORAL,QD,DYSPNEA
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-01-12,2012-01-12,,,,,C,Y,400,mg,ORAL,BID,MAGNESIUM REPLACEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,CALCIUM 500 + VITAMIN D,CALCIUM D3                         /01483701/,2011-05,2011-04-30,D,,,,C,Y,500,mg,ORAL,QD,CALCIUM RERPLACEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,ENBREL,ETANERCEPT,2009,2009-12-31,M,2011-06,2011-06-30,D,C,,25,mg,SUBCUTANEOUS,QS,PSORIATIC ARTHRITIS
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2011-06-16,2011-06-16,,2012-01-12,2012-01-12,,C,,27,mg,ORAL,QD,MAGNESIUM REPLACEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,MAGNESIUM,MAGNESIUM,2012-01-12,2012-01-12,,,,,C,Y,400,mg,ORAL,QD,MAGNESIUM REPLACEMENT
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2009,2009-12-31,M,,,,C,Y,500,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,27.0,CONCOMITANT MEDICATIONS,,,NORTRIPTYLINE,NORTRIPTYLINE,2008,2008-12-31,M,,,,C,Y,50,mg,ORAL,QD,PERIPHERAL NEUROPATHY
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,28.0,CONCOMITANT MEDICATIONS,,,PRILOSE,OMEPRAZOLE,2009,2009-12-31,M,,,,C,Y,20,mg,ORAL,QD,ACID REFLUX PROPHYLAXIS
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-09-12,2011-09-12,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,MILK OF MAGNESIA,MAGNESIUM HYDROXIDE,2011-08-10,2011-08-10,,,,,C,Y,2,Tbsp,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,NORCO,VICODIN,2011-06-24,2011-06-24,,2011-07-28,2011-07-28,,C,,one,TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011,2011-07-28,M,,,,C,Y,200,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,PRILOSEC,OMEPRAZOLE,2011-07-05,2011-07-05,,,,,C,Y,20,mg,ORAL,BID,HEARTBURN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-07-28,2011-07-28,,2011-07-29,2011-07-29,,C,,5-10,mg,ORAL,q 3-4 hrs prn,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DILAUDID,HYDROMORPHONE HYDROCHLORIDE,2011-07-29,2011-07-29,,2011-07-29,2011-07-29,,C,,1,mg,INTRAVENOUS,ONCE,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2011-07-22,2011-07-22,,,,,C,Y,1000,mg,INTRAVENOUS,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-07-29,2011-07-29,,,,,C,Y,0.5,mg,INTRAVENOUS,PRN,ANXIETY
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2011-07-28,2011-07-28,,,,,C,Y,1000,ug,INTRAVENOUS,PRN,CHEMO PRE-MED
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-07-28,2011-07-28,,,,,C,Y,0.5,mg,INTRAVENOUS,PRN,CHEMO PRE-MED
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-22,2011-07-22,,,,,C,Y,10,mg,INTRAVENOUS,PRN,"NAUSEA, VOMITING"
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2011-08-10,2011-08-10,,,,,C,Y,unk,,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-07-28,2011-07-28,,,,,C,Y,8,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,SCOPALAMINE PATCH,HYOSCINE BUTYLBROMIDE,2011-07-29,2011-07-29,,,,,C,Y,1.5,mg,TRANSDERMAL,Q3D,NAUSEA
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2011-07-29,2011-07-29,,2011-08-06,2011-08-06,,C,,20,mg/mL,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2011-07-22,2011-07-22,,,,,C,Y,1000,mL,INTRAVENOUS,PRN,DEHYDRATION
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2011-07-29,2011-07-29,,,,,C,Y,1,TABLET,ORAL,BID,CONSTIPATION
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,EMLA CREAM,EMLA                               /00675501/,2011-07-29,2011-07-29,,,,,C,Y,1,BLOB,TRANSDERMAL,PRN,PORT NEEDLE INSERTION
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-08-10,2011-08-10,,,,,C,Y,5,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2011-08-18,2011-08-18,,,,,C,Y,10,mg,ORAL,PRN,VOMITING
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,DRONABINOL,DRONABINOL,2011-08-25,2011-08-25,,,,,C,Y,5,mg,ORAL,PRN,NAUSEA AND VOMITING
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,VALTREX,VALACICLOVIR HYDROCHLORIDE,2011-08-25,2011-08-25,,,,,C,Y,1,g,ORAL,TID,SHINGLES
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-08-25,2011-08-25,,,,,C,Y,15,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2011-07-05,2011-07-05,,2011-07-11,2011-07-11,,P,,15,mg,ORAL,BID,ABDOMINAL PAIN
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,26.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011-07-05,2011-07-05,,2011-07-13,2011-07-13,,P,,40,mg,ORAL,QD,HEARTBURN
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,GARBAPENTIN,GABAPENTIN,2011-11-09,2011-11-09,,,,,C,Y,400,mg,ORAL,BID,PERIPHERAL NEUROPATHY
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,SENOKOT,SENNA ALEXANDRINA,2012-01-30,2012-01-30,,,,,C,Y,1,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,ZOYSN,PIP/TAZO,2012-01-27,2012-01-27,,2012-01-29,2012-01-29,,P,,4.5,mg,INTRAVENOUS,QD,PANCREATITIS
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,LEVAQUIN,LEVOFLOXACIN,2012-01-29,2012-01-29,,2012-02-03,2012-02-03,,C,,750,mg,ORAL,QD,PANCREATITIS
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,FLAGYL,METRONIDAZOLE,2012-01-29,2012-01-29,,2012-02-03,2012-02-03,,C,,500,mg,ORAL,QD,PANCREATITIS
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2012-05-17,2012-05-17,,2012-05-17,2012-05-17,,C,,4,mg,INTRAVENOUS,TID,VOMITING
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2010-05-17,2010-05-17,,2012-05-19,2012-05-19,,C,,12.5,mg,RECTAL,BID,NAUSEA
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,PIPERACILLIN TAZOBACTAM,PIP/TAZO,2012-05-17,2012-05-17,,2012-05-20,2012-05-20,,C,,4.5,g,INTRAVENOUS,TID,FEVER
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,ACETAMINOPHEN,PARACETAMOL,2012-05-17,2012-05-17,,2012-05-20,2012-05-20,,C,,500,mg,ORAL,QID,FEVER
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2012-05-18,2012-05-18,,2012-05-20,2012-05-20,,C,,1250,mg,INTRAVENOUS,BID,FEVER
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2012-05-20,2012-05-20,,,,,C,Y,750,mg,ORAL,QD,FEVER
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-01-16,2012-01-16,,,,,C,Y,10,mg,ORAL,PRN,PAIN - NECK AND BACK
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,METRONIDAZOLE,METRONIDAZOLE,2012-05-20,2012-05-20,,,,,C,Y,500,mg,ORAL,TID,FEVER
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,PEPCID,FAMOTIDINE,2012-01-16,2012-01-16,,,,,C,Y,20,mg,ORAL,QHS,DYSPEPSIA
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2012-01-16,2012-01-16,,,,,C,Y,10,mg,ORAL,Q12H,PAIN-BACK/NECK
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2012-01-30,2012-01-30,,,,,C,Y,10,mg,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,NORMAL SALINE,SODIUM CHLORIDE,2012-01-30,2012-01-30,,,,,C,Y,1000,mL,INTRAVENOUS,PRN,DEHYDRATION
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,EMLA,EMLA                               /00675501/,2012-01-30,2012-01-30,,,,,C,Y,1,APPLICATION,TOPICAL,1 hr prior to txt,PORT ACCESS
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2012-01-27,2012-01-27,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-02-28,2012-02-28,,,,,C,Y,17,g,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2011-09-20,2011-09-20,,2011-10-19,2011-10-19,,,,,,,,
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2011-11-08,2011-11-08,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,TYLENOL ARTHRITIS PAIN,PARACETAMOL,2008-09-04,2008-09-04,,,,,C,Y,650,mg,ORAL,BID,ARTHRITIS PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-29,2011-07-29,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA/VOMITING
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,PROCHLORPERAZINE MALEATE,PROCHLORPERAZINE MALEATE,2011-07-29,2011-07-29,,2011-09-12,2011-09-12,,C,,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-08-02,2011-08-02,,2011-09-12,2011-09-12,,C,,2,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-08-10,2011-08-10,,,,,C,Y,100,mg,ORAL,TID,CONSTIPATION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2011-08-10,2011-08-10,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,OXYCONTIN,OXYCODONE HYDROCHLORIDE,2011-08-10,2011-08-10,,,,,C,Y,80,mg,ORAL,"20mg in AM, 20mg @ 8th hour and 40mg QPM",ABDOMINAL PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2011-08-10,2011-08-10,,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-08-11,2011-08-11,,,,,C,Y,2,TABLET,ORAL,QHS,CONSTIPATION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-08,2011-08-04,D,,,,C,Y,0.5,mg,ORAL,PRN,NAUSEA/ANXIETY/SLEEP
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,SCOPOLAMINE,HYOSCINE BUTYLBROMIDE,2011-08-15,2011-08-15,,2011,2011-12-31,M,C,,1,PATCH,TRANSDERMAL,Q3D,NAUSEA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,CIALIS,TADALAFIL,2008-10-13,2008-10-13,,,,,C,Y,20,mg,ORAL,PRN,ERECTILE DYSFUNCTION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2011-08,2011-08-04,D,2011-08,2011-08-31,D,C,,500,mg,ORAL,PRN,PAIN FROM PHLEBITIS
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,CEPHALEXIN,CEFALEXIN,2011-08-13,2011-08-13,,2011-08-18,2011-08-18,,C,,250,mg,ORAL,TID,PHLEBITIS INFECTIVE
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,LIDOCAINE-PRILOCAINE 2.5-2.5%,EMLA                               /00675501/,2011-08-25,2011-08-25,,,,,C,Y,1,IN,TOPICAL,PRN,PRIOR TO PORT ACCESS
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,LYRICA,PREGABALIN,2011-08-29,2011-08-29,,,,,C,Y,50,mg,ORAL,BID,LOW BACK PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-09-02,2011-09-02,,,,,C,Y,10000,IU,SUBCUTANEOUS,QD,PRIOR HISTORY OF PE
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,ACTIQ (FENTANYL CITRATE LOLLIPOP),FENTANYL CITRATE,2011-08-26,2011-08-26,,,,,C,Y,200,ug,ORAL,PRN,SEVERE ACUTE-ON-CHRONIC BACK PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,PHENERGAN,PROMETHAZINE,2011-09-03,2011-09-03,,2011-09-26,2011-09-26,,C,,12.5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,22.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-08-29,2011-08-29,,2011-09-08,2011-09-08,,C,,tapered dose,mg,ORAL,tapered dose,NAUSEA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,23.0,CONCOMITANT MEDICATIONS,,,OMEPRAZOLE,OMEPRAZOLE,2011-10-03,2011-10-03,,,,,C,Y,40,mg,ORAL,QD,NAUSEA/FAILURE TO THRIVE
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,24.0,CONCOMITANT MEDICATIONS,,,REMERON,MIRTAZAPINE,2011-10-03,2011-10-03,,,,,C,Y,15,mg,ORAL,QHS,ANTIDEPRESSANT
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,25.0,CONCOMITANT MEDICATIONS,,,SIMVASTATIN,SIMVASTATIN,2008-10-13,2008-10-13,,2011-09-03,2011-09-03,,C,,40,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,26.0,CONCOMITANT MEDICATIONS,,,ADVAIR DISKUS,SERETIDE,2010-01-18,2010-01-18,,,,,C,Y,100-50,ug,RESPIRATORY (INHALATION),BID,ASTHMA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,27.0,CONCOMITANT MEDICATIONS,,,PROVENTIL HFA,SALBUTAMOL,2008-12-02,2008-12-02,,,,,C,Y,108 (90 base),ug,RESPIRATORY (INHALATION),PRN,ASTHMA
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,28.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE BESY-BENAZEPRIL HCL,AMLODIPINE BESYLATE W/BENAZEPRIL HYDROCHLOR.,2010-07-30,2010-07-30,,,,,C,Y,5-20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,29.0,CONCOMITANT MEDICATIONS,,,WARFARIN SODIUM,WARFARIN SODIUM,1996,1996-12-31,M,2011-09,2011-09-30,D,C,,2-5,mg,ORAL,QD,ANTICOAGULANT
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,30.0,CONCOMITANT MEDICATIONS,,,OXYCODONE-ACETAMINOPHEN,OXYCOCET,2011-06-29,2011-06-29,,,,,C,Y,5-325,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,31.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-08-02,2011-08-02,,,,,C,Y,2,Tbsp,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMCITABINE,,2011-09-30,2011-09-30,,2011-11-03,2011-11-03,,,,,,,,
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,RADIOTHERAPY,RADIATION THERAPY TO PELVIS,,2011-12-12,2011-12-12,,,2011-12-31,Y,,,,,,,
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,DIOVAN,VALSARTAN,2007,2007-12-31,M,2011-09-08,2011-09-08,,C,,40,mg,ORAL,QD,HIGH BLOOD PRESSURE
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,HYDROMORPHONE,HYDROMORPHONE,2011-09,2011-09-01,D,,,,C,Y,2,mg,ORAL,PRN,ABDOMINAL (AND OCCASIONAL LEG) PAIN
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-09,2011-09-01,D,,,,C,Y,100,mg,ORAL,PRN,STOOL SOFTENER
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-09,2011-09-01,D,,,,C,Y,1-2 (8.6 mg each),mg,ORAL,PRN,STOOL SOFTENER
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,CELEBREX,CELECOXIB,2011-09,2011-09-01,D,,,,C,Y,100,mg,ORAL,PRN,ABDOMINAL/LEG PAIN
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,XANAX,ALPRAZOLAM,2011-09-22,2011-09-22,,,,,C,Y,0.25,mg,ORAL,PRN,ANXIETY
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,LIPITOR,ATORVASTATIN CALCIUM,2006,2006-12-31,M,2011-08-25,2011-08-25,,C,,10,mg,ORAL,QD,HIGH CHOLESTEROL
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,PROTONIX,PANTOPRAZOLE SODIUM SESQUIHYDRATE,2011-02,2011-01-31,D,,,,C,Y,40,mg,ORAL,QD,GERD
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,TRAMADOL,TRAMADOL,2011-08-18,2011-08-18,,,,,C,Y,50-100,mg,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,BISACODYL/DULCOLAX,BISACODYL,2011-08-25,2011-08-25,,,,,C,Y,1-2,TABLET,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,LASIX,FUROSEMIDE,2011-09-01,2011-09-01,,2011-09-08,2011-09-08,,C,,20,mg,ORAL,"QD, PRN",BILATERAL ANKLE EDEMA
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2011-09-08,2011-09-08,,,,,C,Y,1-2 (500mg each),TABLET,ORAL,PRN,ABDOMINAL PAIN
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,FRAGMIN,DALTEPARIN SODIUM,2011-09-09,2011-09-09,,,,,C,Y,10000,IU,SUBCUTANEOUS,QD,BILATERAL CALF VEIN THROMBOSIS
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,COUMADIN (WARFARIN),WARFARIN,2011-09-09,2011-09-09,,,,,C,Y,1-5,mg,ORAL,QD,BILATERAL CALF VEIN THROMBOSIS
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX,,2012-01-18,2012-01-18,,2012-08-24,2012-08-24,,,,,,,,
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFIRI,,2012-09-05,2012-09-05,,,2012-09-05,Y,,,,,,,
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2002,2002-12-31,M,2011-12-28,2011-12-28,,C,,7.5 mg,mg,ORAL,QD,ATRIAL FIBRILLATION
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,VITAMIN C,ASCORBIC ACID,2010,2010-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,VITAMIN SUPPLEMENT
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2011,2011-11-09,M,,,,C,Y,40,mg,ORAL,QD,ABDOMINAL DISCOMFORT
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,HUMALOG INSULIN,INSULIN LISPRO,2011-09,2011-08-31,D,,,,C,Y,sliding scale,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,LANTUS INSULIN,INSULIN GLARGINE,2011-09,2011-08-31,D,,,,C,Y,sliding scale,IU,SUBCUTANEOUS,PRN,DIABETES MELLITUS
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-11-09,2011-11-09,,,,,C,Y,10,mg,ORAL,PRN,PROPHYLACTIC NAUSEA & VOMITING
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,GLIPIZIDE,GLIPIZIDE,2011-09,2011-08-31,D,,,,C,Y,5,mg,ORAL,QD,DIABETES MELLITUS
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,PRADAXA,DABIGATRAN ETEXILATE MESILATE,2010,2010-12-31,M,,,,C,Y,150,mg,ORAL,BID,ATRIAL FIBRILLIATION
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,TOPROL XL,METOPROLOL SUCCINATE,2002,2002-12-31,M,,,,C,Y,100,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,METHOTREXATE,METHOTREXATE,2011,2011-11-09,M,2011-10,2011-11-09,D,C,,2.5,mg,ORAL,5 tabs per week,RHEUMATOID ARTHRITIS
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,2002,2002-12-31,M,,,,C,Y,12.5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FOLIC ACID,FOLIC ACID,2011,2011-11-09,M,,,,C,Y,1,mg,ORAL,QD,VITAMIN SUPPLEMENT
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011,2011-11-09,M,,,,C,Y,10,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,PREDNISONE,PREDNISONE,2011-11-03,2011-11-03,,,,,C,Y,10,mg,ORAL,QD,RHEUMATOID ARTHRITIS
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,CONCOMITANT MEDICATIONS,,,MEGESTROL,MEGESTROL,2012-03-11,2012-03-11,,2012-07-20,2012-07-20,,C,,2,tsp,ORAL,QD,FOR DECREASED APPETITE
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,ATENOLOL,ATENOLOL,2012-06-28,2012-06-28,,2012-07-20,2012-07-20,,C,,50,mg,ORAL,QD,BLOOD PRESSURE
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,LISINOPRIL,LISINOPRIL,2012-06-29,2012-06-29,,2012-07-20,2012-07-20,,C,,30,mg,ORAL,QD,BLOOD PRESSURE
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2012-06-29,2012-06-29,,2012-07-20,2012-07-20,,C,,15,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2012-03-28,2012-03-28,,2012-07-20,2012-07-20,,C,,1,mg,INTRAVENOUS,Q chemo infusion,NAUSEA
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,2012-07-18,2012-07-18,,2012-07-20,2012-07-20,,C,,40,mEq,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2012-01,2011-12-31,D,,,,C,Y,As Needed,TABLET,ORAL,PRN,PAIN
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,IBUPROFEN,IBUPROFEN,2011-09,2011-08-31,D,2012-07-20,2012-07-20,,C,,As Needed,TABLET,ORAL,PRN,FOR PAIN
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,KAPPAREST,KAPPAREST,2012-03,2012-03-28,D,2012-07-20,2012-07-20,,C,,2,TABLET,ORAL,TID,HOLISTIC - VITAMIN
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,OPTIMAL-INGREDIENTS UNKNOWN,ALL OTHER THERAPEUTIC PRODUCTS,2012-03,2012-03-28,D,,,,C,Y,1,TABLET,ORAL,TID,HOLISTIC
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,CALCIUM,CALCIUM,2012-03,2012-03-28,D,,,,C,Y,6,TABLET,ORAL,TID,HOLISTIC
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,DRONABUNOL,DRONABINOL,2012-05-09,2012-05-09,,2012-07-20,2012-07-20,,C,,2.5,mg,ORAL,BID,ANOREXIA
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,MORPHINE,MORPHINE,2012-05-09,2012-05-09,,2012-07-20,2012-07-20,,C,,15,mg,ORAL,q4 hours,PAIN
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,FENTANYL,FENTANYL,2012-06-28,2012-06-28,,2012-07-20,2012-07-20,,C,,25,ug,TRANSDERMAL,QD,PAIN
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,FOLFOX-6,,2011-12-05,2011-12-05,,2012-03-29,2012-03-29,,,,,,,,
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,2.0,CONCOMITANT MEDICATIONS,,,AMLODIPINE,AMLODIPINE,2011,2011-07-12,M,,,,C,Y,5,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,3.0,CONCOMITANT MEDICATIONS,,,BENADRYL,DIPHENHYDRAMINE HYDROCHLORIDE,2011-07-16,2011-07-16,,2011-07-18,2011-07-18,,C,,25,mg,ORAL,QID,ITCHING
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,4.0,CONCOMITANT MEDICATIONS,,,FAMOTIDINE,FAMOTIDINE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,40,mg,INTRAVENOUS,ONCE,RASH
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,5.0,CONCOMITANT MEDICATIONS,,,DIPHENHYDRAMINE,DIPHENHYDRAMINE,2011-07-26,2011-07-26,,2011-07-26,2011-07-26,,C,,25,mg,INTRAVENOUS,ONCE,ITCHING
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,6.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2011-08-05,2011-08-05,,2011-08-10,2011-08-10,,C,,10,mg,ORAL,TID,NAUSEA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,7.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2011-08-05,2011-08-05,,,,,C,Y,1,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,8.0,CONCOMITANT MEDICATIONS,,,PRILOSEC,OMEPRAZOLE,2011-08-05,2011-08-05,,,,,C,Y,20,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,9.0,CONCOMITANT MEDICATIONS,,,MEGESTROL,MEGESTROL,2011-08-19,2011-08-19,,,,,C,Y,800,mg,ORAL,BID,ANOREXIA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,10.0,CONCOMITANT MEDICATIONS,,,LACTULOSE,LACTULOSE,2011-07-18,2011-07-18,,2011-08-10,2011-08-10,,C,,20,g,ORAL,BID PRN,CONSTIPATION
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,11.0,CONCOMITANT MEDICATIONS,,,COLACE,DOCUSATE SODIUM,2011-08-10,2011-08-10,,2011-08-24,2011-08-24,,C,,100,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,12.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2011-07-12,2011-07-12,,,,,C,Y,1,mg,INTRAVENOUS,QS,ANTIEMETIC
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,13.0,CONCOMITANT MEDICATIONS,,,BENAZEPRIL,BENAZEPRIL,2011,2011-07-12,M,,,,C,Y,20,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,14.0,CONCOMITANT MEDICATIONS,,,DEXAMETHASONE,DEXAMETHASONE,2011-07-12,2011-07-12,,,,,C,Y,4,mg,INTRAVENOUS,QS,ANITEMETIC
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,15.0,CONCOMITANT MEDICATIONS,,,SITAGLIPTIN,SITAGLIPTIN,2011,2011-07-12,M,,,,C,Y,50,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,16.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2011,2011-07-12,M,,,,C,Y,1000,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,17.0,CONCOMITANT MEDICATIONS,,,PRAVASTATIN,PRAVASTATIN,2011,2011-07-12,M,,,,C,Y,20,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,18.0,CONCOMITANT MEDICATIONS,,,MS CONTIN,MORPHINE SULFATE,2011-07-05,2011-07-05,,,,,C,Y,15,mg,ORAL,BID,PAIN
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,19.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-07-12,2011-07-12,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,20.0,CONCOMITANT MEDICATIONS,,,PROCHLORPERAZINE MALEATE,PROCHLORPERAZINE MALEATE,2011-07-08,2011-07-08,,,,,C,Y,10,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,21.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2011-07-05,2011-07-05,,,,,C,Y,5/500,mg,ORAL,q4hrs prn,PAIN
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,AMBIEN,ZOLPIDEM TARTRATE,2011-09-29,2011-09-29,,,,,C,Y,5,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2011-10-12,2011-10-12,,,,,C,Y,0.5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,METOCLOPRAMIDE,METOCLOPRAMIDE,2011-10-13,2011-10-13,,,,,C,Y,10,mg,ORAL,QID,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,0.9% SALINE,SODIUM CHLORIDE,2011-10-11,2011-10-11,,,,,C,Y,1000,mL,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2011-10-13,2011-10-13,,,,,C,Y,40,mEq,INTRAVENOUS,PRN,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,PEPCID,FAMOTIDINE,2011-10-13,2011-10-13,,2011-10-13,2011-10-13,,C,,40,mg,INTRAVENOUS,ONCE,DYSPEPSIA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,SOLUMEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2011-11-01,2011-11-01,,2011-11-01,2011-11-01,,C,,25,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2012-11-15,2012-11-15,,2012-11-25,2012-11-25,,,,400,mg,INTRAVENOUS,BID,PERITONEAL INFECTION
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,KAYEXALATE,SODIUM POLYSTYRENE SULFONATE,2011-10-13,2011-10-13,,2011-10-15,2011-10-15,,C,,4,g,ORAL,QD,HYPERKALEMIA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,FUROSEMIDE,FUROSEMIDE,2011-10-15,2011-10-15,,2011-10-18,2011-10-18,,C,,40,mg,ORAL,QD,DIURESIS
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,ALBUMIN,ALBUMIN HUMAN,2011-10-19,2011-10-19,,,,,C,Y,25,%/1000ml,INTRAVENOUS,PRN,PROTEIN DEPLETION
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,GRANISETRON,GRANISETRON,2011-10-11,2011-10-11,,2011-10-16,2011-10-16,,C,,3.1/24h,mg,TRANSDERMAL,QS,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,REGLAN,METOCLOPRAMIDE,2011-11-01,2011-11-01,,,,,C,Y,10,mg,INTRAVENOUS,TID,GASTROPARESIS
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,SOLUCORTEF,HYDROCORTISONE SODIUM SUCCINATE,2011-11-01,2011-11-01,,,,,C,Y,40,mg,INTRAVENOUS,QD,ADRENAL INSUFFICIENCY
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,TPN,SOLUTIONS FOR PARENTERAL NUTRITION,2011-10-29,2011-10-29,,,,,C,Y,2500,mL,INTRAVENOUS,14hrs/day,ANOREXIA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ZOMETA,ZOLEDRONIC ACID,2011-10-07,2011-10-07,,,,,C,Y,4,mg,INTRAVENOUS,QM,MALIGNANT BONE NEOPLASM
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2011-10-04,2011-10-04,,2011-11-01,2011-11-01,,C,,1,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,18.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-10-04,2011-10-04,,2011-11-01,2011-11-01,,C,,4,mg,INTRAVENOUS,QS,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,19.0,CONCOMITANT MEDICATIONS,,,MILK OF MAGNESIA,MAGNESIUM HYDROXIDE,2011-09-27,2011-09-27,,,,,C,Y,30,mL,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,20.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2011-09-27,2011-09-27,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,21.0,CONCOMITANT MEDICATIONS,,,ONDANSETRON,ONDANSETRON,2011-10-04,2011-10-04,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,22.0,CONCOMITANT MEDICATIONS,,,PRILOSEC,OMEPRAZOLE,2011-09-29,2011-09-29,,2011-11-04,2011-11-04,,C,,40,mg,ORAL,BID,HEARTBURN
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,23.0,CONCOMITANT MEDICATIONS,,,PROCHLORPERAZINE,PROCHLORPERAZINE,2011-10-11,2011-10-11,,,,,C,Y,5,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,24.0,CONCOMITANT MEDICATIONS,,,SENNA,SENNA ALEXANDRINA,2011-10-04,2011-10-04,,,,,C,Y,8.6,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,25.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2011-09-29,2011-09-29,,,,,C,Y,5,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,CONCOMITANT MEDICATIONS,,,ADVIL,IBUPROFEN,2011,2011-12-31,M,,,,C,Y,200,mg,ORAL,PRN,PAIN
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,LUNESTA,ESZOPICLONE,2012-01-10,2012-01-10,,2012-04-10,2012-04-10,,C,,2,mg,ORAL,PRN,INSOMNIA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,SANCUSO,GRANISETRON HYDROCHLORIDE,2012-01-31,2012-01-31,,2012-03-20,2012-03-20,,C,,3.1,mg/day,TRANSDERMAL,QS,ANTINAUSEA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2012-03-06,2012-03-06,,2012-03-27,2012-03-27,,C,,600,mg,ORAL,BID,ANOREXIA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2012-02-21,2012-02-21,,,,,C,Y,1,mg,ORAL,PRN,ANTINAUSEA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,BIOTIN,BIOTIN,2012-03-15,2012-03-15,,,,,C,Y,5000,ug,ORAL,QD,HAIR GROWTH
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,DULCOLAX,BISACODYL,2012-03-20,2012-03-20,,,,,C,Y,5,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,ZITHROMAX,AZITHROMYCIN,2012-04-03,2012-04-03,,2012-04-07,2012-04-07,,C,,250,mg,ORAL,QD,PRODUCTIVE COUGH
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2012-03-28,2012-03-28,,,,,C,Y,600,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2012-01-10,2012-01-10,,,,,C,Y,1,mg,INTRAVENOUS,PRN,ANTINAUSEA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-10,2012-01-10,,,,,C,Y,4,mg,INTRAVENOUS,PRN,ANTINAUSEA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,LORAZEPAM,LORAZEPAM,2012-01-06,2012-01-06,,,,,C,Y,0.5,mg,ORAL,PRN,SLEEP
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,PRILOSEC OTC,OMEPRAZOLE,2012-01-07,2012-01-07,,,,,C,Y,20,mg,ORAL,QD,STOMACH PROTECTION
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-01-05,2012-01-05,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,15.0,CONCOMITANT MEDICATIONS,,,AREDIA,PAMIDRONATE DISODIUM,2012-01-06,2012-01-06,,,,,C,Y,90,mg,INTRAVENOUS,QM,HYPERCALCEMIA
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,16.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-01-06,2012-01-06,,,,,C,Y,8,mg,ORAL,PRN,NAUSEA PREVENTION
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,17.0,CONCOMITANT MEDICATIONS,,,PROCHLOROPERAZINE,PROCHLORPERAZINE,2012-01-17,2012-01-17,,2012-01-20,2012-01-20,,C,,10,mg,ORAL,PRN,ANTINAUSEA
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR/ CISPLATIN,,2012-01-09,2012-01-09,,2012-02-09,2012-02-09,,,,,,,,
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,2.0,CONCOMITANT MEDICATIONS,,,DIOVAN,VALSARTAN,2007,2007-12-31,M,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,3.0,CONCOMITANT MEDICATIONS,,,LEVOFLOXACIN,LEVOFLOXACIN,2011-11-21,2011-11-21,,2011-11-30,2011-11-30,,C,,500,mg,ORAL,QD,CHEST CONGESTION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,4.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-08,2011-11-08,,2011-12-20,2011-12-20,,C,,12,mg,INTRAVENOUS,day 1 of chemo,CHEMO PREMEDICATION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,5.0,CONCOMITANT MEDICATIONS,,,ALOXI,PALONOSETRON HYDROCHLORIDE,2011-11-08,2011-11-08,,2011-12-20,2011-12-20,,C,,0.25,mg,INTRAVENOUS,day 1 of chemo,CHEMO PREMEDICATION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,6.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2011-12-13,2011-12-13,,2011-12-13,2011-12-13,,C,,0.5,mg,INTRAVENOUS,ONCE,NAUSEA
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,7.0,CONCOMITANT MEDICATIONS,,,METOPROLOL TARTRATE,METOPROLOL TARTRATE,2009-10,2009-09-30,D,,,,C,Y,25,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,8.0,CONCOMITANT MEDICATIONS,,,KOMBIGLYZE,KOMBIGLYZE,2011-11-14,2011-11-14,,,,,C,Y,5/500,mg,ORAL,QD,TYPE II DIABETES
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,9.0,CONCOMITANT MEDICATIONS,,,TUMS,CALCIUM CARBONATE,2011-11-10,2011-11-10,,2011-11-15,2011-11-15,,C,,500,mg,ORAL,PRN,INDIGESTION
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,10.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2011-11-10,2011-11-10,,2011-11-15,2011-11-15,,C,,650,mg,ORAL,PRN,BACK PAIN
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,11.0,CONCOMITANT MEDICATIONS,,,CHERATUSSIN AC,CHERATUSSIN AC,2011-11-15,2011-11-15,,2011-11-22,2011-11-22,,C,,5,mL,ORAL,As directed,COUGH
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,12.0,CONCOMITANT MEDICATIONS,,,TYLENOL,PARACETAMOL,2011-11-18,2011-11-18,,2011-11-22,2011-11-22,,C,,650,mg,ORAL,PRN,FEVER
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,13.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-12-12,2011-12-12,,,,,C,Y,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,14.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2011-12-13,2011-12-13,,,,,C,Y,1,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,TOPROL XL,METOPROLOL SUCCINATE,2007-04-27,2007-04-27,,,,,C,Y,50,mg,ORAL,QD,HYPERTENSION
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,NEXIUM,ESOMEPRAZOLE,2012-01-12,2012-01-12,,,,,C,Y,40,mg,ORAL,QD,INDIGESTION
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,CIPROFLOXACIN,CIPROFLOXACIN,2011-12-12,2011-12-12,,2011-12-21,2011-12-21,,P,,500,mg,ORAL,BID,PROPHYLAXIS
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,ZENPEP,PANCRELIPASE,2011-12-12,2011-12-12,,,,,C,Y,10000,IU,ORAL,BID,PANCREATIC CANCER SUPPLEMENT
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,URSODIOL,URSODEOXYCHOLIC ACID,2011-12-12,2011-12-12,,,,,C,Y,300,mg,ORAL,BID,PANCREATIC CANCER SUPPLEMENT
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,12,mg,INTRAVENOUS,ONCE,PREMED
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,KYTRIL,GRANISETRON HYDROCHLORIDE,2012-01-17,2012-01-17,,2012-01-17,2012-01-17,,C,,1,mg,INTRAVENOUS,ONCE,PREMED
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,ALTOPREV,LOVASTATIN,2005-05-25,2005-05-25,,,,,C,Y,40,mg,ORAL,QD,HYPERCHOLESTEROLEMIA
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,GLUMETZA,METFORMIN HYDROCHLORIDE,2011-12-08,2011-12-08,,,,,C,Y,500,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,MEGACE ES,MEGESTROL ACETATE,2011-12-13,2011-12-13,,,,,C,Y,20,mL,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2012-01-17,2012-01-17,,,,,C,Y,10,mg,ORAL,PRN,MILD NAUSEA/VOMITING
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,ATIVAN,LORAZEPAM,2012-01-17,2012-01-17,,,,,C,Y,1,mg,ORAL,PRN,SEVERE NAUSE/VOMITING
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-01-18,2012-01-18,,2012-01-18,2012-01-18,,C,,8,mg,ORAL,TID,NAUSEA PROPHYLAXIS
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,VICODIN,VICODIN,2011-12-01,2011-12-01,,,,,C,Y,5/500,mg,ORAL,PRN,SHOULDER PAIN/GENERAL PAIN
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2012-01-17,2012-01-17,,2012-01-21,2012-01-21,,C,,20,mg,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,GEMZAR,,2012-09-04,2012-09-04,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,ANTI-CANCER,FOLLOW-UP PANCREATIC CANCER TREATMENT,CHEMOTHERAPY,CISPLATIN,,2012-09-04,2012-09-04,,,2012-12-31,Y,,,,,,,
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,AMLOPIDINE,AMLODIPINE,2005,2005-12-31,M,,,,C,Y,5,mg,ORAL,BID,HYPERTENSION
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,GAS-X,SIMETICONE,2012-02-21,2012-02-21,,,,,C,Y,unknown,,ORAL,PRN,ABDOMINAL GAS
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,POTASSIUM,POTASSIUM,2012-02-09,2012-02-09,,2012-02-20,2012-02-20,,P,,40,mEq,ORAL,QD,HYPOKALEMIA
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,METFORMIN,METFORMIN,2012-02-28,2012-02-28,,,,,C,Y,500,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,CREON,PANCREATIN,2012-02-21,2012-02-21,,,,,C,Y,1-3,TABLET,ORAL,with meals and snacks,SUPPLEMENT
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,ACTOS,PIOGLITAZONE HYDROCHLORIDE,2012-03-01,2012-03-01,,,,,C,Y,15,mg,ORAL,QD,DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,VANCOMYCIN,VANCOMYCIN,2012-05-05,2012-05-05,,2012-05-07,2012-05-07,,C,,1000,mg,INTRAVENOUS,Q12 hrs,CHOLANGITIS SECONDARY TO STENT INFECTION
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,CEFEPIME,CEFEPIME,2012-05-05,2012-05-05,,2012-05-07,2012-05-07,,C,,1000,mg,INTRAVENOUS,Q12 hrs,CHOLANGITIS SECONDARY TO STENT INFECTION
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,LEVAQUIN,LEVOFLOXACIN,2012-05-07,2012-05-07,,2012-05-07,2012-05-07,,C,,500,mg,INTRAVENOUS,q 24 hrs,CHOLANGITIS SECONDARY TO STENT INFECTION
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,FLAGYL,METRONIDAZOLE,2012-05-07,2012-05-07,,2012-05-08,2012-05-08,,C,,500,mg,INTRAVENOUS,Q8 hrs,CHOLANGITIS SECONDARY TO STENT INFECTION
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,IRON,IRON,2012-04-17,2012-04-17,,,,,C,Y,325,mg,ORAL,QD,ANEMIA
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,CENTRUM,MINERALS NOS W/VITAMINS NOS,2002,2002-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,SUPPLEMENT
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,HUMALOG,INSULIN LISPRO,2012-03-27,2012-03-27,,,,,C,Y,6,IU,INTRAMUSCULAR,"6 units day 1, then as directed",DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,16.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2012-02-17,2012-02-17,,,,,C,Y,20,IU,INTRAMUSCULAR,"20 units day 1, 2 3 of chemo",DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,17.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2012-02-17,2012-02-17,,,,,C,Y,18,IU,INTRAMUSCULAR,QD,DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,18.0,CONCOMITANT MEDICATIONS,,,LANTUS,INSULIN GLARGINE,2011-12-25,2011-12-25,,,,,C,Y,12,IU,SUBCUTANEOUS,PRN,DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,19.0,CONCOMITANT MEDICATIONS,,,LUTEIN-ZEAXANTHIN,LUTEIN ZEAXANTHIN,2007,2007-12-31,M,,,,C,Y,1,TABLET,ORAL,QD,RETINOPATHY
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,20.0,CONCOMITANT MEDICATIONS,,,GLYBURIDE,GLIBENCLAMIDE,1997,1997-12-31,M,2012-02-28,2012-02-28,,C,,10,mg,ORAL,BID,DIABETES
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,21.0,CONCOMITANT MEDICATIONS,,,PLAVIX,CLOPIDOGREL BISULFATE,2007,2007-12-31,M,,,,C,Y,75,mg,ORAL,QD,HYPERLIPIDEMIA
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,22.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2012-02-21,2012-02-21,,,,,C,Y,12,mg,ORAL,day of chemo,PREMED
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,23.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2012-02-21,2012-02-21,,,,,C,Y,8,mg,ORAL,"TID day of chemo, and 2 days after chemo",PREMED
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,24.0,CONCOMITANT MEDICATIONS,,,IMODIUM,LOPERAMIDE HYDROCHLORIDE,2012-02-16,2012-02-16,,,,,C,Y,2,mg,ORAL,PRN,DIARRHEA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,1.0,CONCOMITANT MEDICATIONS,,,KADIAN,MORPHINE SULFATE,2011-11-04,2011-11-04,,2012-01-19,2012-01-19,,C,,50,mg,ORAL,BID,BACK/ABD PAIN
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,2.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,C,,16,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,3.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-30,2011-11-30,,2011-11-30,2011-11-30,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,4.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,16,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,5.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-07,2011-12-07,,2011-12-07,2011-12-07,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,6.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-12-03,2011-12-03,,2011-12-04,2011-12-04,,C,,10,mg,ORAL,ONCE,NAUSEA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,7.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-12-09,2011-12-09,,2011-12-12,2011-12-12,,C,,10,mg,ORAL,x3,NAUSEA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,8.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-12-18,2011-12-18,,2012-03-11,2012-03-11,,C,,10,mg,ORAL,PRN,NAUSEA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,9.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,16,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,10.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-14,2011-12-14,,2011-12-14,2011-12-14,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,11.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-12-21,2011-12-21,,2012-02-22,2012-02-22,,C,,16,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,12.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2011-11-01,2011-11-01,,2012-01-11,2012-01-11,,C,,10-20,mg,ORAL,PRN,BACK/ABD PAIN
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,13.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-12-21,2011-12-21,,2012-02-22,2012-02-22,,C,,10,mg,INTRAVENOUS,ONCE,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,14.0,CONCOMITANT MEDICATIONS,,,MEGACE,MEGESTROL ACETATE,2012-01-18,2012-01-18,,,,,C,Y,400,mg,ORAL,QD,ANOREXIA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,15.0,CONCOMITANT MEDICATIONS,,,AMBIEN,ZOLPIDEM TARTRATE,2012-01-18,2012-01-18,,,,,C,Y,5,mg,ORAL,QHS,INSOMNIA
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,16.0,CONCOMITANT MEDICATIONS,,,KADIAN,MORPHINE SULFATE,2012-01-19,2012-01-19,,,,,C,Y,50,mg,ORAL,QD,BACK/ABD PAIN
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,17.0,CONCOMITANT MEDICATIONS,,,MIRALAX,MACROGOL,2012-01-19,2012-01-19,,,,,C,Y,17,g,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,18.0,CONCOMITANT MEDICATIONS,,,DULCOLAX,BISACODYL,2012-01-26,2012-01-26,,2012-01-26,2012-01-26,,C,,10,mg,ORAL,ONCE,CONSTIPATION
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,19.0,CONCOMITANT MEDICATIONS,,,BACITRACIN,BACITRACIN,2012-01-30,2012-01-30,,2012-02-15,2012-02-15,,C,,sm amt,IU,TOPICAL,BID,PREVENT INFECTION - HAND WOUND
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,20.0,CONCOMITANT MEDICATIONS,,,LOVENOX,ENOXAPARIN SODIUM,2012-03-08,2012-03-08,,,,,C,Y,70,mg,SUBCUTANEOUS,BID,BLOOD CLOTS
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,21.0,CONCOMITANT MEDICATIONS,,,OXYCODONE,OXYCODONE,2012-03-07,2012-03-07,,,,,C,Y,10-20,mg,ORAL,PRN,BACK/ABD BT PAIN
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,22.0,CONCOMITANT MEDICATIONS,,,DOCUSATE SODIUM,DOCUSATE SODIUM,2011-11-04,2011-11-04,,2012-01-19,2012-01-19,,C,,250,mg,ORAL,QD,CONSTIPATION
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,23.0,CONCOMITANT MEDICATIONS,,,SENNA-S,COLOXYL WITH SENNA,2011-11-04,2011-11-04,,2012-01-19,2012-01-19,,C,,8.6,mg,ORAL,PRN,CONSTIPATION
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,24.0,CONCOMITANT MEDICATIONS,,,GINGKO BILOBA,GINKGO BILOBA,2011-08,2011-07-31,D,,,,C,Y,120,mg,ORAL,QD,GENERAL HEALTH
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,25.0,CONCOMITANT MEDICATIONS,,,ONCOTERE,ALL OTHER THERAPEUTIC PRODUCTS,2011-08,2011-07-31,D,,,,C,Y,500,mg,ORAL,BID,GENERAL HEALTH
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,26.0,CONCOMITANT MEDICATIONS,,,DECADRON,DEXAMETHASONE,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,10,mg,INTRAVENOUS,QD,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,27.0,CONCOMITANT MEDICATIONS,,,ZOFRAN,ONDANSETRON,2011-11-23,2011-11-23,,2011-11-23,2011-11-23,,C,,16,mg,INTRAVENOUS,QD,NAUSEA/VOMITING
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,28.0,CONCOMITANT MEDICATIONS,,,COMPAZINE,PROCHLORPERAZINE,2011-11-24,2011-11-24,,2011-11-24,2011-11-24,,C,,10,mg,ORAL,ONCE,NAUSEA/VOMITING
